Relation Extraction Examples (3845)

check_circle_outline   F1 = 100.000
check_circle_outline   F1 >= 50.00
highlight_off   F1 < 50.00
  True Positive  
  False Positive  
  False Negative

Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugIsotretinoin Adverse-Effectteratogenicity .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugNiacin Adverse-Effectmaculopathy .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugAllopurinol Adverse-Effecthypersensitivity .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugTamoxifen Adverse-Effectretinopathy .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugMetronidazole Adverse-Effectneuropathy .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugCyclophosphamide Adverse-Effectpneumonitis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugGold Adverse-Effectnephropathy .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectOcular ethambutol toxicity Drugethambutol toxicity.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugClozapine induced Adverse-Effectpolyserositis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugSulfadiazine Adverse-Effectcrystalluria revisited.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Adverse-EffectPulmonary gold toxicity Druggold toxicity.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectAnaphylaxis to Drugcalcitonin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectDermatitis to Drugcaptopril .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Severe Drugdapsone Adverse-Effecthypersensitivity syndrome .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectAnisocoria from transdermal Drugscopolamine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectPriapism associated with Drugolanzapine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectAnaphylaxis to intrathecal Drugdiamorphine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugDiclofenac - associated Adverse-Effecthepatitis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugCarbamazepine - induced Adverse-Effecthyperammonemia .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect DrugImidazoline Adverse-EffectImidazoline intoxication in children.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugGold - induced Adverse-Effectpneumonitis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugCarbamazepine - induced Adverse-Effecttics .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectPriapism associated with Drugzuclopenthixol .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectDelayed hypersensitivity to Drugflurbiprofen .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectMorphea after Drugbromocriptine therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugAmpicillin - associated Adverse-Effectseizures .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugAtenolol - induced Adverse-Effectpseudolymphoma .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugLosartan - induced Adverse-Effectangioedema .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugDisulfiram - induced Adverse-Effecthepatitis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugMetoclopramide - induced Adverse-Effectparkinsonism .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugPhenylpropanolamine - induced Adverse-Effectpsychosis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugClofazimine induced Adverse-Effectnail changes .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugCiprofloxacin - induced Adverse-Effectpsychosis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectJaundice induced by Drugstreptokinase .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectAgranulocytosis during Drugclozapine therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugHeparin - induced Adverse-Effecthyperkalemia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectStupor from Druglamotrigine toxicity.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugCimetidine - induced Adverse-Effectfever .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugVancomycin - induced Adverse-Effectvasculitis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectGigantomastia induced by Drugbucillamine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugIsoniazid - induced Adverse-Effectanaphylaxis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugVincristine induced Adverse-Effectcranial polyneuropathy .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugBromocriptine - induced Adverse-Effectschizophrenia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectHepatic reactions to Drugcyclofenil .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugQuetiapine - induced Adverse-Effectmyoclonus .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugEnalaprilat induced Adverse-Effectacute parotitis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugTemsirolimus - induced Adverse-Effectglomerulopathy .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectRhabdomyolysis following Drugclarithromycin monotherapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugTaxane - induced Adverse-Effectglaucoma .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugFurosemide - associated Adverse-Effectfever .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugThalidomide Adverse-Effectneuropathy in childhood.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectHepatitis following Drugcimetidine administration.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugLansoprazole - induced Adverse-Effectthrombocytopenia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugColchicine - induced Adverse-Effectrhabdomyolysis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectKeratitis in Drugmethamphetamine abusers.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectLocalized purpura associated with Druglamotrigine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugCiprofloxacin - induced Adverse-Effecthemorrhagic vasculitis .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect DrugCodeine Adverse-EffectCodeine intoxication in the neonate.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectRosaceiform eruption induced by Drugerlotinib .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugMethyldopa - induced Adverse-Effectliver injury .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugAcetazolamide - accelerated anticonvulsant Adverse-Effectosteomalacia .
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect DrugCephalexin Adverse-EffectCephalexin rash in infectious mononucleosis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectScleritis complicating Drugzoledronic acid infusion.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectSeizures associated with Drugfluoxetine therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectPulmonary fibrosis associated with Drugnabumetone .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectMetabolic acidosis induced by Drugacetazolamide .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Probable Drugenoxaparin - induced Adverse-Effecthepatotoxicity .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectPulmonary toxicity associated with Drugerlotinib .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectFixed drug eruption to Drugrofecoxib .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugEnoxaparin - induced Adverse-Effectgeneralized exanthem .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Biomicroscopy revealed Drugamiodarone Adverse-Effectcorneal deposits .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugAlbendazole - induced Adverse-Effectpseudomembranous colitis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectCatatonia associated with Drugdisulfiram therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugPropylthiouracil - induced Adverse-Effectcutaneous vasculitis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectNodular scleritis following Drugalendronate therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectAcute dystonia induced by Druglamivudine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Occult Drugquinine - induced Adverse-Effectthrombocytopenia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugProtamine - induced Adverse-Effectfatal anaphylaxis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugChlorpropamide - induced Adverse-Effecthemolytic anemia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectParaplegia following intrathecal Drugcytosine arabinoside .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectSarcoma complicating therapy with Drugcyclophosphamide .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugQuinine - induced Adverse-Effecthearing loss .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugGold - induced Adverse-Effectaplastic anemia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectTardive dyskinesia induced by Drugsulpiride .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Intravenous Drugdiazepam exacerbated the Adverse-Effectseizures .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugEzetimibe - induced Adverse-Effectacute pancreatitis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugCefuroxime - induced Adverse-Effectimmune hemolysis .
Score Relation Text (Head - Tail)
0.9995 Adverse-Effect Adverse-EffectLamotrigine toxicity secondary to Drugsertraline .
0.9992 Adverse-Effect DrugLamotrigine Adverse-EffectLamotrigine toxicity secondary to sertraline.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugAzathioprine can cause severe Adverse-Effectmyelosuppression .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectAcute leukaemia during Drugtamoxifen therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectVortex keratopathy associated with Drugatovaquone .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Paradoxical Adverse-Effectseizures in Drugphenytoin toxicity.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectHepatic damage after Drugdanazol treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugInsulin - induced Adverse-Effectcardiac failure .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectNail staining from Drughydroquinone cream.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectDelusional parasitosis associated with Drugphenelzine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugPiritrexim - induced Adverse-Effectpulmonary toxicity .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugPropecia - associated Adverse-Effectbilateral cataract .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugTerlipressin - induced Adverse-Effectventricular arrhythmia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectAsterixis induced by Drugcarbamazepine therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectCardiorespiratory toxicity due to Drugmiconazole .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugNabumetone - associated Adverse-Effectinterstitial nephritis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugHuman insulin - induced Adverse-Effectlipoatrophy .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugSulfasalazine - induced Adverse-Effectlupus erythematosus .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectLichenoid drug eruption to Drugsalsalate .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Uncontrolled Adverse-Effectheadache induced by Drugoxcarbazepine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Intravenous Drugazithromycin - induced Adverse-Effectototoxicity .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectFulminant hepatitis associated with Drugdisulfiram .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectPulmonary toxicity secondary to Drugprocarbazine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugMesalamine - induced Adverse-Effecthypersensitivity pneumonitis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectPsychotic disorder associated with Drugisoniazid .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect DrugMagnesium Adverse-EffectMagnesium toxicosis in two horses.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectSeizures associated with Drugofloxacin therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectPemphigus foliaceus induced by Drugrifampicin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectAnaphylactic reaction to Drugbacitracin ointment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugRifampicin - induced Adverse-Effectrenal failure .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Intranasal Drugdesmopressin - induced Adverse-Effecthyponatremia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugChloroquine - induced Adverse-Effectbilateral ptosis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugDisopyramide - induced Adverse-Effectheart block .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugCarbamazepine - induced Adverse-EffectDiabetes mellitus .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugEtoposide - related Adverse-Effectmyocardial infarction .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectMyoclonic spasms following intrathecal Drugmorphine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugMethotrexate - induced Adverse-Effectliver cirrhosis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugCefoxitin - associated Adverse-Effectrenal failure .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectAcute psychosis associated with Druglevetiracetam .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectMetastatic osteomyelitis following DrugBCG vaccination.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectAtrial fibrillation after Drugvardenafil therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectVisual hallucinations associated with Drugzonisamide .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugGliclazide - induced Adverse-Effectacute hepatitis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugRisperidone - induced Adverse-Effecttardive dyskinesia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectAllergic contact dermatitis from Drug4 - chloro - 7 - nitrobenzofurazan .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugNitrendipine - induced Adverse-Effectgingival hyperplasia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugAdenosine - induced Adverse-Effectventricular fibrillation .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectEdema associated with Drugibuprofen therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugTegaserod - associated Adverse-Effectischemic colitis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectProgressive hypokalemia developed during Drugphosphate treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectProgressive pulmonary fibrosis complicating Drugcyclophosphamide therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectCardiopulmonary arrest following intravenous Drugphenytoin loading.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugQuetiapine - induced Adverse-Effectleucopenia and thrombocytopenia.
0.9999 Adverse-Effect DrugQuetiapine - induced leucopenia and Adverse-Effectthrombocytopenia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A Adverse-Effectparadoxical ocular effect of Drugbrimonidine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Severe Drugvancomycin - induced Adverse-Effectanaphylactic reaction .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectFulminant hepatic failure associated with Drugbicalutamide .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectTuberculous uveitis after treatment with Drugetanercept .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectCardiac arrest following use of Drugsumatriptan .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Early Drugritonavir - induced Adverse-Effectmaculopapular eruption .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugCarbamazepine - induced Adverse-Effectsystemic lupus erythematosus .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugSalicylate - induced Adverse-Effecthepatotoxicity is reviewed.
Score Relation Text (Head - Tail)
0.9997 Adverse-Effect An unusual case of DrugEcstasy Adverse-EffectEcstasy poisoning .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectOculomotor disturbances associated with Drug5 - fluorouracil chemotherapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Does Drugacyclovir Adverse-Effectincrease serum lithium levels ?
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Exacerbation of Adverse-Effectschizophrenia associated with Drugamantadine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Diagnosis : Drugpractolol induced Adverse-Effectsclerosing peritonitis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectErythema multiforme bullosum due to Drugrifampicin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Suspected Drugciprofloxacin - induced Adverse-Effectinterstitial nephritis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Widespread Adverse-Effectcutaneous vasculitis associated with Drugdiltiazem .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectAcute interstitial nephritis due to Drugpantoprazole .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectAllergic contact angioedema to Drugbenzoyl peroxide .
Score Relation Text (Head - Tail)
0.9985 Adverse-Effect DrugDapsone Adverse-EffectDapsone syndrome in cutaneous lupus erythematosus.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectNonconvulsive status epilepticus due to Drugifosfamide .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectPersisent ocular hypertension following intravitreal Drugranibizumab .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectTrichiasis associated with Drugprostaglandin analog use.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectPersistent light reactivity from systemic Drugquinine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectInterstitial granulomatous dermatitis associated with Drugdarifenacin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugIfosfamide - induced Adverse-Effectnonconvulsive status epilepticus .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectNephrotic syndrome associated with Druglithium therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Aminophylline Adverse-Effecthypersensitivity apparently due to Drugethylenediamine .
0.9999 Adverse-Effect DrugAminophylline Adverse-Effecthypersensitivity apparently due to ethylenediamine.
Adverse-Effect DrugAminophylline Adverse-EffectAminophylline hypersensitivity apparently due to ethylenediamine.
Adverse-Effect Adverse-EffectAminophylline hypersensitivity apparently due to Drugethylenediamine .
Score Relation Text (Head - Tail)
0.9996 Adverse-Effect The 3 - week Drugsulphasalazine Adverse-Effectsulphasalazine syndrome strikes again.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugDoxycycline - induced Adverse-Effectphoto - onycholysis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugBleomycin Adverse-Effectpneumonitis potentiated by oxygen administration.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Acute Drugvalproate ingestion induces Adverse-Effectsymptomatic methemoglobinemia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugMethotrexate induced Adverse-Effectsprue - like syndrome .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectPolymyositis after Drugpropylthiouracil treatment for hyperthyroidism.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectAtrial fibrillation following Drugmethylprednisolone pulse therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectOesophageal ulceration due to Drugemepronium bromide .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugTroglitazone - induced Adverse-Effectfulminant hepatic failure .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectToxic epidermal necrolysis associated with Druginterleukin - 2 .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugCaptopril - associated " Adverse-Effectpseudocholangitis '.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectFulminant liver failure associated with Drugclarithromycin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugCefuroxime - induced Adverse-Effectacute renal failure .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectNail - changes induced by Drugpenicillamine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectPsoriasis induced by Druginterferon - alpha .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugGentamicin - associated Adverse-Effectacute renal failure .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectRadiation recall pneumonitis induced by Druggemcitabine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Can Drugmagnesium sulfate therapy impact Adverse-Effectlactogenesis ?
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugSalicylate Adverse-Effecthepato toxicity in rheumatic fever.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectPemphigus vulgaris precipitated by Drugglibenclamide therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugFlurbiprofen - associated Adverse-Effectacute tubulointerstitial nephritis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Fluorouracil for Adverse-Effectallergic reactions to Drugcapecitabine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Chronic Drugfentanyl application induces Adverse-Effectadrenocortical insufficiency .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Agranulocytosis and Adverse-Effectgranulocytopenia associated with Drugquetiapine .
0.9999 Adverse-Effect Adverse-EffectAgranulocytosis and granulocytopenia associated with Drugquetiapine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Treatment of Druglithium Adverse-Effecttremor with metoprolol.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugBarbiturate - induced Adverse-Effectsubmassive hepatic necrosis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectUlcerating enteritis associated with Drugflucytosine therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectExfoliative dermatitis secondary to Drugtobramycin sulfate .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Protease inhibitor - induced Drugcarbamazepine Adverse-Effectcarbamazepine toxicity .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectSevere hepatitis caused by Drugcyproterone acetate .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugGabapentin withdrawal presenting as Adverse-Effectstatus epilepticus .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugSuxamethonium Adverse-Effectapnoea terminated with commercial serumcholinesterase.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectTransient hemiparesis caused by Drugphenytoin toxicity.
Score Relation Text (Head - Tail)
Adverse-Effect Systemic corticosteroids in the Drugphenytoin Adverse-Effectphenytoin hypersensitivity syndrome .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectNeurotoxicity of intrathecal administration of Drugamphotericin B .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectSustained monomorphic ventricular tachycardia after Drugadenosine infusion.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectSevere hepatocellular dysfunction following Drugcyproterone acetate therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugBleomycin induced Adverse-Effecthyperpigmentation with yolk sac tumor.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Atypical Adverse-Effectneuroleptic malignant syndrome associated with Drugolanzapine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectFocal renal cortical necrosis associated with Drugzomepirac .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugCapecitabine - induced Adverse-Effectheadache responding to diltiazem.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectAcute coronary syndrome induced by Drugcapecitabine therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Acute Drugisoniazid Adverse-Effectneurotoxicity in an urban hospital.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectInappropriate antidiuretic hormone following Drugadenine arabinoside administration.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Skin rash and Adverse-Effectsplinter hemorrhages from Drugganciclovir .
0.9998 Adverse-Effect Adverse-EffectSkin rash and splinter hemorrhages from Drugganciclovir .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectPriapism as a complication of Drugheparin therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectThrombocytosis under Drugciprofloxacin and tazobactam / piperacillin.
0.9999 Adverse-Effect Adverse-EffectThrombocytosis under ciprofloxacin and Drugtazobactam / piperacillin.
0.9999 Adverse-Effect Adverse-EffectThrombocytosis under ciprofloxacin and tazobactam / Drugpiperacillin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectNonoliguric acute renal failure after Drugcaptopril therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugCaptopril - induced Adverse-Effectacute reversible renal failure .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectGastro - oesophageal reflux associated with Drugnifedipine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugIsoniazid associated, painful, Adverse-Effectbilateral gynaecomastia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectPiloerection induced by replacing Drugfluvoxamine with milnacipran.
0.9999 Adverse-Effect Adverse-EffectPiloerection induced by replacing fluvoxamine with Drugmilnacipran .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Allergic and Adverse-Effectirritant contact dermatitis to Drugcalcipotriol .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Case studies in Drugheparin - induced Adverse-Effectthrombocytopenia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The Adverse-Effectbleeding resolved on discontinuation of DrugAPV .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DIAGNOSIS : DrugInterferon alpha - 2b - induced Adverse-Effectcardiomyopathy .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Case study : Adverse-Effectadverse response to Drugclonidine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectSyncope induced by Drugpropranolol in hypertrophic cardiomyopathy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Prolonged Adverse-Effectsevere cholestasis induced by Drugoxacillin derivatives.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugLithium - induced Adverse-EffectCreutzfeldt - Jakob syndrome .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectEctropion secondary to bolus injection of Drug5 - fluorouracil .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugCarbamazepine - related Adverse-Effecthyponatremia following cardiopulmonary bypass.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Clinical and morphological features of Druggold Adverse-Effectneuropathy .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectSporadic rippling muscle disease unmasked by Drugsimvastatin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectRefractory hypoglycemia from Drugciprofloxacin and glyburide interaction.
0.9999 Adverse-Effect Adverse-EffectRefractory hypoglycemia from ciprofloxacin and Drugglyburide interaction.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Two patients had Drugampicillin - associated Adverse-Effectseizures .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectAngioimmunoblastic lymphadenopathy with dysproteinemia following Drugdoxycycline administration.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugMethadone - induced Adverse-Effectmyoclonus in advanced cancer.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectParadoxical cerebral cortical hyperexcitability following Drugflupirtine overdose.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectTorsade de pointes during loading with Drugamiodarone .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Severe Adverse-Effectabdominal pain in low dosage Drugclofazimine .
1.0000 Adverse-Effect Adverse-EffectSevere abdominal pain in low dosage Drugclofazimine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectIschaemic colitis in a patient taking Drugmeloxicam .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Probable Drugpropafenone - induced Adverse-Effecttransient global amnesia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectAcute myocardial necrosis during administration of Drugamsacrine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectGeneralized argyria after habitual use of DrugAgNO3 .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Adverse-EffectCorneal endothelial dysfunction associated with Drugamantadine toxicity.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Reversible Adverse-Effectnonthrombocytopenic palpable purpura associated with Drugmetoclopramide .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Methylphenidate and Drugdextroamphetamine - induced Adverse-Effectperipheral vasculopathy .
0.9998 Adverse-Effect DrugMethylphenidate and dextroamphetamine - induced Adverse-Effectperipheral vasculopathy .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectPure red cell aplasia associated with Drugfenoprofen .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectCicatricial entropion associated with chronic Drugdipivefrin application.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugLeflunomide - associated Adverse-Effectinfections in rheumatoid arthritis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A possible case of Drugcarbamazepine induced Adverse-Effectpancreatitis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Lichen planus and Adverse-Effectacne provoked by Druggold .
0.9999 Adverse-Effect Adverse-EffectLichen planus and acne provoked by Druggold .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectCutaneous mycobacterial infection post intravesical DrugBCG installation.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect An Drugamiodarone Adverse-Effectoptic neuropathy has been described.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Regression of Adverse-Effectthyrotoxic ophthalmopathy following Druglithium withdrawal.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectAcute leukopenia associated with Drugsilver sulfadiazine therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugTrimethoprim - sulfamethoxazole - induced Adverse-Effectaseptic meningitis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Unique Adverse-Effectbehavioral change with Drugcinepazide in parkinsonism.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugIsoniazid induced Adverse-Effectgynaecomastia : a case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Rapidly developing Adverse-Effecthyperglycemia during treatment with Drugolanzapine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The disease predisposes to severe Drugvincristine Adverse-Effectneurotoxicity .
Adverse-Effect The disease predisposes to severe Drugvincristine Adverse-Effectvincristine neurotoxicity .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Intrahepatic cholestasis and Adverse-Effectsicca complex after Drugthiabendazole .
0.9999 Adverse-Effect Adverse-EffectIntrahepatic cholestasis and sicca complex after Drugthiabendazole .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugNaproxen - associated Adverse-Effectsudden sensorineural hearing loss .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Neonatal Adverse-Effectmydriasis : intravenous Druglidocaine adverse reaction.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectLinear IgA bullous dermatosis occurring after Drugcarbamazepine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectBilateral anterior uveitis associated with Drugclomiphene citrate .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect DrugEthambutol toxicity manifesting as Adverse-Effectacute onset psychosis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A Adverse-Effectdrug interaction between Drugzafirlukast and theophylline.
0.9998 Adverse-Effect A Adverse-Effectdrug interaction between zafirlukast and Drugtheophylline .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectRecurrent hyponatremia associated with Drugcitalopram and mirtazapine.
0.9999 Adverse-Effect Adverse-EffectRecurrent hyponatremia associated with citalopram and Drugmirtazapine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectSeizures associated with Drugfluoxetine therapy are uncommon.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectSpontaneous splenic infarction associated with Drugsumatriptan use.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugNicotinic acid - induced Adverse-Effectfulminant hepatic failure .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugTriazolam - induced Adverse-Effectnocturnal bingeing with amnesia.
1.0000 Adverse-Effect DrugTriazolam - induced nocturnal bingeing with Adverse-Effectamnesia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Asthma and Adverse-Effecturticaria during Drugdisodium cromoglycate treatment.
0.9997 Adverse-Effect Adverse-EffectAsthma and urticaria during Drugdisodium cromoglycate treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectCerebral and ocular toxicity induced by Drugdesferrioxamine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Acute drug induced Adverse-Effecthepatitis due to Drugerlotinib .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectPanic anxiety after abrupt discontinuation of Drugmianserin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect One patient on Drugouabain also developed Adverse-Effectcardiomyopathy .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugSotalol - induced Adverse-Effectbradycardia reversed by glucagon.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect DrugPilocarpine Adverse-EffectPilocarpine toxicity and the treatment of xerostomia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Probable early Adverse-Effectacute hepatitis with parenteral Drugamiodarone .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectAcute respiratory distress syndrome after Drugrituximab infusion.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectBromide intoxication secondary to Drugpyridostigmine bromide therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectAcute generalized exanthematous pustulosis induced by Drugnimesulide .
Score Relation Text (Head - Tail)
0.9997 Adverse-Effect DrugPhenytoin Adverse-EffectPhenytoin toxicity due to concomitant antituberculosis therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Unusual Adverse-Effectpigmentary changes associated with Drug5 - fluorouracil therapy.
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect Adverse-EffectJuvenile absence epilepsy exacerbated by Drugvalproic acid .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectInterstitial pneumopathy and low - dosage Drugamiodarone .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugLevofloxacin - induced Adverse-Effectdelirium with psychotic features .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectMultifocal inflammatory leukoencephalopathy associated with Druglevamisole therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugProthipendylhydrochloride - induced Adverse-Effectpriapism : case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugPravastatin is associated with Adverse-Effectmyotonia in animals.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectHemodynamic collapse following Druglabetalol administration in preeclampsia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Severe Adverse-Effectserotonin syndrome induced by Drugmirtazapine monotherapy.
1.0000 Adverse-Effect Adverse-EffectSevere serotonin syndrome induced by Drugmirtazapine monotherapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugGemcitabine - induced Adverse-Effectrectus abdominus radiation recall .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Life - threatening Adverse-Effecthyponatremia caused by Drugvinblastine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Long lasting Adverse-Effectrespiratory depression induced by Drugmorphine - 6 - glucuronide ?
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectGlaucoma secondary to epithelial downgrowth and Drug5 - fluorouracil .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Drug - induced Adverse-Effectfever due to Drugdiltiazem .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case of Adverse-Effectmania associated with Drugfluoxetine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugColchicine - induced Adverse-Effectmyopathy in renal failure.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Life - threatening Adverse-Effecthyperkalemia induced by Drugarginine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectDepressive symptoms disappeared after Druginterferon therapy was stopped.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectEruptive epidermoid cysts resulting from treatment with Drugimiquimod .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectDeepening of lid sulcus from topical Drugbimatoprost therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We diagnosed this case as Drugdanazol induced Adverse-Effectthrombocytopenia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugAliskiren - associated Adverse-Effectacute renal failure with hyperkalemia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugCiprofloxacin - induced Adverse-Effectrenal insufficiency in cystic fibrosis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Fixed drug Adverse-Effecteruption in hands caused by Drugomeprazole .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectReversible cardiomyopathy caused by administration of Druginterferon alpha .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugAlprazolam - induced Adverse-Effectmania : two clinical cases.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Adverse-EffectFulminant hepatitis and lymphocyte sensitization due to Drugpropylthiouracil .
1.0000 Adverse-Effect Fulminant hepatitis and Adverse-Effectlymphocyte sensitization due to Drugpropylthiouracil .
Score Relation Text (Head - Tail)
0.9989 Adverse-Effect Adverse-EffectTheophylline intoxication following Drugviloxazine induced decrease in clearance.
0.9959 Adverse-Effect DrugTheophylline Adverse-EffectTheophylline intoxication following viloxazine induced decrease in clearance.
Adverse-Effect Theophylline intoxication following Drugviloxazine induced Adverse-Effectdecrease in clearance .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugMycophenolate mofetil - induced Adverse-Effectneutropenia in liver transplantation.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectAllergic contact dermatitis to compound tincture of Drugbenzoin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Pulmonary infiltrates and Adverse-Effectskin pigmentation associated with Drugsulfasalazine .
1.0000 Adverse-Effect Adverse-EffectPulmonary infiltrates and skin pigmentation associated with Drugsulfasalazine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectSpindle coma in Drugbenzodiazepine toxicity : case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugTiclopidine - induced Adverse-Effectmarrow aplasia treated with cyclosporine.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectPriapism associated with Drugtrazodone therapy : case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect MR findings in Drugmethotrexate - induced Adverse-EffectCNS abnormalities .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Reversible findings of restricted diffusion in Drug5 - fluorouracil Adverse-Effectneurotoxicity .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect RESULTS : DrugBudesonide use can cause Adverse-Effectcontact dermatitis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectRestless legs syndrome due to Druginterferon - alpha .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A Adverse-Effectlethal complication of peripheral vein Drugvasopressin infusion.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Allergic reaction to Druggemfibrozil manifesting as Adverse-Effecteosinophilic gastroenteritis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectProgressive interstitial lung disease from prolonged Drugmethotrexate therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Angioedema and Adverse-Effectmaculopapular eruptions associated with Drugcarbamazepine administration.
0.9999 Adverse-Effect Adverse-EffectAngioedema and maculopapular eruptions associated with Drugcarbamazepine administration.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectFatal toxic epidermal necrolysis related to Druglamotrigine administration.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugNitrofurantoin - induced Adverse-Effectacute liver damage in pregnancy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugCyclophosphamide can rarely cause Adverse-Effectinterstitial pneumonitis and fibrosis.
1.0000 Adverse-Effect DrugCyclophosphamide can rarely cause interstitial pneumonitis and Adverse-Effectfibrosis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectAcute bilateral phrenic neuropathy following treatment with Drugadalimumab .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugAmpicillin may aggravate clinical and experimental Adverse-Effectmyasthenia gravis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The Adverse-Effectincreased libido disappeared after Drugfluvoxamine was discontinued.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugAmiodarone was discontinued, and Adverse-Effectthyrotoxicosis gradually abated.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectVisceral herpesvirus infections in leukemic patients receiving Drugcytarabine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectBowel perforation associated with intraperitoneal Drugchromic phosphate instillation.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugCo - trimoxazole Adverse-Effectred cell aplasia in leukaemia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Recurrent hypotension immediately after Adverse-Effectseizures in Drugnortriptyline overdose.
0.9999 Adverse-Effect Adverse-EffectRecurrent hypotension immediately after seizures in Drugnortriptyline overdose.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectNephropathy caused by Drugmethicillin therapy for staphylococcal septicemia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugDapsone - induced Adverse-Effecterythroderma with Beau's lines.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectEsophageal spasm following Drugpropranolol overdose relieved by glucagon.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugMetformin - associated Adverse-Effectlactic acidosis precipitated by diarrhea.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugAmoxapine - induced Adverse-Effectcognitive impairment in two patients.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect First case of Drugivermectin - induced Adverse-Effectsevere hepatitis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectAcute sensorineural hearing loss following intravenous Drugketoralac administration.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectLeishmania infantum leishmaniasis in Drugcorticosteroid - - treated patients.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectMethemoglobinemia : an occupational hazard of Drugphenylpropanolamine production.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugPentazocine - induced Adverse-Effectfibrous myopathy and localized neuropathy.
0.9997 Adverse-Effect DrugPentazocine - induced fibrous myopathy and localized Adverse-Effectneuropathy .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectAnaphylactoid reaction to 50 % solution of Drugdextrose .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugLeflunomide - associated Adverse-Effectweight loss in rheumatoid arthritis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectAnterior ischemic optic neuropathy secondary to Druginterferon alfa .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugPhenobarbital Adverse-Effecthepatotoxicity in an 8 - month - old infant.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We conclude Adverse-Effectperipheral neuropathy with Drug5 - FU is rare.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect PET scintigraphy of Drugetoposide - induced Adverse-Effectpulmonary toxicity .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect He had Adverse-Effectpriapism following the use of Drugolanzapine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectAnaphylaxis to Drugcisplatin following nine previous uncomplicated cycles.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect BACKGROUND : Adverse-EffectHypersensitivity reactions to Drugcyclosporine are rare.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectPulmonary oedema after Drughexoprenaline administration in preterm labour.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect After abstinence from Drugoolong tea his Adverse-Effectdelirium resolved.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugQuinine induced Adverse-Effectcoagulopathy - - a near fatal experience.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The Adverse-Effectpulmonary toxicity is probably induced by Drugpiritrexim .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect MR findings in Drugmethotrexate - induced Adverse-EffectCNS abnormalities .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectOsteomyelitis occurring during Druginfliximab treatment of severe psoriasis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect She was thus diagnosed as having DrugAZ Adverse-EffectAZ intoxication .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectRenal failure associated with the use of Drugdextran - 40 .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugAripiprazole - induced Adverse-Effecthiccups : a case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectRhabdomyolysis associated with the use of intravenous Drugvasopressin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Other Adverse-Effectupper tract neoplasms after Drugcyclophosphamide are reviewed.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugBisphosphonate - related Adverse-Effectosteonecrosis of the skull base .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectAcute asthma associated with sustained - release Drugverapamil .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectErosion of psoriatic plaques after chronic Drugmethotrexate administration.
Score Relation Text (Head - Tail)
Adverse-Effect We suspect that nefazodone Adverse-Effectinhibits metabolism of tacrolimus Drugtacrolimus .
Adverse-Effect We suspect that Drugnefazodone Adverse-Effectinhibits metabolism of tacrolimus .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectHyponatraemia developed after rechallenge with controlled release Drugcarbamazepine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugTriiodothyronine - induced Adverse-Effectthyrotoxicosis in ophthalmic Graves disease.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugInsulin - induced Adverse-Effectlipoatrophy in type I diabetes.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectOptic neuropathy in Drugethambutol - treated renal tuberculosis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Localized dyskeratotic plaque with Adverse-Effectmilia associated with Drugsorafenib .
0.9999 Adverse-Effect Adverse-EffectLocalized dyskeratotic plaque with milia associated with Drugsorafenib .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Adverse-EffectChoroidal hemorrhage associated with systemic Drugtissue plasminogen activator .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectSevere acute encephalopathy following inadvertent intrathecal Drugdoxorubicin administration.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectPulmonary lymphohistiocytic reactions temporally related to Drugetanercept therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case of Adverse-EffectSIADH induced by Drugmizoribin administration.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectPhoto - onycholysis caused by Drugolanzapine and aripiprazole.
0.9999 Adverse-Effect Adverse-EffectPhoto - onycholysis caused by olanzapine and Drugaripiprazole .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A woman developed Adverse-Effectdelusional parasitosis when taking Drugphenelzine .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Adverse-EffectEosinophilic cystitis after bladder instillation with Drugdimethyl sulfoxide .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectTransient asymptomatic bradycardia in patients on infusional Drug5 - fluorouracil .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Easily reversible hypoxemia and Adverse-Effecthypotension induced by Drugnimodipine .
0.9999 Adverse-Effect Easily reversible Adverse-Effecthypoxemia and hypotension induced by Drugnimodipine .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect DrugGelofusine Adverse-EffectGelofusine allergy - - the need for identification jewellery.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectDisseminated salmonellosis in a patient treated with Drugtemozolomide .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugEpoprostenol may be associated rarely with severe Adverse-Effecterythroderma .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectChromosome abnormalities after Drugchlorambucil therapy of polycythaemia vera.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectAcute acoustic nerve palsy associated with Drugvincristine therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Case report of withdrawal Adverse-Effectdyskinesia associated with Drugamoxapine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectInsulin - dependent diabetes mellitus associated with Drugdanazol .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectAcute dystonic reaction with low - dose Drugpimozide .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectFalling backward in two elderly patients taking Drugbupropion .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Reversible Drugsirolimus - associated Adverse-Effectpneumonitis after heart transplantation.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugRifampin - associated Adverse-Effectthrombocytopenia secondary to poor compliance.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectInappropriate antidiuretic hormone secretion after high dose Drugvinblastine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugClozapine - induced Adverse-Effectakathisia in children with schizophrenia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A Adverse-Effectfatal case of pancytopenia due to Druglevomepromazine .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Near fatal acute Drugcolchicine Adverse-Effectcolchicine intoxication in a child.
0.9999 Adverse-Effect Adverse-EffectNear fatal acute Drugcolchicine intoxication in a child.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugAtenolol induced Adverse-Effectmemory impairment : a case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect After discontinuation of Drugdanazol the Adverse-Effectdiabetes completely resolved.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugMethotrexate Adverse-Effectpneumonitis in nonsurgical treatment of ectopic pregnancy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectTardive dyskinesia in 2 patients treated with Drugziprasidone .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Encephalopathy and Adverse-Effectseizures induced by intravesical Drugalum irrigations.
0.9999 Adverse-Effect Adverse-EffectEncephalopathy and seizures induced by intravesical Drugalum irrigations.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Life - threatening Adverse-Effectcranial dystonia following Drugtrihexyphenidyl withdrawal.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectFlaccid quadriparesis was noted after discontinuation of Drugvecuronium .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect DrugTheophylline Adverse-EffectTheophylline intoxication mimicking diabetic ketoacidosis in a child.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Intraventricular Drugnafcillin - induced Adverse-Effectseizures in a neonate.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectLinear immunoglobulin A bullous dermatosis induced by Druggemcitabine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectRenal failure associated with Drugacetazolamide therapy for glaucoma.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectGangrene of the fingertips after Drugbleomycin and methotrexate.
1.0000 Adverse-Effect Adverse-EffectGangrene of the fingertips after bleomycin and Drugmethotrexate .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugFlucloxacillin - induced Adverse-Effectaplastic anaemia and liver failure.
0.9999 Adverse-Effect DrugFlucloxacillin - induced aplastic anaemia and Adverse-Effectliver failure .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The course of Adverse-Effectdelirium due to Druglithium intoxication.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectSevere neurotoxicity with Drugmethyl G : CALGB experience.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Spontaneous Adverse-Effectbacterial peritonitis induced by intraarterial Drugvasopressin therapy.
1.0000 Adverse-Effect Adverse-EffectSpontaneous bacterial peritonitis induced by intraarterial Drugvasopressin therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Their Adverse-Effectparkinsonism improved on discontinuation of Drugmetoclopramide therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugLinezolid - induced Adverse-Effectdyserythropoiesis : chloramphenicol toxicity revisited.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugRifampin - induced Adverse-Effecthypothyroidism without underlying thyroid disease.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectSevere acidosis from Drugacetazolamide in a diabetic patient.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectAcute pancreatitis associated with Drugdanazol treatment for endometriosis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugSirolimus - associated Adverse-Effecthepatotoxicity in the kidney graft recipient.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Transient Drugphenytoin induced Adverse-EffectIgA deficiency and permanent IgE increase.
0.9998 Adverse-Effect Transient Drugphenytoin induced IgA deficiency and permanent Adverse-EffectIgE increase .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugMefloquine - associated Adverse-Effecthypoglycaemia in a cachectic AIDS patient.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugLansoprazole - associated Adverse-Effectcollagenous colitis : a case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugEnalapril - induced Adverse-Effectanemia in two kidney transplant recipients.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Transient leucopenia and Adverse-Effectthrombocytopenia associated with Drugsodium nitroprusside infusion.
0.9990 Adverse-Effect Transient Adverse-Effectleucopenia and thrombocytopenia associated with Drugsodium nitroprusside infusion.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case of Drugcolchicine - induced Adverse-Effectrhabdomyolysis is reported.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A diagnosis of Drugtrastuzumab - induced Adverse-Effectpneumonitis was made.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugAlprazolam withdrawal Adverse-Effectdelirium unresponsive to diazepam : case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectAbnormal retinal function associated with Drugisotretinoin therapy for acne.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectRupture of a cerebral aneurysm associated with Drugnifedipine treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Phantom limb pain as a manifestation of Drugpaclitaxel Adverse-Effectneurotoxicity .
1.0000 Adverse-Effect Adverse-EffectPhantom limb pain as a manifestation of Drugpaclitaxel neurotoxicity.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectPapillary necrosis associated with the HIV protease inhibitor Drugindinavir .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugAmpicillin - induced Adverse-Effectinterstitial nephritis with generalised exfoliative dermatitis.
0.9999 Adverse-Effect DrugAmpicillin - induced interstitial nephritis with Adverse-Effectgeneralised exfoliative dermatitis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Traumatic late flap dehiscence and Adverse-EffectEnterobacter keratitis following DrugLASIK .
0.9999 Adverse-Effect Adverse-EffectTraumatic late flap dehiscence and Enterobacter keratitis following DrugLASIK .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugOfloxacin : a probable cause of Adverse-Effecttoxic epidermal necrolysis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugBisphosphonate induced Adverse-Effectosteochemonecrosis of the jaw mimicking a tumour.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This case report illustrates the Adverse-Effectneurotoxicity unique to DrugHDARAC .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Three cases of Druggold - related Adverse-Effectneuropathy are reported.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugPropranolol - induced Adverse-Effecthypertension in treatment of cocaine intoxication.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectSerotonin syndrome caused by interaction between Drugcitalopram and fentanyl.
1.0000 Adverse-Effect Adverse-EffectSerotonin syndrome caused by interaction between citalopram and Drugfentanyl .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectHepatotoxicity after high - dose Drugmethylprednisolone for demyelinating disease.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectAccelerated nodulosis during Drugmethotrexate therapy for juvenile rheumatoid arthritis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectThrombotic thrombocytopenic purpura during Drugpenicillamine therapy in rheumatoid arthritis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectAcute respiratory depression as a complication of nebulised Drugmorphine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugCeftriaxone - induced Adverse-Effectfixed drug eruption : first report.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Adverse-EffectComeoscleral perforation after pterygium excision and intraoperative Drugmitomycin C .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugIfosfamide is a known nephrotoxic drug with demonstrated Adverse-Effecttubulopathies .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectHepatotoxicity associated with Drug6 - thioguanine therapy for Crohn's disease.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectHepatotoxicity of Drughycanthone in patients with metastatic breast cancer.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugDisulfiram Adverse-Effectencephalopathy as a cause of the catatonia syndrome.
0.9999 Adverse-Effect DrugDisulfiram encephalopathy as a cause of the Adverse-Effectcatatonia syndrome .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectSensorimotor polyneuropathy with Drug5 - aminosalicylic acid : a case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Delayed Adverse-Effectneurotoxicity of intraventricular Druginterleukin - 2 : a case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Unusual Adverse-Effecthypersensitivity to Drugwarfarin in a critically ill patient.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectVasomotor reactions after Druggold sodium thiomalate are well recognized.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Intrahepatic cholestasis and Adverse-Effectcutaneous bullae associated with Drugglibenclamide therapy.
0.9999 Adverse-Effect Adverse-EffectIntrahepatic cholestasis and cutaneous bullae associated with Drugglibenclamide therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugTrazodone - induced Adverse-Effecttransient hypomanic symptoms and their management.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Some patients develop Adverse-Effecthypersensitivity rash in response to DrugHCQ .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Possible recurrence of Drugamiodarone Adverse-Effectpulmonary toxicity following corticosteroid therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectHepatotoxicity related to Drugitraconazole : report of three cases.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectSeptic knee arthritis after intra - articular Drughyaluronate injection.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectMultiple sclerosis - like disease secondary to Drugalpha interferon .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The literature of Drugvincristine Adverse-Effectoptic nerve toxicity is reviewed.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect An Adverse-Effectintertrigo - like eruption from pegylated liposomal Drugdoxorubicin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Hypotension and Adverse-Effectsinus arrest with Drugnifedipine in pulmonary hypertension.
0.9999 Adverse-Effect Adverse-EffectHypotension and sinus arrest with Drugnifedipine in pulmonary hypertension.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Liver transplantation for Adverse-Effectfulminant hepatitis related to Drugnevirapine therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectDiabetes Mellitus was observed in a patient given Drugcarbamazepine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugMethotrexate - induced Adverse-Effectpapular eruption following treatment of psoriasis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectPulmonary hypertension during Druglithium therapy : clinical case study.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugClofazimine Adverse-Effectenteropathy in a pediatric bone marrow transplant recipient.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectCardiac arrest associated with Drugsulprostone use during caesarean section.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugPropafenone - induced Adverse-Effectataxia : report of three cases.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Disseminated muscular cysticercosis with Adverse-Effectmyositis induced by Drugpraziquantel therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of Adverse-Effectmyoclonus induced by Drugquetiapine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectHepatopathy subsided after the cessation of Drugcarbamazepine and lynestrenol.
1.0000 Adverse-Effect Adverse-EffectHepatopathy subsided after the cessation of carbamazepine and Druglynestrenol .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Large dose of Drugmethylphenidate may cause Adverse-Effectcataract and glaucoma.
1.0000 Adverse-Effect Large dose of Drugmethylphenidate may cause cataract and Adverse-Effectglaucoma .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectSyndrome of inappropriate antidiuretic hormone associated with Drugvinorelbine therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectAcute pancreatitis after long - term Drug5 - aminosalicylic acid therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugFoscarnet - induced Adverse-Effectsevere hypomagnesemia and other electrolyte disorders.
0.9999 Adverse-Effect DrugFoscarnet - induced severe hypomagnesemia and other Adverse-Effectelectrolyte disorders .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectAnaphylactoid reaction to Drugmethylprednisolone pulsed therapy for multiple sclerosis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Simvastatin - induced Adverse-Effectrhabdomyolysis following Drugcyclosporine treatment for uveitis.
1.0000 Adverse-Effect DrugSimvastatin - induced Adverse-Effectrhabdomyolysis following cyclosporine treatment for uveitis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The spectrum of Drugnitrofurantoin Adverse-Effectlung injury continues to widen.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Paradoxical ventricular tachycardia and Adverse-Effectfibrillation after intravenous Drugbretylium therapy.
0.9999 Adverse-Effect Adverse-EffectParadoxical ventricular tachycardia and fibrillation after intravenous Drugbretylium therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The patient developed grade 3 Drugcapecitabine - induced Adverse-Effectheadache .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectEmbolia cutis medicamentosa following subcutaneous injection of Drugglatiramer acetate .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect These results indicate that Druglithium may cause Adverse-Effectbiochemical hyperparathyroidism .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A new type of Drugminocycline - induced Adverse-Effectcutaneous hyperpigmentation .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectReversible corneal keratinization following trabeculectomy and treatment with Drug5 - fluorouracil .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectAcute endophthalmitis following intravitreal Drugbevacizumab ( Avastin ) injection.
1.0000 Adverse-Effect Adverse-EffectAcute endophthalmitis following intravitreal bevacizumab ( DrugAvastin ) injection.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectCamptocormia , a new side effect of Drugsodium valproate .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Histopathology of the thyroid in Drugamiodarone - induced Adverse-Effecthypothyroidism .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectMultiple seizures after Drugbupropion overdose in a small child.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Successful challenge with Drugclozapine in a history of Adverse-Effecteosinophilia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case of Drugpyridoxine - dependent Adverse-Effectseizures is reported.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectSystemic lupus erythematosus during Drugpenicillamine therapy for rheumatoid arthritis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Two Adverse-Effectfatal cases of poisoning by Drugparacetamol are described.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectNephrotic range pseudoproteinuria in a Drugtolmetin - treated patient.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugCaptopril - related ( and - induced? ) Adverse-Effectasthma .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case of Adverse-Effectnoncardiogenic pulmonary edema by Drugethanolamine oleate .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectHypercalcemia in an AIDS patient treated with Druggrowth hormone .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectSystemic vasculitis complicating hairy cell leukaemia treatment with Drugcladribine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugCephalosporins are most likely associated with Adverse-EffectVitamin K deficiency .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Reversible cholestasis with Adverse-Effectbile duct injury following Drugazathioprine therapy.
0.9999 Adverse-Effect Reversible Adverse-Effectcholestasis with bile duct injury following Drugazathioprine therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectUveitis associated with Drugrifabutin therapy : a clinical alert.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugAmiodarone - induced Adverse-Effectthyrotoxicosis associated with thyrotropin receptor antibody.
0.9999 Adverse-Effect DrugAmiodarone - induced thyrotoxicosis associated with Adverse-Effectthyrotropin receptor antibody .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Peripheral neuropathy and Adverse-Effectcerebellar syndrome associated with Drugamiodarone therapy.
0.9999 Adverse-Effect Adverse-EffectPeripheral neuropathy and cerebellar syndrome associated with Drugamiodarone therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case of Adverse-Effectpriapism associated with Drugtrazodone is described.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DISCUSSION : Adverse-EffectElectrolyte disorders associated with Drugfoscarnet are reviewed.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectMyocardial ischemia associated with high - dose Drugcarmustine infusion.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugMethylphenidate - associated Adverse-Effectenuresis in attention deficit hyperactivity disorder.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Development of Adverse-Effectporphyria cutanea tarda after treatment with Drugcyclophosphamide .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectAcute reversible ataxo - myoclonic encephalopathy with Drugflecainide therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Thus cabergoline may cause similar Adverse-Effectpleuropulmonary abnormalities to Drugbromocriptine .
1.0000 Adverse-Effect Thus Drugcabergoline may cause similar Adverse-Effectpleuropulmonary abnormalities to bromocriptine.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectHigh - grade atrioventricular block during Drugdipyridamole stress testing.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectDisulfiram - like reactions with newer cephalosporins : Drugcefmenoxime .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We suggest discontinuing Druggemcitabine if Adverse-Effectradiation recall is observed.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugFluoxetine - induced Adverse-Effectakathisia : clinical and theoretical implications.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The Adverse-Effectharlequin color change and association with Drugprostaglandin E1 .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Management and successful desensitization in Drugmethotrexate - induced Adverse-Effectanaphylaxis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Response of a Drugpromethazine - induced Adverse-Effectcoma to flumazenil.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Multifocal electroretinographic abnormalities in Drugethambutol - induced Adverse-Effectvisual loss .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectAcute renal failure in a child associated with Drugacyclovir .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Withdrawal of DrugDepakote resulted in resolution of the Adverse-Effecteffusion .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugDipyrone - induced Adverse-Effectgranulocytopenia : a case for awareness.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The second patient exhibited sudden Adverse-EffectPLMS following Drugolanzapine injection.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectFixed drug eruption of the scrotum due to Drugmethylphenidate .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectHepatotoxic effects in a child receiving Drugvalproate and carnitine.
0.9999 Adverse-Effect Adverse-EffectHepatotoxic effects in a child receiving valproate and Drugcarnitine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Isoniazid and Drugethambutol as a cause of Adverse-Effectoptic neuropathy .
0.9999 Adverse-Effect DrugIsoniazid and ethambutol as a cause of Adverse-Effectoptic neuropathy .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect DrugAmphotericin B Adverse-Effectnephrotoxicity in humans decreased by salt repletion.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugLevofloxacin induced Adverse-Effectpolymorphic ventricular tachycardia with normal QT interval.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectPulmonary edema as a delayed complication of Drugritodrine therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectToxicity related to Drugchloroquine treatment of resistant vivax malaria.
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect Adverse-EffectCarbamazepine toxicity induced by Drugclarithromycin coadministration in psychiatric patients.
0.9994 Adverse-Effect DrugCarbamazepine Adverse-EffectCarbamazepine toxicity induced by clarithromycin coadministration in psychiatric patients.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Circulating anticoagulant in the Drugprocainamide - induced Adverse-Effectlupus syndrome .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectMyotonia associated with sarcoidosis : marked exacerbation with Drugpravastatin .
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect Gold Adverse-Effectnephropathy due to Drugauranofin obscured by tolmetin pseudoproteinuria.
0.9998 Adverse-Effect DrugGold Adverse-Effectnephropathy due to auranofin obscured by tolmetin pseudoproteinuria.
0.9742 Adverse-Effect Gold Adverse-Effectnephropathy due to auranofin obscured by Drugtolmetin pseudoproteinuria.
Adverse-Effect DrugGold Adverse-EffectGold nephropathy due to auranofin obscured by tolmetin pseudoproteinuria.
Adverse-Effect Gold nephropathy due to auranofin obscured by Drugtolmetin Adverse-Effectpseudoproteinuria .
Adverse-Effect Adverse-EffectGold nephropathy due to auranofin obscured by Drugtolmetin pseudoproteinuria.
Adverse-Effect Adverse-EffectGold nephropathy due to Drugauranofin obscured by tolmetin pseudoproteinuria.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugDoxycycline - induced Adverse-Effecthypoglycemia in a nondiabetic young man.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectTetany in a child with AIDS receiving intravenous Drugtobramycin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Case report : Adverse-Effectacute renal failure after administering intravenous Drugimmunoglobulin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectDyspnea possibly associated with controlled - release Drugmorphine sulfate tablets.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Acute kidney injury caused by Drugzonisamide - induced Adverse-Effecthypersensitivity syndrome .
0.9999 Adverse-Effect Adverse-EffectAcute kidney injury caused by Drugzonisamide - induced hypersensitivity syndrome.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The renal consequences of Drugindinavir - associated Adverse-Effectnephrotoxicity are uncertain.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Occurrence of Adverse-EffectIDDM during Druginterferon therapy for chronic viral hepatitis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A further case of Adverse-Effectanaphylactoid reaction to Drugmethylprednisolone is reported.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectBull's - eye maculopathy associated with Drugquinacrine therapy for malaria.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Can Drugpropofol precipitate Adverse-Effectpancreatitis in patients with Cushing's syndrome?
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugClonidine - induced Adverse-Effectbradycardia in patients with spinal cord injury.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectLymphoma developing in a patient with rheumatoid arthritis taking Drugmethotrexate .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugAmphotericin B overdose in pediatric patients with associated Adverse-Effectcardiac arrest .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugIsoniazid causing Adverse-Effectbreast tissue enlargement has been very rarely reported.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectParadoxical pulmonary vasoconstriction induced by Drugnitroglycerin in idiopathic pulmonary hypertension.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect However, recurrent Adverse-Effectstaphylococcus aureus sepsis developed during DrugCyA therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectNoncardiogenic pulmonary edema during intrabiliary infusion of Drugmono - octanoin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugMoxalactam is more likely to be associated with Adverse-Effectplatelet dysfunction .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectSevere Raynaud's phenomenon with Drugyohimbine therapy for erectile dysfunction.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectSevere systemic hypersensitivity reaction to Drugibuprofen occurring after prolonged therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Fatal Druggemcitabine - induced Adverse-Effectpulmonary toxicity in metastatic gallbladder adenocarcinoma.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Massive plasmocytosis due to Drugmethimazole - induced Adverse-Effectbone marrow toxicity .
0.9999 Adverse-Effect Adverse-EffectMassive plasmocytosis due to Drugmethimazole - induced bone marrow toxicity.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Ketanserin in the treatment of Drugprotamine - induced Adverse-Effectpulmonary hypertension .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Bradycardia and Adverse-Effectcongestive heart failure associated with ocular Drugtimolol maleate .
0.9996 Adverse-Effect Adverse-EffectBradycardia and congestive heart failure associated with ocular Drugtimolol maleate .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectUlcerative proctitis in juvenile systemic lupus erythematosus after Drugibuprofen treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A patient developed Adverse-Effectcholestatic hepatitis while being treated with Drugnitrofurantoin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugDorzolamide - induced Adverse-Effectchoroidal detachment in a surgically untreated eye.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugMitomycin C - related Adverse-Effecthemolytic uremic syndrome in cancer patients.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Possible Adverse-Effectserotonin syndrome associated with Drugclomipramine after withdrawal of clozapine.
0.9996 Adverse-Effect Possible Adverse-Effectserotonin syndrome associated with clomipramine after withdrawal of Drugclozapine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case of Adverse-Effectrecall pneumonitis induced by Druggemcitabine is reported.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Myoglobinuria and Adverse-Effectacute renal failure associated with intravenous Drugvasopressin infusion.
1.0000 Adverse-Effect Adverse-EffectMyoglobinuria and acute renal failure associated with intravenous Drugvasopressin infusion.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugAmphotericin B - induced Adverse-Effectseizures in a patient with AIDS.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The Drugallopurinol Adverse-Effecthypersensitivity syndrome is a rare adverse drug reaction.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect PURPOSE : We report an unusual Adverse-Effectparadoxical effect of Drugbrimonidine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The most likely cause of such Adverse-Effecthyponatremic episode is Drugvinblastine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugCefoxitin therapy for Mycobacterium fortuitum bacteremia with associated Adverse-Effectgranulomatous hepatitis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectAcceleration of ventricular response to atrial flutter after intravenous Drugadenosine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We present a case of Adverse-Effecthypereosinophilia related to Drugzafirlukast therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectRenal damage associated with long term use of Druglithium carbonate .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Reversible Drugvalproic acid - induced Adverse-Effectdementia : a case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectSevere hypo - alpha - lipoproteinemia during treatment with Drugrosiglitazone .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Excluding other causes, DrugPentasa - associated Adverse-Effectpancytopenia was considered.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectThrombo - embolic complication after Drugstreptokinase therapy of pulmonary emboli.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Development of Adverse-Effectpersistent late onset asthma following treatment with Drugcaptopril .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugAmphotericin B - induced Adverse-Effectcutaneous leucocytoclastic vasculitis : case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugPropranolol - related Adverse-Effectbronchospasm in patients without history of asthma.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugTrimethoprim - sulfamethoxazole - induced Adverse-Effecthepatotoxicity in a pediatric patient.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectBronchiolitis obliterans organising pneumonia associated with the use of Drugnitrofurantoin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectCerebral edema associated with DrugGliadel wafers : two case studies.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectAgranulocytosis induced by Drugvancomycin in an ESRD patient on CAPD.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugZidovudine induced Adverse-Effectpure red cell aplasia : a case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Various case reports concerning Drugdapsone - induced Adverse-Effectagranulocytosis are reviewed.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectNeurotoxicity of Drugvalacyclovir in peritoneal dialysis : a pharmacokinetic study.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Recently, Adverse-EffectCD20 - negative tumors have been described after DrugRituximab therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectCutaneous ulceration : an unusual complication of intravenous Drugpentamidine therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Aplastic anemia and Adverse-Effectagranulocytosis in patients using Drugmethazolamide for glaucoma.
0.9999 Adverse-Effect Adverse-EffectAplastic anemia and agranulocytosis in patients using Drugmethazolamide for glaucoma.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Adverse-EffectLethargy in a newborn : Druglithium toxicity or lab error?
Adverse-Effect Lethargy in a newborn : Druglithium Adverse-Effectlithium toxicity or lab error?
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugLevofloxacin - induced Adverse-Effecttoxic epidermal necrolysis in an elderly patient.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectMental nerve neuropathy as a result of Drughepatitis B vaccination .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugMuzolimine - induced Adverse-Effectsevere neuromyeloencephalopathy : report of seven cases.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect After Drug5 - ASA was discontinued, the Adverse-Effectpolyneuropathy symptoms recovered gradually.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugCimetidine is a rare cause of drug - induced Adverse-Effectfever .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect He was later skin tested to confirm Adverse-Effectallergy to DrugMTX .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Secondary Adverse-Effectacute myeloid leukemia after Drugetoposide therapy for haemophagocytic lymphohistiocytosis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugMinocycline as a cause of drug - induced Adverse-Effectautoimmune hepatitis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectMacular infarction after endophthalmitis treated with vitrectomy and intravitreal Druggentamicin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 57 - year - old man developed Adverse-Effectmorphea while taking Drugbromocriptine .
Score Relation Text (Head - Tail)
Adverse-Effect DrugMethotrexate is an effective but Adverse-Effectpotentially toxic treatment for psoriasis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugIsonicotinic acid hydrazide induced Adverse-Effectanagen effluvium and associated lichenoid eruption.
0.9994 Adverse-Effect DrugIsonicotinic acid hydrazide induced anagen effluvium and associated Adverse-Effectlichenoid eruption .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugLovastatin - induced Adverse-Effectrhabdomyolysis possibly associated with clarithromycin and azithromycin.
1.0000 Adverse-Effect Lovastatin - induced Adverse-Effectrhabdomyolysis possibly associated with Drugclarithromycin and azithromycin.
0.9992 Adverse-Effect Lovastatin - induced Adverse-Effectrhabdomyolysis possibly associated with clarithromycin and Drugazithromycin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The occurrence of Adverse-Effectacute hepatitis is best known for Drugketoconazole .
Adverse-Effect The occurrence of acute Adverse-Effecthepatitis is best known for Drugketoconazole .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Our experience supports hemodialysis for ESRF patients with Drugatenolol Adverse-Effectatenolol toxicity .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectStevens - Johnson syndrome caused by the antiretroviral drug Drugnevirapine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugDasatinib - induced Adverse-Effectpleural effusions : a lymphatic network disorder?
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Increasing the Drugolanzapine dosage severely aggravated the symptoms of Adverse-EffectRLS .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Hemodialysis was also shown to reverse Drugifosfamide - related Adverse-Effectneurotoxicity .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectNeurologic toxicity associated with hepatic artery infusion HAI of DrugFUdR .
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect Adverse-EffectPapilledema without peripheral neuropathy in a patient taking Drugperhexiline maleate .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Sudden cardiac death due to Adverse-Effecthypersensitivity myocarditis during Drugclozapine treatment.
0.9999 Adverse-Effect Adverse-EffectSudden cardiac death due to hypersensitivity myocarditis during Drugclozapine treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Marked Adverse-Effectelevation of serum creatine kinase associated with Drugolanzapine therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugDoxorubicin Adverse-Effectcardiotoxicity : possible role of digoxin in its prevention.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectParoxysmal supraventricular tachycardia during treatment with Drugcisplatin and etoposide combination.
0.9999 Adverse-Effect Adverse-EffectParoxysmal supraventricular tachycardia during treatment with cisplatin and Drugetoposide combination.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectFatal acute encephalomyelitis after a single dose of intrathecal Drugmethotrexate .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Oxygen potentiation of Drugbleomycin - induced Adverse-Effectpulmonary toxicity is discussed.
0.9978 Adverse-Effect DrugOxygen potentiation of bleomycin - induced Adverse-Effectpulmonary toxicity is discussed.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectAllergy to Drugcloxacillin with normal tolerance to amoxicillin and cefuroxime.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugMagnesium tocolysis as the cause of Adverse-Effecturinary calculus during pregnancy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectHemorrhagic cystitis is a significant toxic effect of Drugcyclophosphamide therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectHypokalemia after normal doses of neubulized Drugalbuterol ( salbutamol ).
1.0000 Adverse-Effect Adverse-EffectHypokalemia after normal doses of neubulized albuterol ( Drugsalbutamol ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectToxic hepatitis induced by Drugdisulfiram in a non - alcoholic.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectAcute renal failure during Druglisinopril and losartan therapy for proteinuria.
0.9999 Adverse-Effect Adverse-EffectAcute renal failure during lisinopril and Druglosartan therapy for proteinuria.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectHair loss associated with Drugparoxetine treatment : a case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectSevere diffuse interstitial pneumonitis induced by Drugcarmustine ( BCNU ).
0.9999 Adverse-Effect Adverse-EffectSevere diffuse interstitial pneumonitis induced by carmustine ( DrugBCNU ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The Adverse-Effectcough continued for the duration of therapy with Drugquinapril .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectMulticentric hepatocellular carcinoma following Drugphosphate diethylstilbestrol therapy for prostatic cancer.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectCough induced by Drugquinapril with resolution after changing to fosinopril.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Adverse-EffectLipoid pneumonia : a silent complication of Drugmineral oil aspiration.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectCorneal edema recurred when the administration of Drugamantadine was resumed.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugFluphenazine - induced Adverse-Effectneuroleptic malignant syndrome in a schizophrenic patient.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect After stopping Drugindapamide , Adverse-Effectglucose tolerance impairing may be reversed.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectTransient acute myopia resulting from Drugisotretinoin ( accutane ) therapy.
1.0000 Adverse-Effect Adverse-EffectTransient acute myopia resulting from isotretinoin ( Drugaccutane ) therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectCardiac decompensation following Drugverapamil therapy in infants with supraventricular tachycardia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Three patients developed Adverse-Effectproteinuria following Druggold therapy for rheumatoid arthritis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Nephrotic syndrome related to Adverse-Effectsystemic lupus erythematosus after Druggriseofulvin therapy.
0.9999 Adverse-Effect Adverse-EffectNephrotic syndrome related to systemic lupus erythematosus after Druggriseofulvin therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Colitis as a manifestation of Druginfliximab - associated Adverse-Effectdisseminated cryptococcosis .
1.0000 Adverse-Effect Adverse-EffectColitis as a manifestation of Druginfliximab - associated disseminated cryptococcosis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugGabapentin - induced Adverse-Effectmood changes with hypomanic features in adults.
0.9999 Adverse-Effect DrugGabapentin - induced mood changes with Adverse-Effecthypomanic features in adults.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Discontinuation of the Drugitraconazole caused resolution of the Adverse-Effectdrug eruption .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Tacrolimus ( DrugFK506 ) - induced Adverse-Effectmutism after liver transplant.
0.9999 Adverse-Effect DrugTacrolimus ( FK506 ) - induced Adverse-Effectmutism after liver transplant.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugCarbamazepine induced Adverse-Effectright bundle branch block in a Greenlandic patient.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Angioedema and Adverse-Effectdysphagia caused by contact allergy to inhaled Drugbudesonide .
1.0000 Adverse-Effect Adverse-EffectAngioedema and dysphagia caused by contact allergy to inhaled Drugbudesonide .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Apparent Drugcyclophosphamide ( cytoxan ) Adverse-Effectembryopathy : a distinct phenotype?
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect One patient had MRI T2 abnormalities compatible with Drugcyclosporin Adverse-Effectneurotoxicity .
0.9997 Adverse-Effect One patient had Adverse-EffectMRI T2 abnormalities compatible with Drugcyclosporin neurotoxicity.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectAcute renal failure in a patient receiving treatment with Drugsuramin .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect DrugCarboplatin hypersensitivity presenting as Adverse-Effectcoronary vasospasm - a case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectSevere symptomatic hyponatremia during Drugsibutramine therapy : a case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugPhenytoin toxicity : an easily missed cause of Adverse-Effectcerebellar syndrome .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This pattern is suggestive of Adverse-Effectrenal toxicity due to Drugtobramycin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectDelay of corneal wound healing in patients treated with Drugcolchicine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugWarfarin - associated Adverse-Effectthoracic aortic dissection in an elderly woman.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectHypersensitivity to Drugzonisamide was confirmed by the skin patch test.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugPseudoephedrine - induced Adverse-Effecthemorrhage associated with a cerebral vascular malformation.
0.9997 Adverse-Effect DrugPseudoephedrine - induced hemorrhage associated with a Adverse-Effectcerebral vascular malformation .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case of acute cardiomyopathy and Adverse-Effectpericarditis associated with Drugmethylphenidate .
0.9999 Adverse-Effect A case of Adverse-Effectacute cardiomyopathy and pericarditis associated with Drugmethylphenidate .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectSyncope in a 65 - year - old woman after Drugnitrate ingestion.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DIAGNOSIS : Adverse-EffectSustained ventricular tachycardia possibly owing to Drugthalidomide treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectAcute lung injury associated with Drug5 - fluorouracil and oxaliplatinum combined chemotherapy.
0.9999 Adverse-Effect Adverse-EffectAcute lung injury associated with 5 - fluorouracil and Drugoxaliplatinum combined chemotherapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectCardiac toxicity related to DrugBCNU has not been described well.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugCiprofloxacin - induced Adverse-Effecthemorrhagic vasculitis is a rare side effect.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect An immediate Adverse-Effecthemolytic reaction induced by repeated administration of Drugoxaliplatin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugAcyclovir Adverse-Effectneurotoxicity : clinical experience and review of the literature.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectAcute syphilitic posterior placoid chorioretinitis following intravitreal Drugtriamcinolone acetonide injection.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugRisperidone - induced Adverse-Effectobsessive - compulsive symptoms in two children.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectFibrosis of corpus cavernosum after intracavernous injection of Drugphentolamine / papaverine.
1.0000 Adverse-Effect Adverse-EffectFibrosis of corpus cavernosum after intracavernous injection of phentolamine / Drugpapaverine .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect This Adverse-Effecteruption appears to be a distinct cutaneous toxicity of DrugPLD .
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect Adverse-EffectErosion of psoriatic plaques : an early sign of Drugmethotrexate toxicity.
Adverse-Effect Erosion of psoriatic plaques : an early sign of Drugmethotrexate Adverse-Effectmethotrexate toxicity .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect After nine previous uncomplicated cycles she developed severe Adverse-Effectanaphylaxis to Drugcisplatin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugColchicine - induced Adverse-Effectmyopathy in a teenager with familial Mediterranean fever.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugIbopamine - induced reversible Adverse-Effectleukopenia during treatment for congestive heart failure.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We also describe a case of Drugtimolol - induced Adverse-Effectocular pemphigoid .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectAcute aluminum toxicity after continuous intravesical Drugalum irrigation for hemorrhagic cystitis.
Adverse-Effect Acute Adverse-Effectaluminum toxicity after continuous intravesical Drugalum irrigation for hemorrhagic cystitis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Only a few reports of overt Adverse-Effectjaundice are associated with Drugstreptokinase .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Sensory neuropathy revealing Adverse-Effectnecrotizing vasculitis during Druginfliximab therapy for rheumatoid arthritis.
0.9999 Adverse-Effect Adverse-EffectSensory neuropathy revealing necrotizing vasculitis during Druginfliximab therapy for rheumatoid arthritis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectElectrical proarrhythmia with Drugprocainamide : a new ICD - drug interaction.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectLivedo reticularis associated with Druginterferon alpha therapy in two melanoma patients.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The association of Drugphenothiazine overdose and Adverse-Effectrespiratory distress syndrome merits consideration.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectMethemoglobinemia associated with dermal application of Drugbenzocaine cream in a cat.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect When the Drugtrazodone was reduced, the Adverse-Effectinvoluntary movements promptly ceased.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugAnastrozole - associated Adverse-Effectsclerosing glomerulonephritis in a patient with breast cancer.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectTransfusion haemosiderosis inspite of regular use of Drugdesferrioxamine : case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This concerns 2 male patients who experienced Adverse-Effectincontinence while taking Drugvenlafaxine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect One patient had Adverse-Effectsevere temporary weakness after an Drugampicillin sodium challenge.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectArterial hypertension associated with topical ocular use of Drugphenylephrine in dogs.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugTigecycline - induced Adverse-Effectacute pancreatitis : case report and literature review.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectAntineutrophil cytoplasmic antibody - positive crescentic glomerulonephritis associated with Drugpropylthiouracil therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Chronic Drughydroxychloroquine use associated with Adverse-EffectQT prolongation and refractory ventricular arrhythmia.
1.0000 Adverse-Effect Chronic Drughydroxychloroquine use associated with QT prolongation and Adverse-Effectrefractory ventricular arrhythmia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report here a rare case of Adverse-Effectpleuropericarditis due to Drugmethotrexate .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Inadvertent and accidental Drugepinephrine overdose might result in potentially Adverse-Effectlethal complications .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectReversible heart failure in a patient receiving Drugetanercept for ankylosing spondylitis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectExtensive forearm deep venous thrombosis following a severe Druginfliximab infusion reaction.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the first case of Adverse-Effecttuberculous uveitis due to Drugetanercept .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Five months after initiating Drugmirtazapine therapy, she developed Adverse-Effectsymptomatic hyponatremia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect PURPOSE : A case of Drugcarbamazepine - induced Adverse-Effecthyperammonemia is presented.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Pneumonitis with pleural and pericardial effusion and Adverse-Effectneuropathy during Drugamiodarone therapy.
0.9999 Adverse-Effect Adverse-EffectPneumonitis with pleural and pericardial effusion and neuropathy during Drugamiodarone therapy.
0.9999 Adverse-Effect Pneumonitis with Adverse-Effectpleural and pericardial effusion and neuropathy during Drugamiodarone therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectFatal hepatitis after long - term pulse Drugitraconazole treatment for onychomycosis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This is a rare case of Adverse-EffectARDS associated with Druglithium intoxication.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectHypersensitivity reactions due to Drugchloramphenicol are rarely reported in the literature.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectIschaemia following selfadministered intra - arterial injection of Drugmethylphenidate and diamorphine.
1.0000 Adverse-Effect Adverse-EffectIschaemia following selfadministered intra - arterial injection of methylphenidate and Drugdiamorphine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Unaccountable severe Adverse-Effecthypercalcemia in a patient treated for hypoparathyroidism with Drugdihydrotachysterol .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugAllopurinol - associated Adverse-Effecthand and foot deformities in chronic tophaceous gout.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of DrugRitalin - associated Adverse-Effectcataract and glaucoma.
1.0000 Adverse-Effect We report a case of DrugRitalin - associated cataract and Adverse-Effectglaucoma .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Nephrogenic diabetes insipidus and Adverse-Effectrenal tubular acidosis secondary to Drugfoscarnet therapy.
0.9999 Adverse-Effect Adverse-EffectNephrogenic diabetes insipidus and renal tubular acidosis secondary to Drugfoscarnet therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report here a case of Adverse-EffectTEN after administration of Drugciprofloxacin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DISCUSSION : Adverse-EffectAnaphylactoid reactions have been described previously with Drugcisplatin administration.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectCentral nervous system toxicity associated with Drugmeperidine use in hepatic disease.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Drug - induced Adverse-Effectagranulocytosis during treatment with Druginfliximab in enteropathic spondyloarthropathy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect One other patient on Drugdigoxin stopped taking it and developed Adverse-Effectcardiomyopathy .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugAdrenaline Adverse-Effectdacryolith : detection by ultrasound examination of the nasolacrimal duct.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugGabapentin toxicity in Adverse-Effectrenal failure : the importance of dose adjustment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Severe steroid - induced Adverse-Effectglaucoma following intravitreal injection of Drugtriamcinolone acetonide .
1.0000 Adverse-Effect Severe Drugsteroid - induced Adverse-Effectglaucoma following intravitreal injection of triamcinolone acetonide.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A short review on Drugimatinib - related Adverse-Effecthepatotoxicity is also presented.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectInteraction between Drugtacrolimus and nefazodone in a stable renal transplant recipient.
1.0000 Adverse-Effect Adverse-EffectInteraction between tacrolimus and Drugnefazodone in a stable renal transplant recipient.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectSevere apnea in an infant exposed to Druglamotrigine in breast milk.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugHalothane Adverse-Effecthepatitis and prompt resolution with methionine therapy : case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The elicitation of a Adverse-Effectmovement disorder by Drugtrazodone : case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectPrimary central nervous system lymphoma in a patient treated with Drugnatalizumab .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report three cases of Drugamiodarone - induced Adverse-Effecttorsades de pointe .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Prominent Adverse-Effectpositive U waves appearing with high - dose intravenous Drugphenylephrine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectCentral nervous system manifestations of an Drugibuprofen overdose reversed by naloxone.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Development of Adverse-EffectPeyronie's disease during long - term Drugcolchicine treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectAcne provoked by Druggold seems not to have been described elsewhere.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Severe Drugsulfadiazine Adverse-Effecthypersensitivity in a child with reactivated congenital toxoplasmic chorioretinitis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Sustained - release Drugprocainamide - induced Adverse-Effectreversible granulocytopenia after myocardial infarction.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Carbamyl phosphate synthetase - 1 deficiency discovered after Drugvalproic acid - induced Adverse-Effectcoma .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectHepatobiliary disorders associated with orally administered Drugterbinafine have rarely been reported.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Diffusion - weighted MRI correlates of subacute Drugmethotrexate - related Adverse-Effectneurotoxicity .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectWithdrawal emergent syndrome in an infant associated with maternal Drughaloperidol therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The patient suffered a Adverse-Effectlife - threatening anaphylactoid reaction to Drugamifostine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Three senile patients developed Adverse-Effectfatal acute encephalopathy while receiving Drugcalcium hopantenate .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectHepatocellular damage following therapeutic intravenous Drugiron sucrose infusion in a child.
Score Relation Text (Head - Tail)
0.9991 Adverse-Effect This paper reports a case of Adverse-Effectfatal perhexiline maleate liver injury Drugperhexiline maleate liver injury.
0.9991 Adverse-Effect This paper reports a case of Adverse-Effectfatal perhexiline maleate liver injury Drugmaleate liver injury.
0.9981 Adverse-Effect This paper reports a case of fatal Drugperhexiline maleate Adverse-Effectperhexiline maleate liver injury .
0.9980 Adverse-Effect This paper reports a case of fatal Adverse-Effectperhexiline maleate liver injury Drugmaleate liver injury.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Proton MRS examination demonstrated a persistent Adverse-Effectlactate elevation during Drugmetronidazole treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A typical case of Drugdextran - 40 associated Adverse-Effectacute renal failure is presented.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectMycobacterium marinum infection complicating Crohn's disease, treated with Druginfliximab .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect CONCLUSION : DrugAcetic acid is corrosive and may cause Adverse-Effectvagina bleeding .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a patient who became Adverse-Effecthypothyroid while taking Drugferrous sulfate .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugCaptopril - induced Adverse-Effectlichen planus pemphigoides with pemphigus - like features.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectThrombocytosis associated with Drugenoxaparin : A very rare cause in newborns.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectHypersensitivity reaction following Drugchloramphenicol administration in a patient with typhoid fever.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectAnaphylactic reaction to Drugrecombinant insulin - like growth factor - I .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Two reports of Adverse-Effectspindle coma are noted with alcohol and Drugimipramine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This therapy was also complicated by DrugWarfarin - induced Adverse-Effectskin necrosis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugMetipranolol associated Adverse-Effectgranulomatous anterior uveitis : not so uncommon as thought.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Choanal atresia and athelia : Drugmethimazole Adverse-Effectteratogenicity or a new syndrome?
1.0000 Adverse-Effect Choanal atresia and Adverse-Effectathelia : Drugmethimazole teratogenicity or a new syndrome?
0.9996 Adverse-Effect Adverse-EffectChoanal atresia and athelia : Drugmethimazole teratogenicity or a new syndrome?
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Erythropoietin is beneficial in Drugmitomycin - induced Adverse-Effecthemolytic - uremic syndrome .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report four cases of Adverse-Effectsevere corneal ulceration in Drugmethamphetamine abusers.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectPneumocystis carinii pneumonia as a complication of Drugmethotrexate treatment of asthma.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugClofazimine Adverse-Effectenteropathy caused by crystal deposition can be life - threatening.
0.9994 Adverse-Effect DrugClofazimine enteropathy caused by crystal deposition can be Adverse-Effectlife - threatening .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectInterference with the cortisol axis by the microtubule antagonist, DrugCPH82 .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugDisulfiram - induced Adverse-Effectfulminant hepatic failure in an active duty soldier.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect High - dose Drugphosphate treatment leads to Adverse-Effecthypokalemia in hypophosphatemic osteomalacia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Possible mechanisms for Adverse-Effectdamage to the urothelium by Drugketamine are suggested.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectHepatotoxicity induced by Drugcyproterone acetate : a report of three cases.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Caution with use of cimetidine in Drugtolazoline induced Adverse-Effectupper gastrointestinal bleeding .
0.9998 Adverse-Effect Caution with use of Drugcimetidine in tolazoline induced Adverse-Effectupper gastrointestinal bleeding .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectHypersensitivity pneumonitis - like syndrome associated with the use of Druglenalidomide .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The medical examiner's report indicated Adverse-Effectdeath caused by Drugfluoxetine toxicity.
0.9999 Adverse-Effect The medical examiner's report indicated death caused by Drugfluoxetine Adverse-Effectfluoxetine toxicity .
Score Relation Text (Head - Tail)
Adverse-Effect In all the patients, Adverse-Effectpellagra symptoms appeared during Drugisoniazid therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We hypothesize that Drugcapecitabine - induced Adverse-Effectheadache is vascular in nature.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugDesipramine - associated Adverse-EffectSIADH in an elderly woman : case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugMitomycin - C induced Adverse-Effecthemolytic uremic syndrome : a case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectEsophageal candidiasis following Drugomeprazole therapy : a report of two cases.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The syndrome of irreversible Druglithium - effectuated Adverse-Effectneurotoxicity ( SILENT ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Thrombotic microangiopathy with Adverse-Effectrenal failure in two patients undergoing Druggemcitabine chemotherapy.
0.9999 Adverse-Effect Adverse-EffectThrombotic microangiopathy with renal failure in two patients undergoing Druggemcitabine chemotherapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Severe heparin associated Adverse-Effectthrombocytopenia is a rare complication of Drugheparin therapy.
1.0000 Adverse-Effect Severe Drugheparin associated Adverse-Effectthrombocytopenia is a rare complication of heparin therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectMammary gigantism is a rare complication of DrugD - penicillamine treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Zolpidem tissue concentrations in a multiple drug related Adverse-Effectdeath involving DrugAmbien .
Adverse-Effect DrugZolpidem tissue concentrations in a multiple drug related Adverse-Effectdeath involving Ambien.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Patient 1 presented Adverse-Effectbilateral ballism 1 week after intravenous Drugheroin injection.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect It occasionally accompanies the Drugheparin - associated Adverse-Effectthrombocytopenia and thrombosis syndrome.
0.9999 Adverse-Effect It occasionally accompanies the Drugheparin - associated thrombocytopenia and Adverse-Effectthrombosis syndrome .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Selective estrogen receptor modulator Drugraloxifene - associated Adverse-Effectaggravation of nonalcoholic steatohepatitis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectHemolytic uremic syndrome following the infusion of Drugoxaliplatin : case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Dose - dependent Drugolanzapine - associated Adverse-Effectleukopenia : three case reports.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectPellagra encephalopathy among tuberculous patients : its relation to Drugisoniazid therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the first case of Adverse-EffectIHA associated with Drugcefuroxime administration.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The HIV protease inhibitor Drugindinavir may cause Adverse-Effectnephrolithiasis and interstitial nephritis.
0.9999 Adverse-Effect The HIV protease inhibitor Drugindinavir may cause nephrolithiasis and Adverse-Effectinterstitial nephritis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Physicians should be aware that Drugindinavir Adverse-Effectnephrolithiasis may cause papillary necrosis.
0.9998 Adverse-Effect Physicians should be aware that Drugindinavir nephrolithiasis may cause Adverse-Effectpapillary necrosis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugTenofovir - associated Adverse-Effectnephrotoxicity in two HIV - infected adolescent males.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Adverse-EffectCarbamazepine toxicity following DrugOxybutynin and Dantrolene administration : a case report.
0.9997 Adverse-Effect DrugCarbamazepine Adverse-EffectCarbamazepine toxicity following Oxybutynin and Dantrolene administration : a case report.
0.9972 Adverse-Effect Adverse-EffectCarbamazepine toxicity following Oxybutynin and DrugDantrolene administration : a case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect When Drugco - trimoxazole was stopped the Adverse-Effectred cell aplasia resolved.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugGemcitabine - induced Adverse-Effectpericardial effusion and tamponade after unblocked cardiac irradiation.
0.9999 Adverse-Effect DrugGemcitabine - induced pericardial effusion and Adverse-Effecttamponade after unblocked cardiac irradiation.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugCytarabine - induced Adverse-Effectcerebellar syndrome : case report and literature review.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugGemcitabine - related Adverse-Effectradiation recall preferentially involves internal tissue and organs.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Can roxithromycin and Drugbetamethasone induce Adverse-Effectacute pancreatitis ? A case report.
0.9999 Adverse-Effect Can Drugroxithromycin and betamethasone induce Adverse-Effectacute pancreatitis ? A case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a patient who developed Adverse-Effectacute pancreatitis during Drugamiodarone therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This report describes a case of Adverse-Effectbilateral ptosis induced by Drugchloroquine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugSorafenib induced Adverse-Effecttumor lysis syndrome in an advanced hepatocellular carcinoma patient.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectToxic optic neuropathy associated with Drugethambutol : implications for current therapy.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Adverse-EffectLeukaemoid monocytosis in M4 AML following chemotherapy and DrugG - CSF .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Heparin - dependent antibodies and thrombosis without Drugheparin - induced Adverse-Effectthrombocytopenia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect However, an association of DrugRitalin with Adverse-Effectglaucoma has been reported.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectNonconvulsive status epilepticus : the role of Drugmorphine and its antagonist.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A patient with Adverse-Effectsevere cholestatic jaundice induced by Drugcaptopril is presented.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectInterstitial pneumonitis associated with Drugsirolimus : a dilemma for lung transplantation.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Complete remission of the Adverse-Effectnephrosis occurred after discontinuation of Drughydroxychloroquine therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugGold Adverse-Effectnephropathy : tissue analysis by X - ray fluorescent spectroscopy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The role of DrugAdriamycin in the production of Adverse-Effectcardiotoxicity is reviewed.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectHyponatremia in patients treated with Druglorcainide , a new antiarrhythmic drug.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectSpontaneous hemothorax following anticoagulation with low - molecular - weight Drugheparin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The Adverse-Effectpsychotic behavior resolved completely soon after the discontinuation of Druglevetiracetam .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugRetinoic acid may increase the risk of Adverse-Effectbone marrow transplant nephropathy .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The relationship between Druginfliximab treatment and Adverse-Effectlymphoma in Crohn's disease.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Therefore, Drugamantadine was permanently discontinued and the Adverse-Effectcornea cleared again.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This is the first reported case of Adverse-Effecthepatolithiasis during Drugoctreotide therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The literature search revealed 22 cases of Adverse-Effecthypersensitivity reaction to Drugcyclosporine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Seizure with Adverse-Effecthyponatremia in a child prescribed Drugdesmopressin for nocturnal enuresis.
1.0000 Adverse-Effect Adverse-EffectSeizure with hyponatremia in a child prescribed Drugdesmopressin for nocturnal enuresis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Rebound Adverse-Effecthyperglycemia following overdosing of Druginsulin in cats with diabetes mellitus.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectVocal cord paralysis as a consequence of peritonsillar infiltration with Drugbupivacaine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugGemcitabine - related Adverse-Effectradiation recall in a patient with pancreatic cancer.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugPropylthiouracil - induced Adverse-Effectsensorineural hearing loss associated with antineutrophil cytoplasmic antibodies.
0.9999 Adverse-Effect DrugPropylthiouracil - induced sensorineural hearing loss associated with Adverse-Effectantineutrophil cytoplasmic antibodies .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectHepatotoxicity associated with use of DrugD - penicillamine in rheumatoid arthritis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugMesalamine may cause Adverse-Effecthypersensitivity pneumonitis in patients with Crohn's disease.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect However, Drugcyclosporine dependency is associated with the risk of Adverse-Effectnephrotoxicity .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugCapecitabine - induced Adverse-Effectmultifocal leukoencephalopathy : a report of five cases.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In the third child, the Adverse-Effecttics ceased after DrugCBZ discontinuation.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Can Drugketamine prescribed for pain cause Adverse-Effectdamage to the urinary tract ?
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect There have been only two reports of Drugcimetidine - induced Adverse-Effecthepatitis .
Score Relation Text (Head - Tail)
Adverse-Effect Lower extremity Adverse-Effectarterial insufficiency after long - term Drugmethysergide maleate therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectElevated serum triglycerides with Drugclozapine resolved with risperidone in four patients.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectUlcer became worse after Drugtobramycin and gentamycin treatment for 2 days.
1.0000 Adverse-Effect Adverse-EffectUlcer became worse after tobramycin and Druggentamycin treatment for 2 days.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In some cases this seems to happen because Drugspironolactone causes Adverse-Effectdiarrhoea .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Secondary hyperparathyroidism in certain patients with Druglithium Adverse-Effectnephrotoxicity is also possible.
0.9999 Adverse-Effect Adverse-EffectSecondary hyperparathyroidism in certain patients with Druglithium nephrotoxicity is also possible.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect There have been several reported cases of Drugomeprazole - induced Adverse-EffectAIN .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Stroke - like syndrome after Druggold sodium thiomalate induced Adverse-Effectvasomotor reaction .
0.9999 Adverse-Effect Adverse-EffectStroke - like syndrome after Druggold sodium thiomalate induced vasomotor reaction.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectTorsade de pointes represents a potential complication of chronic Drugamiodarone therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Intraventricular Drugvancomycin - induced Adverse-Effectcerebrospinal fluid eosinophilia : report of two patients.
Score Relation Text (Head - Tail)
0.9996 Adverse-Effect The Drugampicillin Adverse-Effectampicillin rash occurring in cases of infectious mononucleosis is well documented.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report an unusual pattern of Adverse-Effectsupravenous hyperpigmentation occurring after DrugCHOP chemotherapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugHydroxyurea - induced Adverse-Effectacute interstitial pneumonitis in a patient with essential thrombocythemia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectGraft versus host - like illness in a child with Drugphenobarbital hypersensitivity.
1.0000 Adverse-Effect Graft versus host - like illness in a child with Drugphenobarbital Adverse-Effecthypersensitivity .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Neutropenia and Adverse-Effectagranulocytosis are risks known to occur with Drugphenothiazines and clozapine.
1.0000 Adverse-Effect Neutropenia and Adverse-Effectagranulocytosis are risks known to occur with phenothiazines and Drugclozapine .
0.9999 Adverse-Effect Adverse-EffectNeutropenia and agranulocytosis are risks known to occur with Drugphenothiazines and clozapine.
0.9998 Adverse-Effect Adverse-EffectNeutropenia and agranulocytosis are risks known to occur with phenothiazines and Drugclozapine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectMilk - alkali syndrome induced by Drug1, 25 ( OH ) 2D in a patient with hypoparathyroidism.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugPregabalin - induced Adverse-Effectcortical negative myoclonus in a patient with neuropathic pain.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Arthritis and Adverse-Effectbursitis in multiple sclerosis patients treated with Druginterferon - beta .
0.9997 Adverse-Effect Adverse-EffectArthritis and bursitis in multiple sclerosis patients treated with Druginterferon - beta .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 53 - year - old man developed Adverse-EffectNMS without rigidity while taking Drugolanzapine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Accordingly, Adverse-Effectcamptocormia is a dose - dependent side effect of Drugvalproate .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a patient who experienced Adverse-EffectLABD shortly after starting Drugcarbamazepine therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugTiclopidine - induced Adverse-Effectaplastic anemia ( TIAA ) is considered very uncommon.
1.0000 Adverse-Effect DrugTiclopidine - induced aplastic anemia ( Adverse-EffectTIAA ) is considered very uncommon.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectDystonia associated with Drugcarbamazepine administration : experience in brain - damaged children.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report on a patient who developed Adverse-Effectacute rhabdomyolysis after taking Drugcerivastatin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect One patient with systemic lupus erythematosus developed Adverse-Effecterythema multiforme after taking Druggriseofulvin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Listeria brain abscess, Pneumocystis pneumonia and Adverse-EffectKaposi's sarcoma after Drugtemozolomide .
0.9999 Adverse-Effect Listeria brain abscess, Adverse-EffectPneumocystis pneumonia and Kaposi's sarcoma after Drugtemozolomide .
0.9999 Adverse-Effect Adverse-EffectListeria brain abscess , Pneumocystis pneumonia and Kaposi's sarcoma after Drugtemozolomide .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In these patients, long - acting Drugoctreotide may trigger Adverse-Effectserious hypoglycemia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugAlbuterol - induced Adverse-Effecthypokalemia and its potential cardiac toxicity are discussed briefly.
0.9997 Adverse-Effect DrugAlbuterol - induced hypokalemia and its potential Adverse-Effectcardiac toxicity are discussed briefly.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : Adverse-EffectInfectious endophthalmitis is a potential complication of intravitreal Drugbevacizumab injection.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectHeat stroke in schizophrenia during Drugclozapine treatment : rapid recognition and management.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectCutaneous reactions to Drugpropylthiouracil and methimazole occur in 3 % - 5 % of adults.
0.9999 Adverse-Effect Adverse-EffectCutaneous reactions to propylthiouracil and Drugmethimazole occur in 3 % - 5 % of adults.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This report describes a probable case of Druginfliximab - induced Adverse-Effectmembranous nephropathy .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugTemozolomide - induced Adverse-Effectdesquamative skin rash in a patient with metastatic melanoma.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This represents the first report of Adverse-Effectnonconvulsive status epilepticus induced by Drugifosfamide .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We present a case of Drugsotalol - induced Adverse-Effectbradycardia reversed by glucagon.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectEye movement disorders in bone marrow transplant patients on Drugcyclosporin and ganciclovir.
0.9999 Adverse-Effect Adverse-EffectEye movement disorders in bone marrow transplant patients on cyclosporin and Drugganciclovir .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The Adverse-Effectphotosensitivity is still present 3 years after the withdrawal of Drugquinine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The clinical picture was identical to that of chloroquine and Drughydroxychloroquine Adverse-Effectmaculopathy .
0.9993 Adverse-Effect The clinical picture was identical to that of Drugchloroquine and hydroxychloroquine Adverse-Effectmaculopathy .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Life - threatening Adverse-Effectinterstitial lung disease associated with Drugtrastuzumab : case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Combining Drugmethylephedrine and Chinese herbal drugs might carry a risk of Adverse-Effectstroke .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Physicians should be aware of the potentially Adverse-Effectlethal side effects of Drugdapsone .
Score Relation Text (Head - Tail)
0.9987 Adverse-Effect The use of pamidronate for hypercalcemia secondary to acute Drugvitamin D Adverse-Effectvitamin D intoxication .
0.9998 Adverse-Effect The use of Drugpamidronate for Adverse-Effecthypercalcemia secondary to acute vitamin D intoxication.
0.9966 Adverse-Effect The use of pamidronate for Adverse-Effecthypercalcemia secondary to acute Drugvitamin D intoxication.
0.9677 Adverse-Effect The use of Drugpamidronate for hypercalcemia secondary to acute Adverse-Effectvitamin D intoxication .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Both patients suddenly became Adverse-Effecthypotensive after injection of Drugchymopapain into a disk.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect PURPOSE : A case of probable Drugenoxaparin - induced Adverse-Effecthepatotoxicity is described.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugLithium - associated Adverse-Effecttransient thyrotoxicosis in 4 Chinese women with autoimmune thyroiditis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The literature search found 12 cases of Adverse-Effectradiation recall caused by Druggemcitabine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Two patients on long - term Druglithium therapy developed the Adverse-Effectnephrotic syndrome .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectFulminant hepatic failure is a rare complication of Drugdisulfiram treatment for alcoholism.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Incidence of Adverse-Effectseizures in pediatric cancer patients treated with Drugimipenem / cilastatin.
1.0000 Adverse-Effect Incidence of Adverse-Effectseizures in pediatric cancer patients treated with imipenem / Drugcilastatin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectIncomplete posterior hyaloid detachment after intravitreal Drugpegaptanib injection in diabetic macular edema.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectSevere corneal toxicity after topical Drugfluoroquinolone therapy : report of two cases.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectTardive oculogyric crisis during treatment with Drugclozapine : report of three cases.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Intravenous Drugvalproate associated with significant Adverse-Effecthypotension in the treatment of status epilepticus.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectAnterior spinal artery syndrome - - a complication of cervical intrathecal Drugphenol injection.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectPericardial hemorrhage due to Drugacetylsalicylic acid in a patient with essential thrombocythemia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect He developed a late Adverse-Effectsecondary infection in some sites treated with Drugimiquimod .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect PURPOSE : To report a case of Adverse-Effectnodular scleritis following Drugalendronate sodium .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectToxic hepatitis due to combination therapy with Drugmethotrexate and etretinate in psoriasis.
0.9999 Adverse-Effect Adverse-EffectToxic hepatitis due to combination therapy with methotrexate and Drugetretinate in psoriasis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugSuccinylcholine - induced Adverse-Effecthyperkalemia in a patient with mucositis secondary to chemotherapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectNonsustained polymorphous ventricular tachycardia during Drugamiodarone therapy for atrial fibrillation complicating cardiomyopathy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : DrugAmphotericin B overdose can be Adverse-Effectfatal in children and infants.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectStupor and fast activity on electroencephalography in a child treated with Drugvalproate .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectNeurological side effects in two patients receiving Druggold injections for rheumatoid arthritis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectIncreased libido in a woman treated with Drugfluvoxamine : a case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Marked Adverse-Effectsinus tachycardia resulting from the synergistic effects of marijuana and Drugnortriptyline .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The Adverse-Effectexophthalmos improved dramatically within 72 hours of the withdrawal of Druglithium .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Hyperglycemia and Adverse-Effectdiabetic coma : possible relationship to diuretic - Drugpropranolol therapy.
1.0000 Adverse-Effect Adverse-EffectHyperglycemia and diabetic coma : possible relationship to diuretic - Drugpropranolol therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectDisseminated cellulitic cryptococcosis in the setting of Drugprednisone monotherapy for pemphigus vulgaris.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a case of prolonged Drugterbinafine - induced Adverse-Effectcholestatic liver disease .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect However, 1 eye had Adverse-Effectvitreous hemorrhage after repeated injections of DrugtPA .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectStuttering priapism complicating Drugwarfarin therapy in a patient with protein C deficiency.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Delayed Adverse-Effectbowel injury is an infrequently observed complication of Drugchromic phosphate administration.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectMalignant mixed mullerian tumor of the uterus in a patient taking Drugraloxifene .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Drug5 - Fluorouracil Adverse-Effectcardiotoxicity complicating treatment of stage IIB cervical cancer - - case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Physicians should be aware that Adverse-EffectPLP can occur after initiation of Drugpaclitaxel .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectGynaecomastia is a rarely reported adverse drug reaction due to Drugisoniazid therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Autopsy findings were consistent with bleomycin and Drugoxygen - induced Adverse-Effectpulmonary damage .
0.9999 Adverse-Effect Autopsy findings were consistent with Drugbleomycin and oxygen - induced Adverse-Effectpulmonary damage .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectPolymyoclonus seizure resulting from accidental injection of Drugtranexamic acid in spinal anesthesia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Pediatric Drugheparin - induced Adverse-Effectthrombocytopenia : management with Danaparoid ( orgaran ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of Adverse-Effectsustained hypotension after administration of parenteral Drugverapamil .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The clinical course suggests that the Adverse-Effectinterstitial pneumonitis was induced by Drughydroxyurea .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect 5 - fluorouracil ( Drug5 - FU ) - associated Adverse-Effectperipheral neuropathy is an uncommon event.
0.9999 Adverse-Effect Drug5 - fluorouracil ( 5 - FU ) - associated Adverse-Effectperipheral neuropathy is an uncommon event.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Abdominal wall ulceration and Adverse-Effectmucinosis secondary to Drugrecombinant human interferon - beta - 1b .
0.9992 Adverse-Effect Adverse-EffectAbdominal wall ulceration and mucinosis secondary to Drugrecombinant human interferon - beta - 1b .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectToxic epidermal necrolysis after the use of high - dose Drugcytosine arabinoside .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectSymptomatic hypoglycemia secondary to a Drugglipizide - trimethoprim / sulfamethoxazole drug interaction.
0.9998 Adverse-Effect Adverse-EffectSymptomatic hypoglycemia secondary to a glipizide - Drugtrimethoprim / sulfamethoxazole drug interaction.
0.9998 Adverse-Effect Adverse-EffectSymptomatic hypoglycemia secondary to a glipizide - trimethoprim / Drugsulfamethoxazole drug interaction.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectAngio - oedema as an unusual tolerable side effect of Drugvoriconazole therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Life - threatening Adverse-Effectacute hyponatraemia induced by low dose Drugcyclophosphamide and indomethacin.
0.9999 Adverse-Effect Life - threatening Adverse-Effectacute hyponatraemia induced by low dose cyclophosphamide and Drugindomethacin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The authors report five additional cases of Drugcapecitabine - induced Adverse-Effectmultifocal leukoencephalopathy .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugChlormadinone acetate Adverse-Effectwithdrawal syndrome under combined androgen blockade for advanced prostate cancer.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectPulmonary fibrosis subsequent to high doses of DrugCCNU for chronic myeloid leukemia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Three distinct types of Drugminocycline - induced Adverse-Effectcutaneous pigmentation have been described.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugDocetaxel - induced Adverse-EffectMeibomian duct inflammation and blockage leading to chalazion formation.
0.9999 Adverse-Effect DrugDocetaxel - induced Meibomian duct inflammation and blockage leading to Adverse-Effectchalazion formation.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugAmikacin - induced Adverse-Effecttype 5 Bartter - like syndrome with severe hypocalcemia.
0.9999 Adverse-Effect DrugAmikacin - induced type 5 Bartter - like syndrome with Adverse-Effectsevere hypocalcemia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectFatal outcome of intravesical Drugformalin instillation, with changes mimicking renal tuberculosis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The use of Drugrituximab has been uncommonly associated with Adverse-Effectdelayed pulmonary toxicity .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectNeuroleptic malignant syndrome in an adolescent receiving Drugolanzapine - lithium combination therapy.
0.9999 Adverse-Effect Adverse-EffectNeuroleptic malignant syndrome in an adolescent receiving olanzapine - Druglithium combination therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSION : Therapy with Drugindapamide may induce Adverse-Effectdiabetes in essential hypertension patients.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugAdriamycin - induced Adverse-Effectcardiomyopathy aggravated by cis - platinum nephrotoxicity requiring dialysis.
Adverse-Effect Adriamycin - induced cardiomyopathy aggravated by Drugcis - platinum Adverse-Effectnephrotoxicity requiring dialysis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectReversible MR imaging and MR spectroscopy abnormalities in association with Drugmetronidazole therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : DrugCefazolin was a probable cause of this patient's Adverse-Effectleukopenia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Evaluation revealed Adverse-Effectelevated serum LTG levels DrugLTG levels and no other etiology for encephalopathy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Three diabetic cases of Adverse-Effectacute dizziness due to initial administration of Drugvoglibose .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Hemodialysis should be performed for rapid reversal of Drugmannitol - induced Adverse-EffectARF .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 54 - year - old man, treated with Drugamiodarone , developed Adverse-Effectthyrotoxicosis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : DrugMetoclopramide may cause reversible Adverse-Effectnonthrombocytopenic vascular - type palpable purpura .
Score Relation Text (Head - Tail)
0.9996 Adverse-Effect Adverse-EffectFatal pulmonary fibrosis following 1, 3 - bis ( 2 - chloroethyl ) - 1 - nitrosourea ( DrugBCNU ) therapy.
Adverse-Effect Adverse-EffectFatal pulmonary fibrosis following Drug1, 3 - bis ( 2 - chloroethyl ) - 1 - nitrosourea ( BCNU ) therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This report presents a potential case of Drugrisperidone - induced Adverse-Effecttardive dyskinesia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To report a case of Adverse-Effectangioedema associated with Druglosartan administration.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A patient developed Adverse-Effectoptic neuropathy while being treated with Drugisoniazid and ethambutol.
1.0000 Adverse-Effect A patient developed Adverse-Effectoptic neuropathy while being treated with isoniazid and Drugethambutol .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectPeripheral nervous system disturbances caused by Drugcytosine arabinoside have rarely been reported.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect These cases demonstrate that DrugCBZ can induce simple Adverse-Effectmotor tics in children.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSION : Adverse-EffectAnterior ischemic optic neuropathy may complicate treatment with Druginterferon alfa .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectOptic neuropathy associated with Drugpenicillamine therapy in a patient with rheumatoid arthritis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectDiffuse alveolar hemorrhage after Drugleflunomide therapy in a patient with rheumatoid arthritis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This is the first reported case of suspected Adverse-EffectDIAN due to Drugcefuroxime .
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect Adverse-EffectGeneralized lichen nitidus with involvement of the palms following Druginterferon alpha treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectHigh - grade endometrial stromal sarcoma after Drugtamoxifen therapy for breast cancer.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Correction of serum electrolyte imbalance prevents Adverse-Effectcardiac arrhythmia during Drugamphotericin B administration.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectOphthalmologic and neurologic findings in two children exposed to Drugvigabatrin in utero.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The exact mechanism of DrugIVIG - associated Adverse-Effectacute renal failure remains unclear.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Due to the severity of the Adverse-Effectrash , Drugtemozolomide was permanently discontinued.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Possible interaction between lopinavir / ritonavir and Drugvalproic Acid exacerbates Adverse-Effectbipolar disorder .
0.9999 Adverse-Effect Possible interaction between Druglopinavir / ritonavir and valproic Acid exacerbates Adverse-Effectbipolar disorder .
0.9999 Adverse-Effect Possible interaction between lopinavir / Drugritonavir and valproic Acid exacerbates Adverse-Effectbipolar disorder .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Retinal dysfunction and Adverse-Effectanterior segment deposits in a patient treated with Drugrifabutin .
1.0000 Adverse-Effect Adverse-EffectRetinal dysfunction and anterior segment deposits in a patient treated with Drugrifabutin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a case of Adverse-EffectEGE manifested as an allergy to Druggemfibrozil .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Myasthenic patients receiving Drugampicillin should be closely monitored for possible Adverse-Effectacute exacerbations .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectHyperpigmentation during Druginterferon - alpha therapy for chronic hepatitis C virus infection.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Primary cutaneous coccidioidomycosis and subsequent Adverse-Effectdrug eruption to Drugitraconazole in a dog.
0.9999 Adverse-Effect Adverse-EffectPrimary cutaneous coccidioidomycosis and subsequent drug eruption to Drugitraconazole in a dog.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectOtotoxicity as a result of Drugcis - platinum administration is well documented.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of pediatric Drugbupropion ingestion resulting in Adverse-Effectmultiple seizures .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Adverse-EffectNephrotic syndrome in a multiple sclerosis patient treated with Druginterferon beta 1a .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugAmifostine - induced Adverse-Effectfever : case report and review of the literature.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectFatal intravascular autoimmune hemolytic anemia after Drugfludarabine treatment for chronic lymphocytic leukemia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report three cases of patients who developed Adverse-Effectleukopenia during Drugolanzapine treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect He became Adverse-Effecthyperkalemic on rechallenge with Drugtimolol and normokalemic following its withdrawal.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectSerious adverse events experienced by patients with chronic heart failure taking Drugspironolactone .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugAminoglutethimide was discontinued until completion of radiotherapy, and the Adverse-Effectrash resolved.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugLeflunomide - induced Adverse-Effecttoxic epidermal necrolysis in a patient with rheumatoid arthritis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Abnormalities of the pupil and visual - evoked potential in Drugquinine Adverse-Effectamblyopia .
0.9999 Adverse-Effect Adverse-EffectAbnormalities of the pupil and visual - evoked potential in Drugquinine amblyopia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectAcute myocardial ischemia following accidental intravenous administration of Drugepinephrine in high concentration.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectHepato - biliary abnormalities secondary to Drugceftriaxone use : a case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectMetabolic acidosis induced by Drugcetrimide - chlorhexidine solution in hydatid cyst surgery.
0.9997 Adverse-Effect Adverse-EffectMetabolic acidosis induced by cetrimide - Drugchlorhexidine solution in hydatid cyst surgery.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Adverse-EffectBone formation induced in an infant by systemic Drugprostaglandin - E2 administration.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugInfliximab - induced Adverse-Effectlupus in Crohn's disease : a case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectProtamine allergy as a complication of Druginsulin hypersensitivity : A case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Additionally, Drugdanazol produces Adverse-Effecthepatocellular damage in approximately 10 % of women.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectThymic enlargement in a patient with juvenile idiopathic arthritis during Drugetanercept therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectEsophageal candidiasis was diagnosed at endoscopy in two patients receiving Drugomeprazole therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Symptoms and Adverse-Effectendoscopic lesions quickly regressed within 1 week of Drugmeloxicam withdrawal.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 61 year - old male patient developed Adverse-Effectgynecomastia after starting Drugtheophylline .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Papilloedema and Adverse-Effecthepatic dysfunction apparently induced by Drugperhexiline maleate ( Pexid ).
0.9997 Adverse-Effect Adverse-EffectPapilloedema and hepatic dysfunction apparently induced by Drugperhexiline maleate ( Pexid ).
0.9997 Adverse-Effect Papilloedema and Adverse-Effecthepatic dysfunction apparently induced by perhexiline maleate ( DrugPexid ).
0.9995 Adverse-Effect Adverse-EffectPapilloedema and hepatic dysfunction apparently induced by perhexiline maleate ( DrugPexid ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Managing Adverse-Effectcardiovascular collapse in severe Drugflecainide overdose without recourse to extracorporeal therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect These Adverse-Effectnail changes gradually disappeared when the dose of Drugclofazimine was reduced.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectReflex sympathetic dystrophy syndrome in renal transplanted patients under immunosuppression with Drugtacrolimus .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSION : Severe and Adverse-Effectsustained ocular hypertension may occur after intravitreal Drugranibizumab .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugOxcarbazepine - induced Drug Reaction with Eosinophilia and Systemic Symptoms ( Adverse-EffectDRESS ).
1.0000 Adverse-Effect DrugOxcarbazepine - induced Adverse-EffectDrug Reaction with Eosinophilia and Systemic Symptoms ( DRESS ).
Adverse-Effect DrugOxcarbazepine - induced Adverse-EffectDrug Reaction with Eosinophilia and Systemic Symptoms ( DRESS ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectSerotonin syndrome induced by transitioning from Drugphenelzine to venlafaxine : four patient reports.
1.0000 Adverse-Effect Adverse-EffectSerotonin syndrome induced by transitioning from phenelzine to Drugvenlafaxine : four patient reports.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectRadiation recall related to Druggemcitabine has been reported in lung and breast cancer.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugHeparin - induced Adverse-Effectthrombocytopenia is a rare and serious complication of anticoagulation therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A patient developed papilloedema and Adverse-Effecthepatic dysfunction while being treated with Drugperhexiline maleate .
0.9997 Adverse-Effect A patient developed Adverse-Effectpapilloedema and hepatic dysfunction while being treated with Drugperhexiline maleate .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectRestless legs syndrome may thus be an adverse effect of DrugIFN alpha treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The responsibility of DrugCCNU in the pathogenesis of Adverse-Effectpulmonary fibrosis seems very likely.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Indolent Adverse-Effectaspergillus arthritis complicating Drugfludarabine - based non - myeloablative stem cell transplantation.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This report suggests that Drugbleomycin Adverse-Effectlung toxicity may be reversible if treated aggressively.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Three days after intravitreal injection of Drugbevacizumab , Adverse-Effectacute ocular ischemic syndrome occurred.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect PURPOSE : To report two cases of Adverse-Effectacute endophthalmitis following intravitreal Drugbevacizumab injection.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : DrugAmphotericin B seems to be the probable cause of the Adverse-Effectseizures .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Acute myocardial infarction due to Adverse-Effectcoronary spasm associated with DrugL - thyroxine therapy.
0.9983 Adverse-Effect Adverse-EffectAcute myocardial infarction due to coronary spasm associated with DrugL - thyroxine therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectHepatotoxicity of Drugparacetamol enhanced by ingestion of alcohol : report of two cases.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Early Adverse-Effectoveranticoagulation with Drugacenocoumarol due to a genetic polymorphism of cytochrome P450 CYP2C9.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectAcute pancreatitis is a known, although rare, complication of Drugmesalamine treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DISCUSSION : The occurrence of Adverse-Effectpriapism in our patient was related to Drugzuclopenthixol .
Score Relation Text (Head - Tail)
0.9986 Adverse-Effect Neurointensive care management of Adverse-Effectraised intracranial pressure caused by severe Drugvalproic acid intoxication.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case of Adverse-Effectnormotensive scleroderma renal crisis after high - dose Drugmethylprednisolone treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectRhabdomyolysis has been recognized as a complication of tocolytic therapy with Drugritodrine hydrochloride .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugIbuprofen - induced Adverse-Effectmeningitis : detection of intrathecal IgG synthesis and immune complexes.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Transtentorial herniation caused by an Adverse-Effectintracranial mass lesion following high - dose Drugmethotrexate .
0.9999 Adverse-Effect Adverse-EffectTranstentorial herniation caused by an intracranial mass lesion following high - dose Drugmethotrexate .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectNeuroleptic malignant syndrome due to Drugrisperidone treatment in a child with Joubert syndrome.
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect Adverse-EffectSkin necrosis after extravasation of low - dose Drugvasopressin administered for septic shock.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Histological examination of the Adverse-Effectdacryolith suggested its derivation from breakdown products of Drugadrenaline .
Score Relation Text (Head - Tail)
0.9994 Adverse-Effect Itraconazole - related increased Drugvincristine Adverse-Effectneurotoxicity : case report and review of literature.
0.9821 Adverse-Effect DrugItraconazole - related increased vincristine Adverse-Effectneurotoxicity : case report and review of literature.
Adverse-Effect Itraconazole - related increased Drugvincristine Adverse-Effectvincristine neurotoxicity : case report and review of literature.
Adverse-Effect DrugItraconazole - related increased Adverse-Effectvincristine neurotoxicity : case report and review of literature.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugPara - aminosalicylic acid - induced Adverse-Effecthypoglycaemia in a patient with diabetic nephropathy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Prolonged severe Drug5 - fluorouracil - associated Adverse-Effectneurotoxicity in a patient with dihydropyrimidine dehydrogenase deficiency.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect BACKGROUND : reports on Adverse-Effectdelated cutaneous reactions to Drugcaptopril have been seldom reported.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Severe leukopenia associated with Adverse-Effectmild hepatotoxicity in an HIV carrier treated with Drugnevirapine .
0.9999 Adverse-Effect Adverse-EffectSevere leukopenia associated with mild hepatotoxicity in an HIV carrier treated with Drugnevirapine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse reaction in a patient with Drugaspirin - induced Adverse-Effectasthma treated with zafirlukast.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectFatal complication of intravesical Drugformalin during control of intractable hemorrhage from radiation cystitis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectCerebral infarcts in a pediatric patient secondary to Drugphenylpropanolamine , a recalled medication.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 45 - year - old woman with thyrotoxicosis developed Adverse-Effectagranulocytosis after treatment with Drugpropylthiouracil .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectFatal interstitial lung disease after Drugerlotinib administration in a patient with radiation fibrosis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectAcute renal failure following intravenous Drugimmunoglobulin therapy in a HIV - infected patient.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Restless legs syndrome and Adverse-Effectperiodic limb movements during sleep probably associated with Drugolanzapine .
1.0000 Adverse-Effect Adverse-EffectRestless legs syndrome and periodic limb movements during sleep probably associated with Drugolanzapine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectPancytopenia associated with Drug5 - aminosalicylic acid use in a patient with Crohn's disease.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The authors report the first case of Drugbucillamine - induced Adverse-Effectgiant mammary hyperplasia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectAcute myeloid leukemia evolving from essential thrombocythemia in two patients treated with Drughydroxyurea .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect There is no consensus on the treatment of Drugticlopidine - induced Adverse-Effectmarrow aplasia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugRisperidone - induced Adverse-Effectpsychosis and depression in a child with a mitochondrial disorder.
0.9999 Adverse-Effect DrugRisperidone - induced psychosis and Adverse-Effectdepression in a child with a mitochondrial disorder.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectStevens - Johnson syndrome in a boy with nephrotic syndrome during Drugprednisolone therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugAcyclovir - induced Adverse-Effectneurotoxicity : concentration - side effect relationship in acyclovir overdose.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSION : DrugAlendronate led to Adverse-Effectnodular scleritis and rechallenge caused recurrence of scleritis.
0.9999 Adverse-Effect CONCLUSION : DrugAlendronate led to nodular scleritis and rechallenge caused recurrence of Adverse-Effectscleritis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectDeposits of plasma proteins in the skin during treatment with Drugcarbamazepine and diphenylhydantoin.
1.0000 Adverse-Effect Adverse-EffectDeposits of plasma proteins in the skin during treatment with carbamazepine and Drugdiphenylhydantoin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugL - asparaginase - provoked Adverse-Effectseizures as singular expression of central nervous toxicity.
0.9984 Adverse-Effect DrugL - asparaginase - provoked seizures as singular expression of Adverse-Effectcentral nervous toxicity .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Provocation of Adverse-Effectnon - convulsive status epilepticus by Drugtiagabine in three adolescent patients.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Nineteen cases of Adverse-Effectallergic contact dermatitis to compound tincture of Drugbenzoin are described.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This case extends the spectrum of Drugfludarabine Adverse-Effectpulmonary toxicity to include pulmonary nodules.
0.9998 Adverse-Effect This case extends the spectrum of Drugfludarabine pulmonary toxicity to include Adverse-Effectpulmonary nodules .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case of Adverse-Effectoculogyric crisis induced by Drugmetoclopramide is described in this paper.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectClostridium difficile toxin - induced colitis after use of Drugclindamycin phosphate vaginal cream.
1.0000 Adverse-Effect Clostridium difficile toxin - induced Adverse-Effectcolitis after use of Drugclindamycin phosphate vaginal cream.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CASE SUMMARIES : Two patients who received Drugifosfamide - containing chemotherapy developed Adverse-EffectNCSE .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The authors describe a case of the Adverse-Effectcatatonia syndrome associated with Drugdisulfiram therapy.
Score Relation Text (Head - Tail)
0.9996 Adverse-Effect Adverse-EffectProlonged prostate - specific antigen response in Drugflutamide withdrawal syndrome despite disease progression.
Adverse-Effect Prolonged prostate - specific antigen response in Drugflutamide Adverse-Effectflutamide withdrawal syndrome despite disease progression.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectAnticonvulsant hypersensitivity syndrome associated with DrugBellamine S , a therapy for menopausal symptoms.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Two weeks following rechallenge with Drugalendronate sodium resulted in recurrence of his Adverse-Effectscleritis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect One patient developed Adverse-Effectlarge intramural esophageal hematoma as a complication of Drugheparin therapy.
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect The patient was diagnosed with Adverse-Effectcarbamazepine toxicity related to the introduction of Drugritonavir .
0.9997 Adverse-Effect The patient was diagnosed with Drugcarbamazepine Adverse-Effectcarbamazepine toxicity related to the introduction of ritonavir.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugL - asparaginase - induced Adverse-Effectsevere necrotizing pancreatitis successfully treated with percutaneous drainage.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We present a case of a Adverse-Effectsustained monomorphic ventricular tachycardia following Drugadenosine infusion.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectTremor : a newly described adverse event with long - term Drugitraconazole therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report 2 patients who developed Adverse-Effectpolyarteritis nodosa following Drugvaccination against hepatitis B .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Three patients receiving Druggold salt treatment for rheumatoid arthritis developed severe Adverse-Effectaplastic anemia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectHemorrhage from a falx meningioma after internal use of low - dose Drugaspirin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugTemozolomide was restarted 2 months later ; the patient again developed a Adverse-Effectfever .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectRenal injury due to Druganastrozole has not been published in the English literature.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Mechanism of Drugtopiramate - induced Adverse-Effectacute - onset myopia and angle closure glaucoma.
0.9999 Adverse-Effect Mechanism of Drugtopiramate - induced acute - onset myopia and Adverse-Effectangle closure glaucoma .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect There is a putative role of Drugliothyronine administration in precipitating or activating Adverse-Effecthyperthyroidism .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect She was treated with Drugacyclovir and subsequently developed Adverse-EffectVZV antigen - positive zoster .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectClostridium difficile colitis associated with Drugcisplatin - based chemotherapy in ovarian cancer patients.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Polysomnographic and pharmacokinetic findings in Druglevodopa - induced augmentation of Adverse-Effectrestless legs syndrome .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectPemphigus foliaceus was seen in a patient with pulmonary tuberculosis during Drugrifampicin therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : Intrathecal Drugbaclofen can Adverse-Effectimpair sexual function and ejaculation in some patients.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Acute Adverse-Effectrenal failure should be recognized as a potential complication of Drugsuramin treatment.
Score Relation Text (Head - Tail)
Adverse-Effect Lower extremity Adverse-Effectarterial thrombosis following sonographically guided Drugthrombin injection of a femoral pseudoaneurysm.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectEEG abnormalities were observed in two of the nine children during Drugchlorambucil therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectSchneiderian first - rank symptoms associated with Drugfluvoxamine treatment : a case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Progression of chronic myeloid leukemia to Adverse-Effectblast crisis during treatment with Drugimatinib mesylate .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectAnaphylaxis from Drugisoniazid is a possible side effect to this commonly prescribed antibiotic.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Differential diagnoses included ocular rosacea with cicatrizing conjunctivitis and Drug5 - FU - induced Adverse-Effectectropion .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of Drugbaclofen Adverse-Effectwithdrawal syndrome resulting from oral baclofen underdosing.
0.9999 Adverse-Effect We report a case of baclofen Adverse-Effectwithdrawal syndrome resulting from oral Drugbaclofen underdosing.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectReversible posterior leukoencephalopathy syndrome in systemic lupus erythematosus with thrombocytopenia treated with Drugcyclosporine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A MEDLINE search identified all the reported cases of Adverse-Effecthypersensitivity reactions to Drugcyclosporine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The mechanism of Adverse-EffectRTA induced by DrugFK506 has not yet been clearly elucidated.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugMethysergide - induced Adverse-Effectretroperitoneal fibrosis : successful outcome and two new laboratory features.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Two renal transplant patients developed Adverse-Effectanemia during treatment of hypertension with Drugenalapril medication.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Thus, the Adverse-Effecteosinophilia myalgia syndrome can be associated with parenteral Drugtryptophan administration.
Score Relation Text (Head - Tail)
Adverse-Effect When measured, the Adverse-Effectserum lithium level had increased Druglithium level had increased 4 - fold during acyclovir therapy.
Adverse-Effect When measured, the Adverse-Effectserum lithium level had increased 4 - fold during Drugacyclovir therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of Adverse-Effectpapillary necrosis in a patient treated with Drugindinavir .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugFluoxetine - related Adverse-Effectdeath in a child with cytochrome P - 450 2D6 genetic deficiency.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectVisual loss after a single small dose of Drugvincristine has never been reported.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectLaryngeal dyspnea in relation to an interaction between Drugacenocoumarol and topical econazole lotion.
0.9999 Adverse-Effect Adverse-EffectLaryngeal dyspnea in relation to an interaction between acenocoumarol and topical Drugeconazole lotion.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect PURPOSE : To report that acute Druglamotrigine poisoning may result in severe Adverse-Effectencephalopathy .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect RESULTS : Extensive Adverse-Effectsquamous metaplasia was found in endometrial glands following Drugprogestin therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect They continued to rise for five more days before Drugsalicylate Adverse-Effecthepatotoxicity was suspected.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To describe a patient with Drugifosfamide - induced Adverse-Effectnonconvulsive status epilepticus .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect After four months, while receiving DrugRH , he developed painful Adverse-Effectbilateral gynaecomastia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Five cases of Drugclindamycin - associated Adverse-Effectpseudomembranous colitis in leukaemic patients are reported.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugTrimethoprim - sulfamethoxazole - induced Adverse-Effecthypersensitivity syndrome associated with reactivation of human herpesvirus - 6.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect However, several case reports have suggested that Drugclozapine could also cause Adverse-EffectTD .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectAtrial fibrillation occurring in a patient taking Drugetanercept plus methotrexate for rheumatoid arthritis.
0.9999 Adverse-Effect Adverse-EffectAtrial fibrillation occurring in a patient taking etanercept plus Drugmethotrexate for rheumatoid arthritis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect RESULTS : All cases developed Adverse-Effectcorneal endothelial deposits after previous use of Drugrifabutin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of Adverse-EffectRTA secondary to DrugFK506 administration in liver transplantation.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect An adverse reaction to DrugIFN was strongly suspected as the cause of Adverse-EffectCHF .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Both PAN and Drugmethotrexate have been independently demonstrated to cause Adverse-Effectsensorineural hearing loss .
0.9999 Adverse-Effect Both DrugPAN and methotrexate have been independently demonstrated to cause Adverse-Effectsensorineural hearing loss .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : DrugAnastrozole may be the causative factor in patients with Adverse-Effectsclerosing glomerulonephritis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectThrombotic thrombocytopenic purpura induced by Drugtrimethoprim - sulfamethoxazole in a Jehovah's Witness.
0.9996 Adverse-Effect Adverse-EffectThrombotic thrombocytopenic purpura induced by trimethoprim - Drugsulfamethoxazole in a Jehovah's Witness.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectSubacute cholestatic hepatitis likely related to the use of Drugsenna for chronic constipation.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectAcute myocardial infarction during high - dose Drugmethylprednisolone therapy for Graves'ophthalmopathy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Only 3 cases of Drugimatinib - induced Adverse-Effecttumor lysis syndrome have been reported.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugCiprofloxacin - induced Adverse-Effecttoxic epidermal necrolysis in a patient with systemic lupus erythematosus.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To report two cases of Adverse-Effectfixed drug eruption induced by Drugmethylphenidate .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Concomitant administration of lithium with Drugolanzapine may place patients at risk for Adverse-EffectNMS .
0.9999 Adverse-Effect Concomitant administration of Druglithium with olanzapine may place patients at risk for Adverse-EffectNMS .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect METHODS : Three patients with apparent Drugitraconazole - induced Adverse-Effectliver injury were studied.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Clinical profile of Drugoxcarbazepine - related Adverse-Effectangioneurotic edema : case report and review.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Our series of 3 patients supports a causal connection between Drugbleomycin and Adverse-Effectscleroderma .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect It is concluded that Adverse-EffectSIADH is an important side effect of Druglorcainide therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Treatment - related Adverse-Effectmyelodysplastic syndrome after Drugtemozolomide for recurrent high - grade glioma.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectSustained hypothyroidism induced by Drugrecombinant alpha interferon in patients with chronic hepatitis C.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectLeukopenia due to parvovirus B19 in a Crohn's disease patient using Drugazathioprine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Bleomycin and Drugcyclophosphamide toxicity simulating Adverse-Effectmetastatic nodules to the lungs in childhood cancer.
0.9998 Adverse-Effect DrugBleomycin and cyclophosphamide toxicity simulating Adverse-Effectmetastatic nodules to the lungs in childhood cancer.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugVerapamil in effort - induced Adverse-Effectangina pectoris in patients with normal coronary arteries.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This is the first report of DrugUFT - induced Adverse-Effectscleroderma - like reaction .
Adverse-Effect This is the first report of DrugUFT Adverse-EffectUFT - induced scleroderma - like reaction .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectSelf - limited edema is a well - recognized complication of Druginsulin therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectCeliac disease onset after Drugpegylated interferon and ribavirin treatment of chronic hepatitis C.
0.9999 Adverse-Effect Adverse-EffectCeliac disease onset after pegylated interferon and Drugribavirin treatment of chronic hepatitis C.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectSexual dysfunction associated with intrathecal Drugbaclofen use : a report of two cases.
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect Adverse-EffectScleromyxedema in a patient with multiple sclerosis and monoclonal gammopathy on Druginterferon beta - 1a .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The cases of DrugCBZ - induced Adverse-EffectSLE reported in the literature were reviewed.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Treatment of Drugcarbimazole - induced Adverse-Effectagranulocytosis and sepsis with granulocyte colony stimulating factor.
1.0000 Adverse-Effect Treatment of Drugcarbimazole - induced agranulocytosis and Adverse-Effectsepsis with granulocyte colony stimulating factor.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Early peritoneal dialysis has not previously been reported for Druglisinopril induced Adverse-Effectmultiorgan failure .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugCyclosporine - induced Adverse-Effectpain syndrome in a child undergoing hematopoietic stem cell transplant.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugBaclofen withdrawal : a cause of prolonged Adverse-Effectfever in the intensive care unit.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectGeneralised cutaneous rash associated with Drugganciclovir therapy has rarely been reported in literature.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugValproate Adverse-Effectembryopathy in three sets of siblings : further proof of hereditary susceptibility.
Adverse-Effect DrugValproate Adverse-EffectValproate embryopathy in three sets of siblings : further proof of hereditary susceptibility.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Granulocytopenia and Adverse-Effectagranulocytosis are considered among the most dangerous adverse effects of Drugclozapine .
1.0000 Adverse-Effect Adverse-EffectGranulocytopenia and agranulocytosis are considered among the most dangerous adverse effects of Drugclozapine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The observations suggest that testicular swelling and Adverse-Effectpain are side effects of Drugdesipramine .
1.0000 Adverse-Effect The observations suggest that Adverse-Effecttesticular swelling and pain are side effects of Drugdesipramine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectNeurologic degeneration associated with Drugnitrous oxide anesthesia in patients with vitamin B12 deficiency.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This is the first report of a Adverse-Effectdisulfiram - like reaction with Drugcefmenoxime .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect METHODS : We report two cases of Adverse-Effectpseudoporphyria caused by Drugnaproxen and oxaprozin.
1.0000 Adverse-Effect METHODS : We report two cases of Adverse-Effectpseudoporphyria caused by naproxen and Drugoxaprozin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case of Adverse-Effectcontact dermatitis due to Drugsodium bisulfite in an ophthalmic solution.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The authors report 2 cases of Adverse-Effectrenal damage associated with Druglithium carbonate treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Cutaneous rashes and Adverse-Effecteruptions can be caused by many medications, including Drugcarbamazepine .
1.0000 Adverse-Effect Adverse-EffectCutaneous rashes and eruptions can be caused by many medications, including Drugcarbamazepine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectAcute generalized exanthematous pustulosis induced by Drugsalazosulfapyridine in a patient with ulcerative colitis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Possible linkage of Drugamprenavir with Adverse-Effectintracranial bleeding in an HIV - infected hemophiliac.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugTamoxifen is suggested to be Adverse-Effectcarcinogenic both through direct genotoxic and epigenetic mechanisms.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Clearance rates of cerivastatin metabolites in a patient with Drugcerivastatin - induced Adverse-Effectrhabdomyolysis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Two cases of Drugsirolimus - associated Adverse-Effectpneumonitis have been reported after cardiac transplantation.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Seizures and Adverse-Effecttransient blindness following intravenous pulse Drugmethylprednisolone in children with primary glomerulonephritis.
1.0000 Adverse-Effect Adverse-EffectSeizures and transient blindness following intravenous pulse Drugmethylprednisolone in children with primary glomerulonephritis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We conclude that MB is an effective treatment for Drugifosfamide - induced Adverse-Effectencephalopathy .
Adverse-Effect We conclude that MB is an effective treatment for Drugifosfamide Adverse-Effectifosfamide - induced encephalopathy .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Possible Adverse-Effectheart failure exacerbation associated with Drugrosiglitazone : case report and literature review.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectAcute interstitial pneumonia induced by DrugONO - 1078 ( pranlukast ), a leukotriene receptor antagonist.
0.9999 Adverse-Effect Adverse-EffectAcute interstitial pneumonia induced by ONO - 1078 ( Drugpranlukast ), a leukotriene receptor antagonist.
Adverse-Effect Acute Adverse-Effectinterstitial pneumonia induced by DrugONO - 1078 ( pranlukast ), a leukotriene receptor antagonist.
Adverse-Effect Acute Adverse-Effectinterstitial pneumonia induced by ONO - 1078 ( Drugpranlukast ), a leukotriene receptor antagonist.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 48 - year - old woman who was treated for thyrotoxicosis with Drugmethimazole developed Adverse-Effectagranulocytosis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Rapid resolution of topiramate - induced Adverse-Effectangle - closure glaucoma with Drugmethylprednisolone and mannitol.
1.0000 Adverse-Effect Rapid resolution of Drugtopiramate - induced Adverse-Effectangle - closure glaucoma with methylprednisolone and mannitol.
0.9998 Adverse-Effect Rapid resolution of topiramate - induced Adverse-Effectangle - closure glaucoma with methylprednisolone and Drugmannitol .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Adverse-EffectRetinopathy in hepatitis C patients due to combination therapy with Drugpegylated interferon and ribavirin.
0.9998 Adverse-Effect Adverse-EffectRetinopathy in hepatitis C patients due to combination therapy with pegylated interferon and Drugribavirin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect However, DrugEO - induced Adverse-Effectnoncardiogenic pulmonary edema has not been reported in human.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case is reported of a child with Adverse-Effectfatal pulmonary fibrosis following DrugBCNU therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectFatal interstitial pneumonitis following high - dose intermittent Drugchlorambucil therapy for chronic lymphocyte leukemia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectAnaphylactic reaction to oral Drugprednisone : a case report and review of the literature.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The following is a report of 2 cases of Drugrifampicin - induced Adverse-Effectrenal insufficiency .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect High - dose Drugmethotrexate - associated Adverse-Effectacute renal failure may be an avoidable complication.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : Adverse-EffectFixed drug rash induced by Drugmethylphenidate is a possible but rare phenomenon.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Here, we report a case of Adverse-Effectangio - oedema associated with DrugVRC therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugMethotrexate - induced Adverse-Effecthepatic necrosis requiring liver transplantation in a patient with rheumatoid arthritis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectScleroderma in association with the use of Drugbleomycin : a report of 3 cases.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Voriconazole ( DrugVRC ) has not previously been reported to cause Adverse-Effectangio - oedema .
0.9999 Adverse-Effect DrugVoriconazole ( VRC ) has not previously been reported to cause Adverse-Effectangio - oedema .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Five days after the fourth dose of Drugvincristine , she presented with Adverse-Effectbilateral ptosis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect However, repeated intracameral DrugtPA injections may cause unwanted complications such as Adverse-Effectvitreous hemorrhage .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Oral Drug25 - hydroxyvitain D3 in treatment of osteomalacia associated with Adverse-Effectileal resection and cholestyramine therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectSideroblastic anemia due to Druglinezolid in a patient with a left ventricular assist device.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectIdiosyncratic pulmonary reactions to Drugnitrofurantoin are not unusual, often presenting as eosinophilic pneumonia.
1.0000 Adverse-Effect Idiosyncratic pulmonary reactions to Drugnitrofurantoin are not unusual, often presenting as Adverse-Effecteosinophilic pneumonia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectHepatotoxicity resolved once Drugerlotinib was discontinued and serum transaminases returned to baseline normal values.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A patient with acute changes suggesting Adverse-Effectacute hepatitis after parenteral Drugamiodarone administration is described.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectCardiomyopathy after widely separated courses of Drugadriamycin exacerbated by actinomycin - D and mithramycin.
0.9984 Adverse-Effect Adverse-EffectCardiomyopathy after widely separated courses of adriamycin exacerbated by actinomycin - D and Drugmithramycin .
0.9980 Adverse-Effect Adverse-EffectCardiomyopathy after widely separated courses of adriamycin exacerbated by Drugactinomycin - D and mithramycin.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Because Adverse-Effectnephrotic syndrome may be induced by DrugIFN therapy, the IFN was stopped.
0.9963 Adverse-Effect Because Adverse-Effectnephrotic syndrome may be induced by IFN therapy, the DrugIFN was stopped.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectDecreased plasma cortisol level during Drugalprazolam treatment of panic disorder : a case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Neurological improvement and rehabilitation potential following Adverse-Effecttoxic myelopathy due to intrathecal injection of Drugdoxorubicin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectPersistent hypoglycemia in a patient with diabetes taking Drugetanercept for the treatment of psoriasis.
Score Relation Text (Head - Tail)
0.6311 Adverse-Effect An unusual cause of Adverse-Effectburn injury : unsupervised use of drugs that contain Adverse-Effectpsoralens .
Adverse-Effect An unusual cause of Drugburn injury : unsupervised use of drugs that contain Adverse-Effectpsoralens .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Intravenous Drughaloperidol is generally well tolerated, but Adverse-Effectmultiform ventricular tachycardia has been reported.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect When DrugDSCG was withdrawn, Adverse-Effecturticaria vanished and the child remained symptom - free.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectGrowth and adrenal suppression in asthmatic children treated with high - dose Drugfluticasone propionate .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Development of Adverse-EffectCrohn's disease in a patient with multiple sclerosis treated with Drugcopaxone .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A young woman developed Adverse-Effectgalactorrhea during treatment with a new Drugdibenzoxazepine antidepressant, amoxapine.
0.9999 Adverse-Effect A young woman developed Adverse-Effectgalactorrhea during treatment with a new dibenzoxazepine antidepressant, Drugamoxapine .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Central pontine myelinolysis manifested by Adverse-Effecttemporary blindness : a possible complication of Druglithium toxicity.
Adverse-Effect Adverse-EffectCentral pontine myelinolysis manifested by temporary blindness : a possible complication of Druglithium toxicity.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Skin manifestations of a case of Drugphenylbutazone - induced Adverse-Effectserum sickness - like reactions .
0.9999 Adverse-Effect Adverse-EffectSkin manifestations of a case of Drugphenylbutazone - induced serum sickness - like reactions.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectCardiac arrest after Drugesmolol administration : a review of acute beta - blocker toxicity.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The Adverse-Effectnephrotic syndrome developed in a patient receiving therapy with Druggold for rheumatoid arthritis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectVitiligo associated with Drugalpha - interferon in a patient with chronic active hepatitis C.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugAll - trans retinoic acid - induced Adverse-Effectfocal myositis , synovitis, and mononeuritis.
0.9995 Adverse-Effect DrugAll - trans retinoic acid - induced focal myositis, Adverse-Effectsynovitis , and mononeuritis.
0.9993 Adverse-Effect DrugAll - trans retinoic acid - induced focal myositis, synovitis, and Adverse-Effectmononeuritis .
Score Relation Text (Head - Tail)
Adverse-Effect Subcutaneous DrugIL - 2 is safe and well tolerated, with a Adverse-Effectmortality rate < 3 %.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of Adverse-EffectIDDM which occurred during Druginterferon therapy for chronic hepatitis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectSevere autoimmune hemolytic anemia following Drugrituximab therapy in a patient with a lymphoproliferative disorder.
Adverse-Effect Severe Adverse-Effectautoimmune hemolytic anemia following Drugrituximab therapy in a patient with a lymphoproliferative disorder.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CCBs should be considered in the treatment of 5 - FU or Drugcapecitabine - induced Adverse-Effectheadaches .
0.9999 Adverse-Effect CCBs should be considered in the treatment of Drug5 - FU or capecitabine - induced Adverse-Effectheadaches .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect She developed a Adverse-Effectsevere urticarial rash 3 weeks following initiation of therapy with DrugEnoxaparin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Three months after starting Drugcitalopram , she experienced episodes of Adverse-Effectchest tightness and dizziness.
1.0000 Adverse-Effect Three months after starting Drugcitalopram , she experienced episodes of chest tightness and Adverse-Effectdizziness .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectInterstitial pneumonia probably associated with Drugsorafenib treatment : An alert of an adverse event.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Detection of activated eosinophils in nasal polyps of an Drugaspirin - induced Adverse-Effectasthma patient.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectToxic epidermal necrolysis resulted after 19 days of treatment with Drug5 - fluorocytosine and amphotericin B.
0.9998 Adverse-Effect Adverse-EffectToxic epidermal necrolysis resulted after 19 days of treatment with 5 - fluorocytosine and Drugamphotericin B .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case of Adverse-Effectsevere aplastic anemia secondary to treatment with Druglenalidomide for multiple myeloma.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectHepatic angiosarcoma occurring after Drugcyclophosphamide therapy : case report and review of the literature.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report three cases of Adverse-Effectsevere hepatotoxicity related to Drugbenzarone , a benzofuran derivative.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Two infants developed Adverse-Effecthyperkalemia shortly after cessation of prolonged DrugACTH therapy for infantile spasms.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect However, acute cardiomyopathy and Adverse-Effectpericarditis secondary to Drugmethylphenidate use has been rarely reported.
0.9999 Adverse-Effect However, Adverse-Effectacute cardiomyopathy and pericarditis secondary to Drugmethylphenidate use has been rarely reported.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We now present four cases of Adverse-EffectRSDS in kidney transplant recipients treated with Drugtacrolimus .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This sulfonamide like nephropathy should be differentiated from Drugacetazolamide - related Adverse-Effectcalcium phosphate nephrolithiasis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectAlveolar - interstitial pneumopathy after Druggold - salts compounds administration, requiring mechanical ventilation.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The epivodes of Adverse-EffectNMS occured under treatment with Drugclozapine , risperidone, and amisulpride.
1.0000 Adverse-Effect The epivodes of Adverse-EffectNMS occured under treatment with clozapine, Drugrisperidone , and amisulpride.
1.0000 Adverse-Effect The epivodes of Adverse-EffectNMS occured under treatment with clozapine, risperidone, and Drugamisulpride .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Cardiac hypersensitivity and Adverse-Effectmyopericarditis have been reported during long - term treatment with Drugmesalazine .
0.9999 Adverse-Effect Adverse-EffectCardiac hypersensitivity and myopericarditis have been reported during long - term treatment with Drugmesalazine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectInterstitial fibrosis of the lung is a potential complication of Drugmethotrexate therapy for psoriasis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The events of Adverse-Effectnon - convulsive status epilepticus subsided following reduction in Drugtiagabine dosages.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSION : This case illustrates a potential link between Adverse-Effectdermatologic and ocular 5 - FU toxicities Drug5 - FU toxicities.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectVisual hallucinations after intravitreal injection of Drugbevacizumab in vascular age - related macular degeneration.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : Symptoms and pathologic changes of Adverse-Effectcolitis are associated with exposure to Drugrofecoxib .
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect Adverse-EffectReye - like syndrome following treatment with the pantothenic acid antagonist, Drugcalcium hopantenate .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Presented is a case of Adverse-Effectacute renal failure induced by Drugacetazolamide therapy for glaucoma.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Such anagen effluvium with Adverse-Effectlichenoid eruption following DrugINH therapy has not been observed previously.
0.9999 Adverse-Effect Such Adverse-Effectanagen effluvium with lichenoid eruption following DrugINH therapy has not been observed previously.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The mean time from starting DrugMMF to the development of Adverse-Effectneutropenia was 4 months.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectPsoriasis - like skin reaction in a patient with rheumatoid arthritis after Drugsulphasalazine therapy.
Score Relation Text (Head - Tail)
0.9996 Adverse-Effect Severe rhabdomyolysis following massive ingestion of Drugoolong tea : Adverse-Effectcaffeine intoxication with coexisting hyponatremia.
0.9990 Adverse-Effect Severe rhabdomyolysis following massive ingestion of oolong tea : Drugcaffeine Adverse-Effectcaffeine intoxication with coexisting hyponatremia.
1.0000 Adverse-Effect Adverse-EffectSevere rhabdomyolysis following massive ingestion of Drugoolong tea : caffeine intoxication with coexisting hyponatremia.
0.9991 Adverse-Effect Adverse-EffectSevere rhabdomyolysis following massive ingestion of oolong tea : Drugcaffeine intoxication with coexisting hyponatremia.
Adverse-Effect Severe Adverse-Effectrhabdomyolysis following massive ingestion of Drugoolong tea : caffeine intoxication with coexisting hyponatremia.
Adverse-Effect Severe Adverse-Effectrhabdomyolysis following massive ingestion of oolong tea : Drugcaffeine intoxication with coexisting hyponatremia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugIbuprofen overdose is usually characterized by Adverse-EffectGI upset , dizziness, and mild sedation.
1.0000 Adverse-Effect DrugIbuprofen overdose is usually characterized by GI upset, Adverse-Effectdizziness , and mild sedation.
0.9999 Adverse-Effect DrugIbuprofen overdose is usually characterized by GI upset, dizziness, and Adverse-Effectmild sedation .
Score Relation Text (Head - Tail)
0.9997 Adverse-Effect Administration of cisplatin in three patients with Drugcarboplatin Adverse-Effecthypersensitivity : is skin testing useful?
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectSevere hepatotoxicity related to Drugbenzarone : a report of three cases with two fatalities.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To report a case of reversible Adverse-Effectnonthrombocytopenic palpable purpura associated with Drugmetoclopramide .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugActinomycin D associated Adverse-Effecthepatic veno - occlusive disease - - a report of 2 cases.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A patient developed typical Adverse-EffectECM after subcutaneous selfinjection of Drugglatiramer acetate for multiple sclerosis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Two patients are described who developed testicular swelling and Adverse-Effectpain during treatment with Drugdesipramine .
1.0000 Adverse-Effect Two patients are described who developed Adverse-Effecttesticular swelling and pain during treatment with Drugdesipramine .
Score Relation Text (Head - Tail)
0.9997 Adverse-Effect Putaminal infarct in Drugmethanol Adverse-Effectmethanol intoxication : case report and role of brain imaging studies.
0.9966 Adverse-Effect Adverse-EffectPutaminal infarct in Drugmethanol intoxication : case report and role of brain imaging studies.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectWorsening of neurologic syndrome in patients with Wilson's disease with initial Drugpenicillamine therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This is the first histologically confirmed case of Adverse-EffectNASH that was aggravated by Drugraloxifene .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This was accepted as evidence for Drugpropranolol being the cause of this Adverse-Effectconduction disorder .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectPeripheral nerve dysfunction is a potentially serious complication of high - dose Drugcytosine arabinoside .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectTorsade de pointes associated with Drugmoxifloxacin : a rare but potentially fatal adverse event.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectHyperammonemia secondary to Drugvalproic acid as a cause of lethargy in a postictal patient.
0.9997 Adverse-Effect Hyperammonemia secondary to Drugvalproic acid as a cause of Adverse-Effectlethargy in a postictal patient.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A small number of Drugoxaliplatin - related Adverse-Effecthemolytic and / or thrombocytopenic reactions have been reported.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Clinical signs of Adverse-Effecthypermagnesemia are an uncommon complication following oral administration of Drugmagnesium sulfate .
Score Relation Text (Head - Tail)
0.9997 Adverse-Effect Adverse-EffectAcute hemorrhagic gastritis associated with Drugacetazolamide intoxication in a patient with chronic renal failure.
Adverse-Effect Acute hemorrhagic gastritis associated with Drugacetazolamide Adverse-Effectacetazolamide intoxication in a patient with chronic renal failure.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectMyasthenia gravis during low - dose DrugIFN - alpha therapy for chronic hepatitis C.
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect His fever resolved, but he developed symptoms consistent with those of Drugchloroquine Adverse-Effectchloroquine toxicity .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectLupus - like syndrome caused by Drug5 - aminosalicylic acid in patients with inflammatory bowel disease.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Intensive high - flux hemodiafiltration is often used in the management of Drugvancomycin Adverse-Effectvancomycin toxicity .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect She developed Adverse-Effectneurotoxicity with an adjustment dosage of Drugvalacyclovir for a cutaneous zoster infection.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugThalidomide was withdrawn from world markets in 1961 following recognition of its Adverse-Effectteratogenic effects .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Itch and Adverse-Effectskin rash from chocolate during Drugfluoxetine and sertraline treatment : case report.
1.0000 Adverse-Effect Adverse-EffectItch and skin rash from chocolate during Drugfluoxetine and sertraline treatment : case report.
0.9999 Adverse-Effect Adverse-EffectItch and skin rash from chocolate during fluoxetine and Drugsertraline treatment : case report.
0.9998 Adverse-Effect Itch and Adverse-Effectskin rash from chocolate during fluoxetine and Drugsertraline treatment : case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To describe a case of Adverse-Effectthrombocytopenia associated with the administration of Druglansoprazole .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Special care should be taken when Adverse-Effectpulmonary symptoms appear in association with Drugticlopidine treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect It is well - recognized that Drugflucloxacillin may occasionally result in Adverse-Effectfatal hepatic injury .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect It is the first case of Drugciprofloxacin - induced Adverse-EffectVBDS successfully treated with tacrolimus.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We attribute the clinical and radiographic findings to Adverse-Effectcytotoxic edema secondary to intrathecal Drugmethotrexate .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugBenzocaine - induced Adverse-Effectmethemoglobinemia has been reported in man, dogs, and cats.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectSquamous - cell carcinoma arising in a basal - cell epithelioma treated with Drug5 - fluorouracil .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugRisperidone withdrawal - related Adverse-Effectrespiratory dyskinesia : a case diagnosed by spirography and fibroscopy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Induction of Adverse-Effectrapid mood cycling during DrugL - dopa treatment in a bipolar patient.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Drug induced Adverse-Effectpolymyositis secondary to Drugleuprolide acetate ( Lupron ) therapy for prostate carcinoma.
0.9999 Adverse-Effect Drug induced Adverse-Effectpolymyositis secondary to leuprolide acetate ( DrugLupron ) therapy for prostate carcinoma.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectAnaphylaxis to intravenous Drugcyclosporine and tolerance to oral cyclosporine : case report and review.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectAcute renal failure in a patient treated by continuous Drugpovidone - iodine mediastinal irrigation.
0.9999 Adverse-Effect Adverse-EffectAcute renal failure in a patient treated by continuous povidone - Drugiodine mediastinal irrigation.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe the first case of Adverse-Effectdisseminated salmonellosis in a patient treated with Drugtemozolomide .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect New onset of Adverse-EffectCrohn's disease during treatment of active ankylosing spondylitis with Drugetanercept .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : Topical Drugbrimonidine may be associated with Adverse-Effectcentral nervous system depression in infants.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectPseudomembranous colitis readily occurs in at least certain population groups receiving Drugtrimethoprim - sulfamethoxazole.
0.9999 Adverse-Effect Adverse-EffectPseudomembranous colitis readily occurs in at least certain population groups receiving trimethoprim - Drugsulfamethoxazole .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We believe that the Adverse-Effectacute renal failure in our patient was associated with Druganastrozole .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Myoclonus was induced and enhanced by DrugL - dopa , developing into Adverse-Effectgeneralized seizures .
1.0000 Adverse-Effect Adverse-EffectMyoclonus was induced and enhanced by DrugL - dopa , developing into generalized seizures.
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect Intravenous administration of levodopa ameliorated a refractory Adverse-Effectakathisia case induced by Druginterferon - alpha .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectCutaneous seeding after ultrasound - guided percutaneous Drugethanol injection for treatment of hepatocellular carcinoma.
Adverse-Effect Adverse-EffectCutaneous seeding after ultrasound - guided percutaneous Drugethanol injection for treatment of hepatocellular carcinoma.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A patient presented with Adverse-Effectdilated cardiomyopathy after many years of overusing an Drugadrenaline inhaler.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Are nasal decongestants safer than rhinitis? A case of Drugoxymetazoline - induced Adverse-Effectsyncope .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Sixteen of 33 patients developed significant hyponatremia and Adverse-Effecthypoosmolality during oral treatment with Druglorcainide .
1.0000 Adverse-Effect Sixteen of 33 patients developed significant Adverse-Effecthyponatremia and hypoosmolality during oral treatment with Druglorcainide .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Serious Drugphenytoin Adverse-Effecthypersensitivity reactions may appear as dermatologic, lymphoid, or hepatic syndromes.
0.9999 Adverse-Effect Serious Drugphenytoin hypersensitivity reactions may appear as Adverse-Effectdermatologic, lymphoid, or hepatic syndromes .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugGemcitabine should be added to the list of drugs known to cause Adverse-Effectradiation recall .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Symptomatic hypocalcaemia and Adverse-Effectrenal impairment associated with Drugbisphosphonate treatment in patients with multiple myeloma.
0.9999 Adverse-Effect Adverse-EffectSymptomatic hypocalcaemia and renal impairment associated with Drugbisphosphonate treatment in patients with multiple myeloma.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In one case, Drugdisulfiram was the only potential Adverse-Effectteratogen exposed to the fetus.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Conventional and diffusion - weighted MRI findings of Drugmethotrexate related Adverse-Effectsub - acute neurotoxicity .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect METHOD : We describe three case - reports concerning Adverse-Effecthaematological adverse effects of Drugquetiapine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Oral intake and Drugacarbose were withheld and the Adverse-Effectileus spontaneously resolved after 2 days.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectKaposi's sarcoma in a patient treated with Drugimatinib mesylate for chronic myeloid leukemia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Drug2 - CdA induces Adverse-Effectlymphocytopenia , which may explain the improvement in this patient's psoriasis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Development of Adverse-Effecttics in a thirteen - year - old male following Drugatomoxetine use.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectGynecomastia in epileptics treated with Drugphenobarbital , phenytoin and fluoresone : two case reports.
1.0000 Adverse-Effect Adverse-EffectGynecomastia in epileptics treated with phenobarbital, Drugphenytoin and fluoresone : two case reports.
1.0000 Adverse-Effect Adverse-EffectGynecomastia in epileptics treated with phenobarbital, phenytoin and Drugfluoresone : two case reports.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The two middle aged women presented with Adverse-Effectrespiratory symptoms after prolonged treatment with Drugnitrofurantoin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Visual system side effects caused by Adverse-Effectparasympathetic dysfunction after Drugbotulinum toxin type B injections.
0.9988 Adverse-Effect Adverse-EffectVisual system side effects caused by parasympathetic dysfunction after Drugbotulinum toxin type B injections.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectNeutropenic colitis during standard dose combination chemotherapy with Drugnedaplatin and irinotecan for testicular cancer.
1.0000 Adverse-Effect Adverse-EffectNeutropenic colitis during standard dose combination chemotherapy with nedaplatin and Drugirinotecan for testicular cancer.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Pharmacokinetic determinants of Drug6 - mercaptopurine Adverse-Effectmyelotoxicity and therapeutic failure in children with acute lymphoblastic leukemia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This supports the well - reported potential of Drugbleomycin to trigger Adverse-Effectacral vascular toxicity .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We discuss a variety of bronchopulmonary complications of Adverse-EffectIBD and their association with Drugsulfasalazine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugMethotrexate - induced Adverse-Effectpapular eruption following treatment of psoriasis has not been previously reported.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectAcute erythroid leukemia after Drugcyclophosphamide therapy for multiple myeloma : report of two cases.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of Drugibuprofen - induced Adverse-Effectmeningitis in an otherwise healthy individual.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Adverse-EffectFatal digoxin poisoning Drugdigoxin poisoning : an unsuccessful resuscitation with use of digoxin - immune Fab.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect BACKGROUND : Adverse-EffectHeadaches have been reported as a potential side effect of Drugcapecitabine therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectTransient cardiac arrhythmias related to Druglopinavir / ritonavir in two patients with HIV infection.
0.9999 Adverse-Effect Adverse-EffectTransient cardiac arrhythmias related to lopinavir / Drugritonavir in two patients with HIV infection.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugChlorambucil - induced Adverse-Effectchromosome damage to human lymphocytes is dose - dependent and cumulative.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A complex pattern of melanonychia and Adverse-Effectonycholysis after treatment with Drugpemetrexed for lung cancer.
1.0000 Adverse-Effect A complex pattern of Adverse-Effectmelanonychia and onycholysis after treatment with Drugpemetrexed for lung cancer.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugNiflumic acid - induced Adverse-Effectskeletal fluorosis : iatrogenic disease or therapeutic perspective for osteoporosis?
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Bone marrow aplasia and Adverse-Effectsevere skin rash after a single low dose of Drugmethotrexate .
0.9999 Adverse-Effect Adverse-EffectBone marrow aplasia and severe skin rash after a single low dose of Drugmethotrexate .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Adverse-EffectDelayed pseudocyst of the pancreas can be a complication of intramuscular DrugL - asparaginase .
Score Relation Text (Head - Tail)
Adverse-Effect Adverse-EffectDrug rash with eosinophilia and systemic symptoms after Drugchlorambucil treatment in chronic lymphocytic leukaemia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The patient was initially treated with hydration and Drugfurosemide but developed Adverse-Effectcongestive heart failure .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect There are now reports of Adverse-Effectliver failure following treatment of childhood cancers with DrugAMD .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Calcification and Adverse-Effectossification of the spinal arachnoid after intrathecal administration of DrugDepo - Medrol .
0.9998 Adverse-Effect Adverse-EffectCalcification and ossification of the spinal arachnoid after intrathecal administration of DrugDepo - Medrol .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The association of central diabetes insipidus ( Adverse-EffectCDI ) with Druglithium use is rare.
0.9999 Adverse-Effect The association of Adverse-Effectcentral diabetes insipidus ( CDI ) with Druglithium use is rare.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugProcainamide - induced Adverse-Effectincessant supraventricular tachycardia in the Wolff - Parkinson - White syndrome.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectUpper tract urothelial malignancy after Drugcyclophosphamide therapy : a case report and literature review.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case of Adverse-Effectsevere visual loss following a single dose of Drugvincristine is described.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Graves'hyperthyroidism following Adverse-Effecttransient thyrotoxicosis during Druginterferon therapy for chronic hepatitis type C.
0.9999 Adverse-Effect Adverse-EffectGraves'hyperthyroidism following transient thyrotoxicosis during Druginterferon therapy for chronic hepatitis type C.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect After 5 weeks of therapy, she stopped taking Drugpantoprazole due to Adverse-Effectgeneral malaise .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Acute severe intoxication with Drugcarbamazepine is associated with Adverse-Effectseizures , coma and respiratory depression.
1.0000 Adverse-Effect Acute severe intoxication with Drugcarbamazepine is associated with seizures, coma and Adverse-Effectrespiratory depression .
0.9999 Adverse-Effect Acute severe intoxication with Drugcarbamazepine is associated with seizures, Adverse-Effectcoma and respiratory depression.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To describe a probable case of Adverse-Effecttransient global amnesia caused by Drugpropafenone .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This clinical course suggests that the Adverse-Effectsensorimotor polyneuropathy may have been caused by Drug5 - ASA .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Vanishing bile duct and Adverse-EffectStevens - Johnson syndrome associated with Drugciprofloxacin treated with tacrolimus.
0.9999 Adverse-Effect Adverse-EffectVanishing bile duct and Stevens - Johnson syndrome associated with Drugciprofloxacin treated with tacrolimus.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectParadoxical precipitation of tonic seizures by Druglorazepam in a child with atypical absence seizures.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugCaptopril - induced Adverse-Effectpulmonary infiltrates with eosinophilia in an infant with congenital heart disease.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Reduction of Drugmethylprednisolone dosage rather than insulin therapy resulted in better control of Adverse-Effectglycemia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of chronic use of DrugHCQ associated with Adverse-Effecttorsade de pointes .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectHepatolithiasis ( intrahepatic stone ) during Drugoctreotide therapy for acromegaly : a case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of Adverse-Effectglaucoma induced by Drugdoxetaxel therapy for metastatic breast cancer.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugLithium therapy was discontinued because of poor compliance to the medication and intolerable Adverse-Effectpolyuria .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Horner's syndrome and Adverse-Effectdemyelinating peripheral neuropathy caused by high - dose Drugcytosine arabinoside .
0.9997 Adverse-Effect Adverse-EffectHorner's syndrome and demyelinating peripheral neuropathy caused by high - dose Drugcytosine arabinoside .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectLeiomyosarcoma in urinary bladder after Drugcyclophosphamide therapy for retinoblastoma and review of bladder sarcomas.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The authors caution that treatment with Drugalprazolam may be complicated by the induction of Adverse-Effectmania .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect To treat hepatitis B, Druginterferon alpha was administered until the proximal Adverse-Effectmuscle weakness developed.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectAggressive endometrial carcinoma in a breast cancer patient treated with Drugtamoxifen with normal transvaginal ultrasonography.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Two children with rheumatic fever developed Adverse-Effectanicteric hepatitis while on high - dose Drugaspirin therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectMyoclonus associated with continuous Drugdobutamine infusion in a patient with end - stage renal disease.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Induction of Adverse-Effectsystemic lupus erythematosus by Druginterferon - gamma in a patient with rheumatoid arthritis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe the case of Adverse-Effectacute hepatitis induced by Druggliclazide , a second generation sulfonylurea.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugAcyclovir produces Adverse-Effectneurologic symptoms that resemble extension of viral infection into the central nervous system.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To report the occurrence of Adverse-Effectanaphylactoid reactions to intraperitoneal Drugcisplatin in 3 patients.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case of polymyositis with Adverse-Effectdilated cardiomyopathy associated with Druginterferon alpha treatment for hepatitis B.
0.9996 Adverse-Effect A case of Adverse-Effectpolymyositis with dilated cardiomyopathy associated with Druginterferon alpha treatment for hepatitis B.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Focal glomerulonephritis and Adverse-Effectinterstitial nephritis in Drugmethicillin - treated, heroin - related infective endocarditis.
0.9999 Adverse-Effect Adverse-EffectFocal glomerulonephritis and interstitial nephritis in Drugmethicillin - treated, heroin - related infective endocarditis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe two women who developed Adverse-EffectHUS after DrugMMC therapy and presented massive pulmonary bleeding.
0.9999 Adverse-Effect We describe two women who developed HUS after DrugMMC therapy and presented Adverse-Effectmassive pulmonary bleeding .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Basilar invagination and Adverse-Effectmid - line skeletal abnormalities due to in utero exposure to Drugphenytoin .
1.0000 Adverse-Effect Adverse-EffectBasilar invagination and mid - line skeletal abnormalities due to in utero exposure to Drugphenytoin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : There is very little published information regarding Drugofloxacin - induced Adverse-Effecttoxic epidermal necrolysis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect While undergoing treatment with Drugalbendazole , he developed Adverse-Effectworsening diarrhea with abdominal pain and fever.
1.0000 Adverse-Effect While undergoing treatment with Drugalbendazole , he developed worsening diarrhea with Adverse-Effectabdominal pain and fever.
0.9999 Adverse-Effect While undergoing treatment with Drugalbendazole , he developed worsening diarrhea with abdominal pain and Adverse-Effectfever .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This is the first report of Adverse-Effectpulmonary hypertension in an adult patient during Druglithium therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectCystoid macular edema in a low - risk patient after switching from Druglatanoprost to bimatoprost.
0.9999 Adverse-Effect Adverse-EffectCystoid macular edema in a low - risk patient after switching from latanoprost to Drugbimatoprost .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The patient's Adverse-Effectarthritis flared after the second infusion of Druginfliximab , which was discontinued.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Therefore, parenteral Drugamiodarone was implicated as the cause of Adverse-Effectacute hepatitis in this patient.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The other patient developed Adverse-Effecttransient intraoperative hypertension immediately after inadvertent submucosal injection of concentrated Drugepinephrine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectSustained ventricular tachycardia in a Drugthalidomide - treated patient with primary plasma - cell leukemia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectVogt - Koyanagi - Harada disease occurring during Druginterferon alpha therapy for chronic hepatitis C.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Following discontinuation of Drugclozapine , she was rechallenged and again was observed to have Adverse-Effectseizures .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Discontinuation of simvastatin and Drugcyclosporine resulted in resolution of Adverse-Effectrhabdomyolysis and normalization of renal function.
1.0000 Adverse-Effect Discontinuation of Drugsimvastatin and cyclosporine resulted in resolution of Adverse-Effectrhabdomyolysis and normalization of renal function.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugClozapine is speculated to cause Adverse-Effectrhabdomyolysis in patients with defective calcium - activated K + channels.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectRecurrent palmar - plantar erythrodysaesthesia following high - dose Drugcytarabine treatment for acute lymphoblastic leukemia.
Adverse-Effect Recurrent Adverse-Effectpalmar - plantar erythrodysaesthesia following high - dose Drugcytarabine treatment for acute lymphoblastic leukemia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectRenal tubular acidosis secondary to DrugFK506 in living donor liver transplantation : a case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 58 - year - old man with rheumatoid arthritis developed Adverse-Effectlichen planus during treatment with Druggold .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We present an AIDS patient with severe and prolonged Adverse-Effectlactic acidosis on Drugstavudine and lamivudine.
0.9999 Adverse-Effect We present an AIDS patient with severe and prolonged Adverse-Effectlactic acidosis on stavudine and Druglamivudine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugDiphenylhydantoin apparently adversely affected both the clinical and biochemical parameters of the Adverse-Effectacute intermittent porphyria .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Two patients who were receiving DrugTolazoline by infusion developed Adverse-Effectduodenal ulceration and subsequent intestinal perforation.
0.9999 Adverse-Effect Two patients who were receiving DrugTolazoline by infusion developed duodenal ulceration and subsequent Adverse-Effectintestinal perforation .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Here, we report a case of DrugRFP - induced Adverse-Effecthypothyroidism without underlying thyroid disease.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectGeneralized maculopapular and papular purpuric eruptions are perhaps the most common Drugthionamide - induced reactions.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This case illustrates the potential Adverse-Effectdecoupling of PSA response from disease status in Drugflutamide withdrawal.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectIntracranial haemorrhage from a meningioma in a patient receiving Drugaspirin prophylaxis : a case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect It is likely that DrugRA contributed to the Adverse-Effectdeterioration in renal function in these patients.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the case of a 21 - year - old female patient with Drugdapsone Adverse-Effecthypersensitivity syndrome .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugNitrofurantoin - induced Adverse-Effectlung disease : two cases demonstrating resolution of apparently irreversible CT abnormalities.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectSevere hemolytic uremic syndrome in an advanced ovarian cancer patient treated with Drugcarboplatin and gemcitabine.
1.0000 Adverse-Effect Adverse-EffectSevere hemolytic uremic syndrome in an advanced ovarian cancer patient treated with carboplatin and Druggemcitabine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Polyarthritis, hepatitis and Adverse-Effectanti - native DNA antibodies after treatment with Drugethambutol and rifampicin.
1.0000 Adverse-Effect Polyarthritis, Adverse-Effecthepatitis and anti - native DNA antibodies after treatment with Drugethambutol and rifampicin.
1.0000 Adverse-Effect Adverse-EffectPolyarthritis , hepatitis and anti - native DNA antibodies after treatment with Drugethambutol and rifampicin.
0.9999 Adverse-Effect Polyarthritis, Adverse-Effecthepatitis and anti - native DNA antibodies after treatment with ethambutol and Drugrifampicin .
0.9999 Adverse-Effect Polyarthritis, hepatitis and Adverse-Effectanti - native DNA antibodies after treatment with ethambutol and Drugrifampicin .
0.9999 Adverse-Effect Adverse-EffectPolyarthritis , hepatitis and anti - native DNA antibodies after treatment with ethambutol and Drugrifampicin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect There was a clear relationship between restarting the DrugAccutane and recurrence of the Adverse-Effecttransient myopia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect To our knowledge, this is the first Adverse-Effectgranulomatous reaction described after Drugcalcium hydroxylapatite injection.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Myelodysplasia terminating in Adverse-Effectacute myeloid leukemia in a hairy cell leukemia patient treated with Drug2 - deoxycoformycin .
0.9999 Adverse-Effect Adverse-EffectMyelodysplasia terminating in acute myeloid leukemia in a hairy cell leukemia patient treated with Drug2 - deoxycoformycin .
Score Relation Text (Head - Tail)
Adverse-Effect Adverse-EffectProconvulsive tendency of imipenem / Drugcilastatin is one of its well - known side effects.
Adverse-Effect Adverse-EffectProconvulsive tendency of Drugimipenem / cilastatin is one of its well - known side effects.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Thoracoscopic biopsy to confirm metastasis revealed instead Adverse-Effectfibrotic lesions apparently attributable to Drugbleomycin or cyclophosphamide.
1.0000 Adverse-Effect Thoracoscopic biopsy to confirm metastasis revealed instead Adverse-Effectfibrotic lesions apparently attributable to bleomycin or Drugcyclophosphamide .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugFlecainide - associated Adverse-Effectpneumonitis with acute respiratory failure in a patient with the LEOPARD syndrome.
0.9998 Adverse-Effect DrugFlecainide - associated pneumonitis with Adverse-Effectacute respiratory failure in a patient with the LEOPARD syndrome.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect We report a case of Adverse-Effectcontact dermatitis due to Drugsodium bisulfite in Tathion eye drops.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectNeutrophilic eccrine hidradenitis mimicking cutaneous vasculitis in a lupus patient : a complication of Drugcyclophosphamide .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect DrugEpsilon - aminocaproic acid and Adverse-Effectrenal complications : case report and review of the literature.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The use of Drugbeclomethasone diproprionate inhaler complicated by the development of an Adverse-Effecteosinophilic pneumonia reaction .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectDe novo absence status of late onset following withdrawal of Druglorazepam : a case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Two elderly women suffered an Adverse-Effectacute deterioration of renal function after treatment with Drugcefoxitin sodium .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Case study : a modified topical treatment regimen for sodium Drugwarfarin - induced Adverse-Effectnecrotizing fasciitis .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Adverse-EffectThyroid dysfunction has been reported in patients with malignant disease treated with Drugrecombinant alpha interferon .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect BACKGROUND : DrugAccutane a Adverse-Effectteratogenic prescription drug licensed to treat severe, recalcitrant nodular acne.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The use of Drugcyclosporin has been associated with the development of Adverse-Effectcholelithiasis in transplant recipients.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSION : These cases suggest that Drugmoxifloxacin may interfere with the healing of Adverse-Effectcorneal ulcers .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The literature on Drugthiabendazole - induced Adverse-Effectcholestasis and its association with sicca complex is reviewed.
0.9999 Adverse-Effect The literature on Drugthiabendazole - induced cholestasis and its association with Adverse-Effectsicca complex is reviewed.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Patients with vitamin B12 deficiency are exceedingly sensitive to Adverse-Effectneurologic deterioration following Drugnitrous oxide anesthesia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Clinicians should include Drugphenolphthalein in their list of possible causes of drug - induced Adverse-EffectTEN .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugStatin - associated Adverse-Effectmyasthenia gravis : report of 4 cases and review of the literature.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Fever, pulmonary infiltrates, and Adverse-Effectpleural effusion following Drugacyclovir therapy for herpes zoster ophthalmicus.
0.9999 Adverse-Effect Adverse-EffectFever , pulmonary infiltrates, and pleural effusion following Drugacyclovir therapy for herpes zoster ophthalmicus.
0.9999 Adverse-Effect Fever, Adverse-Effectpulmonary infiltrates , and pleural effusion following Drugacyclovir therapy for herpes zoster ophthalmicus.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect However, other factors or drugs ( e. g. Drugcresol ) are thought to induce Adverse-EffectMH .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report two cases of Adverse-Effectneutropenia following Drugcaptopril use in cardiac patients with trisomy 21.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Life - threatening Adverse-Effectalterations in heart rate after the use of Drugadenosine in atrial flutter.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case of Adverse-Effectliver damage following treatment with DrugDanazol for fibrocystic breast disease is reported.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Alopecia, nausea, and Adverse-Effectvomiting were attributed to the Drugcyclophosphamide component of the therapy.
1.0000 Adverse-Effect Alopecia, Adverse-Effectnausea , and vomiting were attributed to the Drugcyclophosphamide component of the therapy.
1.0000 Adverse-Effect Adverse-EffectAlopecia , nausea, and vomiting were attributed to the Drugcyclophosphamide component of the therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In one case, the readministration of Drugriluzole was followed by the relapse of Adverse-Effecthepatitis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectSubfulminant hepatitis B after Druginfliximab in Crohn's disease : need for HBV - screening?
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectSystemic capillary leak syndrome after Druggranulocyte colony - stimulating factor ( G - CSF ).
0.9992 Adverse-Effect Adverse-EffectSystemic capillary leak syndrome after granulocyte colony - stimulating factor ( DrugG - CSF ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Markedly Adverse-Effectincreased pigmementation of skin immediately overlying veins used for multiple Drug5 - fluorouracil infusions was noted.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectSevere hyperkalemia as a complication of Drugtimolol , a topically applied beta - adrenergic antagonist.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This is the second report of Adverse-Effectlactic acidosis in a patient on Drugstavudine and lamivudine.
1.0000 Adverse-Effect This is the second report of Adverse-Effectlactic acidosis in a patient on stavudine and Druglamivudine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Drug - induced Adverse-Effecteosinophilia is a non - dose - dependent side effect of Drugclozapine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A review of the literature showed no previous description of this pattern in Drugbenzodiazepine Adverse-Effectcoma .
0.9993 Adverse-Effect A review of the literature showed no previous description of this pattern in Drugbenzodiazepine Adverse-Effectbenzodiazepine coma .
0.9159 Adverse-Effect A review of the literature showed no previous description of this pattern in Adverse-Effectbenzodiazepine coma Adverse-Effectcoma .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of intrathecal Drugmethotrexate Adverse-Effectneurotoxicity manifesting as left arm weakness and aphasia.
0.9998 Adverse-Effect We report a case of intrathecal Drugmethotrexate neurotoxicity manifesting as left arm weakness and Adverse-Effectaphasia .
0.9997 Adverse-Effect We report a case of intrathecal Drugmethotrexate neurotoxicity manifesting as Adverse-Effectleft arm weakness and aphasia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Prior neurologic illness and the syndrome of irreversible Druglithium - effectuated Adverse-Effectneurotoxicity ( SILENT ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Herein we report four patients who underwent liver transplantation and developed Adverse-Effectneutropenia while receiving DrugMMF .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Multiple myeloma complicated by Adverse-Effectcongestive heart failure following first administration of Drugrecombinant alpha - interferon .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Thus, Drugtacrolimus - induced Adverse-EffectHUS is a rare cause of ARF in nephrotic syndrome.
0.9999 Adverse-Effect Thus, Drugtacrolimus - induced HUS is a rare cause of Adverse-EffectARF in nephrotic syndrome.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect According to the Naranjo probability scale, the Adverse-Effectpapular eruption was probably caused by Drugmethotrexate .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectCerebral demyelinating disease developed in a patient during adjuvant therapy with Druglevamisole for malignant melanoma.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect However, re - initiation of Drugsunitinib treatment was followed by Adverse-Effectbilateral breast enlargement again.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Two patients developed Adverse-Effectdiabetic coma when taking a combination of a Drugthiazide diuretic and propranolol.
1.0000 Adverse-Effect Two patients developed Adverse-Effectdiabetic coma when taking a combination of a thiazide diuretic and Drugpropranolol .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Surprisingly, we found that three patients appeared to develop Adverse-Effecttardive OGC while taking Drugclozapine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect So far, few cases of Adverse-Effectpulmonary side effects caused by Drugticlopidine have been reported.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSION : The present findings suggest that Drugfluvoxamine can cause Adverse-Effectincreased libido in some patients.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectRenal hypophosphatemia in this patient was caused by the erroneous intake of 1 g Drugdoxycycline .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectFatal pulmonary fibrosis induced by Drugpaclitaxel : a case report and review of the literature.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectAdrenal suppression in a fetus due to administration of Drugmethylprednisolone has hitherto been rarely published.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Cis - retinoic acid ( DrugRA ) may further increase the risk of developing Adverse-EffectBMTN .
0.9999 Adverse-Effect DrugCis - retinoic acid ( RA ) may further increase the risk of developing Adverse-EffectBMTN .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe 3 cases of Drugdiphenhydramine - induced Adverse-Effectcardiac toxicity that were responsive to bicarbonate.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugPropoxyphene - induced Adverse-Effectwide QRS complex dysrhythmia responsive to sodium bicarbonate - - a case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectPleuropulmonary fibrosis after long - term treatment with the dopamine agonist Drugpergolide for Parkinson Disease.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Acute onset of Adverse-Effectnephrotic syndrome during Druginterferon - alpha retreatment for chronic active hepatitis C.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectSweet's syndrome associated with Drugsargramostim ( granulocyte - macrophage colony stimulating factor ) treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the first case of Drugdoxycycline - induced Adverse-Effecthypoglycemia in a young nondiabetic man.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Under the suspicion of Drugamiodarone - induced Adverse-Effectacute pancreatitis , amiodarone was substituted by propafenone.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A diagnosis of Druginfliximab - induced Adverse-Effectlupus was made and the drug treatment was withdrawn.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Aggressive management of Drugdoxorubicin - induced Adverse-Effectcardiomyopathy associated with'low'doses of doxorubicin.
0.9945 Adverse-Effect Aggressive management of doxorubicin - induced Adverse-Effectcardiomyopathy associated with'low'doses of Drugdoxorubicin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectHypertension develops in most patients after transplantation when immunosuppression is based on Drugcyclosporine and prednisone.
1.0000 Adverse-Effect Adverse-EffectHypertension develops in most patients after transplantation when immunosuppression is based on cyclosporine and Drugprednisone .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect However, each infant demonstrated Adverse-Effecthemodynamic decompensation shortly after Drugverapamil administration and required cardiopulmonary resuscitation.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case of Adverse-Effectaseptic pleuropericarditis in a patient with chronic plaque psoriasis under Drugmethotrexate therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of a Adverse-Effectbullous lichenoid eruption due to the intake of Drugcaptopril .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Therapy with DrugIFN - beta has rarely been associated with the development of Adverse-Effectautoimmune disorders .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect The side effects of DrugMMF , such as Adverse-Effectbone marrow toxicity , have been reported.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectHypoglycemia induced by long - acting Drugsomatostatin analogues in a patient with nonfunctional neuroendocrine tumor.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect PURPOSE : Symptomatic Adverse-Effectvisual field constriction thought to be associated with Drugvigabatrin has been reported.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect An 11 - day - old infant became lethargic and Adverse-Effectapneic after a single drop of Drugbrimonidine .
1.0000 Adverse-Effect An 11 - day - old infant became Adverse-Effectlethargic and apneic after a single drop of Drugbrimonidine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Ballistic movements due to Adverse-Effectischemic infarcts after intravenous Drugheroin overdose : report of two cases.
0.9999 Adverse-Effect Adverse-EffectBallistic movements due to ischemic infarcts after intravenous Drugheroin overdose : report of two cases.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Although myelosuppression is mild, immunosuppression and Adverse-Effectsuperinfection are potential hazards of treatment with DrugDCF .
0.9999 Adverse-Effect Although myelosuppression is mild, Adverse-Effectimmunosuppression and superinfection are potential hazards of treatment with DrugDCF .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect To our knowledge, this recurrence of Drugamiodarone Adverse-Effectpulmonary toxicity has not been reported previously.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSION : Adverse-EffectSquamous metaplasia in these cases appears to be a consequence of Drugprogestin therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a patient in whom Adverse-Effectnoncardiogenic pulmonary edema developed during intrabiliary infusion of Drugmonooctanoin .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Occurrence of withdrawal Adverse-Effectdyskinesia indicates that the neuroleptic effects of Drugamoxapine may be clinically significant.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Adverse-EffectPulmonary fibrosis is a severe complication associated with Drugbis - chloronitrosourea ( BCNU ) therapy.
0.9997 Adverse-Effect Adverse-EffectPulmonary fibrosis is a severe complication associated with bis - chloronitrosourea ( DrugBCNU ) therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Clinicians should be aware of the possibility that Drugvinorelbine may cause Adverse-EffectSIADH and possibly hypokalemia.
1.0000 Adverse-Effect Clinicians should be aware of the possibility that Drugvinorelbine may cause SIADH and possibly Adverse-Effecthypokalemia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Early recognition of Adverse-Effectrenal toxicity of high - dose Drugmethotrexate therapy : a case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectReactivation of cytomegalovirus probably followed the treatment of Wegener's granulomatosis with corticosteroids and Drugazathioprine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectInfections are a major adverse effect during the treatment with Druganti - TNF - alpha .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A Adverse-Effect15 - kg weight gain developed in a patient during the third week of Drugibuprofen therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Nephrogenic diabetes insipidus ( Adverse-EffectNDI ) is a well - documented complication of Druglithium use.
1.0000 Adverse-Effect Adverse-EffectNephrogenic diabetes insipidus ( NDI ) is a well - documented complication of Druglithium use.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Introduction of Drugetanercept was also clinically effective but followed by development of Adverse-Effectsevere heart failure .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Nineteen cases of unusual enhanced Drugvincristine Adverse-Effectneurotoxicity related to itraconazole have been reported in children.
0.9999 Adverse-Effect Nineteen cases of unusual enhanced vincristine Adverse-Effectneurotoxicity related to Drugitraconazole have been reported in children.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugPropranolol : an unrecognized cause of Adverse-Effectcentral nervous system dysfunction in patients undergoing cardiopulmonary bypass.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectSevere acidosis in patients taking Drugmetformin - - rapid reversal and survival despite high APACHE score.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report on a child with fatal Drugvalproate - related Adverse-Effecthepatotoxic effects despite this supplementation.
Adverse-Effect We report on a child with Adverse-Effectfatal Drugvalproate - related hepatotoxic effects despite this supplementation.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectHypogammaglobulinemia associated with Druggold therapy : evidence for a partial maturation blockade of B cells.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Erythromycin is a macrolide antibiotic that may increase the risk of Druglovastatin - induced Adverse-Effectrhabdomyolysis .
0.9997 Adverse-Effect DrugErythromycin is a macrolide antibiotic that may increase the risk of lovastatin - induced Adverse-Effectrhabdomyolysis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The mechanism of Adverse-Effectanaphylactoid reaction to Drugzomepirac in this case, therefore, remains unclear.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect However, the occurrence and management of Adverse-Effectakathisia induced by Drugfluvoxamine have not been described.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Upon discontinuation of DrugMTX , her Adverse-Effectascites resolved, and her arthritis became more active.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectPulmonary fibrosis is a complication of Drugpaclitaxel therapy that may occur despite treatments with corticosteroids.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Onset of male Adverse-Effectgynaecomastia in a patient treated with Drugsunitinib for metastatic renal cell carcinoma.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectMethemoglobinemia after axillary block with Drugbupivacaine and additional injection of lidocaine in the operative field.
0.9999 Adverse-Effect Adverse-EffectMethemoglobinemia after axillary block with bupivacaine and additional injection of Druglidocaine in the operative field.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Acute dystonia with Adverse-Effectthalamic and brainstem lesions after initial Drugpenicillamine treatment in Wilson's disease.
0.9999 Adverse-Effect Adverse-EffectAcute dystonia with thalamic and brainstem lesions after initial Drugpenicillamine treatment in Wilson's disease.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect In two patients Drugclozapine was reinstated after risperidone was discontinued ; Adverse-Effectserum triglyceride levels increased .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugNifedipine may induce, or aggravate, pre - existing, Adverse-Effectgastro - oesophageal reflux .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A major limitation in the use of Drugamphotericin B is its potential to cause Adverse-Effectnephrotoxicity .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect After receiving 3 doses of ifosfamide / Drugmesna , she was found to be Adverse-Effectunresponsive .
1.0000 Adverse-Effect After receiving 3 doses of Drugifosfamide / mesna, she was found to be Adverse-Effectunresponsive .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectRhabdomyolysis caused by tocolysis with oral Drugritodrine hydrochloride in a pregnant patient with myotonic dystrophy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case of Adverse-EffectSIADH associated with Drugdesipramine treatment in an elderly depressed woman is described.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We assume that DrugrIFN - gamma induced the de novo development of Adverse-EffectSLE in our patient.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectHypernatraemia induced by Drugsodium polystyrene sulphonate ( Kayexalate ) in two extremely low birth weight newborns.
0.9997 Adverse-Effect Adverse-EffectHypernatraemia induced by sodium polystyrene sulphonate ( DrugKayexalate ) in two extremely low birth weight newborns.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugRifampicin - induced Adverse-Effectadrenal insufficiency in the acquired immunodeficiency syndrome : difficulties in diagnosis and treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugRituximab - CHOP induced Adverse-Effectinterstitial pneumonitis in patients with disseminated extranodal marginal zone B cell lymphoma.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Early - onset Adverse-Effectacute transverse myelitis following Drughepatitis B vaccination and respiratory infection : case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case is presented which illustrates a probably Adverse-Effectfatal interaction between Drugminoxidil and a coagulation disorder.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A patient developed transient, Adverse-Effectacute myopia while on Drugisotretinoin ( Accutane ) therapy for acne.
0.9999 Adverse-Effect A patient developed transient, Adverse-Effectacute myopia while on isotretinoin ( DrugAccutane ) therapy for acne.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A patient that received Drugmethadone for cancer - associated pain developed Adverse-Effectmyoclonus as a side effect.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Recovery of the Adverse-Effecttubular dysfunction took 15 days following cessation of the offending drug, DrugAmikacin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectRenal toxicities have been reported in less than one percent of the patients receiving Drugciprofloxacin therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Myoglobinuria and Adverse-Effectacute renal failure were observed in two patients with Drugvasopressin - treated gastrointestinal hemorrhage.
0.9999 Adverse-Effect Adverse-EffectMyoglobinuria and acute renal failure were observed in two patients with Drugvasopressin - treated gastrointestinal hemorrhage.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugValproic acid induced Adverse-Effectcoma is presented in an adult patient without a history of metabolic disease.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report two patients with Adverse-Effectinfectious mononucleosis - like syndrome induced by Drugsalazosulfapyridine ( SASP ).
0.9999 Adverse-Effect We report two patients with Adverse-Effectinfectious mononucleosis - like syndrome induced by salazosulfapyridine ( DrugSASP ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect over the past 3 years there have been several reports of Adverse-Effectuveitis associated with Drugrifabutin therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectPosterior leukoencephalopathy following Drugcisplatin , bleomycin and vinblastine therapy for germ cell tumor of the ovary.
0.9999 Adverse-Effect Adverse-EffectPosterior leukoencephalopathy following cisplatin, Drugbleomycin and vinblastine therapy for germ cell tumor of the ovary.
0.9998 Adverse-Effect Adverse-EffectPosterior leukoencephalopathy following cisplatin, bleomycin and Drugvinblastine therapy for germ cell tumor of the ovary.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectColonic mucosal necrosis following administration of Drugcalcium polystryrene sulfonate ( Kalimate ) in a uremic patient.
0.9999 Adverse-Effect Adverse-EffectColonic mucosal necrosis following administration of calcium polystryrene sulfonate ( DrugKalimate ) in a uremic patient.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Two patients are described in whom subtle Adverse-Effectcognitive impairments are associated with therapeutic doses of Drugamoxapine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Thus, Adverse-Effecttardive seizures in our cases are thought to be related to Drugpiperacillin and cefotiam.
0.9999 Adverse-Effect Thus, Adverse-Effecttardive seizures in our cases are thought to be related to piperacillin and Drugcefotiam .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectSecondary leukemia in a child with neuroblastoma while on oral Drugetoposide : what is the cause?
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The incidence of Adverse-Effectangioedema secondary to Druglosartan , an angiotensin II receptor antagonist, is unknown.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case report of a patient with probable cisplatin and Drugbleomycin - induced Adverse-EffectTMA is presented.
0.9998 Adverse-Effect A case report of a patient with probable Drugcisplatin and bleomycin - induced Adverse-EffectTMA is presented.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Adverse-EffectSkin necrosis secondary to Druglow - molecular weight heparin in a patient with antiphospholipid antibody syndrome.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect These case reports provide evidence that Drug5 - aminosalicylic acid may induce Adverse-Effectacute pancreatitis after long term treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The fifth patient exhibited paraesthesia and Adverse-Effectagitation caused by Drugolanzapine that was misdiagnosed as psychotic agitation.
0.9999 Adverse-Effect The fifth patient exhibited Adverse-Effectparaesthesia and agitation caused by Drugolanzapine that was misdiagnosed as psychotic agitation.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectSevere respiratory syncytial virus pulmonary infection in a patient treated with Drugfludarabine for chronic lymphocytic leukemia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report here a case of cardiovascular and Adverse-Effectneurological depression induced by Drugoxymetalzoline in a toddler.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Dihydropyrimidine dehydrogenase deficiency : a pharmacogenetic defect causing Adverse-Effectsevere adverse reactions to Drug5 - fluorouracil - based chemotherapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectThrombotic stroke associated with the use of Drugporcine factor VIII in a patient with acquired haemophilia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe four patients who had Adverse-Effectseizures while receiving Drugofloxacin ; no other causes were evident.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report two adults who received gabapentin ( DrugGBP ) and subsequently developed Adverse-Effectbehavioural side effects .
0.9999 Adverse-Effect We report two adults who received Druggabapentin ( GBP ) and subsequently developed Adverse-Effectbehavioural side effects .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect When tuberculosis patients on Drugisoniazid eat certain varieties of fish they may develop a Adverse-Effecthistamine reaction .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of Adverse-Effectexfoliative dermatitis clearly linked to intravenous and intraperitoneal administration of Drugtobramycin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Within 24 hours of fluid restriction and cessation of Drugdesmopressin , her symptoms and Adverse-Effecthyponatremia resolved.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Hepatitis with bridging fibrosis and Adverse-Effectreversible hepatic insufficiency in a woman with rheumatoid arthritis taking Drugmethotrexate .
1.0000 Adverse-Effect Adverse-EffectHepatitis with bridging fibrosis and reversible hepatic insufficiency in a woman with rheumatoid arthritis taking Drugmethotrexate .
1.0000 Adverse-Effect Hepatitis with Adverse-Effectbridging fibrosis and reversible hepatic insufficiency in a woman with rheumatoid arthritis taking Drugmethotrexate .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 64 - year - old man with schizophrenia developed Adverse-Effectmyoclonic jerks when given higher doses of Drugquetiapine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectAcute renal failure is a rare complication following the administration of intravenous Drugimmunoglobulin ( IVIG ).
1.0000 Adverse-Effect Acute Adverse-Effectrenal failure is a rare complication following the administration of intravenous Drugimmunoglobulin ( IVIG ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect It is concluded that simultaneous administration of ciprofloxacin and tazobactam / Drugpiperacillin may cause marked Adverse-Effectthrombocytosis .
0.9999 Adverse-Effect It is concluded that simultaneous administration of ciprofloxacin and Drugtazobactam / piperacillin may cause marked Adverse-Effectthrombocytosis .
0.9999 Adverse-Effect It is concluded that simultaneous administration of Drugciprofloxacin and tazobactam / piperacillin may cause marked Adverse-Effectthrombocytosis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The present report describes the first case of Adverse-Effectacute pancreatitis associated with Drugdanazol treatment of endometriosis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Emergence of Adverse-EffectPhiladelphia positive chronic myeloid leukaemia during treatment with Drughydroxyurea for Philadelphia negative essential thrombocythaemia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The patient experienced muscle twitches, tremulousness, and Adverse-Effectanxiety on day 17 of Drugfoscarnet therapy.
1.0000 Adverse-Effect The patient experienced muscle twitches, Adverse-Effecttremulousness , and anxiety on day 17 of Drugfoscarnet therapy.
0.9999 Adverse-Effect The patient experienced Adverse-Effectmuscle twitches , tremulousness, and anxiety on day 17 of Drugfoscarnet therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectScrotal ulceration induced by Drugall - trans retinoic acid in a patient with acute promyelocytic leukemia.
Adverse-Effect Adverse-EffectScrotal ulceration induced by all - trans Drugretinoic acid in a patient with acute promyelocytic leukemia.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Acute Drugesmolol Adverse-Effectesmolol toxicity may be self - limiting because of its extremely short half - life.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We present a surprising case of a woman schizophrenic patient treated with Drugclozapine suffering from Adverse-EffectEPS .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This is the first description, to our knowledge, of Adverse-Effectductopenia apparently caused by Drugclindamycin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect To our knowledge, this case is the first published report of Druglevofloxacin - induced Adverse-EffectTEN .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectCutaneous sarcoidosis during Druginterferon alfa and ribavirin treatment of hepatitis C virus infection : two cases.
0.9997 Adverse-Effect Adverse-EffectCutaneous sarcoidosis during interferon alfa and Drugribavirin treatment of hepatitis C virus infection : two cases.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectLichen planus induced by Drughepatitis B vaccination : a new case and review of the literature.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectContact dermatitis due to Drugbudesonide : report of five cases and review of the Japanese literature.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Potential mechanisms involved in the occurrence of Adverse-Effectischemic colitis in patients receiving Drugtegaserod are also discussed.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In four patients, Adverse-Effectspasm occurred spontaneous and in one patient after 0. 05 mg of Drugergonovine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect There is a dose - effect relationship between Drugdoxorubicin and the incidence of Adverse-Effectsymptomatic cardiac failure .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A rechallenge, performed in both patients, confirmed the diagnosis of Drugmesalamine - induced Adverse-Effectpancreatitis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSION : The findings in these two patients suggest that Drugcolchicine may Adverse-Effectdelay corneal wound healing .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 69 - year - old man developed Adverse-Effectpure red cell aplasia after taking Drugfenoprofen for ten months.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect New onset of CD may be considered as an Adverse-Effectimmune - mediated injury induced by Drugetanercept .
0.9999 Adverse-Effect New onset of Adverse-EffectCD may be considered as an immune - mediated injury induced by Drugetanercept .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Three patients with no history of asthma or allergy developed Adverse-Effectbronchospasm while taking Drugpropranolol for hypertension.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect OBJECTIVE : To report a case of Adverse-EffectCarbamazepine toxicity following the administration of DrugOxybutynin and Dantrolene.
0.9995 Adverse-Effect OBJECTIVE : To report a case of DrugCarbamazepine Adverse-EffectCarbamazepine toxicity following the administration of Oxybutynin and Dantrolene.
0.9984 Adverse-Effect OBJECTIVE : To report a case of Adverse-EffectCarbamazepine toxicity following the administration of Oxybutynin and DrugDantrolene .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The delayed Adverse-Effectencephalopathy developed 9 and 22 months respectively after the first dose of intrathecal Drugmethotrexate .
Score Relation Text (Head - Tail)
0.9977 Adverse-Effect Hepatotoxicity associated with choline magnesium trisalicylate : case report and review of Drugsalicylate - induced Adverse-Effecthepatotoxicity .
Adverse-Effect Adverse-EffectHepatotoxicity associated with Drugcholine magnesium trisalicylate : case report and review of salicylate - induced hepatotoxicity.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugSulfasalazine has been associated with Adverse-Effectbronchopulmonary complications of inflammatory bowel disease ( IBD ) in adults.
1.0000 Adverse-Effect DrugSulfasalazine has been associated with bronchopulmonary complications of inflammatory bowel disease ( Adverse-EffectIBD ) in adults.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugZoledronic acid - induced Adverse-Effectsevere hypocalcaemia in a prostate cancer patient with extensive osteoblastic bone metastases.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugInfliximab therapy may cause a Adverse-Effectlupus - like syndrome that is reversible upon discontinuing this agent.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DISCUSSION : This case shows that switching to Drugzidovudine potentially can lead to a Adverse-Effecthyperlactatemia relapse .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 15 - year follow - up of Drugphenytoin - induced Adverse-Effectunilateral gingival hyperplasia : a case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This finding suggests that Drugfluvoxamine can precipitate Adverse-EffectSchneiderian first - rank symptoms in some susceptible patients.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The hearing impairment and Adverse-Effecttinnitus were gradually reduced after DrugPTU withdrawal and corticosteroid and azathioprine treatment.
0.9989 Adverse-Effect The Adverse-Effecthearing impairment and tinnitus were gradually reduced after DrugPTU withdrawal and corticosteroid and azathioprine treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The changes were progressive regardless of discontinuation of Drugcyclophosphamide and led to Adverse-Effectsevere restrictive ventilatory defect .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectSevere hyperkalemia occurred in a patient with radiation pneumonitis and glaucoma shortly after beginning Drugprednisone therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectGlomerulonephritis in Drugprocainamide induced lupus erythematosus : report of a case and review of the literature.
1.0000 Adverse-Effect Glomerulonephritis in Drugprocainamide induced Adverse-Effectlupus erythematosus : report of a case and review of the literature.
Score Relation Text (Head - Tail)
0.9983 Adverse-Effect Atrial fibrillation was induced by diltiazem in two patients and Drugverapamil induced Adverse-Effectsyncope in one patient.
0.9932 Adverse-Effect Adverse-EffectAtrial fibrillation was induced by Drugdiltiazem in two patients and verapamil induced syncope in one patient.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To present a single case of Drugzuclopenthixol - induced Adverse-Effectpriapism and a literature review.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case of Drugallopurinol Adverse-Effecthypersensitivity , possibly the first in a black African, is reported.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Prolonged used of Drughydroxyurea in patients with ET may lead to therapy - associated Adverse-Effectacute leukemia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugSulfasalazine - induced Adverse-Effecthypersensitivity syndrome and hemophagocytic syndrome associated with reactivation of Epstein - Barr virus.
1.0000 Adverse-Effect DrugSulfasalazine - induced hypersensitivity syndrome and Adverse-Effecthemophagocytic syndrome associated with reactivation of Epstein - Barr virus.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In one child, a second course of Drugcarbamazepine resulted in a return of the Adverse-Effectdystonia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect RESULTS : Two patients with ocular inflammation of unknown origin developed Adverse-Effectsevere chorioretinitis after DrugIVTA injection.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Flumazenil reversal of Drugbenzodiazepine - induced Adverse-Effectsedation for a patient with severe pre - ECT anxiety.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect These multiple overlapping factors probably lead to Adverse-Effectrhabdomyolysis in a minority of patients receiving Drugvasopressin infusion.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Six patients with rheumatoid arthritis developed a syndrome resembling Adverse-Effectlupus erythematosus while being treated with Drugpenicillamine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectAcute neutrophilic dermatosis induced by Drugall - trans - retinoic acid treatment for acute promyelocytic leukemia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A second episode of Adverse-Effectjaundice followed the intravaginal administration of a mixture of Drugfurazolidone and nifuroxime.
1.0000 Adverse-Effect A second episode of Adverse-Effectjaundice followed the intravaginal administration of a mixture of furazolidone and Drugnifuroxime .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In addition, the Adverse-Effecttachycardia persisted and was repeatedly spontaneously reinitiated for prolonged periods after Drugprocainamide .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Within 6 months of Drugpranlukast withdrawal, Adverse-Effectanemia resolved and urinary sediment and renal function normalized.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Successful treatment of hyperthyroidism with amiodarone in a patient with Drugpropylthiouracil - induced Adverse-Effectacute hepatic failure .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect An objective causality assessment suggests that the Adverse-EffectJHR in our patient was probably related to Drugpenicillin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectAcute pancreatitis in a child with idiopathic ulcerative colitis on long - term Drug5 - aminosalicylic acid therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Systemic disease, most commonly renal dysfunction, preceded all 30 reported cases of Drugacyclovir Adverse-Effectneurotoxicity .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Two cases of Adverse-Effectpolymorphic ventricular tachycardia induced by the administration of Drugverapamil against paroxysmal supraventricular tachycardia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This is the first case of Drughydroxyurea - induced Adverse-Effectacute interstitial pneumonitis reported in the literature.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The Adverse-Effectsub - conjunctival haematoma in a patient receiving Drugwarfarin can pose a significant management challenge.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugGemcitabine therapy has been associated with Adverse-Effectradiation recall reactions when used in the treatment of carcinoma.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectSkin necrosis is a rare complication of subcutaneous Drugheparin therapy that usually occurs at injection sites.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect It may cause a severe adverse drug reaction with multiorgan involvement known as Drugdapsone Adverse-Effecthypersensitivity syndrome .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectReversible sclerotic changes of lumbar spine and femur due to long - term oral Drugisotretinoin therapy.
Adverse-Effect Reversible Adverse-Effectsclerotic changes of lumbar spine and femur due to long - term oral Drugisotretinoin therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We explored Adverse-Effectophthalmic and neurologic findings in two children who have been exposed prenatally to DrugVGB .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The possible role of Druginterferon beta in the pathogenesis of Adverse-Effectsarcoidosis in this patient is discussed.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We observed transient Adverse-Effectpanhypogammaglobulinaemia in a patient with neuropsychiatric SLE after treatment with Drugprednisolone and cyclophosphamide.
0.9999 Adverse-Effect We observed transient Adverse-Effectpanhypogammaglobulinaemia in a patient with neuropsychiatric SLE after treatment with prednisolone and Drugcyclophosphamide .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectMassive prolapse of the urethral mucosa following periurethral injection of Drugcalcium hydroxylapatite for stress urinary incontinence.
1.0000 Adverse-Effect Massive prolapse of the Adverse-Effecturethral mucosa following periurethral injection of Drugcalcium hydroxylapatite for stress urinary incontinence.
Adverse-Effect Massive Adverse-Effectprolapse of the urethral mucosa following periurethral injection of Drugcalcium hydroxylapatite for stress urinary incontinence.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This is the second report of acute lung injury and Adverse-Effectdiffuse alveolar damage caused by Drugmefloquine .
0.9999 Adverse-Effect This is the second report of Adverse-Effectacute lung injury and diffuse alveolar damage caused by Drugmefloquine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectSudden death in an infant from methemoglobinemia after administration of " Drugsweet spirits of nitre ".
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A patient with rheumatoid arthritis developed an Adverse-Effectacute intrahepatic cholestasis after 100 mg of Drugsodium aurothiomalate .
Adverse-Effect A patient with rheumatoid arthritis developed an acute Adverse-Effectintrahepatic cholestasis after 100 mg of Drugsodium aurothiomalate .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Acute myopathy with selective Adverse-Effectdegeneration of myosin filaments following status asthmaticus treated with Drugmethylprednisolone and vecuronium.
1.0000 Adverse-Effect Acute myopathy with selective Adverse-Effectdegeneration of myosin filaments following status asthmaticus treated with methylprednisolone and Drugvecuronium .
0.9999 Adverse-Effect Adverse-EffectAcute myopathy with selective degeneration of myosin filaments following status asthmaticus treated with Drugmethylprednisolone and vecuronium.
0.9998 Adverse-Effect Adverse-EffectAcute myopathy with selective degeneration of myosin filaments following status asthmaticus treated with methylprednisolone and Drugvecuronium .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We discuss the association between Drugcarbamazepine and Adverse-Effecthyponatremia and the causes of hyponatremia after cardiopulmonary bypass.
0.9998 Adverse-Effect We discuss the association between Drugcarbamazepine and hyponatremia and the causes of Adverse-Effecthyponatremia after cardiopulmonary bypass.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case of Drugbarbiturate - induced Adverse-Effectsubmassive hepatic necrosis is presented and the literature is reviewed.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A Adverse-Effectreversible toxic liver damage was observed in a non - alcoholic woman treated with Drugdisulfiram .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectHaemolytic - uraemic syndrome complicating long - term Drugmitomycin C and 5 - fluorouracil therapy for gastric carcinoma.
0.9999 Adverse-Effect Adverse-EffectHaemolytic - uraemic syndrome complicating long - term mitomycin C and Drug5 - fluorouracil therapy for gastric carcinoma.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugZidovudine use in pregnancy : a report on 104 cases and the occurrence of Adverse-Effectbirth defects .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectCoagulopathy associated with the use of Drugcephalosporin or moxalactam antibiotics in acute and chronic renal failure.
1.0000 Adverse-Effect Adverse-EffectCoagulopathy associated with the use of cephalosporin or Drugmoxalactam antibiotics in acute and chronic renal failure.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Pulmonary hemorrhage as a clinical manifestation of Adverse-Effecthemolytic - uremic syndrome associated with Drugmitomycin C therapy.
0.9989 Adverse-Effect Adverse-EffectPulmonary hemorrhage as a clinical manifestation of hemolytic - uremic syndrome associated with Drugmitomycin C therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectSyringotropic hypersensitivity reaction associated with Druginfliximab and leflunomide combination therapy in a child with psoriatic arthritis.
0.9999 Adverse-Effect Adverse-EffectSyringotropic hypersensitivity reaction associated with infliximab and Drugleflunomide combination therapy in a child with psoriatic arthritis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This is the first report of a Adverse-Effectcatatonic syndrome occurring in a patient receiving Drugdisulfiram treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DLST is a good diagnostic tool for DrugAZA Adverse-Effectallergy , especially for severe drug allergy cases.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case of Drugtimolol - associated Adverse-Effectheart failure in a 73 - year old white man is reported.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a renal transplant recipient maintained on cyclosporine and Drugprednisone developing Adverse-EffectNocardia Asteroides brain abscess .
0.9999 Adverse-Effect We describe a renal transplant recipient maintained on Drugcyclosporine and prednisone developing Adverse-EffectNocardia Asteroides brain abscess .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Visceral leishmaniasis and Adverse-Effectmacrophagic activation syndrome in a patient with rheumatoid arthritis under treatment with Drugadalimumab .
1.0000 Adverse-Effect Adverse-EffectVisceral leishmaniasis and macrophagic activation syndrome in a patient with rheumatoid arthritis under treatment with Drugadalimumab .
Score Relation Text (Head - Tail)
0.9997 Adverse-Effect Cholesterol crystal embolization - associated Adverse-Effectrenal failure after therapy with recombinant Drugtissue - type plasminogen activator .
0.9969 Adverse-Effect Adverse-EffectCholesterol crystal embolization - associated renal failure after therapy with recombinant Drugtissue - type plasminogen activator .
1.0000 Adverse-Effect Cholesterol crystal embolization - associated Adverse-Effectrenal failure after therapy with Drugrecombinant tissue - type plasminogen activator .
0.9992 Adverse-Effect Adverse-EffectCholesterol crystal embolization - associated renal failure after therapy with Drugrecombinant tissue - type plasminogen activator .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugHeparin - induced Adverse-Effectthrombocytopenia complicated with massive thrombosis of the inferior vena cava after filter placement.
0.9998 Adverse-Effect DrugHeparin - induced thrombocytopenia complicated with Adverse-Effectmassive thrombosis of the inferior vena cava after filter placement.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Cholelithiasis and Adverse-Effectthrombosis of the central retinal vein in a renal transplant recipient treated with Drugcyclosporin .
1.0000 Adverse-Effect Adverse-EffectCholelithiasis and thrombosis of the central retinal vein in a renal transplant recipient treated with Drugcyclosporin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Young children undergoing Drugcisplatin chemotherapy are known to be at risk for Adverse-Effectprogressive sensorineural hearing loss .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Prolongation of the QT interval and Adverse-Effectventricular tachyarrhymias have been described in patients on Drugamiodarone therapy.
0.9999 Adverse-Effect Adverse-EffectProlongation of the QT interval and ventricular tachyarrhymias have been described in patients on Drugamiodarone therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectDiarrhea - associated over - anticoagulation in a patient taking Drugwarfarin : therapeutic role of cholestyramine.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The patient whose case is reviewed had Adverse-Effectmigraine headaches and received Drugmethysergide maleate for 13 years.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : Adverse-EffectAcute severe hepatitis though rare is occasionally observed with EGFR inhibitors Druggefitinib or erlotinib.
1.0000 Adverse-Effect CONCLUSIONS : Adverse-EffectAcute severe hepatitis though rare is occasionally observed with EGFR inhibitors gefitinib or Drugerlotinib .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Hypoxia is a predisposing factor for Adverse-Effectpremature ductal closure and often occurs after maternal Drugindomethacin therapy.
1.0000 Adverse-Effect Adverse-EffectHypoxia is a predisposing factor for premature ductal closure and often occurs after maternal Drugindomethacin therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Patients should be informed about the risk of Adverse-Effectosteonecrosis when taking Drugdexamethasone as an antiemetic drug.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Rapid onset of Drugquetiapine - induced Adverse-Effectdiabetic ketoacidosis in an elderly patient : a case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect On the other hand, Drugaspirin may have promoted the Adverse-Effectenlargement of spontaneous hemorrhage from meningioma.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectRenal failure after high - dose Drugmethotrexate in a child homozygous for MTHFR C677 T polymorphism.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectFatal interstitial pneumonitis associated with Drugdocetaxel administration in a patient with hormone - refractory prostate cancer.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect In vitro Adverse-Effectinhibition of hematopoiesis in a patient with systemic sclerosis treated with DrugD - penicillamine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Severe adenovirus pneumonia ( Adverse-EffectAVP ) following Druginfliximab infusion for the treatment of Crohn's disease.
1.0000 Adverse-Effect Adverse-EffectSevere adenovirus pneumonia ( AVP ) following Druginfliximab infusion for the treatment of Crohn's disease.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugCapecitabine was discontinued and the Adverse-Effectallergic reactions resolved after the woman took diphenhydramine for 1 week.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We present a unique case of Adverse-EffectGTBM in a patient with myeloma following treatment with DrugMelphalan .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Based on our findings, it is thus concluded that Drugcisplatin may cause Adverse-EffectC. difficile colitis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Administration of excessive Druginsulin induced Adverse-Effecthypoglycemia within 4 to 8 hours, followed by rebound hyperglycemia.
0.9996 Adverse-Effect Administration of excessive Druginsulin induced hypoglycemia within 4 to 8 hours, followed by Adverse-Effectrebound hyperglycemia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case of Drugfluoxetine induced Adverse-Effectseizures , in a person with Down syndrome, is described.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectPulmonary edema occurred 24 hours after intravenous Drugritodrine therapy and 10 hours after subcutaneous terbutaline therapy.
0.9995 Adverse-Effect Adverse-EffectPulmonary edema occurred 24 hours after intravenous ritodrine therapy and 10 hours after subcutaneous Drugterbutaline therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect After treatment with a beta - sympathomimetic drug ( DrugPartusisten ) one fetus developed Adverse-Effectsupraventricular tachycardia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugChlorambucil Adverse-Effectcentral nervous toxicity : a significant side effect of chlorambucil therapy in childhood nephrotic syndrome.
1.0000 Adverse-Effect Chlorambucil Adverse-Effectcentral nervous toxicity : a significant side effect of Drugchlorambucil therapy in childhood nephrotic syndrome.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The Adverse-Effectpulmonary toxicity of Druggold salts is an uncommon cause of life - threatening respiratory failure.
0.9999 Adverse-Effect The pulmonary toxicity of Druggold salts is an uncommon cause of life - threatening Adverse-Effectrespiratory failure .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Antacid and Drugsucralfate - induced Adverse-Effecthypophosphatemic osteomalacia : a case report and review of the literature.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Following are two clinical case reports demonstrating profound Adverse-Effectcerebral edema associated with implantation of DrugGliadel wafers.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectSevere visual loss after a single dose of Drugvincristine in a patient with spinal cord astrocytoma.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Thus any case of Adverse-Effectsevere neutropenia occurring in a patient receiving Drugolanzapine is alarming to clinicians.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The 9 other reported cases of DrugD - penicillamine induced Adverse-Effectrapidly progressive glomerulonephritis have been reviewed.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectPigmentary disorders are recognized adverse effects of the semi - synthetic tetracycline derivative antibiotic, Drugminocycline .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectHerpes simplex esophagitis in a renal transplant patient treated with Drugcyclosporine A : a case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a patient with idiopathic RLS who developed Adverse-Effectaugmentation after 8 months of Druglevodopa treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Two patients with osteomyelitis who developed Adverse-Effectreversible cholestatic jaundice during treatment with Drugoxacillin derivatives are described.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Only one report links Drugphenylpropanolamine consumption to an Adverse-Effectintracerebral hemorrhage in a patient with an AVM.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugOlanzapine - induced Adverse-Effecthyperglycaemic coma and neuroleptic malignant syndrome : case report and review of literature.
0.9999 Adverse-Effect DrugOlanzapine - induced hyperglycaemic coma and Adverse-Effectneuroleptic malignant syndrome : case report and review of literature.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In all cases, Adverse-Effectseizures were controlled by withdrawal of Drugphenytoin and reduction of drug levels.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A young patient experienced marked Adverse-Effectsinus tachycardia while smoking marijuana and receiving therapeutic doses of Drugnortriptyline .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A severe form of Adverse-Effectexophthalmos resulting from Druglithium therapy has not been described in the literature.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Bulbar and Adverse-Effectpseudobulbar palsy complicating therapy with high - dose Drugcytosine arabinoside in children with leukemia.
0.9998 Adverse-Effect Adverse-EffectBulbar and pseudobulbar palsy complicating therapy with high - dose Drugcytosine arabinoside in children with leukemia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The cause of his bleeding was a Adverse-Effectsevere thrombocytopoaenia , induced by chronic ingestion of Drugquinine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugL - asparaginase - induced Adverse-Effectposterior reversible encephalopathy syndrome during acute lymphoblastic leukemia treatment in children.
Adverse-Effect DrugL - asparaginase - induced Adverse-Effectposterior reversible encephalopathy syndrome during acute lymphoblastic leukemia treatment in children.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Nevertheless, the Adverse-Effectcoagulopathy seemed to be most closely associated with the administration of the Drugcephalosporin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Favorable outcome of de novo Adverse-Effecthepatitis B infection after liver transplantation with Druglamivudine and adefovir therapy.
1.0000 Adverse-Effect Favorable outcome of de novo Adverse-Effecthepatitis B infection after liver transplantation with lamivudine and Drugadefovir therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectThrombocytosis induced by Drugenoxaparin has been reported as a rare adverse effect of this medication in adults.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This is the first report of Adverse-Effectnon - convulsive status epilepticus provoked by Drugtiagabine in adolescent patients.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugL - asparaginase - induced Adverse-Effectpancreatitis has been reported during or closely following administration of the drug.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The majority of Adverse-Effectradiation recall reactions attributed to Druggemcitabine are reported to affect internal tissue or organs.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectMinimal change disease in a patient receiving DrugIFN - alpha therapy for chronic hepatitis C virus infection.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugClozapine - induced Adverse-Effecteosinophilia and switch to quetiapine in a patient with chronic schizophrenia with suicidal tendencies.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In association with this tocolysis, Adverse-Effecturinary calculus of Drugmagnesium ammonium phosphate occurred at 34 weeks gestation.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Cessation of DrugD - Pen and the start of corticosteroid therapy were followed by recovery from Adverse-Effectbicytopenia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report on a 37 - year - old female who complained of moderate Adverse-Effecthair loss during Drugparoxetine treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect These novel findings may offer specific therapeutic targets in the treatment of DrugBCNU - associated Adverse-Effectpulmonary fibrosis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect An insulin - dependent diabetic patient with nephropathy developed Adverse-Effectsevere acidosis after treatment with Drugacetazolamide for glaucoma.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Interstitial lung disease ( Adverse-EffectILD ) related to therapy with the drug Druggefitinib has been well reported.
1.0000 Adverse-Effect Adverse-EffectInterstitial lung disease ( ILD ) related to therapy with the drug Druggefitinib has been well reported.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : This study confirmed that in most patients DrugMTX - induced Adverse-Effectliver cirrhosis is not aggressive.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Since Drugtamoxifen therapy can induce Adverse-Effectendometrial disorders , surveillance schemes of women taking tamoxifen have been recommended.
1.0000 Adverse-Effect Since tamoxifen therapy can induce Adverse-Effectendometrial disorders , surveillance schemes of women taking Drugtamoxifen have been recommended.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Intravenous cytarabine and Drugmethotrexate appear to act synergistically to enhance the potential for Adverse-Effectcentral nervous system toxicity .
0.9999 Adverse-Effect Intravenous Drugcytarabine and methotrexate appear to act synergistically to enhance the potential for Adverse-Effectcentral nervous system toxicity .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : The fundus picture shown in these cases may be typical of Adverse-EffectASPPC after DrugIVTA injection.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : DrugLTG overdose may result in a severe but reversible Adverse-Effectencephalopathy , a previously undescribed phenomenon.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Several such Adverse-EffectHBV reactivations were reported after combined Drugrituximab and multiagent chemotherapy for B - cell lymphomas.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectAcute renal insufficiency is known to occur in patients who are taking Drugciprofloxacin , particularly the elderly.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Soon after its introduction in 1952, Drugchlorpromazine was noted to induce Adverse-Effectsymptoms resembling Parkinson's disease .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A young woman with epilepsy had Adverse-Effecttonic - clonic seizures during antineoplastic therapy with Drugadriamycin and cisplatin.
1.0000 Adverse-Effect A young woman with epilepsy had Adverse-Effecttonic - clonic seizures during antineoplastic therapy with adriamycin and Drugcisplatin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe six patients who developed Adverse-Effecttardive dyskinesia after treatment with Drugsulpiride for depression or gastrointestinal symptoms.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Two heroin addicts, aged 34 and 19 years, developed Adverse-Effectballistic movements after intravenous Drugheroin overdose.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectGeneralised pustular psoriasis induced by Drugcyclosporin a withdrawal responding to the tumour necrosis factor alpha inhibitor etanercept.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugClozapine - induced Adverse-Effecttardive dyskinesia in schizophrenic patients taking clozapine as a first - line antipsychotic drug.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Interstitial pneumonitis and Adverse-Effectalveolar hemorrhage complicating use of Drugrituximab : case report and review of the literature.
1.0000 Adverse-Effect Adverse-EffectInterstitial pneumonitis and alveolar hemorrhage complicating use of Drugrituximab : case report and review of the literature.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Use of the Naranjo probability scale determined the association between Drugcephalosporin use and Adverse-Effectleukopenia to be probable.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : DrugAmantadine can cause Adverse-Effectreversible corneal edema but can irreversibly reduce the density of endothelial cells.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Failure of plasmapheresis, corticosteroids and thionamides to ameliorate a case of protracted Drugamiodarone - induced Adverse-Effectthyroiditis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect An asymptomatic HIV - infected woman experienced right - sided Adverse-Effectrenal colicky pain during treatment with Drugindinavir .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The temporal relationship suggests that the Adverse-Effectspinal cord infarction may be related to the use of Drugzolmitriptan .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect To date, there have been few reports of Adverse-Effectvisual disturbances associated with DrugBTX - B use.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe two cases of Adverse-Effectacute pancreatitis that occurred after long term Drugmesalamine therapy for ulcerative colitis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Despite administration of phenytoin and lorazepam, the Adverse-Effectseizures persisted and occurred only during Drugamphotercin B administration.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In both patients the Adverse-Effectrippling phenomena worsened with Drugpyridostigmine treatment but markedly improved after immunosuppression with azathioprine.
0.9999 Adverse-Effect In both patients the Adverse-Effectrippling phenomena worsened with pyridostigmine treatment but markedly improved after immunosuppression with Drugazathioprine .
Score Relation Text (Head - Tail)
Adverse-Effect Acute Adverse-Effecthyperphosphatemia caused by Drugsodium phosphate enema in a patient with liver dysfunction and chronic renal failure.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A new case of Adverse-EffectCreutzfeldt - Jakob disease associated with Drughuman growth hormone therapy in New Zealand.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The Naranjo probability scale suggests a highly probable relationship between Adverse-EffectAIN and Drugpantoprazole therapy in this patient.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Inadvertent subsequent rechallenge with Drugceliprolol led to recurrence of the Adverse-Effectpneumonitis , 10 weeks after drug readministration.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This is the first report of acute kidney injury due to Drugzonisamide - induced Adverse-EffectDRESS / DIHS.
1.0000 Adverse-Effect This is the first report of Adverse-Effectacute kidney injury due to Drugzonisamide - induced DRESS / DIHS.
0.9999 Adverse-Effect This is the first report of acute kidney injury due to Drugzonisamide - induced DRESS / Adverse-EffectDIHS .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Early recognition of hereditary motor and sensory neuropathy type 1 can avoid life - threatening Drugvincristine Adverse-Effectneurotoxicity .
Adverse-Effect Early recognition of hereditary motor and sensory neuropathy type 1 can avoid Adverse-Effectlife - threatening vincristine neurotoxicity Drugvincristine neurotoxicity.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect It is tempting to speculate that Druginterferon alpha may be involved in the pathogenesis of Adverse-Effectlichen nitidus .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect These data indicated that Druginfliximab possibly triggered Adverse-Effectproduction of granulocyte and neutrophil autoantibodies with resultant autoimmune agranulocytosis.
1.0000 Adverse-Effect These data indicated that Druginfliximab possibly triggered production of granulocyte and neutrophil autoantibodies with resultant Adverse-Effectautoimmune agranulocytosis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Clinicians should be aware of Adverse-Effectfasting hypoglycemia as an unusual but potentially serious complication of Drugdisopyramide therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugIFNalpha - induced recurrence of Adverse-EffectGraves'disease ten years after thyroidectomy in chronic viral hepatitis C.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Following 7 days of Drugtigecycline she developed Adverse-Effectsevere abdominal pain and elevated pancreatic enzymes suggesting acute pancreatitis.
0.9999 Adverse-Effect Following 7 days of Drugtigecycline she developed severe abdominal pain and Adverse-Effectelevated pancreatic enzymes suggesting acute pancreatitis.
0.9999 Adverse-Effect Following 7 days of Drugtigecycline she developed severe abdominal pain and elevated pancreatic enzymes suggesting Adverse-Effectacute pancreatitis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Since its FDA approval in 2002, there are no known citations of Drugezetimibe - induced Adverse-Effectpancreatitis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a case of life - threatening Adverse-Effecthyponatremia associated with Drugsibutramine use in an obese woman.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 14 - year - old girl with newly diagnosed SLE developed a Adverse-Effectpruritic bullous eruption while on Drugprednisone .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSION : DrugTamoxifen may cause Adverse-Effectmalignant transformation of endometriosis through atypical endometriosis even in the postmenopausal state.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Administration of Drugpyridoxine to an infant after a long period of convulsions was followed by Adverse-Effectacute hypotonia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case report of fatal Drugdapsone - induced Adverse-Effectagranulocytosis in an Indian mid - borderline leprosy patient.
Score Relation Text (Head - Tail)
0.9910 Adverse-Effect Warfarin - induced skin necrosis and Drugheparin - induced Adverse-Effectthrombocytopenia following mitral valve replacement for marantic endocarditis.
0.9653 Adverse-Effect DrugWarfarin - induced Adverse-Effectskin necrosis and heparin - induced thrombocytopenia following mitral valve replacement for marantic endocarditis.
0.9996 Adverse-Effect Warfarin - induced skin necrosis and heparin - induced Adverse-Effectthrombocytopenia following Drugmitral valve replacement for marantic endocarditis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Clinicians should be vigilant when monitoring for Adverse-Effectcardiotoxicity in patients receiving Drugpentamidine throughout the duration of therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We present a depressive patient who developed mild parkinsonian signs and Adverse-Effectcamptocormia after the introduction of Drugolanzapine .
0.9999 Adverse-Effect We present a depressive patient who developed Adverse-Effectmild parkinsonian signs and camptocormia after the introduction of Drugolanzapine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Despite the underlying hepatitis C, this case represents Adverse-Effectrenal abnormalities consistent with DrugIFNalpha therapy for CML.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The ocular motor disturbances are probably an expression of regional Drug5 - FU Adverse-Effectneurotoxicity primarily affecting the brain stem.
1.0000 Adverse-Effect The Adverse-Effectocular motor disturbances are probably an expression of regional Drug5 - FU neurotoxicity primarily affecting the brain stem.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect RESULTS : DrugQuetiapine was associated with Adverse-Effectleucopenia in two patients and clinically apparent agranulocytosis in one patient.
0.9996 Adverse-Effect RESULTS : DrugQuetiapine was associated with leucopenia in two patients and clinically apparent Adverse-Effectagranulocytosis in one patient.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In a 61 - year - old man receiving chronic low - dosage Drugamiodarone an Adverse-Effectinterstitial pneumopathy was observed.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectCerebrovascular complications of DrugL - asparaginase therapy in children with leukemia : aphasia and other neuropsychological deficits.
1.0000 Adverse-Effect Cerebrovascular complications of DrugL - asparaginase therapy in children with leukemia : Adverse-Effectaphasia and other neuropsychological deficits.
0.9993 Adverse-Effect Cerebrovascular complications of DrugL - asparaginase therapy in children with leukemia : aphasia and other Adverse-Effectneuropsychological deficits .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case of Drugmetoclopramide - induced Adverse-Effectoculogyric crisis in a 16 - year - old girl with cystic fibrosis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a case of severe aplastic anemia ( Adverse-EffectAA ) that was probably induced by Druglenalidomide .
1.0000 Adverse-Effect We describe a case of Adverse-Effectsevere aplastic anemia ( AA ) that was probably induced by Druglenalidomide .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Case report : Drugdapsone Adverse-Effecthypersensitivity syndrome associated with treatment of the bite of a brown recluse spider.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Experience with five patients in whom Adverse-Effectimpaired renal function developed early during Drugamphotericin B therapy is reported.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect METHODS : We report a patient who had an Adverse-Effectanaphylactic reaction during the intravenous infusion of Drugcyclosporine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSION : There may be an association between Drugraloxifene and the development of Adverse-Effectmalignant mixed mesodermal tumor .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect BACKGROUND : To describe the occurrence of Adverse-Effectocular hypertension in four patients following injection of Drugranibizumab intravitreally.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugVancomycin is the most frequently implicated drug, but other agents have been reported to cause Adverse-EffectLABD .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Two of our patients developed Adverse-EffectTD after 23 months and 34 months of Drugziprasidone monotherapy, respectively.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect While both amiodarone and Drugdigoxin can cause permanent Adverse-Effectvisual changes , the ocular effects are often reversible.
0.9999 Adverse-Effect While both amiodarone and Drugdigoxin can cause permanent visual changes, the Adverse-Effectocular effects are often reversible.
0.9998 Adverse-Effect While both Drugamiodarone and digoxin can cause permanent visual changes, the Adverse-Effectocular effects are often reversible.
0.9998 Adverse-Effect While both Drugamiodarone and digoxin can cause permanent Adverse-Effectvisual changes , the ocular effects are often reversible.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A Adverse-Effectfatal massive pulmonary embolus developed in a patient treated with Drugstreptokinase for acute deep vein thrombosis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect L - Carnitine supplementation has been recommended to prevent the Adverse-Effectfatal hepatotoxic effects associated with Drugvalproic acid .
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect Biopsy - proven Adverse-Effectacute interstitial nephritis associated with the tyrosine kinase inhibitor Drugsunitinib : a class effect?
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Four patients receiving high - dose Drugtamoxifen for greater than 1 year have demonstrated similar Adverse-Effectretinal changes .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect After five and six weeks of continuous oral administration of Drugmethylprednisolone , the boys developed Adverse-Effectsteroid diabetes .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Multiple complications of Drugpropylthiouracil treatment : Adverse-Effectgranulocytopenia , eosinophilia, skin reaction and hepatitis with lymphocyte sensitization.
1.0000 Adverse-Effect Multiple complications of Drugpropylthiouracil treatment : granulocytopenia, eosinophilia, skin reaction and Adverse-Effecthepatitis with lymphocyte sensitization.
0.9999 Adverse-Effect Multiple complications of Drugpropylthiouracil treatment : granulocytopenia, Adverse-Effecteosinophilia , skin reaction and hepatitis with lymphocyte sensitization.
0.9999 Adverse-Effect Multiple complications of Drugpropylthiouracil treatment : granulocytopenia, eosinophilia, skin reaction and hepatitis with Adverse-Effectlymphocyte sensitization .
0.9999 Adverse-Effect Multiple complications of Drugpropylthiouracil treatment : granulocytopenia, eosinophilia, Adverse-Effectskin reaction and hepatitis with lymphocyte sensitization.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Myoclonus and Adverse-Effectseizures in a patient with parkinsonism : induction by Druglevodopa and its confirmation on SEPs.
0.9999 Adverse-Effect Adverse-EffectMyoclonus and seizures in a patient with parkinsonism : induction by Druglevodopa and its confirmation on SEPs.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a patient of organic bipolar affective disorder who developed Adverse-Effecthiccups with the atypical antipsychotic Drugaripiprazole .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Based on the history and clinical features, a diagnosis of Druginsulin - induced Adverse-Effectlipohypertrophy was made.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We present a neonate with a seizure disorder who acutely developed Adverse-Effectpupillary mydriasis secondary to Druglidocaine overdose.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect There are, however, case studies describing patients experiencing recurrences of Adverse-Effecttics following treatment with Drugatomoxetine .
Score Relation Text (Head - Tail)
0.9976 Adverse-Effect We report the use of pamidronate for acute, severe hypercalcemia secondary to iatrogenic Drugvitamin D Adverse-Effectvitamin D poisoning .
0.9744 Adverse-Effect We report the use of pamidronate for acute, Adverse-Effectsevere hypercalcemia secondary to iatrogenic Drugvitamin D poisoning.
0.9994 Adverse-Effect We report the use of Drugpamidronate for acute, Adverse-Effectsevere hypercalcemia secondary to iatrogenic vitamin D poisoning.
0.6577 Adverse-Effect We report the use of Drugpamidronate for acute, severe hypercalcemia secondary to iatrogenic Adverse-Effectvitamin D poisoning .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We present a case of Adverse-Effectphoto - onycholysis in a patient treated with Drugdoxycycline for acne vulgaris.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We herein report this rare case of acute onset of Adverse-Effectnephrotic syndrome during Druginterferon - alpha retreatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The occurrence of severe Adverse-EffectAIHA in CLL patients treated with Drugfludarabine has been reported by several authors.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We present the first case of a patient with Adverse-Effectpriapism after oral intake of the phenothiazine Drugprothipendylhydrochloride .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectAcute asymptomatic hepatitis in a healthy normal volunteer exposed to 2 oral doses of Drugamodiaquine and artesunate.
1.0000 Adverse-Effect Adverse-EffectAcute asymptomatic hepatitis in a healthy normal volunteer exposed to 2 oral doses of amodiaquine and Drugartesunate .
Adverse-Effect Acute Adverse-Effectasymptomatic hepatitis in a healthy normal volunteer exposed to 2 oral doses of Drugamodiaquine and artesunate.
Adverse-Effect Acute Adverse-Effectasymptomatic hepatitis in a healthy normal volunteer exposed to 2 oral doses of amodiaquine and Drugartesunate .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This case highlights the possible development of Adverse-Effectacute coronary syndrome as a side effect of DrugCapecitabine therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectAvascular necrosis of the femoral head in patients with prostate cancer treated with Drugcyproterone acetate and radiotherapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugTorsemide appears to also be a part of a long list of agents that can cause Adverse-Effectpancreatitis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectAcute renal failure most likely was secondary to the nephrotoxic effect of Drugcaptopril on chronically hypoperfused kidneys.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The patient was given Drugmethimazole instead of propylthiouracil but, 10 weeks later, Adverse-Effectagranulocytosis again occurred.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The present case is the first report of Adverse-Effecthypercalcemia induced by Drugvitamin D3 ointment and thiazide simultaneously.
0.9998 Adverse-Effect The present case is the first report of Adverse-Effecthypercalcemia induced by vitamin D3 ointment and Drugthiazide simultaneously.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a case of Drugclozapine - induced Adverse-Effectseizures in a patient with treatment - resistant schizophrenia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectPleuropulmonary changes during treatment of Parkinson's disease with a long - acting ergot derivative, Drugcabergoline .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect However, because Drugdiphenhydramine also exhibits type IA sodium channel blockade, Adverse-Effectcardiac toxicity is also possible.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect While 40 mg / day of Drugprednisolone improved hepatic dysfunction dramatically, her Adverse-Effectdiabetic milieu deteriorated seriously.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Two cases of Adverse-Effecthypothyroidism in patients with chronic hepatitis C treated with Drugrecombinant alpha interferon are reported.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report DrugAZA - induced Adverse-Effectdrug eruption that developed in two cases of systemic scleroderma with polymyositis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The condition should be suspected in patients who develop unexplained abdominal pain or Adverse-Effectcollapse following Drugvasopressin treatment.
1.0000 Adverse-Effect The condition should be suspected in patients who develop unexplained Adverse-Effectabdominal pain or collapse following Drugvasopressin treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Reversal of Druggold - induced Adverse-Effectneutropenia with granulocyte colony - stimulating factor ( G - CSF ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectPsychosis in a 12 - year - old HIV - positive girl with an increased serum concentration of Drugefavirenz .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 35 - year - old man with seropositive rheumatoid arthritis developed selective Adverse-EffectIgA deficiency during treatment with Drugfenclofenac .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of recurrent Adverse-Effecttorsades de pointes following treatment with pentavalent antimonial drugs and Drugamiodarone .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect SUBSEQUENT COURSE : The Adverse-Effectnephrosis resolved almost completely once the Druginterferon was stopped and after immunosuppressive treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectAsthenozoospermia : possible association with long - term exposure to an anti - epileptic drug of Drugcarbamazepine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect PURPOSE : We studied a case of Adverse-Effectvortex keratopathy that was associated with the use of Drugatovaquone .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To report 2 cases of nonconvulsive status epilepticus ( Adverse-EffectNCSE ) following infusion of Drugifosfamide .
1.0000 Adverse-Effect OBJECTIVE : To report 2 cases of Adverse-Effectnonconvulsive status epilepticus ( NCSE ) following infusion of Drugifosfamide .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The cause is presumed to be secondary to hypercoagulability due to Drugasparaginase - induced Adverse-Effectantithrombin III deficiency .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To describe the development of Drugvalproate - related Adverse-Effectreproductive endocrine disorders in women with epilepsy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Physicians treating patients with Drugmethotrexate for juvenile rheumatoid arthritis must be aware of this Adverse-Effectextraarticular side effect .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Slow acetylator genotypes as a possible risk factor for Adverse-Effectinfectious mononucleosis - like syndrome induced by Drugsalazosulfapyridine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the first case, to our knowledge, of Drugrituximab - related Adverse-Effectautoimmune hemolytic anemia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A depressed woman with no history of bipolar illness developed a Adverse-Effectmanic episode during treatment with Drugfluoxetine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect With Drugitraconazole , Adverse-Effecthepatotoxic reactions have only very rarely been reported, and histologic data are lacking.
1.0000 Adverse-Effect With Drugitraconazole , Adverse-Effecthepatotoxic reactions have only very rarely been reported, and histologic data are lacking.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The other woman had rheumatoid arthritis and developed Adverse-Effectacute tubular necrosis after treatment with Druggentamicin and cefoxitin.
0.9999 Adverse-Effect The other woman had rheumatoid arthritis and developed Adverse-Effectacute tubular necrosis after treatment with gentamicin and Drugcefoxitin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To report a case of possible Drugfoscarnet - induced Adverse-Effectsevere hypomagnesemia and other electrolyte disorders.
1.0000 Adverse-Effect OBJECTIVE : To report a case of possible Drugfoscarnet - induced severe hypomagnesemia and other Adverse-Effectelectrolyte disorders .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect CONCLUSION : Adverse-EffectLipoid pneumonia as a result of Drugmineral oil aspiration still occurs in the pediatric population.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectSecretory endometrial adenocarcinoma in a patient on Drugtamoxifen for breast cancer : a report of a case.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect METHODS : Five cases of Adverse-Effectcontact dermatitis due to Drugbudesonide , a nonhalogenated steroid, are described.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe 2 children with cerebral palsy who suffered significant Adverse-Effectmorbidity immediately after treatment with Drughyperbaric oxygen .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Cyclosporine is a potent inhibitor of simvastatin metabolism, and may therefore facilitate Drugsimvastatin - induced Adverse-Effectrhabdomyolysis .
0.9990 Adverse-Effect DrugCyclosporine is a potent inhibitor of simvastatin metabolism, and may therefore facilitate simvastatin - induced Adverse-Effectrhabdomyolysis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect To our knowledge, no prior cases of Drugpenicillamine - induced Adverse-EffectTTP in RA have been reported.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report two patients with acne vulgaris with a fourth type of Drugminocycline - induced Adverse-Effectcutaneous pigmentation .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectTumor lysis syndrome after transcatheter arterial infusion of Drugcisplatin and embolization therapy for liver metastases of melanoma.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectSevere cardiomyopathy following treatment with the tumour necrosis factor - alpha inhibitor Drugadalimumab for Crohn's disease.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Detection of antineutrophil cytoplasmic antibody in a patient with DrugL - tryptophan induced Adverse-Effecteosinophilia - myalgia syndrome .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A patient with seropositive rheumatoid arthritis developed Adverse-Effectascites while taking weekly doses of Drugmethotrexate ( MTX ).
1.0000 Adverse-Effect A patient with seropositive rheumatoid arthritis developed Adverse-Effectascites while taking weekly doses of methotrexate ( DrugMTX ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe 3 elderly patients with moderate to severe Adverse-Effectataxia that occurred while they were taking Drugpropafenone .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect DrugAluminum intoxication, along with other factors, was considered to be the cause of Adverse-EffectTC development.
0.9998 Adverse-Effect DrugAluminum Adverse-EffectAluminum intoxication , along with other factors, was considered to be the cause of TC development.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectTransient central diabetes insipidus in the setting of underlying chronic nephrogenic diabetes insipidus associated with Druglithium use.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectProlongation of the QT interval observed in a Japanese patient with vivax malaria following treatment with Drughalofantrine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the first histopathologically documented case of Adverse-Effectoral mucosa pigmentation after OLP treatment with topical Drugtacrolimus .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect After cessation of Drugamantadine , the Adverse-Effectedema resolved, and the endothelial cell densities were < or = 600 / mm.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A possible mechanism for Adverse-Effectfocal neurological deficit in brain - damaged patients on Drugphenytoin therapy is discussed.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectAcute generalized exanthematous pustulosis caused by Drugmorphine , confirmed by positive patch test and lymphocyte transformation test.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To report a patient developing Adverse-Effectfulminant liver failure while being treated with Drugclarithromycin for pneumonia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect One patient suffered Adverse-Effectcoronary artery vasospasm , attributed to the use of topical 1 : 1000 Drugepinephrine during surgery.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugAcetazolamide may have accelerated the development of Adverse-Effectosteomalacia by several mechanisms, including increased renal calcium excretion.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The incidence of 5 - fluorouracil ( Drug5 - FU ) - related Adverse-Effectcardiotoxicity seems to be dosage and schedule dependent.
0.9998 Adverse-Effect The incidence of Drug5 - fluorouracil ( 5 - FU ) - related Adverse-Effectcardiotoxicity seems to be dosage and schedule dependent.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect A case of Adverse-Effectacute respiratory failure due to diaphragmatic weakness following Drugadalimumab therapy for psoriasis is described.
1.0000 Adverse-Effect A case of acute respiratory failure due to Adverse-Effectdiaphragmatic weakness following Drugadalimumab therapy for psoriasis is described.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugIndinavir - associated Adverse-Effectnephrolithiasis and chronic interstitial nephritis were the only possible causes identified in this patient.
0.9995 Adverse-Effect DrugIndinavir - associated nephrolithiasis and chronic Adverse-Effectinterstitial nephritis were the only possible causes identified in this patient.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Diagnosis of Adverse-Effecthypothyroidism during treatment can be difficult because of the common side effects of Drugalpha interferon .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To report a case of Adverse-Effectcutaneous and hematologic toxicity in a patient treated with DrugIL - 2 .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Improved awareness of and further investigation into the Adverse-Effectneurotoxic effects of Drugofloxacin may enhance its safe use.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Several possible explanations of the mechanism of Adverse-Effectrenal failure associated with the use of Drugdextran - 40 are discussed.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We postulate that the bolus of Drugsulprostone resulted in possible Adverse-Effectcoronary spasm that resulted in cardiac arrest.
0.9999 Adverse-Effect We postulate that the bolus of Drugsulprostone resulted in possible coronary spasm that resulted in Adverse-Effectcardiac arrest .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Neurophysiological mechanisms which aid in elucidating the role of Drugdisulfiram in the etiology of Adverse-Effectcatatonia are discussed.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect There is documentation of Adverse-Effectocular toxicity with Drugethambutol when administered at dosages generally pronounced as being safe.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Hydrocortisone may decrease the incidence of mortality associated with Adverse-Effectcardiac arrhythmias in children receiving Drugamphotericin B overdoses.
0.9995 Adverse-Effect Hydrocortisone may decrease the incidence of Adverse-Effectmortality associated with cardiac arrhythmias in children receiving Drugamphotericin B overdoses.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect There are no previous reports in the literature about the emergence of Adverse-EffectCML during treatment with Drughydroxyurea .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect An infertile patient with amenorrhea - galactorrhea syndrome Adverse-Effectlost vision during a pregnancy occurring after DrugBromocryptine treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Herein, we present a patient with severe and prolonged Adverse-Effecthypoglycemia after long - acting Drugoctreotide treatment.
Adverse-Effect Herein, we present a patient with severe and Adverse-Effectprolonged hypoglycemia after long - acting Drugoctreotide treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a case of Adverse-Effectpneumonitis following local administration of Drugmethotrexate for nonsurgical termination of an ectopic pregnancy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectProgressive hypoxemia mandated endotracheal intubation 1 week after Drugrituximab administration and led to death 4 weeks after admission.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Adverse-EffectHUS has been reported after several anticancer chemotherapies and most often after Drugmitomycin C - based chemotherapy regimens.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect RESULTS : Evidence of neurological improvement and rehabilitation potential after Adverse-Effectsevere myelopathy due to intrathecal injection of Drugdoxorubicin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Hyperkalaemia with Adverse-Effectrenal tubular dysfunction by Drugsulfamethoxazole - trimethoprim for Pneumocystis carinii pneumonia in patients with lymphoid malignancy.
0.9992 Adverse-Effect Adverse-EffectHyperkalaemia with renal tubular dysfunction by Drugsulfamethoxazole - trimethoprim for Pneumocystis carinii pneumonia in patients with lymphoid malignancy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSION : DrugAtovaquone should be added to the list of agents causing Adverse-Effectvortex keratopathy involving the corneal epithelium.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectPosterior reversible encephalopathy syndrome associated with Drugmethotrexate neurotoxicity : conventional magnetic resonance and diffusion - weighted imaging findings.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 23 - year - old woman with systemic lupus erythematosus had a Adverse-Effectsevere hypersensitivity reaction to the drug Drugibuprofen .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of Adverse-EffectGraves'hyperthyroidism induced by long - term Druginterferon ( IFN ) therapy.
0.9999 Adverse-Effect We report a case of Adverse-EffectGraves'hyperthyroidism induced by long - term interferon ( DrugIFN ) therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a case of Adverse-Effectulcerative proctitis after Drugibuprofen treatment in a girl with juvenile systemic lupus erythematosus.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect These cases indicate that Drugsulpiride can cause Adverse-Effecttardive dyskinesia and that this drug should be administered with caution.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectPremature closure of the ductus arteriosus : variable response among monozygotic twins after in utero exposure to Drugindomethacin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect When Adverse-Effectvague symptoms develop during Drugdesmopressin therapy, hyponatremia must be considered as part of the differential diagnosis.
1.0000 Adverse-Effect When vague symptoms develop during Drugdesmopressin therapy, Adverse-Effecthyponatremia must be considered as part of the differential diagnosis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 78 - year - old man with a transvenous cardioverter defibrillator system developed frequent Adverse-Effectshocks during oral Drugprocainamide therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Transient left homonymous hemianopsia and Adverse-Effectencephalopathy following treatment of testicular carcinoma with Drugcisplatinum , vinblastine, and bleomycin.
1.0000 Adverse-Effect Adverse-EffectTransient left homonymous hemianopsia and encephalopathy following treatment of testicular carcinoma with Drugcisplatinum , vinblastine, and bleomycin.
0.9999 Adverse-Effect Transient left homonymous hemianopsia and Adverse-Effectencephalopathy following treatment of testicular carcinoma with cisplatinum, Drugvinblastine , and bleomycin.
0.9999 Adverse-Effect Transient left homonymous hemianopsia and Adverse-Effectencephalopathy following treatment of testicular carcinoma with cisplatinum, vinblastine, and Drugbleomycin .
0.9999 Adverse-Effect Adverse-EffectTransient left homonymous hemianopsia and encephalopathy following treatment of testicular carcinoma with cisplatinum, Drugvinblastine , and bleomycin.
0.9999 Adverse-Effect Adverse-EffectTransient left homonymous hemianopsia and encephalopathy following treatment of testicular carcinoma with cisplatinum, vinblastine, and Drugbleomycin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugPirmenol hydrochloride - induced Adverse-EffectQT prolongation and T wave inversion on electrocardiogram during treatment for symptomatic atrial fibrillation.
0.9992 Adverse-Effect DrugPirmenol hydrochloride - induced QT prolongation and Adverse-EffectT wave inversion on electrocardiogram during treatment for symptomatic atrial fibrillation.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Reported are three children who developed Adverse-Effectprogressive paraparesis after intrathecal Drugmethotrexate administration followed by complete or partial recovery.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Dexamethasone treatment of Drugamiodarone - induced Adverse-Effectthyrotoxicosis ( AIT ) with or without persistent administration of the drug.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Gallstones and Adverse-Effectbile sludge are common side effects of Drugoctreotide therapy but rarely become symptomatic or require treatment.
1.0000 Adverse-Effect Adverse-EffectGallstones and bile sludge are common side effects of Drugoctreotide therapy but rarely become symptomatic or require treatment.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect DrugIsoniazid inhibits the conversion of tryptophan to niacin and may induce Adverse-Effectpellagra , particularly in poorly nourished patients.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DISCUSSION : A review of the cases of Adverse-EffectSS with implication of Drugmirtazapine as the cause was performed.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Both 6 - MP and DrugAZA are widely used and are known to cause Adverse-Effecthepatotoxicity in a proportion of patients.
0.9999 Adverse-Effect Both Drug6 - MP and AZA are widely used and are known to cause Adverse-Effecthepatotoxicity in a proportion of patients.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of radiotherapy - enhanced Drugaminoglutethimide Adverse-Effectskin toxicity in a patient with metastatic breast cancer.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect It is increasingly recognized that dose adjustment of oral Drugvalacyclovir in renal failure is necessary to avoid Adverse-Effectneurotoxicity .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Long - term follow - up after Adverse-Effectneoplastic seeding complicating percutaneous Drugethanol injection for treatment of hepatocellular carcinoma.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Administration of lamotrigine, especially in combination with Drugvalproic acid , may lead to the development of Adverse-EffectTEN .
0.9999 Adverse-Effect Administration of Druglamotrigine , especially in combination with valproic acid, may lead to the development of Adverse-EffectTEN .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We believe that this is the first report of Adverse-Effectsecretory carcinoma of the endometrium associated with Drugtamoxifen use.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect To our knowledge, four cases of Adverse-Effectinterstitial pneumonitis associated with Drugfludarabine have been reported in medical literature.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Two cases of widespread Adverse-Effectcutaneous vasculitis are described in association with Drugdiltiazem , a recently introduced calcium antagonist.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect To our knowledge, this is the first reported case of Adverse-Effectbromide intoxication due to Drugpyridostigmine bromide administration.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugVerapamil is widely used for the termination of paroxysmal supraventricular tachycardia ( PSVT ) with little Adverse-Effectproarrhythmic effect .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect However, the amount of Drugprednisone required to maintain normotension resulted in Adverse-EffectCushingoid features and has been discontinued.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This is a case of Drugpseudoephedrine - induced Adverse-Effectintracerebral hemorrhage in a patient with an underlying vascular malformation.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugNitrofurantoin - induced Adverse-Effectpulmonary toxicity during pregnancy : a report of a case and review of the literature.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Knowledge regarding potential adverse effects of DrugCAP is paramount and dose modification is indicated with development of Adverse-Effectneurotoxicity .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect A 75 - year - old man developed Adverse-Effectbilateral lower leg edema 6 months after switching from troglitazone to Drugpioglitazone .
1.0000 Adverse-Effect A 75 - year - old man developed Adverse-Effectbilateral lower leg edema 6 months after switching from Drugtroglitazone to pioglitazone.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A patient with an allergy to a macrolide antibiotic was given Drugtacrolimus and developed a Adverse-Effectsudden cutaneous reaction .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect However, there are few reports in the literature of Drugampicillin as a cause of Adverse-Effectacute interstitial nephritis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Pulmonary eosinophilia or granulomas, classically seen in previously reported cases of Drugmethotrexate Adverse-Effectpneumonitis , were not observed.
1.0000 Adverse-Effect Pulmonary eosinophilia or Adverse-Effectgranulomas , classically seen in previously reported cases of Drugmethotrexate pneumonitis, were not observed.
0.9998 Adverse-Effect Adverse-EffectPulmonary eosinophilia or granulomas, classically seen in previously reported cases of Drugmethotrexate pneumonitis, were not observed.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectAcute myelogenous leukemia in patients receiving Drugchlorambucil as long - term adjuvant chemotherapy for stage II breast cancer.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectHepatoxicity is a rare complication of DrugSRL therapy and may be connected with some diagnostic and / or therapeutic problems.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect RESULTS : Replacing Drugvalproate with lamotrigine resulted in a Adverse-Effectdecrease in serum testosterone concentrations in all 3 women.
Adverse-Effect RESULTS : Replacing Drugvalproate with lamotrigine resulted in a decrease in Adverse-Effectserum testosterone concentrations in all 3 women.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Tacrolimus ( DrugFK506 ), an immunosuppressant, has been associated with Adverse-Effectmutism in adults after liver transplant.
1.0000 Adverse-Effect DrugTacrolimus ( FK506 ), an immunosuppressant, has been associated with Adverse-Effectmutism in adults after liver transplant.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Both the longitudinal melanonychia and the Adverse-Effectmultiple skin cancers first appeared after approximately 6 months of Drughydroxyurea treatment.
1.0000 Adverse-Effect Both the Adverse-Effectlongitudinal melanonychia and the multiple skin cancers first appeared after approximately 6 months of Drughydroxyurea treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The NZ Pharmacovigilance Centre has received 7 additional reports of Adverse-Effectsevere infections in patients with RA taking Drugleflunomide .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugINH , which is a leading cause of Adverse-Effectdrug eruptions in the above group of drugs was withdrawn.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report two cases of cerebrospinal fluid eosinophilia ( Adverse-EffectCSFE ) secondary to the intraventricular administration of Drugvancomycin .
1.0000 Adverse-Effect We report two cases of Adverse-Effectcerebrospinal fluid eosinophilia ( CSFE ) secondary to the intraventricular administration of Drugvancomycin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DISCUSSION : The Naranjo probability scale indicated a probable relationship between Drugsertraline treatment and the onset of Adverse-Effectrhabdomyolysis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSION : We have introduced a case of Adverse-Effectanaphylaxis by Drugcalcitonin that suggest an IgE mediated hypersensitivity reaction.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect No explanation for this delay was found, other than the possibility that Drugmagnesium sulfate treatment Adverse-Effectimpeded lactogenesis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Here we report Drugramipril - induced Adverse-Effectcutaneous vasculitis in a patient who required steroid therapy to control it.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugHydroxyurea associated with concomitant occurrence of Adverse-Effectdiffuse longitudinal melanonychia and multiple squamous cell carcinomas in an elderly subject.
1.0000 Adverse-Effect DrugHydroxyurea associated with concomitant occurrence of diffuse longitudinal melanonychia and Adverse-Effectmultiple squamous cell carcinomas in an elderly subject.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This case suggests the importance of careful observation for Adverse-Effectextramedullary relapse in patients who are treated with DrugATRA .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect With the increasing use of DrugCyclosporine A in transplant patients, the incidence of Adverse-Effectherpes esophagitis may increase.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugIsotretinoin , a drug used for the treatment of acne, has been shown to have Adverse-Effectteratogenic effects .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The Drugazathioprine dose was low ( 1 mg / kg ) and Adverse-Effectpancytopenia occurred after 56 days therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report 3 patients with Adverse-Effectsevere hepatocellular damage due to DrugCPA therapy, 2 with fatal fulminant hepatitis.
0.9994 Adverse-Effect We report 3 patients with severe hepatocellular damage due to DrugCPA therapy, 2 with Adverse-Effectfatal fulminant hepatitis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This case study describes an atypical case of refractory, Drugsodium warfarin - induced Adverse-Effectnecrotizing fasciitis and myonecrosis.
0.9995 Adverse-Effect This case study describes an atypical case of refractory, Drugsodium warfarin - induced necrotizing fasciitis and Adverse-Effectmyonecrosis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 77 - year - old man developed Adverse-Effectankle, hand, and facial swelling 2 weeks after starting Drugrosiglitazone .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect It has been reported that Drugfluoroquinolone antimicrobials prolong the corrected QT interval but rarely cause Adverse-Effecttorsade de pointes .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Beneficial effect of low - dose mianserin on Drugfluvoxamine - induced Adverse-Effectakathisia in an obsessive - compulsive patient.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugLinezolid - associated Adverse-Effectacute interstitial nephritis and drug rash with eosinophilia and systemic symptoms ( DRESS ) syndrome.
0.9999 Adverse-Effect DrugLinezolid - associated acute interstitial nephritis and Adverse-Effectdrug rash with eosinophilia and systemic symptoms ( DRESS ) syndrome.
0.9999 Adverse-Effect DrugLinezolid - associated acute interstitial nephritis and drug rash with eosinophilia and systemic symptoms ( Adverse-EffectDRESS ) syndrome.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Immunosuppression elicited by the extensive administration of Drugprednisolone was suspected for the initiation of the generalized Adverse-Effectmite infestation .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect BACKGROUND : Adverse-EffectAphthous stomatitis , a common mucocutaneous disorder, is a well accepted complication of Drugsirolimus therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The authors report two cases of acute dystonic reactions ( Adverse-EffectADRs ) as a side effect of Druglamivudine .
1.0000 Adverse-Effect The authors report two cases of Adverse-Effectacute dystonic reactions ( ADRs ) as a side effect of Druglamivudine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 52 - year - old woman developed symmetric sensorimotor polyneuropathy and Adverse-Effectcerebellar syndrome after 24 months of Drugamiodarone treatment.
0.9999 Adverse-Effect A 52 - year - old woman developed Adverse-Effectsymmetric sensorimotor polyneuropathy and cerebellar syndrome after 24 months of Drugamiodarone treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect It is hoped that this case report creates awareness that Drugofloxacin - induced Adverse-Effecttoxic epidermal necrolysis is possible.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A second possibility is an interaction between clarithromycin and Drugisradipine , potentially Adverse-Effectincreasing the hepatic toxicity of isradipine.
0.9999 Adverse-Effect A second possibility is an interaction between clarithromycin and isradipine, potentially Adverse-Effectincreasing the hepatic toxicity of Drugisradipine .
0.9994 Adverse-Effect A second possibility is an interaction between Drugclarithromycin and isradipine, potentially Adverse-Effectincreasing the hepatic toxicity of isradipine.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect These cases highlight the occurrence of Adverse-Effectlivedo reticularis as an uncommon side - effect of Druginterferon alpha treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSION : Significant Adverse-Effectweight loss is a potential adverse event in patients with rheumatoid arthritis treated with Drugleflunomide .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of Adverse-Effectacne fulminans occurring during treatment with Drug13 - cis - retinoic acid for cystic acne.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Fever and Adverse-Effectmaculopapular rashes appeared at 10 days after Drugphenytoin initiation, and then the drug was discontinued.
0.9999 Adverse-Effect Adverse-EffectFever and maculopapular rashes appeared at 10 days after Drugphenytoin initiation, and then the drug was discontinued.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This case and other published evidence should alert physicians to the possibility of fatal Drugerlotinib - induced Adverse-EffectILD .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The Adverse-Effectototoxicity of Drugquinine can accurately be studied with ultrahigh frequency audiometry ( up to 20 kHz ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect One case of Adverse-Effectpriapism occurred during Drugheparin therapy for a previous surgical operation to the knee is reported.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This prompted us to suspect that DrugddI might be responsible for Adverse-Effectfulminant hepatitis in all three AIDS patients.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectDrug eruption caused by Drugazathioprine : value of using the drug - induced lymphocytes stimulation test for diagnosis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Reye syndrome ( Adverse-EffectRS ) is believed to occur infrequently among children receiving long - term Drugaspirin therapy.
1.0000 Adverse-Effect Adverse-EffectReye syndrome ( RS ) is believed to occur infrequently among children receiving long - term Drugaspirin therapy.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect A retrospective study was conducted of 40 Drugloperamide Adverse-Effectloperamide poisoning cases recorded at the Centre National d'Informations Toxicologiques Veterinaires.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The case of a bipolar patient who developed thyrotoxicosis with Adverse-Effectsevere exophthalmos while on Druglithium therapy is described.
0.9999 Adverse-Effect The case of a bipolar patient who developed Adverse-Effectthyrotoxicosis with severe exophthalmos while on Druglithium therapy is described.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Reports of Adverse-Effectcolonic perforation as a result of the administration of Drugcalcium polystyrene sulfonate and sorbitol are rare.
0.9998 Adverse-Effect Reports of Adverse-Effectcolonic perforation as a result of the administration of calcium polystyrene sulfonate and Drugsorbitol are rare.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect BACKGROUND : Adverse-EffectOvarian cancer arising from an endometriotic cyst in a postmenopausal woman under Drugtamoxifen therapy is rare.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Administration of steroid and decreasing the dose of DrugPTU produced a good clinical response and the Adverse-EffectANCA disappeared.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Prior reports have emphasized the Adverse-Effecttubular and interstitial lesions associated with intermittent or discontinuous Drugrifampin therapy for tuberculosis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of a Adverse-Effectscleroderma - like reaction induced by long - term administration of DrugUFT .
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect DrugFludarabine induced Adverse-Effectlung toxicity must be considered in all patients who develop unexplained lung disease while receiving fludarabine.
Adverse-Effect DrugFludarabine induced lung toxicity must be considered in all patients who develop unexplained Adverse-Effectlung disease while receiving fludarabine.
Adverse-Effect Fludarabine induced lung toxicity must be considered in all patients who develop unexplained Adverse-Effectlung disease while receiving Drugfludarabine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Phenylpropanolamine ( DrugPPA ) recently has been publicly implicated as a cause of Adverse-Effectstroke and other neurologic events.
1.0000 Adverse-Effect Phenylpropanolamine ( DrugPPA ) recently has been publicly implicated as a cause of stroke and other Adverse-Effectneurologic events .
1.0000 Adverse-Effect DrugPhenylpropanolamine ( PPA ) recently has been publicly implicated as a cause of Adverse-Effectstroke and other neurologic events.
1.0000 Adverse-Effect DrugPhenylpropanolamine ( PPA ) recently has been publicly implicated as a cause of stroke and other Adverse-Effectneurologic events .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This is the first case, to our knowledge, of onset of prolonged Druginfliximab - induced Adverse-Effectlupus .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugRitonavir should be added to the list of drugs that can induce Adverse-Effectadverse cutaneous reactions in HIV patients.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect High - dose Drugmethylprednisolone in a pregnant woman with Crohn's disease and Adverse-Effectadrenal suppression in her newborn.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 55 - year - old woman developed symptoms suggestive of Adverse-Effecthepatitis 12 weeks after first receiving Drugmethyldopa for hypertension.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Successful recovery from Adverse-Effectinterstitial pneumonitis , induced by Drugbicalutamide and leuprorelin acetate given as treatment for prostate cancer.
0.9996 Adverse-Effect Successful recovery from Adverse-Effectinterstitial pneumonitis , induced by bicalutamide and Drugleuprorelin acetate given as treatment for prostate cancer.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect After the patient discontinued Drugrifampicin , the Adverse-Effectskin lesions cleared completely within 5 weeks without any systemic medication.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugMannitol - induced Adverse-EffectARF responds promptly to hemodialysis with rapid resolution of anuria and recovery of renal failure.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In a patient with severe renovascular hypertension, Adverse-Effectnonoliguric acute renal failure developed after she received Drugcaptopril treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We present a case of Adverse-Effectcutaneous leucocytoclastic vasculitis in which Drugamphotericin B might presumably be the aetiological factor.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This is the first report of an adverse effect of Adverse-Effectfetal renal circulation by maternal ingestion of Drugnimesulide .
Adverse-Effect This is the first report of an Adverse-Effectadverse effect of fetal renal circulation by maternal ingestion of Drugnimesulide .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report on a patient who developed Adverse-Effecthypersensitivity pneumonitis during treatment with the beta - blocker, Drugceliprolol .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect He developed recurrent skin rash, fever, hypereosinophilia, and Adverse-Effectacute renal failure after rechallenge with Drugchlorambucil .
1.0000 Adverse-Effect He developed recurrent skin rash, fever, Adverse-Effecthypereosinophilia , and acute renal failure after rechallenge with Drugchlorambucil .
1.0000 Adverse-Effect He developed recurrent skin rash, Adverse-Effectfever , hypereosinophilia, and acute renal failure after rechallenge with Drugchlorambucil .
0.9999 Adverse-Effect He developed recurrent Adverse-Effectskin rash , fever, hypereosinophilia, and acute renal failure after rechallenge with Drugchlorambucil .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a male patient with advanced AIDS who developed Adverse-Effecthypercalcemia 2 weeks after institution of DrugrhGH therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A rare case of advanced ovarian carcinoma who developed Adverse-Effectdifficulty walking 25 days after treatment with weekly Drugpaclitaxel .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report two cases that developed acute myeloid leukaemia ( Adverse-EffectAML ) during Drugtamoxifen therapy for breast cancer.
1.0000 Adverse-Effect We report two cases that developed Adverse-Effectacute myeloid leukaemia ( AML ) during Drugtamoxifen therapy for breast cancer.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report three cases of Adverse-Effectsevere hypocalcaemia associated with i. v. Drugbisphosphonate treatment in patients with multiple myeloma.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect The authors report two cases of Adverse-Effectdelayed elimination of Drugmethotrexate in patients receiving ciprofloxacin, with severe toxicity.
0.9943 Adverse-Effect The authors report two cases of Adverse-Effectdelayed elimination of methotrexate in patients receiving Drugciprofloxacin , with severe toxicity.
0.9983 Adverse-Effect The authors report two cases of delayed elimination of methotrexate in patients receiving Drugciprofloxacin , with Adverse-Effectsevere toxicity .
0.9534 Adverse-Effect The authors report two cases of delayed elimination of Drugmethotrexate in patients receiving ciprofloxacin, with Adverse-Effectsevere toxicity .
Adverse-Effect The authors report two cases of delayed elimination of methotrexate in patients receiving Drugciprofloxacin , with severe Adverse-Effecttoxicity .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Administration of Drugamantadine was associated with Adverse-Effectpsychotic decompensations in two schizophrenic patients being maintained on concomitant neuroleptic medication.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Two patients are described who developed Adverse-Effectsensory neuropathy after the ingestion of 30. 6 and 114 g Drugmetronidazole respectively.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectFatal ventricular fibrillation after treatment with Drugdigoxin in a 27 - year - old man with mitral leaflet prolapse syndrome.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of interstitial pulmonary disease that occurred together with Adverse-Effectlymphocytic colitis during treatment with Drugticlopidine .
0.9999 Adverse-Effect We report a case of Adverse-Effectinterstitial pulmonary disease that occurred together with lymphocytic colitis during treatment with Drugticlopidine .
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect These Adverse-Effectskin lesions may be induced or worsened during antiviral therapy with Druginterferon - alpha ( IFN ).
0.9996 Adverse-Effect These Adverse-Effectskin lesions may be induced or worsened during antiviral therapy with interferon - alpha ( DrugIFN ).
Score Relation Text (Head - Tail)
0.9993 Adverse-Effect After treatment with Drugcimetidine , there was a rapid deterioration with Adverse-Effectdecreased oxygen saturation and arterial PO2 values.
1.0000 Adverse-Effect After treatment with Drugcimetidine , there was a rapid Adverse-Effectdeterioration with decreased oxygen saturation and arterial PO2 values.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugFlecainide overdose can rapidly result in profound Adverse-Effectcardiovascular collapse , and is associated with a relatively high mortality.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The three reported cases demonstrate that Drugtroglitazone is an idiosyncratic hepatotoxin that can lead to Adverse-Effectirreversible liver injury .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : The aim of this paper is to describe a case of Adverse-Effectincreased libido during Drugfluvoxamine therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The development of erythroid leukemia plus Adverse-Effectcarcinoma in these two men suggests mutagenic change secondary to Drugcyclophosphamide therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Acute renal failure with Adverse-Effectsevere tubulointerstitial changes in a patient with minimal change nephrotic syndrome treated with Drugenalapril .
1.0000 Adverse-Effect Adverse-EffectAcute renal failure with severe tubulointerstitial changes in a patient with minimal change nephrotic syndrome treated with Drugenalapril .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DISCUSSION : To our knowledge this is the first reported case of Adverse-Effecttuberculous uveitis following treatment with Drugetanercept .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugL - asparaginase - induced Adverse-Effectpancreatitis is an uncommon but potential lethal complication of the treatment of leukemia.
0.9970 Adverse-Effect DrugL - asparaginase - induced pancreatitis is an uncommon but potential Adverse-Effectlethal complication of the treatment of leukemia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The cases of two asthmatic patients who became Adverse-Effecthypokalemic after inhalation of normal doses of Drugalbuterol are presented.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect How low can you go? Use of very low dosage of Druggold in patients with Adverse-Effectmucocutaneous reactions .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectRhabdomyolysis associated with Drugclozapine treatment in a patient with decreased calcium - dependent potassium permeability of cell membranes.
Score Relation Text (Head - Tail)
0.9938 Adverse-Effect Adverse-EffectPosterior reversible encephalopathy syndrome ( PRES ) induced by Drugcyclosporine use in a patient with collapsing focal glomeruloesclerosis.
Adverse-Effect Adverse-EffectPosterior reversible encephalopathy syndrome ( DrugPRES ) induced by cyclosporine use in a patient with collapsing focal glomeruloesclerosis.
Adverse-Effect Posterior reversible encephalopathy syndrome ( DrugPRES ) induced by Adverse-Effectcyclosporine use in a patient with collapsing focal glomeruloesclerosis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The association of Drugvenlafaxine treatment with Adverse-Effectischaemic events could be explained by its unique pharmacological and haemodynamic properties.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To report a case of a Adverse-Effectdiffuse papular eruption following treatment of psoriasis with Drugmethotrexate injections.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Attenuation of Drugasparaginase - induced Adverse-Effecthyperglycemia after substitution of the Erwinia carotovora for the Escherichia coli enzyme preparation.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Posthypoglycemic hyperglycemia ( Adverse-Effectrebound hyperglycemia ) after overdosing of Druginsulin was diagnosed in 6 cats with diabetes mellitus.
0.9999 Adverse-Effect Adverse-EffectPosthypoglycemic hyperglycemia ( rebound hyperglycemia ) after overdosing of Druginsulin was diagnosed in 6 cats with diabetes mellitus.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case of Drugclozapine - induced Adverse-Effecttonic - clonic seizures managed with valproate : implications for clinical care.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This report describes a case of Adverse-Effectneuroleptic malignant syndrome due to Drugrisperidone in a child with Joubert syndrome.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect It has been suggested that Adverse-EffectPPE caused by Drugcytarabine does not recur with subsequent cytarabine re - challenge.
0.9602 Adverse-Effect It has been suggested that Adverse-EffectPPE caused by cytarabine does not recur with subsequent Drugcytarabine re - challenge.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Treatment of Drugamiodarone - induced Adverse-Effectthyrotoxicosis ( AIT ) with thionamide, lithium or radioactive iodine is ineffective.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 68 - year - old female patient with advanced ovarian carcinoma Adverse-Effectcollapsed whilst receiving a Drugcarboplatin and cyclophosphamide infusion.
1.0000 Adverse-Effect A 68 - year - old female patient with advanced ovarian carcinoma Adverse-Effectcollapsed whilst receiving a carboplatin and Drugcyclophosphamide infusion.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect DrugImidazoline Adverse-EffectImidazoline intoxication due to overdose or accidental ingestion but also after normal therapeutic usage is frequent in children.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The occurrence of Adverse-EffectBMTN in two children treated with DrugRA in our unit is unlikely to be coincidental.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Multiple pulmonary nodules : an unusual presentation of Drugfludarabine Adverse-Effectpulmonary toxicity : case report and review of literature.
0.9997 Adverse-Effect Adverse-EffectMultiple pulmonary nodules : an unusual presentation of Drugfludarabine pulmonary toxicity : case report and review of literature.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectExtrapyramidal symptoms are well - documented complications of therapy with Drughaloperidol , even when small doses are used.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Case report : Adverse-Effectlife - threatening hypoglycaemia associated with Drugsulfadoxine - pyrimethamine , a commonly used antimalarial drug.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugBenzocaine , an ester - type local anesthetic, was believed responsible for apparent Adverse-Effectmethemoglobinemia in a cat.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of Adverse-EffectNEH masquerading as cutaneous vasculitis in a woman receiving Drugcyclophosphamide for lupus nephritis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report two cases of tenofovir ( DrugTDF ) - associated Adverse-Effectnephrotoxicity in perinatally HIV - infected adolescents.
0.9997 Adverse-Effect We report two cases of Drugtenofovir ( TDF ) - associated Adverse-Effectnephrotoxicity in perinatally HIV - infected adolescents.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugMethotrexate may rarely provoke Adverse-Effectserositis , even with low doses and after just a few weeks of therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In addition, Drugethambutol rarely causes Adverse-Effectvisual loss during the early period or when given at lower doses.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectCushing's syndrome persisted more than 6 months while DrugTCA concentrations remained detectable for at least 80 days.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Two patients with bipolar affective disorder and a history of bronchospastic phenomena experienced Adverse-Effecttremor during Druglithium carbonate therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect RESULTS : Both patients experienced a previously unreported side effect - - Adverse-Effectfalling backward - - associated with Drugbupropion use.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectVision declined after treatment with Drugmethylprednisolone , after which fundus examination became consistent with progressive outer retinal necrosis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A patient with chronic myelomonocytic leukemia developed drug - induced Adverse-Effectpulmonary toxicity after using low dose oral Drugetoposide .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Physicians should be aware of the possible association between the use of Drugalteplase and the development of Adverse-Effectsubfascial hemorrhage .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A patient, while on intravenous Drugritodrine therapy for preterm labor, experienced an episode of Adverse-Effectacute chest pain .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Fever, lymphadenopathy, eosinophilia, lymphocytosis, hepatitis, and Adverse-Effectdermatitis : a severe adverse reaction to Drugminocycline .
1.0000 Adverse-Effect Fever, lymphadenopathy, eosinophilia, lymphocytosis, Adverse-Effecthepatitis , and dermatitis : a severe adverse reaction to Drugminocycline .
1.0000 Adverse-Effect Fever, lymphadenopathy, eosinophilia, Adverse-Effectlymphocytosis , hepatitis, and dermatitis : a severe adverse reaction to Drugminocycline .
0.9999 Adverse-Effect Fever, lymphadenopathy, Adverse-Effecteosinophilia , lymphocytosis, hepatitis, and dermatitis : a severe adverse reaction to Drugminocycline .
0.9999 Adverse-Effect Adverse-EffectFever , lymphadenopathy, eosinophilia, lymphocytosis, hepatitis, and dermatitis : a severe adverse reaction to Drugminocycline .
0.9999 Adverse-Effect Fever, Adverse-Effectlymphadenopathy , eosinophilia, lymphocytosis, hepatitis, and dermatitis : a severe adverse reaction to Drugminocycline .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case of Adverse-EffectErythema Multiforme Bullosum in patient of lepromatous leprosy with pulmonary tuberculosis due to DrugRifampicin is described.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : DrugColchicine - induced Adverse-Effectmyopathy should be excluded in patients with FMF who present with generalized muscle weakness.
0.9941 Adverse-Effect CONCLUSIONS : DrugColchicine - induced myopathy should be excluded in patients with FMF who present with Adverse-Effectgeneralized muscle weakness .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Because of a Adverse-Effecthypersensitivity reaction , initial therapy with Drugpenicillin G and gentamicin was stopped and substituted with cefazolin.
0.9998 Adverse-Effect Because of a Adverse-Effecthypersensitivity reaction , initial therapy with penicillin G and Druggentamicin was stopped and substituted with cefazolin.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The authors describe a case of Adverse-Effectneuroleptic malignant syndrome that occurred in a patient on Drugamitriptyline and lithium carbonate.
0.9996 Adverse-Effect The authors describe a case of Adverse-Effectneuroleptic malignant syndrome that occurred in a patient on amitriptyline and Druglithium carbonate .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Typically, drug - induced Adverse-Effectneutropenia occurs in a patient receiving a semisynthetic Drugpenicillin for two weeks or more.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugMethimazole - induced Adverse-Effectaplastic anemia in third exposure : successful treatment with recombinant human granulocyte colony - stimulating factor.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The newborn manifested a four day course of Adverse-Effectlethargy with unexplained high Druglithium levels in the adult toxic range.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We experienced 2 cases of Drugmequitazine - induced Adverse-Effectphotosensitivity reaction in patients who took mequitazine for their dermatologic problems.
1.0000 Adverse-Effect We experienced 2 cases of mequitazine - induced Adverse-Effectphotosensitivity reaction in patients who took Drugmequitazine for their dermatologic problems.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSION : Fixed drug Adverse-Effecteruption is associated with many drugs but this is the first such report with Drugomeprazole .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectFSGS induced by DrugAdriamycin ( Pharmacia & Upjohn, Columbus, OH ) has been observed experimentally in rats.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectPulmonary leukostasis secondary to Drugall - trans retinoic acid in the treatment of acute promyelocytic leukemia in first relapse.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect An objective causality assessment by use of the Naranjo probability scale revealed that Adverse-EffectNCSE due to Drugifosfamide was probable.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A patient with acute esophageal variceal bleeding developed Adverse-Effectfatal rhabdomyolysis during treatment with a continuous intravenous infusion of Drugvasopressin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Electrocardiographic findings and laboratory data indicated a diagnosis of Adverse-Effectacute myocardial infarction due to the DrugL - thyroxine therapy.
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect Establishment of diuresis with fluids and IV administration of calcium may provide successful treatment of Drugmagnesium Adverse-Effectmagnesium toxicosis in horses.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a patient who presented with Adverse-Effectbloody diarrhoea after 15 mg Drugmeloxicam daily for 10 days for osteoarthritis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Four cases of Adverse-Effectoesophageal damage associated with ingestion of the urinary anti - spasmodic agent Drugemepronium bromide are described.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case of Adverse-Effectheatstroke is reported in a 32 - year - old man diagnosed with schizophrenia and on Drugclozapine monotherapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Due to discomfort, diplopia and lagophthalmos, the Adverse-Effecthaematoma necessitated suspension of Drugwarfarin therapy and a surgical evacuation.
0.9999 Adverse-Effect Due to discomfort, diplopia and Adverse-Effectlagophthalmos , the haematoma necessitated suspension of Drugwarfarin therapy and a surgical evacuation.
0.9999 Adverse-Effect Due to discomfort, Adverse-Effectdiplopia and lagophthalmos, the haematoma necessitated suspension of Drugwarfarin therapy and a surgical evacuation.
0.9999 Adverse-Effect Due to Adverse-Effectdiscomfort , diplopia and lagophthalmos, the haematoma necessitated suspension of Drugwarfarin therapy and a surgical evacuation.
Score Relation Text (Head - Tail)
0.9988 Adverse-Effect Atypical ventricular tachycardia ( Adverse-Effecttorsade de pointes ) induced by Drugamiodarone : arrhythmia previously induced by quinidine and disopyramide.
0.9972 Adverse-Effect Atypical ventricular tachycardia ( torsade de pointes ) induced by amiodarone : Adverse-Effectarrhythmia previously induced by Drugquinidine and disopyramide.
0.9657 Adverse-Effect Adverse-EffectAtypical ventricular tachycardia ( torsade de pointes ) induced by Drugamiodarone : arrhythmia previously induced by quinidine and disopyramide.
0.7344 Adverse-Effect Atypical ventricular tachycardia ( torsade de pointes ) induced by amiodarone : Adverse-Effectarrhythmia previously induced by quinidine and Drugdisopyramide .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To describe a case of Drugsertraline - induced Adverse-Effectrhabdomyolysis in an elderly patient with dementia and comorbidities.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectFatal eosinophilia myalgia syndrome in a marrow transplant patient attributed to total parenteral nutrition with a solution containing Drugtryptophan .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the first case of a patient in a Drugpromethazine - induced Adverse-Effectcoma responding to treatment with flumazenil.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect DrugMineral oil , a hydrocarbon, may not elicit a normal protective cough reflex and may Adverse-Effectimpair mucociliary transport .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report 3 children with epilepsy who developed Adverse-Effectfacial motor tics after initiation of DrugCBZ for complex partial seizures.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 43 - year - old white man developed a shallow Adverse-Effecterosion of a psoriatic plaque after chronic administration of Drugmethotrexate .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect One case of Drugtacrolimus - induced Adverse-Effecthepatic VOD developing after lung transplantation ( LT ) has been recently reported.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect While the mechanism of Drugdextran - associated Adverse-Effectrenal failure remains unsolved, plasma exchange seems to be effective therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Myoclonus and Adverse-Effectseizures disappeared after discontinuation of DrugL - dopa and the introduction of valproate sodium ( VPA ).
0.9999 Adverse-Effect Adverse-EffectMyoclonus and seizures disappeared after discontinuation of DrugL - dopa and the introduction of valproate sodium ( VPA ).
0.9999 Adverse-Effect Myoclonus and Adverse-Effectseizures disappeared after discontinuation of L - dopa and the introduction of Drugvalproate sodium ( VPA ).
0.9999 Adverse-Effect Myoclonus and Adverse-Effectseizures disappeared after discontinuation of L - dopa and the introduction of valproate sodium ( DrugVPA ).
0.9995 Adverse-Effect Adverse-EffectMyoclonus and seizures disappeared after discontinuation of L - dopa and the introduction of valproate sodium ( DrugVPA ).
0.9995 Adverse-Effect Adverse-EffectMyoclonus and seizures disappeared after discontinuation of L - dopa and the introduction of Drugvalproate sodium ( VPA ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CASE DESCRIPTION : A 59 - year - old man with known neurocysticercosis developed a Adverse-Effectlarge cerebral infarction during Drugpraziquantel therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Atypical endometriosis may act as a precancerous lesion in the process of Drugtamoxifen - induced Adverse-Effectmalignant transformation of endometriosis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Mechanisms and triggering factors of Adverse-Effecthypoglycaemia induced by Drugmefloquine and some other anti - malarial quinine analogues are discussed.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect a 67 - year - old man with bipolar disorder developed a Adverse-EffectCreutzfeldt - Jakob like syndrome during Druglithium carbonate treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugTiagabine overdose causes an unusual array of Adverse-Effectneurological symptoms , many similar to reported adverse effects during therapeutic use.
Adverse-Effect DrugTiagabine overdose causes an Adverse-Effectunusual array of neurological symptoms , many similar to reported adverse effects during therapeutic use.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Increased lash length, thickness, and Adverse-Effectpigmentation are well - documented side effects of Drugprostaglandin analog glaucoma drops.
1.0000 Adverse-Effect Adverse-EffectIncreased lash length , thickness, and pigmentation are well - documented side effects of Drugprostaglandin analog glaucoma drops.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We have reported six cases of Drugmetoclopramide - induced Adverse-Effectparkinsonism seen in consultation over a two - year period.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect METHOD : We describe two patients who presented with Adverse-Effectdiabetic ketoacidosis after treatment with Drugquetiapine and risperidone, respectively.
1.0000 Adverse-Effect METHOD : We describe two patients who presented with Adverse-Effectdiabetic ketoacidosis after treatment with quetiapine and Drugrisperidone , respectively.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe two cases of PSVT that changed to Adverse-Effectnon - sustained polymorphic ventricular tachycardia after administration of Drugverapamil .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Gastric tumor, endometrial carcinoma and Adverse-Effectcervical adenocarcinoma in situ were detected after treatment with Drugtamoxifen for breast cancer.
1.0000 Adverse-Effect Adverse-EffectGastric tumor , endometrial carcinoma and cervical adenocarcinoma in situ were detected after treatment with Drugtamoxifen for breast cancer.
1.0000 Adverse-Effect Gastric tumor, Adverse-Effectendometrial carcinoma and cervical adenocarcinoma in situ were detected after treatment with Drugtamoxifen for breast cancer.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Intravenous sodium bicarbonate appears to be indicated prophylactically in combating the associated Adverse-Effectmetabolic acidosis due to absorbed Drugformic acid .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a detailed case of Adverse-Effectfulminant hepatitis induced by Drugnevirapine ( Viramune ) and treated by liver transplantation.
0.9999 Adverse-Effect We describe a detailed case of Adverse-Effectfulminant hepatitis induced by nevirapine ( DrugViramune ) and treated by liver transplantation.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugInterferon - alpha - induced Adverse-Effecthyperthyroidism : a three - stage evolution from silent thyroiditis towards Graves'disease.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect A diagnosis of masked Drugtheophylline Adverse-Effecttheophylline poisoning should be considered in similar situations involving a rapid decrease of insulin requirements.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect To our knowledge, our report is one of the first on shock and Adverse-Effectangio - oedema from Drugirbesartan .
0.9999 Adverse-Effect To our knowledge, our report is one of the first on Adverse-Effectshock and angio - oedema from Drugirbesartan .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The authors report a case of Balint syndrome with irreversible Adverse-Effectposterior leukoencephalopathy on MRI following intrathecal Drugmethotrexate and cytarabine.
1.0000 Adverse-Effect The authors report a case of Adverse-EffectBalint syndrome with irreversible posterior leukoencephalopathy on MRI following intrathecal Drugmethotrexate and cytarabine.
0.9999 Adverse-Effect The authors report a case of Balint syndrome with irreversible Adverse-Effectposterior leukoencephalopathy on MRI following intrathecal methotrexate and Drugcytarabine .
0.9999 Adverse-Effect The authors report a case of Adverse-EffectBalint syndrome with irreversible posterior leukoencephalopathy on MRI following intrathecal methotrexate and Drugcytarabine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Aseptic meningitis, hemolytic anemia, hepatitis, and Adverse-Effectorthostatic hypotension in a patient treated with Drugtrimethoprim - sulfamethoxazole.
0.9999 Adverse-Effect Aseptic meningitis, hemolytic anemia, hepatitis, and Adverse-Effectorthostatic hypotension in a patient treated with trimethoprim - Drugsulfamethoxazole .
0.9999 Adverse-Effect Aseptic meningitis, hemolytic anemia, Adverse-Effecthepatitis , and orthostatic hypotension in a patient treated with Drugtrimethoprim - sulfamethoxazole.
0.9999 Adverse-Effect Aseptic meningitis, Adverse-Effecthemolytic anemia , hepatitis, and orthostatic hypotension in a patient treated with Drugtrimethoprim - sulfamethoxazole.
0.9999 Adverse-Effect Adverse-EffectAseptic meningitis , hemolytic anemia, hepatitis, and orthostatic hypotension in a patient treated with Drugtrimethoprim - sulfamethoxazole.
0.9998 Adverse-Effect Aseptic meningitis, hemolytic anemia, Adverse-Effecthepatitis , and orthostatic hypotension in a patient treated with trimethoprim - Drugsulfamethoxazole .
0.9998 Adverse-Effect Aseptic meningitis, Adverse-Effecthemolytic anemia , hepatitis, and orthostatic hypotension in a patient treated with trimethoprim - Drugsulfamethoxazole .
0.9998 Adverse-Effect Adverse-EffectAseptic meningitis , hemolytic anemia, hepatitis, and orthostatic hypotension in a patient treated with trimethoprim - Drugsulfamethoxazole .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Successful treatment of visceral leishmaniasis with allopurinol plus ketoconazole in an infant who developed Adverse-Effectpancreatitis caused by Drugmeglumine antimoniate .
0.9995 Adverse-Effect Successful treatment of visceral leishmaniasis with allopurinol plus Drugketoconazole in an infant who developed Adverse-Effectpancreatitis caused by meglumine antimoniate.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect CONCLUSIONS : The administration of Drugprostaglandin E1 to neonates can cause Adverse-Effectgastric - outlet obstruction due to antral hyperplasia.
0.9991 Adverse-Effect CONCLUSIONS : The administration of Drugprostaglandin E1 to neonates can cause gastric - outlet obstruction due to Adverse-Effectantral hyperplasia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the first case of Adverse-Effectrhabdomyolysis related to the administration of Drugclarithromycin without concurrent use of other medications.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe 2 cases of Adverse-EffectSJS related to Drugnevirapine use and review the literature on this newly recognized association.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Used injudiciously, Drugnaloxone can lead to Adverse-Effectwithdrawal syndrome , return of severe pain, and other adverse effects.
0.9999 Adverse-Effect Used injudiciously, Drugnaloxone can lead to withdrawal syndrome, return of Adverse-Effectsevere pain , and other adverse effects.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The case concerns the Adverse-Effectsudden death of a 29 - year - old male during Drugclozapine therapy started 2 weeks before.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Prior neurologic illness or CNS insult of any kind is known to increase the vulnerability to Adverse-Effectneurotoxicity of Druglithium .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The objective of this report is to describe a case of fixed drug Adverse-Effecteruption that occurred during Drugomeprazole treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectIatrogenic Cushing syndrome after epidural Drugtriamcinolone injections in an HIV type 1 - infected patient receiving therapy with ritonavir - lopinavir.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The clinical symptoms of Adverse-Effectgastric mucosa foveolar hyperplasia due to long - term DrugPGE1 therapy simulate hypertrophic pyloric stenosis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Occasionally, despite good therapeutic response, Drugclozapine must be stopped due to dangerous side effects such as Adverse-Effectagranulocytosis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Findings on discontinuation and rechallenge supported the assumption that the Adverse-Effecthair loss was a side effect of the Drugparoxetine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectPsoriasis triggered by toll - like receptor 7 agonist Drugimiquimod in the presence of dermal plasmacytoid dendritic cell precursors.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectIatrogenic hypercalcemia due to Drugvitamin D3 ointment ( 1, 24 ( OH ) 2D3 ) combined with thiazide diuretics in a case of psoriasis.
0.9996 Adverse-Effect Adverse-EffectIatrogenic hypercalcemia due to vitamin D3 ointment ( Drug1, 24 ( OH ) 2D3 ) combined with thiazide diuretics in a case of psoriasis.
0.9994 Adverse-Effect Adverse-EffectIatrogenic hypercalcemia due to vitamin D3 ointment ( 1, 24 ( OH ) 2D3 ) combined with Drugthiazide diuretics in a case of psoriasis.
Adverse-Effect Iatrogenic Adverse-Effecthypercalcemia due to vitamin D3 ointment ( Drug1, 24 ( OH ) 2D3 ) combined with thiazide diuretics in a case of psoriasis.
Adverse-Effect Iatrogenic Adverse-Effecthypercalcemia due to Drugvitamin D3 ointment ( 1, 24 ( OH ) 2D3 ) combined with thiazide diuretics in a case of psoriasis.
Adverse-Effect Iatrogenic Adverse-Effecthypercalcemia due to vitamin D3 ointment ( 1, 24 ( OH ) 2D3 ) combined with Drugthiazide diuretics in a case of psoriasis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A patient with ulcerative colitis developed skin pigmentation and Adverse-Effectdiffuse pulmonary shadowing without respiratory symptomatology, while taking Drugsulfasalazine .
0.9999 Adverse-Effect A patient with ulcerative colitis developed Adverse-Effectskin pigmentation and diffuse pulmonary shadowing without respiratory symptomatology, while taking Drugsulfasalazine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In this case, Adverse-EffectCIPS was considered to be probably associated with Drugcyclosporine according to the Naranjo probability scale.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This treatment has the potential to cause severe vision loss as a result of intractable Drugcorticosteroid - induced Adverse-Effectglaucoma .
0.9999 Adverse-Effect This treatment has the potential to cause Adverse-Effectsevere vision loss as a result of intractable Drugcorticosteroid - induced glaucoma.
Score Relation Text (Head - Tail)
0.9996 Adverse-Effect DrugLithium neurotoxicity should be considered in Adverse-EffectCreutzfeldt - Jakob disease differential diagnosis, serial electroencephalograms being the most valuable.
1.0000 Adverse-Effect DrugLithium Adverse-Effectneurotoxicity should be considered in Creutzfeldt - Jakob disease differential diagnosis, serial electroencephalograms being the most valuable.
Adverse-Effect DrugLithium Adverse-EffectLithium neurotoxicity should be considered in Creutzfeldt - Jakob disease differential diagnosis, serial electroencephalograms being the most valuable.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of Adverse-Effectpenile fibrosis after intracavernous self - injection of a combination of Drugphentolamine and papaverine.
1.0000 Adverse-Effect We report a case of Adverse-Effectpenile fibrosis after intracavernous self - injection of a combination of phentolamine and Drugpapaverine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the first case of a 54 - year - old Turkish woman who presented with Drugceftriaxone - induced Adverse-EffectFDE .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report such a series of patients who had Adverse-Effecttransient asymptomatic bradycardia after being treated with continuous infusion Drug5 - FU .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Relief by naloxone of Drugmorphine - induced Adverse-Effectspasm of the sphincter of Oddi in a post - cholecystectomy patient.
Score Relation Text (Head - Tail)
0.9993 Adverse-Effect The present report suggests that clarithromycin coadministration induces increased plasma carbamazepine concentrations, which may result in Drugcarbamazepine Adverse-Effectcarbamazepine toxicity .
0.9985 Adverse-Effect The present report suggests that clarithromycin coadministration induces increased plasma Drugcarbamazepine concentrations, which may result in Adverse-Effectcarbamazepine toxicity .
0.9926 Adverse-Effect The present report suggests that Drugclarithromycin coadministration induces increased plasma carbamazepine concentrations, which may result in Adverse-Effectcarbamazepine toxicity .
Adverse-Effect The present report suggests that clarithromycin coadministration induces Adverse-Effectincreased plasma carbamazepine Drugcarbamazepine concentrations, which may result in carbamazepine toxicity.
Adverse-Effect The present report suggests that Drugclarithromycin coadministration induces Adverse-Effectincreased plasma carbamazepine concentrations, which may result in carbamazepine toxicity.
Adverse-Effect The present report suggests that clarithromycin coadministration induces Adverse-Effectincreased plasma carbamazepine concentrations, which may result in Drugcarbamazepine toxicity.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case of Drugphenobarbital Adverse-Effectexacerbation of a preexisting maladaptive behavior partially suppressed by chlorpromazine and misinterpreted as chlorpromazine efficacy.
0.9999 Adverse-Effect A case of Drugphenobarbital Adverse-Effectphenobarbital exacerbation of a preexisting maladaptive behavior partially suppressed by chlorpromazine and misinterpreted as chlorpromazine efficacy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Intracranial hemorrhage and Adverse-Effectfocal seizures secondary to use of DrugL - asparaginase during induction therapy of acute lymphocytic leukemia.
0.9997 Adverse-Effect Adverse-EffectIntracranial hemorrhage and focal seizures secondary to use of DrugL - asparaginase during induction therapy of acute lymphocytic leukemia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case of prolonged Drugsuxamethonium Adverse-Effectapnoea successfully terminated by the infusion of a commercial preparation of serumcholinesterase is reported.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect After the Drugchlorambucil was discontinued, the wbc count began to slowly rise and the patient developed clinical Adverse-EffectAML .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe 2 patients with prior amputation who experienced phantom limb pain ( Adverse-EffectPLP ) after receiving Drugpaclitaxel therapy.
1.0000 Adverse-Effect We describe 2 patients with prior amputation who experienced Adverse-Effectphantom limb pain ( PLP ) after receiving Drugpaclitaxel therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Localized panniculitis and subsequent Adverse-Effectlipoatrophy with subcutaneous Drugglatiramer acetate ( Copaxone ) injection for the treatment of multiple sclerosis.
0.9999 Adverse-Effect Localized panniculitis and subsequent Adverse-Effectlipoatrophy with subcutaneous glatiramer acetate ( DrugCopaxone ) injection for the treatment of multiple sclerosis.
0.9997 Adverse-Effect Adverse-EffectLocalized panniculitis and subsequent lipoatrophy with subcutaneous Drugglatiramer acetate ( Copaxone ) injection for the treatment of multiple sclerosis.
0.9992 Adverse-Effect Adverse-EffectLocalized panniculitis and subsequent lipoatrophy with subcutaneous glatiramer acetate ( DrugCopaxone ) injection for the treatment of multiple sclerosis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The aim of our paper was to describe Adverse-Effecthepatotoxicity of Drugsirolimus ( SRL ) in a kidney graft recipient.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of drug - induced Adverse-Effectpemphigus caused by an angiotensin - converting enzyme inhibitor, Drugcaptopril .
Score Relation Text (Head - Tail)
0.9993 Adverse-Effect OBJECTIVE : To report Drugteicoplanin - related Adverse-Effectneutropenia that developed after an episode of neutropenia induced by vancomycin therapy.
0.9988 Adverse-Effect OBJECTIVE : To report teicoplanin - related neutropenia that developed after an episode of Adverse-Effectneutropenia induced by Drugvancomycin therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Two patients with HLH developed Drugetoposide - related Adverse-Effectsecondary acute myeloid leukemia ( sAML ) following therapy for HLH.
0.9999 Adverse-Effect Two patients with HLH developed Drugetoposide - related secondary acute myeloid leukemia ( Adverse-EffectsAML ) following therapy for HLH.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The first patient is undergoing hemodialysis and, though responding to Drugsunitinib , is having significant Adverse-Effectfatigue and hypertension.
1.0000 Adverse-Effect The first patient is undergoing hemodialysis and, though responding to Drugsunitinib , is having significant fatigue and Adverse-Effecthypertension .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This communication describes a patient who developed Adverse-EffectSchneiderian first - rank symptoms in the course of treatment with Drugfluvoxamine .
Score Relation Text (Head - Tail)
0.9996 Adverse-Effect Initiation of Drugposaconazole led to clinical improvement until the patient's demise from bacteremic vancomycin - resistant Adverse-Effectenterococcal peritonitis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectRed blood cell anemia in a patient with pemphigus vulgaris induced by the use of Drugmycophenolate mofetil and prednisone.
0.9998 Adverse-Effect Adverse-EffectRed blood cell anemia in a patient with pemphigus vulgaris induced by the use of mycophenolate mofetil and Drugprednisone .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect After 3 - to 13 - month period of therapy without Drugindapamide , glucose levels of all patients decreased and Adverse-Effectdiabetes disappeared.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To report a case of Adverse-Effectsevere apnea in an infant exposed to Druglamotrigine through breast - feeding.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect According to the Naranjo adverse drug reaction probability scale, Drugtigecycline was the probable cause of her Adverse-Effectacute pancreatitis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The time course of events suggested that Drugamphotericin B was the cause of the Adverse-Effectseizures in this AIDS patient.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The case history and toxicological findings of an infant Adverse-Effectfatality involving Drugpseudoephedrine , brompheniramine, and dextromethorphan are presented.
1.0000 Adverse-Effect The case history and toxicological findings of an infant Adverse-Effectfatality involving pseudoephedrine, Drugbrompheniramine , and dextromethorphan are presented.
1.0000 Adverse-Effect The case history and toxicological findings of an infant Adverse-Effectfatality involving pseudoephedrine, brompheniramine, and Drugdextromethorphan are presented.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This regimen could prove useful for other patients who develop Adverse-Effecthypersensitivity reactions to Drugcarboplatin and allow therapy to continue.
1.0000 Adverse-Effect This regimen could prove useful for other patients who develop Adverse-Effecthypersensitivity reactions to Drugcarboplatin and allow therapy to continue.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The most common side effects associated with Drugamifostine are Adverse-Effectnausea , vomiting, hypotension, hypocalcemia and allergic reactions.
1.0000 Adverse-Effect The most common side effects associated with Drugamifostine are nausea, Adverse-Effectvomiting , hypotension, hypocalcemia and allergic reactions.
1.0000 Adverse-Effect The most common side effects associated with Drugamifostine are nausea, vomiting, Adverse-Effecthypotension , hypocalcemia and allergic reactions.
0.9999 Adverse-Effect The most common side effects associated with Drugamifostine are nausea, vomiting, hypotension, Adverse-Effecthypocalcemia and allergic reactions.
0.9999 Adverse-Effect The most common side effects associated with Drugamifostine are nausea, vomiting, hypotension, hypocalcemia and Adverse-Effectallergic reactions .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 51 - year old physically fit woman experienced angio - oedema and Adverse-Effecthypotensive shock after Drugirbesartan ingestion requiring noradrenaline infusion.
0.9997 Adverse-Effect A 51 - year old physically fit woman experienced Adverse-Effectangio - oedema and hypotensive shock after Drugirbesartan ingestion requiring noradrenaline infusion.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This case supports the assessment that MH and diabetes are associated diseases and that Drugcresol could possibly trigger Adverse-EffectMH .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This is the third report of reversible Adverse-Effecthepatic decompensation associated with prolonged DrugMTX therapy in patients with rheumatoid arthritis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A patient is described who developed a poorly differentiated Adverse-Effectsarcoma after Drugcyclophosphamide was used to treat his rheumatoid arthritis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Both colchicine and Drugstatin therapy may be associated with Adverse-Effectmyopathy , which usually occurs after several months of therapy.
1.0000 Adverse-Effect Both Drugcolchicine and statin therapy may be associated with Adverse-Effectmyopathy , which usually occurs after several months of therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report two patients with anhedonic ejaculation ( Adverse-Effectejaculation without orgasm ) associated with initiation of treatment with Drugdesipramine .
1.0000 Adverse-Effect We report two patients with Adverse-Effectanhedonic ejaculation ( ejaculation without orgasm ) associated with initiation of treatment with Drugdesipramine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect RESULTS : Including our own patient, a total of 26 cases of Druggemcitabine - associated Adverse-EffectHUS were identified.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a 5 - year - old girl showed recovery of Drugvincristine induced Adverse-Effectcranial polyneuropathy with pyridoxine and pyridostigmine treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect She was placed on adjuvant Adriamycin ( Drugdoxorubicin ) chemotherapy, but 6 months later Adverse-Effectdied of Adriamycin toxicity.
0.9998 Adverse-Effect She was placed on adjuvant DrugAdriamycin ( doxorubicin ) chemotherapy, but 6 months later Adverse-Effectdied of Adriamycin toxicity.
0.9993 Adverse-Effect She was placed on adjuvant Adriamycin ( doxorubicin ) chemotherapy, but 6 months later died of DrugAdriamycin Adverse-EffectAdriamycin toxicity .
0.9989 Adverse-Effect She was placed on adjuvant Adriamycin ( Drugdoxorubicin ) chemotherapy, but 6 months later died of Adverse-EffectAdriamycin toxicity .
0.9962 Adverse-Effect She was placed on adjuvant Adriamycin ( doxorubicin ) chemotherapy, but 6 months later Adverse-Effectdied of DrugAdriamycin toxicity.
0.9942 Adverse-Effect She was placed on adjuvant DrugAdriamycin ( doxorubicin ) chemotherapy, but 6 months later died of Adverse-EffectAdriamycin toxicity .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Quinine and its isomer Drugquinidine are well - known causes of Adverse-Effectiatrogenic hypoglycaemia , due to excessive insulin secretion.
0.9997 Adverse-Effect DrugQuinine and its isomer quinidine are well - known causes of Adverse-Effectiatrogenic hypoglycaemia , due to excessive insulin secretion.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect However, he developed acute renal failure, hyperkalemia, and Adverse-Effecthyperuricemia 30 d after receiving the Drugsorafenib treatment.
0.9999 Adverse-Effect However, he developed acute renal failure, Adverse-Effecthyperkalemia , and hyperuricemia 30 d after receiving the Drugsorafenib treatment.
0.9999 Adverse-Effect However, he developed Adverse-Effectacute renal failure , hyperkalemia, and hyperuricemia 30 d after receiving the Drugsorafenib treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSION : A woman receiving Drugenoxaparin every 12 hours developed signs and symptoms of Adverse-Effecthepatotoxicity after the second dose.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect She had been on DrugCopaxone 20 mg / day treatment for 2 years when she first exhibited Adverse-Effectgastrointestinal symptoms .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect However, dermatologists should be cautious about a Adverse-Effectphotosensitivity reaction induced by Drugmequitazine or other phenothiazine - derivative drugs.
1.0000 Adverse-Effect However, dermatologists should be cautious about a Adverse-Effectphotosensitivity reaction induced by Drugmequitazine or other phenothiazine - derivative drugs.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect To date, this is the first reported case of what appears to be isolated Adverse-Effectthrombocytopenia associated with Druglansoprazole .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This report describes the first case of Druginsulin - induced Adverse-Effectcardiac failure in a patient without underlying heart disease.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Patients receiving Drugneutral protamine Hagedorn ( NPH ) insulin are at increased risk for the development of Adverse-Effectprotamine hypersensitivity .
1.0000 Adverse-Effect Patients receiving neutral Drugprotamine Hagedorn ( NPH ) insulin are at increased risk for the development of Adverse-Effectprotamine hypersensitivity .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectRadiation recall from Druggemcitabine is rare, but can potentially arise in any site that has been previously irradiated.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectNeutropenia is an infrequent complication following administration of the angiotensin - converting enzyme ( ACE ) inhibitor, Drugcaptopril .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Cholestatic liver disease with ductopenia ( Adverse-Effectvanishing bile duct syndrome ) after administration of Drugclindamycin and trimethoprim - sulfamethoxazole.
0.9999 Adverse-Effect Adverse-EffectCholestatic liver disease with ductopenia ( vanishing bile duct syndrome ) after administration of Drugclindamycin and trimethoprim - sulfamethoxazole.
0.9999 Adverse-Effect Cholestatic liver disease with Adverse-Effectductopenia ( vanishing bile duct syndrome ) after administration of Drugclindamycin and trimethoprim - sulfamethoxazole.
0.9998 Adverse-Effect Cholestatic liver disease with ductopenia ( Adverse-Effectvanishing bile duct syndrome ) after administration of clindamycin and Drugtrimethoprim - sulfamethoxazole .
0.9992 Adverse-Effect Adverse-EffectCholestatic liver disease with ductopenia ( vanishing bile duct syndrome ) after administration of clindamycin and Drugtrimethoprim - sulfamethoxazole .
0.9990 Adverse-Effect Cholestatic liver disease with Adverse-Effectductopenia ( vanishing bile duct syndrome ) after administration of clindamycin and Drugtrimethoprim - sulfamethoxazole .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Physicians should keep in mind that taxanes such as Drugpaclitaxel have the potential to cause Adverse-Effectpneumonitis and lung fibrosis.
0.9999 Adverse-Effect Physicians should keep in mind that taxanes such as Drugpaclitaxel have the potential to cause pneumonitis and Adverse-Effectlung fibrosis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Hypersensitivity to Drugaspirin can be manifested as acute asthma, Adverse-Effecturticaria and / or angioedema, or a systemic anaphylactoid reaction.
0.9999 Adverse-Effect Hypersensitivity to Drugaspirin can be manifested as acute asthma, urticaria and / or Adverse-Effectangioedema , or a systemic anaphylactoid reaction.
0.9999 Adverse-Effect Hypersensitivity to Drugaspirin can be manifested as acute asthma, urticaria and / or angioedema, or a Adverse-Effectsystemic anaphylactoid reaction .
1.0000 Adverse-Effect Hypersensitivity to Drugaspirin can be manifested as Adverse-Effectacute asthma , urticaria and / or angioedema, or a systemic anaphylactoid reaction.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Intravitreal Drugtriamcinolone may have had an influence on the Adverse-Effectexacerbation of retinochoroiditis in the posterior pole of the patient.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 30 - year - old pharmacist suffered from Adverse-Effectacute allergic contact dermatitis due to Drug4 - chloro - 7 - nitrobenzofurazan ( NBD - Cl ).
0.9996 Adverse-Effect A 30 - year - old pharmacist suffered from Adverse-Effectacute allergic contact dermatitis due to 4 - chloro - 7 - nitrobenzofurazan ( DrugNBD - Cl ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectPneumonitis is emerging as one of the most unpredictable and potentially serious, adverse effects of treatment with DrugMTX .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The female patient received Drugclozapine in a daily dose of 400 mg, which induced Adverse-Effectagranulocytosis after 2 months.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect She continued to receive regular Druginsulin 4 times per day over the following 3 years with only occasional Adverse-Effecthives .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugPropoxyphene - induced Adverse-Effectwide complex dysrhythmia responsive to sodium bicarbonate therapy has not been previously reported in the literature.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectProgressive anemia following combination therapy with Druginterferon - alpha and interleukin - 2 in a patient with metastatic renal cell carcinoma.
0.9991 Adverse-Effect Adverse-EffectProgressive anemia following combination therapy with interferon - alpha and Druginterleukin - 2 in a patient with metastatic renal cell carcinoma.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectVisual changes secondary to initiation of Drugamiodarone : a case report and review involving ocular management in cardiac polypharmacy.
Score Relation Text (Head - Tail)
0.9990 Adverse-Effect Metabolic balance studies and rechallenge with Drughydrochlorothiazide were undertaken to investigate the mechanism of the thiazide - induced Adverse-Effecthyponatremia .
1.0000 Adverse-Effect Metabolic balance studies and rechallenge with hydrochlorothiazide were undertaken to investigate the mechanism of the Drugthiazide - induced Adverse-Effecthyponatremia .
Score Relation Text (Head - Tail)
0.9962 Adverse-Effect Goiter and hypothyroidism during re - treatment with amiodarone in a patient who previously experienced Drugamiodarone - induced Adverse-Effectthyrotoxicosis .
0.9934 Adverse-Effect Goiter and Adverse-Effecthypothyroidism during re - treatment with Drugamiodarone in a patient who previously experienced amiodarone - induced thyrotoxicosis.
0.9165 Adverse-Effect Adverse-EffectGoiter and hypothyroidism during re - treatment with Drugamiodarone in a patient who previously experienced amiodarone - induced thyrotoxicosis.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Other thiazolidinediones currently in clinical trials may be able to provide the therapeutic benefits of Drugtroglitazone without significant Adverse-Effecthepatotoxicity .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Our case is the second one in which Adverse-Effecthemorrhage from a meningioma may have been induced by Drugaspirin prophylaxis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The authors report one case of Adverse-Effectincomplete posterior hyaloid detachment ( PHD ) following intravitreal Drugpegaptanib to treat DME.
1.0000 Adverse-Effect The authors report one case of incomplete posterior hyaloid detachment ( Adverse-EffectPHD ) following intravitreal Drugpegaptanib to treat DME.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect DrugL - DOPA - induced excessive Adverse-Effectdaytime sleepiness in PD : a placebo - controlled case with MSLT assessment.
1.0000 Adverse-Effect DrugL - DOPA - induced Adverse-Effectexcessive daytime sleepiness in PD : a placebo - controlled case with MSLT assessment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Nine azotemic patients who developed a Adverse-Effectcoagulopathy associated with the use of either Drugcephalosporin or moxalactam antibiotics are reported.
1.0000 Adverse-Effect Nine azotemic patients who developed a Adverse-Effectcoagulopathy associated with the use of either cephalosporin or Drugmoxalactam antibiotics are reported.
Score Relation Text (Head - Tail)
0.9995 Adverse-Effect Two patients treated with Drugalprazolam had histories suggestive of a bipolar disorder and developed lithium - responsive Adverse-Effectmanic episodes .
1.0000 Adverse-Effect Two patients treated with alprazolam had histories suggestive of a bipolar disorder and developed Druglithium - responsive Adverse-Effectmanic episodes .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A patient with generalized MG was effectively managed with DrugMM but developed Adverse-EffectCNS lymphoma after 3 years of treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect High - dose intravenous Drugmannitol infusion in various clinical settings may result in Adverse-Effectacute renal failure ( ARF ).
1.0000 Adverse-Effect High - dose intravenous Drugmannitol infusion in various clinical settings may result in acute renal failure ( Adverse-EffectARF ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This progressed to Adverse-Effecttracheal compression with stridor after he had taken some Drugaspirin for relief of the neck pain.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : There was a temporal relationship between the onset of Adverse-Effectnonconvulsive status epilepticus and initiation of Drugifosfamide infusion.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : Clinicians should be aware that Adverse-EffectCrohn's disease is a potential novel adverse drug effect of DrugCopaxone .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a 45 - year - old psoriasis patient who developed Adverse-Effecteruptive mollusca contagiosa during an antipsoriatic treatment with Drugefalizumab .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of Adverse-EffectSweet's syndrome in association with Drugsargramostim treatment following chemotherapy for acute myelogenous leukemia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectScleroderma - like reaction induced by Druguracil - tegafur ( UFT ), a second - generation anticancer agent.
0.9997 Adverse-Effect Adverse-EffectScleroderma - like reaction induced by uracil - tegafur ( DrugUFT ), a second - generation anticancer agent.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : We report a case of Adverse-Effectcutaneous KS lesions in a patient affected by CML treated with Drugimatinib .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case of a 53 - year - old man who developed Adverse-Effectacute pneumonitis after Drugbleomycin and moderate oxygen administration is presented.
0.9997 Adverse-Effect A case of a 53 - year - old man who developed Adverse-Effectacute pneumonitis after bleomycin and moderate Drugoxygen administration is presented.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Caution is, therefore, needed to prevent undesired accumulation of DrugTCA that may lead to protracted Adverse-EffectCushing's syndrome .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In a postoperative patient with pre - existent myasthenia gravis, oral Drugverapamil caused a marked Adverse-Effectexacerbation in myasthenic weakness .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The concomitant use, however, of colchicine and Drugstatin has been associated with the rapid onset of Adverse-Effectmuscle weakness .
0.9998 Adverse-Effect The concomitant use, however, of Drugcolchicine and statin has been associated with the rapid onset of Adverse-Effectmuscle weakness .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 64 - year - old man presented with Adverse-Effectproteinuria during postoperative Druginterferon ( IFN ) - beta therapy against malignant melanoma.
0.9999 Adverse-Effect A 64 - year - old man presented with Adverse-Effectproteinuria during postoperative interferon ( DrugIFN ) - beta therapy against malignant melanoma.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Recognition of a potential drug - induced Adverse-EffectFanconi syndrome is important when managing pediatric oncology patients previously treated with Drugifosfamide .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect We experienced a case of chronic renal failure in a patient suffering from acute hemorrhagic gastritis associated with DrugAZ Adverse-EffectAZ intoxication .
0.9985 Adverse-Effect We experienced a case of chronic renal failure in a patient suffering from Adverse-Effectacute hemorrhagic gastritis associated with DrugAZ intoxication.
0.9991 Adverse-Effect We experienced a case of chronic Adverse-Effectrenal failure in a patient suffering from acute hemorrhagic gastritis associated with DrugAZ intoxication.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The patient's other comorbidities and medications have not been suggested as possible interactions with Drugsertraline that can cause Adverse-Effectrhabdomyolysis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect To the best of the authors'knowledge, this is the first reported case of DrugPropecia - associated Adverse-Effectcataract .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect RESULTS : Our patient developed Crohn's disease while on DrugCopaxone treatment as a consequence of Adverse-Effectlong - term immunosuppression .
Adverse-Effect RESULTS : Our patient developed Adverse-EffectCrohn's disease while on DrugCopaxone treatment as a consequence of long - term immunosuppression.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In this report, we describe a fatal Druggemcitabine - induced Adverse-Effectpulmonary toxicity in a patient with gallbladder metastatic adenocarcinoma.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We suggest that Drugmeloxicam might have Adverse-Effectintestinal toxic effects when taken in high doses, because of reduced COX - 2 selectivity.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A chronic reaction associated with long - term treatment with Drugnitrofurantoin has also been reported and causes irreversible Adverse-Effectpulmonary fibrosis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect One patient developed Adverse-Effectsevere hyponatremia with serum Na + of 108 mEq / L when Drughydrochlorothiazide was given to control hypertension.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a 43 - year - old man who developed signs and symptoms of Adverse-Effectbilateral optic neuropathy during treatment with Drugethambutol .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of Adverse-Effectnoncardiogenic pulmonary edema developed after therapeutic trial of DrugEO as sclerosing agent for esophageal varix.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSION : A patient with CHF and ESRD developed Adverse-Effectmyoclonic muscle spasms after receiving Drugdobutamine by continuous i. v. infusion.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of an 11 - year - old boy who experienced an Adverse-Effectanaphylactic reaction after administration of Drugbacitracin ointment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect These two cases highlight the importance of considering lopinavir / Drugritonavir induced Adverse-Effectarrhythmias when dealing with HIV - positive individuals.
0.9999 Adverse-Effect These two cases highlight the importance of considering Druglopinavir / ritonavir induced Adverse-Effectarrhythmias when dealing with HIV - positive individuals.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect On the other hand, DrugMTX - induced Adverse-Effectpneumonitis seems to be very rare in psoriatic arthritis ( PsA ).
Score Relation Text (Head - Tail)
0.9931 Adverse-Effect Patients treated with captopril who develop " atypical cholangitis " should be suspected of having Drugcaptopril - associated Adverse-Effectliver damage .
0.9883 Adverse-Effect Patients treated with Drugcaptopril who develop " Adverse-Effectatypical cholangitis " should be suspected of having captopril - associated liver damage.
0.9736 Adverse-Effect Patients treated with Drugcaptopril who develop " Adverse-Effectatypical cholangitis " should be suspected of having captopril - associated liver damage.
0.9736 Adverse-Effect Patients treated with Drugcaptopril who develop " Adverse-Effectatypical cholangitis " should be suspected of having captopril - associated liver damage.
0.9735 Adverse-Effect Patients treated with Drugcaptopril who develop " Adverse-Effectatypical cholangitis " should be suspected of having captopril - associated liver damage.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect He developed fever, nausea, diarrhea, and Adverse-Effectmalaise and stopped taking on the third day after commencing DrugPentasa .
1.0000 Adverse-Effect He developed fever, nausea, Adverse-Effectdiarrhea , and malaise and stopped taking on the third day after commencing DrugPentasa .
1.0000 Adverse-Effect He developed fever, Adverse-Effectnausea , diarrhea, and malaise and stopped taking on the third day after commencing DrugPentasa .
1.0000 Adverse-Effect He developed Adverse-Effectfever , nausea, diarrhea, and malaise and stopped taking on the third day after commencing DrugPentasa .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The authors'results suggest that DrugL - dopa may cause Adverse-Effectdaytime somnolence in some patients with Parkinson's disease.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The aim of this study was to describe the occurrence of Adverse-Effectacute coronary syndromes in 3 cases of Drugrituximab infusions.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Despite a very low complication rate, several Adverse-Effectsevere arterial thrombotic events have been reported following Drugthrombin injection of pseudoaneurysms.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In the first patient, two episodes of Adverse-Effectventricular tachycardia requiring cardioversion occurred in close temporal sequence with administering Drugbretylium .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To report a case of multiple episodes of Adverse-Effectseizure activity in an AIDS patent following Drugamphotericin B infusion.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A drug addict with staphylococcal endocarditis treated with Drugmethicillin , who developed Adverse-Effectmassive proteinuria and acute nephritic syndrome is described.
1.0000 Adverse-Effect A drug addict with staphylococcal endocarditis treated with Drugmethicillin , who developed massive proteinuria and Adverse-Effectacute nephritic syndrome is described.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : Prolonged exposure to Drugitraconazole , administered either continuously or intermittently, may precipitate Adverse-Effectsevere and irreversible hepatotoxic events .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The patient's defects may be due to Drugmethimazole Adverse-Effectteratogenicity or could represent a previously undescribed syndrome affecting ectodermal structures.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectGestational diabetes was no less severe ( degree of hyperglycaemia, need for insulin therapy ) when associated with Drugnorethisterone .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectUveitis during treatment of disseminated Mycobacterium avium - intracellulare complex infection with the combination of Drugrifabutin , clarithromycin and ethambutol.
1.0000 Adverse-Effect Adverse-EffectUveitis during treatment of disseminated Mycobacterium avium - intracellulare complex infection with the combination of rifabutin, Drugclarithromycin and ethambutol.
1.0000 Adverse-Effect Adverse-EffectUveitis during treatment of disseminated Mycobacterium avium - intracellulare complex infection with the combination of rifabutin, clarithromycin and Drugethambutol .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Following several of these courses of therapy, Adverse-Effectrespiratory distress occurred 9 to 12 days after the Drugchlorambucil was given.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Three cases of Adverse-Effectacute renal toxicity in patients receiving long - term therapy with Drugmitomycin C and 5 - fluorouracil are reported.
0.9999 Adverse-Effect Three cases of Adverse-Effectacute renal toxicity in patients receiving long - term therapy with mitomycin C and Drug5 - fluorouracil are reported.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugRamipril - induced Adverse-Effectcutaneous vasculitis is particularly rare and our case was atypical because the patient had tolerated lisinopril before.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report on a young adolescent with Adverse-Effectbenign intracranial hypertension which we attribute to the use of Drugminocycline for acne.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect An adolescent male developed acute pancreatitis and Adverse-Effectpseudocyst of the pancreas 16 weeks after cessation of intramuscular DrugL - asparaginase .
0.9994 Adverse-Effect An adolescent male developed Adverse-Effectacute pancreatitis and pseudocyst of the pancreas 16 weeks after cessation of intramuscular DrugL - asparaginase .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Four cases of Adverse-Effectfat embolism are described in infants receiving prolonged intravenous infusion of fat ( DrugIntralipid 20 % ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect According to the Naranjo probability scale, the relationship of Druggemcitabine treatment with Adverse-Effectcutaneous eruption in our patient is possible.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A boy with chronic neutropenia and recurrent inflammatory skin lesions developed Adverse-Effectmultiple erythematous nodules following administration of DrugG - CSF .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Despite the known Adverse-Effectpulmonary side effects of Drugnitrofurantoin , there is no report of this toxicity occurring in pregnant patients.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Evidence is shown in this report that Drugadenosine was associated with dangerous worsening of Adverse-Effectarrhythmia in patients with atrial flutter.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A third patient experienced Adverse-Effectdisabling neurotoxicity in the extremity of a prior ulnar nerve and tendon transposition after receiving Drugpaclitaxel .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The authors report a case of urinary incontinence ( Adverse-EffectUI ) that occurred in a woman after administration of Drugvenlafaxine .
1.0000 Adverse-Effect The authors report a case of Adverse-Effecturinary incontinence ( UI ) that occurred in a woman after administration of Drugvenlafaxine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Four days after intravenous DrugZoledronic acid , the patient presented to emergency room with complaints of Adverse-Effectcarpopedal spasm and bronchospasm.
0.9995 Adverse-Effect Four days after intravenous DrugZoledronic acid , the patient presented to emergency room with complaints of carpopedal spasm and Adverse-Effectbronchospasm .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Four patients who manifested symptoms of the antiepileptic drug ( AED ) Adverse-Effecthypersensitivity syndrome during therapy with Drugcarbamazepine are reported.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A review of the literature revealed two other cases of Adverse-Effecthepatic angiosarcoma in patients after long - term Drugcyclophosphamide treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The Adverse-Effectneurotoxicity seen with DrugHDARAC is dose - related and has occurred in up to 60 percent of treated patients.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectIntra - neural ceroid - like pigment following the treatment of lepromatous leprosy with Drugclofazimine ( B663 ; Lamprene ).
0.9999 Adverse-Effect Adverse-EffectIntra - neural ceroid - like pigment following the treatment of lepromatous leprosy with clofazimine ( B663 ; DrugLamprene ).
0.9999 Adverse-Effect Adverse-EffectIntra - neural ceroid - like pigment following the treatment of lepromatous leprosy with clofazimine ( DrugB663 ; Lamprene ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This is the first report on the histopathological findings of thyroid tissue from a patient with Drugamiodarone - induced Adverse-Effecthypothyroidism .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Herein, we describe 2 patients who developed unusual Adverse-EffectCD8 + cutaneous lymphoproliferative disorders after treatment with Drugefalizumab and infliximab.
0.9999 Adverse-Effect Herein, we describe 2 patients who developed unusual Adverse-EffectCD8 + cutaneous lymphoproliferative disorders after treatment with efalizumab and Druginfliximab .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect After excluding other causes of long QT syndrome, the DrugHCQ was suspected as the cause of her Adverse-Effectventricular tachycardia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We conclude that neurosurgeons and neurologists should be aware of calcium antagonist - - related Adverse-Effectileus in patients treated with Drugnimodipine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectNMS is a drug - related response to various medications, such as DrugHaloperidol , which the patient was receiving.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect The noted Adverse-Effectincrease in the theophylline level after Drugzafirlukast administration is in contrast to the original reports by the manufacturer.
0.9998 Adverse-Effect The noted Adverse-Effectincrease in the theophylline level Drugtheophylline level after zafirlukast administration is in contrast to the original reports by the manufacturer.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect To our knowledge, this is the first case of Drugivermectin - induced Adverse-Effectsevere liver disease published in the literature.
Score Relation Text (Head - Tail)
0.9997 Adverse-Effect Adverse-EffectPalpable purpuric skin lesions on the anterior surface of both legs appeared on the 55th day of Drugamphotericin B treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Three years later, treatment with Drugampicillin caused another episode of Adverse-Effectcholestatic hepatitis with cholestasis and duct paucity on rebiopsy.
1.0000 Adverse-Effect Three years later, treatment with Drugampicillin caused another episode of cholestatic hepatitis with Adverse-Effectcholestasis and duct paucity on rebiopsy.
0.9999 Adverse-Effect Three years later, treatment with Drugampicillin caused another episode of cholestatic hepatitis with cholestasis and Adverse-Effectduct paucity on rebiopsy.
Score Relation Text (Head - Tail)
0.9988 Adverse-Effect Teicoplanin - induced agranulocytosis that followed Drugvancomycin - induced Adverse-Effectagranulocytosis suggests a possible cross - reactivity between the 2 drugs.
0.9897 Adverse-Effect DrugTeicoplanin - induced Adverse-Effectagranulocytosis that followed vancomycin - induced agranulocytosis suggests a possible cross - reactivity between the 2 drugs.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This unusual pattern of low - grade endometrial carcinoma adds to the spectrum of Adverse-Effectuterine neoplasia associated with Drugtamoxifen therapy.
0.9999 Adverse-Effect This unusual pattern of Adverse-Effectlow - grade endometrial carcinoma adds to the spectrum of uterine neoplasia associated with Drugtamoxifen therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This is a case report of subtle, mild Adverse-Effecthypothermia in a 54 - year old female patient receiving Drugrisperidone for schizophrenia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Infliximab and its serious adverse effects are discussed, and other cases of Adverse-Effectosteomyelitis with Druginfliximab use are also reviewed.
0.9943 Adverse-Effect DrugInfliximab and its serious adverse effects are discussed, and other cases of Adverse-Effectosteomyelitis with infliximab use are also reviewed.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This is a unique autopsy case of Adverse-Effecthepatocellular carcinoma closely related to Drugdiethylstilbestrol ( DES ) therapy for prostatic cancer.
0.9999 Adverse-Effect This is a unique autopsy case of Adverse-Effecthepatocellular carcinoma closely related to diethylstilbestrol ( DrugDES ) therapy for prostatic cancer.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugVigabatrin - induced Adverse-Effectvisual field defects are at present the most important safety issue in the use of the drug.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the case of a child with metastatic osteosarcoma, who experienced an Adverse-Effectanaphylactic / anaphylactoid reaction to Drugmethotrexate .
1.0000 Adverse-Effect We report the case of a child with metastatic osteosarcoma, who experienced an anaphylactic Adverse-Effect/ anaphylactoid reaction to Drugmethotrexate .
1.0000 Adverse-Effect We report the case of a child with metastatic osteosarcoma, who experienced an anaphylactic / Adverse-Effectanaphylactoid reaction to Drugmethotrexate .
Score Relation Text (Head - Tail)
0.9928 Adverse-Effect Complications of chemotherapy for a synovial sarcoma in an eight - year old boy included Drugcisplatinum Adverse-Effectnephrotoxicity and adriamycin cardiotoxicity.
0.9832 Adverse-Effect Complications of chemotherapy for a synovial sarcoma in an eight - year old boy included Drugcisplatinum Adverse-Effectcisplatinum nephrotoxicity and adriamycin cardiotoxicity.
Adverse-Effect Complications of chemotherapy for a synovial sarcoma in an eight - year old boy included cisplatinum nephrotoxicity and Drugadriamycin Adverse-Effectcardiotoxicity .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect RTA is one type of Adverse-Effectnephrotoxicity induced by DrugFK506 , and it is reversible in mild cases when appropriately treated.
0.9999 Adverse-Effect Adverse-EffectRTA is one type of nephrotoxicity induced by DrugFK506 , and it is reversible in mild cases when appropriately treated.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Three male patients aged 78 - 83 years are presented, in whom Adverse-Effectsevere hepatotoxic reactions emerged after DrugCPA administration.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Two patients with Adverse-Effectextrapyramidal side effects after the use of Drugfluphenazine decanoate were evaluated by means of IBZM - SPECT.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Muscle biopsy revealed variation in muscle fiber size and few vacuolated fibers which were features of Drugcolchicine - induced Adverse-Effectmyopathy .
1.0000 Adverse-Effect Muscle biopsy revealed variation in muscle fiber size and few Adverse-Effectvacuolated fibers which were features of Drugcolchicine - induced myopathy.
0.9998 Adverse-Effect Muscle biopsy revealed Adverse-Effectvariation in muscle fiber size and few vacuolated fibers which were features of Drugcolchicine - induced myopathy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Allergic side effects of AZA are rare, and reported Adverse-Effectallergic skin eruptions from DrugAZA are very limited in Japan.
0.9999 Adverse-Effect Allergic side effects of DrugAZA are rare, and reported Adverse-Effectallergic skin eruptions from AZA are very limited in Japan.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse effects of Drugamiodarone including Adverse-Effectpulmonary toxicity , hepatotoxicity, aggravation of arrhythmia, and thyroid diseases are well understood.
0.9999 Adverse-Effect Adverse effects of Drugamiodarone including pulmonary toxicity, hepatotoxicity, Adverse-Effectaggravation of arrhythmia , and thyroid diseases are well understood.
0.9999 Adverse-Effect Adverse effects of Drugamiodarone including pulmonary toxicity, hepatotoxicity, aggravation of arrhythmia, and Adverse-Effectthyroid diseases are well understood.
0.9998 Adverse-Effect Adverse effects of Drugamiodarone including pulmonary toxicity, Adverse-Effecthepatotoxicity , aggravation of arrhythmia, and thyroid diseases are well understood.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The patient presented with fulminant microangiopathic hemolytic anemia and Adverse-Effectthrombocytopenia within 48 hr of initiating therapy with Drugtrimethoprim - sulfamethoxazole.
1.0000 Adverse-Effect The patient presented with fulminant microangiopathic hemolytic anemia and Adverse-Effectthrombocytopenia within 48 hr of initiating therapy with trimethoprim - Drugsulfamethoxazole .
0.9999 Adverse-Effect The patient presented with Adverse-Effectfulminant microangiopathic hemolytic anemia and thrombocytopenia within 48 hr of initiating therapy with Drugtrimethoprim - sulfamethoxazole.
0.9997 Adverse-Effect The patient presented with Adverse-Effectfulminant microangiopathic hemolytic anemia and thrombocytopenia within 48 hr of initiating therapy with trimethoprim - Drugsulfamethoxazole .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : For all patients with Drugvancomycin - induced Adverse-Effectneutropenia , possible cross - reactivity of teicoplanin should be monitored.
Score Relation Text (Head - Tail)
0.9996 Adverse-Effect Reinstitution of penicillamine treatment caused a recurrence thus proving a causal relationship between Drugpenicillamine and the described Adverse-Effectnail - changes .
0.9937 Adverse-Effect Reinstitution of Drugpenicillamine treatment caused a recurrence thus proving a causal relationship between penicillamine and the described Adverse-Effectnail - changes .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To investigate the mechanisms involved in Adverse-Effecthypersensitivity reactions to Drugcyclosporine and determine the feasibility of future cyclosporine use.
0.9990 Adverse-Effect OBJECTIVE : To investigate the mechanisms involved in Adverse-Effecthypersensitivity reactions to cyclosporine and determine the feasibility of future Drugcyclosporine use.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case of Adverse-Effecttuberculosis in a patient on DrugEfalizumab and Etanercept for treatment of refractory palmopustular psoriasis and psoriatic arthritis.
1.0000 Adverse-Effect A case of Adverse-Effecttuberculosis in a patient on Efalizumab and DrugEtanercept for treatment of refractory palmopustular psoriasis and psoriatic arthritis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Development of Adverse-Effectnephrotic syndrome in a patient with acute myeloblastic leukemia after treatment with Drugmacrophage - colony - stimulating factor .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Typical symptoms of active Adverse-EffectCD occurred 11, 12, and 26 months after start of Drugetanercept therapy, respectively.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The dermatology literature heretofore has not noted that Adverse-Effectanemia is a side effect of patients taking DrugMMF to treat pemphigus.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a girl with the Rett syndrome who had Adverse-Effectacute encephalopathy probably induced by Drugcalcium hopantenate ( HOPA ).
0.9996 Adverse-Effect We report a girl with the Rett syndrome who had Adverse-Effectacute encephalopathy probably induced by calcium hopantenate ( DrugHOPA ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Increased awareness is needed on the possible occurrence of Adverse-EffectLPD resembling gastric cancer in rheumatoid arthritis patients treated with DrugMTX .
1.0000 Adverse-Effect Increased awareness is needed on the possible occurrence of LPD resembling Adverse-Effectgastric cancer in rheumatoid arthritis patients treated with DrugMTX .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Adverse-EffectOptic neuropathy developed in a patient with rheumatoid arthritis who had been receiving DrugD - penicillamine for about 1 year.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Surgeons and physicians should therefore be aware of the potential for Adverse-EffectRTA to occur with DrugFK506 after any organ transplantation.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report 4 patients who developed symptoms of Adverse-Effectmyasthenia gravis within 2 weeks of starting treatment with a Drugstatin drug.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect She was treated with DrugPancrease MT 16 , but had consistent Adverse-Effectvomiting 1 to 2 hours after administration of enzymes.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report here a rare case of Drugritodrine - hydrochloride - induced Adverse-Effectrhabdomyolysis in a pregnant patient with myotonic dystrophy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Our literature review revealed an additional six cases of onset of Adverse-Effectinflammatory arthritis in MS patients receiving DrugIFN - beta .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugImatinib mesylate - related Adverse-Effectfatal acute hepatic failure in a patient with chronic myeloid leukaemia and chronic hepatitis B infection.
Score Relation Text (Head - Tail)
0.9995 Adverse-Effect PURPOSE : To describe Adverse-Effectbilateral optic neuritis that occurred as an adverse effect of recombinant and natural Druginterferon alpha administration.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Our findings reveal that even in patients without a history of seizures, Drugpregabalin can cause a Adverse-Effectcortical negative myoclonus .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Disseminated intravascular coagulation associated with acute hemoglobinemia or Adverse-Effecthemoglobinuria following DrugRh ( 0 ) ( D ) immune globulin intravenous administration for immune thrombocytopenic purpura.
0.9993 Adverse-Effect Disseminated intravascular coagulation associated with Adverse-Effectacute hemoglobinemia or hemoglobinuria following DrugRh ( 0 ) ( D ) immune globulin intravenous administration for immune thrombocytopenic purpura.
0.9993 Adverse-Effect Adverse-EffectDisseminated intravascular coagulation associated with acute hemoglobinemia or hemoglobinuria following DrugRh ( 0 ) ( D ) immune globulin intravenous administration for immune thrombocytopenic purpura.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Pneumocystis pneumonia should be considered in asthmatic patients taking Drugmethotrexate who present with Adverse-Effectfever , pulmonary infiltrates, and hypoxia.
1.0000 Adverse-Effect Adverse-EffectPneumocystis pneumonia should be considered in asthmatic patients taking Drugmethotrexate who present with fever, pulmonary infiltrates, and hypoxia.
1.0000 Adverse-Effect Pneumocystis pneumonia should be considered in asthmatic patients taking Drugmethotrexate who present with fever, pulmonary infiltrates, and Adverse-Effecthypoxia .
0.9999 Adverse-Effect Pneumocystis pneumonia should be considered in asthmatic patients taking Drugmethotrexate who present with fever, Adverse-Effectpulmonary infiltrates , and hypoxia.
Score Relation Text (Head - Tail)
0.9950 Adverse-Effect Adverse-EffectADH hypersecretion in relation to plasma osmolality was reversed by Drugmizoribin withdrawal, suggesting that bredinin might adversely induce SIADH.
0.9997 Adverse-Effect ADH hypersecretion in relation to Adverse-Effectplasma osmolality was reversed by Drugmizoribin withdrawal, suggesting that bredinin might adversely induce SIADH.
0.8839 Adverse-Effect ADH hypersecretion in relation to plasma osmolality was reversed by Drugmizoribin withdrawal, suggesting that bredinin might adversely induce Adverse-EffectSIADH .
Adverse-Effect ADH hypersecretion in relation to plasma osmolality was reversed by mizoribin withdrawal, suggesting that Drugbredinin might adversely induce Adverse-EffectSIADH .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The known side effects of Drugsibutramine , ie, Adverse-Effecthypertension and tachycardia, depend on its adrenergic and serotoninergic effects.
0.9998 Adverse-Effect The known side effects of Drugsibutramine , ie, hypertension and Adverse-Effecttachycardia , depend on its adrenergic and serotoninergic effects.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect During the anti - tuberculous therapy, Adverse-Effectvisual loss can be related to Drugethambutol toxicity or the tuberculosis infection itself.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Late development of Adverse-Effectdiabetes mellitus after Druginterferon - alfa and ribavirin therapy for chronic hepatitis C : a case report.
0.9995 Adverse-Effect Late development of Adverse-Effectdiabetes mellitus after interferon - alfa and Drugribavirin therapy for chronic hepatitis C : a case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVES : To describe clinical and pathologic findings in patients noted to develop Adverse-Effectlower gastrointestinal symptoms when exposed to Drugrofecoxib .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The probability of developing Adverse-Effectacute leukemia in this study was not significantly correlated to the total cumulative dosage of DrugTreosulfan .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Carboplatin Adverse-Effecthypersensitivity induced by low - dose Drugpaclitaxel / carboplatin in multiple platinum - treated patients with recurrent ovarian cancer.
1.0000 Adverse-Effect DrugCarboplatin Adverse-Effecthypersensitivity induced by low - dose paclitaxel / carboplatin in multiple platinum - treated patients with recurrent ovarian cancer.
0.9995 Adverse-Effect Carboplatin Adverse-Effecthypersensitivity induced by low - dose paclitaxel / Drugcarboplatin in multiple platinum - treated patients with recurrent ovarian cancer.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Elderly patients for whom Drugnitrate has been prescribed should be warned of the occurrence of Adverse-Effecthypotension , leading to unconsciousness.
0.9999 Adverse-Effect Elderly patients for whom Drugnitrate has been prescribed should be warned of the occurrence of hypotension, leading to Adverse-Effectunconsciousness .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugQuetiapine and Adverse-Effectobsessive - compulsive symptoms ( OCS ) : case report and review of atypical antipsychotic - induced OCS.
0.9999 Adverse-Effect DrugQuetiapine and obsessive - compulsive symptoms ( Adverse-EffectOCS ) : case report and review of atypical antipsychotic - induced OCS.
0.9958 Adverse-Effect DrugQuetiapine and obsessive - compulsive symptoms ( OCS ) : case report and review of atypical antipsychotic - induced Adverse-EffectOCS .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Unintended exposure to Drugacyclovir early in pregnancy, which is not uncommon, may cause Adverse-Effectexcessive maternal and physician anxiety .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect After the second Druginfliximab infusion, he was found to have a Adverse-Effectsevere transient neutropenia ( 0. 5 x 10 ( 9 ) / L ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect INTERPRETATION : When high doses of Drugfluticasone propionate are used, Adverse-Effectgrowth may be retarded and adrenal suppression may occur.
0.9996 Adverse-Effect INTERPRETATION : When high doses of Drugfluticasone propionate are used, growth may be retarded and Adverse-Effectadrenal suppression may occur.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect OBJECTIVE : To report the first five cases of Drugamphotericin B overdose with secondary Adverse-Effectcardiac complications in a pediatric population.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Because Drugpsoralens sensitize skin to ultraviolet A light, Adverse-Effectphototoxic reactions are the most frequent adverse effect of this treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A unique case of a transient, nonpigmenting Adverse-Effectfixed drug eruption caused by the radiopaque contrast medium Drugiothalamate is reported.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case of Drughalothane induced Adverse-Effecthepatitis is reported in a middle aged woman who underwent gastric surgery for morbid obesity.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect With the first Drugcyclosporine dose, the patient complained of Adverse-Effectleg pain that was most severe during the cyclosporine infusion.
0.9999 Adverse-Effect With the first cyclosporine dose, the patient complained of Adverse-Effectleg pain that was most severe during the Drugcyclosporine infusion.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectColonic necrosis is known as a rare complication following the administration of DrugKayexalate ( sodium polystryrene sulfonate ) in sorbitol.
0.9997 Adverse-Effect Adverse-EffectColonic necrosis is known as a rare complication following the administration of Kayexalate ( Drugsodium polystryrene sulfonate ) in sorbitol.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect It is suggested therefore that Drugmethotrexate be added to the list of agents capable of inducing Adverse-Effectdiffuse interstitial pulmonary fibrosis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The renal insufficiency of three patients and the timing of the Adverse-Effectseizures implicate accumulation of Drugofloxacin as a contributing factor.
0.9994 Adverse-Effect The Adverse-Effectrenal insufficiency of three patients and the timing of the seizures implicate accumulation of Drugofloxacin as a contributing factor.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Although an association between exposure to Drugbleomycin and the development of Adverse-Effectscleroderma has been suspected, few cases are reported.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The cause of death was determined to be Adverse-Effectacute intoxication by Drugolanzapine , and the manner of death was accidental.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We recommended periodic examination of the serum proteins in patients receiving Drugdiphenylhydantoin in order to detect development of Adverse-Effectmonoclonal gammopathy .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectAcute non - lymphocytic leukemia in patients with ovarian carcinoma following long - term treatment with DrugTreosulfan ( = dihydroxybusulfan ).
1.0000 Adverse-Effect Adverse-EffectAcute non - lymphocytic leukemia in patients with ovarian carcinoma following long - term treatment with Treosulfan ( = Drugdihydroxybusulfan ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In our patient, Adverse-EffectDIAN possibly was related to Drugcefuroxime , but the patient did not experience associated allergic symptoms.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CASES : Two postmenopausal women treated with Drugtamoxifen and progestational agents for breast carcinoma developed Adverse-Effectuterine enlargement and intermittent spotting.
1.0000 Adverse-Effect CASES : Two postmenopausal women treated with Drugtamoxifen and progestational agents for breast carcinoma developed uterine enlargement and Adverse-Effectintermittent spotting .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect As far as we know, this is the first case report of acute hemorrhagic gastritis associated with DrugAZ Adverse-EffectAZ intoxication .
0.9995 Adverse-Effect As far as we know, this is the first case report of Adverse-Effectacute hemorrhagic gastritis associated with DrugAZ intoxication.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugRitonavir acted as a CYP3A4 inhibitor, Adverse-Effectdiminishing carbamazepine metabolism and provoking an increase in serum levels and clinical toxicity.
1.0000 Adverse-Effect DrugRitonavir acted as a CYP3A4 inhibitor, diminishing carbamazepine metabolism and provoking an Adverse-Effectincrease in serum levels and clinical toxicity.
0.9999 Adverse-Effect DrugRitonavir acted as a CYP3A4 inhibitor, diminishing carbamazepine metabolism and provoking an increase in serum levels and Adverse-Effectclinical toxicity .
Score Relation Text (Head - Tail)
0.9995 Adverse-Effect Diagnosis of Adverse-Effectsclerosing glomerulonephritis occurred in this patient during Druganastrozole use, suggesting a newly defined side effect of anastrozole.
0.9647 Adverse-Effect Diagnosis of Adverse-Effectsclerosing glomerulonephritis occurred in this patient during anastrozole use, suggesting a newly defined side effect of Druganastrozole .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a patient who developed Adverse-Effectspontaneous splenic infarction after the use of Drugsumatriptan for the treatment of migraine headache.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A potential role for renal and hepatic impairment in the observed protracted course of Drugamiodarone - induced Adverse-Effectthyrotoxicosis is suggested.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To report a case of marked Adverse-Effectelevation of serum creatine kinase ( CK ) associated with Drugolanzapine therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 21 - year - old patient developed Adverse-Effectrhabdomyolysis during his nineteenth week of treatment with Drugclozapine for drug - resistant schizophrenia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the first case of acute renal failure with Adverse-Effecthyperkalemia associated with the recently marketed direct renin inhibitor Drugaliskiren .
0.9999 Adverse-Effect We report the first case of Adverse-Effectacute renal failure with hyperkalemia associated with the recently marketed direct renin inhibitor Drugaliskiren .
Score Relation Text (Head - Tail)
0.9988 Adverse-Effect A case is reported of Drugtheophylline Adverse-Effecttheophylline intoxication due to a dramatic decrease in theophylline clearance following concomitant administration of viloxazine.
0.9616 Adverse-Effect A case is reported of Adverse-Effecttheophylline intoxication due to a dramatic decrease in theophylline clearance following concomitant administration of Drugviloxazine .
0.4835 Adverse-Effect A case is reported of Adverse-Effecttheophylline intoxication due to a dramatic decrease in Drugtheophylline clearance following concomitant administration of viloxazine.
Adverse-Effect A case is reported of theophylline intoxication due to a dramatic Adverse-Effectdecrease in theophylline clearance following concomitant administration of Drugviloxazine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Postoperative Adverse-Effecthypocalcemic tetany caused by Drugfleet phospho - soda preparation in a patient taking alendronate sodium : report of a case.
0.9988 Adverse-Effect Postoperative Adverse-Effecthypocalcemic tetany caused by fleet phospho - soda preparation in a patient taking Drugalendronate sodium : report of a case.
Score Relation Text (Head - Tail)
0.9987 Adverse-Effect The patient expired after seven cycles of treatment had been completed because of Adverse-Effectpulmonary fibrosis and the drug toxicity of Drugbleomycin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Thus, we confirm that desensitization may be a safe procedure in patients with cancer who experience Drugmethotrexate - induced Adverse-Effectanaphylaxis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 10 - year - old girl with Lennox - Gastaut syndrome who received intravenous Druglorazepam for atypical absence status Adverse-Effectseizures is reported.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The induction of Adverse-Effecthypoglycaemia with DrugPAS in this patient suggests a potential role for PAS in the treatment of diabetes mellitus.
0.9885 Adverse-Effect The induction of Adverse-Effecthypoglycaemia with PAS in this patient suggests a potential role for DrugPAS in the treatment of diabetes mellitus.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In two patients, Drugapomorphine remained effective in the morning, but increased the intensity of the Adverse-Effectdyskinesias in the afternoon.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The visual loss in this patient seems to result from Drugphenol Adverse-Effectneurotoxicity rather than mechanical compression of the intraorbital optic nerve.
0.9999 Adverse-Effect The Adverse-Effectvisual loss in this patient seems to result from Drugphenol neurotoxicity rather than mechanical compression of the intraorbital optic nerve.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Here we describe another case of Adverse-EffectVOD occurring after LT, but in which the causative role was played by Drugazathioprine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To report the safe use of fluorouracil in a patient with breast cancer who had Adverse-Effectallergic reactions to Drugcapecitabine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect METHODS : The patient required insulin desensitization for severe urticaria, angioedema, and occasional Adverse-Effectwheezing resulting from her Druginsulin dose.
1.0000 Adverse-Effect METHODS : The patient required Druginsulin desensitization for Adverse-Effectsevere urticaria , angioedema, and occasional wheezing resulting from her insulin dose.
0.9999 Adverse-Effect METHODS : The patient required Druginsulin desensitization for severe urticaria, Adverse-Effectangioedema , and occasional wheezing resulting from her insulin dose.
0.9999 Adverse-Effect METHODS : The patient required Druginsulin desensitization for severe urticaria, angioedema, and occasional Adverse-Effectwheezing resulting from her insulin dose.
0.9999 Adverse-Effect METHODS : The patient required insulin desensitization for severe urticaria, Adverse-Effectangioedema , and occasional wheezing resulting from her Druginsulin dose.
0.9999 Adverse-Effect METHODS : The patient required insulin desensitization for Adverse-Effectsevere urticaria , angioedema, and occasional wheezing resulting from her Druginsulin dose.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Arrhythmias and Adverse-Effectcardiac arrest have been reported during Drugamphotericin B administration but no effective technique has been described to prevent them.
0.9998 Adverse-Effect Adverse-EffectArrhythmias and cardiac arrest have been reported during Drugamphotericin B administration but no effective technique has been described to prevent them.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe the first case of de novo Adverse-Effectasthma following treatment with the angiotensin converting enzyme ( ACE ) inhibitor Drugcaptopril .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report two new cases of Adverse-Effectsarcoidosis in two patients with hepatitis C virus infection treated with Druginterferon alfa and ribavirin.
0.9999 Adverse-Effect We report two new cases of Adverse-Effectsarcoidosis in two patients with hepatitis C virus infection treated with interferon alfa and Drugribavirin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect BACKGROUND : Methotrexate ( DrugMTX ) may induce Adverse-Effectliver damage , which in some psoriatics will lead to fibrosis or cirrhosis.
0.9999 Adverse-Effect BACKGROUND : DrugMethotrexate ( MTX ) may induce Adverse-Effectliver damage , which in some psoriatics will lead to fibrosis or cirrhosis.
0.9999 Adverse-Effect BACKGROUND : Methotrexate ( DrugMTX ) may induce liver damage, which in some psoriatics will lead to Adverse-Effectfibrosis or cirrhosis.
0.9999 Adverse-Effect BACKGROUND : Methotrexate ( DrugMTX ) may induce liver damage, which in some psoriatics will lead to fibrosis or Adverse-Effectcirrhosis .
0.9998 Adverse-Effect BACKGROUND : DrugMethotrexate ( MTX ) may induce liver damage, which in some psoriatics will lead to fibrosis or Adverse-Effectcirrhosis .
0.9997 Adverse-Effect BACKGROUND : DrugMethotrexate ( MTX ) may induce liver damage, which in some psoriatics will lead to Adverse-Effectfibrosis or cirrhosis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Inhaled Drugtobramycin solution - associated Adverse-Effectrecurrent eosinophilia and severe persistent bronchospasm in a patient with cystic fibrosis : a case report.
0.9999 Adverse-Effect Inhaled Drugtobramycin solution - associated recurrent eosinophilia and Adverse-Effectsevere persistent bronchospasm in a patient with cystic fibrosis : a case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Within 3 weeks of beginning continuous daily isoniazid and Drugrifampin therapy for pulmonary tuberculosis, a patient developed Adverse-Effectacute renal failure .
0.9999 Adverse-Effect Within 3 weeks of beginning continuous daily Drugisoniazid and rifampin therapy for pulmonary tuberculosis, a patient developed Adverse-Effectacute renal failure .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Patient B developed Adverse-Effectperioral and upper extremity paresthesias during the fourth cycle of DrugCAP alone ( 2500 mg / m2 ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Moreover, these findings suggest that the incidence of Adverse-EffectBOOP following Drugrituximab therapy may be higher than has been previously appreciated.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect This compound, used by adults in the child's home, had caused accidental Drugtheophylline Adverse-Effecttheophylline poisoning , mimicking diabetic ketoacidosis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Up to four percent of patients treated with Drugimatinib may develop Adverse-Effecthepatotoxicity , which usually resolves with discontinuation of the drug.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugL - Thyroxine - induced Adverse-Effectleukopenia in a patient with Hashimoto's disease : involvement of suppressor - cytotoxic T cells.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugMethotrexate - induced Adverse-Effectleukoencephalopathy is treatable with high - dose folinic acid : a case report and analysis of the literature.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of Adverse-Effecthyperpigmentation due to Drugbleomycin treatment in a patient with acquired immune deficiency syndrome ( AIDS ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Although Drugfluoxetine - induced Adverse-Effectheadache occurred in one patient, the other five reported no side effects at the doses used.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugRifampin can be associated with severe adverse effects such as Adverse-Effecthepatitis , acute renal failure, hemolytic anemia, and thrombocytopenia.
1.0000 Adverse-Effect DrugRifampin can be associated with severe adverse effects such as hepatitis, acute renal failure, Adverse-Effecthemolytic anemia , and thrombocytopenia.
1.0000 Adverse-Effect DrugRifampin can be associated with severe adverse effects such as hepatitis, Adverse-Effectacute renal failure , hemolytic anemia, and thrombocytopenia.
1.0000 Adverse-Effect DrugRifampin can be associated with severe adverse effects such as hepatitis, acute renal failure, hemolytic anemia, and Adverse-Effectthrombocytopenia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect To date, eight cases of TEN and one of Adverse-EffectSJS related to Druglamotrigine administration have been reported in the literature.
1.0000 Adverse-Effect To date, eight cases of Adverse-EffectTEN and one of SJS related to Druglamotrigine administration have been reported in the literature.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DISCUSSION : Patients with Drug5 - FU - induced Adverse-Effectectropion experience tender, red, scaled lids, making contact lens wear difficult.
0.9999 Adverse-Effect DISCUSSION : Patients with Drug5 - FU - induced ectropion experience Adverse-Effecttender, red, scaled lids , making contact lens wear difficult.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We present the case of a 5 - year - old girl who developed Adverse-Effectbilateral vocal cord paralysis following preoperative peritonsillar Drugbupivacaine infiltration.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect It remains to be seen whether the Adverse-Effecthepatotoxicity associated with Drugtroglitazone is a drug - class effect or specific to troglitazone.
0.9966 Adverse-Effect It remains to be seen whether the Adverse-Effecthepatotoxicity associated with troglitazone is a drug - class effect or specific to Drugtroglitazone .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectSevere hepatotoxicity from Drugphenobarbital occurred in an infant boy who had a complicated illness with chronic bilateral subdural hematomas and sepsis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect To the best of our knowledge, this is the first case of Druglithium - associated Adverse-EffectCDI and NDI presenting concurrently.
1.0000 Adverse-Effect To the best of our knowledge, this is the first case of Druglithium - associated CDI and Adverse-EffectNDI presenting concurrently.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To report the finding of Adverse-Effectsquamous metaplasia within endometrial glands occurring as a result of Drugprogestin therapy of hyperplasia.
Adverse-Effect OBJECTIVE : To report the finding of Adverse-Effectsquamous metaplasia within endometrial glands occurring as a result of Drugprogestin therapy of hyperplasia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect It was concluded that potassium loss occurred by a non - renal ( intestinal ) route in Drugphosphate - induced Adverse-Effecthypokalemia .
0.9999 Adverse-Effect It was concluded that Adverse-Effectpotassium loss occurred by a non - renal ( intestinal ) route in Drugphosphate - induced hypokalemia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSION : Significant ocular complications such as an Adverse-Effectirreversible decrease of visual acuity may develop in patients treated with Drugpegylated interferon .
0.9996 Adverse-Effect CONCLUSION : Significant Adverse-Effectocular complications such as an irreversible decrease of visual acuity may develop in patients treated with Drugpegylated interferon .
1.0000 Adverse-Effect CONCLUSION : Significant ocular complications such as an irreversible Adverse-Effectdecrease of visual acuity may develop in patients treated with Drugpegylated interferon .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CD4 T - lymphocyte depletion, myelosuppression, and subsequent Adverse-Effectsevere infections are the major side effects of Drugfludarabine phosphate therapy.
0.9998 Adverse-Effect Adverse-EffectCD4 T - lymphocyte depletion , myelosuppression, and subsequent severe infections are the major side effects of Drugfludarabine phosphate therapy.
0.9996 Adverse-Effect CD4 T - lymphocyte depletion, Adverse-Effectmyelosuppression , and subsequent severe infections are the major side effects of Drugfludarabine phosphate therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect METHODS : Repeated blood samples were drawn in a patient with severe Drugacyclovir overdose who developed Adverse-Effectcoma and nonoliguric renal failure.
1.0000 Adverse-Effect METHODS : Repeated blood samples were drawn in a patient with severe Drugacyclovir overdose who developed coma and Adverse-Effectnonoliguric renal failure .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSION : This is, to our knowledge, the first report of Adverse-Effectsevere myelopathy following accidental intrathecal administration of Drugdoxorubicin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the case of a man, treated with Drugmesalazine for Crohn's disease who developed drug - induced Adverse-Effectpericarditis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The authors presented a case of Adverse-Effectpulmonary hypertension during Druglithium therapy, while she has been on lithium for 6 years.
0.9992 Adverse-Effect The authors presented a case of Adverse-Effectpulmonary hypertension during lithium therapy, while she has been on Druglithium for 6 years.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Following the institution of intravenous therapy with Drugacyclovir , the patient developed Adverse-Effectfever , hemoptysis, and a pleural friction rub.
1.0000 Adverse-Effect Following the institution of intravenous therapy with Drugacyclovir , the patient developed fever, Adverse-Effecthemoptysis , and a pleural friction rub.
0.9999 Adverse-Effect Following the institution of intravenous therapy with Drugacyclovir , the patient developed fever, hemoptysis, and a Adverse-Effectpleural friction rub .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report 3 cases of children with acute lymphoblastic leukemia who developed seizures and Adverse-Effectaltered sensorium after DrugL - asparaginase therapy.
0.9997 Adverse-Effect We report 3 cases of children with acute lymphoblastic leukemia who developed Adverse-Effectseizures and altered sensorium after DrugL - asparaginase therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSION : There are only a few confirmed cases of Druggemcitabine - associated Adverse-EffectHUS despite the widespread use of the drug.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect We report a case of Adverse-Effectacute generalized exanthematous pustulosis ( AGEP ) induced by Drugsalazosulfapyridine in a patient with ulcerative colitis.
1.0000 Adverse-Effect We report a case of acute generalized exanthematous pustulosis ( Adverse-EffectAGEP ) induced by Drugsalazosulfapyridine in a patient with ulcerative colitis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We presented a patient with status asthmaticus treated with a combination of theophylline and Drugprednisone who developed a Adverse-Effectperforated gastric ulcer .
1.0000 Adverse-Effect We presented a patient with status asthmaticus treated with a combination of Drugtheophylline and prednisone who developed a Adverse-Effectperforated gastric ulcer .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The patient described feeling cold with worsening headache and Adverse-Effectchills approximately one hour after infusion of the first dose of Drugpenicillin .
1.0000 Adverse-Effect The patient described feeling cold with Adverse-Effectworsening headache and chills approximately one hour after infusion of the first dose of Drugpenicillin .
0.9999 Adverse-Effect The patient described Adverse-Effectfeeling cold with worsening headache and chills approximately one hour after infusion of the first dose of Drugpenicillin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The capacity of Drugzuclopenthixol to induce Adverse-Effectpriapism is thought to be due to its antagonist activity on alpha - adrenergic receptors.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect After discontinuing Drugcaptopril and starting systemic steroids, her symptomatology rapidly improved, and her Adverse-Effecteosinophilia and radiographic abnormalities both resolved.
0.9999 Adverse-Effect After discontinuing Drugcaptopril and starting systemic steroids, her symptomatology rapidly improved, and her eosinophilia and Adverse-Effectradiographic abnormalities both resolved.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a 13 year - old male who developed life - threatening Adverse-Effectanaphylaxis early in the course of DrugIncrelex therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect PURPOSE : To report patients who presented to the oculoplastics department for repair of Adverse-Effectcicatrical entropion after topical use of Drugdipivefrin .
Score Relation Text (Head - Tail)
Adverse-Effect CONCLUSION : Long - term treatment with Drugrifabutin may have a reversible and previously undescribed Adverse-Effectside - effect on retinal function .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : DrugClozapine causes few Adverse-Effectextrapyramidal symptoms and is recommended as a treatment drug for severe tardive dyskinesia ( TD ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the case of a 27 - year - old Indian woman who developed maculopapular rash and Adverse-Effectangioedema secondary to Drugcarbamazepine administration.
1.0000 Adverse-Effect We report the case of a 27 - year - old Indian woman who developed Adverse-Effectmaculopapular rash and angioedema secondary to Drugcarbamazepine administration.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The present study describes a patient who had Adverse-Effectunusual weight fluctuation under corticosteroid and psychotropic treatment such as Drugmianserin and aripiprazole.
1.0000 Adverse-Effect The present study describes a patient who had Adverse-Effectunusual weight fluctuation under corticosteroid and psychotropic treatment such as mianserin and Drugaripiprazole .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a patient who developed Drugheparin associated Adverse-Effectthrombocytopenia during continuous arteriovenous haemofiltration and discuss its implications and alternative anticoagulant treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The case of an adult who developed both hepatic dysfunction and an Adverse-Effectimpaired macrophage migration after exposure to Drugcimetidine is discussed.
1.0000 Adverse-Effect The case of an adult who developed both Adverse-Effecthepatic dysfunction and an impaired macrophage migration after exposure to Drugcimetidine is discussed.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugIbuprofen rarely causes lower Adverse-Effectgastrointestinal adverse reactions but has been implicated in systemic and local side effects in patients with lupus.
1.0000 Adverse-Effect DrugIbuprofen rarely causes Adverse-Effectlower gastrointestinal adverse reactions but has been implicated in systemic and local side effects in patients with lupus.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Presently, treatment of acute Drugibuprofen Adverse-Effectibuprofen intoxication with complications requires supportive therapy until the symptoms resolve over 24 to 48 hours.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The international literature regarding Adverse-Effectopportunistic infections after immunosuppressive therapy with Drugalemtuzumab with particular attention on fungal infections has also been reviewed.
1.0000 Adverse-Effect The international literature regarding opportunistic infections after immunosuppressive therapy with Drugalemtuzumab with particular attention on Adverse-Effectfungal infections has also been reviewed.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Investigation confirmed the diagnosis of rhabdomyolysis, and discontinuation of Drugcolchicine resulted in resolution of clinical and biochemical features of Adverse-Effectrhabdomylysis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a 15 - year - old female patient diagnosed with Adverse-Effectacute lymphoblastic leukemia presenting with status epilepticus after receiving intrathecal Drugmethotrexate .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The mechanism by which Drugsunitinib induces Adverse-Effectgynaecomastia is thought to be associated with an unknown direct action on breast hormonal receptors.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In the following case report, a patient developed acute interstitial nephritis with renal failure and Adverse-Effectexfoliative dermatitis following Drugampicillin therapy.
0.9999 Adverse-Effect In the following case report, a patient developed acute interstitial nephritis with Adverse-Effectrenal failure and exfoliative dermatitis following Drugampicillin therapy.
0.9999 Adverse-Effect In the following case report, a patient developed Adverse-Effectacute interstitial nephritis with renal failure and exfoliative dermatitis following Drugampicillin therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe two dark - skinned patients who developed Adverse-Effecthyperpigmented skin and tongue lesions during combination therapy with DrugIFN and ribavirin.
1.0000 Adverse-Effect We describe two dark - skinned patients who developed hyperpigmented skin and Adverse-Effecttongue lesions during combination therapy with DrugIFN and ribavirin.
0.9999 Adverse-Effect We describe two dark - skinned patients who developed Adverse-Effecthyperpigmented skin and tongue lesions during combination therapy with IFN and Drugribavirin .
0.9999 Adverse-Effect We describe two dark - skinned patients who developed hyperpigmented skin and Adverse-Effecttongue lesions during combination therapy with IFN and Drugribavirin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To report a case of Drugcolchicine - induced Adverse-Effectmyopathy in a teenager with familial Mediterranean fever ( FMF ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case of Adverse-Effectbasilar invagination which is thought to have arisen from the patient's intrauterine exposure to Drugphenytoin is presented.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugInterferon - alpha - induced Adverse-Effectfocal segmental glomerulosclerosis in chronic myelogenous leukemia : a case report and review of the literature.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe Adverse-Effectrupture of a cerebral arterial aneurysm in a 32 year old hypertensive woman following the introduction of Drugnifedipine treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Presentation of three palliative care patients who were given Drugketamine as an analgesic and subsequently developed significant and debilitating Adverse-Effecturological symptoms .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A patient with the Wolff - Parkinson - White syndrome presented with Adverse-Effectincessant orthodromic atrioventricular tachycardia following initiation of Drugprocainamide therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To report a case of linear immunoglobulin ( Ig ) A bullous dermatosis ( Adverse-EffectLABD ) induced by Druggemcitabine .
0.9999 Adverse-Effect OBJECTIVE : To report a case of Adverse-Effectlinear immunoglobulin ( Ig ) A bullous dermatosis ( LABD ) induced by Druggemcitabine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The Naranjo probability scale indicated a probable relationship between Adverse-Effectapnea and exposure to Druglamotrigine through breast - feeding in this infant.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In patients with Drugmethotrexate - induced Adverse-Effectanaphylaxis , discontinuation of treatment may increase the risk of death due to cancer progression.
0.9993 Adverse-Effect In patients with Drugmethotrexate - induced anaphylaxis, discontinuation of treatment may increase the risk of Adverse-Effectdeath due to cancer progression.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect On the fifth day of tocolysis with magnesium sulfate, nifedipine, terbutaline and Drugbetamethasone , Adverse-Effectedema developed in both labia.
0.9999 Adverse-Effect On the fifth day of tocolysis with magnesium sulfate, nifedipine, Drugterbutaline and betamethasone, Adverse-Effectedema developed in both labia.
0.9999 Adverse-Effect On the fifth day of tocolysis with magnesium sulfate, Drugnifedipine , terbutaline and betamethasone, Adverse-Effectedema developed in both labia.
0.9998 Adverse-Effect On the fifth day of tocolysis with Drugmagnesium sulfate , nifedipine, terbutaline and betamethasone, Adverse-Effectedema developed in both labia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of Adverse-Effectseizure associated with DrugL - asparaginase therapy but no evidence of hemorrhagic or thrombotic cerebrovascular events.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 28 year old white schizophrenic male has been under Drugrisperidone monotherapy for about one year when he developed Adverse-Effectdyskinetic movements .
Score Relation Text (Head - Tail)
Adverse-Effect The second patient, who developed Adverse-Effectcholestasis after receiving Drugtrimethoprim - sulfamethoxazole , had marked duct paucity in the liver biopsy.
Adverse-Effect The second patient, who developed cholestasis after receiving Drugtrimethoprim - sulfamethoxazole , had marked Adverse-Effectduct paucity in the liver biopsy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugTiclopidine - induced Adverse-Effectaplastic anemia : two new case reports, review, and meta - analysis of 55 additional cases.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectFulminant hepatic failure developed in a 24 - year - old black woman who had been treated with Drugpropylthiouracil and propranolol for hyperthyroidism.
0.9999 Adverse-Effect Adverse-EffectFulminant hepatic failure developed in a 24 - year - old black woman who had been treated with propylthiouracil and Drugpropranolol for hyperthyroidism.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Children receiving Drugzonisamide should be monitored for Adverse-Effectoligohidrosis and the development of neurological symptoms associated with an elevation of body temperature.
0.9999 Adverse-Effect Children receiving Drugzonisamide should be monitored for oligohidrosis and the development of Adverse-Effectneurological symptoms associated with an elevation of body temperature.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 72 - year - old woman with a history of thyrotoxicosis presented with sore throat and Adverse-Effectfever two weeks after starting Drugcarbimazole .
1.0000 Adverse-Effect A 72 - year - old woman with a history of thyrotoxicosis presented with Adverse-Effectsore throat and fever two weeks after starting Drugcarbimazole .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Soon after introduction of Druginsulin therapy, she developed Adverse-Effectsevere anasarca , including marked peripheral oedema, ascites and pleural effusion.
1.0000 Adverse-Effect Soon after introduction of Druginsulin therapy, she developed severe anasarca, including marked Adverse-Effectperipheral oedema , ascites and pleural effusion.
0.9999 Adverse-Effect Soon after introduction of Druginsulin therapy, she developed severe anasarca, including marked peripheral oedema, Adverse-Effectascites and pleural effusion.
0.9999 Adverse-Effect Soon after introduction of Druginsulin therapy, she developed severe anasarca, including marked peripheral oedema, ascites and Adverse-Effectpleural effusion .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugNiacin causes a Adverse-Effectreversible toxic cystoid maculopathy that occurs in approximately 0. 67 % of patients taking high doses of the drug.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect After the addition of Drugcitalopram , a Adverse-Effectdesmethylclomipramine plasma level increase and an 8 - hydroacy - desmethylclomipramine plasma level decrease were observed.
0.9998 Adverse-Effect After the addition of Drugcitalopram , a desmethylclomipramine plasma level increase and an Adverse-Effect8 - hydroacy - desmethylclomipramine plasma level decrease were observed.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect An 8 - year - old child with familial Mediterranean fever exhibited signs of Drugcolchicine Adverse-Effectcolchicine intoxication while receiving prophylactic doses of the drug.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Two patients treated with 5 - fluorouracil ( 5 - FU ) for disseminated adenocarcinoma of the colon developed cerebellar dysfunction typical of Drug5 - FU Adverse-Effectneurotoxicity .
1.0000 Adverse-Effect Two patients treated with 5 - fluorouracil ( Drug5 - FU ) for disseminated adenocarcinoma of the colon developed Adverse-Effectcerebellar dysfunction typical of 5 - FU neurotoxicity.
0.9999 Adverse-Effect Two patients treated with Drug5 - fluorouracil ( 5 - FU ) for disseminated adenocarcinoma of the colon developed Adverse-Effectcerebellar dysfunction typical of 5 - FU neurotoxicity.
0.9993 Adverse-Effect Two patients treated with 5 - fluorouracil ( 5 - FU ) for disseminated adenocarcinoma of the colon developed Adverse-Effectcerebellar dysfunction typical of Drug5 - FU neurotoxicity.
0.9990 Adverse-Effect Two patients treated with Drug5 - fluorouracil ( 5 - FU ) for disseminated adenocarcinoma of the colon developed cerebellar dysfunction typical of 5 - FU Adverse-Effectneurotoxicity .
0.9989 Adverse-Effect Two patients treated with 5 - fluorouracil ( Drug5 - FU ) for disseminated adenocarcinoma of the colon developed cerebellar dysfunction typical of 5 - FU Adverse-Effectneurotoxicity .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe the first documented case of Drugazathioprine - induced severe Adverse-Effectmyelosuppression due to thiopurine methyltransferase deficiency in autoimmune liver disease.
1.0000 Adverse-Effect We describe the first documented case of Drugazathioprine - induced Adverse-Effectsevere myelosuppression due to thiopurine methyltransferase deficiency in autoimmune liver disease.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We recommend that clinicians monitor patients for signs and symptoms of pancreatitis, including Adverse-Effectabdominal pain , during treatment with Drugtigecycline .
1.0000 Adverse-Effect We recommend that clinicians monitor patients for signs and symptoms of Adverse-Effectpancreatitis , including abdominal pain, during treatment with Drugtigecycline .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugBortezomib - induced Adverse-Effectparalytic ileus is a potential gastrointestinal side effect of this first - in - class anticancer proteasome inhibitor.
0.9998 Adverse-Effect DrugBortezomib - induced paralytic ileus is a potential Adverse-Effectgastrointestinal side effect of this first - in - class anticancer proteasome inhibitor.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The male patient was treated with 225 - mg / day Drugclozapine and the time to the diagnosis of Adverse-Effectagranulocytosis was 6 weeks.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect BACKGROUND : How to best treat psychotic patients who have had past Drugclozapine - induced agranulocytosis or Adverse-Effectgranulocytopenia remains a problem.
1.0000 Adverse-Effect BACKGROUND : How to best treat psychotic patients who have had past Drugclozapine - induced Adverse-Effectagranulocytosis or granulocytopenia remains a problem.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We have cared for three children in whom four episodes of dystonia proceeding to Adverse-Effectopisthotonus occurred in association with Drugcarbamazepine use.
0.9999 Adverse-Effect We have cared for three children in whom four episodes of Adverse-Effectdystonia proceeding to opisthotonus occurred in association with Drugcarbamazepine use.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Ten hours after the second Drugmethotrexate injection, the patient experienced a Adverse-Effectdiffuse pruritic papular eruption located mainly on the limbs.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectCryptococcus neoformans fatal sepsis in a chronic lymphocytic leukemia patient treated with Drugalemtuzumab : case report and review of the literature.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : The pathogenesis of Drugmethotrexate - induced Adverse-Effectpapular eruption in collagen vascular diseases may suggest cutaneous small - vessel vasculitis.
0.9947 Adverse-Effect CONCLUSIONS : The pathogenesis of Drugmethotrexate - induced papular eruption in collagen vascular diseases may suggest Adverse-Effectcutaneous small - vessel vasculitis .
Score Relation Text (Head - Tail)
Adverse-Effect The patient developed occipital infarcts and was found to have Adverse-Effectextremely elevated levels of PPA DrugPPA in his blood and dialysis fluid.
Adverse-Effect The patient developed Adverse-Effectoccipital infarcts and was found to have extremely elevated levels of DrugPPA in his blood and dialysis fluid.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Two cases of childhood - onset schizophrenia associated with Drugclozapine - induced Adverse-Effectakathisia responsive to beta - blocker treatment are described.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectPolymyositis is a rare complication of Druginterferon alpha treatment as a result of immune - modulating role of the drug itself.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect On the next day, after a total dose of only 600 mg of Drugdanazol , Adverse-Effectgingival bleeding and purpura occurred.
1.0000 Adverse-Effect On the next day, after a total dose of only 600 mg of Drugdanazol , gingival bleeding and Adverse-Effectpurpura occurred.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe two patients with Adverse-Effectaspergillus arthritis of the knee joint following Drugfludarabine - based non - myeloablative stem cell transplantation.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Concurrent acute megaloblastic anaemia and Adverse-Effectpneumonitis : a severe side - effect of low - dose Drugmethotrexate therapy during rheumatoid arthritis.
0.9999 Adverse-Effect Concurrent Adverse-Effectacute megaloblastic anaemia and pneumonitis : a severe side - effect of low - dose Drugmethotrexate therapy during rheumatoid arthritis.
Adverse-Effect Adverse-EffectConcurrent acute megaloblastic anaemia and pneumonitis : a severe side - effect of low - dose Drugmethotrexate therapy during rheumatoid arthritis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We present findings from three patients who experienced a Adverse-Effectpsoriasiform eruption apparently due to the antiepileptic agents Drugsodium valproate and carbamazepine.
0.9999 Adverse-Effect We present findings from three patients who experienced a Adverse-Effectpsoriasiform eruption apparently due to the antiepileptic agents sodium valproate and Drugcarbamazepine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case of a 21 - year - old woman who had developed mild Adverse-Effecthepatotoxicity while receiving Drugcholine magnesium trisalicylate therapy is described.
1.0000 Adverse-Effect A case of a 21 - year - old woman who had developed Adverse-Effectmild hepatotoxicity while receiving Drugcholine magnesium trisalicylate therapy is described.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect PURPOSE : DrugTopiramate - induced Adverse-Effectangle - closure glaucoma ( TiACG ) is believed to be related to its sulfonamide moiety.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : We report this case of the concomitant appearance of multiple skin cancers and Adverse-Effectnail changes associated with Drughydroxyurea use.
0.9999 Adverse-Effect CONCLUSIONS : We report this case of the concomitant appearance of Adverse-Effectmultiple skin cancers and nail changes associated with Drughydroxyurea use.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The authors report on two patients with Adverse-Effectcorneal ulcers refractory to conventional treatment while the patients were undergoing oral Drugcolchicine therapy.
1.0000 Adverse-Effect The authors report on two patients with Adverse-Effectcorneal ulcers refractory to conventional treatment while the patients were undergoing oral Drugcolchicine therapy.
1.0000 Adverse-Effect The authors report on two patients with Adverse-Effectcorneal ulcers refractory to conventional treatment while the patients were undergoing oral Drugcolchicine therapy.
1.0000 Adverse-Effect The authors report on two patients with Adverse-Effectcorneal ulcers refractory to conventional treatment while the patients were undergoing oral Drugcolchicine therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To report a case of Adverse-Effectfatal hyperkalemia owing to Drugsuccinylcholine administration in a patient with mucositis secondary to chemotherapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 52 - year - old Black woman on Drugphenytoin therapy for post - traumatic epilepsy developed Adverse-Effecttransient hemiparesis contralateral to the injury.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The pharmacology and toxicology of Drugchloral hydrate are discussed with particular reference to the Adverse-Effectcardiac arrhythmias that are seen with overdosage.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect To our knowledge, this is the first case of Druggriseofulvin - exacerbated Adverse-Effectlupus in which nephrotic syndrome has been observed.
0.9999 Adverse-Effect To our knowledge, this is the first case of Druggriseofulvin - exacerbated lupus in which Adverse-Effectnephrotic syndrome has been observed.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report in detail an unusual adverse reaction to Druginfliximab therapy, a drug - induced Adverse-Effectlupus - like clinical syndrome .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect When the disease recurred conventional Drugamphotericin B was used again, but had to be stopped because of Adverse-Effectsevere side effects .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect We report a case of acute Adverse-Effecthyperphosphatemia secondary to rectal administration of Drugsodium phosphate and sodium biphosphate ( Fleet enema ).
0.9988 Adverse-Effect We report a case of acute Adverse-Effecthyperphosphatemia secondary to rectal administration of sodium phosphate and Drugsodium biphosphate ( Fleet enema ).
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect A case of Drugphenytoin - induced Adverse-Effecthepatitis with mononucleosis is reported, and syndromes associated with phenytoin hypersensitivity reactions are discussed.
0.9097 Adverse-Effect A case of Drugphenytoin - induced hepatitis with Adverse-Effectmononucleosis is reported, and syndromes associated with phenytoin hypersensitivity reactions are discussed.
0.9871 Adverse-Effect A case of phenytoin - induced hepatitis with mononucleosis is reported, and syndromes associated with Drugphenytoin Adverse-Effectphenytoin hypersensitivity reactions are discussed.
Adverse-Effect A case of phenytoin - induced hepatitis with mononucleosis is reported, and syndromes associated with Drugphenytoin Adverse-Effecthypersensitivity reactions are discussed.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : DrugClarithromycin may be a cause of Adverse-Effectfulminant liver failure either alone or by inhibiting the metabolism of other drugs.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a patient who developed Adverse-EffectNEH on three separate occasions provoked by two different chemotherapeutic agents - - Drugcytarabine and mitoxantrone.
1.0000 Adverse-Effect We describe a patient who developed Adverse-EffectNEH on three separate occasions provoked by two different chemotherapeutic agents - - cytarabine and Drugmitoxantrone .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVES : A delayed Adverse-Effectstroke - like leukoencephalopathy has been observed in patients receiving Drugmethotrexate ( MTX ) for childhood leukemia.
0.9999 Adverse-Effect OBJECTIVES : A delayed Adverse-Effectstroke - like leukoencephalopathy has been observed in patients receiving methotrexate ( DrugMTX ) for childhood leukemia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case of Adverse-Effectacute subdural haematoma originating spontaneously from an angiomatous meningioma in a patient receiving prophylactic Drugaspirin therapy is presented.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a 41 yr old leprosy patient treated for 10 yrs with Drugclofazimine who underwent laparotomy for severe Adverse-Effectabdominal pain .
1.0000 Adverse-Effect We describe a 41 yr old leprosy patient treated for 10 yrs with Drugclofazimine who underwent Adverse-Effectlaparotomy for severe abdominal pain.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectBrugada type electrocardiographic changes induced by concomitant use of Druglithium and propafenone in patient with Wolff - Parkinson - White syndrome.
1.0000 Adverse-Effect Adverse-EffectBrugada type electrocardiographic changes induced by concomitant use of lithium and Drugpropafenone in patient with Wolff - Parkinson - White syndrome.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We evaluated a patient who developed a Adverse-Effectpsychotic disorder after 4 months of Drugisoniazid prophylaxis for a positive tuberculosis tine test.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect To our knowledge, these cases are the first published reports of Druglovastatin - induced Adverse-Effectrhabdomyolysis associated with azithromycin and clarithromycin.
1.0000 Adverse-Effect To our knowledge, these cases are the first published reports of lovastatin - induced Adverse-Effectrhabdomyolysis associated with Drugazithromycin and clarithromycin.
0.9998 Adverse-Effect To our knowledge, these cases are the first published reports of lovastatin - induced Adverse-Effectrhabdomyolysis associated with azithromycin and Drugclarithromycin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 60 year - old woman with chronic renal failure developed Adverse-Effectacute proximal muscle weakness after receiving a regular dosage of Drugcolchicine .
Adverse-Effect A 60 year - old woman with chronic renal failure developed acute Adverse-Effectproximal muscle weakness after receiving a regular dosage of Drugcolchicine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To report a fatal case of Adverse-Effecttoxic epidermal necrolysis in a man who was treated with oral Drugofloxacin for epididymitis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectDural sinus thrombosis developed in two children with acute lymphoblastic leukemia during induction treatment with Drugvincristine sulfate , prednisone, and asparaginase.
0.9998 Adverse-Effect Adverse-EffectDural sinus thrombosis developed in two children with acute lymphoblastic leukemia during induction treatment with vincristine sulfate, Drugprednisone , and asparaginase.
0.9997 Adverse-Effect Adverse-EffectDural sinus thrombosis developed in two children with acute lymphoblastic leukemia during induction treatment with vincristine sulfate, prednisone, and Drugasparaginase .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We present the first case ( to our knowledge ) of a potentially serious Adverse-Effectdrug - drug interaction between Drugzafirlukast and theophylline.
1.0000 Adverse-Effect We present the first case ( to our knowledge ) of a potentially serious Adverse-Effectdrug - drug interaction between zafirlukast and Drugtheophylline .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The Adverse-Effectfetal valproate syndrome Drugvalproate syndrome ( FVS ) is characterized by distinctive facial appearance, major and minor malformations, and developmental delay.
1.0000 Adverse-Effect The fetal Drugvalproate syndrome ( Adverse-EffectFVS ) is characterized by distinctive facial appearance, major and minor malformations, and developmental delay.
0.9999 Adverse-Effect The fetal Drugvalproate syndrome ( FVS ) is characterized by Adverse-Effectdistinctive facial appearance , major and minor malformations, and developmental delay.
0.9999 Adverse-Effect The fetal Drugvalproate syndrome ( FVS ) is characterized by distinctive facial appearance, Adverse-Effectmajor and minor malformations , and developmental delay.
0.9999 Adverse-Effect The fetal Drugvalproate syndrome ( FVS ) is characterized by distinctive facial appearance, major and minor malformations, and Adverse-Effectdevelopmental delay .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This patient rapidly progressed from mild neurotoxicity to Adverse-Effectfatal encephalopathy after one dose of intrathecal Drugmethotrexate during his third cycle of chemotherapy.
0.9999 Adverse-Effect This patient rapidly progressed from Adverse-Effectmild neurotoxicity to fatal encephalopathy after one dose of intrathecal Drugmethotrexate during his third cycle of chemotherapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect She died within six weeks of developing congestive heart failure coupled with liver failure due to Adverse-Effecthaemosiderosis despite regular use of Drugdesferrioxamine .
0.9999 Adverse-Effect She died within six weeks of developing Adverse-Effectcongestive heart failure coupled with liver failure due to haemosiderosis despite regular use of Drugdesferrioxamine .
0.9999 Adverse-Effect She died within six weeks of developing congestive heart failure coupled with Adverse-Effectliver failure due to haemosiderosis despite regular use of Drugdesferrioxamine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A second patient with a similar glucose tolerance test result showed Adverse-Effectpostprandial hyperglycemia when treated similarly with Drugbetamethasone valerate cream 0. 1 %.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe the clinical and liver biopsy morphologic features for 4 patients with Drugminocycline - induced Adverse-Effectautoimmune hepatitis ( group 1 ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Without other causes for the hyponatremia, she was diagnosed with the Adverse-Effectsyndrome of inappropriate antidiuretic hormone , presumably caused by Drugdesmopressin .
0.9999 Adverse-Effect Without other causes for the Adverse-Effecthyponatremia , she was diagnosed with the syndrome of inappropriate antidiuretic hormone, presumably caused by Drugdesmopressin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In contrast to chronic or subacute thyroiditis, Adverse-EffectGraves'disease rarely complicates DrugIFN - alpha therapy for chronic viral C hepatitis.
0.9999 Adverse-Effect In contrast to chronic or Adverse-Effectsubacute thyroiditis , Graves'disease rarely complicates DrugIFN - alpha therapy for chronic viral C hepatitis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the case of a female acromegalic patient in whom multiple Adverse-Effecthepatic adenomas appeared soon after Drugdanazol treatment for uterine fibromatosis.
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect CONCLUSIONS : We have seen an increased incidence of acute DrugINH Adverse-Effectneurotoxicity because of the resurgence of TB in New York City.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectParalytic ileus in patients undergoing Drugbortezomib treatment has been reported, although a definite attribution to bortezomib administration has not been established.
0.9743 Adverse-Effect Adverse-EffectParalytic ileus in patients undergoing bortezomib treatment has been reported, although a definite attribution to Drugbortezomib administration has not been established.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect STUDY DESIGN : Case report of a 31 - year - old woman who presented with Adverse-Effecttoxic myelopathy due to intrathecal administration of Drugdoxorubicin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugColchicine - induced Adverse-Effectrhabdomyolysis is a rare complication, and the postulated mechanisms and risk factors for this severe complication are discussed.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectTelescoped digits of the hands and feet developed in a 69 - year - old male with severe chronic tophaceous gout during Drugallopurinol treatment.
Score Relation Text (Head - Tail)
0.9995 Adverse-Effect Although other nitrites induce Adverse-Effectmethemoglobinemia , exposure to Drugmethyl nitrite during phenylpropanolamine production appears to be a new cause of occupational methemoglobinemia.
0.9994 Adverse-Effect Although other nitrites induce methemoglobinemia, exposure to Drugmethyl nitrite during phenylpropanolamine production appears to be a new cause of occupational Adverse-Effectmethemoglobinemia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect FINDINGS : Six children with growth retardation noted after treatment with high - dose Drugfluticasone propionate were found to have Adverse-Effectadrenal suppression .
0.9999 Adverse-Effect FINDINGS : Six children with Adverse-Effectgrowth retardation noted after treatment with high - dose Drugfluticasone propionate were found to have adrenal suppression.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Thus, the possible in vivo effects of insulin on adipocytes were clearly observed in this case of Druginsulin - induced Adverse-Effectlipohypertrophy .
0.9947 Adverse-Effect Thus, the possible in vivo effects of Druginsulin on adipocytes were clearly observed in this case of insulin - induced Adverse-Effectlipohypertrophy .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugNaproxen is a commonly used nonsteroidal anti - inflammatory drug ( NSAID ) whose side effects include Adverse-Effecttinnitus and transient hearing loss.
1.0000 Adverse-Effect DrugNaproxen is a commonly used nonsteroidal anti - inflammatory drug ( NSAID ) whose side effects include tinnitus and Adverse-Effecttransient hearing loss .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We reviewed the records of 3 patients with lymphoproliferative disorders who experienced Adverse-Effectacute coronary syndromes associated with their initial infusion of Drugrituximab .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The patient, a 28 - year - old man suffering from panic disorder, developed several Adverse-Effectfirst - rank symptoms during Drugfluvoxamine administration.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Although this DrugG - CSF - driven Adverse-Effectleucocytosis was alarming it did not appear to have adversely affected the patient's prognosis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We also describe a new, noninvasive method to assess Drugmagnesium - induced Adverse-Effectneuromuscular block when curariform muscle relaxant was given simultaneously.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectAcute non - lymphocytic leukemia occurred in eight women following long - term treatment with DrugTreosulfan ( = dihydroxybusulfan ) for ovarian carcinoma.
1.0000 Adverse-Effect Adverse-EffectAcute non - lymphocytic leukemia occurred in eight women following long - term treatment with Treosulfan ( = Drugdihydroxybusulfan ) for ovarian carcinoma.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We concluded that the colonic ulcer and the Adverse-Effectsigmoidovesical fistula had been caused by the administration of Drugcalcium polystyrene sulfonate and sorbitol.
0.9998 Adverse-Effect We concluded that the colonic ulcer and the Adverse-Effectsigmoidovesical fistula had been caused by the administration of calcium polystyrene sulfonate and Drugsorbitol .
0.9995 Adverse-Effect We concluded that the Adverse-Effectcolonic ulcer and the sigmoidovesical fistula had been caused by the administration of Drugcalcium polystyrene sulfonate and sorbitol.
0.9993 Adverse-Effect We concluded that the Adverse-Effectcolonic ulcer and the sigmoidovesical fistula had been caused by the administration of calcium polystyrene sulfonate and Drugsorbitol .
Score Relation Text (Head - Tail)
Adverse-Effect This case suggests that acyclovir when given intravenously in doses of 10 mg / kg may result in Adverse-Effectincreased serum lithium Druglithium concentrations.
Adverse-Effect This case suggests that Drugacyclovir when given intravenously in doses of 10 mg / kg may result in Adverse-Effectincreased serum lithium concentrations.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectAcute delirium resulting from Druglevofloxacin therapy is an exceedingly rare complication that has been thought to occur more commonly in elderly patients.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Sixteen hours after the first administration of IFN, DrugIFN was suspended by the symptoms of Adverse-Effectcongestive heart failure ( CHF ).
0.9998 Adverse-Effect Sixteen hours after the first administration of IFN, DrugIFN was suspended by the symptoms of congestive heart failure ( Adverse-EffectCHF ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The case of a 4 - year - old girl with Drugvalproate - induced Adverse-Effectstupor and electroencephalographic pattern of increased fast activity is reported.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of biopsy proven Adverse-Effectmyositis whose symptoms began within 10 days of receiving Drugleuprolide acetate therapy for prostate cancer.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectOsteonecrosis is a serious side effect of antiemetic treatment with Drugdexamethasone and this serious complication should be incorporated in the current guidelines.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Case report : lack of control of diabetes and Adverse-Effectweight gain in a patient on initiation and rechallenge of therapy with Drugolanzapine .
1.0000 Adverse-Effect Case report : lack of control of Adverse-Effectdiabetes and weight gain in a patient on initiation and rechallenge of therapy with Drugolanzapine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect She developed a generalized rash and itching, sore throat, and Adverse-Effectdizziness approximately 4 hours after the first dose of Drugcapecitabine .
1.0000 Adverse-Effect She developed a generalized rash and itching, Adverse-Effectsore throat , and dizziness approximately 4 hours after the first dose of Drugcapecitabine .
1.0000 Adverse-Effect She developed a Adverse-Effectgeneralized rash and itching, sore throat, and dizziness approximately 4 hours after the first dose of Drugcapecitabine .
1.0000 Adverse-Effect She developed a generalized rash and Adverse-Effectitching , sore throat, and dizziness approximately 4 hours after the first dose of Drugcapecitabine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We described the occurrence of DrugL - dopa - induced Adverse-Effectmyoclonus and seizures in a case of parkinsonism with its SEPs findings.
0.9998 Adverse-Effect We described the occurrence of DrugL - dopa - induced myoclonus and Adverse-Effectseizures in a case of parkinsonism with its SEPs findings.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A patient developed Adverse-Effectrestless legs symptoms paralleling the course of Druginterferon - alpha ( IFN alpha ) therapy for chronic hepatitis C.
0.9997 Adverse-Effect A patient developed Adverse-Effectrestless legs symptoms paralleling the course of interferon - alpha ( DrugIFN alpha ) therapy for chronic hepatitis C.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In the other patient, a 78 - year - old woman, Adverse-EffectNeisseria mucosa knee arthritis occurred after a single Drugsodium hyaluronate injection.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Prominent eye movements during NREM sleep and Adverse-EffectREM sleep behavior disorder associated with Drugfluoxetine treatment of depression and obsessive - compulsive disorder.
1.0000 Adverse-Effect Adverse-EffectProminent eye movements during NREM sleep and REM sleep behavior disorder associated with Drugfluoxetine treatment of depression and obsessive - compulsive disorder.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In patients with chronic heart failure, Drugspironolactone added to conventional treatment may lead to serious and, occasionally, Adverse-Effectfatal hyperkalaemia .
Adverse-Effect In patients with chronic heart failure, Drugspironolactone added to conventional treatment may lead to Adverse-Effectserious and, occasionally, fatal hyperkalaemia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of Adverse-Effectvitiligo that occurred during the second month of Druginterferon alpha 2a therapy for chronic active hepatitis C.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Second, we report a case of Adverse-Effectneutropenia , which proved to be fatal in a schizophrenia patient receiving Drugolanzapine and thiazide.
0.9999 Adverse-Effect Second, we report a case of Adverse-Effectneutropenia , which proved to be fatal in a schizophrenia patient receiving olanzapine and Drugthiazide .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The results of the ultrasound examination combined with clinical anamnesis allowed diagnosis of Adverse-Effectgastric mucosa foveolar hyperplasia due to prolonged DrugPGE1 therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The potential role of Drugpropranolol in inducing Adverse-Effectcentral nervous system disturbances is emphasized, and the literature on the subject is reviewed.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Therefore, we concluded that this patient's Adverse-Effectpulmonary disease was caused by Drugcalcium stearate , an additive for an antihistaminic drug.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DATA SYNTHESIS : A 49 - year - old man developed symptoms of Adverse-Effectsevere psychosis concomitant with Drugciprofloxacin ( 250 mg bid ) treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We present a patient with human immunodeficiency virus infection under treatment with Drugfoscarnet for CMV retinitis who complained of Adverse-Effectthirst and polyuria.
1.0000 Adverse-Effect We present a patient with human immunodeficiency virus infection under treatment with Drugfoscarnet for CMV retinitis who complained of thirst and Adverse-Effectpolyuria .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a fatal case of Adverse-Effectacute interstitial pneumonitis in a patient treated with Drugcarmustine ( BCNU ) for a brain tumor.
1.0000 Adverse-Effect We report a fatal case of Adverse-Effectacute interstitial pneumonitis in a patient treated with carmustine ( DrugBCNU ) for a brain tumor.
0.9999 Adverse-Effect We report a Adverse-Effectfatal case of acute interstitial pneumonitis in a patient treated with Drugcarmustine ( BCNU ) for a brain tumor.
0.9997 Adverse-Effect We report a Adverse-Effectfatal case of acute interstitial pneumonitis in a patient treated with carmustine ( DrugBCNU ) for a brain tumor.
Adverse-Effect We report a Adverse-Effectfatal case of acute interstitial pneumonitis in a patient treated with carmustine ( DrugBCNU ) for a brain tumor.
Adverse-Effect We report a Adverse-Effectfatal case of acute interstitial pneumonitis in a patient treated with Drugcarmustine ( BCNU ) for a brain tumor.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CASE SUMMARY : A 10 - year - old white girl with bilateral optic glioma developed a Adverse-Effecthypersensitivity reaction to Drugcarboplatin after nine courses.
1.0000 Adverse-Effect CASE SUMMARY : A 10 - year - old white girl with bilateral optic glioma developed a Adverse-Effecthypersensitivity reaction to Drugcarboplatin after nine courses.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the case of a young healthy woman who presented an early Adverse-Effectoveranticoagulation when receiving Drugacenocoumarol for a first thromboembolic episode.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Beginning ductopenia was present in two, suggesting that Drugitraconazole might be responsible for the occurrence of prolonged drug - induced Adverse-Effectcholangiopathy .
1.0000 Adverse-Effect Beginning Adverse-Effectductopenia was present in two, suggesting that Drugitraconazole might be responsible for the occurrence of prolonged drug - induced cholangiopathy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Early - onset Drugpentamidine - associated Adverse-Effectsecond - degree heart block and sinus bradycardia : case report and review of the literature.
1.0000 Adverse-Effect Early - onset Drugpentamidine - associated second - degree heart block and Adverse-Effectsinus bradycardia : case report and review of the literature.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSION : We believe this to be the first reported case of DrugrhGH - induced Adverse-Effecthypercalcemia in an HIV - infected patient.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We reported a case of Drugdisulfiram - induced Adverse-Effecthepatitis with unique clinical features and compared our case with others in the literature.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of severe Adverse-Effecthypotension associated with intravenous Drugvalproate used to treat status epilepticus in an 11 - year - old girl.
1.0000 Adverse-Effect We report a case of Adverse-Effectsevere hypotension associated with intravenous Drugvalproate used to treat status epilepticus in an 11 - year - old girl.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect AIM : To report three cases of extensive Adverse-Effectskin necrosis in cirrhotic patients treated with the vasoconstrictor agent Drugterlipressin ( Glypressin ).
0.9999 Adverse-Effect AIM : To report three cases of extensive Adverse-Effectskin necrosis in cirrhotic patients treated with the vasoconstrictor agent terlipressin ( DrugGlypressin ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The occurrence of neuromuscular blockade and the resulting Adverse-Effectpotentiation of muscle relaxants during Drugmagnesium sulfate ( MgSO4 ) administration is well known.
0.9999 Adverse-Effect The occurrence of neuromuscular blockade and the resulting Adverse-Effectpotentiation of muscle relaxants during magnesium sulfate ( DrugMgSO4 ) administration is well known.
0.9997 Adverse-Effect The occurrence of Adverse-Effectneuromuscular blockade and the resulting potentiation of muscle relaxants during Drugmagnesium sulfate ( MgSO4 ) administration is well known.
0.9994 Adverse-Effect The occurrence of Adverse-Effectneuromuscular blockade and the resulting potentiation of muscle relaxants during magnesium sulfate ( DrugMgSO4 ) administration is well known.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Thirty patients with Adverse-Effecthepatic reactions to Drugcyclofenil , a non - steroidal drug with a stimulating effect on ovulation, are reviewed.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect His symptoms of brain stem compression were alleviated and the role of Drugphenytoin in the production of his Adverse-Effectcraniocervical abnormality is discussed.
0.9999 Adverse-Effect His symptoms of Adverse-Effectbrain stem compression were alleviated and the role of Drugphenytoin in the production of his craniocervical abnormality is discussed.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The second had acute cystitis and was treated by sulphonamide and the third developed Adverse-Effectmyopia coincident with Drugmetronidazole treatment for trichomonas vaginalis.
0.9999 Adverse-Effect The second had acute cystitis and was treated by Drugsulphonamide and the third developed Adverse-Effectmyopia coincident with metronidazole treatment for trichomonas vaginalis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The renal biopsy showed Adverse-Effectfocal segmental glomerulosclerosis , which has only been previously reported in two cases of CML treated with DrugIFNalpha .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The most commonly recognized toxic effect of Drugethambutol is Adverse-Effectoptic neuropathy , which generally is considered uncommon and reversible in medical literature.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Based on the clinical status of the patient, it was suspected that several conditions contributed to the Adverse-Effectabnormal hypersensitivity to Drugwarfarin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case is presented in which a 68 - year - old man became Adverse-Effectdelirious after being withdrawn from a low dosage of Drugalprazolam .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect However, Drugadenosine shortens the antegrade refractoriness of accessory atrioventricular connections and may cause Adverse-Effectacceleration of the ventricular rate during atrial fibrillation.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Nonspecific but Adverse-Effectsignificant abnormalities have been described in the infants of women treated with Drugdisulfiram in the first trimester of their pregnancies.
1.0000 Adverse-Effect Nonspecific but significant Adverse-Effectabnormalities have been described in the infants of women treated with Drugdisulfiram in the first trimester of their pregnancies.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectToxicity , pharmacokinetics, and in vitro hemodialysis clearance of Drugifosfamide and metabolites in an anephric pediatric patient with Wilms'tumor.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The case resembles two previously reported cases of Adverse-Effectoptic neuropathy which occurred in patients with Wilson's disease who were receiving Drugpenicillamine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In the present paper, we discuss the first Japanese vivax malaria patient whose Adverse-EffectQT interval was prolonged after treatment with Drughalofantrine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Anaphylactoid shock, disseminated intravascular coagulation, and Adverse-Effectanuric renal failure requiring dialysis occurred in a patient receiving Drugzomepirac sodium for toothache.
0.9998 Adverse-Effect Adverse-EffectAnaphylactoid shock , disseminated intravascular coagulation, and anuric renal failure requiring dialysis occurred in a patient receiving Drugzomepirac sodium for toothache.
0.9996 Adverse-Effect Anaphylactoid shock, Adverse-Effectdisseminated intravascular coagulation , and anuric renal failure requiring dialysis occurred in a patient receiving Drugzomepirac sodium for toothache.
Adverse-Effect Anaphylactoid shock, Adverse-Effectdisseminated intravascular coagulation , and anuric renal failure requiring dialysis occurred in a patient receiving Drugzomepirac sodium for toothache.
Adverse-Effect Adverse-EffectAnaphylactoid shock , disseminated intravascular coagulation, and anuric renal failure requiring dialysis occurred in a patient receiving Drugzomepirac sodium for toothache.
Adverse-Effect Anaphylactoid shock, disseminated intravascular coagulation, and Adverse-Effectanuric renal failure requiring dialysis occurred in a patient receiving Drugzomepirac sodium for toothache.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect High - resolution computed tomography scan findings were consistent with ILD, which was sufficient to diagnose as Drugerlotinib - induced Adverse-EffectILD .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect She had been taking Drugnabumetone for 6 months, but had discontinued the agent 2 weeks before admission due to progressive Adverse-Effectedema .
Score Relation Text (Head - Tail)
Adverse-Effect The reversal of heparin by Drugprotamine may cause severe hemodynamic deterioration, characterized by systemic hypotension, pulmonary hypertension, and Adverse-Effectbronchoconstriction .
Adverse-Effect The reversal of heparin by Drugprotamine may cause severe hemodynamic deterioration, characterized by Adverse-Effectsystemic hypotension , pulmonary hypertension, and bronchoconstriction.
Adverse-Effect The reversal of heparin by Drugprotamine may cause Adverse-Effectsevere hemodynamic deterioration , characterized by systemic hypotension, pulmonary hypertension, and bronchoconstriction.
Adverse-Effect The reversal of heparin by Drugprotamine may cause severe hemodynamic deterioration, characterized by systemic hypotension, Adverse-Effectpulmonary hypertension , and bronchoconstriction.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect PURPOSE : To report a case of angiographically documented Adverse-Effectcystoid macula edema occurring after switching a pseudophakic patient from Druglatanoprost to bimatoprost.
0.9999 Adverse-Effect PURPOSE : To report a case of angiographically documented Adverse-Effectcystoid macula edema occurring after switching a pseudophakic patient from latanoprost to Drugbimatoprost .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The Adverse-Effectnodules regressed after withdrawal of Drugmethotrexate therapy in one patient and were arrested with the addition of hydroxychloroquine in the other.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : Clinicians should be aware of the possible association of Adverse-Effectthrombocytopenia with Druglansoprazole and discontinue the drug if thrombocytopenia becomes apparent.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect To our knowledge, these cases represent the first reports of DrugTDF - associated Adverse-Effectirreversible renal failure and rickets in pediatric patients.
0.9999 Adverse-Effect To our knowledge, these cases represent the first reports of DrugTDF - associated irreversible renal failure and Adverse-Effectrickets in pediatric patients.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugCyclosporin side effects included Adverse-Effecthirsutism , hypertension, increased blood levels of urea and creatinine, and abnormalities in liver function tests.
1.0000 Adverse-Effect DrugCyclosporin side effects included hirsutism, Adverse-Effecthypertension , increased blood levels of urea and creatinine, and abnormalities in liver function tests.
0.9999 Adverse-Effect DrugCyclosporin side effects included hirsutism, hypertension, increased blood levels of urea and creatinine, and Adverse-Effectabnormalities in liver function tests .
0.9999 Adverse-Effect DrugCyclosporin side effects included hirsutism, hypertension, Adverse-Effectincreased blood levels of urea and creatinine , and abnormalities in liver function tests.
0.9999 Adverse-Effect DrugCyclosporin side effects included hirsutism, hypertension, Adverse-Effectincreased blood levels of urea and creatinine, and abnormalities in liver function tests.
0.9999 Adverse-Effect DrugCyclosporin side effects included hirsutism, hypertension, Adverse-Effectincreased blood levels of urea and creatinine, and abnormalities in liver function tests.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Atrioventricular block complicating Drugamiodarone - induced Adverse-Effecthypothyroidism in a patient with pre - excitation and rate - dependent bilateral bundle branch block.
1.0000 Adverse-Effect Adverse-EffectAtrioventricular block complicating Drugamiodarone - induced hypothyroidism in a patient with pre - excitation and rate - dependent bilateral bundle branch block.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Behavioral side effects associated with Drugclonazepam may include Adverse-Effectagitation , aggression, hyperactivity, irritability, property destruction, and temper tantrums.
1.0000 Adverse-Effect Behavioral side effects associated with Drugclonazepam may include agitation, Adverse-Effectaggression , hyperactivity, irritability, property destruction, and temper tantrums.
1.0000 Adverse-Effect Behavioral side effects associated with Drugclonazepam may include agitation, aggression, Adverse-Effecthyperactivity , irritability, property destruction, and temper tantrums.
1.0000 Adverse-Effect Behavioral side effects associated with Drugclonazepam may include agitation, aggression, hyperactivity, Adverse-Effectirritability , property destruction, and temper tantrums.
0.9999 Adverse-Effect Behavioral side effects associated with Drugclonazepam may include agitation, aggression, hyperactivity, irritability, property destruction, and Adverse-Effecttemper tantrums .
0.9999 Adverse-Effect Behavioral side effects associated with Drugclonazepam may include agitation, aggression, hyperactivity, irritability, Adverse-Effectproperty destruction , and temper tantrums.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To determine the frequency of Adverse-Effectweight loss in patients treated with Drugleflunomide for rheumatoid arthritis at an arthritis referral center.
Score Relation Text (Head - Tail)
0.9994 Adverse-Effect A well - recognized complication of Drugethambutol use is Adverse-Effectoptic neuropathy , but the potential ocular toxicity of isoniazid is often overlooked.
0.9899 Adverse-Effect A well - recognized complication of ethambutol use is optic neuropathy, but the potential Adverse-Effectocular toxicity of Drugisoniazid is often overlooked.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : The increasing prevalence of Type 2 diabetes and its treatment with Drugmetformin might result in more cases of Adverse-Effectlactic acidosis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Treatment of APL in pregnancy is controversial as the use of DrugATRA has been questioned due to the Adverse-Effectteratogenic effect of retinoids.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect RESULTS : One case of recurrent primary peritoneal carcinoma previously treated with a Drugcarboplatin - based regimen, developed a Adverse-Effectplatinum hypersensitivity .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Controversy concerning the nephrotoxicity of lithium is discussed, and recommendations for the evaluation of Adverse-Effectrenal failure during Druglithium therapy are provided.
0.9997 Adverse-Effect Controversy concerning the Adverse-Effectnephrotoxicity of Druglithium is discussed, and recommendations for the evaluation of renal failure during lithium therapy are provided.
0.6897 Adverse-Effect Controversy concerning the nephrotoxicity of Druglithium is discussed, and recommendations for the evaluation of Adverse-Effectrenal failure during lithium therapy are provided.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect PURPOSE : To describe Adverse-Effectbilateral corneal endothelial dysfunction in a patient with Parkinson disease who was treated with long - term Drugamantadine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugMethotrexate - induced Adverse-Effectpneumonitis in patients with rheumatoid arthritis and psoriatic arthritis : report of five cases and review of the literature.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Type I second - degree AV block ( Mobitz type I, Adverse-EffectWenckebach AV block ) during Drugritodrine therapy for preterm labor.
1.0000 Adverse-Effect Type I second - degree AV block ( Adverse-EffectMobitz type I , Wenckebach AV block ) during Drugritodrine therapy for preterm labor.
0.9999 Adverse-Effect Adverse-EffectType I second - degree AV block ( Mobitz type I, Wenckebach AV block ) during Drugritodrine therapy for preterm labor.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We present the case of a 58 - year - old woman who ingested more than 35 g of Drugcaffeine in a Adverse-Effectsuicide attempt .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectInsulin - dependent diabetes mellitus developed in a young woman 8 weeks after the initiation of Drugdanazol for treatment of pelvic endometriosis.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect A patient with coccidioidal meningitis was treated with intrathecally administered Drugamphotericin B , and an Adverse-Effectacute toxic delirium with EEG abnormalities developed.
0.9992 Adverse-Effect A patient with coccidioidal meningitis was treated with intrathecally administered Drugamphotericin B , and an acute toxic delirium with Adverse-EffectEEG abnormalities developed.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a 46 - yr - old woman with ovarian carcinoma who developed Adverse-Effectporphyria cutanea tarda while undergoing treatment with Drugcisplatin and cyclophosphamide.
1.0000 Adverse-Effect We report a 46 - yr - old woman with ovarian carcinoma who developed Adverse-Effectporphyria cutanea tarda while undergoing treatment with cisplatin and Drugcyclophosphamide .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Based on these findings, the patient was diagnosed with Adverse-Effectdiabetes insipidus secondary to Druglithium therapy and was treated successfully with amiloride.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Thus, the patient's clinical course and workup strongly support a diagnosis of Druglenalidomide - induced Adverse-Effecthypersensitivity pneumonitis - like syndrome .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Severe Adverse-EffectC. difficile colitis occurred in 2 patients ( 6. 1 % ) after receiving Drugcisplatin - based combination chemotherapy for ovarian malignancies.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Physicians should be aware of the potential for developing a Druggemcitabine - induced Adverse-Effectradiation recall reaction resulting in hemodynamically significant pericardial effusion.
0.9998 Adverse-Effect Physicians should be aware of the potential for developing a Druggemcitabine - induced radiation recall reaction resulting in hemodynamically significant Adverse-Effectpericardial effusion .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A cause - effect relationship to capecitabine was suggested due to resolution of Adverse-Effectheadache with Drugcapecitabine withdrawal and reappearance with capecitabine rechallenge.
0.9998 Adverse-Effect A cause - effect relationship to Drugcapecitabine was suggested due to resolution of Adverse-Effectheadache with capecitabine withdrawal and reappearance with capecitabine rechallenge.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This report highlights a case of drug - induced Adverse-Effectdysphagia in a patient receiving Drughaloperidol for obsessive nocturnal thoughts and auditory disturbances.
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect Does the use of Druginsulin in a patient with liver dysfunction increase water retention in the body, i. e. cause insulin Adverse-Effectoedema ?
0.9950 Adverse-Effect Does the use of Druginsulin in a patient with liver dysfunction increase water retention in the body, i. e. cause Adverse-Effectinsulin oedema ?
0.5166 Adverse-Effect Does the use of insulin in a patient with liver dysfunction increase water retention in the body, i. e. cause Adverse-Effectinsulin oedema Adverse-Effectoedema ?
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This article describes the case of a 25 - year - old man found Adverse-Effectdead at home who had been prescribed Drugolanzapine for schizophrenia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect It is very likely that the Drugdexamethasone used in the antiemetic drug regimen contributed to the development of Adverse-Effectosteonecrosis in these patients.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectAngioedema , a rare side effect of Drugcarbamazepine , involves vascular leakage in dermis and subcutis mediated by immunoglobulin E and / or bradykinins.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Like other atypical neuroleptics Drugolanzapine is considered to show a reduced prevalence of Adverse-Effectextrapyramidal side effects when compared to classical neuroleptic drugs.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect The favourable outcome in these two patients contrasts with the Adverse-Effectfatal outcome of the two other reported cases of Drugnitrofurantoin induced BOOP.
1.0000 Adverse-Effect The favourable outcome in these two patients contrasts with the fatal outcome of the two other reported cases of Drugnitrofurantoin induced Adverse-EffectBOOP .
Adverse-Effect The favourable outcome in these two patients contrasts with the fatal outcome of the two other reported cases of Drugnitrofurantoin Adverse-Effectnitrofurantoin induced BOOP .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect RESULTS : A clinical diagnosis of Adverse-Effectfixed drug eruption owing to use of the PDE5 inhibitor Drugtadalafil ( Cialis ) was made.
1.0000 Adverse-Effect RESULTS : A clinical diagnosis of Adverse-Effectfixed drug eruption owing to use of the PDE5 inhibitor tadalafil ( DrugCialis ) was made.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Protease inhibitors ( ritonavir and Drugsaquinavir ) were added to the treatment and the patient developed Adverse-Effectprogressive ataxia related to carbamazepine toxicity.
0.9999 Adverse-Effect Protease inhibitors ( Drugritonavir and saquinavir ) were added to the treatment and the patient developed Adverse-Effectprogressive ataxia related to carbamazepine toxicity.
0.9999 Adverse-Effect Protease inhibitors ( ritonavir and saquinavir ) were added to the treatment and the patient developed progressive ataxia related to Drugcarbamazepine Adverse-Effectcarbamazepine toxicity .
0.9987 Adverse-Effect Protease inhibitors ( ritonavir and Drugsaquinavir ) were added to the treatment and the patient developed progressive ataxia related to Adverse-Effectcarbamazepine toxicity .
0.9984 Adverse-Effect Protease inhibitors ( ritonavir and saquinavir ) were added to the treatment and the patient developed Adverse-Effectprogressive ataxia related to Drugcarbamazepine toxicity.
0.9965 Adverse-Effect Protease inhibitors ( Drugritonavir and saquinavir ) were added to the treatment and the patient developed progressive ataxia related to Adverse-Effectcarbamazepine toxicity .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 56 - year - old male parkinsonian patient developed a unique Adverse-Effectbehavioral change following the oral administration of Drugcinepazide , a cerebral vasodilator.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectOvarian endometrioid adenocarcinoma arising from an endometriotic cyst in a postmenopausal woman under Drugtamoxifen therapy for breast cancer : a case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This is the first case of DrugTMP - SMX - induced Adverse-Effecthypersensitivity syndrome associated with the reactivation of a latent viral infection.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of 48 - year - old woman with seizure disorder on divalproex sodium ( DrugDepakote ) who presented with Adverse-Effectdyspnea .
0.9999 Adverse-Effect We report a case of 48 - year - old woman with seizure disorder on Drugdivalproex sodium ( Depakote ) who presented with Adverse-Effectdyspnea .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Skin rash began after 2 weeks of treatment, and signs of Adverse-Effecthepatocellular failure developed 3 weeks after Drugphenobarbital had been started.
0.9995 Adverse-Effect Adverse-EffectSkin rash began after 2 weeks of treatment, and signs of hepatocellular failure developed 3 weeks after Drugphenobarbital had been started.
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect OBJECTIVE : To report a case of Adverse-Effectsevere chloroquine toxicity Drugchloroquine toxicity in the presence of high - grade chloroquine - resistant Plasmodium vivax.
0.9993 Adverse-Effect OBJECTIVE : To report a case of severe Drugchloroquine Adverse-Effectchloroquine toxicity in the presence of high - grade chloroquine - resistant Plasmodium vivax.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect RESULTS : Ethambutol, and to a lesser extent Drugisoniazid , are both implicated in the Adverse-Effectdevelopment of visually related side effects .
1.0000 Adverse-Effect RESULTS : DrugEthambutol , and to a lesser extent isoniazid, are both implicated in the Adverse-Effectdevelopment of visually related side effects .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Our objective is to present a retrospective analysis of the DWI findings in four patients who suffered Adverse-Effectsubacute neurotoxicity after intrathecal DrugMTX .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Rituximab - based therapy for Druggemcitabine - induced Adverse-Effecthemolytic uremic syndrome in a patient with metastatic pancreatic adenocarcinoma : a case report.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a patient receiving chronic Druglithium therapy who presented with a transient Adverse-EffectCDI occurring in the setting of underlying chronic NDI.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Syndrome of inappropriate secretion of ADH ( Adverse-EffectSIADH ) following Drugcisplatin administration in a pulmonary adenocarcinoma patient with a malignant pleural effusion.
0.9998 Adverse-Effect Adverse-EffectSyndrome of inappropriate secretion of ADH ( SIADH ) following Drugcisplatin administration in a pulmonary adenocarcinoma patient with a malignant pleural effusion.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In this paper, we report a patient with primary anti - phospholipid syndrome treated by Drugcorticosteroid , who developed Adverse-Effectdisseminated nocardiosis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A wide variety of Adverse-Effectadverse central nervous system effects have been reported in association with Drugpropafenone ; dizziness is the most common.
1.0000 Adverse-Effect A wide variety of adverse central nervous system effects have been reported in association with Drugpropafenone ; Adverse-Effectdizziness is the most common.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Pulmonary hemorrhage is an uncommon feature in the HUS, and seems to appear especially in the Adverse-EffectHUS associated with DrugMMC therapy.
0.9999 Adverse-Effect Pulmonary hemorrhage is an uncommon feature in the Adverse-EffectHUS , and seems to appear especially in the HUS associated with DrugMMC therapy.
0.9999 Adverse-Effect Adverse-EffectPulmonary hemorrhage is an uncommon feature in the HUS, and seems to appear especially in the HUS associated with DrugMMC therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The Center for Disease Control has received numerous reports of an Adverse-Effecteosinophilia - myalgia syndrome related to products containing DrugL - tryptophan .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of Adverse-Effectfatal pulmonary toxicity in a patient with advanced non - small cell lung cancer who received Drugerlotinib .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a 76 - year - old man who developed an Adverse-Effectacute blistering eruption following high - dose Drugpenicillin treatment for pneumococcal septicaemia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The spectrum of Adverse-Effectrenal lesions occurring during antituberculous therapy, particularly in association with Drugrifampin , may be wider than previously suspected.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Complications associated with Adverse-Effectprimary and secondary perforation of the bladder following immediate instillations of Drugepirubicin after transurethral resection of superficial urothelial tumours.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Drug2 - Chloro - deoxyadenosine induces durable complete remission in Castleman's disease but may accelerate its transformation to Adverse-Effectnon - Hodgkin's lymphoma .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 42 year old man, treated for testicular carcinoma with combination chemotherapy that included Drugbleomycin , developed life threatening Adverse-Effectinterstitial pneumonitis .
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect Severe histological Adverse-Effectosteomalacia developed in a woman with Crohn's disease 2 years after ileal resection and the start of Drugcholestyramine therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the first case of Adverse-Effectherpes esophagitis in a renal transplant patient treated with DrugCyclosporine A while on chronic steroid therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case is reported of a 40 year old woman treated with intraventricular DrugIL - 2 for leptomeningeal disease who developed progressive Adverse-Effectcognitive dysfunction .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Although the essential cause of Adverse-EffectPV is unclear, its onset has occasionally been associated with drug therapy, in particular Drugpenicillamine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case history of a 15 - year - old boy who developed incapacitating Adverse-Effecttardive dyskinesia that resolved during treatment with Drugdeanol is presented.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect These cases suggest the possibility that, in some patients, leukopenia or Adverse-Effectagranulocytosis during Drugolanzapine treatment might be dose - related.
0.9999 Adverse-Effect These cases suggest the possibility that, in some patients, Adverse-Effectleukopenia or agranulocytosis during Drugolanzapine treatment might be dose - related.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugInterferon - induced Adverse-Effectpsychosis as a " psychiatric contraindication " to hepatitis C treatment : a review and case - based discussion.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : The use of fluorouracil treatment with careful monitoring can be considered in a patient with mild Adverse-Effectallergic reactions to Drugcapecitabine .
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect In patients with a known access to INH, Adverse-Effectseizures should be considered to be caused by DrugINH toxicity unless proved otherwise.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect During the first treatment, dysarthria and Adverse-Effectataxia were seen after completion of the patient's eighth and final dose of DrugHDARAC .
1.0000 Adverse-Effect During the first treatment, Adverse-Effectdysarthria and ataxia were seen after completion of the patient's eighth and final dose of DrugHDARAC .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To describe onset of syndrome of inappropriate antidiuretic hormone ( Adverse-EffectSIADH ) associated with Drugvinorelbine therapy for advanced breast cancer.
1.0000 Adverse-Effect OBJECTIVE : To describe onset of Adverse-Effectsyndrome of inappropriate antidiuretic hormone ( SIADH ) associated with Drugvinorelbine therapy for advanced breast cancer.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Pancreatitis has been associated with the tetracycline class of antibiotics and concerns about Drugtigecycline - induced Adverse-Effectacute pancreatitis have recently been raised.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Only one case of Adverse-Effectsevere symptomatic hepatitis occurring after pulse therapy with Drugitraconazole for onychomycosis and requiring transplantation has been reported previously.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To report a case of rapidly occurring Adverse-Effecthyperglycemia that occurred in a geriatric patient 3 days after treatment with Drugolanzapine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect While on a maximal dose of Drugphenylephrine she developed prominent Adverse-Effectpositive U waves , which disappeared with the cessation of the drug.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect It is suggested that the fatal stroke may have resulted from Adverse-Effectarterial spasm caused by Drugergotamine overdosage and possibly complicated by thrombosis.
0.9999 Adverse-Effect It is suggested that the Adverse-Effectfatal stroke may have resulted from arterial spasm caused by Drugergotamine overdosage and possibly complicated by thrombosis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Electro - oculography, electroretinography, visual evoked potentials, and multifocal electroretinography in patients with Drugvigabatrin - attributed Adverse-Effectvisual field constriction .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Recombinant VIIa concentrate in the management of bleeding following Drugprothrombin complex concentrate - related Adverse-Effectmyocardial infarction in patients with haemophilia and inhibitors.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of Adverse-Effectfatal fulminant hepatitis caused by the use of Drugdisulfiram in a man with previously normal hepatocellular function.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a 73 - year - old woman who developed serious systemic vasculitis with associated Adverse-Effectthrombocytopenia in the course of treatment with Drugcladribine .
0.9997 Adverse-Effect We describe a 73 - year - old woman who developed serious Adverse-Effectsystemic vasculitis with associated thrombocytopenia in the course of treatment with Drugcladribine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A combination of behavioural and cognitive adverse effects is illustrated in this case report of a recurrent Drugtriazolam - induced Adverse-Effecteating disorder .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Extra caution should be taken in using Drugoctreotide or its long - acting analog in patients otherwise predisposed to Adverse-Effectintrahepatic bile stasis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report 3 cases of HIV - 1 infected patients who experienced symptomatic Adverse-Effectangiolipomas shortly after starting antiretroviral therapy including the protease inhibitor Drugindinavir .
1.0000 Adverse-Effect We report 3 cases of HIV - 1 infected patients who experienced Adverse-Effectsymptomatic angiolipomas shortly after starting antiretroviral therapy including the protease inhibitor Drugindinavir .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In this case Drugsenna was likely the cause of a Adverse-Effectsubacute cholestatic hepatitis exemplifying again the potential role of herbal related liver injury.
0.9998 Adverse-Effect In this case Drugsenna was likely the cause of a subacute cholestatic hepatitis exemplifying again the potential role of herbal related Adverse-Effectliver injury .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Chronic myelogenous leukemia ( CML ), hepatitis C, and interferon alpha ( DrugIFNalpha ) have all been associated with Adverse-Effectrenal dysfunction .
0.9998 Adverse-Effect Chronic myelogenous leukemia ( CML ), hepatitis C, and Druginterferon alpha ( IFNalpha ) have all been associated with Adverse-Effectrenal dysfunction .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The authors conclude that among patients taking high doses of oral Drugniacin only those who experience Adverse-Effectvisual symptoms need to be ophthalmologically evaluated.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 37 - year - old woman with relapsing invasive vertebral aspergillosis received intravenous DrugVRC and developed Adverse-Effectangio - oedema 10 days after starting therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This case demonstrates the association of selective Adverse-EffectIgA deficiency with remission in rheumatoid arthritis induced by Drugfenclofenac as well as aurothiomalate and sulphasalazine.
0.9997 Adverse-Effect This case demonstrates the association of selective Adverse-EffectIgA deficiency with remission in rheumatoid arthritis induced by fenclofenac as well as aurothiomalate and Drugsulphasalazine .
0.9997 Adverse-Effect This case demonstrates the association of selective Adverse-EffectIgA deficiency with remission in rheumatoid arthritis induced by fenclofenac as well as Drugaurothiomalate and sulphasalazine.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect METHODS : A 55 - year - old woman became Adverse-Effectstuporous after overdose with Druglamotrigine ( LTG ) and valproic acid ( VPA ) tablets.
1.0000 Adverse-Effect METHODS : A 55 - year - old woman became Adverse-Effectstuporous after overdose with lamotrigine ( DrugLTG ) and valproic acid ( VPA ) tablets.
1.0000 Adverse-Effect METHODS : A 55 - year - old woman became Adverse-Effectstuporous after overdose with lamotrigine ( LTG ) and valproic acid ( DrugVPA ) tablets.
0.9999 Adverse-Effect METHODS : A 55 - year - old woman became Adverse-Effectstuporous after overdose with lamotrigine ( LTG ) and Drugvalproic acid ( VPA ) tablets.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect She received an accidental 450 - mg bolus injection of Drugmorphine intrathecally and developed Adverse-Effecthypertension , status epilepticus, intracerebral hemorrhage, and respiratory failure.
1.0000 Adverse-Effect She received an accidental 450 - mg bolus injection of Drugmorphine intrathecally and developed hypertension, status epilepticus, Adverse-Effectintracerebral hemorrhage , and respiratory failure.
1.0000 Adverse-Effect She received an accidental 450 - mg bolus injection of Drugmorphine intrathecally and developed hypertension, status epilepticus, intracerebral hemorrhage, and Adverse-Effectrespiratory failure .
0.9999 Adverse-Effect She received an accidental 450 - mg bolus injection of Drugmorphine intrathecally and developed hypertension, Adverse-Effectstatus epilepticus , intracerebral hemorrhage, and respiratory failure.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 49 - year - old man with Crohn's disease treated with prednisone and mesalamine ( Drug5 - ASA ) developed Adverse-Effectworsening respiratory distress and fever.
1.0000 Adverse-Effect A 49 - year - old man with Crohn's disease treated with prednisone and Drugmesalamine ( 5 - ASA ) developed Adverse-Effectworsening respiratory distress and fever.
1.0000 Adverse-Effect A 49 - year - old man with Crohn's disease treated with Drugprednisone and mesalamine ( 5 - ASA ) developed Adverse-Effectworsening respiratory distress and fever.
0.9999 Adverse-Effect A 49 - year - old man with Crohn's disease treated with prednisone and Drugmesalamine ( 5 - ASA ) developed worsening respiratory distress and Adverse-Effectfever .
0.9999 Adverse-Effect A 49 - year - old man with Crohn's disease treated with Drugprednisone and mesalamine ( 5 - ASA ) developed worsening respiratory distress and Adverse-Effectfever .
0.9999 Adverse-Effect A 49 - year - old man with Crohn's disease treated with prednisone and mesalamine ( Drug5 - ASA ) developed worsening respiratory distress and Adverse-Effectfever .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Massive pulmonary embolism due to late - onset Drugheparin - induced Adverse-Effectthrombocytopenia following coronary artery bypass graft surgery : successful treatment with lepirudin.
0.9994 Adverse-Effect Adverse-EffectMassive pulmonary embolism due to late - onset Drugheparin - induced thrombocytopenia following coronary artery bypass graft surgery : successful treatment with lepirudin.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectMethemoglobinemia is another common finding among patients receiving Drugdapsone therapy, but rarely does it result in prominent symptoms other than transient pallor.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Physicians using this " new " drug must be aware of the potential danger of Drugsulfonamide - induced Adverse-Effectinjury to the urinary tract .
Score Relation Text (Head - Tail)
0.9885 Adverse-Effect Since the Adverse-Effectbronchospasm was relieved with discontinuation of Drugpropranolol and supportive bronchodilator therapy, the bronchospasm was believed to be caused by propranolol.
0.9694 Adverse-Effect Since the bronchospasm was relieved with discontinuation of propranolol and supportive bronchodilator therapy, the Adverse-Effectbronchospasm was believed to be caused by Drugpropranolol .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Destructive Adverse-Effectthyrotoxicosis appeared 4 - 6 months after starting DrugIFN - alpha , followed by Graves'hyperthyroidism within 8 to 11 months.
0.9985 Adverse-Effect Destructive thyrotoxicosis appeared 4 - 6 months after starting DrugIFN - alpha , followed by Adverse-EffectGraves'hyperthyroidism within 8 to 11 months.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Sagittal sinus thrombosis associated with Adverse-Effecttransient free protein S deficiency after DrugL - asparaginase treatment : case report and review of the literature.
0.9993 Adverse-Effect Adverse-EffectSagittal sinus thrombosis associated with transient free protein S deficiency after DrugL - asparaginase treatment : case report and review of the literature.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectReversible leukopenia was documented in an 81 - year - old woman treated with adjunctive Drugibopamine 100 mg t. i. d. for chronic congestive heart failure.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The possibility of severe rhabdomyolysis should be considered in a patient with Adverse-Effectwater intoxication due to massive ingestion of Drugcaffeine - containing beverages.
0.9999 Adverse-Effect The possibility of severe Adverse-Effectrhabdomyolysis should be considered in a patient with water intoxication due to massive ingestion of Drugcaffeine - containing beverages.
0.9999 Adverse-Effect The possibility of Adverse-Effectsevere rhabdomyolysis should be considered in a patient with water intoxication due to massive ingestion of Drugcaffeine - containing beverages.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The second patient developed both autoimmune thyroid disease and a Adverse-Effectrefractory pre - patellar bursitis after 50 months of DrugIFN - beta therapy.
0.9996 Adverse-Effect The second patient developed both Adverse-Effectautoimmune thyroid disease and a refractory pre - patellar bursitis after 50 months of DrugIFN - beta therapy.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect DrugAmiodarone hydrochloride , a new antiarrhythmic agent, has been associated with Adverse-Effectpulmonary toxicity characterized by cough, dyspnea and diffuse pulmonary infiltrates.
0.9998 Adverse-Effect DrugAmiodarone hydrochloride , a new antiarrhythmic agent, has been associated with pulmonary toxicity characterized by Adverse-Effectcough , dyspnea and diffuse pulmonary infiltrates.
0.9998 Adverse-Effect DrugAmiodarone hydrochloride , a new antiarrhythmic agent, has been associated with pulmonary toxicity characterized by cough, Adverse-Effectdyspnea and diffuse pulmonary infiltrates.
0.9997 Adverse-Effect DrugAmiodarone hydrochloride , a new antiarrhythmic agent, has been associated with pulmonary toxicity characterized by cough, dyspnea and Adverse-Effectdiffuse pulmonary infiltrates .
Score Relation Text (Head - Tail)
0.9918 Adverse-Effect The biochemistry of paracetamol hepatotoxicity is outlined and the increased susceptibility of alcoholic patients to the Adverse-Effecthepatotoxic effects of Drugparacetamol is remarked upon.
0.9896 Adverse-Effect The biochemistry of Drugparacetamol Adverse-Effecthepatotoxicity is outlined and the increased susceptibility of alcoholic patients to the hepatotoxic effects of paracetamol is remarked upon.
0.9701 Adverse-Effect The biochemistry of Drugparacetamol Adverse-Effectparacetamol hepatotoxicity is outlined and the increased susceptibility of alcoholic patients to the hepatotoxic effects of paracetamol is remarked upon.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the development of Adverse-Effectsquamous - cell carcinoma within a basal - cell epithelioma that was treated with intralesional injections of Drug5 - FU .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A patient presented with a Adverse-Effectpainful , oedematous, cyanosed hand having injected a solution of Drugdiamorphine and methylphenidate into his radial artery.
0.9999 Adverse-Effect A patient presented with a Adverse-Effectpainful , oedematous, cyanosed hand having injected a solution of diamorphine and Drugmethylphenidate into his radial artery.
Adverse-Effect A patient presented with a Adverse-Effectpainful, oedematous, cyanosed hand having injected a solution of diamorphine and Drugmethylphenidate into his radial artery.
Adverse-Effect A patient presented with a Adverse-Effectpainful, oedematous, cyanosed hand having injected a solution of Drugdiamorphine and methylphenidate into his radial artery.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report on three patients who developed Adverse-Effectacute liver damage during therapy with Drugitraconazole , and in whom liver biopsy specimens were obtained.
Adverse-Effect We report on three patients who developed acute Adverse-Effectliver damage during therapy with Drugitraconazole , and in whom liver biopsy specimens were obtained.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Thiopurine methyltransferase deficiency occurs at a frequency of one in 300 and is associated with profound Adverse-Effectmyelosuppression after a short course of Drugazathioprine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect AIM : To report a patient with diabetic rubeosis who suffered from acute retinal ischemic change and Adverse-Effectstroke after intravitreal injection of Drugbevacizumab .
1.0000 Adverse-Effect AIM : To report a patient with diabetic rubeosis who suffered from Adverse-Effectacute retinal ischemic change and stroke after intravitreal injection of Drugbevacizumab .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This is a case report of possible association of Drugmethylphenidate and Adverse-Effectenuresis in an 11 - year - old boy with attention deficit hyperactivity disorder.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Methylene blue in the treatment and prevention of Drugifosfamide - induced Adverse-Effectencephalopathy : report of 12 cases and a review of the literature.
Adverse-Effect Methylene blue in the treatment and prevention of Drugifosfamide Adverse-Effectifosfamide - induced encephalopathy : report of 12 cases and a review of the literature.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectNCSE , an epileptic disorder in which typical convulsive activity is absent, has previously been reported in only 4 patients receiving Drugifosfamide .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This is the first case of Adverse-EffectHBV reactivation occurring during the year following Drugrituximab monotherapy in the absence of any other immunosuppressive factor.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a case of Adverse-Effectsubcutaneous metastasis along the needle track after percutaneous Drugethanol injection ( PEI ) for treatment of hepatocellular carcinoma.
1.0000 Adverse-Effect We describe a case of Adverse-Effectsubcutaneous metastasis along the needle track after percutaneous Drugethanol injection ( PEI ) for treatment of hepatocellular carcinoma.
0.9999 Adverse-Effect We describe a case of Adverse-Effectsubcutaneous metastasis along the needle track after percutaneous ethanol injection ( DrugPEI ) for treatment of hepatocellular carcinoma.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This report describes an unexpected drug - induced Adverse-Effecthepatitis in a previously healthy young woman exposed to 2 doses of Drugamodiaquine and artesunate.
1.0000 Adverse-Effect This report describes an unexpected drug - induced Adverse-Effecthepatitis in a previously healthy young woman exposed to 2 doses of amodiaquine and Drugartesunate .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectTumor - volume increase at beginning of primary treatment with topical Druginterferon alpha 2 - beta in a case of conjunctiva - cornea intraepithelial neoplasia.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect This entity is probably related to a combination of high doses of corticosteroids, Drugvecuronium administration and metabolic abnormalities associated with Adverse-Effectrespiratory failure .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a patient who, after receiving his first dose of Drugpregabalin to relieve neuropathic pain, presented with a Adverse-Effectnegative myoclonus .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a patient who had a Adverse-Effectsystemic allergic contact dermatitis to Drug8 - MOP develop during her second course of PUVA treatment for psoriasis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In two of these cases Adverse-Effectakathisia resolved after withdrawal of Drugolanzapine and substitution by a classical or an atypical neuroleptic agent, respectively.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Although the Adverse-Effectmovement disorder could not with certainty be attributed to Drugtrazodone alone, the drug at least acted as an eliciting agent.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DISCUSSION : Adverse-EffectCentral nervous system ( CNS ) toxicity has been described with Drugifosfamide , with most cases reported in the pediatric population.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Albeit rare among Western patients, such Druglithium - associated Adverse-Effectthyroid dysfunctions appeared to be more likely to occur in Hong Kong Chinese.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectFever caused by the use of Drugfurosemide was proved ; the fever resolved after discontinuation of this medication and recurred after its reintroduction.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a 10 - year - old boy with ulcerative colitis who developed Adverse-Effectacute pancreatitis while on long - term treatment with Drug5 - aminosalicylic acid .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect This case represents the third example of Adverse-Effecterythroid aplasia associated with an anti - inflammatory agent and the first instance due to Drugfenoprofen .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect After approximately two weeks of Drugsertraline treatment he noted an Adverse-Effectintense itching sensation in his scalp after eating a piece of chocolate cake.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectEosinophilia has been encountered from 0. 2 to 61. 7 % in Drugclozapine - treated patients, mostly with a transient course and spontaneous remission.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectAcute intravascular hemolysis developed when a diabetic patient, previously treated with Drugglyburide , was started on another oral sulfonylurea drug, chlorpropamide.
0.9998 Adverse-Effect Adverse-EffectAcute intravascular hemolysis developed when a diabetic patient, previously treated with glyburide, was started on another oral sulfonylurea drug, Drugchlorpropamide .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Thus, clinical recognition of Adverse-Effectsleep disordered breathing should be taken into account when rheumatoid arthritis patients are to be treated with Druginfliximab .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A patient with disseminated herpes zoster developed a syndrome of inappropriate antidiuretic hormone and profound Adverse-Effecthyponatremia secondary to the administration of Drugadenine arabinoside .
0.9995 Adverse-Effect A patient with disseminated herpes zoster developed a Adverse-Effectsyndrome of inappropriate antidiuretic hormone and profound hyponatremia secondary to the administration of Drugadenine arabinoside .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CASE REPORT : We report a case of Adverse-Effectacute severe hepatitis resulting from Drugerlotinib monotherapy in a patient with locally advanced pancreatic cancer.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Described here are 2 patients who developed Adverse-Effectthrombotic microangiopathy of the kidneys after receiving high cumulative doses of the new anticancer drug Druggemcitabine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the first case of Drugchlorambucil - induced Adverse-EffectDRESS syndrome in a 70 - year - old man recently diagnosed with chronic lymphocytic leukaemia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In this report, we describe a patient receiving Druglenalidomide in whom Adverse-Effectdyspnea , fever, hypoxia, and diffuse pulmonary infiltrates developed.
1.0000 Adverse-Effect In this report, we describe a patient receiving Druglenalidomide in whom dyspnea, fever, Adverse-Effecthypoxia , and diffuse pulmonary infiltrates developed.
1.0000 Adverse-Effect In this report, we describe a patient receiving Druglenalidomide in whom dyspnea, Adverse-Effectfever , hypoxia, and diffuse pulmonary infiltrates developed.
0.9999 Adverse-Effect In this report, we describe a patient receiving Druglenalidomide in whom dyspnea, fever, hypoxia, and Adverse-Effectdiffuse pulmonary infiltrates developed.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Based on the Naranjo probability scale, Adverse-Effectserotonin syndrome was a probable adverse reaction associated with co - administration of Drugcitalopram and fentanyl.
1.0000 Adverse-Effect Based on the Naranjo probability scale, Adverse-Effectserotonin syndrome was a probable adverse reaction associated with co - administration of citalopram and Drugfentanyl .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect METHOD : The authors followed a patient with chronic HCV who received interferon and Drugribavirin and who developed Adverse-Effecthallucinations ultimately requiring psychiatric hospitalization.
1.0000 Adverse-Effect METHOD : The authors followed a patient with chronic HCV who received Druginterferon and ribavirin and who developed Adverse-Effecthallucinations ultimately requiring psychiatric hospitalization.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Case 2 : A 43 - year - old male alcoholic remained completely abstinent with Drugcyanamide treatment for 5 years and complained of Adverse-Effectgeneral fatigue .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A healthy, 30 - year - old man, exposed to Drugsulindac on two separate occasions, had an incapacitating Adverse-Effectisolated idential sensory neuropathy .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect According to the Naranjo et al. adverse - reaction probability scale, Drugenoxaparin was the probable cause of Adverse-Effecthepatotoxicity in this patient.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : Clinicians treating elderly patients with Drugolanzapine should be aware of the potential for rapidly developing Adverse-Effecthyperglycemia and monitor such patients accordingly.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a patient with extranodal non - Hodgkin lymphoma who developed Adverse-Effectsystemic candidiasis after treatment with a Drugcyclophosphamide - based chemotherapy regimen.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Mitomycin C ( DrugMMC ) is an alkylating agent that has been recently associated with the Adverse-Effecthemolytic - uremic syndrome ( HUS ).
0.9999 Adverse-Effect Mitomycin C ( DrugMMC ) is an alkylating agent that has been recently associated with the hemolytic - uremic syndrome ( Adverse-EffectHUS ).
0.9998 Adverse-Effect DrugMitomycin C ( MMC ) is an alkylating agent that has been recently associated with the Adverse-Effecthemolytic - uremic syndrome ( HUS ).
0.9997 Adverse-Effect DrugMitomycin C ( MMC ) is an alkylating agent that has been recently associated with the hemolytic - uremic syndrome ( Adverse-EffectHUS ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DISCUSSION : DrugOlanzapine , like other atypical antipsychotic drugs, may cause Adverse-Effectmuscle injury with concomitant elevations of serum CK of muscle origin.
Adverse-Effect DISCUSSION : DrugOlanzapine , like other atypical antipsychotic drugs, may cause Adverse-Effectmuscle injury with concomitant elevations of serum CK of muscle origin.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CASE SUMMARY : Two children with attention deficit disorder treated with Drugmethylphenidate as a simple drug developed Adverse-Effectfixed drug eruption of the scrotum .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : Jet - injection devices might constitute a helpful method to treat those patients affected by severe Drughuman insulin - induced Adverse-Effectlipoatrophy .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectAkathisia is a relatively rare side effect with the newer atypical antipsychotic agents, particularly Drugclozapine , and is easily misdiagnosed in children.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect METHODS / RESULTS : This paper presents a new case of Drugrifabutin Adverse-Effectuveitis and a review of the various published reports to date.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Effect of beta - blockade on symptomatic Drugdexamethasone - induced Adverse-Effecthypertrophic obstructive cardiomyopathy in premature infants : three case reports and literature review.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVES : To describe the presentation and treatment of acute isoniazid ( DrugINH ) Adverse-Effectneurotoxicity appearing at an inner - city municipal hospital.
0.9996 Adverse-Effect OBJECTIVES : To describe the presentation and treatment of acute Drugisoniazid ( INH ) Adverse-Effectneurotoxicity appearing at an inner - city municipal hospital.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect An 11 - year - old boy developed a Adverse-Effectsevere enteropathy 2 years after initiation of Drugclofazimine treatment for graft - versus - host disease.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Because the Adverse-Effectcerebellar toxicity may be worsened by continuation of therapy after initial onset of symptoms, prompt termination of DrugHDARAC is recommended.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect To our knowledge, this is the first case of spontaneous remission of DrugMTX - associated Adverse-Effectgastric LPD after discontinuation of MTX therapy.
0.9999 Adverse-Effect To our knowledge, this is the first case of spontaneous remission of MTX - associated Adverse-Effectgastric LPD after discontinuation of DrugMTX therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSION : Under certain circumstances topical Drugbrimonidine can cause Adverse-Effectparadoxical raised IOP necessitating vigilance in follow - up of patients on topical brimonidine.
1.0000 Adverse-Effect CONCLUSION : Under certain circumstances topical Drugbrimonidine can cause Adverse-Effectparadoxical raised IOP necessitating vigilance in follow - up of patients on topical brimonidine.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case of Drugpropranolol overdose complicated by Adverse-Effectesophageal spasm preventing extrication of an orogastric lavage tube and relieved by intravenous glucagon is presented.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We present the first case of ovarian endometrioid carcinoma and Adverse-Effectendometriosis in a postmenopausal patient who was treated with Drugtamoxifen for breast cancer.
0.9999 Adverse-Effect We present the first case of Adverse-Effectovarian endometrioid carcinoma and endometriosis in a postmenopausal patient who was treated with Drugtamoxifen for breast cancer.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Clinicians should be cognizant of this possibility and consider a diagnosis of HDAs in patients with ongoing Adverse-Effectthrombosis who are receiving Drugheparin therapy.
1.0000 Adverse-Effect Clinicians should be cognizant of this possibility and consider a diagnosis of Adverse-EffectHDAs in patients with ongoing thrombosis who are receiving Drugheparin therapy.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Second cancers including various types of Adverse-Effecthematological malignancy have been reported in patients with hairy cell leukemia treated with chemotherapy or Druginterferon alfa .
0.9999 Adverse-Effect Adverse-EffectSecond cancers including various types of hematological malignancy have been reported in patients with hairy cell leukemia treated with chemotherapy or Druginterferon alfa .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The Adverse-Effectabnormal rhythm disappeared with the withdrawal of Drugpropranolol and when the drug was restarted a 2 / 1 S - A block was seen.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In both cases, high fever, skin rash, liver dysfunction and Adverse-Effectatypical lymphocytosis developed 3 weeks after initiating treatment with DrugSASP .
1.0000 Adverse-Effect In both cases, Adverse-Effecthigh fever , skin rash, liver dysfunction and atypical lymphocytosis developed 3 weeks after initiating treatment with DrugSASP .
0.9999 Adverse-Effect In both cases, high fever, skin rash, Adverse-Effectliver dysfunction and atypical lymphocytosis developed 3 weeks after initiating treatment with DrugSASP .
0.9999 Adverse-Effect In both cases, high fever, Adverse-Effectskin rash , liver dysfunction and atypical lymphocytosis developed 3 weeks after initiating treatment with DrugSASP .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the specifics of 12 cases of Adverse-Effectsevere hypertension after the intraoperative use of topical Drugphenylephrine , submucosal epinephrine, or both.
1.0000 Adverse-Effect We report the specifics of 12 cases of Adverse-Effectsevere hypertension after the intraoperative use of topical phenylephrine, submucosal Drugepinephrine , or both.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect RESULTS : Three patients who developed symptoms of inflammatory bowel disease ( Adverse-EffectIBD ) during Drugrofecoxib exposure are described along with pathology findings.
1.0000 Adverse-Effect RESULTS : Three patients who developed symptoms of Adverse-Effectinflammatory bowel disease ( IBD ) during Drugrofecoxib exposure are described along with pathology findings.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of secondary Adverse-Effectglaucoma caused by epithelial downgrowth in which filtration surgery was performed with adjunctive use of subconjunctival Drug5 - fluorouracil .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report an allogeneic bone marrow transplant recipient who developed Adverse-EffectCMV infection refractory to sequential therapy with Drugganciclovir , foscarnet, and cidofovir.
1.0000 Adverse-Effect We report an allogeneic bone marrow transplant recipient who developed Adverse-EffectCMV infection refractory to sequential therapy with ganciclovir, Drugfoscarnet , and cidofovir.
1.0000 Adverse-Effect We report an allogeneic bone marrow transplant recipient who developed Adverse-EffectCMV infection refractory to sequential therapy with ganciclovir, foscarnet, and Drugcidofovir .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectPtosis occurring 24 h after Drugchloroquine therapy, with full recovery 48 h after cessation of chloroquine, has not been described previously.
0.9997 Adverse-Effect Adverse-EffectPtosis occurring 24 h after chloroquine therapy, with full recovery 48 h after cessation of Drugchloroquine , has not been described previously.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Dyspnea, hypoxemia, and Adverse-Effectpleuritic chest pain occurred within 24 hours of Drugrituximab administration, and there was no other apparent explanation.
1.0000 Adverse-Effect Dyspnea, Adverse-Effecthypoxemia , and pleuritic chest pain occurred within 24 hours of Drugrituximab administration, and there was no other apparent explanation.
1.0000 Adverse-Effect Adverse-EffectDyspnea , hypoxemia, and pleuritic chest pain occurred within 24 hours of Drugrituximab administration, and there was no other apparent explanation.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Emphasis is given to the differentiation of Drugdiphenylhydantoin induced Adverse-Effectgingival hyperplasia from the angiomatous enlargement of the gingiva before any treatment is planned.
Score Relation Text (Head - Tail)
0.9992 Adverse-Effect Most cases of Adverse-Effectpancreatitis associated with DrugL - asparaginase toxicity are self - limiting and respond favorably to nasogastric decompression and intravenous hyperalimentation.
0.9938 Adverse-Effect Most cases of pancreatitis associated with DrugL - asparaginase Adverse-EffectL - asparaginase toxicity are self - limiting and respond favorably to nasogastric decompression and intravenous hyperalimentation.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We present a case of significant over - anticoagulation temporally associated with a bout of protracted Adverse-Effectdiarrhea in a patient on Drugwarfarin therapy.
0.9998 Adverse-Effect We present a case of significant Adverse-Effectover - anticoagulation temporally associated with a bout of protracted diarrhea in a patient on Drugwarfarin therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Regardless of a negative history of asthma, therefore, life - threatening Adverse-Effectbronchospasm must be considered a possible complication of Drugpropranolol therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect After three weeks of Drugcarbamazepine therapy, the patient arrived at the emergency department ( ED ) with Adverse-Effectsevere agitation and aggressive behavior.
1.0000 Adverse-Effect After three weeks of Drugcarbamazepine therapy, the patient arrived at the emergency department ( ED ) with severe agitation and Adverse-Effectaggressive behavior .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the case of Adverse-Effectintoxication of a 41 - year - old female patient suffering from major depression with Drugmirtazapine complicated by severe hypothermia.
0.9912 Adverse-Effect We report the case of intoxication of a 41 - year - old female patient suffering from major depression with Drugmirtazapine complicated by Adverse-Effectsevere hypothermia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 57 - year - old woman developed Adverse-Effectpulmonary sarcoidosis during therapy with Druginterferon beta for advanced renal cell carcinoma metastatic to mediastinal lymph nodes.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect In addition to the recognized arrhythmic complications, the authors emphasize myocardial necrosis as a possible further manifestation of Drugamsacrine - related Adverse-Effectcardiotoxicity .
0.9989 Adverse-Effect In addition to the recognized arrhythmic complications, the authors emphasize Adverse-Effectmyocardial necrosis as a possible further manifestation of Drugamsacrine - related cardiotoxicity.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This article presents a case of an Adverse-Effectatypical localized cutaneous eruption with an unusual course and protracted resolution time associated with Drugsorafenib therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Infant twins sustained Adverse-Effectsevere circumoral and pharyngeal burns from a concentrated solution of Drugbenzalkonium ( Zephiran ) chloride prescribed for treatment of candidiasis.
0.9999 Adverse-Effect Infant twins sustained Adverse-Effectsevere circumoral and pharyngeal burns from a concentrated solution of benzalkonium ( DrugZephiran ) chloride prescribed for treatment of candidiasis.
Adverse-Effect Infant twins sustained severe Adverse-Effectcircumoral and pharyngeal burns from a concentrated solution of benzalkonium ( DrugZephiran ) chloride prescribed for treatment of candidiasis.
Adverse-Effect Infant twins sustained severe Adverse-Effectcircumoral and pharyngeal burns from a concentrated solution of Drugbenzalkonium ( Zephiran ) chloride prescribed for treatment of candidiasis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectEpstein - Barr virus - associated lymphoproliferative disorder in a patient with rheumatoid arthritis on Drugmethotrexate and rofecoxib : idiosyncratic reaction or pharmacogenetics?
0.9999 Adverse-Effect Adverse-EffectEpstein - Barr virus - associated lymphoproliferative disorder in a patient with rheumatoid arthritis on methotrexate and Drugrofecoxib : idiosyncratic reaction or pharmacogenetics?
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugNorethisterone in these 69 pregnancies accounted for 33. 3 % ( 5 of 15 ) cases of Adverse-Effectclitoral hypertrophy diagnosed in 100, 756 consecutive births.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The Adverse-Effectocular toxicity of DrugDCF , previously described as conjunctivitis, appears to be a keratitis of moderate severity which requires further study.
0.9997 Adverse-Effect The ocular toxicity of DrugDCF , previously described as Adverse-Effectconjunctivitis , appears to be a keratitis of moderate severity which requires further study.
0.9994 Adverse-Effect The ocular toxicity of DrugDCF , previously described as conjunctivitis, appears to be a Adverse-Effectkeratitis of moderate severity which requires further study.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a rare case of recurrent ( stuttering ) Adverse-Effectpriapism in a patient with protein C deficiency while maintained on DrugWarfarin therapy.
1.0000 Adverse-Effect We report a rare case of recurrent ( Adverse-Effectstuttering ) priapism in a patient with protein C deficiency while maintained on DrugWarfarin therapy.
Score Relation Text (Head - Tail)
0.9997 Adverse-Effect We report a case of severe Adverse-Effectrespiratory failure due to Druggold salt toxicity in a patient suffering from rheumatoid arthritis requiring mechanical ventilation.
0.9998 Adverse-Effect We report a case of Adverse-Effectsevere respiratory failure due to Druggold salt toxicity in a patient suffering from rheumatoid arthritis requiring mechanical ventilation.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect He was diagnosed with possible Adverse-Effectserotonin syndrome ; his symptoms resolved after Drugclomipramine was stopped but before clozapine was restarted eight days later.
0.9994 Adverse-Effect He was diagnosed with possible Adverse-Effectserotonin syndrome ; his symptoms resolved after clomipramine was stopped but before Drugclozapine was restarted eight days later.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Since amiodarone was first marketed in 1992 in Japan, the incidence of Drugamiodarone - induced Adverse-Effectthyrotoxicosis ( AIT ) has been increasing.
0.9984 Adverse-Effect Since amiodarone was first marketed in 1992 in Japan, the incidence of Drugamiodarone - induced thyrotoxicosis ( Adverse-EffectAIT ) has been increasing.
0.9920 Adverse-Effect Since Drugamiodarone was first marketed in 1992 in Japan, the incidence of amiodarone - induced Adverse-Effectthyrotoxicosis ( AIT ) has been increasing.
0.9871 Adverse-Effect Since Drugamiodarone was first marketed in 1992 in Japan, the incidence of amiodarone - induced thyrotoxicosis ( Adverse-EffectAIT ) has been increasing.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A patient suffering from a rare enzyme deficiency developed a Adverse-Effectmalignant neuroleptic syndrome after having been treated with one single dose of Drughaloperidol .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect One of the subjects who was using extemporaneous topical Drugminoxidil had Adverse-Effecthypertension and arteriosclerotic disease and the other died of a myocardial infarction.
0.9999 Adverse-Effect One of the subjects who was using extemporaneous topical Drugminoxidil had hypertension and Adverse-Effectarteriosclerotic disease and the other died of a myocardial infarction.
0.9997 Adverse-Effect One of the subjects who was using extemporaneous topical Drugminoxidil had hypertension and arteriosclerotic disease and the other died of a Adverse-Effectmyocardial infarction .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectAutoimmune thyroid disease is a common side - effect of Druginterferon - alpha ( IFN - alpha ) treatment of viral hepatitis C.
0.9996 Adverse-Effect Adverse-EffectAutoimmune thyroid disease is a common side - effect of interferon - alpha ( DrugIFN - alpha ) treatment of viral hepatitis C.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A noninvasive method in the differential diagnosis of vecuronium - induced and Drugmagnesium - induced Adverse-Effectprotracted neuromuscular block in a severely preeclamptic patient.
0.9993 Adverse-Effect A noninvasive method in the differential diagnosis of Drugvecuronium - induced and magnesium - induced Adverse-Effectprotracted neuromuscular block in a severely preeclamptic patient.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The patient received only the ophthalmic Drugsulfonamide , and it was used for one day, but he developed Adverse-EffectStevens - Johnson syndrome .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This review presents the first case series of DIC associated with acute hemoglobinemia or Adverse-Effecthemoglobinuria following Druganti - D IGIV administration for ITP.
0.9997 Adverse-Effect This review presents the first case series of Adverse-EffectDIC associated with acute hemoglobinemia or hemoglobinuria following Druganti - D IGIV administration for ITP.
0.9991 Adverse-Effect This review presents the first case series of DIC associated with Adverse-Effectacute hemoglobinemia or hemoglobinuria following Druganti - D IGIV administration for ITP.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Patient A reported right leg weakness ( Adverse-Effectfoot drop ) during week 4 of DrugCAP - XRT ( 1600 mg / m2 ).
0.9998 Adverse-Effect Patient A reported Adverse-Effectright leg weakness ( foot drop ) during week 4 of DrugCAP - XRT ( 1600 mg / m2 ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Two case reports of Adverse-Effectbilateral granulomatous anterior uveitis are described in patients with open angle glaucoma treated with Drugmetripranolol 0. 6 % eye drops.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CASE SUMMARY : A 58 - year - old white woman developed Adverse-Effectfulminant liver failure while being treated with the macrolide antibiotic Drugclarithromycin for pneumonia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugMethamphetamine ' s extensive physiologic effects, inconsistent street purity, and multiple routes of administration offer many possibilities for Adverse-Effectinjury to the cornea .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect TREATMENT / OUTCOME : Standard anti - tuberculosis therapy was administered but was complicated by interaction with Drugcyclosporine and drug - induced Adverse-Effectcholestasis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We suggest that objective evaluation of retinal function with electrophysiological methods should be performed in patients with Adverse-Effectvisual disturbance during treatment with Drugrifabutin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect After reviewing the literature we suggest the Adverse-EffectCPM was a complication of Druglithium toxicity which affected the lateral geniculate nucleus which produced blindness.
0.9998 Adverse-Effect After reviewing the literature we suggest the CPM was a complication of Druglithium toxicity which affected the lateral geniculate nucleus which produced Adverse-Effectblindness .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The pathophysiological mechanisms remain unknown, although the drug could act through massive cytokines liberation after Adverse-Effectdestruction of CD20 positive cells by Drugrituximab .
0.9999 Adverse-Effect The pathophysiological mechanisms remain unknown, although the drug could act through Adverse-Effectmassive cytokines liberation after destruction of CD20 positive cells by Drugrituximab .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of a patient with Drugciprofloxacin - induced Adverse-EffectSJS and acute onset of VBDS, and reviewed the related literature.
0.9997 Adverse-Effect We report a case of a patient with Drugciprofloxacin - induced SJS and acute onset of Adverse-EffectVBDS , and reviewed the related literature.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSION : DrugZidovudine is well a known cause of Adverse-Effectanaemia and thus should be used with caution in the initiation of antiretroviral therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectMotor fluctuations appear after 2 - 3 years of Druglevodopa treatment, and affect at least 50 % of patients after five years.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The second patient experienced Adverse-Effectmild nitritoid symptoms following several DrugGSTM injections prior experiencing a cerebrovascular accident within several hours of her next injection.
1.0000 Adverse-Effect The second patient experienced mild nitritoid symptoms following several DrugGSTM injections prior experiencing a Adverse-Effectcerebrovascular accident within several hours of her next injection.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect We describe a case of Adverse-Effectfibrosing alveolitis , diagnosed by lung biopsy, in a patient receiving Drugamiodarone which responded to corticosteroid therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect One type of SMON is associated with Adverse-Effectacrodermatitis enteropathica which has a very high frequency of occurrence in association with administration of Drugclioquinol .
1.0000 Adverse-Effect One type of Adverse-EffectSMON is associated with acrodermatitis enteropathica which has a very high frequency of occurrence in association with administration of Drugclioquinol .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Intrahepatic cholestasis and Adverse-Effectcutaneous bullae associated with Drugglibenclamide therapy are described in a 61 - year - old diabetic patient who presented wit hypoglycaemic coma.
0.9999 Adverse-Effect Adverse-EffectIntrahepatic cholestasis and cutaneous bullae associated with Drugglibenclamide therapy are described in a 61 - year - old diabetic patient who presented wit hypoglycaemic coma.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We present a case of Adverse-Effectsevere unilateral posterior scleritis associated with Drugzoledronic acid administration that was recognized and treated in a timely manner.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Both had impaired lung function and Adverse-Effectabnormal computed tomographic scans , and their condition improved when Drugnitrofurantoin was withdrawn and corticosteroid treatment commenced.
1.0000 Adverse-Effect Both had Adverse-Effectimpaired lung function and abnormal computed tomographic scans, and their condition improved when Drugnitrofurantoin was withdrawn and corticosteroid treatment commenced.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the first biopsy confirmed occurrence of Adverse-Effectacute interstitial nephritis in a patient receiving treatment with DrugSunitinib for metastatic renal cell cancer.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugMeperidine - associated Adverse-Effectcentral nervous system ( CNS ) excitatory toxicities are believed to be caused by accumulation of the active metabolite normeperidine.
0.9965 Adverse-Effect DrugMeperidine - associated central nervous system ( CNS ) excitatory toxicities are believed to be caused by Adverse-Effectaccumulation of the active metabolite normeperidine .
0.9983 Adverse-Effect DrugMeperidine - associated central nervous system ( CNS ) excitatory toxicities are believed to be caused by Adverse-Effectaccumulation of the active metabolite normeperidine.
Score Relation Text (Head - Tail)
0.9997 Adverse-Effect DrugAmiodarone is well recognized as an anti - arrhythmic drug containing a high dose of iodine with considerable potential to cause Adverse-Effectthyroid dysfunction .
1.0000 Adverse-Effect Amiodarone is well recognized as an anti - arrhythmic drug containing a high dose of Drugiodine with considerable potential to cause Adverse-Effectthyroid dysfunction .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case report of the Adverse-Effecthypersensitivity syndrome occurring in a patient being treated with Drugdapsone for a brown recluse spider bite is presented.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Physicians who use sulfasalazine to treat patients with inflammatory bowel disease should be aware of the signs of Drugsulfasalazine - induced Adverse-Effectlupus syndrome .
0.9954 Adverse-Effect Physicians who use Drugsulfasalazine to treat patients with inflammatory bowel disease should be aware of the signs of sulfasalazine - induced Adverse-Effectlupus syndrome .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In this article, we describe a Japanese patient with Adverse-Effectsevere interstitial pneumonia probably caused by Drugsorafenib treatment for metastatic renal cell carcinoma.
1.0000 Adverse-Effect In this article, we describe a Japanese patient with severe Adverse-Effectinterstitial pneumonia probably caused by Drugsorafenib treatment for metastatic renal cell carcinoma.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Recognizing early signs of HMSN, such as areflexia and pes cavus deformity, can prevent Adverse-Effectsevere neurotoxicity of polychemotherapy by avoiding Drugvincristine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect She was diagnosed with Epstein - Barr virus - associated polymorphic lymphoproliferative disorder ( LPD ) due to Adverse-Effectimmunodeficiency caused by DrugMTX administration.
0.9971 Adverse-Effect She was diagnosed with Epstein - Barr virus - associated polymorphic lymphoproliferative disorder ( Adverse-EffectLPD ) due to immunodeficiency caused by DrugMTX administration.
0.9949 Adverse-Effect She was diagnosed with Adverse-EffectEpstein - Barr virus - associated polymorphic lymphoproliferative disorder ( LPD ) due to immunodeficiency caused by DrugMTX administration.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We present three cases from the Provincial Toxicology Center of British Columbia, Canada in which Adverse-Effectsuicidal overdose deaths were associated with Drugquetiapine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Although Drugtaxol has shown significant activity in advanced ovarian cancer, Adverse-Effectperipheral neuropathy is likely to become the major dose - limiting toxicity.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect It was concluded that ANCA is closely related to the pathogenesis of crescentic glomerulonephritis and that treatment with DrugPTU appeared to induce Adverse-EffectANCA .
0.9997 Adverse-Effect It was concluded that Adverse-EffectANCA is closely related to the pathogenesis of crescentic glomerulonephritis and that treatment with DrugPTU appeared to induce ANCA.
Score Relation Text (Head - Tail)
0.9995 Adverse-Effect We recommend the cautious use of Drugketorolac in patients with underlying illnesses where NSAID - induced Adverse-Effectototoxicity could result in adverse otologic consequences.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectAnaphylaxis to Drugcisplatin is an infrequent life - threatening complication which may occur even in patients who have received prior treatment with cisplatin.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a case of significant Adverse-Effectelevation of serum transaminases in a patient treated with Drug6 - TG for a flare of Crohn's disease.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect RESULTS : Similar to previous findings of drug - induced vortex keratopathy, Drugatovaquone Adverse-Effectvortex keratopathy is presumably caused by its lipophilic properties.
0.9973 Adverse-Effect RESULTS : Similar to previous findings of drug - induced Adverse-Effectvortex keratopathy , Drugatovaquone vortex keratopathy is presumably caused by its lipophilic properties.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSION : Although a definite association has not been proven, clinicians should be aware of the possibility of Adverse-Effectagranulocytosis while using Drugquetiapine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 54 - year - old man developed Adverse-EffectTEN 4 weeks after beginning Druglamotrigine for complex partial seizures related to a glioblastoma multiforme brain tumor.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We have safely used recombinant factor VIIa to treat bleeding in the immediate and long - term period following DrugPCC - related Adverse-EffectMI .
0.9977 Adverse-Effect We have safely used Drugrecombinant factor VIIa to treat bleeding in the immediate and long - term period following PCC - related Adverse-EffectMI .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a patient with inoperable pancreatic cancer who developed gastrointestinal bleeding secondary to Adverse-Effectradiation - recall related to Druggemcitabine and review literature.
0.9999 Adverse-Effect We report a patient with inoperable pancreatic cancer who developed Adverse-Effectgastrointestinal bleeding secondary to radiation - recall related to Druggemcitabine and review literature.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect METHODS : Adverse-EffectGrowth retardation was observed in six severely asthmatic children after introduction of high - dose Drugfluticasone propionate treatment ( dry powder ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the case of a 40 - year - old woman who developed fulminant hepatic failure and Adverse-Effectaplastic anaemia following a course of oral Drugflucloxacillin .
1.0000 Adverse-Effect We report the case of a 40 - year - old woman who developed Adverse-Effectfulminant hepatic failure and aplastic anaemia following a course of oral Drugflucloxacillin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The hospital course of the acute renal failure is presented with a review of the literature on cases of Adverse-Effectacute renal failure after DrugIVIG .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Use of the Naranjo probability scale indicated a highly probable relationship between the observed Adverse-Effectcardiac toxicity and Drugamphotericin B deoxycholate therapy in this patient.
Score Relation Text (Head - Tail)
0.9985 Adverse-Effect We describe 2 patients with cutaneous lupus erythematosus who developed severe Drugdapsone Adverse-Effectdapsone reaction after low dose therapy, with a fatal outcome in one.
0.9977 Adverse-Effect We describe 2 patients with cutaneous lupus erythematosus who developed severe Drugdapsone reaction after low dose therapy, with a Adverse-Effectfatal outcome in one.
0.9994 Adverse-Effect We describe 2 patients with cutaneous lupus erythematosus who developed severe Drugdapsone reaction after low dose therapy, with a Adverse-Effectfatal outcome in one.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : Because of its structural similarity to the other vinca alkaloids, Drugvinorelbine is believed to be responsible for Adverse-EffectSIADH in our patient.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugInterferon - based treatments have the potential to decrease the burden of disease, but are complicated by side effects, including Adverse-Effectneuropsychiatric symptoms .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectSevere osteomalacia was present in two epileptic patients who were under long - term treatment with congeners of Drugphenytoin , phenobarbital, and acetazolamide.
1.0000 Adverse-Effect Adverse-EffectSevere osteomalacia was present in two epileptic patients who were under long - term treatment with congeners of phenytoin, Drugphenobarbital , and acetazolamide.
1.0000 Adverse-Effect Adverse-EffectSevere osteomalacia was present in two epileptic patients who were under long - term treatment with congeners of phenytoin, phenobarbital, and Drugacetazolamide .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Acute myeloid leukemia and Adverse-Effectlung cancer occurring in a chronic lymphocytic leukemia patient treated with Drugfludarabine and autologous peripheral blood stem - cell transplantation.
1.0000 Adverse-Effect Adverse-EffectAcute myeloid leukemia and lung cancer occurring in a chronic lymphocytic leukemia patient treated with Drugfludarabine and autologous peripheral blood stem - cell transplantation.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : 1 ) To describe a patient with rheumatoid arthritis receiving Drugadalimumab who developed Adverse-Effectfever , pancytopenia, splenomegaly, and extreme hyperferritinemia.
1.0000 Adverse-Effect OBJECTIVE : 1 ) To describe a patient with rheumatoid arthritis receiving Drugadalimumab who developed fever, Adverse-Effectpancytopenia , splenomegaly, and extreme hyperferritinemia.
1.0000 Adverse-Effect OBJECTIVE : 1 ) To describe a patient with rheumatoid arthritis receiving Drugadalimumab who developed fever, pancytopenia, Adverse-Effectsplenomegaly , and extreme hyperferritinemia.
0.9999 Adverse-Effect OBJECTIVE : 1 ) To describe a patient with rheumatoid arthritis receiving Drugadalimumab who developed fever, pancytopenia, splenomegaly, and Adverse-Effectextreme hyperferritinemia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The hyperpigmentation was diffuse scattered, flagellate like and linear streaking which was thought to be mainly related to the Adverse-Effectskin toxicity of Drugbleomycin .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect OBJECTIVE : This case report outlines a significant type of morbidity due to continued use of Druggabapentin during an episode of Adverse-Effectacute renal failure .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The findings were judged to be consistent with Adverse-Effectsoft - tissue injury associated with intravenous administration of Drugphenytoin , also termed purple glove syndrome.
0.9999 Adverse-Effect The findings were judged to be consistent with soft - tissue injury associated with intravenous administration of Drugphenytoin , also termed Adverse-Effectpurple glove syndrome .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Several case reports of Adverse-Effectaplastic anemia with use of Drugacetazolamide , and two cases with use of methazolamide, have appeared in the literature.
0.9995 Adverse-Effect Several case reports of Adverse-Effectaplastic anemia with use of acetazolamide, and two cases with use of Drugmethazolamide , have appeared in the literature.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 2 - year - old mentally retarded boy with frontal lobe epilepsy presented with an episode that resembled Adverse-Effectheat stroke during the administration of Drugzonisamide .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectFracture of the femoral neck occurred in one patient during DrugPSL therapy, although the relationship between the fracture and PSL therapy was uncertain.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Despite a postulated dopaminergic mechanism, there seems to have been only one previous report of Drugamantadine ' s Adverse-Effectprecipitating psychosis in a schizophrenic patient.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a 78 - year - old man who had Adverse-Effectacute unilateral total visual loss after retrogasserian Drugphenol injection for the treatment of trigeminal neuralgia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In addition to its known effect on gallbladder stasis, Drugoctreotide Adverse-Effectalters bile acid composition and may thus hasten intrahepatic sludge and stone formation.
1.0000 Adverse-Effect In addition to its known effect on Adverse-Effectgallbladder stasis , Drugoctreotide alters bile acid composition and may thus hasten intrahepatic sludge and stone formation.
0.9999 Adverse-Effect In addition to its known effect on gallbladder stasis, Drugoctreotide alters bile acid composition and may thus Adverse-Effecthasten intrahepatic sludge and stone formation.
0.9996 Adverse-Effect In addition to its known effect on gallbladder stasis, Drugoctreotide alters bile acid composition and may thus hasten intrahepatic sludge and Adverse-Effectstone formation .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect To our knowledge, this is the first case reported in the English literature of a Adverse-Effectgeneralized exanthem due to subcutaneous injection of Drugenoxaparin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In keeping with findings in the literature, the Adverse-Effectaortic wall in this case was damaged by secondary changes following irradiation and DrugBleomycin treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the case of a patient with Adverse-Effectincreased cerebral cortical excitability following intoxication with Drugflupirtine , a centrally acting analgesic and antispastic drug.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 10 - year - old asthmatic boy began to suffer from urticarial rash and Adverse-Effectmoderately severe bronchospasm after 8 weeks'treatment with Drugdisodium cromoglycate .
0.9998 Adverse-Effect A 10 - year - old asthmatic boy began to suffer from Adverse-Effecturticarial rash and moderately severe bronchospasm after 8 weeks'treatment with Drugdisodium cromoglycate .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of long lasting Adverse-Effectrespiratory depression after intravenous administration of Drugmorphine to a 7 year old girl with haemolytic uraemic syndrome.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect We believe that these skin eruptions belong to a spectrum of Adverse-Effectneutrophilic dermatoses that can be induced or aggravated by DrugG - CSF therapy.
0.9990 Adverse-Effect We believe that these Adverse-Effectskin eruptions belong to a spectrum of neutrophilic dermatoses that can be induced or aggravated by DrugG - CSF therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe the clinical course of 2 patients with Crohn's disease ( CD ) in whom Adverse-Effectlymphoma was diagnosed after treatment with Druginfliximab .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Ovarian endometrioid carcinoma and Adverse-Effectendometriosis developing in a postmenopausal breast cancer patient during Drugtamoxifen therapy : a case report and review of the literature.
0.9999 Adverse-Effect Adverse-EffectOvarian endometrioid carcinoma and endometriosis developing in a postmenopausal breast cancer patient during Drugtamoxifen therapy : a case report and review of the literature.
Score Relation Text (Head - Tail)
0.9938 Adverse-Effect We report here two cases of Adverse-Effectdyserythropoietic anaemia associated with long - term Druglinezolid use that share striking similarities to chloramphenicol - associated myelotoxicity.
0.9922 Adverse-Effect We report here two cases of dyserythropoietic anaemia associated with long - term linezolid use that share striking similarities to Drugchloramphenicol - associated Adverse-Effectmyelotoxicity .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect With the negative viral serologies, the clinical picture was most consistent with an infectious Adverse-Effectmononucleosis - like syndrome produced by the Drugminocycline ingestion.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The association between Drugheparin and Adverse-Effectpriapism is often recognized ; abnormal platelet aggregation could play a role in the pathogenesis of this side effect.
0.9999 Adverse-Effect The association between Drugheparin and priapism is often recognized ; Adverse-Effectabnormal platelet aggregation could play a role in the pathogenesis of this side effect.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a premenopausal woman who, while having Drugtamoxifen due to a diagnosis of in situ ductal carcinoma, developed Adverse-Effectendometriosis requiring surgery.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This case describes Adverse-Effectfulminant hepatic failure in a patient taking Drugdisulfiram with no previous liver disease and report of being compliant with alcohol abstinence.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Ophthalmologists should be aware of the Adverse-Effectocular side effects of DrugIFN therapy and carefully monitor patients for the possible occurrence of hypoalbuminemia and thrombocytopenia.
1.0000 Adverse-Effect Ophthalmologists should be aware of the ocular side effects of DrugIFN therapy and carefully monitor patients for the possible occurrence of Adverse-Effecthypoalbuminemia and thrombocytopenia.
0.9997 Adverse-Effect Ophthalmologists should be aware of the ocular side effects of DrugIFN therapy and carefully monitor patients for the possible occurrence of hypoalbuminemia and Adverse-Effectthrombocytopenia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The authors describe Adverse-Effectpericardial hemorrhage , which is related to the use of low - dose Drugacetylsalicylic acid in a patient with essential thrombocythemia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The case of a 29 - year - old man suffering from falciparum malaria disease who got a Adverse-Effectreversible hearing loss from Drugquinine therapy is presented.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a case of Adverse-Effectinterstitial hypoxaemiant pneumonitis probably related to Drugflecainide in a patient with the LEOPARD syndrome, a rare congenital disorder.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect To our knowledge, the syndrome of fever, pulmonary infiltrates, and Adverse-Effectpleural effusion following use of Drugacyclovir has not been previously reported.
1.0000 Adverse-Effect To our knowledge, the syndrome of Adverse-Effectfever , pulmonary infiltrates, and pleural effusion following use of Drugacyclovir has not been previously reported.
1.0000 Adverse-Effect To our knowledge, the syndrome of fever, Adverse-Effectpulmonary infiltrates , and pleural effusion following use of Drugacyclovir has not been previously reported.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report two patients who developed intense Adverse-Effectlivedo reticularis clearly related to the administration of Druginterferon alpha 2b as an adjuvant therapy for melanoma.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This profile should trigger a " red flag " as to the possibility of Drugphenobarbital Adverse-Effectbehavioral side effects or exacerbation of preexisting maladaptive behaviors.
0.9998 Adverse-Effect This profile should trigger a " red flag " as to the possibility of Drugphenobarbital behavioral side effects or Adverse-Effectexacerbation of preexisting maladaptive behaviors .
0.9999 Adverse-Effect This profile should trigger a " red flag " as to the possibility of Drugphenobarbital Adverse-Effectphenobarbital behavioral side effects or exacerbation of preexisting maladaptive behaviors.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 70 - year - old man was admitted to our hospital because of Adverse-Effectdyspnea after taking an antihistaminic agent ( Drughomochlorcyclizine hydrochloride ) for itching.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Marked QT prolongation and torsades de pointes secondary to Adverse-Effectacute ischemia in an elderly man taking Drugdofetilide for atrial fibrillation : a cautionary tale.
1.0000 Adverse-Effect Marked QT prolongation and Adverse-Effecttorsades de pointes secondary to acute ischemia in an elderly man taking Drugdofetilide for atrial fibrillation : a cautionary tale.
0.9999 Adverse-Effect Adverse-EffectMarked QT prolongation and torsades de pointes secondary to acute ischemia in an elderly man taking Drugdofetilide for atrial fibrillation : a cautionary tale.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case is described of Adverse-Effectsevere splenic hemorrhage and rupture which developed 3 h after completion of DrugtPA infusion for suspected acute myocardial infarction.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The authors present a case report of a granulomatous reaction leading to Adverse-Effecturethral prolapse , 3 months after the transurethral injection of Drugcalcium hydroxylapatite .
0.9998 Adverse-Effect The authors present a case report of a Adverse-Effectgranulomatous reaction leading to urethral prolapse, 3 months after the transurethral injection of Drugcalcium hydroxylapatite .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect After only the third dose of Drugpentamidine , it was noted that the patient's Adverse-Effectheart rate had decreased to 48 beats / minute.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect However, prolongation of 5 - FU half - life and an Adverse-Effectincrease in INR have been reported with the concurrent use of Drug5 - FU and warfarin.
1.0000 Adverse-Effect However, prolongation of 5 - FU half - life and an Adverse-Effectincrease in INR have been reported with the concurrent use of 5 - FU and Drugwarfarin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The association with prolonged unopposed estrogen - like stimulation with Drugtamoxifen as a possible factor in the development of Adverse-Effectovarian endometrioid carcinoma is discussed.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To describe a patient with asymptomatic bronchial asthma and hypertension who developed an Adverse-Effectacute asthma attack after receiving sustained - release Drugverapamil .
1.0000 Adverse-Effect OBJECTIVE : To describe a patient with asymptomatic bronchial asthma and hypertension who developed an Adverse-Effectacute asthma attack after receiving sustained - release Drugverapamil .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a 53 - year - old - man who developed rippling muscle disease ( Adverse-EffectRMD ) 2 months after starting Drugsimvastatin therapy for hypercholesterolemia.
1.0000 Adverse-Effect We report a 53 - year - old - man who developed Adverse-Effectrippling muscle disease ( RMD ) 2 months after starting Drugsimvastatin therapy for hypercholesterolemia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This case report describes a 38 - year - old male in whom Adverse-EffectSIADH was strongly suspected secondary to DrugTegretol therapy to control a seizure disorder.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect PURPOSE : The aim of this study was to report on the possible development of Adverse-Effectcorneal endothelial deposits resulting from the use of Drugrifabutin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect METHODS : In an institutional practice setting, two women, aged 25 and 45, developed Adverse-Effectacute myopia after starting Drugtopiramate for epilepsy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Our case points to the need for increased awareness by the general pediatricians of the Adverse-Effectpotential hazards of Drugmineral oil use for chronic constipation.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Although lung specimens were lacking from these three patients, it is suggested that the Adverse-Effectpulmonary toxicity of DrugCCNU may be dose - related.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugBaclofen Adverse-Effectwithdrawal syndrome resulting from underdosing of oral baclofen should be considered as a potential source of prolonged fever in the intensive care unit.
1.0000 Adverse-Effect Baclofen Adverse-Effectwithdrawal syndrome resulting from underdosing of oral Drugbaclofen should be considered as a potential source of prolonged fever in the intensive care unit.
0.9999 Adverse-Effect Baclofen withdrawal syndrome resulting from underdosing of oral Drugbaclofen should be considered as a potential source of prolonged Adverse-Effectfever in the intensive care unit.
0.9990 Adverse-Effect DrugBaclofen withdrawal syndrome resulting from underdosing of oral baclofen should be considered as a potential source of prolonged Adverse-Effectfever in the intensive care unit.
Score Relation Text (Head - Tail)
0.9758 Adverse-Effect PURPOSE : We evaluated the in vitro hemodialysis ratio and subsequent Adverse-Effecttoxicity and pharmacokinetics of Drugifosfamide in an anephric patient with Wilms'tumor.
Adverse-Effect PURPOSE : We evaluated the in vitro hemodialysis ratio and subsequent Drugtoxicity and pharmacokinetics of Adverse-Effectifosfamide in an anephric patient with Wilms'tumor.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect RESULTS : Five of 70 patients who had begun Drugleflunomide therapy had significant Adverse-Effectweight loss that could not be linked to other identifiable etiologies.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Eleven days after initiation of therapy with Drugamiodarone , the patient experienced Adverse-Effectsyncope and was noted to have recurrent episodes of polymorphous ventricular tachycardia.
0.9998 Adverse-Effect Eleven days after initiation of therapy with Drugamiodarone , the patient experienced syncope and was noted to have recurrent episodes of Adverse-Effectpolymorphous ventricular tachycardia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Severe loss of vision after removal of Adverse-Effectcataract caused by intravitreal Drugtriamcinolone in combination with photodynamic therapy for exudative age - related macular degeneration.
1.0000 Adverse-Effect Adverse-EffectSevere loss of vision after removal of cataract caused by intravitreal Drugtriamcinolone in combination with photodynamic therapy for exudative age - related macular degeneration.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect BACKGROUND : The risk / benefit ratio of Drugwarfarin therapy changes in the over 75s, when Adverse-Effecthaemorrhagic side - effects become more common.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We present a case report of a patient who developed a Adverse-Effectprolonged QT while being treated with oral Drugmethadone for a chronic pain syndrome.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DISCUSSION : DrugMethotrexate - induced Adverse-Effectpapular eruption is rarely reported shortly after beginning methotrexate therapy in patients with acute exacerbation of collagen vascular diseases.
0.9990 Adverse-Effect DISCUSSION : Methotrexate - induced Adverse-Effectpapular eruption is rarely reported shortly after beginning Drugmethotrexate therapy in patients with acute exacerbation of collagen vascular diseases.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect RESULTS : Both cases presented here describe Adverse-Effectcorneal ulcers that persisted and showed signs of worsening during weeks of frequent topical dosing with Drugmoxifloxacin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We present a case of Adverse-Effecthemolytic - uremic syndrome that developed during the 4th cycle of combination chemotherapy with Drugoxaliplatin , 5 - fluorouracil and leucovorin.
1.0000 Adverse-Effect We present a case of Adverse-Effecthemolytic - uremic syndrome that developed during the 4th cycle of combination chemotherapy with oxaliplatin, Drug5 - fluorouracil and leucovorin.
1.0000 Adverse-Effect We present a case of Adverse-Effecthemolytic - uremic syndrome that developed during the 4th cycle of combination chemotherapy with oxaliplatin, 5 - fluorouracil and Drugleucovorin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The authors think that although Druglamivudine is widely used and well tolerated, it can cause Adverse-EffectADRs , which are reversible after drug withdrawal.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The case of a patient with infectious mononucleosis treated with Drugcephalexin who later showed a Adverse-Effectrash is presented and the previous literature is reviewed.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Twenty - four hours after the administration of Druggemcitabine , a Adverse-Effectsymmetric, bullous, herpetiform eruption appeared on his trunk and upper limbs.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report 4 patients, 2 on methylphenidate and 2 on Drugdextroamphetamine who presented with Adverse-Effectacral cyanosis , livedo reticularis, or Raynaud phenomenon.
0.9999 Adverse-Effect We report 4 patients, 2 on methylphenidate and 2 on Drugdextroamphetamine who presented with acral cyanosis, livedo reticularis, or Adverse-EffectRaynaud phenomenon .
0.9999 Adverse-Effect We report 4 patients, 2 on methylphenidate and 2 on Drugdextroamphetamine who presented with acral cyanosis, Adverse-Effectlivedo reticularis , or Raynaud phenomenon.
0.9998 Adverse-Effect We report 4 patients, 2 on Drugmethylphenidate and 2 on dextroamphetamine who presented with Adverse-Effectacral cyanosis , livedo reticularis, or Raynaud phenomenon.
0.9998 Adverse-Effect We report 4 patients, 2 on Drugmethylphenidate and 2 on dextroamphetamine who presented with acral cyanosis, livedo reticularis, or Adverse-EffectRaynaud phenomenon .
0.9997 Adverse-Effect We report 4 patients, 2 on Drugmethylphenidate and 2 on dextroamphetamine who presented with acral cyanosis, Adverse-Effectlivedo reticularis , or Raynaud phenomenon.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect From these data, acute generalized dystonia with Adverse-Effectbrainstem and thalamic lesions may occur in WD patients after an initial Drugd - penicillamine therapy.
0.9995 Adverse-Effect From these data, Adverse-Effectacute generalized dystonia with brainstem and thalamic lesions may occur in WD patients after an initial Drugd - penicillamine therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We present a case report of a patient with typhoid fever who experienced a Adverse-Effecthypersensitivity reaction subsequent to the infusion of Drugchloramphenicol sodium succinate .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect A patient who had been treated with large doses of Drugthyroid hormone for several years developed features of secondary Adverse-Effecthypothyroidism after thyroid hormone withdrawal.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectSeizures occurred in two patients with probable Alzheimer's disease who were receiving long - term treatment with Drugmetrifonate , an irreversible acetylcholinesterase inhibitor.
Score Relation Text (Head - Tail)
Adverse-Effect RESULTS : A previously healthy 42 - year - old woman presented with Adverse-Effectacute - onset delirium with psychotic features as a consequence of Druglevofloxacin therapy.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect The Adverse-Effectexacerbation of psoriasis was accompanied by a massive induction of lesional type I interferon activity, detected by MxA expression after Drugimiquimod therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Although adverse effects are usually mild, the author reports here a case of leucocytopenia and Adverse-Effectthrombocytopenia with Drugquetiapine treatment that required its discontinuation.
0.9999 Adverse-Effect Although adverse effects are usually mild, the author reports here a case of Adverse-Effectleucocytopenia and thrombocytopenia with Drugquetiapine treatment that required its discontinuation.
Score Relation Text (Head - Tail)
0.9997 Adverse-Effect DrugMethanol toxicity can cause Adverse-Effectsevere central nervous system insult in which a characteristic pattern of bilateral putaminal injury is noted on brain imaging studies.
0.9992 Adverse-Effect DrugMethanol toxicity can cause severe central nervous system insult in which a characteristic pattern of Adverse-Effectbilateral putaminal injury is noted on brain imaging studies.
Adverse-Effect DrugMethanol Adverse-EffectMethanol toxicity can cause severe central nervous system insult in which a characteristic pattern of bilateral putaminal injury is noted on brain imaging studies.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report on a 14 - year - old boy with severe haemophilia A who developed a Adverse-Effectportal vein thrombosis during continuous infusion of DrugF VIII .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : The 3 cases presented here illustrate the development of Adverse-Effectreproductive endocrine disorders after the initiation of Drugvalproate therapy in women with epilepsy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of Adverse-Effectsevere AVP three weeks following the administration of Druginfliximab for the treatment of Crohn's disease ( CD ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSION : During and after DrugIFN therapy, OCT is a useful examination technique for revealing Adverse-Effectmacular edema in patients who have decreased vision.
0.9998 Adverse-Effect CONCLUSION : During and after DrugIFN therapy, OCT is a useful examination technique for revealing macular edema in patients who have Adverse-Effectdecreased vision .
Score Relation Text (Head - Tail)
0.9988 Adverse-Effect The increasing prevalence of methamphetamine abuse and the severity of the associated ulcers should alert ophthalmologists to the problem of Drugmethamphetamine - related Adverse-Effectkeratitis .
0.9978 Adverse-Effect The increasing prevalence of Drugmethamphetamine abuse and the severity of the associated Adverse-Effectulcers should alert ophthalmologists to the problem of methamphetamine - related keratitis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A patient with Parkinson's disease, initially treated with bromocriptine and subsequently with Drugcabergoline , developed progressive Adverse-Effectpleuropulmonary abnormalities during the latter therapy.
0.9998 Adverse-Effect A patient with Parkinson's disease, initially treated with Drugbromocriptine and subsequently with cabergoline, developed progressive Adverse-Effectpleuropulmonary abnormalities during the latter therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect It is believed that this is the first reported case of reversible Drugazathioprine - induced Adverse-Effectcholestasis associated with histological evidence of bile duct injury.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The pathogenic mechanisms involved in the development of Drugadriamycin Adverse-Effectcardiomyopathy are reviewed, and the possible synergistic effect of other antitumor antibiotics is discussed.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect One should therefore be aware of possible Adverse-Effectextrapyramidal side effects with Drugolanzapine that are reduced compared to classical neuroleptic drugs but not completely eliminated.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Development of Adverse-Effectsarcoidosis during Druginterferon alpha 2b and ribavirin combination therapy for chronic hepatitis C - - a case report and review of the literature.
0.9999 Adverse-Effect Development of Adverse-Effectsarcoidosis during interferon alpha 2b and Drugribavirin combination therapy for chronic hepatitis C - - a case report and review of the literature.
1.0000 Adverse-Effect Development of Adverse-Effectsarcoidosis during Druginterferon alpha 2b and ribavirin combination therapy for chronic hepatitis C - - a case report and review of the literature.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Exacerbation of Druganthracycline - induced Adverse-Effectearly chronic cardiomyopathy with ATRA : role of B - type natriuretic peptide as an indicator of cardiac dysfunction.
0.9863 Adverse-Effect Exacerbation of Druganthracycline - induced early chronic cardiomyopathy with ATRA : role of B - type natriuretic peptide as an indicator of Adverse-Effectcardiac dysfunction .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect RESULTS : A male and a female patient with spasticity treated with intrathecal Drugbaclofen were recognized to have Adverse-Effectsexual dysfunction side effects from treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The diagnosis of Adverse-Effecthypothermia was delayed until it was apparent for several days but resolved with the discontinuation of Drugrisperidone and continuation of clozapine.
0.9999 Adverse-Effect The diagnosis of Adverse-Effecthypothermia was delayed until it was apparent for several days but resolved with the discontinuation of risperidone and continuation of Drugclozapine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Other potential causes of Adverse-Effectrenal failure were not present in our patient and his renal function gradually recovered with the cessation of Drugsuramin treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In this paper we report a case of Drugnimodipine overdosage resulting in Adverse-Effectprolonged hypotension and hypoxemia, which was successfully treated with calcium gluconate.
0.9999 Adverse-Effect In this paper we report a case of Drugnimodipine overdosage resulting in prolonged hypotension and Adverse-Effecthypoxemia , which was successfully treated with calcium gluconate.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The first case concerns a 70 - year - old man who developed severe Adverse-Effectaplastic anemia 7 weeks after treatment with 500 mg of Drugticlopidine daily.
1.0000 Adverse-Effect The first case concerns a 70 - year - old man who developed Adverse-Effectsevere aplastic anemia 7 weeks after treatment with 500 mg of Drugticlopidine daily.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Thus, an immunological mechanism might be involved in the mechanism of Drugpirmenol - induced Adverse-EffectQT prolongation and T wave inversion on the electrocardiogram.
0.9999 Adverse-Effect Thus, an immunological mechanism might be involved in the mechanism of Drugpirmenol - induced QT prolongation and Adverse-EffectT wave inversion on the electrocardiogram.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DISCUSSION : DrugColchicine , the most important drug in treatment of FMF, can cause Adverse-Effectmyopathy in patients with impaired renal and hepatic function.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect After other potential causes of liver toxicity were excluded, DrugTMP - SMX was determined to be the cause of his Adverse-Effectacute liver toxicity .
0.9996 Adverse-Effect After other potential causes of Adverse-Effectliver toxicity were excluded, DrugTMP - SMX was determined to be the cause of his acute liver toxicity.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The autopsy findings and a detailed medical history supported the conclusion that Drugclozapine - induced Adverse-Effecthypersensitivity myocarditis was the most likely cause of death.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Moreover, treatment with immunosuppressive drugs such as cyclosporine, cisplatin, tacrolimus, and Druginterferon - alpha can induce a condition resembling Adverse-EffectRPLS .
0.9999 Adverse-Effect Moreover, treatment with immunosuppressive drugs such as cyclosporine, Drugcisplatin , tacrolimus, and interferon - alpha can induce a condition resembling Adverse-EffectRPLS .
0.9998 Adverse-Effect Moreover, treatment with immunosuppressive drugs such as cyclosporine, cisplatin, Drugtacrolimus , and interferon - alpha can induce a condition resembling Adverse-EffectRPLS .
0.9998 Adverse-Effect Moreover, treatment with immunosuppressive drugs such as Drugcyclosporine , cisplatin, tacrolimus, and interferon - alpha can induce a condition resembling Adverse-EffectRPLS .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We have recently encountered a patient with acquired haemophilia who developed a Adverse-Effectthrombotic left middle cerebral artery distribution stroke while being treated with DrugpFVIII .
Score Relation Text (Head - Tail)
0.9996 Adverse-Effect We believe this is the first report of myocardial infarction due to Adverse-Effectcoronary spasm , demonstrated by angiography associated with DrugL - thyroxine therapy.
0.9982 Adverse-Effect We believe this is the first report of Adverse-Effectmyocardial infarction due to coronary spasm, demonstrated by angiography associated with DrugL - thyroxine therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We present the case of an adult Crohn's disease patient with a parvovirus B19 infection and Adverse-Effectleukopenia during long - term DrugAZA therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugThalidomide Adverse-Effectneuropathy is often associated with proximal weakness and may progress even after discontinuation of treatment, in the phenomenon of'coasting '.
0.9997 Adverse-Effect DrugThalidomide neuropathy is often associated with Adverse-Effectproximal weakness and may progress even after discontinuation of treatment, in the phenomenon of'coasting '.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect The possibility of Drugphenytoin Adverse-Effecthypersensitivity reactions should be considered when patients receiving phenytoin have unusual symptoms, particularly fever, rash, and lymphadenopathy.
0.9997 Adverse-Effect The possibility of phenytoin hypersensitivity reactions should be considered when patients receiving Drugphenytoin have unusual symptoms, particularly Adverse-Effectfever , rash, and lymphadenopathy.
0.9997 Adverse-Effect The possibility of phenytoin hypersensitivity reactions should be considered when patients receiving Drugphenytoin have unusual symptoms, particularly fever, Adverse-Effectrash , and lymphadenopathy.
0.9996 Adverse-Effect The possibility of phenytoin Adverse-Effecthypersensitivity reactions should be considered when patients receiving Drugphenytoin have unusual symptoms, particularly fever, rash, and lymphadenopathy.
0.9990 Adverse-Effect The possibility of phenytoin hypersensitivity reactions should be considered when patients receiving Drugphenytoin have unusual symptoms, particularly fever, rash, and Adverse-Effectlymphadenopathy .
0.9973 Adverse-Effect The possibility of Drugphenytoin hypersensitivity reactions should be considered when patients receiving phenytoin have unusual symptoms, particularly fever, Adverse-Effectrash , and lymphadenopathy.
0.9960 Adverse-Effect The possibility of Drugphenytoin hypersensitivity reactions should be considered when patients receiving phenytoin have unusual symptoms, particularly Adverse-Effectfever , rash, and lymphadenopathy.
0.9947 Adverse-Effect The possibility of Drugphenytoin hypersensitivity reactions should be considered when patients receiving phenytoin have unusual symptoms, particularly fever, rash, and Adverse-Effectlymphadenopathy .
0.9994 Adverse-Effect The possibility of Drugphenytoin Adverse-Effectphenytoin hypersensitivity reactions should be considered when patients receiving phenytoin have unusual symptoms, particularly fever, rash, and lymphadenopathy.
0.9962 Adverse-Effect The possibility of Adverse-Effectphenytoin hypersensitivity reactions should be considered when patients receiving Drugphenytoin have unusual symptoms, particularly fever, rash, and lymphadenopathy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect She was administered Drugmetoclopramide because of nausea and, within 2 hours, developed Adverse-Effectagitation , dysarthria, diaphoresis, and a movement disorder.
1.0000 Adverse-Effect She was administered Drugmetoclopramide because of nausea and, within 2 hours, developed agitation, Adverse-Effectdysarthria , diaphoresis, and a movement disorder.
1.0000 Adverse-Effect She was administered Drugmetoclopramide because of nausea and, within 2 hours, developed agitation, dysarthria, Adverse-Effectdiaphoresis , and a movement disorder.
0.9999 Adverse-Effect She was administered Drugmetoclopramide because of nausea and, within 2 hours, developed agitation, dysarthria, diaphoresis, and a Adverse-Effectmovement disorder .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Four Chinese female patients who suffered from manic - depressive disorder and underlying autoimmune thyroiditis developed transient episodes of Adverse-Effectthyrotoxicosis during maintenance Druglithium therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The patient described in this paper was a 78 - year - old diabetic man who developed Adverse-Effectoral lesions of PV following institution of Drugglibenclamide therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To report on the possible development of Adverse-Effectserotonin syndrome in a patient receiving Drugclomipramine after clozapine was withdrawn from the treatment regimen.
0.9996 Adverse-Effect OBJECTIVE : To report on the possible development of Adverse-Effectserotonin syndrome in a patient receiving clomipramine after Drugclozapine was withdrawn from the treatment regimen.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe two patients with rheumatoid factor - positive, polyarticular - onset juvenile rheumatoid arthritis in whom Adverse-Effectaccelerated nodulosis developed during Drugmethotrexate therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Development of an Adverse-Effectextensive skin rash following a single dose of DrugMTX may be an early warning sign for life - threatening bone marrow aplasia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect However, follow - up revealed that Adverse-Effectgestational diabetes when associated with Drugnorethisterone had a lesser risk of emerging diabetes mellitus and impaired glucose tolerance.
1.0000 Adverse-Effect However, follow - up revealed that gestational diabetes when associated with Drugnorethisterone had a lesser risk of emerging Adverse-Effectdiabetes mellitus and impaired glucose tolerance.
1.0000 Adverse-Effect However, follow - up revealed that gestational diabetes when associated with Drugnorethisterone had a lesser risk of emerging diabetes mellitus and Adverse-Effectimpaired glucose tolerance .
Score Relation Text (Head - Tail)
0.9996 Adverse-Effect After administration of Oxybutynin concomitantly with an increase in the dose of Dantrolene, she presented the clinical symptoms and laboratory finding of DrugCarbamazepine Adverse-EffectCarbamazepine intoxication .
0.9967 Adverse-Effect After administration of Oxybutynin concomitantly with an increase in the dose of DrugDantrolene , she presented the clinical symptoms and laboratory finding of Adverse-EffectCarbamazepine intoxication .
0.9928 Adverse-Effect After administration of DrugOxybutynin concomitantly with an increase in the dose of Dantrolene, she presented the clinical symptoms and laboratory finding of Adverse-EffectCarbamazepine intoxication .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect We report a case of Drugcodeine Adverse-Effectcodeine intoxication in the neonate, in which the drug was prescribed for cough control during an emergency department visit.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report 5 cases of Adverse-Effectacute reversible renal failure coinciding with the onset of treatment with Drugcaptopril in patients with severe drug - resistant hypertension.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect We present a Adverse-Effectfatal case of subacute Drugmethanol toxicity with associated diffuse brain involvement, including bilateral putaminal necrosis and cerebral edema with ventricular compression.
0.9999 Adverse-Effect We present a fatal case of subacute Drugmethanol toxicity with associated Adverse-Effectdiffuse brain involvement , including bilateral putaminal necrosis and cerebral edema with ventricular compression.
0.9997 Adverse-Effect We present a fatal case of subacute Drugmethanol toxicity with associated diffuse brain involvement, including Adverse-Effectbilateral putaminal necrosis and cerebral edema with ventricular compression.
0.9997 Adverse-Effect We present a fatal case of subacute Drugmethanol toxicity with associated diffuse brain involvement, including bilateral putaminal necrosis and cerebral edema with Adverse-Effectventricular compression .
0.9995 Adverse-Effect We present a fatal case of subacute Drugmethanol toxicity with associated diffuse brain involvement, including bilateral putaminal necrosis and Adverse-Effectcerebral edema with ventricular compression.
Adverse-Effect We present a fatal case of subacute Drugmethanol Adverse-Effectmethanol toxicity with associated diffuse brain involvement, including bilateral putaminal necrosis and cerebral edema with ventricular compression.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Abrupt, accidental withdrawal of Drugtrihexyphenidyl triggered severe exacerbation of the Adverse-Effectcranial dystonia associated with inspiratory stridor and acute respiratory difficulties, prompting emergency admission.
1.0000 Adverse-Effect Abrupt, accidental withdrawal of Drugtrihexyphenidyl triggered severe exacerbation of the cranial dystonia associated with Adverse-Effectinspiratory stridor and acute respiratory difficulties, prompting emergency admission.
0.9999 Adverse-Effect Abrupt, accidental withdrawal of Drugtrihexyphenidyl triggered severe exacerbation of the cranial dystonia associated with inspiratory stridor and Adverse-Effectacute respiratory difficulties , prompting emergency admission.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Such a case induced by Adverse-Effecthypothyroidism complicating long - term therapy with Drugamiodarone in a 45 year old woman with pre - excitation is presented.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect After having received Druggemcitabine on day 1 of the second course, the patient developed Adverse-Effectdry cough , subfebrile temperatures and dyspnea within 48 h.
1.0000 Adverse-Effect After having received Druggemcitabine on day 1 of the second course, the patient developed dry cough, Adverse-Effectsubfebrile temperatures and dyspnea within 48 h.
1.0000 Adverse-Effect After having received Druggemcitabine on day 1 of the second course, the patient developed dry cough, subfebrile temperatures and Adverse-Effectdyspnea within 48 h.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of a young woman with SLE and thrombocytopenia, who developed severe perspiration, headache, and Adverse-Effectseizure after receiving Drugcyclosporine .
1.0000 Adverse-Effect We report a case of a young woman with SLE and thrombocytopenia, who developed severe perspiration, Adverse-Effectheadache , and seizure after receiving Drugcyclosporine .
1.0000 Adverse-Effect We report a case of a young woman with SLE and thrombocytopenia, who developed Adverse-Effectsevere perspiration , headache, and seizure after receiving Drugcyclosporine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The more common grade 3 or 4 adverse effects of Drugsunitinib include Adverse-Effecthypertension , fatigue, hand - foot syndrome, elevated lipase and lymphopenia.
1.0000 Adverse-Effect The more common grade 3 or 4 adverse effects of Drugsunitinib include hypertension, Adverse-Effectfatigue , hand - foot syndrome, elevated lipase and lymphopenia.
1.0000 Adverse-Effect The more common grade 3 or 4 adverse effects of Drugsunitinib include hypertension, fatigue, hand - foot syndrome, elevated lipase and Adverse-Effectlymphopenia .
0.9999 Adverse-Effect The more common grade 3 or 4 adverse effects of Drugsunitinib include hypertension, fatigue, Adverse-Effecthand - foot syndrome , elevated lipase and lymphopenia.
0.9999 Adverse-Effect The more common grade 3 or 4 adverse effects of Drugsunitinib include hypertension, fatigue, hand - foot syndrome, Adverse-Effectelevated lipase and lymphopenia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Four patients in whom Adverse-Effectpulmonary oedema developed during tocolysis with Drughexoprenaline are described and the aetiological factors and pathogenesis of this potentially lethal complication discussed.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We present a case of a diabetic patient taking glyburide who was prescribed Drugciprofloxacin and developed Adverse-Effectprolonged hypoglycemia , which persisted for over 24 hours.
0.9995 Adverse-Effect We present a case of a diabetic patient taking Drugglyburide who was prescribed ciprofloxacin and developed Adverse-Effectprolonged hypoglycemia , which persisted for over 24 hours.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugZiprasidone is an atypical antipsychotic drug that is believed to have a low propensity for inducing Adverse-Effectextrapyramidal symptoms , including tardive dyskinesia ( TD ).
1.0000 Adverse-Effect DrugZiprasidone is an atypical antipsychotic drug that is believed to have a low propensity for inducing extrapyramidal symptoms, including tardive dyskinesia ( Adverse-EffectTD ).
1.0000 Adverse-Effect DrugZiprasidone is an atypical antipsychotic drug that is believed to have a low propensity for inducing extrapyramidal symptoms, including Adverse-Effecttardive dyskinesia ( TD ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Drug - induced Adverse-Effecthepatitis in an acromegalic patient during combined treatment with Drugpegvisomant and octreotide long - acting repeatable attributed to the use of pegvisomant.
0.9998 Adverse-Effect Drug - induced Adverse-Effecthepatitis in an acromegalic patient during combined treatment with pegvisomant and Drugoctreotide long - acting repeatable attributed to the use of pegvisomant.
0.9997 Adverse-Effect Drug - induced Adverse-Effecthepatitis in an acromegalic patient during combined treatment with pegvisomant and octreotide long - acting repeatable attributed to the use of Drugpegvisomant .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect MATERIALS AND METHODS : We present two cases of significant morbidity related to Adverse-Effectprimary and secondary perforation of the bladder following two instillations of Drugepirubicin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Our patient developed both nephrogenic diabetes insipidus and Adverse-Effectrenal tubular acidosis with a temporal pattern that demonstrated a link between Drugfoscarnet therapy and these abnormalities.
0.9999 Adverse-Effect Our patient developed both Adverse-Effectnephrogenic diabetes insipidus and renal tubular acidosis with a temporal pattern that demonstrated a link between Drugfoscarnet therapy and these abnormalities.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect There have been numerous case reports of Adverse-Effecthyperglycemia with Drugolanzapine in the literature, but none reported hyperglycemia within days of initiation of the medication.
0.9970 Adverse-Effect There have been numerous case reports of hyperglycemia with Drugolanzapine in the literature, but none reported Adverse-Effecthyperglycemia within days of initiation of the medication.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect To our knowledge, drug - induced Adverse-Effectfever has not been reported with the use of Drugdiltiazem hydrochloride , a commonly prescribed calcium channel blocker.
Score Relation Text (Head - Tail)
0.9996 Adverse-Effect We present the case of a postictal patient with lethargy, Adverse-Effecthyperammonemia , otherwise normal liver function tests, and a therapeutic Drugvalproic acid level.
0.9995 Adverse-Effect We present the case of a postictal patient with Adverse-Effectlethargy , hyperammonemia, otherwise normal liver function tests, and a therapeutic Drugvalproic acid level.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In two patients with mycosis fungoides, a Adverse-Effectsquamous cell carcinoma developed during therapy with Drugpsoralens plus long - wave ultraviolet radiation ( PUVA ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectSunburn may sometimes be a major injury in Drugpsoralen users because high doses or inappropriate use of the drug may render the skin extremely sensitive.
1.0000 Adverse-Effect Sunburn may sometimes be a major injury in Drugpsoralen users because high doses or inappropriate use of the drug may render the Adverse-Effectskin extremely sensitive .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect A 35 - year - old nephrotic man developed Adverse-Effectacute renal failure with serum creatinine to 1543 micromol / l after a month of therapy with Drugenalapril .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 33 - year - old man with a history of recreational Drugbenztropine abuse presented to the emergency department with Adverse-Effectconfusion , abdominal pain, and distention.
1.0000 Adverse-Effect A 33 - year - old man with a history of recreational Drugbenztropine abuse presented to the emergency department with confusion, Adverse-Effectabdominal pain , and distention.
1.0000 Adverse-Effect A 33 - year - old man with a history of recreational Drugbenztropine abuse presented to the emergency department with confusion, abdominal pain, and Adverse-Effectdistention .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a fatal case of toxic epidermal necrolysis ( Adverse-EffectTEN ) resulting from a high dose of Drugcytosine arabinoside ( ARA - C ).
0.9998 Adverse-Effect We report a fatal case of toxic epidermal necrolysis ( Adverse-EffectTEN ) resulting from a high dose of cytosine arabinoside ( DrugARA - C ).
0.9997 Adverse-Effect We report a fatal case of Adverse-Effecttoxic epidermal necrolysis ( TEN ) resulting from a high dose of Drugcytosine arabinoside ( ARA - C ).
0.9987 Adverse-Effect We report a fatal case of Adverse-Effecttoxic epidermal necrolysis ( TEN ) resulting from a high dose of cytosine arabinoside ( DrugARA - C ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a third case of a 6 - week - old infant with Escherichia coli sepsis who received Drugampicillin and other antibiotics and subsequently developed Adverse-EffectTEN .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 58 - year old patient is reported who developed an Adverse-Effectischaemic cerebrovascular accident 22 hours after successful thrombolysis with Drugstreptokinase for life - threatening pulmonary emboli.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect It should be recognized that Drugibuprofen may be associated with Adverse-Effectsalt and water retention in the same fashion as previously described with phenylbutazone and indomethacin.
1.0000 Adverse-Effect It should be recognized that ibuprofen may be associated with Adverse-Effectsalt and water retention in the same fashion as previously described with Drugphenylbutazone and indomethacin.
0.9998 Adverse-Effect It should be recognized that ibuprofen may be associated with Adverse-Effectsalt and water retention in the same fashion as previously described with phenylbutazone and Drugindomethacin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect To our knowledge, we describe the first reported case of isolated paresthesia and Adverse-Effectperipheral neuropathy , without systemic involvement, secondary to Drugsulindac administration.
0.9999 Adverse-Effect To our knowledge, we describe the first reported case of Adverse-Effectisolated paresthesia and peripheral neuropathy, without systemic involvement, secondary to Drugsulindac administration.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugMetoclopramide - induced Adverse-Effectparkinsonism is not rare, and appropriate dose reduction in patients with renal failure will help reduce the incidence of this morbidity.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DISCUSSION : DrugPhenolphthalein is the active ingredient in several over - the - counter laxative preparations and has only rarely been reported to cause Adverse-EffectTEN .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Charcoal haemoperfusion and cysteamine therapy led to the rapid removal of the Drugparacetamol from the body and consequently prevented the development of Adverse-Effectsevere hepatic necrosis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report on three patients with acute schizophrenia, who developed Adverse-Effectsevere akathisia during treatment with Drugolanzapine ( 20 - 25 mg / d ).
1.0000 Adverse-Effect We report on three patients with acute schizophrenia, who developed severe Adverse-Effectakathisia during treatment with Drugolanzapine ( 20 - 25 mg / d ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectMultiple syncopal episodes started to occur during Drugthalidomide treatment, and a Holter electrocardiogram showed multiple abnormalities, with an episode of sustained ventricular tachycardia.
0.9996 Adverse-Effect Multiple syncopal episodes started to occur during Drugthalidomide treatment, and a Holter electrocardiogram showed multiple abnormalities, with an episode of Adverse-Effectsustained ventricular tachycardia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect He had an immediate Adverse-Effecthypersensitivity reaction during the initiation of the DrugMTX infusion with diffuse urticaria, facial swelling, cough, and chest tightness.
1.0000 Adverse-Effect He had an immediate hypersensitivity reaction during the initiation of the DrugMTX infusion with Adverse-Effectdiffuse urticaria , facial swelling, cough, and chest tightness.
0.9999 Adverse-Effect He had an immediate hypersensitivity reaction during the initiation of the DrugMTX infusion with diffuse urticaria, facial swelling, Adverse-Effectcough , and chest tightness.
0.9999 Adverse-Effect He had an immediate hypersensitivity reaction during the initiation of the DrugMTX infusion with diffuse urticaria, Adverse-Effectfacial swelling , cough, and chest tightness.
0.9996 Adverse-Effect He had an immediate hypersensitivity reaction during the initiation of the DrugMTX infusion with diffuse urticaria, facial swelling, cough, and Adverse-Effectchest tightness .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This report presents a case of Adverse-Effectcolon perforation which occurred 4 months after treatment with intraperitoneal Drugchromic phosphate for stage IB ovarian papillary serous cystadenocarcinoma.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We suggest that Drugitraconazole should be added to the list of drugs that may be responsible for a drug - induced Adverse-Effectvanishing bile duct syndrome .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect AIM : Report of a case of a woman patient who developed Adverse-Effectceliac disease after Drugpegylated interferon alpha - 2a and ribavirin use for chronic hepatitis C.
0.9999 Adverse-Effect AIM : Report of a case of a woman patient who developed Adverse-Effectceliac disease after pegylated interferon alpha - 2a and Drugribavirin use for chronic hepatitis C.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect These findings suggest that Adverse-Effectbicytopenia in this patient was caused by DrugD - Pen and may be due to different sensitivities in the hematopoietic lineage.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect We describe a case of needle - track Adverse-Effectcutaneous seeding of hepatocellular carcinoma ( HCC ) after sonographically guided percutaneous Drugethanol injection ( PEI ).
1.0000 Adverse-Effect We describe a case of needle - track Adverse-Effectcutaneous seeding of hepatocellular carcinoma ( HCC ) after sonographically guided percutaneous Drugethanol injection ( PEI ).
0.9999 Adverse-Effect We describe a case of needle - track Adverse-Effectcutaneous seeding of hepatocellular carcinoma ( HCC ) after sonographically guided percutaneous ethanol injection ( DrugPEI ).
0.9983 Adverse-Effect We describe a case of needle - track Adverse-Effectcutaneous seeding of hepatocellular carcinoma ( DrugHCC ) after sonographically guided percutaneous ethanol injection ( PEI ).
0.6993 Adverse-Effect We describe a case of needle - track cutaneous seeding of hepatocellular carcinoma ( DrugHCC ) after sonographically guided percutaneous Drugethanol injection ( PEI ).
0.5987 Adverse-Effect We describe a case of needle - track cutaneous seeding of hepatocellular carcinoma ( DrugHCC ) after sonographically guided percutaneous Drugethanol injection ( PEI ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This article reports the occurrence of Drugrifampin - associated Adverse-Effectthrombocytopenia in an indigent patient after a four - month lapse in therapy for pulmonary tuberculosis.
Score Relation Text (Head - Tail)
Adverse-Effect Recent studies have shown that under experimental conditions Drugferrous sulfate may Adverse-Effectreduce the gastrointestinal absorption of orally administered levothyroxine sodium in patients with primary hypothyroidism.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We postulate that cyclosporin, possibly together with Drugganciclovir , can produce Adverse-Effecttransient brain stem or neuromuscular dysfunction with eye movement abnormality in occasional patients.
0.9999 Adverse-Effect We postulate that Drugcyclosporin , possibly together with ganciclovir, can produce Adverse-Effecttransient brain stem or neuromuscular dysfunction with eye movement abnormality in occasional patients.
0.9999 Adverse-Effect We postulate that cyclosporin, possibly together with Drugganciclovir , can produce transient brain stem or neuromuscular dysfunction with Adverse-Effecteye movement abnormality in occasional patients.
0.9997 Adverse-Effect We postulate that Drugcyclosporin , possibly together with ganciclovir, can produce transient brain stem or neuromuscular dysfunction with Adverse-Effecteye movement abnormality in occasional patients.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect We believe that this is the first description of Adverse-Effectacute hepatitis caused by an idiosyncratic adverse reaction to Druggliclazide or to one of its metabolites.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The second is a 29 - year - old man with CD in whom Adverse-Effectnodular sclerosing Hodgkin's lymphoma was diagnosed 3 weeks after infusion with Druginfliximab .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Five personal observations of an Adverse-Effectacute amnestic episode in younger individuals after intake of Drugclioquinol are described together with three observations from the medical literature.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In this case, Druginterferon alpha induced Adverse-Effectpolymyositis and cardiomyopathy is diagnosed in a 33 - yr - old male patient with history of chronic hepatitis B.
0.9994 Adverse-Effect In this case, Druginterferon alpha induced polymyositis and Adverse-Effectcardiomyopathy is diagnosed in a 33 - yr - old male patient with history of chronic hepatitis B.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Case 3 : A 29 - year - old female alcoholic complained of general fatigue and a slight Adverse-Effectfever after 1. 5 years of abstinence with Drugcyanamide treatment.
0.9999 Adverse-Effect Case 3 : A 29 - year - old female alcoholic complained of Adverse-Effectgeneral fatigue and a slight fever after 1. 5 years of abstinence with Drugcyanamide treatment.
Adverse-Effect Case 3 : A 29 - year - old female alcoholic complained of general Adverse-Effectfatigue and a slight fever after 1. 5 years of abstinence with Drugcyanamide treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A twelve year - old - girl with idiopathic partial epilepsy with secondary generalization, developed Adverse-Effectacute psychosis 10 days after the administration of Druglevetiracetam .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In addition to disease refractoriness, rare instances of disease progression from chronic phase to Adverse-Effectblast crisis during Drugimatinib therapy have recently been anecdotally reported.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The authors suggest that in patients with Adverse-Effectcorneal ulcers refractory to conventional treatment who are receiving Drugcolchicine , cessation of colchicine therapy should be considered.
0.9994 Adverse-Effect The authors suggest that in patients with Adverse-Effectcorneal ulcers refractory to conventional treatment who are receiving colchicine, cessation of Drugcolchicine therapy should be considered.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To describe a case of Drugcefazolin - induced Adverse-Effectleukopenia in a critically ill patient who developed this adverse reaction upon rechallenge with cefoxitin.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a case of infection with Adverse-EffectMycobacterium abscessus in a 67 - year - old woman receiving Druginfliximab as a component of her therapy for RA.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect This case study is the second report of Adverse-Effectlocalized purpura after prolonged Druglamotrigine treatment suggesting this may be an atypical lamotrigine - induced drug reaction.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect After identification of the index patient, additional inquiry revealed that the patient's mother was hospitalized previously for overwhelming Adverse-Effectsepsis associated with Drugmetamizole use.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Although a few case reports link Drugmetronidazole with the development of Adverse-Effectpseudomembranous colitis , albendazole has not been associated with the development of this condition.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Three cases of Adverse-Effectpseudocyst of the pancreas in two women and one man have previously been reported with the use of intravenous DrugL - asparaginase .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The Adverse-Effectoligohidrosis caused by Drugzonisamide was reversible in that the patient regained the ability to sweat within 2 weeks of the cessation of drug administration.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Massive DrugCBZ OD may produce a Adverse-Effectreversible encephalopathy that includes cortical hyperexcitability, a profound burst - suppression EEG pattern, and cranial nerve areflexia.
0.9999 Adverse-Effect Massive DrugCBZ OD may produce a reversible encephalopathy that includes cortical hyperexcitability, a Adverse-Effectprofound burst - suppression EEG pattern , and cranial nerve areflexia.
0.9998 Adverse-Effect Massive DrugCBZ OD may produce a reversible encephalopathy that includes Adverse-Effectcortical hyperexcitability , a profound burst - suppression EEG pattern, and cranial nerve areflexia.
0.9998 Adverse-Effect Massive DrugCBZ OD may produce a reversible encephalopathy that includes cortical hyperexcitability, a profound burst - suppression EEG pattern, and Adverse-Effectcranial nerve areflexia .
0.9996 Adverse-Effect Massive DrugCBZ OD may produce a reversible encephalopathy that includes cortical hyperexcitability, a profound burst - suppression EEG pattern, and cranial Adverse-Effectnerve areflexia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectProgressive interstitial fibrosis with roentgenographic honeycombing developed in the case of a psoriatic patient who had been on a regimen of Drugmethotrexate for 18 years.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Case 4 : A 61 - year - old male alcoholic who remained completely abstinent while taking Drugcyanamide for 3 years showed slight Adverse-Effectelevation of serum transaminases .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A retrospective review of TTP patients with Drugquinine - associated Adverse-Effectthrombotic microangiopathy ( TMA ) for whom ADAMTS13 was measured before plasma exchange was performed.
0.9991 Adverse-Effect A retrospective review of TTP patients with Drugquinine - associated thrombotic microangiopathy ( Adverse-EffectTMA ) for whom ADAMTS13 was measured before plasma exchange was performed.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe children and adolescents with chronic hematologic and oncologic diseases who exhibited drug - seeking behavior or Adverse-Effectanticholinergic symptoms with the use of Drugdiphenhydramine .
1.0000 Adverse-Effect We describe children and adolescents with chronic hematologic and oncologic diseases who exhibited Adverse-Effectdrug - seeking behavior or anticholinergic symptoms with the use of Drugdiphenhydramine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Three patients are reported without a history of angina pectoris who had clinical and electrocardiographic evidence of Adverse-Effectmyocardial ischemia during and immediately after DrugBCNU infusion.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect No cases of renal acidosis, and only one case of Adverse-Effectnephrogenic diabetes insipidus , has been previously reported as a complication of Drugfoscarnet treatment.
0.9999 Adverse-Effect No cases of Adverse-Effectrenal acidosis , and only one case of nephrogenic diabetes insipidus, has been previously reported as a complication of Drugfoscarnet treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Clinicians have been aware of lithium toxicity for many years and traditionally have administered thiazide diuretics for Druglithium - induced Adverse-Effectpolyuria and nephrogenic diabetes insipidus.
0.9989 Adverse-Effect Clinicians have been aware of lithium toxicity for many years and traditionally have administered thiazide diuretics for Druglithium - induced polyuria and Adverse-Effectnephrogenic diabetes insipidus .
0.9490 Adverse-Effect Clinicians have been aware of Druglithium toxicity for many years and traditionally have administered thiazide diuretics for lithium - induced Adverse-Effectpolyuria and nephrogenic diabetes insipidus.
0.9259 Adverse-Effect Clinicians have been aware of Druglithium toxicity for many years and traditionally have administered thiazide diuretics for lithium - induced polyuria and Adverse-Effectnephrogenic diabetes insipidus .
0.9978 Adverse-Effect Clinicians have been aware of lithium toxicity for many years and traditionally have administered Drugthiazide diuretics for lithium - induced Adverse-Effectpolyuria and nephrogenic diabetes insipidus.
0.9909 Adverse-Effect Clinicians have been aware of lithium toxicity for many years and traditionally have administered Drugthiazide diuretics for lithium - induced polyuria and Adverse-Effectnephrogenic diabetes insipidus .
Adverse-Effect Clinicians have been aware of Druglithium Adverse-Effectlithium toxicity for many years and traditionally have administered thiazide diuretics for lithium - induced polyuria and nephrogenic diabetes insipidus.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Thrombotic thrombocytopenic purpura ( Adverse-EffectTTP ) developed in a patient with seropositive rheumatoid arthritis ( RA ) after 2 1 / 2 months of treatment with Drugpenicillamine .
0.9999 Adverse-Effect Adverse-EffectThrombotic thrombocytopenic purpura ( TTP ) developed in a patient with seropositive rheumatoid arthritis ( RA ) after 2 1 / 2 months of treatment with Drugpenicillamine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect These evolutional changes in both proteinuria and glomerular histology suggest a close linkage between the DrugM - CSF treatment and Adverse-Effectmacrophage - related glomerular injury .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A previous review described data on 15 patients who experienced acute hemoglobinemia or Adverse-Effecthemoglobinuria following Druganti - D IGIV administration for ITP or secondary thrombocytopenia.
0.9992 Adverse-Effect A previous review described data on 15 patients who experienced Adverse-Effectacute hemoglobinemia or hemoglobinuria following Druganti - D IGIV administration for ITP or secondary thrombocytopenia.
1.0000 Adverse-Effect A previous review described data on 15 patients who experienced acute hemoglobinemia or Adverse-Effecthemoglobinuria following Druganti - D IGIV administration for ITP or secondary thrombocytopenia.
0.9992 Adverse-Effect A previous review described data on 15 patients who experienced Adverse-Effectacute hemoglobinemia or hemoglobinuria following Druganti - D IGIV administration for ITP or secondary thrombocytopenia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This is an image and brief case report of a 13 - year - old boy who presented with Adverse-Effectsevere rash and systemic symptoms after starting Drugoxcarbazepine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The authors describe a case of Adverse-Effectoral - facial dyskinesia that occurred after discontinuation of Drugamoxapine , and antidepressant which may also have neuroleptic effects.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect After Adverse-Effectgastric - outlet obstruction was recognized in several infants who received Drugprostaglandin E1 , we studied the association between the drug and this complication.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectGynecomastia developed in two epileptic patients some months after the addition of oral Drugfluoresone 750 mg daily to the phenobarbital and phenytoin already being administered.
0.9999 Adverse-Effect Adverse-EffectGynecomastia developed in two epileptic patients some months after the addition of oral fluoresone 750 mg daily to the Drugphenobarbital and phenytoin already being administered.
0.9999 Adverse-Effect Adverse-EffectGynecomastia developed in two epileptic patients some months after the addition of oral fluoresone 750 mg daily to the phenobarbital and Drugphenytoin already being administered.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case admitted with a first - detected, Adverse-Effectsymptomatic paroxysmal atrial fibrillation in a healthy patient after self - medication with Drugvardenafil .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : We present a case of a patient with CML who developed Adverse-EffectKS 12 months after starting treatment with Drugimatinib 400 mg / d.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The probable Adverse-Effectproarrhythmic action of Drugamiodarone , although rare, is reviewed along with a discussion of the novel use of intravenous magnesium sulfate therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report three cases of DrugIFN beta induced Adverse-Effecthepatitis in MS and discuss the pathology findings and possible mechanisms of drug - induced liver injury.
0.9964 Adverse-Effect We report three cases of DrugIFN beta induced hepatitis in MS and discuss the pathology findings and possible mechanisms of drug - induced Adverse-Effectliver injury .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We conclude that low - dose DrugHU therapy in patients with thalassemia intermedia may Adverse-Effectincrease total Hb levels sufficiently to eliminate the need for transfusions.
1.0000 Adverse-Effect We conclude that low - dose DrugHU therapy in patients with thalassemia intermedia may Adverse-Effectincrease total Hb levels sufficiently to eliminate the need for transfusions.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This case report describes the development of asymptomatic visual field defects ( Adverse-EffectVFDs ) in a psychiatric patient with bipolar disorder receiving adjunctive Drugtiagabine treatment.
0.9999 Adverse-Effect This case report describes the development of asymptomatic Adverse-Effectvisual field defects ( VFDs ) in a psychiatric patient with bipolar disorder receiving adjunctive Drugtiagabine treatment.
1.0000 Adverse-Effect This case report describes the development of Adverse-Effectasymptomatic visual field defects ( VFDs ) in a psychiatric patient with bipolar disorder receiving adjunctive Drugtiagabine treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugAmiodarone was the third drug to induce Adverse-EffectAVT in this patient ; she received 200 mg / day six days per week for six months.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Three days after receiving intravitreal injection of Drugbevacizumab ( 1. 25 mg in 0. 1 ml ), he developed Adverse-Effectacute vision loss and change of consciousness.
1.0000 Adverse-Effect Three days after receiving intravitreal injection of Drugbevacizumab ( 1. 25 mg in 0. 1 ml ), he developed acute vision loss and Adverse-Effectchange of consciousness .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Two of these patients, who also received the anti - emetic Drugprochlorperazine , Adverse-Effectlost consciousness for 48 - 72 h and then fully recovered.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect CONCLUSIONS : This is the second case report that describes Druggemcitabine - induced Adverse-Effectradiation recall in rectus abdominus muscles after gemcitabine - based radiation therapy.
0.9557 Adverse-Effect CONCLUSIONS : This is the second case report that describes gemcitabine - induced Adverse-Effectradiation recall in rectus abdominus muscles after Druggemcitabine - based radiation therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The 5 patients had severe renovascular disease which might thus represent a significant risk factor in the development of Drugcaptopril - induced Adverse-Effectacute renal failure .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Although Adverse-Effectvasculitis has been reported in the course of hairy cell leukaemia, it has only rarely been reported as the consequence of Drugcladribine treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Treatment of ELP in children is generally supportive, with the symptoms and Adverse-Effectroentgenographic abnormalities resolving within months after stopping the use of Drugmineral oil .
0.9998 Adverse-Effect Treatment of Adverse-EffectELP in children is generally supportive, with the symptoms and roentgenographic abnormalities resolving within months after stopping the use of Drugmineral oil .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect This case illustrates that the Adverse-Effecthemophagocytic syndrome associated with reactivation of EBV can occur as part of drug hypersensitivity reactions in RA patients taking Drugsulfasalazine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect One patient was an 80 - year - old woman who was admitted for Adverse-EffectStaphylococcus aureus knee arthritis after several intraarticular injections of Drugsodium hyaluronate and corticosteroids.
1.0000 Adverse-Effect One patient was an 80 - year - old woman who was admitted for Adverse-EffectStaphylococcus aureus knee arthritis after several intraarticular injections of sodium hyaluronate and Drugcorticosteroids .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The incidence of oral - Drugverapamil - induced Adverse-Effecthypotension in the presence of concomitant beta - adrenergic blockade by the oral route is quite rare.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Painful Adverse-Effectneutrophilic skin lesions were observed in two children receiving Druggranulocyte colony - stimulating factor ( G - CSF ) for treatment of idiopathic neutropenia.
0.9994 Adverse-Effect Painful Adverse-Effectneutrophilic skin lesions were observed in two children receiving granulocyte colony - stimulating factor ( DrugG - CSF ) for treatment of idiopathic neutropenia.
1.0000 Adverse-Effect Adverse-EffectPainful neutrophilic skin lesions were observed in two children receiving Druggranulocyte colony - stimulating factor ( G - CSF ) for treatment of idiopathic neutropenia.
0.9998 Adverse-Effect Adverse-EffectPainful neutrophilic skin lesions were observed in two children receiving granulocyte colony - stimulating factor ( DrugG - CSF ) for treatment of idiopathic neutropenia.
Adverse-Effect Adverse-EffectPainful neutrophilic skin lesions were observed in two children receiving Druggranulocyte colony - stimulating factor ( G - CSF ) for treatment of idiopathic neutropenia.
Adverse-Effect Adverse-EffectPainful neutrophilic skin lesions were observed in two children receiving granulocyte colony - stimulating factor ( DrugG - CSF ) for treatment of idiopathic neutropenia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This case had radiation fibrosis, so we suggest that radiation fibrosis may be another contributor of the occurrence of Adverse-EffectILD in patients taking Drugerlotinib .
0.9998 Adverse-Effect This case had radiation fibrosis, so we suggest that Adverse-Effectradiation fibrosis may be another contributor of the occurrence of ILD in patients taking Drugerlotinib .
0.9989 Adverse-Effect This case had Adverse-Effectradiation fibrosis , so we suggest that radiation fibrosis may be another contributor of the occurrence of ILD in patients taking Drugerlotinib .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect We cared for a patient with progressive renal impairment who presented with blurred vision, QRS broadening and cardiac failure due to chronic Drugcibenzoline Adverse-Effectcibenzoline intoxication .
0.9998 Adverse-Effect We cared for a patient with progressive renal impairment who presented with Adverse-Effectblurred vision , QRS broadening and cardiac failure due to chronic Drugcibenzoline intoxication.
0.9997 Adverse-Effect We cared for a patient with progressive renal impairment who presented with blurred vision, Adverse-EffectQRS broadening and cardiac failure due to chronic Drugcibenzoline intoxication.
0.9993 Adverse-Effect We cared for a patient with progressive renal impairment who presented with blurred vision, QRS broadening and Adverse-Effectcardiac failure due to chronic Drugcibenzoline intoxication.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Seizures and Adverse-Effectextrapyramidal symptoms in a patient with Tourette's syndrome, Asperger's syndrome, and multiple sclerosis treated with Druginterferon beta - 1a and clomipramine.
0.9998 Adverse-Effect Seizures and Adverse-Effectextrapyramidal symptoms in a patient with Tourette's syndrome, Asperger's syndrome, and multiple sclerosis treated with interferon beta - 1a and Drugclomipramine .
0.9997 Adverse-Effect Adverse-EffectSeizures and extrapyramidal symptoms in a patient with Tourette's syndrome, Asperger's syndrome, and multiple sclerosis treated with Druginterferon beta - 1a and clomipramine.
0.9996 Adverse-Effect Adverse-EffectSeizures and extrapyramidal symptoms in a patient with Tourette's syndrome, Asperger's syndrome, and multiple sclerosis treated with interferon beta - 1a and Drugclomipramine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect BACKGROUND : DrugColchicine has a known adverse effect on Adverse-Effectwound healing through its inhibitory effect on tubulin - dependent cell functions and through collagenase activation.
Adverse-Effect BACKGROUND : DrugColchicine has a known adverse effect on wound healing through its inhibitory effect on tubulin - dependent cell functions and through Adverse-Effectcollagenase activation .
Adverse-Effect BACKGROUND : DrugColchicine has a known Adverse-Effectadverse effect on wound healing through its inhibitory effect on tubulin - dependent cell functions and through collagenase activation.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Thrombolytic therapy with tissue plasminogen activator ( DrugtPA ) for acute myocardial infarction may result in major bleeding complications such as Adverse-Effectgastrointestinal or intracranial bleeding .
0.9998 Adverse-Effect Thrombolytic therapy with Drugtissue plasminogen activator ( tPA ) for acute myocardial infarction may result in major bleeding complications such as Adverse-Effectgastrointestinal or intracranial bleeding .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe the development of Adverse-Effectcutaneous scleroderma in 3 patients coincident with the use of Drugbleomycin in low cumulative doses of less than 100 U.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Drug - induced Adverse-Effectpsychosis resulted from the administration of Drugquinacrine hydrochloride at a dosage of 100 mg twice daily for the treatment of discoid lupus.
Score Relation Text (Head - Tail)
0.9987 Adverse-Effect The interval between initiating treatment with Druginterferon alfa and onset of Adverse-Effectanterior ischemic optic neuropathy was similar to that of interferon - associated vascular retinopathy.
0.9952 Adverse-Effect The interval between initiating treatment with interferon alfa and onset of anterior ischemic optic neuropathy was similar to that of Druginterferon - associated Adverse-Effectvascular retinopathy .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of AILD in an 80 - year - old male who presented with a generalized pruritic maculopapular eruption and Adverse-Effectfever following Drugdoxycycline administration.
1.0000 Adverse-Effect We report a case of Adverse-EffectAILD in an 80 - year - old male who presented with a generalized pruritic maculopapular eruption and fever following Drugdoxycycline administration.
1.0000 Adverse-Effect We report a case of AILD in an 80 - year - old male who presented with a Adverse-Effectgeneralized pruritic maculopapular eruption and fever following Drugdoxycycline administration.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Post marketing studies of Interferon - beta ( DrugIFN beta ) therapy in multiple sclerosis ( MS ) have demonstrated surprisingly high rates of Adverse-Effecthepatotoxicity .
0.9993 Adverse-Effect Post marketing studies of DrugInterferon - beta ( IFN beta ) therapy in multiple sclerosis ( MS ) have demonstrated surprisingly high rates of Adverse-Effecthepatotoxicity .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectHypersensitivity to Drugcarboplatin has been reported in up to 44 % of patients receiving this antineoplastic agent, usually occurring after several courses of treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect During her third cycle, she again received Drugcisplatin Adverse-Effect100 mg / m2 over 30 minutes and developed palmar pruritus, urticaria, and edema.
0.9999 Adverse-Effect During her third cycle, she again received Drugcisplatin 100 mg / m2 over 30 minutes and developed Adverse-Effectpalmar pruritus , urticaria, and edema.
0.9999 Adverse-Effect During her third cycle, she again received Drugcisplatin 100 mg / m2 over 30 minutes and developed palmar pruritus, Adverse-Effecturticaria , and edema.
0.9999 Adverse-Effect During her third cycle, she again received Drugcisplatin 100 mg / m2 over 30 minutes and developed palmar pruritus, urticaria, and Adverse-Effectedema .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The authors report a further case of Drugmethimazole - associated Adverse-Effectliver damage and present a brief review of eleven previous cases found in the literature.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of fulminant Adverse-Effectneuroleptic malignant syndrome in a man aged 70 developing within 12 hours of starting six - hourly intravenous Drugmetoclopramide .
1.0000 Adverse-Effect We report a case of Adverse-Effectfulminant neuroleptic malignant syndrome in a man aged 70 developing within 12 hours of starting six - hourly intravenous Drugmetoclopramide .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect We describe 3 AS patients treated with Drugetanercept for active AS who developed new onset of Adverse-EffectCD while AS related symptoms responded well to etanercept.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect After a two - month interruption of interferon administration, natural Druginterferon alpha was given but followed by another episode of the same Adverse-Effectneurological manifestations .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a patient with androgen - independent prostate cancer in whom Adverse-EffectPSA continued to decrease for a period of 15 months after Drugflutamide withdrawal.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect 46 - year - old woman developed painful ulcers over her lower abdomen in the form of Adverse-Effectreticulate erythema after injecting Druginterferon beta - 1b subcutaneously for multiple sclerosis.
0.9997 Adverse-Effect 46 - year - old woman developed Adverse-Effectpainful ulcers over her lower abdomen in the form of reticulate erythema after injecting Druginterferon beta - 1b subcutaneously for multiple sclerosis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of Adverse-EffectSJS in a 14 - year - old male with nephrotic syndrome, who was treated with oral Drugprednisolone for 6 weeks.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Data have been published regarding the possibility that Drugtamoxifen may be responsible for the subsequent development of Adverse-Effectcarcinoma of the corpus uteri in these patients.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 56 - year - old Caucasian man who received concomitant chemotherapy and radiation for head and neck cancer developed Adverse-Effectfever concurrent with the administration of Drugamifostine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugCalcipotriol ( Daivonex R ; Leo Pharmaceuticals, Zurich, Switzerland ) may cause Adverse-Effectirritation of the skin , whereas allergic reactions are less common.
1.0000 Adverse-Effect DrugCalcipotriol ( Daivonex R ; Leo Pharmaceuticals, Zurich, Switzerland ) may cause irritation of the skin, whereas Adverse-Effectallergic reactions are less common.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect CONCLUSION : Patients with Druginsulin allergy may not have complete resolution of their symptoms after standard desensitization, particularly those patients with concomitant Adverse-Effectprotamine allergy .
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect OBJECTIVE : To report a case of Adverse-Effecttoxin - positive Clostridium difficile - induced colitis ( CDIC ) after use of Drugclindamycin phosphate vaginal cream.
1.0000 Adverse-Effect OBJECTIVE : To report a case of toxin - positive Clostridium difficile - induced colitis ( Adverse-EffectCDIC ) after use of Drugclindamycin phosphate vaginal cream.
Score Relation Text (Head - Tail)
0.9996 Adverse-Effect Pathogenesis of methotrexate - induced papular eruption in psoriasis may involve immune mechanisms other than those of Drugmethotrexate - induced Adverse-Effectcutaneous vasculitis in collagen vascular disease.
0.9996 Adverse-Effect Pathogenesis of Drugmethotrexate - induced Adverse-Effectpapular eruption in psoriasis may involve immune mechanisms other than those of methotrexate - induced cutaneous vasculitis in collagen vascular disease.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Two of the five patients who worsened motorically also developed Adverse-Effectencephalopathy during Drugrisperidone treatment ; the encephalopathy resolved when the patients were switched to clozapine treatment.
0.9998 Adverse-Effect Two of the five patients who Adverse-Effectworsened motorically also developed encephalopathy during Drugrisperidone treatment ; the encephalopathy resolved when the patients were switched to clozapine treatment.
0.9999 Adverse-Effect Two of the five patients who worsened motorically also developed encephalopathy during risperidone treatment ; the Adverse-Effectencephalopathy resolved when the patients were switched to Drugclozapine treatment.
0.9890 Adverse-Effect Two of the five patients who worsened motorically also developed encephalopathy during Drugrisperidone treatment ; the Adverse-Effectencephalopathy resolved when the patients were switched to clozapine treatment.
0.9818 Adverse-Effect Two of the five patients who Adverse-Effectworsened motorically also developed encephalopathy during risperidone treatment ; the encephalopathy resolved when the patients were switched to Drugclozapine treatment.
0.9608 Adverse-Effect Two of the five patients who worsened motorically also developed Adverse-Effectencephalopathy during risperidone treatment ; the encephalopathy resolved when the patients were switched to Drugclozapine treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectAcute ocular ischemic change may be associated with intravitreal injection of Drugbevacizumab in patients with vascular compromised diabetic retinopathy and / or underlying stenosis of the carotid artery.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect She was receiving phenytoin sodium 300 mg / day ; Drugcarbamazepine 200 mg four times daily had been discontinued four days before admission because of Adverse-Effectleukopenia .
0.9992 Adverse-Effect She was receiving Drugphenytoin sodium 300 mg / day ; carbamazepine 200 mg four times daily had been discontinued four days before admission because of Adverse-Effectleukopenia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect His Adverse-Effectimpaired memory was found to be due to the Drugatenolol he was on and he made a complete recovery on withdrawing the beta - blocker.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To describe two cases of Adverse-Effectrhabdomyolysis in patients taking Druglovastatin that were precipitated by the use of the newer macrolide antibiotics clarithromycin and azithromycin.
0.9999 Adverse-Effect OBJECTIVE : To describe two cases of Adverse-Effectrhabdomyolysis in patients taking lovastatin that were precipitated by the use of the newer macrolide antibiotics Drugclarithromycin and azithromycin.
0.9998 Adverse-Effect OBJECTIVE : To describe two cases of Adverse-Effectrhabdomyolysis in patients taking lovastatin that were precipitated by the use of the newer macrolide antibiotics clarithromycin and Drugazithromycin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This experience supports the hypothesis that heparin can be readministered early to patients with Drugheparin - associated Adverse-Effectthrombocytopenia and thrombosis, provided antiplatelet therapy is given.
0.9994 Adverse-Effect This experience supports the hypothesis that heparin can be readministered early to patients with Drugheparin - associated thrombocytopenia and Adverse-Effectthrombosis , provided antiplatelet therapy is given.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The frequency and relationship of Adverse-Effectgranulocytopenia caused by sustained - release Drugprocainamide in patients with tachyarrhythmias are briefly discussed, and prior reported cases are reviewed.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect To our knowledge, this is the first report of significant Adverse-Effecthypotension associated with intravenous Drugvalproate in the treatment of status epilepticus in the pediatric population.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a patient with rheumatoid arthritis treated with Druggold salts, who developed Adverse-Effectbilateral interstitial pulmonary abnormalities and showed a dramatic response on corticosteroid therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In this case, discontinuing Drugpiroxicam , a nonsteroidal anti - inflammatory drug, and starting a palliative treatment plan helped resolve a patient's Adverse-Effectulcers .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We observed Adverse-Effectventricular fibrillation in 2 patients who presented to the emergency department with pre - excited atrial fibrillation and were given 12 mg of Drugadenosine .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect On the 3rd day, an inferior vena cava ( IVC ) filter was placed with a Drugheparin flush, after which massive Adverse-EffectIVC thrombosis developed.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect An 8 - year - old girl, who had been vaccinated with DrugBCG without subsequent regional reactions, developed Adverse-Effectosteomyelitis in the left calcaneus 7 months later.
1.0000 Adverse-Effect An 8 - year - old girl, who had been vaccinated with DrugBCG without subsequent regional reactions, developed Adverse-Effectosteomyelitis in the left calcaneus 7 months later.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect In a female with acute lymphoblastic leukemia, inadvertent Drugdoxorubicin administration intrathecally caused severe, life - threatening, Adverse-Effectacute encephalopathy with high - pressure hydrocephalus.
0.9999 Adverse-Effect In a female with acute lymphoblastic leukemia, inadvertent Drugdoxorubicin administration intrathecally caused severe, life - threatening, acute encephalopathy with Adverse-Effecthigh - pressure hydrocephalus .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In conclusion, this case strongly suggests that Druggliclazide can induce Adverse-Effectacute icteric liver necro - inflammation which may be misdiagnosed clinically as acute viral hepatitis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of reversible DKA and new - onset Adverse-EffectDM that developed in a demented patient who was treated with Drugquetiapine for 14 days.
1.0000 Adverse-Effect We report a case of reversible Adverse-EffectDKA and new - onset DM that developed in a demented patient who was treated with Drugquetiapine for 14 days.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Mean time between initiation of Druggemcitabine therapy and onset of Adverse-EffectHUS was 7. 4 + / - 3. 5 months, or 21. 9 + / - 10. 9 doses of gemcitabine.
1.0000 Adverse-Effect Mean time between initiation of gemcitabine therapy and onset of Adverse-EffectHUS was 7. 4 + / - 3. 5 months, or 21. 9 + / - 10. 9 doses of Druggemcitabine .
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect Sodium phenylbutyrate was added to treatment with DrugHU in two patients, but failed to produce an increase in total Hb despite Adverse-Effectincreasing Hb F levels.
0.9994 Adverse-Effect DrugSodium phenylbutyrate was added to treatment with HU in two patients, but failed to produce an increase in total Hb despite Adverse-Effectincreasing Hb F levels.
1.0000 Adverse-Effect Sodium phenylbutyrate was added to treatment with DrugHU in two patients, but failed to produce an Adverse-Effectincrease in total Hb despite increasing Hb F levels.
0.9998 Adverse-Effect DrugSodium phenylbutyrate was added to treatment with HU in two patients, but failed to produce an Adverse-Effectincrease in total Hb despite increasing Hb F levels.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect INTERVENTIONS AND RESULTS : Adverse-EffectCardiac complications were observed in five pediatric patients who received between 4. 6 and 40. 8 mg / kg / d of Drugamphotericin B .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe the case of a nonatopic 17 - year - old girl with bronchial asthma and aspirin intolerance who developed a dramatic Adverse-Effectanaphylactic reaction to oral Drugprednisone .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect There remains a paucity of information pertaining to alternative anticoagulation strategies for use during cardiopulmonary bypass concomitant with Drugheparin - induced Adverse-Effectthrombocytopenia , especially in children.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectRenal failure is a rare complication associated with the use of Drugrifampicin for the treatment of tuberculosis, usually occurring well into the course of therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Of the four patients who responded to DrugHU with an Adverse-Effectincrease in total Hb , all reported symptomatic improvement and three have not required further transfusions.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Although moderate myelosuppression is not uncommonly seen in patients treated with Druglenalidomide , Adverse-Effectaplastic anemia has not previously been reported to be associated with this agent.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect The disease - modifying drugs he was taking, cyclosporin and Drugmethotrexate , were stopped, and the Adverse-Effectlymphoma resolved spontaneously without the use of chemotherapy.
0.9999 Adverse-Effect The disease - modifying drugs he was taking, Drugcyclosporin and methotrexate, were stopped, and the Adverse-Effectlymphoma resolved spontaneously without the use of chemotherapy.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect The results clearly demonstrate that DrugCPH82 was associated with suppression of the endogeneous production of ACTH and cortisol with a concomitant paradoxical picture of clinical Adverse-Effecthypercortisolism .
Adverse-Effect The results clearly demonstrate that DrugCPH82 was associated with Adverse-Effectsuppression of the endogeneous production of ACTH and cortisol with a concomitant paradoxical picture of clinical hypercortisolism.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect However, peripheral neuropathy and Adverse-Effectbone marrow depression led to Druglinezolid withdrawal in seven patients, and neuropathy may not be fully reversible in all patients.
0.9999 Adverse-Effect However, Adverse-Effectperipheral neuropathy and bone marrow depression led to Druglinezolid withdrawal in seven patients, and neuropathy may not be fully reversible in all patients.
0.9999 Adverse-Effect However, peripheral neuropathy and bone marrow depression led to Druglinezolid withdrawal in seven patients, and Adverse-Effectneuropathy may not be fully reversible in all patients.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugDocetaxel induced Adverse-EffectMeibomian duct inflammation and blockage is the likely cause of this presentation in a patient with no history of eyelid masses in the past.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We present a case of Adverse-Effectstroke after DrugPPA ingestion that occurred 4 months after the recall in an 8 - year - old boy on chronic peritoneal dialysis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The authors describe a case of combined lithium and Drughaloperidol toxicity characterized by Adverse-Effecthyperpyrexia , severe rigidity, mutism, and development of irreversible tardive dyskinesia.
0.9999 Adverse-Effect The authors describe a case of combined lithium and Drughaloperidol toxicity characterized by hyperpyrexia, severe rigidity, mutism, and development of Adverse-Effectirreversible tardive dyskinesia .
0.9999 Adverse-Effect The authors describe a case of combined lithium and Drughaloperidol toxicity characterized by hyperpyrexia, severe rigidity, Adverse-Effectmutism , and development of irreversible tardive dyskinesia.
0.9998 Adverse-Effect The authors describe a case of combined lithium and Drughaloperidol toxicity characterized by hyperpyrexia, Adverse-Effectsevere rigidity , mutism, and development of irreversible tardive dyskinesia.
0.9998 Adverse-Effect The authors describe a case of combined Druglithium and haloperidol toxicity characterized by Adverse-Effecthyperpyrexia , severe rigidity, mutism, and development of irreversible tardive dyskinesia.
0.9997 Adverse-Effect The authors describe a case of combined Druglithium and haloperidol toxicity characterized by hyperpyrexia, severe rigidity, mutism, and development of Adverse-Effectirreversible tardive dyskinesia .
0.9996 Adverse-Effect The authors describe a case of combined Druglithium and haloperidol toxicity characterized by hyperpyrexia, severe rigidity, Adverse-Effectmutism , and development of irreversible tardive dyskinesia.
0.9993 Adverse-Effect The authors describe a case of combined Druglithium and haloperidol toxicity characterized by hyperpyrexia, Adverse-Effectsevere rigidity , mutism, and development of irreversible tardive dyskinesia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a child with yolk sac tumor who developed Adverse-Effectlocalized pigmentation after the first course of chemotherapy regimen that included Drugcisplatin , etoposide and bleomycin.
1.0000 Adverse-Effect We report a child with yolk sac tumor who developed Adverse-Effectlocalized pigmentation after the first course of chemotherapy regimen that included cisplatin, Drugetoposide and bleomycin.
1.0000 Adverse-Effect We report a child with yolk sac tumor who developed Adverse-Effectlocalized pigmentation after the first course of chemotherapy regimen that included cisplatin, etoposide and Drugbleomycin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The site of thrombosis and the chronological relationship with the IIR implicates a Adverse-Effecthypersensitivity to Druginfliximab in the causation of the venous thrombosis in this case.
0.9998 Adverse-Effect The site of thrombosis and the chronological relationship with the Adverse-EffectIIR implicates a hypersensitivity to Druginfliximab in the causation of the venous thrombosis in this case.
0.9997 Adverse-Effect The site of thrombosis and the chronological relationship with the IIR implicates a hypersensitivity to Druginfliximab in the causation of the Adverse-Effectvenous thrombosis in this case.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect The authors describe three families in whom the occurrence of Adverse-EffectFVS in all the siblings strongly suggests hereditary susceptibility to Drugvalproic acid - induced adverse outcome.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the case of a 60 - year - old woman who developed erythema and Adverse-Effecterosions in the axilla and groin while on DrugPLD for breast cancer.
1.0000 Adverse-Effect We report the case of a 60 - year - old woman who developed Adverse-Effecterythema and erosions in the axilla and groin while on DrugPLD for breast cancer.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 73 - year - old woman presented with fever and Adverse-Effectcough 2 weeks after completing the third cycle of Drugfludarabine for chronic lymphocytic leukemia ( CLL ).
1.0000 Adverse-Effect A 73 - year - old woman presented with Adverse-Effectfever and cough 2 weeks after completing the third cycle of Drugfludarabine for chronic lymphocytic leukemia ( CLL ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We observed 3 diabetic patients with intolerable dizziness followed by nausea and Adverse-Effectvomiting immediately after an initial administration of the alpha - glucosidase inhibitor, Drugvoglibose .
1.0000 Adverse-Effect We observed 3 diabetic patients with intolerable dizziness followed by Adverse-Effectnausea and vomiting immediately after an initial administration of the alpha - glucosidase inhibitor, Drugvoglibose .
1.0000 Adverse-Effect We observed 3 diabetic patients with Adverse-Effectintolerable dizziness followed by nausea and vomiting immediately after an initial administration of the alpha - glucosidase inhibitor, Drugvoglibose .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Despite minimal short - term side effects and apparent efficacy, chronic treatment of MG with DrugMM may be associated with increased risk of Adverse-Effectlymphoproliferative disorders .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 62 - year - old Indian with diabetic nephropathy controlled with Drugmetformin , developed Adverse-Effectmiliary tuberculosis for which he was treated with rifampicin, isoniazid and ethambutol.
1.0000 Adverse-Effect A 62 - year - old Indian with diabetic nephropathy controlled with metformin, developed Adverse-Effectmiliary tuberculosis for which he was treated with Drugrifampicin , isoniazid and ethambutol.
0.9999 Adverse-Effect A 62 - year - old Indian with diabetic nephropathy controlled with metformin, developed Adverse-Effectmiliary tuberculosis for which he was treated with rifampicin, Drugisoniazid and ethambutol.
0.9999 Adverse-Effect A 62 - year - old Indian with diabetic nephropathy controlled with metformin, developed Adverse-Effectmiliary tuberculosis for which he was treated with rifampicin, isoniazid and Drugethambutol .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We present a case of Drugethylenediamine - induced Adverse-Effectdelayed hypersensitivity reaction in a 46 - year - old woman who received parenteral aminophylline for an acute asthma exacerbation.
1.0000 Adverse-Effect We present a case of ethylenediamine - induced Adverse-Effectdelayed hypersensitivity reaction in a 46 - year - old woman who received parenteral Drugaminophylline for an acute asthma exacerbation.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A mentally retarded 23 - year - old woman with myoclonic astatic epilepsy developed an abnormal posture of extreme forward flexion, called Adverse-Effectcamptocormia , during Drugvalproate monotherapy.
0.9999 Adverse-Effect A mentally retarded 23 - year - old woman with myoclonic astatic epilepsy developed an Adverse-Effectabnormal posture of extreme forward flexion , called camptocormia, during Drugvalproate monotherapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect To the best of our knowledge, Adverse-Effectcorneoscleral melting in the first postoperative week after a single intraoperative application of Drugmitomycin C has not been reported.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect PURPOSE : To describe spectral - domain optical coherence tomography ( SD - OCT ) and adaptive optics ( AO ) imaging in Drughydroxychloroquine Adverse-Effectretinal toxicity .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect One patient who received Drugclindamycin had liver biopsy findings of Adverse-Effectmarked cholestasis , portal inflammation, bile duct injury and bile duct paucity ( ductopenia ).
0.9999 Adverse-Effect One patient who received Drugclindamycin had liver biopsy findings of marked cholestasis, portal inflammation, bile duct injury and bile duct paucity ( Adverse-Effectductopenia ).
0.9999 Adverse-Effect One patient who received Drugclindamycin had liver biopsy findings of marked cholestasis, portal inflammation, Adverse-Effectbile duct injury and bile duct paucity ( ductopenia ).
0.9999 Adverse-Effect One patient who received Drugclindamycin had liver biopsy findings of marked cholestasis, Adverse-Effectportal inflammation , bile duct injury and bile duct paucity ( ductopenia ).
0.9999 Adverse-Effect One patient who received Drugclindamycin had liver biopsy findings of marked cholestasis, portal inflammation, bile duct injury and Adverse-Effectbile duct paucity ( ductopenia ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We present a case in which Drugdipyridamole induced Adverse-Effecthigh - grade atrioventricular ( AV ) block that responded promptly to intravenous aminophylline but not to atropine.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of acute generalized exanthematous pustulosis ( Adverse-EffectAGEP ) in a 50 - year - old woman that was attributed to the ingestion of Drugnimesulide .
1.0000 Adverse-Effect We report a case of Adverse-Effectacute generalized exanthematous pustulosis ( AGEP ) in a 50 - year - old woman that was attributed to the ingestion of Drugnimesulide .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect A girl with cystic fibrosis and cyclic neutropenia developed an Adverse-Effecterythematous papular eruption without fever or neutrophilia 7 months after commencing therapy with DrugG - CSF .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Life - threatening Adverse-Effectanaphylactoid reaction to Drugamifostine used with concurrent chemoradiotherapy for nasopharyngeal cancer in a patient with dermatomyositis : a case report with literature review.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect To the best of our knowledge only two previous cases of Adverse-EffectAML have been linked to treatment of HCL with purine analogs, both with Drug2 - chlorodeoxyadenosine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The possible effects of tamoxifen upon the uterus are discussed in this article, in view of reports of Drugtamoxifen associated with Adverse-Effectendometrial carcinoma and endometriosis.
0.9992 Adverse-Effect The possible effects of tamoxifen upon the uterus are discussed in this article, in view of reports of Drugtamoxifen associated with endometrial carcinoma and Adverse-Effectendometriosis .
0.9938 Adverse-Effect The possible effects of Drugtamoxifen upon the uterus are discussed in this article, in view of reports of tamoxifen associated with Adverse-Effectendometrial carcinoma and endometriosis.
0.9914 Adverse-Effect The possible effects of Drugtamoxifen upon the uterus are discussed in this article, in view of reports of tamoxifen associated with endometrial carcinoma and Adverse-Effectendometriosis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect It is suggested that the patient had Drugsulfasalazine - induced Adverse-Effectlupus , which manifested with serositis and pulmonary parenchymal involvement in the absence of joint symptoms.
0.9999 Adverse-Effect It is suggested that the patient had Drugsulfasalazine - induced lupus, which manifested with Adverse-Effectserositis and pulmonary parenchymal involvement in the absence of joint symptoms.
0.9999 Adverse-Effect It is suggested that the patient had Drugsulfasalazine - induced lupus, which manifested with serositis and Adverse-Effectpulmonary parenchymal involvement in the absence of joint symptoms.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The authors report a case of a patient who received Drugalteplase for acute myocardial infarction and developed spontaneous Adverse-Effectsubfascial hematoma without any evidence of direct trauma.
1.0000 Adverse-Effect The authors report a case of a patient who received Drugalteplase for acute myocardial infarction and developed Adverse-Effectspontaneous subfascial hematoma without any evidence of direct trauma.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report five cases of restless legs syndrome ( RLS ) and periodic limb movements during sleep ( Adverse-EffectPLMS ) that were probably associated with Drugolanzapine .
1.0000 Adverse-Effect We report five cases of Adverse-Effectrestless legs syndrome ( RLS ) and periodic limb movements during sleep ( PLMS ) that were probably associated with Drugolanzapine .
1.0000 Adverse-Effect We report five cases of restless legs syndrome ( RLS ) and Adverse-Effectperiodic limb movements during sleep ( PLMS ) that were probably associated with Drugolanzapine .
1.0000 Adverse-Effect We report five cases of restless legs syndrome ( Adverse-EffectRLS ) and periodic limb movements during sleep ( PLMS ) that were probably associated with Drugolanzapine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The successful development and implementation of this protocol will have impact on patients who have Adverse-Effectanaphylactic reactions to DrugMTX but require this medication for specific diseases.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Rapid identification of Adverse-Effectspeech loss linked to DrugFK506 may be important because reduction or cessation of the drug may be associated with reverse of speech loss.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectOcular hypertension occurred 1 month after the second Drugranibizumab injection in patients 1 and 3, and 1 month after the first ranibizumab in patient 2.
0.9919 Adverse-Effect Adverse-EffectOcular hypertension occurred 1 month after the second ranibizumab injection in patients 1 and 3, and 1 month after the first Drugranibizumab in patient 2.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBSERVATIONS : We observed Adverse-Effectaggravation and spreading of a psoriatic plaque when treated topically with the toll - like receptor ( TLR ) 7 agonist Drugimiquimod .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 59 - year - old woman with myasthenia gravis who received a large dose of Drugpyridostigmine bromide developed Adverse-Effectpostoperative psychosis and was diagnosed as having bromide intoxication.
0.9980 Adverse-Effect A 59 - year - old woman with myasthenia gravis who received a large dose of Drugpyridostigmine bromide developed postoperative psychosis and was diagnosed as having Adverse-Effectbromide intoxication .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect BACKGROUND : DrugHydroxyurea is a cytostatic agent used to treat myeloproliferative disorders and long - term treatment is associated with Adverse-Effectmucocutaneous adverse events and nail hyperpigmentation.
0.9999 Adverse-Effect BACKGROUND : DrugHydroxyurea is a cytostatic agent used to treat myeloproliferative disorders and long - term treatment is associated with mucocutaneous adverse events and Adverse-Effectnail hyperpigmentation .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Due to the increasing use of DrugTMP - SMX in children, clinicians should be aware of this potentially life - threatening, Adverse-Effectimmunemediated hypersensitivity reaction .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of Adverse-Effectgeneralized cutaneous sclerosis associated with muscle and oesophageal involvement in a patient exposed to herbicides containing Drugbromocil , diuron and aminotriazole.
0.9998 Adverse-Effect We report a case of Adverse-Effectgeneralized cutaneous sclerosis associated with muscle and oesophageal involvement in a patient exposed to herbicides containing bromocil, diuron and Drugaminotriazole .
0.9998 Adverse-Effect We report a case of Adverse-Effectgeneralized cutaneous sclerosis associated with muscle and oesophageal involvement in a patient exposed to herbicides containing bromocil, Drugdiuron and aminotriazole.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect These findings suggest that the Adverse-Effectcorneal and retinal changes are the result of a toxic effect of Drugtamoxifen when used in the doses and duration described.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a premature infant who developed Adverse-Effectseizures associated with intraventricular administration of Drugnafcillin and discuss the need for electroencephalographic monitoring of patients receiving intraventricular antibiotics.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the successful treatment of Drugheparin - induced Adverse-Effectthrombocytopenia and subsequent hemorrhagic complications postoperatively in a 2 - year - old child with Danaparoid ( orgaran ).
0.9999 Adverse-Effect We report the successful treatment of Drugheparin - induced thrombocytopenia and subsequent Adverse-Effecthemorrhagic complications postoperatively in a 2 - year - old child with Danaparoid ( orgaran ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This patient, who had a history of osteoarthritis, had severe Adverse-Effecthepatitis 5 weeks after being started on Drugdiclofenac for increasing pain in the joints.
1.0000 Adverse-Effect This patient, who had a history of osteoarthritis, had Adverse-Effectsevere hepatitis 5 weeks after being started on Drugdiclofenac for increasing pain in the joints.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DISCUSSION : The main adverse effects of Drugleflunomide consist of Adverse-Effectdiarrhea , nausea, liver enzyme elevation, hypertension, alopecia, and allergic skin reactions.
1.0000 Adverse-Effect DISCUSSION : The main adverse effects of Drugleflunomide consist of diarrhea, nausea, liver enzyme elevation, hypertension, Adverse-Effectalopecia , and allergic skin reactions.
1.0000 Adverse-Effect DISCUSSION : The main adverse effects of Drugleflunomide consist of diarrhea, Adverse-Effectnausea , liver enzyme elevation, hypertension, alopecia, and allergic skin reactions.
1.0000 Adverse-Effect DISCUSSION : The main adverse effects of Drugleflunomide consist of diarrhea, nausea, liver enzyme elevation, Adverse-Effecthypertension , alopecia, and allergic skin reactions.
1.0000 Adverse-Effect DISCUSSION : The main adverse effects of Drugleflunomide consist of diarrhea, nausea, liver enzyme elevation, hypertension, alopecia, and Adverse-Effectallergic skin reactions .
1.0000 Adverse-Effect DISCUSSION : The main adverse effects of Drugleflunomide consist of diarrhea, nausea, Adverse-Effectliver enzyme elevation , hypertension, alopecia, and allergic skin reactions.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This case supports the view that in Druggold - induced Adverse-Effectpneumonitis a prolonged treatment with corticosteroids may be necessary, as lung function continued to improve.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect METHODS : A patient who developed dramatic, permanent Adverse-Effectvision loss after a 9 - month course of treatment with Drugethambutol and isoniazid for pulmonary tuberculosis is presented.
1.0000 Adverse-Effect METHODS : A patient who developed dramatic, permanent Adverse-Effectvision loss after a 9 - month course of treatment with ethambutol and Drugisoniazid for pulmonary tuberculosis is presented.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The occurrence of symptoms that could be ascribed to an Adverse-Effectacute coronary syndrome should always be taken seriously during the first Drugrituximab infusion and investigated aggressively.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect There have been many reports of probable Druglithium - induced Adverse-Effectorganic brain syndromes occurring when serum lithium levels are within or close to the therapeutic range.
0.9991 Adverse-Effect There have been many reports of probable lithium - induced Adverse-Effectorganic brain syndromes occurring when serum Druglithium levels are within or close to the therapeutic range.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The case demonstrates that Adverse-Effecthypersensitivity reaction to Drugpranlukast and resultant ATIN is possible, and that periodic urine testing in patients receiving pranlukast should be considered.
0.9999 Adverse-Effect The case demonstrates that hypersensitivity reaction to Drugpranlukast and resultant Adverse-EffectATIN is possible, and that periodic urine testing in patients receiving pranlukast should be considered.
0.9980 Adverse-Effect The case demonstrates that hypersensitivity reaction to pranlukast and resultant Adverse-EffectATIN is possible, and that periodic urine testing in patients receiving Drugpranlukast should be considered.
0.9825 Adverse-Effect The case demonstrates that Adverse-Effecthypersensitivity reaction to pranlukast and resultant ATIN is possible, and that periodic urine testing in patients receiving Drugpranlukast should be considered.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect After 1 week of Drugnefazodone therapy the patient experienced Adverse-Effectheadache , confusion, and " gray areas " in her vision, without abnormal ophthalmologic findings.
1.0000 Adverse-Effect After 1 week of Drugnefazodone therapy the patient experienced headache, Adverse-Effectconfusion , and " gray areas " in her vision, without abnormal ophthalmologic findings.
0.9999 Adverse-Effect After 1 week of Drugnefazodone therapy the patient experienced headache, confusion, and " Adverse-Effectgray areas " in her vision, without abnormal ophthalmologic findings.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The diagnosis was supported by the temporal course of Adverse-Effectrenal deterioration during exposure to Drugcefuroxime and improvement on its discontinuation ; the pattern repeated with rechallenge.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Although interferon gamma has been implicated in the pathogenesis of sarcoidosis, only a few cases of Adverse-Effectsarcoidosis associated with Druginterferon alpha therapy have been reported.
0.9507 Adverse-Effect Although Druginterferon gamma has been implicated in the pathogenesis of sarcoidosis, only a few cases of Adverse-Effectsarcoidosis associated with interferon alpha therapy have been reported.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Anti - tuberculous drugs had been stopped on the 2nd day of therapy due to development of Adverse-Effectoptic neuritis secondary to Drugethambutol administration at another hospital.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case is presented of a patient who experienced Adverse-Effectbenzodiazepine withdrawal symptoms on discontinuation of Drugnefazodone , an antidepressant that inhibits the cytochrome P450 3A4 isoenzyme.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We reported 3 patients who developed acute generalized dystonia and Adverse-Effectakinetic rigid syndrome following an initial therapy with Drugd - penicillamine 125 - 500 mg daily.
0.9996 Adverse-Effect We reported 3 patients who developed Adverse-Effectacute generalized dystonia and akinetic rigid syndrome following an initial therapy with Drugd - penicillamine 125 - 500 mg daily.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This case presentation is of a patient who had the clinical appearance of epiglottitis, but actually had an Adverse-Effectoro - pharyngeal dystonic reaction to Drugprochlorperazine .
1.0000 Adverse-Effect This case presentation is of a patient who had the clinical appearance of Adverse-Effectepiglottitis , but actually had an oro - pharyngeal dystonic reaction to Drugprochlorperazine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Therapy with DrugIFN - alpha may be associated with a number of Adverse-Effectneuropsychiatric symptoms , such as Parkinsonism, akathisia, seizure, and depressive disorders.
0.9997 Adverse-Effect Therapy with DrugIFN - alpha may be associated with a number of neuropsychiatric symptoms, such as Adverse-EffectParkinsonism , akathisia, seizure, and depressive disorders.
0.9997 Adverse-Effect Therapy with DrugIFN - alpha may be associated with a number of neuropsychiatric symptoms, such as Parkinsonism, akathisia, seizure, and Adverse-Effectdepressive disorders .
0.9997 Adverse-Effect Therapy with DrugIFN - alpha may be associated with a number of neuropsychiatric symptoms, such as Parkinsonism, Adverse-Effectakathisia , seizure, and depressive disorders.
0.9997 Adverse-Effect Therapy with DrugIFN - alpha may be associated with a number of neuropsychiatric symptoms, such as Parkinsonism, akathisia, Adverse-Effectseizure , and depressive disorders.
Score Relation Text (Head - Tail)
0.9982 Adverse-Effect CONCLUSIONS : Low dosages of Drugquinacrine used for malaria prophylaxis can be associated with a delayed, Adverse-Effectsevere maculopathy indistinguishable from chloroquine maculopathy in certain patients.
0.9964 Adverse-Effect CONCLUSIONS : Low dosages of Drugquinacrine used for malaria prophylaxis can be associated with a delayed, severe Adverse-Effectmaculopathy indistinguishable from chloroquine maculopathy in certain patients.
Adverse-Effect CONCLUSIONS : Low dosages of quinacrine used for malaria prophylaxis can be associated with a delayed, severe maculopathy indistinguishable from Drugchloroquine Adverse-Effectmaculopathy in certain patients.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect However, a recent post - marketing survey in Japan revealed that Adverse-Effectinterstitial pneumonia occurred in 4 among approximately 2 000 Japanese patients treated with Drugsorafenib .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Three patients received respectively 190 mg, 175 mg, and 196 mg of Drugmethotrexate and developed Adverse-Effectbilateral pulmonary infiltrates without evidence of peripheral blood eosinophilia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect An infant who developed Adverse-Effectpancreatitis during Drugmeglumine antimoniate treatment for visceral leishmaniasis and who was successfully treated with a combination of allopurinol and ketoconazole is reported.
0.9998 Adverse-Effect An infant who developed Adverse-Effectpancreatitis during meglumine antimoniate treatment for visceral leishmaniasis and who was successfully treated with a combination of allopurinol and Drugketoconazole is reported.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Normalization of generalized retinal function and progression of maculopathy after cessation of therapy in a case of severe Drughydroxychloroquine Adverse-Effectretinopathy with 19 years follow - up.
1.0000 Adverse-Effect Normalization of generalized retinal function and Adverse-Effectprogression of maculopathy after cessation of therapy in a case of severe Drughydroxychloroquine retinopathy with 19 years follow - up.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect However, as illustrated by these and other cases reported to date, the onset of Drugtroglitazone - induced Adverse-Effectliver injury is insidious and temporally variable.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 55 - year - old woman presented an episode of acute urticaria and Adverse-Effectlabial angioedema 60 minutes after ingesting 500 mg of Drugcloxacillin for a skin abscess.
0.9999 Adverse-Effect A 55 - year - old woman presented an episode of Adverse-Effectacute urticaria and labial angioedema 60 minutes after ingesting 500 mg of Drugcloxacillin for a skin abscess.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect These features have not previously been reported as side effects of glibenclamide therapy, but Adverse-Effectintrahepatic cholestasis may occur with Drugchlorpropamide , a similar sulphonylurea agent.
0.9997 Adverse-Effect These features have not previously been reported as side effects of Drugglibenclamide therapy, but Adverse-Effectintrahepatic cholestasis may occur with chlorpropamide, a similar sulphonylurea agent.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The relation between tacrolimus treatment and staining was suggested by the appearance of Adverse-Effectpigmentation during topical Drugtacrolimus treatment and its clinical disappearance when treatment was stopped.
0.9994 Adverse-Effect The relation between Drugtacrolimus treatment and staining was suggested by the appearance of Adverse-Effectpigmentation during topical tacrolimus treatment and its clinical disappearance when treatment was stopped.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The Adverse-Effecthypercalcemia responded to discontinuation of DrugrhGH and a single dose of intravenous pamidronate disodium and has not recurred in 8 months of follow - up.
0.9998 Adverse-Effect The Adverse-Effecthypercalcemia responded to discontinuation of rhGH and a single dose of intravenous Drugpamidronate disodium and has not recurred in 8 months of follow - up.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We document the abrupt development of an extensive Adverse-Effectchoroidal detachment after initiation of Drugdorzolamide therapy in a surgically untreated eye with primary open - angle glaucoma.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a patient with the antiphospholipid syndrome who had Adverse-Effectskin necrosis develop from Druglow - molecular weight heparin therapy at sites distant from injection sites.
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect Since this amount of FAB was insufficient to bind all DGTX present in the serum, Adverse-Effectcardiac DGTX toxicity DrugDGTX toxicity ( total AV - block ) persisted.
0.9990 Adverse-Effect Since this amount of FAB was insufficient to bind all DGTX present in the serum, cardiac DrugDGTX toxicity ( Adverse-Effecttotal AV - block ) persisted.
0.9990 Adverse-Effect Since this amount of FAB was insufficient to bind Drugall DGTX present in the serum, Adverse-Effectcardiac DGTX toxicity ( total AV - block ) persisted.
0.9983 Adverse-Effect Since this amount of FAB was insufficient to bind Drugall DGTX present in the serum, cardiac DGTX toxicity ( Adverse-Effecttotal AV - block ) persisted.
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect We report four patients, three of whom first developed Adverse-Effectpsoriasis and one who had an aggravation of the condition during treatment with Druginterferon - alpha .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Three months following splenectomy, Adverse-Effectmultiple abscesses occurred in the muscles of both thighs while the patient was receiving the third course of the DrugCHOP regimen.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The possible development of a drug - induced vasculitis or Adverse-Effectlupus - like syndrome should be added to the list of rare toxic effects of Drugvancomycin .
0.9999 Adverse-Effect The possible development of a drug - induced Adverse-Effectvasculitis or lupus - like syndrome should be added to the list of rare toxic effects of Drugvancomycin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : In these 3 cases, the unique positive ocular finding was Adverse-Effectcorneal endothelial deposits , which may be related to the use of Drugrifabutin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectExacerbations of the heart failure were temporally related to the administration of the antitumor antibiotics Drugactinomycin - D ( NSC - 3053 ) and mithramycin ( NSC - 24559 ).
0.9999 Adverse-Effect Adverse-EffectExacerbations of the heart failure were temporally related to the administration of the antitumor antibiotics actinomycin - D ( NSC - 3053 ) and Drugmithramycin ( NSC - 24559 ).
0.9999 Adverse-Effect Adverse-EffectExacerbations of the heart failure were temporally related to the administration of the antitumor antibiotics actinomycin - D ( DrugNSC - 3053 ) and mithramycin ( NSC - 24559 ).
0.9999 Adverse-Effect Adverse-EffectExacerbations of the heart failure were temporally related to the administration of the antitumor antibiotics actinomycin - D ( NSC - 3053 ) and mithramycin ( DrugNSC - 24559 ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A female patient with HER2 positive, metastatic breast cancer presented with pulmonary infiltrates, and a Adverse-Effectplural effusion dyspnoea after several months of Drugtrastuzumab treatment.
0.9999 Adverse-Effect A female patient with HER2 positive, metastatic breast cancer presented with Adverse-Effectpulmonary infiltrates , and a plural effusion dyspnoea after several months of Drugtrastuzumab treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugMorphine , an opium alkaloid, frequently causes side effects such as Adverse-Effecthyperhidrosis and facial flushing, but serious cutaneous adverse drug reactions are seldom observed.
0.9999 Adverse-Effect DrugMorphine , an opium alkaloid, frequently causes side effects such as hyperhidrosis and Adverse-Effectfacial flushing , but serious cutaneous adverse drug reactions are seldom observed.
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect CONCLUSIONS : Adverse-EffectSpontaneous hemothorax is a rare phenomenon in conjunction with DrugLMWH but should be considered in cases of acute respiratory distress following commencement of LMWH.
0.9999 Adverse-Effect CONCLUSIONS : Spontaneous hemothorax is a rare phenomenon in conjunction with LMWH but should be considered in cases of Adverse-Effectacute respiratory distress following commencement of DrugLMWH .
0.9985 Adverse-Effect CONCLUSIONS : Spontaneous hemothorax is a rare phenomenon in conjunction with DrugLMWH but should be considered in cases of Adverse-Effectacute respiratory distress following commencement of LMWH.
0.9964 Adverse-Effect CONCLUSIONS : Adverse-EffectSpontaneous hemothorax is a rare phenomenon in conjunction with LMWH but should be considered in cases of acute respiratory distress following commencement of DrugLMWH .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A patient suffering from Drugheparin - associated Adverse-Effectthrombocytopenia ( HAT ), recurrent arteriothromboses, and acute renal failure after treatment with standard heparin is described.
1.0000 Adverse-Effect A patient suffering from heparin - associated thrombocytopenia ( HAT ), recurrent arteriothromboses, and Adverse-Effectacute renal failure after treatment with standard Drugheparin is described.
0.9999 Adverse-Effect A patient suffering from heparin - associated thrombocytopenia ( HAT ), Adverse-Effectrecurrent arteriothromboses , and acute renal failure after treatment with standard Drugheparin is described.
0.9999 Adverse-Effect A patient suffering from Drugheparin - associated thrombocytopenia ( HAT ), Adverse-Effectrecurrent arteriothromboses , and acute renal failure after treatment with standard heparin is described.
0.9999 Adverse-Effect A patient suffering from Drugheparin - associated thrombocytopenia ( Adverse-EffectHAT ), recurrent arteriothromboses, and acute renal failure after treatment with standard heparin is described.
0.9999 Adverse-Effect A patient suffering from heparin - associated thrombocytopenia ( Adverse-EffectHAT ), recurrent arteriothromboses, and acute renal failure after treatment with standard Drugheparin is described.
0.9999 Adverse-Effect A patient suffering from Drugheparin - associated thrombocytopenia ( HAT ), recurrent arteriothromboses, and Adverse-Effectacute renal failure after treatment with standard heparin is described.
0.9998 Adverse-Effect A patient suffering from heparin - associated Adverse-Effectthrombocytopenia ( HAT ), recurrent arteriothromboses, and acute renal failure after treatment with standard Drugheparin is described.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect AIMS : To present a case of Adverse-Effectpiloerection after replacing Drugfluvoxamine maleate with milnacipran hydrochloride, and to analyse this effect based on receptor occupancy theory.
0.9998 Adverse-Effect AIMS : To present a case of Adverse-Effectpiloerection after replacing fluvoxamine maleate with Drugmilnacipran hydrochloride , and to analyse this effect based on receptor occupancy theory.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect PURPOSE : To determine the cause of Adverse-Effectspontaneous choroidal hemorrhage in a 67 - year - old man after a myocardial infarction and administration of Drugtissue plasminogen activator .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In one instance a systemic hypoglycemic reaction resulting in head trauma and Adverse-Effectconfusion ended in an emegency hospital admission following the substitution of Drugacetohexamide for acetazolamide.
0.9999 Adverse-Effect In one instance a Adverse-Effectsystemic hypoglycemic reaction resulting in head trauma and confusion ended in an emegency hospital admission following the substitution of Drugacetohexamide for acetazolamide.
0.9999 Adverse-Effect In one instance a systemic hypoglycemic reaction resulting in Adverse-Effecthead trauma and confusion ended in an emegency hospital admission following the substitution of Drugacetohexamide for acetazolamide.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : DrugItraconazole - induced Adverse-Effectliver injury presents with a cholestatic pattern of injury with damage to the interlobular bile ducts, possibly leading to ductopenia.
0.9999 Adverse-Effect CONCLUSIONS : DrugItraconazole - induced liver injury presents with a Adverse-Effectcholestatic pattern of injury with damage to the interlobular bile ducts, possibly leading to ductopenia.
0.9999 Adverse-Effect CONCLUSIONS : DrugItraconazole - induced liver injury presents with a cholestatic pattern of injury with Adverse-Effectdamage to the interlobular bile ducts , possibly leading to ductopenia.
0.9999 Adverse-Effect CONCLUSIONS : DrugItraconazole - induced liver injury presents with a cholestatic pattern of injury with damage to the interlobular bile ducts, possibly leading to Adverse-Effectductopenia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report four cases of encephalopathy coincident with elevated aluminum levels as well as one patient who developed Adverse-Effectseizures while receiving continuous bladder irrigations with Drugalum .
0.9990 Adverse-Effect We report four cases of Adverse-Effectencephalopathy coincident with elevated aluminum levels as well as one patient who developed seizures while receiving continuous bladder irrigations with Drugalum .
0.9990 Adverse-Effect We report four cases of encephalopathy coincident with Adverse-Effectelevated aluminum levels as well as one patient who developed seizures while receiving continuous bladder irrigations with Drugalum .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We experienced a male patient with psoriasis and hypertension whose conditions were treated with tacalcitol ointment and Drugthiazide , respectively, resulting in Adverse-Effecthypercalciuria and hypercalcemia.
0.9999 Adverse-Effect We experienced a male patient with psoriasis and hypertension whose conditions were treated with Drugtacalcitol ointment and thiazide, respectively, resulting in Adverse-Effecthypercalciuria and hypercalcemia.
0.9998 Adverse-Effect We experienced a male patient with psoriasis and hypertension whose conditions were treated with Drugtacalcitol ointment and thiazide, respectively, resulting in hypercalciuria and Adverse-Effecthypercalcemia .
0.9992 Adverse-Effect We experienced a male patient with psoriasis and hypertension whose conditions were treated with tacalcitol ointment and Drugthiazide , respectively, resulting in hypercalciuria and Adverse-Effecthypercalcemia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect While for ribavirin antidepressant effects are not known, we suppose that antidepressants may prevent Adverse-Effectchanges in serotonergic or noradrenergic neurotransmission caused by DrugIFN - alpha .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect As Druglinezolid has been shown to have Adverse-Effecthematologic side effects , blood count monitoring is recommended in patients receiving this drug for long - term therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Two patients with extrinsic asthma and coexistent insulin - dependent diabetes mellitus sustained an Adverse-Effectanaphylactoid reaction after the intravenous administration of 50 % solution of Drugdextrose .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A patient is described who developed a rapid onset of Adverse-Effectpulmonary fibrosis following treatment with a new non - steroidal anti - inflammatory drug, Drugnabumetone .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Although its side effects are few, Drugtamoxifen increases the incidence of Adverse-Effectproliferative lesions of the endometrium , which theoretically should be preventable with progestational agents.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In four patients, thrombosis occurred 2 - 45 days after severe hepatic veno - occlusive disease ( Adverse-EffectHVOD ) secondary to intensive chemotherapy containing Drugbusulfan .
1.0000 Adverse-Effect In four patients, Adverse-Effectthrombosis occurred 2 - 45 days after severe hepatic veno - occlusive disease ( HVOD ) secondary to intensive chemotherapy containing Drugbusulfan .
1.0000 Adverse-Effect In four patients, thrombosis occurred 2 - 45 days after severe Adverse-Effecthepatic veno - occlusive disease ( HVOD ) secondary to intensive chemotherapy containing Drugbusulfan .
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect CONCLUSIONS : Although Drugbudesonide may be beneficial because of its anti - inflammatory effects, clinicians should be alert to its potential for causing Adverse-Effectcontact dermatitis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The patient was found to have Adverse-Effectno motile sperm with a normal sperm count, while taking a dose of 400 mg / day of Drugcarbamazepine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectPVT during chemotherapy in children is a rare event and appears to be closely related to intensive chemotherapy containing Drugbusulfan and to be associated with HVOD.
0.9999 Adverse-Effect PVT during chemotherapy in children is a rare event and appears to be closely related to intensive chemotherapy containing Drugbusulfan and to be associated with Adverse-EffectHVOD .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The development of cutaneous ecchymosis associated with a Adverse-Effectsudden fall in hemoglobin after the administration of Drugalteplase should strongly suggest the possibility of diffuse subfascial hematoma.
0.9998 Adverse-Effect The development of Adverse-Effectcutaneous ecchymosis associated with a sudden fall in hemoglobin after the administration of Drugalteplase should strongly suggest the possibility of diffuse subfascial hematoma.
0.9998 Adverse-Effect The development of cutaneous ecchymosis associated with a sudden fall in hemoglobin after the administration of Drugalteplase should strongly suggest the possibility of Adverse-Effectdiffuse subfascial hematoma .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect RESULTS : A 52 - year - old woman with Parkinson disease who had taken Drugamantadine for 6 years had Adverse-Effectbilateral corneal edema for 2 months at baseline.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A few recent individual case reports have suggested that a Adverse-Effectmyasthenic syndrome may be associated with Drugstatin treatment, but this association is not well described.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of Drugamiodarone - induced Adverse-Effectthyrotoxicosis of protracted duration, unresponsive to conventional thionamide therapy, with therapy limited by severe adverse drug reactions.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect We hypothesize that decreased renal elimination of DrugMTX induced by the COX - 2 inhibitor resulted in enhanced Adverse-Effecthematopoietic toxicity and immunosuppression causing the EBV - associated lymphoproliferative disease.
0.9992 Adverse-Effect We hypothesize that decreased renal elimination of DrugMTX induced by the COX - 2 inhibitor resulted in enhanced hematopoietic toxicity and Adverse-Effectimmunosuppression causing the EBV - associated lymphoproliferative disease.
0.9992 Adverse-Effect We hypothesize that decreased renal elimination of DrugMTX induced by the COX - 2 inhibitor resulted in enhanced hematopoietic toxicity and immunosuppression causing the Adverse-EffectEBV - associated lymphoproliferative disease .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugMTX - induced Adverse-Effecthepatic injury and liver enzyme elevations have been demonstrated after treatment of leukemia, gestational disease and during treatment of psoriasis and rheumatoid arthritis.
0.9999 Adverse-Effect DrugMTX - induced hepatic injury and Adverse-Effectliver enzyme elevations have been demonstrated after treatment of leukemia, gestational disease and during treatment of psoriasis and rheumatoid arthritis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We herein described an additional patient with BCR - ABL ( ela2 ) positive acute lymphoblastic leukemia who developed Adverse-Effecttumor lysis syndrome after 10 - day treatment with Drugimatinib .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This article presents a patient with hypoparathyroidism who was treated with calcium carbonate and Drugcalcitriol resulting in two admissions to the hospital for Adverse-Effectmilk - alkali syndrome .
0.9997 Adverse-Effect This article presents a patient with hypoparathyroidism who was treated with Drugcalcium carbonate and calcitriol resulting in two admissions to the hospital for Adverse-Effectmilk - alkali syndrome .
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect Management of hypophosphatemia induced by high - flux hemodiafiltration for the treatment of Drugvancomycin Adverse-Effectvancomycin toxicity : intravenous phosphorus therapy versus use of a phosphorus - enriched dialysate.
0.9989 Adverse-Effect Management of Adverse-Effecthypophosphatemia induced by high - flux hemodiafiltration for the treatment of Drugvancomycin toxicity : intravenous phosphorus therapy versus use of a phosphorus - enriched dialysate.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Although this combination agent has been associated with a hypersensitivity syndrome involving cutaneous skin eruptions, pediatric cases of DrugTMP - SMX - induced Adverse-Effecthepatotoxicity are rare.
0.9674 Adverse-Effect Although this combination agent has been associated with a hypersensitivity syndrome involving Adverse-Effectcutaneous skin eruptions , pediatric cases of DrugTMP - SMX - induced hepatotoxicity are rare.
0.9475 Adverse-Effect Although this combination agent has been associated with a Adverse-Effecthypersensitivity syndrome involving cutaneous skin eruptions, pediatric cases of DrugTMP - SMX - induced hepatotoxicity are rare.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The addition of intrathecal Drugmethotrexate to treatment protocols has increased survival rates in children with acute lymphoblastic leukemia but is also associated with varying degrees of Adverse-Effectneurotoxicity .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A teenage girl with crescentic glomerulonephritis had Adverse-Effectantineutrophil cytoplasmic antibody ( ANCA ) detected after she had received Drugpropylthiouracil ( PTU ) for hyperthyroidism without cutaneous vasculitis.
1.0000 Adverse-Effect A teenage girl with crescentic glomerulonephritis had Adverse-Effectantineutrophil cytoplasmic antibody ( ANCA ) detected after she had received propylthiouracil ( DrugPTU ) for hyperthyroidism without cutaneous vasculitis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 64 year old woman with previous history of coronary stenting five days before was admitted in our institution for Adverse-Effectintracranial bleeding while receiving Drugaspirin and clopidogrel.
1.0000 Adverse-Effect A 64 year old woman with previous history of coronary stenting five days before was admitted in our institution for Adverse-Effectintracranial bleeding while receiving aspirin and Drugclopidogrel .
Score Relation Text (Head - Tail)
0.9985 Adverse-Effect OBJECTIVE : To study therapy with indapamide impairing carbohydrate metabolism in essential hypertension patients and achieve earlier prevention, diagnoses and treatment of Adverse-Effectdiabetes induced by Drugindapamide .
0.6736 Adverse-Effect OBJECTIVE : To study therapy with Drugindapamide impairing carbohydrate metabolism in essential hypertension patients and achieve earlier prevention, diagnoses and treatment of Adverse-Effectdiabetes induced by indapamide.
0.9466 Adverse-Effect OBJECTIVE : To study therapy with indapamide impairing Drugcarbohydrate metabolism in essential hypertension patients and achieve earlier prevention, diagnoses and treatment of Adverse-Effectdiabetes induced by indapamide.
Adverse-Effect OBJECTIVE : To study therapy with Drugindapamide Adverse-Effectimpairing carbohydrate metabolism in essential hypertension patients and achieve earlier prevention, diagnoses and treatment of diabetes induced by indapamide.
Score Relation Text (Head - Tail)
0.9996 Adverse-Effect Coadministration of antidepressant agents such as nefazodone, or any other drug that inhibits the CYP3A4 isoenzyme subfamily, should be anticipated to Adverse-Effectinterfere with tacrolimus metabolism Drugtacrolimus metabolism.
0.9984 Adverse-Effect Coadministration of antidepressant agents such as Drugnefazodone , or any other drug that inhibits the CYP3A4 isoenzyme subfamily, should be anticipated to Adverse-Effectinterfere with tacrolimus metabolism .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect BACKGROUND : Reproductive endocrine disorders characterized by menstrual disorders, polycystic ovaries, and Adverse-Effecthyperandrogenism seem to be common among women treated with Drugsodium valproate for epilepsy.
0.9998 Adverse-Effect BACKGROUND : Reproductive endocrine disorders characterized by Adverse-Effectmenstrual disorders , polycystic ovaries, and hyperandrogenism seem to be common among women treated with Drugsodium valproate for epilepsy.
0.9998 Adverse-Effect BACKGROUND : Reproductive endocrine disorders characterized by menstrual disorders, Adverse-Effectpolycystic ovaries , and hyperandrogenism seem to be common among women treated with Drugsodium valproate for epilepsy.
0.9998 Adverse-Effect BACKGROUND : Adverse-EffectReproductive endocrine disorders characterized by menstrual disorders, polycystic ovaries, and hyperandrogenism seem to be common among women treated with Drugsodium valproate for epilepsy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 52 - year - old, white female developed low - grade fever, cough, and Adverse-Effectdyspnea after 8 weeks treatment with Drugsodium aurothiomalate for rheumatoid arthritis.
0.9998 Adverse-Effect A 52 - year - old, white female developed low - grade fever, Adverse-Effectcough , and dyspnea after 8 weeks treatment with Drugsodium aurothiomalate for rheumatoid arthritis.
0.9998 Adverse-Effect A 52 - year - old, white female developed Adverse-Effectlow - grade fever , cough, and dyspnea after 8 weeks treatment with Drugsodium aurothiomalate for rheumatoid arthritis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of a 60 - year - old woman affected by squamous lung carcinoma, who developed Adverse-Effectparoxysmal supraventricular tachycardia during Drugcisplatin and etoposide combination chemotherapy.
0.9999 Adverse-Effect We report a case of a 60 - year - old woman affected by squamous lung carcinoma, who developed Adverse-Effectparoxysmal supraventricular tachycardia during cisplatin and Drugetoposide combination chemotherapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The patient experienced hallucinations, agitation, vomiting, tachycardia and Adverse-Effectseizures after ingestion of 1050 ( 48 mg / kg ) of extended - release Drugbupropion .
1.0000 Adverse-Effect The patient experienced hallucinations, agitation, vomiting, Adverse-Effecttachycardia and seizures after ingestion of 1050 ( 48 mg / kg ) of extended - release Drugbupropion .
1.0000 Adverse-Effect The patient experienced Adverse-Effecthallucinations , agitation, vomiting, tachycardia and seizures after ingestion of 1050 ( 48 mg / kg ) of extended - release Drugbupropion .
1.0000 Adverse-Effect The patient experienced hallucinations, agitation, Adverse-Effectvomiting , tachycardia and seizures after ingestion of 1050 ( 48 mg / kg ) of extended - release Drugbupropion .
1.0000 Adverse-Effect The patient experienced hallucinations, Adverse-Effectagitation , vomiting, tachycardia and seizures after ingestion of 1050 ( 48 mg / kg ) of extended - release Drugbupropion .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The authors describe Drugvalproate - induced Adverse-Effecthyperammonemia and mental status changes in an 88 - year - old man, the first known reported case in an elderly patient.
0.9998 Adverse-Effect The authors describe Drugvalproate - induced hyperammonemia and Adverse-Effectmental status changes in an 88 - year - old man, the first known reported case in an elderly patient.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DISCUSSION : No published clinical studies in patients receiving Drugclindamycin vaginal cream for bacterial vaginosis have documented C. difficile toxin in stool samples of patients with Adverse-Effectdiarrhea .
1.0000 Adverse-Effect DISCUSSION : No published clinical studies in patients receiving Drugclindamycin vaginal cream for bacterial vaginosis have documented Adverse-EffectC. difficile toxin in stool samples of patients with diarrhea.
Adverse-Effect DISCUSSION : No published clinical studies in patients receiving Drugclindamycin vaginal cream for bacterial vaginosis have documented Adverse-EffectC. difficile toxin in stool samples of patients with diarrhea.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect When Adverse-Effectthrombosis develops during Drugheparin treatment, it is important to suspect HITTs and to assay for the associated antibodies, regardless of the actual platelet count.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A patient with Wegener's granulomatosis rapidly developed a Adverse-Effectcircumferential subglottic stenosis while on a Drugcyclophosphamide regimen that had caused resolution of systemic symptoms and pulmonary infiltrates.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In each of the three reported patients, alteration of eyelid appearance with Adverse-Effectdeepening of the lid sulcus was evident as the result of topical Drugbimatoprost therapy.
1.0000 Adverse-Effect In each of the three reported patients, Adverse-Effectalteration of eyelid appearance with deepening of the lid sulcus was evident as the result of topical Drugbimatoprost therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To evaluate the efficacy of the administration of insulin by a jet - injector device in stopping and reversing severe Drughuman insulin - induced Adverse-Effectlipoatrophy .
0.9979 Adverse-Effect OBJECTIVE : To evaluate the efficacy of the administration of Druginsulin by a jet - injector device in stopping and reversing severe human insulin - induced Adverse-Effectlipoatrophy .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The authors intend to carry out a case - control study on patients treated with Drugtamoxifen for breast carcinoma to reveal the possible presence of Adverse-Effectendometrial carcinoma .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Therefore, clinicians should pay close attention to possible onset of Adverse-EffectRD in patients with multiple risk factors for TD, even when DrugSDA therapy is used.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Children with acute lymphoblastic leukemia ( ALL ), treated with DrugL - asparaginase are at risk for Adverse-Effectcerebral thrombosis or hemorrhage because of coagulation protein deficiencies.
0.9998 Adverse-Effect Children with acute lymphoblastic leukemia ( ALL ), treated with DrugL - asparaginase are at risk for cerebral thrombosis or Adverse-Effecthemorrhage because of coagulation protein deficiencies.
0.9994 Adverse-Effect Children with acute lymphoblastic leukemia ( ALL ), treated with DrugL - asparaginase are at risk for cerebral thrombosis or hemorrhage because of Adverse-Effectcoagulation protein deficiencies .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the case of a patient with chronic lymphocytic leukemia ( CLL ) who developed fatal intravascular autoimmune hemolytic anemia ( Adverse-EffectAIHA ) after Drugfludarabine treatment.
1.0000 Adverse-Effect We report the case of a patient with chronic lymphocytic leukemia ( CLL ) who developed Adverse-Effectfatal intravascular autoimmune hemolytic anemia ( AIHA ) after Drugfludarabine treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe two ELBW infants affected by hyperkalaemia, treated with DrugKayexalate , who developed serious Adverse-Effecthypernatraemia , that has never been reported before in preterm infants.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSION : To the best of our knowledge, this is the first time Drugcolchicine Adverse-Effectcolchicine intoxication in this age group has been described in the English literature.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Initial treatment with Drugheparin was substituted with thrombolysis, which resulted in clinical improvement and dissolution of right heart thrombus but was followed by Adverse-Effectfatal intracerebral haemorrhage .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Nine Adverse-Effectdelirious patients suffering from Druglithium intoxication were examined with the Mini - Mental State Exam ( MMS ) to describe the clinical course of the disorder.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Recently, some studies have also reported association between patients with juvenile rheumatoid arthritis ( JRA ) treated with Methotrexate ( DrugMTX ) and Adverse-Effectmalignant lymphoma developing.
0.9999 Adverse-Effect Recently, some studies have also reported association between patients with juvenile rheumatoid arthritis ( JRA ) treated with DrugMethotrexate ( MTX ) and Adverse-Effectmalignant lymphoma developing.
Score Relation Text (Head - Tail)
0.9997 Adverse-Effect DrugRifampin ( RFP ) increases hepatic microsomal enzyme activity, and there are case reports of RFP - induced Adverse-Effecthypothyroidism , all associated with Hashimoto's thyroiditis.
0.9996 Adverse-Effect Rifampin ( DrugRFP ) increases hepatic microsomal enzyme activity, and there are case reports of RFP - induced Adverse-Effecthypothyroidism , all associated with Hashimoto's thyroiditis.
0.9995 Adverse-Effect DrugRifampin ( RFP ) increases hepatic microsomal enzyme activity, and there are case reports of RFP - induced hypothyroidism, all associated with Adverse-EffectHashimoto's thyroiditis .
0.9994 Adverse-Effect Rifampin ( DrugRFP ) increases hepatic microsomal enzyme activity, and there are case reports of RFP - induced hypothyroidism, all associated with Adverse-EffectHashimoto's thyroiditis .
1.0000 Adverse-Effect Rifampin ( RFP ) increases hepatic microsomal enzyme activity, and there are case reports of DrugRFP - induced Adverse-Effecthypothyroidism , all associated with Hashimoto's thyroiditis.
0.9993 Adverse-Effect Rifampin ( RFP ) increases hepatic microsomal enzyme activity, and there are case reports of DrugRFP - induced hypothyroidism, all associated with Adverse-EffectHashimoto's thyroiditis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To report the late development of Adverse-Effectimmune - mediated diabetes mellitus after completion of Drugalfa - interferon therapy for hepatitis C in an Asian patient.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The authors describe a woman with chronic schizophrenia who experienced delirium, grand mal seizure, and Adverse-Effectphotosensitivity after the addition of Drugpropranolol to her neuroleptic regimen.
1.0000 Adverse-Effect The authors describe a woman with chronic schizophrenia who experienced Adverse-Effectdelirium , grand mal seizure, and photosensitivity after the addition of Drugpropranolol to her neuroleptic regimen.
0.9999 Adverse-Effect The authors describe a woman with chronic schizophrenia who experienced delirium, Adverse-Effectgrand mal seizure , and photosensitivity after the addition of Drugpropranolol to her neuroleptic regimen.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Seven patients with hematologic malignancies who were treated with Drugmiconazole for either suspected or proven fungal infections developed eight episodes of major adverse Adverse-Effectcardiorespiratory and anaphylactic reactions .
1.0000 Adverse-Effect Seven patients with hematologic malignancies who were treated with Drugmiconazole for either suspected or proven fungal infections developed eight episodes of major Adverse-Effectadverse cardiorespiratory and anaphylactic reactions .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect k bipolar manic - depressive patient, developed while on Druglithium prophylaxis, Adverse-Effectakathisia at therapeutic serum lithium levels and subsequently bucco - linguo - masticatory dyskinesia.
0.9985 Adverse-Effect k bipolar manic - depressive patient, developed while on Druglithium prophylaxis, akathisia at therapeutic serum lithium levels and subsequently Adverse-Effectbucco - linguo - masticatory dyskinesia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Hydroxyurea ( HU ) and Drugsodium phenylbutyrate ( SPB ) have been shown to Adverse-Effectincrease fetal hemoglobin ( Hb F ) levels in patients with thalassemia intermedia.
0.9999 Adverse-Effect DrugHydroxyurea ( HU ) and sodium phenylbutyrate ( SPB ) have been shown to Adverse-Effectincrease fetal hemoglobin ( Hb F ) levels in patients with thalassemia intermedia.
0.9999 Adverse-Effect Hydroxyurea ( DrugHU ) and sodium phenylbutyrate ( SPB ) have been shown to Adverse-Effectincrease fetal hemoglobin ( Hb F ) levels in patients with thalassemia intermedia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The second was an 82 - year - old man receiving Drugticlopidine for 2 years when, during a febrile episode, he was found Adverse-Effectneutropenic with marrow aplasia.
0.9999 Adverse-Effect The second was an 82 - year - old man receiving Drugticlopidine for 2 years when, during a febrile episode, he was found neutropenic with Adverse-Effectmarrow aplasia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 73 - year - old woman with non - Hodgkin's lymphoma had two episodes of severe, bilateral, Adverse-Effectsensori - neural hearing loss after Drugvincristine therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectFatal radiation myelopathy after high - dose Drugbusulfan and melphalan chemotherapy and radiotherapy for Ewing's sarcoma : a review of the literature and implications for practice.
1.0000 Adverse-Effect Adverse-EffectFatal radiation myelopathy after high - dose busulfan and Drugmelphalan chemotherapy and radiotherapy for Ewing's sarcoma : a review of the literature and implications for practice.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 57 - year - old man developed chronic, Adverse-Effectwatery diarrhea four weeks after Helicobacter pylori eradication therapy including Druglansoprazole followed by lansoprazole monotherapy for gastroesophageal reflux disease.
0.9997 Adverse-Effect A 57 - year - old man developed chronic, Adverse-Effectwatery diarrhea four weeks after Helicobacter pylori eradication therapy including lansoprazole followed by Druglansoprazole monotherapy for gastroesophageal reflux disease.
Adverse-Effect A 57 - year - old man developed Adverse-Effectchronic, watery diarrhea four weeks after Helicobacter pylori eradication therapy including Druglansoprazole followed by lansoprazole monotherapy for gastroesophageal reflux disease.
Adverse-Effect A 57 - year - old man developed Adverse-Effectchronic, watery diarrhea four weeks after Helicobacter pylori eradication therapy including lansoprazole followed by Druglansoprazole monotherapy for gastroesophageal reflux disease.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect BACKGROUND : DrugCyanamide , an aversive agent widely used in Japan, is known to induce various degrees of Adverse-Effecthepatic lesion with ground - glass inclusion bodies .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect BACKGROUND : To assess the nature, incidence, and risk factors of Adverse-Effectretinopathy associated with Drugpegylated interferon and ribavirin combination therapy in chronic hepatitis C patients.
0.9997 Adverse-Effect BACKGROUND : To assess the nature, incidence, and risk factors of Adverse-Effectretinopathy associated with pegylated interferon and Drugribavirin combination therapy in chronic hepatitis C patients.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect These cases were chosen for study because they were all Adverse-Effectdeaths as a result of suicidal ingestion of drugs in which Drugquetiapine was considered a significant factor.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Exposure of the fetus to Drugindomethacin by administration of the drug to the mother may cause many side effects, including Adverse-Effectpremature closure of the ductus arteriosus .
1.0000 Adverse-Effect Adverse-EffectExposure of the fetus to Drugindomethacin by administration of the drug to the mother may cause many side effects, including premature closure of the ductus arteriosus.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This increase when clozapine was switched to risperidone and vice versa is consistent with our previous report of Adverse-Effectelevated serum triglyceride levels in Drugclozapine - treated patients.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case of Adverse-Effecttoxic hepatitis caused by combination therapy with Drugmethotrexate and etretinate in the treatment of severe psoriasis is presented in a 47 - year - old woman.
1.0000 Adverse-Effect A case of Adverse-Effecttoxic hepatitis caused by combination therapy with methotrexate and Drugetretinate in the treatment of severe psoriasis is presented in a 47 - year - old woman.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We present a case of Adverse-Effectrespiratory failure occurring in a woman at 16 weeks'gestation who was being treated with Drugnitrofurantoin for a urinary tract infection.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugTiclopidine is an oral antiplatelet agent frequently utilized in the treatment of cerebrovascular disease and is rarely associated with Adverse-Effectsevere bone marrow suppression , typically aplastic anemia.
1.0000 Adverse-Effect DrugTiclopidine is an oral antiplatelet agent frequently utilized in the treatment of cerebrovascular disease and is rarely associated with severe bone marrow suppression, typically Adverse-Effectaplastic anemia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Pellagra should be suspected whenever tuberculous patients under treatment with Drugisoniazid develop Adverse-Effectmental, neurological or gastrointestinal symptoms , even in the absence of typical pellagra dermatitis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Treatment with Druginfliximab is known to produce an Adverse-Effectincrease of autoantibodies ( antinuclear antibodies, anti - double - stranded DNA ), but not clinical disease.
1.0000 Adverse-Effect Treatment with Druginfliximab is known to produce an increase of autoantibodies ( Adverse-Effectantinuclear antibodies , anti - double - stranded DNA ), but not clinical disease.
1.0000 Adverse-Effect Treatment with Druginfliximab is known to produce an increase of autoantibodies ( antinuclear antibodies, Adverse-Effectanti - double - stranded DNA ), but not clinical disease.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 21 - year - old man with Tourette's syndrome, pedophilia, Asperger's syndrome, and multiple sclerosis experienced Adverse-Effectseizures after receiving therapy with Druginterferon beta - 1a .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We present a case of a 58 - year - old female patient with Graves'disease who developed Adverse-EffectAA in the third exposure to Drugmethimazole ( MMI ).
1.0000 Adverse-Effect We present a case of a 58 - year - old female patient with Graves'disease who developed Adverse-EffectAA in the third exposure to methimazole ( DrugMMI ).
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Adverse-EffectHypersensitivity to Drugcarboplatin is a rare but real complication of therapy and should be considered in patients presenting with hyperacute changes on ECG whilst receiving carboplatin therapy.
0.9997 Adverse-Effect Hypersensitivity to Drugcarboplatin is a rare but real complication of therapy and should be considered in patients presenting with Adverse-Effecthyperacute changes on ECG whilst receiving carboplatin therapy.
1.0000 Adverse-Effect Hypersensitivity to carboplatin is a rare but real complication of therapy and should be considered in patients presenting with Adverse-Effecthyperacute changes on ECG whilst receiving Drugcarboplatin therapy.
0.9999 Adverse-Effect Hypersensitivity to carboplatin is a rare but real complication of therapy and should be considered in patients presenting with hyperacute Adverse-Effectchanges on ECG whilst receiving Drugcarboplatin therapy.
0.9987 Adverse-Effect Hypersensitivity to Drugcarboplatin is a rare but real complication of therapy and should be considered in patients presenting with hyperacute Adverse-Effectchanges on ECG whilst receiving carboplatin therapy.
0.9577 Adverse-Effect Adverse-EffectHypersensitivity to carboplatin is a rare but real complication of therapy and should be considered in patients presenting with hyperacute changes on ECG whilst receiving Drugcarboplatin therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugARA - C is frequently associated with Adverse-Effectdermatologic toxicity , but this is only the second case of toxic epidermal necrolysis described in connection with this drug.
0.9985 Adverse-Effect DrugARA - C is frequently associated with dermatologic toxicity, but this is only the second case of Adverse-Effecttoxic epidermal necrolysis described in connection with this drug.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect After 5 days of treatment with DrugIL - 2 , the patient developed a Adverse-Effecthemorrhagic lesion that progressed to toxic epidermal necrolysis, as well as grade 4 pancytopenia.
0.9997 Adverse-Effect After 5 days of treatment with DrugIL - 2 , the patient developed a hemorrhagic lesion that progressed to Adverse-Effecttoxic epidermal necrolysis , as well as grade 4 pancytopenia.
0.9995 Adverse-Effect After 5 days of treatment with DrugIL - 2 , the patient developed a hemorrhagic lesion that progressed to toxic epidermal necrolysis, as well as grade 4 Adverse-Effectpancytopenia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect IV Drugpropranolol was used as the initial treatment for his hyperadrenergic state, resulting in a Adverse-Effectdecrease in heart rate but a paroxsymal increase in blood pressure.
1.0000 Adverse-Effect IV Drugpropranolol was used as the initial treatment for his hyperadrenergic state, resulting in a decrease in heart rate but a Adverse-Effectparoxsymal increase in blood pressure .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect The currently available clinical and neuropharmacologic data suggest that Drugcarbamazepine may be an antagonist of dopamine and that this property is responsible for the production of Adverse-Effectdystonia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect All developed Adverse-Effectmucocutaneous side effects within 20 weeks of beginning i m Druggold therapy, at a time when RA had improved markedly compared to pretreatment status.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We present three patients with paradoxical Adverse-Effectseizures ; their serum Drugphenytoin levels were 43. 5 mcg / mL, 46. 5 mcg / mL and 38. 3 mcg / mL.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Two cases of lepromatous leprosy with erythema nodosum leprosum who were on high doses of Drugclofazimine , showed Adverse-Effectdiscoloration of nail plate , subungual hyperkeratosis and onycholysis.
1.0000 Adverse-Effect Two cases of lepromatous leprosy with erythema nodosum leprosum who were on high doses of Drugclofazimine , showed discoloration of nail plate, Adverse-Effectsubungual hyperkeratosis and onycholysis.
0.9999 Adverse-Effect Two cases of lepromatous leprosy with erythema nodosum leprosum who were on high doses of Drugclofazimine , showed discoloration of nail plate, subungual hyperkeratosis and Adverse-Effectonycholysis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : Patients receiving intravitreal injections of Drugbevacizumab should be evaluated for potential systemic risk factors such as Adverse-Effectcarotid insufficiency , coagulopathy and poorly controlled diabetes mellitus.
1.0000 Adverse-Effect CONCLUSIONS : Patients receiving intravitreal injections of Drugbevacizumab should be evaluated for potential systemic risk factors such as carotid insufficiency, Adverse-Effectcoagulopathy and poorly controlled diabetes mellitus.
1.0000 Adverse-Effect CONCLUSIONS : Patients receiving intravitreal injections of Drugbevacizumab should be evaluated for potential systemic risk factors such as carotid insufficiency, coagulopathy and Adverse-Effectpoorly controlled diabetes mellitus .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 53 - year - old man developed Adverse-Effectlower leg edema 4 weeks after Drugrosiglitazone was increased from 4 mg once / day to 4 mg twice / day.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CASE SUMMARY : A 68 - year - old woman developed a dry, Adverse-Effectirritating cough within one month of starting Drugquinapril therapy for the treatment of essential hypertension.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Three patients who had experienced neuroleptic - induced akathisia in the past reported that the symptoms of Drugfluoxetine - induced Adverse-Effectakathisia were identical, although somewhat milder.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Shortly after chemotherapy and an injection of Drugpegfilgrastim , the patient developed poorly defined, Adverse-Effectrapidly progressive erythema , edema, and pain in his right forearm.
1.0000 Adverse-Effect Shortly after chemotherapy and an injection of Drugpegfilgrastim , the patient developed poorly defined, rapidly progressive erythema, edema, and Adverse-Effectpain in his right forearm .
1.0000 Adverse-Effect Shortly after chemotherapy and an injection of Drugpegfilgrastim , the patient developed poorly defined, rapidly progressive erythema, Adverse-Effectedema , and pain in his right forearm.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSION : The results suggest that olanzapine may be useful in treating patients with Drugclozapine - induced Adverse-Effectgranulocytopenia without the risk of recurrence of hematologic side effects.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSION : DrugGemcitabine - induced Adverse-Effectrecall pneumonitis is a rarely reported phenomenon and should be taken into account even after extended time interval to the previous radiotherapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In one patient, treatment with DrugDCA was associated with a Adverse-Effectdecrease in blood lactate levels from 11. 2 mM before treatment to 0. 8 mM 16 h later.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugMitomycin - C is used widely in the treatment of malignancies and is associated with serious dose related adverse effects including the occurrence of Adverse-Effecthemolytic uremic syndrome .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectPancreatitis has been noted to be a complication in 2 - 16 % of patients undergoing treatment with DrugL - asparaginase for a variety of pediatric neoplasms.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect RESULTS : DrugBrimonidine was observed to cause Adverse-EffectIOP elevation , confirmed on rechallenge, scoring 8 ( strong probability ) on an adverse drug reaction probability score.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a case of Adverse-EffectPRES in a patient with collapsing focal glomeruloesclerosis ( collapsing FGS ) with complete recovery after withdrawal of Drugcyclosporine ( CSA ).
1.0000 Adverse-Effect We describe a case of Adverse-EffectPRES in a patient with collapsing focal glomeruloesclerosis ( collapsing FGS ) with complete recovery after withdrawal of cyclosporine ( DrugCSA ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Three of 50 patients treated with Drugisotretinoin ( 1 mg / kg / day ) for cystic acne complained of Adverse-Effectpoor night vision and / or excessive glare sensitivity.
1.0000 Adverse-Effect Three of 50 patients treated with Drugisotretinoin ( 1 mg / kg / day ) for cystic acne complained of poor night vision and / or Adverse-Effectexcessive glare sensitivity .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CASE REPORT : A six - year - old boy with transfusion - dependent beta - thalassaemia developed a Adverse-Effectunilateral hearing loss shortly after commencing Drugdesferrioxamine therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CASE : A Adverse-Effectmalignant mixed mesodermal tumor was diagnosed in a 64 - year - old woman with a bicornuate uterus while she was taking Drugraloxifene for osteoporosis prevention.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe two cases that illustrate the use of Druglithium in the treatment of veterans with PTSD who complained of serious problems with Adverse-Effectirritability or angry outbursts.
0.9999 Adverse-Effect We describe two cases that illustrate the use of Druglithium in the treatment of veterans with PTSD who complained of serious problems with irritability or Adverse-Effectangry outbursts .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugDiazepam use by pregnant women can be associated with a later presentation of Adverse-Effectwithdrawal symptoms in the neonate than that induced by the use of other drugs.
Score Relation Text (Head - Tail)
0.9995 Adverse-Effect She had just finished a 3 - week course of intravenous Drugtobramycin for bronchiectasis and had an elevated serum tobramycin trough level 1 week before the onset of Adverse-Effecttetany .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Although adverse reactions to protamine are reported infrequently and are usually mild, we recently observed the first fatal case of Adverse-Effecttype I anaphylaxis resulting from Drugprotamine .
0.9982 Adverse-Effect Although adverse reactions to Drugprotamine are reported infrequently and are usually mild, we recently observed the first Adverse-Effectfatal case of type I anaphylaxis resulting from protamine.
0.9951 Adverse-Effect Although adverse reactions to Drugprotamine are reported infrequently and are usually mild, we recently observed the first fatal case of Adverse-Effecttype I anaphylaxis resulting from protamine.
0.9924 Adverse-Effect Although adverse reactions to protamine are reported infrequently and are usually mild, we recently observed the first Adverse-Effectfatal case of type I anaphylaxis resulting from Drugprotamine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The treatment for acidosis and hyperkalaemia should be started as soon as Adverse-EffectRTA is diagnosed, and the dosage of DrugFK506 should also be reduced if possible.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugLithium is known to cause Adverse-Effectacute renal failure and tubulo - interstitial disease, but the recently described association with proteinuria or nephrotic syndrome is little recognized.
0.9999 Adverse-Effect DrugLithium is known to cause acute renal failure and Adverse-Effecttubulo - interstitial disease , but the recently described association with proteinuria or nephrotic syndrome is little recognized.
0.9999 Adverse-Effect DrugLithium is known to cause acute renal failure and tubulo - interstitial disease, but the recently described association with proteinuria or Adverse-Effectnephrotic syndrome is little recognized.
0.9999 Adverse-Effect DrugLithium is known to cause acute renal failure and tubulo - interstitial disease, but the recently described association with Adverse-Effectproteinuria or nephrotic syndrome is little recognized.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Awareness of this route of intoxication might be important in patients in whom neurologic or Adverse-Effectpsychiatric symptoms develop while large amounts of Druglidocaine cream are being used.
1.0000 Adverse-Effect Awareness of this route of intoxication might be important in patients in whom Adverse-Effectneurologic or psychiatric symptoms develop while large amounts of Druglidocaine cream are being used.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a 4 - year - old girl who presented with acute bilateral blindness, a focal seizure and Adverse-Effecthypertension 10 days after commencing Drugoxybutynin to treat enuresis.
1.0000 Adverse-Effect We report a 4 - year - old girl who presented with Adverse-Effectacute bilateral blindness , a focal seizure and hypertension 10 days after commencing Drugoxybutynin to treat enuresis.
0.9999 Adverse-Effect We report a 4 - year - old girl who presented with acute bilateral blindness, a Adverse-Effectfocal seizure and hypertension 10 days after commencing Drugoxybutynin to treat enuresis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The purpose of this study was to examine the incidence and cause of Adverse-EffectClostridium difficile colitis occurring after Drugcisplatin - based combination chemotherapy in ovarian cancer patients.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectAgranulocytosis is a rare adverse effect associated with prolonged Drugvancomycin therapy, and is potentially serious, especially in end stage renal disease ( ESRD ) patients.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Two days after administration of DrugKalimate enema, he had Adverse-Effectprofuse hematochezia , and a sigmoidoscopy showed diffuse colonic mucosal necrosis in the rectum and sigmoid colon.
0.9997 Adverse-Effect Two days after administration of DrugKalimate enema, he had profuse hematochezia, and a sigmoidoscopy showed Adverse-Effectdiffuse colonic mucosal necrosis in the rectum and sigmoid colon.
Adverse-Effect Two days after administration of DrugKalimate enema, he had profuse hematochezia, and a sigmoidoscopy showed diffuse Adverse-Effectcolonic mucosal necrosis in the rectum and sigmoid colon.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect RESULTS : A 34 - year - old man acquired visual field defects and Adverse-Effectsevere vision loss in both eyes after intravitreal injection of Drugtriamcinolone for diabetic macular edema.
1.0000 Adverse-Effect RESULTS : A 34 - year - old man acquired Adverse-Effectvisual field defects and severe vision loss in both eyes after intravitreal injection of Drugtriamcinolone for diabetic macular edema.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect METHODS : A case is presented of a 45 - year - old woman on prolonged Druggemcitabine treatment for ovarian cancer who developed Adverse-EffectHUS and recovered after drug discontinuation.
Score Relation Text (Head - Tail)
0.9996 Adverse-Effect The failure of therapy with disopyramide and mexiletine to reproduce this observation suggests either a previously unreported Adverse-Effectelectrophysiologic effect of, or idiosyncratic response to, Drugprocainamide .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect In 2 of the 3 cases the patients were also taking Druglithium carbonate and beta - blockers, both of which could have contributed to the Adverse-Effectincontinence .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Two cases are reported of patients who developed a Adverse-Effecthematologic malignancy several years after intravesical chemotherapy of superficial bladder cancer with Drugetoglucid , doxorubicin, and mitomycin C.
0.9999 Adverse-Effect Two cases are reported of patients who developed a Adverse-Effecthematologic malignancy several years after intravesical chemotherapy of superficial bladder cancer with etoglucid, Drugdoxorubicin , and mitomycin C.
0.9998 Adverse-Effect Two cases are reported of patients who developed a Adverse-Effecthematologic malignancy several years after intravesical chemotherapy of superficial bladder cancer with etoglucid, doxorubicin, and Drugmitomycin C .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Although differential diagnostic alternatives can be considered in all described cases it is very likely that Drugvincristine does cause Adverse-Effectsevere visual loss in a small number of patients.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To report a case of neuroleptic malignant syndrome ( Adverse-EffectNMS ) associated with Drugfluphenazine in a schizophrenic patient and review the literature related to this condition.
0.9999 Adverse-Effect OBJECTIVE : To report a case of Adverse-Effectneuroleptic malignant syndrome ( NMS ) associated with Drugfluphenazine in a schizophrenic patient and review the literature related to this condition.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This latest ( third ) report suggests that the safety profile should be reexamined and at least raises the question of potential Adverse-Effectrenal toxicity of Druginterferons in MS.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect After a second dose of Drugmetoclopramide , these symptoms recurred and were associated with Adverse-Effectconfusion , agitation, fever, diaphoresis, tachypnea, tachycardia, and hypertension.
1.0000 Adverse-Effect After a second dose of Drugmetoclopramide , these symptoms recurred and were associated with confusion, Adverse-Effectagitation , fever, diaphoresis, tachypnea, tachycardia, and hypertension.
1.0000 Adverse-Effect After a second dose of Drugmetoclopramide , these symptoms recurred and were associated with confusion, agitation, fever, Adverse-Effectdiaphoresis , tachypnea, tachycardia, and hypertension.
1.0000 Adverse-Effect After a second dose of Drugmetoclopramide , these symptoms recurred and were associated with confusion, agitation, fever, diaphoresis, tachypnea, Adverse-Effecttachycardia , and hypertension.
1.0000 Adverse-Effect After a second dose of Drugmetoclopramide , these symptoms recurred and were associated with confusion, agitation, fever, diaphoresis, Adverse-Effecttachypnea , tachycardia, and hypertension.
1.0000 Adverse-Effect After a second dose of Drugmetoclopramide , these symptoms recurred and were associated with confusion, agitation, fever, diaphoresis, tachypnea, tachycardia, and Adverse-Effecthypertension .
1.0000 Adverse-Effect After a second dose of Drugmetoclopramide , these symptoms recurred and were associated with confusion, agitation, Adverse-Effectfever , diaphoresis, tachypnea, tachycardia, and hypertension.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Sulindac ( DrugClinoril ), a nonsteroidal anti - inflammatory agent, has few reported Adverse-Effectneurologic toxic effects , all of which have been associated with systemic disease.
0.9999 Adverse-Effect DrugSulindac ( Clinoril ), a nonsteroidal anti - inflammatory agent, has few reported Adverse-Effectneurologic toxic effects , all of which have been associated with systemic disease.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a 59 - year - old patient with chronic myeloid leukemia, who developed Adverse-Effectsevere interstitial lung fibrosis after short term and sequential treatment with Drugmelphalan and busulfan.
1.0000 Adverse-Effect We report a 59 - year - old patient with chronic myeloid leukemia, who developed Adverse-Effectsevere interstitial lung fibrosis after short term and sequential treatment with melphalan and Drugbusulfan .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect An association of granulocytopenia, eosinophilia, skin reaction and Adverse-Effecthepatitis during Drugpropylthiouracil ( PTU ) therapy for thyrotoxicosis in a 47 year old black female is reported.
1.0000 Adverse-Effect An association of granulocytopenia, eosinophilia, skin reaction and Adverse-Effecthepatitis during propylthiouracil ( DrugPTU ) therapy for thyrotoxicosis in a 47 year old black female is reported.
0.9999 Adverse-Effect An association of granulocytopenia, Adverse-Effecteosinophilia , skin reaction and hepatitis during Drugpropylthiouracil ( PTU ) therapy for thyrotoxicosis in a 47 year old black female is reported.
0.9999 Adverse-Effect An association of Adverse-Effectgranulocytopenia , eosinophilia, skin reaction and hepatitis during Drugpropylthiouracil ( PTU ) therapy for thyrotoxicosis in a 47 year old black female is reported.
0.9999 Adverse-Effect An association of granulocytopenia, eosinophilia, Adverse-Effectskin reaction and hepatitis during Drugpropylthiouracil ( PTU ) therapy for thyrotoxicosis in a 47 year old black female is reported.
0.9998 Adverse-Effect An association of granulocytopenia, Adverse-Effecteosinophilia , skin reaction and hepatitis during propylthiouracil ( DrugPTU ) therapy for thyrotoxicosis in a 47 year old black female is reported.
0.9998 Adverse-Effect An association of Adverse-Effectgranulocytopenia , eosinophilia, skin reaction and hepatitis during propylthiouracil ( DrugPTU ) therapy for thyrotoxicosis in a 47 year old black female is reported.
0.9997 Adverse-Effect An association of granulocytopenia, eosinophilia, Adverse-Effectskin reaction and hepatitis during propylthiouracil ( DrugPTU ) therapy for thyrotoxicosis in a 47 year old black female is reported.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The authors report five cases of Adverse-Effecttremor related to Drugitraconazole therapy, which occurred within 1 - 12 months of initiating treatment and resolved gradually following itraconazole withdrawal.
0.9966 Adverse-Effect The authors report five cases of Adverse-Effecttremor related to itraconazole therapy, which occurred within 1 - 12 months of initiating treatment and resolved gradually following Drugitraconazole withdrawal.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In this case, unlike those previously reported, Adverse-Effecthyponatremia recurred 5 months after switching from Drugcitalopram to mirtazapine, which is believed to be a safe antidepressant.
1.0000 Adverse-Effect In this case, unlike those previously reported, Adverse-Effecthyponatremia recurred 5 months after switching from citalopram to Drugmirtazapine , which is believed to be a safe antidepressant.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectTorsades de Pointes induced by a combination of Druggarenoxacin and disopyramide and other cytochrome P450, family 3, subfamily A polypeptide - 4 - influencing drugs during hypokalemia due to licorice.
1.0000 Adverse-Effect Adverse-EffectTorsades de Pointes induced by a combination of garenoxacin and Drugdisopyramide and other cytochrome P450, family 3, subfamily A polypeptide - 4 - influencing drugs during hypokalemia due to licorice.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect When the data of the 57 patients are evaluated, a reversible direct Adverse-Effectcytotoxic effect of Drugticlopidine on the pluripotent / bipotent hematopoietic progenitor stem cell is proposed.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Our cases constitute the most severe cases of benzarone hepatotoxicity reported so far, and comprise the first cases of ( sub ) fulminant hepatitis and Adverse-Effectcirrhosis related to Drugbenzarone .
0.9977 Adverse-Effect Our cases constitute the most severe cases of Drugbenzarone Adverse-Effecthepatotoxicity reported so far, and comprise the first cases of ( sub ) fulminant hepatitis and cirrhosis related to benzarone.
Adverse-Effect Our cases constitute the most severe cases of Drugbenzarone hepatotoxicity reported so far, and comprise the first cases of Adverse-Effect( sub ) fulminant hepatitis and cirrhosis related to benzarone.
Adverse-Effect Our cases constitute the most severe cases of benzarone hepatotoxicity reported so far, and comprise the first cases of Adverse-Effect( sub ) fulminant hepatitis and cirrhosis related to Drugbenzarone .
Adverse-Effect Our cases constitute the most severe cases of Drugbenzarone hepatotoxicity reported so far, and comprise the first cases of ( sub ) fulminant hepatitis and Adverse-Effectcirrhosis related to benzarone.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Case 2 demonstrated after 40 months on Drugchlorambucil the presence of a Adverse-Effectbalanced translocation , t ( 1 ; 5 ) ( p36 ; q31 ) in 90 % of the cells.
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect Adverse-EffectFDE from Drugcephalosporins has been rarely reported, and to the best of our knowledge there is no published report of ceftriaxone - induced FDE in the literature.
Adverse-Effect FDE from cephalosporins has been rarely reported, and to the best of our knowledge there is no published report of Drugceftriaxone - induced Adverse-EffectFDE in the literature.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CASE REPORT : We report the case of a 58 year old patient who, after 2 days of treatment with roxithromycin and Drugbetamethasone , manifested Adverse-Effectacute pancreatitis .
0.9999 Adverse-Effect CASE REPORT : We report the case of a 58 year old patient who, after 2 days of treatment with Drugroxithromycin and betamethasone, manifested Adverse-Effectacute pancreatitis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect One patient had a lower average heart rate and two patients had Adverse-Effectlower average mean blood pressure values during Drugpropranolol treatment, none of which was clinically significant.
0.9999 Adverse-Effect One patient had a Adverse-Effectlower average heart rate and two patients had lower average mean blood pressure values during Drugpropranolol treatment, none of which was clinically significant.
1.0000 Adverse-Effect One patient had a lower average heart rate and two patients had Adverse-Effectlower average mean blood pressure values during Drugpropranolol treatment, none of which was clinically significant.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect These cases and a review of the literature suggested that Adverse-Effecthepatotoxicity , though rare, should be added to the list of adverse reactions to DrugD - penicillamine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the case of a patient with multiple myeloma who developed Adverse-Effectacute life - threatening water intoxication following treatment with oral Drugindomethacin and low dose intravenous cyclophosphamide.
1.0000 Adverse-Effect We report the case of a patient with multiple myeloma who developed acute life - threatening Adverse-Effectwater intoxication following treatment with oral Drugindomethacin and low dose intravenous cyclophosphamide.
0.9999 Adverse-Effect We report the case of a patient with multiple myeloma who developed Adverse-Effectacute life - threatening water intoxication following treatment with oral indomethacin and low dose intravenous Drugcyclophosphamide .
0.9998 Adverse-Effect We report the case of a patient with multiple myeloma who developed acute life - threatening Adverse-Effectwater intoxication following treatment with oral indomethacin and low dose intravenous Drugcyclophosphamide .
Adverse-Effect We report the case of a patient with multiple myeloma who developed acute Adverse-Effectlife - threatening water intoxication following treatment with oral indomethacin and low dose intravenous Drugcyclophosphamide .
Adverse-Effect We report the case of a patient with multiple myeloma who developed acute Adverse-Effectlife - threatening water intoxication following treatment with oral Drugindomethacin and low dose intravenous cyclophosphamide.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect We report the occurrence of renal failure due to Adverse-Effectcholesterol crystal embolization following thrombolytic therapy with intravenous Drugrecombinant tissue - type plasminogen activator ( t - PA ).
0.9996 Adverse-Effect We report the occurrence of renal failure due to Adverse-Effectcholesterol crystal embolization following thrombolytic therapy with intravenous recombinant tissue - type plasminogen activator ( Drugt - PA ).
0.9996 Adverse-Effect We report the occurrence of Adverse-Effectrenal failure due to cholesterol crystal embolization following thrombolytic therapy with intravenous Drugrecombinant tissue - type plasminogen activator ( t - PA ).
0.9994 Adverse-Effect We report the occurrence of Adverse-Effectrenal failure due to cholesterol crystal embolization following thrombolytic therapy with intravenous recombinant tissue - type plasminogen activator ( Drugt - PA ).
0.9997 Adverse-Effect We report the occurrence of renal failure due to Adverse-Effectcholesterol crystal embolization following thrombolytic therapy with intravenous recombinant Drugtissue - type plasminogen activator ( t - PA ).
0.9993 Adverse-Effect We report the occurrence of Adverse-Effectrenal failure due to cholesterol crystal embolization following thrombolytic therapy with intravenous recombinant Drugtissue - type plasminogen activator ( t - PA ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect PURPOSE : The occurrence of Adverse-Effectmyoclonus associated with continuous i. v. infusion of Drugdobutamine in a patient with end - stage renal disease ( ESRD ) is described.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect I saw two patients with kala - azar resistant to sodium stibogluconate who developed Adverse-Effectcardiac arrest after Drugamphotericin infusion ( in spite of tolerating a test dose ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect However, in order to avoid Adverse-Effectneuropathic side effects , patients under Drugthalidomide therapy should be monitored every 6 months with nerve conduction studies while taking the drug.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The Adverse-Effecttoxicity and plasma concentrations of Drugifosfamide , chloroacetaldehyde, and 4 - hydroxyifosfamide were then determined over 24 h after a single 1. 6 g / m2 dose of ifosfamide.
0.9998 Adverse-Effect The Adverse-Effecttoxicity and plasma concentrations of ifosfamide, chloroacetaldehyde, and 4 - hydroxyifosfamide were then determined over 24 h after a single 1. 6 g / m2 dose of Drugifosfamide .
0.9998 Adverse-Effect The Adverse-Effecttoxicity and plasma concentrations of ifosfamide, Drugchloroacetaldehyde , and 4 - hydroxyifosfamide were then determined over 24 h after a single 1. 6 g / m2 dose of ifosfamide.
0.9998 Adverse-Effect The Adverse-Effecttoxicity and plasma concentrations of ifosfamide, chloroacetaldehyde, and Drug4 - hydroxyifosfamide were then determined over 24 h after a single 1. 6 g / m2 dose of ifosfamide.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A brief review of reported cases of Drugchloramphenicol Adverse-Effecthypersensitivity in the English - language literature, as well as possible alternative explanations in this case, are provided.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect In this paper, we report a case of 3 years - old boy who developed Adverse-Effectacute onset tetraparesia following a viral respiratory infecction and Drughepatitis B vaccination .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a patient who developed Adverse-EffectHUS after treatment with Drugmitomycin C ( total dose 144 mg / m2 ) due to a carcinoma of the ascending colon.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect However, as the use of Drughepatitis B vaccination is growing, adverse side effects, including Adverse-Effectmental nerve neuropathy , should be observed with an increased frequency.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a relatively healthy, 9 - year - old boy who developed a CA - MRSA skin and Adverse-Effectsoft tissue infection and was treated with DrugTMP - SMX .
0.9993 Adverse-Effect We describe a relatively healthy, 9 - year - old boy who developed a Adverse-EffectCA - MRSA skin and soft tissue infection and was treated with DrugTMP - SMX .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The mild immunosuppression that occurs with Drugmethotrexate therapy probably places patients with rheumatoid arthritis at added risk of developing Adverse-Effectlymphoproliferative diseases , but coincidence can not be excluded.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect These are the first reported patients to show mfERG abnormalities that correspond to Adverse-Effectbitemporal visual field defects and add to the growing evidence that Drugethambutol damages the retina.
0.9998 Adverse-Effect These are the first reported patients to show Adverse-EffectmfERG abnormalities that correspond to bitemporal visual field defects and add to the growing evidence that Drugethambutol damages the retina.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectMusculoskeletal complaints were the presenting symptoms in four of 44 children ( 9 % ) treated for relapsed Wilms'tumors with Drugifosfamide , a derivative of cyclophosphamide.
0.9997 Adverse-Effect Adverse-EffectMusculoskeletal complaints were the presenting symptoms in four of 44 children ( 9 % ) treated for relapsed Wilms'tumors with ifosfamide, a derivative of Drugcyclophosphamide .
Score Relation Text (Head - Tail)
0.9991 Adverse-Effect This case suggests that DrugBH - AC , a derivative of cytosine arabinoside ( 1 - beta - D - arabinofuranosylcytosine ) could be a cause of reversible Adverse-Effectencephalopathy syndrome .
1.0000 Adverse-Effect This case suggests that BH - AC, a derivative of cytosine arabinoside ( Drug1 - beta - D - arabinofuranosylcytosine ) could be a cause of reversible Adverse-Effectencephalopathy syndrome .
0.9996 Adverse-Effect This case suggests that BH - AC, a derivative of Drugcytosine arabinoside ( 1 - beta - D - arabinofuranosylcytosine ) could be a cause of reversible Adverse-Effectencephalopathy syndrome .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Although the data indicate an immune - complex cause for Druggold - salt Adverse-Effectnephropathy , the incident antigen ( or antigens ) and mechanism of action remain unidentified.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 40 - year - old man with a long standing history of rheumatoid arthritis was treated with DrugMTX over a 6 month period and developed an Adverse-Effectoverwhelming hepatic necrosis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of a 64 - year - old man with secondary Adverse-Effectadrenocortical insufficiency who has been on a chronic transdermal Drugfentanyl treatment because of sciatic pain syndrome.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We now report the first known cancer patient who developed Adverse-Effectlife - threatening complications after treatment with topical Drug5 - FU and was shown subsequently to have profound DPD deficiency.
0.9999 Adverse-Effect We now report the first known cancer patient who developed life - threatening complications after treatment with topical Drug5 - FU and was shown subsequently to have profound Adverse-EffectDPD deficiency .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 62 - year - old Caucasian man with atrial fibrillation who was taking Drugwarfarin reported an episode of Adverse-Effecthematochezia ; his international normalized ratio ( INR ) was 1. 74.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 9 - year - old boy developed Adverse-Effectacute renal failure following intravenous Drugacyclovir ( 30 mg / kg per day ) administered for 6 days to treat herpetic encephalitis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a patient with acute leukemia who developed Horner's syndrome and a severe demyelinating peripheral neuropathy leading to Adverse-Effectdeath after receiving high - dose Drugcytosine arabinoside .
0.9998 Adverse-Effect We describe a patient with acute leukemia who developed Horner's syndrome and a Adverse-Effectsevere demyelinating peripheral neuropathy leading to death after receiving high - dose Drugcytosine arabinoside .
0.9997 Adverse-Effect We describe a patient with acute leukemia who developed Adverse-EffectHorner's syndrome and a severe demyelinating peripheral neuropathy leading to death after receiving high - dose Drugcytosine arabinoside .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of a 23 - year - old man who developed a Drugvancomycin - induced Adverse-Effectanaphylactic reaction in the treatment of methicillin - resistant Staphylococcus aureus infection.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We observed 2 cases of Adverse-Effecthepatotoxicity after a high - dose Drugmethylprednisolone treatment of a demyelinating disease and evaluated the potential relationship in the light of available evidence.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectMasculinization of a female fetus occurred in 5 of 39 ( 12. 8 % ) exposed to Drugnorethisterone ; all were cases of clitoral hypertrophy not requiring surgical treatment.
0.9999 Adverse-Effect Masculinization of a female fetus occurred in 5 of 39 ( 12. 8 % ) exposed to Drugnorethisterone ; all were cases of Adverse-Effectclitoral hypertrophy not requiring surgical treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Observations in our patient suggest that the Adverse-Effectleukoencephalopathy that developed in previously reported patients who received Drug5 - fluorouracil and levamisole may have been caused at least partly by levamisole.
0.9996 Adverse-Effect Observations in our patient suggest that the Adverse-Effectleukoencephalopathy that developed in previously reported patients who received 5 - fluorouracil and Druglevamisole may have been caused at least partly by levamisole.
0.9992 Adverse-Effect Observations in our patient suggest that the Adverse-Effectleukoencephalopathy that developed in previously reported patients who received 5 - fluorouracil and levamisole may have been caused at least partly by Druglevamisole .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSION : In some abstainers who take Drugcyanamide for several years, thin Adverse-Effectseptum - like liver fibrosis progresses along with the emergence of ground - glass hepatocytes.
0.9999 Adverse-Effect CONCLUSION : In some abstainers who take Drugcyanamide for several years, thin septum - like liver fibrosis progresses along with the emergence of Adverse-Effectground - glass hepatocytes .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect DrugArgatroban is hepatically cleared and may be the preferred direct thrombin inhibitor in the presence of significant renal impairment, but conversely has prolonged effects in Adverse-Effecthepatic failure .
0.9999 Adverse-Effect DrugArgatroban is hepatically cleared and may be the preferred direct thrombin inhibitor in the presence of significant Adverse-Effectrenal impairment , but conversely has prolonged effects in hepatic failure.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In patients with cirrhosis, the metabolism of Drugmeperidine is decreased, leading to Adverse-Effectaccumulation of the parent drug and possible CNS depressive effects similar to hepatic encephalopathy.
0.9997 Adverse-Effect In patients with cirrhosis, the metabolism of Drugmeperidine is decreased, leading to accumulation of the parent drug and possible Adverse-EffectCNS depressive effects similar to hepatic encephalopathy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of Adverse-Effecthepatolithiasis ( intrahepatic stone ) complicated by gram - negative sepsis in a 37 year old male with acromegaly being treated with Drugoctreotide .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The Adverse-Effectrash seen in this patient, who was treated with Drugcephalexin , may be similar to the rash seen with ampicillin treatment of patients with infectious mononucleosis.
0.9789 Adverse-Effect The rash seen in this patient, who was treated with Drugcephalexin , may be similar to the Adverse-Effectrash seen with ampicillin treatment of patients with infectious mononucleosis.
Adverse-Effect The rash seen in this patient, who was treated with cephalexin, may be similar to the Adverse-Effectrash seen with Drugampicillin treatment of patients with infectious mononucleosis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report on three observations of parkinsonian patients with Druglevo - dopa - induced Adverse-Effectdiphasic dyskinesias , who received subcutaneous apomorphine to reduce the duration of abnormal movements.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe two cases of Drugsulfadiazine - induced Adverse-Effectcrystalluria and renal failure in patients with acquired immunodeficiency syndrome, review the pertinent literature, and discuss the pathogenesis.
1.0000 Adverse-Effect We describe two cases of Drugsulfadiazine - induced crystalluria and Adverse-Effectrenal failure in patients with acquired immunodeficiency syndrome, review the pertinent literature, and discuss the pathogenesis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Although major hazards of treatment of hypophosphatemic osteomalacia with phosphate and Drugcalcitriol are Adverse-Effectsecondary hyperparathyroidism and vitamin D intoxication, potassium loss also should be kept in mind.
0.9998 Adverse-Effect Although major hazards of treatment of hypophosphatemic osteomalacia with phosphate and Drugcalcitriol are secondary hyperparathyroidism and vitamin D intoxication, Adverse-Effectpotassium loss also should be kept in mind.
0.9996 Adverse-Effect Although major hazards of treatment of hypophosphatemic osteomalacia with phosphate and Drugcalcitriol are secondary hyperparathyroidism and Adverse-Effectvitamin D intoxication , potassium loss also should be kept in mind.
0.9994 Adverse-Effect Although major hazards of treatment of hypophosphatemic osteomalacia with Drugphosphate and calcitriol are secondary hyperparathyroidism and vitamin D intoxication, Adverse-Effectpotassium loss also should be kept in mind.
0.9993 Adverse-Effect Although major hazards of treatment of hypophosphatemic osteomalacia with Drugphosphate and calcitriol are Adverse-Effectsecondary hyperparathyroidism and vitamin D intoxication, potassium loss also should be kept in mind.
0.9979 Adverse-Effect Although major hazards of treatment of hypophosphatemic osteomalacia with Drugphosphate and calcitriol are secondary hyperparathyroidism and Adverse-Effectvitamin D intoxication , potassium loss also should be kept in mind.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect After 39 hours on Drugargatroban , the infusion was stopped when minor Adverse-Effectbleeding was observed with a concurrent activated partial thromboplastin time ( aPTT ) of 100 seconds.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This report rules out other causes of Adverse-Effecttoxic epidermal necrolysis and implicates Drugofloxacin in what appears to be an atypical presentation of drug - induced toxic epidermal necrolysis.
0.9998 Adverse-Effect This report rules out other causes of toxic epidermal necrolysis and implicates Drugofloxacin in what appears to be an atypical presentation of drug - induced Adverse-Effecttoxic epidermal necrolysis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectSensorineural hearing loss due to Drugquinine therapy for malaria has frequently been mentioned in the literature but has not been a subject of research during the last decades.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 31 - year - old female developed multiple episodes of Adverse-Effectgrand mal seizures after combination chemotherapy with Drugcisplatin , vinblastine and bleomycin for germ cell ovarian cancer stage Ic.
1.0000 Adverse-Effect A 31 - year - old female developed multiple episodes of Adverse-Effectgrand mal seizures after combination chemotherapy with cisplatin, Drugvinblastine and bleomycin for germ cell ovarian cancer stage Ic.
1.0000 Adverse-Effect A 31 - year - old female developed multiple episodes of Adverse-Effectgrand mal seizures after combination chemotherapy with cisplatin, vinblastine and Drugbleomycin for germ cell ovarian cancer stage Ic.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 12 year old patient with atrial flutter is presented, in whom intravenous Drugadenosine was followed by Adverse-Effectacceleration of the heart rate to a potentially dangerous arrhythmia.
0.9999 Adverse-Effect A 12 year old patient with atrial flutter is presented, in whom intravenous Drugadenosine was followed by acceleration of the heart rate to a potentially dangerous Adverse-Effectarrhythmia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case in which Adverse-Effecthemorrhage occurred in an asymptomatic falx meningioma known beforehand, after the internal use of low - dose Drugaspirin for 16 months.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of Adverse-Effecthypoglycaemia after Drugmefloquine therapy ( 1, 500 mg over two days ) for severe gastrointestinal cryptosporidiasis in a cachectic AIDS patient with protracted diarrhoea.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This report describes a case of paradoxical, intravenous Drugvalproic acid - induced Adverse-Effectseizure exacerbation in a child with juvenile absence epilepsy, documented by video - electroencephalography.
0.9966 Adverse-Effect This report describes a case of Drugparadoxical , intravenous valproic acid - induced Adverse-Effectseizure exacerbation in a child with juvenile absence epilepsy, documented by video - electroencephalography.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect That review suggested that patients receiving Druganti - D IGIV be monitored for those and other potential complications of Adverse-Effecthemoglobinemia , particularly disseminated intravascular coagulation ( DIC ).
0.9998 Adverse-Effect That review suggested that patients receiving Druganti - D IGIV be monitored for those and other potential complications of hemoglobinemia, particularly disseminated intravascular coagulation ( Adverse-EffectDIC ).
0.9995 Adverse-Effect That review suggested that patients receiving Druganti - D IGIV be monitored for those and other potential complications of hemoglobinemia, particularly Adverse-Effectdisseminated intravascular coagulation ( DIC ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Mequitazine seemed to play a part similar to chlorpromazine, and absence of Drugmequitazine - induced Adverse-Effectphotosensitivity may be due to a relatively low dosage of the drug.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The authors suggest that Drugrisperidone may Adverse-Effectincrease affect in patients with schizophrenia and that some patients, especially those with anxiety, may have difficulty managing the increase.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The risk of new - onset Adverse-Effectdiabetic ketoacidosis in patients with diabetic risk factors who are taking Drugperospirone hydrochloride or other atypical antipsychotics should be kept in mind.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : Among the many presentations of Drugifosfamide Adverse-Effectneurotoxicity , clinicians should consider NCSE as a possible explanation for changes in consciousness in a patient receiving this agent.
0.9831 Adverse-Effect CONCLUSIONS : Among the many presentations of Drugifosfamide neurotoxicity, clinicians should consider Adverse-EffectNCSE as a possible explanation for changes in consciousness in a patient receiving this agent.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This case showed sequential manifestation from transient thyrotoxicosis to the appearance of TSH - receptor autoantibodies, and then the occurrence of Adverse-EffectGraves'hyperthyroidism during DrugIFN therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A transient tonic pupillary response, denervation supersensitivity, and Adverse-Effectabnormal visual - evoked potentials in Drugquinine toxicity, to our knowledge, have not been previously reported.
0.9998 Adverse-Effect A Adverse-Effecttransient tonic pupillary response , denervation supersensitivity, and abnormal visual - evoked potentials in Drugquinine toxicity, to our knowledge, have not been previously reported.
0.9998 Adverse-Effect A transient tonic pupillary response, Adverse-Effectdenervation supersensitivity , and abnormal visual - evoked potentials in Drugquinine toxicity, to our knowledge, have not been previously reported.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect An encephalopathy and Adverse-Effectcardiomyopathy developed in a seventeen - year - old girl with chemotherapy - induced renal failure while receiving an intravesical Drugaluminum infusion for hemorrhagic cystitis.
0.9998 Adverse-Effect An Adverse-Effectencephalopathy and cardiomyopathy developed in a seventeen - year - old girl with chemotherapy - induced renal failure while receiving an intravesical Drugaluminum infusion for hemorrhagic cystitis.
1.0000 Adverse-Effect An encephalopathy and cardiomyopathy developed in a seventeen - year - old girl with chemotherapy - induced Adverse-Effectrenal failure while receiving an intravesical Drugaluminum infusion for hemorrhagic cystitis.
Score Relation Text (Head - Tail)
0.9991 Adverse-Effect Pancreatitis is a very rare adverse effect associated with the use of amiodarone, and only four cases of Drugamiodarone - induced Adverse-Effectpancreatitis have been reported in literature.
0.9967 Adverse-Effect Adverse-EffectPancreatitis is a very rare adverse effect associated with the use of Drugamiodarone , and only four cases of amiodarone - induced pancreatitis have been reported in literature.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONTEXT : Previous investigators have reported Adverse-Effectdiscrepancies between hematologic, marrow morphologic, and cytogenetic responses to Drugimatinib mesylate among patients with chronic myeloid leukemia ( CML ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSION : The administration of Drugtissue plasminogen activator was responsible for the large extent of Adverse-Effecthemorrhage and should be considered in the differential diagnosis of hemorrhagic choroidal detachment.
0.9993 Adverse-Effect CONCLUSION : The administration of Drugtissue plasminogen activator was responsible for the large extent of hemorrhage and should be considered in the differential diagnosis of Adverse-Effecthemorrhagic choroidal detachment .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect PURPOSE : To describe Adverse-Effecttransient structured visual hallucinations in a patient with vascular age - related macular degeneration ( AMD ), following an intravitreal DrugAvastin - injection.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectAtaxia caused by Drugpropafenone has been reported to the pharmaceutical companies and drug monitoring agencies, but has not been well described or emphasized in the medical literature.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 16 - year - old boy developed fever, generalized rigidity, leukocytosis, and Adverse-Effectincreased serum transaminase and creatine kinase levels while receiving treatment with Drugolanzapine and lithium.
1.0000 Adverse-Effect A 16 - year - old boy developed fever, generalized rigidity, Adverse-Effectleukocytosis , and increased serum transaminase and creatine kinase levels while receiving treatment with Drugolanzapine and lithium.
0.9999 Adverse-Effect A 16 - year - old boy developed Adverse-Effectfever , generalized rigidity, leukocytosis, and increased serum transaminase and creatine kinase levels while receiving treatment with Drugolanzapine and lithium.
0.9999 Adverse-Effect A 16 - year - old boy developed fever, Adverse-Effectgeneralized rigidity , leukocytosis, and increased serum transaminase and creatine kinase levels while receiving treatment with Drugolanzapine and lithium.
0.9999 Adverse-Effect A 16 - year - old boy developed fever, generalized rigidity, leukocytosis, and Adverse-Effectincreased serum transaminase and creatine kinase levels while receiving treatment with olanzapine and Druglithium .
0.9998 Adverse-Effect A 16 - year - old boy developed fever, generalized rigidity, Adverse-Effectleukocytosis , and increased serum transaminase and creatine kinase levels while receiving treatment with olanzapine and Druglithium .
0.9998 Adverse-Effect A 16 - year - old boy developed Adverse-Effectfever , generalized rigidity, leukocytosis, and increased serum transaminase and creatine kinase levels while receiving treatment with olanzapine and Druglithium .
0.9998 Adverse-Effect A 16 - year - old boy developed fever, Adverse-Effectgeneralized rigidity , leukocytosis, and increased serum transaminase and creatine kinase levels while receiving treatment with olanzapine and Druglithium .
1.0000 Adverse-Effect A 16 - year - old boy developed fever, generalized rigidity, leukocytosis, and Adverse-Effectincreased serum transaminase and creatine kinase levels while receiving treatment with Drugolanzapine and lithium.
1.0000 Adverse-Effect A 16 - year - old boy developed fever, generalized rigidity, leukocytosis, and Adverse-Effectincreased serum transaminase and creatine kinase levels while receiving treatment with Drugolanzapine and lithium.
1.0000 Adverse-Effect A 16 - year - old boy developed fever, generalized rigidity, leukocytosis, and Adverse-Effectincreased serum transaminase and creatine kinase levels while receiving treatment with Drugolanzapine and lithium.
1.0000 Adverse-Effect A 16 - year - old boy developed fever, generalized rigidity, leukocytosis, and Adverse-Effectincreased serum transaminase and creatine kinase levels while receiving treatment with Drugolanzapine and lithium.
1.0000 Adverse-Effect A 16 - year - old boy developed fever, generalized rigidity, leukocytosis, and Adverse-Effectincreased serum transaminase and creatine kinase levels while receiving treatment with olanzapine and Druglithium .
0.9999 Adverse-Effect A 16 - year - old boy developed fever, generalized rigidity, leukocytosis, and Adverse-Effectincreased serum transaminase and creatine kinase levels while receiving treatment with olanzapine and Druglithium .
0.9999 Adverse-Effect A 16 - year - old boy developed fever, generalized rigidity, leukocytosis, and Adverse-Effectincreased serum transaminase and creatine kinase levels while receiving treatment with olanzapine and Druglithium .
0.9998 Adverse-Effect A 16 - year - old boy developed fever, generalized rigidity, leukocytosis, and Adverse-Effectincreased serum transaminase and creatine kinase levels while receiving treatment with olanzapine and Druglithium .
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect We suggest adding this side effect to the list of untoward effects of lidocaine and to the differential diagnosis of fixed Adverse-Effectdilated pupils in neonates treated with Druglidocaine .
0.9993 Adverse-Effect We suggest adding this side effect to the list of untoward effects of Druglidocaine and to the differential diagnosis of fixed Adverse-Effectdilated pupils in neonates treated with lidocaine.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We conclude that Adverse-Effectmyocardial infarction may develop in patients treated with high - dose Drugglucocorticoids for Graves'ophthalmopathy, and increased blood pressure may herald this complication.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect After intravitreal injection of Drugtriamcinolone acetonide , Adverse-Effectcataract may rapidly develop in eyes that have been intensively treated, topically and systemically, by corticosteroids for several years.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The current study investigated the visual fields and visual electrophysiology of eight patients with known Drugvigabatrin - attributed Adverse-Effectvisual field loss , three of whom were reported previously.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugQuinapril is an angiotensin - converting enzyme inhibitor ( ACE - inhibitor ) and overdose can lead to Adverse-Effectprolonged hypotension and, less frequently, transient renal impairment.
1.0000 Adverse-Effect DrugQuinapril is an angiotensin - converting enzyme inhibitor ( ACE - inhibitor ) and overdose can lead to prolonged hypotension and, less frequently, Adverse-Effecttransient renal impairment .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 60 - year - old woman with diabetes mellitus ( type 2 ) developed an Adverse-Effectacute icteric hepatitis - like illness 6 weeks after the initiation of Druggliclazide therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 58 - yr - old male patient with essential thrombocythaemia ( ET ) developed chronic myeloid leukaemia ( Adverse-EffectCML ) after continuous uneventful treatment with Drughydroxyurea for 18 yr.
1.0000 Adverse-Effect A 58 - yr - old male patient with essential thrombocythaemia ( ET ) developed Adverse-Effectchronic myeloid leukaemia ( CML ) after continuous uneventful treatment with Drughydroxyurea for 18 yr.
Score Relation Text (Head - Tail)
Adverse-Effect The purpose of this report is to document a new case of in utero DrugCP exposure with Adverse-Effectmultiple congenital anomalies and to establish an apparent CP embryopathy phenotype.
Adverse-Effect The purpose of this report is to document a new case of in utero CP exposure with multiple congenital anomalies and to establish an apparent DrugCP Adverse-Effectembryopathy phenotype.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To report a case of Drugcalcineurin - induced Adverse-Effectpain syndrome ( CIPS ) in a child undergoing his second hematopoietic stem cell transplant ( HSCT ).
0.9999 Adverse-Effect OBJECTIVE : To report a case of Drugcalcineurin - induced pain syndrome ( Adverse-EffectCIPS ) in a child undergoing his second hematopoietic stem cell transplant ( HSCT ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 58 - year - old woman with rheumatoid arthritis ( RA ) developed fever, skin eruptions, leukocytopenia, and Adverse-Effectthrombocytopenia , 3 weeks after treatment with Drugsulfasalazine .
1.0000 Adverse-Effect A 58 - year - old woman with rheumatoid arthritis ( RA ) developed fever, skin eruptions, Adverse-Effectleukocytopenia , and thrombocytopenia, 3 weeks after treatment with Drugsulfasalazine .
1.0000 Adverse-Effect A 58 - year - old woman with rheumatoid arthritis ( RA ) developed Adverse-Effectfever , skin eruptions, leukocytopenia, and thrombocytopenia, 3 weeks after treatment with Drugsulfasalazine .
0.9999 Adverse-Effect A 58 - year - old woman with rheumatoid arthritis ( RA ) developed fever, Adverse-Effectskin eruptions , leukocytopenia, and thrombocytopenia, 3 weeks after treatment with Drugsulfasalazine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In deciding if tamoxifen therapy is warranted, all potentially life - threatening adverse events associated with Drugtamoxifen should be considered, including Adverse-Effectendometrial adenocarcinoma or uterine sarcoma.
0.9995 Adverse-Effect In deciding if Drugtamoxifen therapy is warranted, all potentially life - threatening adverse events associated with tamoxifen should be considered, including Adverse-Effectendometrial adenocarcinoma or uterine sarcoma.
0.9995 Adverse-Effect In deciding if tamoxifen therapy is warranted, all potentially life - threatening adverse events associated with Drugtamoxifen should be considered, including endometrial adenocarcinoma or Adverse-Effectuterine sarcoma .
0.9986 Adverse-Effect In deciding if Drugtamoxifen therapy is warranted, all potentially life - threatening adverse events associated with tamoxifen should be considered, including endometrial adenocarcinoma or Adverse-Effectuterine sarcoma .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Although various manifestations of Drugpentamidine - induced Adverse-Effectcardiotoxicity have been reported, to our knowledge, second - degree heart block associated with this agent has not been described.
0.9973 Adverse-Effect Although various manifestations of Drugpentamidine - induced cardiotoxicity have been reported, to our knowledge, Adverse-Effectsecond - degree heart block associated with this agent has not been described.
Score Relation Text (Head - Tail)
Adverse-Effect We report the syndrome of inappropriate Adverse-Effectantidiuresis as a much earlier side - effect of Drugcarbamazepine administration in a 29 - year Nigerian female patient with generalized tonic - elonic seizures.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Amphotericin B ( DrugAmB ) is effective, but its use is limited by toxicity : Adverse-Effectrenal impairment , anaemia, fever, malaise, and hypokalaemia are common.
1.0000 Adverse-Effect Amphotericin B ( DrugAmB ) is effective, but its use is limited by toxicity : renal impairment, Adverse-Effectanaemia , fever, malaise, and hypokalaemia are common.
1.0000 Adverse-Effect Amphotericin B ( DrugAmB ) is effective, but its use is limited by toxicity : renal impairment, anaemia, fever, Adverse-Effectmalaise , and hypokalaemia are common.
0.9999 Adverse-Effect Amphotericin B ( DrugAmB ) is effective, but its use is limited by toxicity : renal impairment, anaemia, fever, malaise, and Adverse-Effecthypokalaemia are common.
0.9999 Adverse-Effect Amphotericin B ( DrugAmB ) is effective, but its use is limited by toxicity : renal impairment, anaemia, Adverse-Effectfever , malaise, and hypokalaemia are common.
0.9998 Adverse-Effect DrugAmphotericin B ( AmB ) is effective, but its use is limited by toxicity : renal impairment, Adverse-Effectanaemia , fever, malaise, and hypokalaemia are common.
0.9998 Adverse-Effect DrugAmphotericin B ( AmB ) is effective, but its use is limited by toxicity : Adverse-Effectrenal impairment , anaemia, fever, malaise, and hypokalaemia are common.
0.9998 Adverse-Effect DrugAmphotericin B ( AmB ) is effective, but its use is limited by toxicity : renal impairment, anaemia, fever, Adverse-Effectmalaise , and hypokalaemia are common.
0.9998 Adverse-Effect DrugAmphotericin B ( AmB ) is effective, but its use is limited by toxicity : renal impairment, anaemia, fever, malaise, and Adverse-Effecthypokalaemia are common.
0.9997 Adverse-Effect DrugAmphotericin B ( AmB ) is effective, but its use is limited by toxicity : renal impairment, anaemia, Adverse-Effectfever , malaise, and hypokalaemia are common.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect This case suggests that sarcoidosis and Drugpravastatin , two entities not frequently associated with myotonia, may interact in a synergistic manner to produce severe clinical Adverse-Effectmyotonia in humans.
0.9999 Adverse-Effect This case suggests that sarcoidosis and Drugpravastatin , two entities not frequently associated with Adverse-Effectmyotonia , may interact in a synergistic manner to produce severe clinical myotonia in humans.
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect We present two cases of Adverse-Effectanaphylaxis under anaesthesia where return of spontaneous circulation was refractory to epinephrine, but occurred following the administration of the alpha - agonist Drugmetaraminol .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We present the cases of two female patients diagnosed with relapsing - remitting multiple sclerosis ( RRMS ) who developed Adverse-Effectinflammatory musculoskeletal manifestations , following DrugIFN - beta therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBSERVATIONS : A 48 - year - old woman presented with Adverse-Effectdisfiguring facial edema 10 weeks after she began antiviral therapy with Drugpeginterferon alfa - 2a and ribavirin for chronic hepatitis C infection.
0.9999 Adverse-Effect OBSERVATIONS : A 48 - year - old woman presented with Adverse-Effectdisfiguring facial edema 10 weeks after she began antiviral therapy with peginterferon alfa - 2a and Drugribavirin for chronic hepatitis C infection.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectAkathisia appeared to be a common side effect of Drugfluoxetine and generally responded well to treatment with the beta - adrenergic antagonist propranolol, dose reduction, or both.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a 45 - year - old Chinese man with CML and chronic hepatitis B virus infection, on Drugimatinib treatment, presenting with Adverse-Effectherpetic rash and acute liver failure.
1.0000 Adverse-Effect We report a 45 - year - old Chinese man with CML and chronic hepatitis B virus infection, on Drugimatinib treatment, presenting with herpetic rash and Adverse-Effectacute liver failure .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectFatal agranulocytosis in an Indian male receiving 100 mg of Drugdapsone daily, hospitalized for mid - borderline leprosy in type I reaction with triple nerve paralysis is reported.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We believe that mucositis was a contributing factor to this case of Adverse-Effectfatal hyperkalemia after administration of Drugsuccinylcholine , with a mechanism similar to that reported with thermal injury.
0.9998 Adverse-Effect We believe that Adverse-Effectmucositis was a contributing factor to this case of fatal hyperkalemia after administration of Drugsuccinylcholine , with a mechanism similar to that reported with thermal injury.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In eight patients, a mean Adverse-Effectdecrease in serum Na + of 8. 25 + / - 3. 2 mEq / L was observed after a single 200 mg intravenous dose of Druglorcainide .
Score Relation Text (Head - Tail)
0.9993 Adverse-Effect Since early symptoms of the toxic effects of Drugtheophylline can mimic Adverse-Effectpeptic ulcer disease , cimetidine might be prescribed for the gastrointestinal symptoms with subsequent worsening of theophylline poisoning.
Score Relation Text (Head - Tail)
0.9988 Adverse-Effect Clinicians should be aware of the signs and symptoms of Adverse-Effectneurotoxicity during treatment, as well as predisposing factors that put patients receiving Drugmethotrexate at risk for neurotoxic effects.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This case describes a 52 - year - old white woman who developed a Adverse-Effectspontaneous nasal septal perforation after given the antiangiogenic drug, Drugbevacizumab , for metastatic ovarian cancer treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This is the first report of a Drugfluoxetine - related Adverse-Effectdeath in a child with a confirmed genetic polymorphism of the CYP2D6 gene that results in impaired drug metabolism.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectCutaneous necrosis as a result of Druginterferon alfa is an infrequent complication with unknown pathogenesis, in which a cutaneous local immune - mediated inflammatory process might be involved.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect There have been more than 20 observations of the appearance or aggravation of this Adverse-Effectgranulomatosis with Druginterferon alfa and more recently with the combination of interferon alfa plus ribavirin.
0.9997 Adverse-Effect There have been more than 20 observations of the appearance or aggravation of this Adverse-Effectgranulomatosis with interferon alfa and more recently with the combination of interferon alfa plus Drugribavirin .
0.9995 Adverse-Effect There have been more than 20 observations of the appearance or aggravation of this Adverse-Effectgranulomatosis with interferon alfa and more recently with the combination of Druginterferon alfa plus ribavirin.
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect We describe a patient with Wilson's disease who presented with neurologic disease, was treated with DrugD - penicillamine , and suffered sudden Adverse-Effectneurologic deterioration coincident with therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This selective closure of the ductus arteriosus suggests that the affected twin was predisposed to hypoxia and thus was more susceptible to Adverse-Effectductal closure in response to Drugindomethacin exposure.
0.9999 Adverse-Effect This selective closure of the ductus arteriosus suggests that the affected twin was predisposed to Adverse-Effecthypoxia and thus was more susceptible to ductal closure in response to Drugindomethacin exposure.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This Adverse-Effecteruption emerged after 1 month of therapy with Drugsalsalate , persisted for as long as salsalate was administered, and cleared within 3 weeks of discontinuing the medication.
0.9995 Adverse-Effect This Adverse-Effecteruption emerged after 1 month of therapy with salsalate, persisted for as long as Drugsalsalate was administered, and cleared within 3 weeks of discontinuing the medication.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of Adverse-Effectcough following the administration of Drugquinapril , with complete resolution after changing to the alternative ACE inhibitor fosinopril in a patient with essential hypertension.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Recent reports have shown that Decadron ( dexamethasone ; Merck Sharp & Dohme, West Point, Pa ) has a significant antiemetic effect on Drugcisplatin - induced Adverse-Effectvomiting .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Prick tests and intradermal tests with a series of dilutions of carboplatin and cisplatin were performed on three patients who had exhibited medium and Adverse-Effectsevere hypersensitivity reactions to Drugcarboplatin .
0.9996 Adverse-Effect Prick tests and intradermal tests with a series of dilutions of carboplatin and Drugcisplatin were performed on three patients who had exhibited medium and Adverse-Effectsevere hypersensitivity reactions to carboplatin.
0.9978 Adverse-Effect Prick tests and intradermal tests with a series of dilutions of Drugcarboplatin and cisplatin were performed on three patients who had exhibited medium and Adverse-Effectsevere hypersensitivity reactions to carboplatin.
Adverse-Effect Prick tests and intradermal tests with a series of dilutions of carboplatin and cisplatin were performed on three patients who had exhibited medium and Adverse-Effectsevere hypersensitivity reactions to Drugcarboplatin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We believe that this represents an unusual case of moderate - dose DrugMTX - induced Adverse-Effectneurotoxicity in a patient with gastric cancer, which has not previously been reported.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect The chemotherapeutics, including vincristine, actinomycin D, and epirubicin in case 1 and vincristine and Drugactinomycin D in case 2, were given before the Adverse-Effecthepatotoxicity developed.
0.9994 Adverse-Effect The chemotherapeutics, including vincristine, actinomycin D, and epirubicin in case 1 and Drugvincristine and actinomycin D in case 2, were given before the Adverse-Effecthepatotoxicity developed.
0.9990 Adverse-Effect The chemotherapeutics, including Drugvincristine , actinomycin D, and epirubicin in case 1 and vincristine and actinomycin D in case 2, were given before the Adverse-Effecthepatotoxicity developed.
0.9990 Adverse-Effect The chemotherapeutics, including vincristine, actinomycin D, and Drugepirubicin in case 1 and vincristine and actinomycin D in case 2, were given before the Adverse-Effecthepatotoxicity developed.
0.9984 Adverse-Effect The chemotherapeutics, including vincristine, Drugactinomycin D , and epirubicin in case 1 and vincristine and actinomycin D in case 2, were given before the Adverse-Effecthepatotoxicity developed.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report on a patient with renal artery stenosis who had only 1 kidney and in whom acute renal impairment developed with Adverse-Effecttransient anuria after the administration of Drugcaptopril .
0.9999 Adverse-Effect We report on a patient with renal artery stenosis who had only 1 kidney and in whom Adverse-Effectacute renal impairment developed with transient anuria after the administration of Drugcaptopril .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Sweet's syndrome is an Adverse-Effectacute febrile neutrophilic dermatosis that is a known complication of the administration of Drugfilgrastim , a drug that causes increased neutrophil proliferation and differentiation.
1.0000 Adverse-Effect Adverse-EffectSweet's syndrome is an acute febrile neutrophilic dermatosis that is a known complication of the administration of Drugfilgrastim , a drug that causes increased neutrophil proliferation and differentiation.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugMetformin - associated Adverse-Effectlactic acidosis ( MALA ) is a serious metabolic complication that occurs because of metformin accumulation in patients who become dehydrated or developed acute renal failure.
0.9966 Adverse-Effect Metformin - associated Adverse-Effectlactic acidosis ( MALA ) is a serious metabolic complication that occurs because of Drugmetformin accumulation in patients who become dehydrated or developed acute renal failure.
0.9989 Adverse-Effect Metformin - associated lactic acidosis ( Adverse-EffectMALA ) is a serious metabolic complication that occurs because of Drugmetformin accumulation in patients who become dehydrated or developed acute renal failure.
0.9987 Adverse-Effect DrugMetformin - associated lactic acidosis ( Adverse-EffectMALA ) is a serious metabolic complication that occurs because of metformin accumulation in patients who become dehydrated or developed acute renal failure.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect However, a new episode of Adverse-Effectneutropenia , with a WBC count of 2. 8 x 10 ( 3 ) / mm3 and ANC of 0. 448 x 10 ( 3 ) / mm3, occurred 11 days after Drugteicoplanin initiation.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of Adverse-Effectsevere anemia , which responded well to steroid therapy, in a patient receiving DrugIL - 2 plus IFN - alpha for metastatic renal cell carcinoma.
0.9998 Adverse-Effect We report a case of Adverse-Effectsevere anemia , which responded well to steroid therapy, in a patient receiving IL - 2 plus DrugIFN - alpha for metastatic renal cell carcinoma.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect After extensive neurological'work up ', we realized that the Adverse-Effectanisocoria was related to the transdermal Drugscopolamine patch that we had prescribed for weaning off the opioid.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a patient in whom the anti - depressant trazodone hydrochloride ( DrugMolipaxin , Roussel ), a serotonin antagonist, provoked Adverse-Effectgeneralized pustular psoriasis ( GPP ).
0.9999 Adverse-Effect We report a patient in whom the anti - depressant trazodone hydrochloride ( DrugMolipaxin , Roussel ), a serotonin antagonist, provoked generalized pustular psoriasis ( Adverse-EffectGPP ).
0.9998 Adverse-Effect We report a patient in whom the anti - depressant Drugtrazodone hydrochloride ( Molipaxin, Roussel ), a serotonin antagonist, provoked Adverse-Effectgeneralized pustular psoriasis ( GPP ).
0.9995 Adverse-Effect We report a patient in whom the anti - depressant Drugtrazodone hydrochloride ( Molipaxin, Roussel ), a serotonin antagonist, provoked generalized pustular psoriasis ( Adverse-EffectGPP ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In addition, there is a report on Adverse-Effectprolonged ECT seizure related to Drugciprofloxacin , which has an epileptogenic property with a similar action to beta - lactam antibiotics.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Here, we present a case of Drugsirolimus - associated Adverse-Effectinterstitial pneumonitis in a cardiac transplant recipient that resolved completely with withdrawal of the drug and treatment with corticosteroids.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In rare cases mitomycin C ( DrugMMC ) may induce cancer - associated Adverse-Effecthemolytic uremic syndrome , which is characterized by hemolytic anemia, thrombocytopenia and progressive renal failure.
0.9998 Adverse-Effect In rare cases mitomycin C ( DrugMMC ) may induce cancer - associated hemolytic uremic syndrome, which is characterized by Adverse-Effecthemolytic anemia , thrombocytopenia and progressive renal failure.
0.9997 Adverse-Effect In rare cases Drugmitomycin C ( MMC ) may induce cancer - associated Adverse-Effecthemolytic uremic syndrome , which is characterized by hemolytic anemia, thrombocytopenia and progressive renal failure.
0.9997 Adverse-Effect In rare cases mitomycin C ( DrugMMC ) may induce cancer - associated hemolytic uremic syndrome, which is characterized by hemolytic anemia, Adverse-Effectthrombocytopenia and progressive renal failure.
0.9995 Adverse-Effect In rare cases Drugmitomycin C ( MMC ) may induce cancer - associated hemolytic uremic syndrome, which is characterized by Adverse-Effecthemolytic anemia , thrombocytopenia and progressive renal failure.
0.9995 Adverse-Effect In rare cases mitomycin C ( DrugMMC ) may induce cancer - associated hemolytic uremic syndrome, which is characterized by hemolytic anemia, thrombocytopenia and Adverse-Effectprogressive renal failure .
0.9993 Adverse-Effect In rare cases Drugmitomycin C ( MMC ) may induce cancer - associated hemolytic uremic syndrome, which is characterized by hemolytic anemia, Adverse-Effectthrombocytopenia and progressive renal failure.
0.9988 Adverse-Effect In rare cases Drugmitomycin C ( MMC ) may induce cancer - associated hemolytic uremic syndrome, which is characterized by hemolytic anemia, thrombocytopenia and Adverse-Effectprogressive renal failure .
0.9995 Adverse-Effect In rare cases mitomycin C ( MMC ) may induce Drugcancer - associated Adverse-Effecthemolytic uremic syndrome , which is characterized by hemolytic anemia, thrombocytopenia and progressive renal failure.
0.9895 Adverse-Effect In rare cases mitomycin C ( DrugMMC ) may induce Drugcancer - associated hemolytic uremic syndrome, which is characterized by hemolytic anemia, thrombocytopenia and progressive renal failure.
0.9796 Adverse-Effect In rare cases mitomycin C ( MMC ) may induce Drugcancer - associated hemolytic uremic syndrome, which is characterized by Adverse-Effecthemolytic anemia , thrombocytopenia and progressive renal failure.
0.9714 Adverse-Effect In rare cases mitomycin C ( MMC ) may induce Drugcancer - associated hemolytic uremic syndrome, which is characterized by hemolytic anemia, Adverse-Effectthrombocytopenia and progressive renal failure.
0.9475 Adverse-Effect In rare cases mitomycin C ( MMC ) may induce Drugcancer - associated hemolytic uremic syndrome, which is characterized by hemolytic anemia, thrombocytopenia and Adverse-Effectprogressive renal failure .
0.5681 Adverse-Effect In rare cases Drugmitomycin C ( MMC ) may induce Drugcancer - associated hemolytic uremic syndrome, which is characterized by hemolytic anemia, thrombocytopenia and progressive renal failure.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugBisphosphonate - related Adverse-Effectosteonecrosis of the jaw ( BRONJ ) is reported in up to 18. 6 % of patients treated with intravenous bisphosphonates and can result in significant morbidity.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSION : Hypersensitivity reaction should be considered in patients who develop recurrent eosinophilia and Adverse-Effectdeterioration of pulmonary function following the use of Drugtobramycin by inhalation or by intravenous administration.
1.0000 Adverse-Effect CONCLUSION : Hypersensitivity reaction should be considered in patients who develop Adverse-Effectrecurrent eosinophilia and deterioration of pulmonary function following the use of Drugtobramycin by inhalation or by intravenous administration.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Finally, Drugreserpine Adverse-Effectreserpine toxicity , in particular central nervous system ( CNS ) disturbances, was reported more frequently in patients also receiving barbiturates, suggesting additive CNS effects.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect RESULTS : At our institution, no children appeared with acute DrugINH Adverse-Effectneurotoxicity in the period 1985 through 1990, whereas seven patients were treated from 1991 through 1993.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect An 83 - year - old man receiving glipizide 10 mg bid developed Adverse-Effectsymptomatic hypoglycemia within three days of adding Drugtrimethoprim / sulfamethoxazole ( TMP / SMX ) to his regimen.
1.0000 Adverse-Effect An 83 - year - old man receiving Drugglipizide 10 mg bid developed Adverse-Effectsymptomatic hypoglycemia within three days of adding trimethoprim / sulfamethoxazole ( TMP / SMX ) to his regimen.
0.9999 Adverse-Effect An 83 - year - old man receiving glipizide 10 mg bid developed Adverse-Effectsymptomatic hypoglycemia within three days of adding trimethoprim / Drugsulfamethoxazole ( TMP / SMX ) to his regimen.
0.9999 Adverse-Effect An 83 - year - old man receiving glipizide 10 mg bid developed Adverse-Effectsymptomatic hypoglycemia within three days of adding trimethoprim / sulfamethoxazole ( DrugTMP / SMX ) to his regimen.
0.9999 Adverse-Effect An 83 - year - old man receiving glipizide 10 mg bid developed Adverse-Effectsymptomatic hypoglycemia within three days of adding trimethoprim / sulfamethoxazole ( TMP / DrugSMX ) to his regimen.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The authors present a case of Adverse-Effectt - AML that developed in a child with metastatic neuroblastoma 18 months after he received oral Drugetoposide , given for palliation purpose.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe the case of a 50 - year - old woman with advanced non - small cell lung cancer who developed Adverse-Effectstatus epilepticus shortly after receiving Drugcisplatin and gemcitabine chemotherapy.
0.9999 Adverse-Effect We describe the case of a 50 - year - old woman with advanced non - small cell lung cancer who developed Adverse-Effectstatus epilepticus shortly after receiving cisplatin and Druggemcitabine chemotherapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a rare case of Adverse-Effectcolonic mucosal necrosis following DrugKalimate ( calcium polystryrene sulfonate ), an analogue of Kayexalate without sorbitol in a 34 - yr - old man.
0.9992 Adverse-Effect We report a rare case of Adverse-Effectcolonic mucosal necrosis following Kalimate ( Drugcalcium polystryrene sulfonate ), an analogue of Kayexalate without sorbitol in a 34 - yr - old man.
0.9985 Adverse-Effect We report a rare case of Adverse-Effectcolonic mucosal necrosis following Kalimate ( calcium polystryrene sulfonate ), an analogue of DrugKayexalate without sorbitol in a 34 - yr - old man.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The most likely cause of Adverse-Effectliver failure in this patient was, therefore, Drugclarithromycin , which undergoes hepatic metabolism and has been reported to cause fulminant hepatic failure.
0.9999 Adverse-Effect The most likely cause of liver failure in this patient was, therefore, Drugclarithromycin , which undergoes hepatic metabolism and has been reported to cause Adverse-Effectfulminant hepatic failure .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The development of an IgG lambda - type monoclonal gammopathy and subsequent Adverse-Effectmultiple myeloma in an epilepsy patient on Drugdiphenylhydantoin ( DILANTIN ) therapy for 20 years is reported.
1.0000 Adverse-Effect The development of an Adverse-EffectIgG lambda - type monoclonal gammopathy and subsequent multiple myeloma in an epilepsy patient on Drugdiphenylhydantoin ( DILANTIN ) therapy for 20 years is reported.
1.0000 Adverse-Effect The development of an IgG lambda - type monoclonal gammopathy and subsequent Adverse-Effectmultiple myeloma in an epilepsy patient on diphenylhydantoin ( DrugDILANTIN ) therapy for 20 years is reported.
0.9999 Adverse-Effect The development of an Adverse-EffectIgG lambda - type monoclonal gammopathy and subsequent multiple myeloma in an epilepsy patient on diphenylhydantoin ( DrugDILANTIN ) therapy for 20 years is reported.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect In all three cases, autopsy revealed gross and microscopic features indistinguishable from those seen in the Hamman - Rich syndrome, and Drugmethotrexate Adverse-Effecthepatotoxicity was present in one.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a 44 - year - old woman with t - MDS ( Adverse-Effectrefractory anemia with excess blasts ) following treatment of recurrent anaplastic astrocytoma with Drugtemozolomide ( TMZ ).
1.0000 Adverse-Effect We report a 44 - year - old woman with t - MDS ( Adverse-Effectrefractory anemia with excess blasts ) following treatment of recurrent anaplastic astrocytoma with temozolomide ( DrugTMZ ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect PURPOSE : To report a case of severe Drugcorticosteroid - induced Adverse-Effectglaucoma after intravitreal injection of triamcinolone acetate in a 34 - year - old man without a history of glaucoma.
0.9997 Adverse-Effect PURPOSE : To report a case of severe corticosteroid - induced Adverse-Effectglaucoma after intravitreal injection of Drugtriamcinolone acetate in a 34 - year - old man without a history of glaucoma.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We present two children with acute lymphocytic leukemia who developed Adverse-Effectleukoencephalopathy following administration of a combination of intravenous Drugara = C and methotrexate during the consolidation phase of chemotherapy.
0.9999 Adverse-Effect We present two children with acute lymphocytic leukemia who developed Adverse-Effectleukoencephalopathy following administration of a combination of intravenous ara = C and Drugmethotrexate during the consolidation phase of chemotherapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect On the second day of hospitalization, it was noted that the patient's dyspnea and Adverse-Effectsinus bradycardia could be related to a recent increase in his Drugtimolol dosage.
0.9999 Adverse-Effect On the second day of hospitalization, it was noted that the patient's Adverse-Effectdyspnea and sinus bradycardia could be related to a recent increase in his Drugtimolol dosage.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Clinicians should be aware that an erythematous and Adverse-Effectexfoliative rash may be induced by Drugtemozolomide , and be familiar with the pharmacologic and supportive measures necessary for its treatment.
0.9998 Adverse-Effect Clinicians should be aware that an Adverse-Effecterythematous and exfoliative rash may be induced by Drugtemozolomide , and be familiar with the pharmacologic and supportive measures necessary for its treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Physicians should be aware of the potential for the development of Adverse-EffectRS among children who are receiving long - term Drugaspirin therapy for the treatment of systemic inflammatory illnesses.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A review of the literature found 11 children and 2 adults in whom intranasal Drugdesmopressin was associated with Adverse-Effecthyponatremia , all of whom experienced seizures or altered mental status.
0.9999 Adverse-Effect A review of the literature found 11 children and 2 adults in whom intranasal Drugdesmopressin was associated with hyponatremia, all of whom experienced Adverse-Effectseizures or altered mental status.
0.9999 Adverse-Effect A review of the literature found 11 children and 2 adults in whom intranasal Drugdesmopressin was associated with hyponatremia, all of whom experienced seizures or Adverse-Effectaltered mental status .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To describe a case of severe Adverse-Effectskin necrosis resulting from peripheral intravenous administration of low - dose Drugvasopressin in a patient with catecholamine - resistant septic shock.
1.0000 Adverse-Effect OBJECTIVE : To describe a case of Adverse-Effectsevere skin necrosis resulting from peripheral intravenous administration of low - dose Drugvasopressin in a patient with catecholamine - resistant septic shock.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Clinicians who manage cachectic patients, particularly those with protracted diarrhoea and / or receiving anti - malarial drugs including Drugmefloquine , should be aware of the risk of Adverse-Effectsevere hypoglycaemia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CASE SUMMARY : A 25 - year - old postpartum white woman developed multiple watery stools and Adverse-Effectabdominal cramping on day 6 of therapy with Drugclindamycin vaginal cream for bacterial vaginosis.
1.0000 Adverse-Effect CASE SUMMARY : A 25 - year - old postpartum white woman developed Adverse-Effectmultiple watery stools and abdominal cramping on day 6 of therapy with Drugclindamycin vaginal cream for bacterial vaginosis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : Clinicians should be aware of this adverse reaction when facing similar complex Adverse-Effectneurologic symptoms in patients who are receiving the antibiotic treatment described here, especially Drugvancomycin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect It is concluded that the aforementioned pathological manifestations were due to chemotherapy and included a Adverse-Effectpulmonary adverse reaction , a feature never previously associated with Drugoxaliplatinum and 5 - fluorouracil regimens.
0.9999 Adverse-Effect It is concluded that the aforementioned pathological manifestations were due to chemotherapy and included a Adverse-Effectpulmonary adverse reaction , a feature never previously associated with oxaliplatinum and Drug5 - fluorouracil regimens.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect For patients who suffer from osteogenic sarcoma and have Adverse-Effectanaphylactic reactions to DrugMTX , this desensitization protocol will allow these patients to continue with needed therapeutic or palliative chemotherapy.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Here we present the case of a Adverse-Effectgeneralized lichen nitidus with involvement of the palms in a patient with hepatitis C after systemic treatment with Druginterferon alpha and ribavirin.
0.9999 Adverse-Effect Here we present the case of a Adverse-Effectgeneralized lichen nitidus with involvement of the palms in a patient with hepatitis C after systemic treatment with interferon alpha and Drugribavirin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect First, a review of the literature produced 41 anecdotic cases of neutropenia or Adverse-Effectagranulocytosis during treatment with Drugolanzapine ( Zyprexa ) reported in a total of 24 publications.
1.0000 Adverse-Effect First, a review of the literature produced 41 anecdotic cases of neutropenia or Adverse-Effectagranulocytosis during treatment with olanzapine ( DrugZyprexa ) reported in a total of 24 publications.
0.9999 Adverse-Effect First, a review of the literature produced 41 anecdotic cases of Adverse-Effectneutropenia or agranulocytosis during treatment with Drugolanzapine ( Zyprexa ) reported in a total of 24 publications.
0.9998 Adverse-Effect First, a review of the literature produced 41 anecdotic cases of Adverse-Effectneutropenia or agranulocytosis during treatment with olanzapine ( DrugZyprexa ) reported in a total of 24 publications.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugCisplatin - induced Adverse-Effectsyndrome of inappropriate antidiuretic hormone ( SIADH ) in a patient with neuroendocrine tumor of the cervix : a case report and review of the literature.
0.9999 Adverse-Effect DrugCisplatin - induced syndrome of inappropriate antidiuretic hormone ( Adverse-EffectSIADH ) in a patient with neuroendocrine tumor of the cervix : a case report and review of the literature.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 21 - year - old woman suffering from bipolar affective disorder developed systemic lupus erythematosus ( Adverse-EffectSLE ) with characteristic laboratory findings, 18 months after starting Drugcarbamazepine maintenance treatment.
1.0000 Adverse-Effect A 21 - year - old woman suffering from bipolar affective disorder developed Adverse-Effectsystemic lupus erythematosus ( SLE ) with characteristic laboratory findings, 18 months after starting Drugcarbamazepine maintenance treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DISCUSSION : To our knowledge, this is the first case report illustrating Adverse-Effectneuralgic amyotrophy triggered by exposure to the antibiotics Drugvancomycin , tobramycin, and piperacillin / tazobactam.
1.0000 Adverse-Effect DISCUSSION : To our knowledge, this is the first case report illustrating Adverse-Effectneuralgic amyotrophy triggered by exposure to the antibiotics vancomycin, Drugtobramycin , and piperacillin / tazobactam.
1.0000 Adverse-Effect DISCUSSION : To our knowledge, this is the first case report illustrating Adverse-Effectneuralgic amyotrophy triggered by exposure to the antibiotics vancomycin, tobramycin, and piperacillin / Drugtazobactam .
0.9999 Adverse-Effect DISCUSSION : To our knowledge, this is the first case report illustrating Adverse-Effectneuralgic amyotrophy triggered by exposure to the antibiotics vancomycin, tobramycin, and Drugpiperacillin / tazobactam.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CASE REPORT : We hereby report a case of radiation recall dermatitis and Adverse-Effectmyositis occurring on Druggemcitabine monotherapy, five months after completing chemoradiation for locally advanced pancreatic cancer.
0.9999 Adverse-Effect CASE REPORT : We hereby report a case of Adverse-Effectradiation recall dermatitis and myositis occurring on Druggemcitabine monotherapy, five months after completing chemoradiation for locally advanced pancreatic cancer.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Caution in longterm usage and early recognition of Drugpentazocine Adverse-Effectpentazocine toxicity as a neuromuscular complication are important in order to prevent irreversible drug - induced fibrous myopathy and localized neuropathy.
0.9986 Adverse-Effect Caution in longterm usage and early recognition of Drugpentazocine toxicity as a Adverse-Effectneuromuscular complication are important in order to prevent irreversible drug - induced fibrous myopathy and localized neuropathy.
0.9964 Adverse-Effect Caution in longterm usage and early recognition of Drugpentazocine toxicity as a neuromuscular complication are important in order to prevent irreversible drug - induced Adverse-Effectfibrous myopathy and localized neuropathy.
0.9960 Adverse-Effect Caution in longterm usage and early recognition of Drugpentazocine toxicity as a neuromuscular complication are important in order to prevent irreversible drug - induced fibrous myopathy and localized Adverse-Effectneuropathy .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 40 - year - old man with advanced HIV infection and Mycobacterium avium complex infection experienced Adverse-Effectrapid cognitive decline after commencement of Drugethambutol , and symptoms fully resolved with cessation.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect He was started on Drugdigoxin , 0. 25 mg daily, because of echocardiographically demonstrated Adverse-Effectleft ventricular dilatation and functional impairment ; he died of ventricular fibrillation 15 days later.
0.9999 Adverse-Effect He was started on Drugdigoxin , 0. 25 mg daily, because of echocardiographically demonstrated left ventricular dilatation and functional impairment ; he died of Adverse-Effectventricular fibrillation 15 days later.
0.9998 Adverse-Effect He was started on Drugdigoxin , 0. 25 mg daily, because of echocardiographically demonstrated left ventricular dilatation and Adverse-Effectfunctional impairment ; he died of ventricular fibrillation 15 days later.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of DrugMMC - related Adverse-Effecthemolytic uremic syndrome , and discuss the etiologic parameters, clinical aspects, prognosis and treatment modalities of this severe syndrome.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect An obese patient, not diabetic, treated with Drugmetformin for some weeks, was referred to us with Adverse-Effectsevere inferior digestive hemorrhage , diagnosed with Meckel's diverticulum.
0.9999 Adverse-Effect An obese patient, not diabetic, treated with Drugmetformin for some weeks, was referred to us with severe inferior digestive hemorrhage, diagnosed with Adverse-EffectMeckel's diverticulum .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 61 - year - old man with early diffuse cutaneous scleroderma with myositis and progressive interstitial pneumonia developed Adverse-Effectgeneralized erythema with high fever 3 weeks after taking Drugsulfamethoxazole / trimethoprim.
0.9999 Adverse-Effect A 61 - year - old man with early diffuse cutaneous scleroderma with myositis and progressive interstitial pneumonia developed Adverse-Effectgeneralized erythema with high fever 3 weeks after taking sulfamethoxazole / Drugtrimethoprim .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The patient had recurrence of urticaria and Adverse-Effectangioedema a year and a half later, at which point the DrugNPH was stopped and she was desensitized to regular insulin.
0.9999 Adverse-Effect The patient had recurrence of urticaria and Adverse-Effectangioedema a year and a half later, at which point the NPH was stopped and she was desensitized to regular Druginsulin .
0.9998 Adverse-Effect The patient had recurrence of Adverse-Effecturticaria and angioedema a year and a half later, at which point the DrugNPH was stopped and she was desensitized to regular insulin.
0.9998 Adverse-Effect The patient had recurrence of Adverse-Effecturticaria and angioedema a year and a half later, at which point the NPH was stopped and she was desensitized to regular Druginsulin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The patient was positive for antibody against complexes of heparin and platelet factor 4, and was diagnosed as Drugheparin - induced Adverse-Effectthrombocytopenia with thrombosis syndrome ( HITTS ).
0.9997 Adverse-Effect The patient was positive for antibody against complexes of heparin and platelet factor 4, and was diagnosed as Drugheparin - induced thrombocytopenia with Adverse-Effectthrombosis syndrome ( HITTS ).
0.9987 Adverse-Effect The patient was positive for antibody against complexes of Drugheparin and platelet factor 4, and was diagnosed as heparin - induced Adverse-Effectthrombocytopenia with thrombosis syndrome ( HITTS ).
0.9979 Adverse-Effect The patient was positive for antibody against complexes of Drugheparin and platelet factor 4, and was diagnosed as heparin - induced thrombocytopenia with Adverse-Effectthrombosis syndrome ( HITTS ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 73 year - old patient with Wolff - Parkinson - White syndrome and paroxysmic supraventricular tachycardia developed an Adverse-Effectacute reversible encephalopathy within 15 days of initiation of Drugflecainide .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect To the best of our knowledge, this is the first reported patient with Drugcaptopril - induced Adverse-Effectpemphigus in whom no new lesions developed after subsequent treatment with enalapril.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Although Drugpraziquantel administration may have been effective in killing the parasite in both patients, we are concerned about the production of marked Adverse-Effectinflammation as a result of treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To report the occurrence of Adverse-Effectanterior ischemic optic neuropathy as a complication of treatment with Druginterferon alfa and to consider the possible underlying mechanisms for this association.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect The authors describe a patient with hemiparesis who developed the syndrome of irreversible Druglithium - effectuated Adverse-Effectneurotoxicity ( SILENT ) while being treated with lithium for a manic episode.
0.9917 Adverse-Effect The authors describe a patient with hemiparesis who developed the syndrome of irreversible lithium - effectuated Adverse-Effectneurotoxicity ( SILENT ) while being treated with Druglithium for a manic episode.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of unintentional overdose of oral Drugpilocarpine tablets that resulted in Adverse-Effectbradycardia , mild hypotension, and muscarinic symptoms in a patient with Sjogren's syndrome.
1.0000 Adverse-Effect We report a case of unintentional overdose of oral Drugpilocarpine tablets that resulted in bradycardia, Adverse-Effectmild hypotension , and muscarinic symptoms in a patient with Sjogren's syndrome.
1.0000 Adverse-Effect We report a case of unintentional overdose of oral Drugpilocarpine tablets that resulted in bradycardia, mild hypotension, and Adverse-Effectmuscarinic symptoms in a patient with Sjogren's syndrome.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugGold - salt therapy may result in Adverse-Effectdamage to proximal tubules that leak renal tubular antigens, which in turn complex with autoantibody and produce an autoimmune membranous nephropathy.
0.9978 Adverse-Effect DrugGold - salt therapy may result in damage to proximal tubules that leak renal tubular antigens, which in turn complex with autoantibody and produce an Adverse-Effectautoimmune membranous nephropathy .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In the present paper, we describe two patients with active UC who developed a Adverse-Effectsevere systemic CMV infection during a treatment with an oral microemulsion form of Drugcyclosporine .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect When the acute manic state is characterized by marked psychotic symptoms and intense anxiety, it may be associated with increased vulnerability to the development of severe Druglithium Adverse-Effectneurotoxicity .
0.9989 Adverse-Effect When the acute manic state is characterized by marked Adverse-Effectpsychotic symptoms and intense anxiety, it may be associated with increased vulnerability to the development of severe Druglithium neurotoxicity.
0.9987 Adverse-Effect When the acute manic state is characterized by marked psychotic symptoms and Adverse-Effectintense anxiety , it may be associated with increased vulnerability to the development of severe Druglithium neurotoxicity.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report on a patient with an embryonal teratocarcinoma of the testicle who had the syndrome of Adverse-Effectinappropriate secretion of antidiuretic hormone after receiving a high dose of Drugvinblastine .
1.0000 Adverse-Effect We report on a patient with an embryonal teratocarcinoma of the testicle who had the Adverse-Effectsyndrome of inappropriate secretion of antidiuretic hormone after receiving a high dose of Drugvinblastine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Although a lot of Drugamiodarone - induced Adverse-Effecttorsades de pointe have been published, a review of all these cases and the underlying risk - factors has never been made.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Type II Drugheparin - induced Adverse-Effectthrombocytopenia ( HIT ) is an immunological disorder characterized by antibodies to heparin - platelet factor 4 complexes and a high risk of thrombotic complications.
0.9991 Adverse-Effect Type II Drugheparin - induced thrombocytopenia ( Adverse-EffectHIT ) is an immunological disorder characterized by antibodies to heparin - platelet factor 4 complexes and a high risk of thrombotic complications.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Immobilization, while Paget's bone disease was present, and perhaps enhanced activation of Drugdihydrotachysterol by rifampicin, could have led to Adverse-Effectincreased calcium - release into the circulation.
1.0000 Adverse-Effect Immobilization, while Paget's bone disease was present, and perhaps enhanced activation of dihydrotachysterol by Drugrifampicin , could have led to Adverse-Effectincreased calcium - release into the circulation.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Although useful in the management of chronic alcoholism, Drugdisulfiram is being increasingly associated with a wide spectrum of side effects and untoward medical sequelae, which now include Adverse-Effectcatatonia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The patient was enrolled in a weight - loss clinic, and his diabetes medications were adjusted. Subsequently, Drugolanzapine was discontinued because of Adverse-Effectweight gain and uncontrolled diabetes.
1.0000 Adverse-Effect The patient was enrolled in a weight - loss clinic, and his diabetes medications were adjusted. Subsequently, Drugolanzapine was discontinued because of weight gain and Adverse-Effectuncontrolled diabetes .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect I report a 35 - year - old woman with occult coronary artery disease who experienced Adverse-Effectcardiac arrest within minutes after receiving a first - time dose of subcutaneous Drugsumatriptan for migraine.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Despite a hematologic response in all 3 patients, none of them achieved cytogenetic remission, and all progressed to Adverse-Effectblast crisis at 7 to 10 months of Drugimatinib therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Because Drugsumatriptan can cause Adverse-Effectcoronary artery vasospasm , patients with significant risk factors for coronary artery disease should be carefully evaluated for cardiovascular disease prior to the use of sumatriptan.
0.9968 Adverse-Effect Because sumatriptan can cause Adverse-Effectcoronary artery vasospasm , patients with significant risk factors for coronary artery disease should be carefully evaluated for cardiovascular disease prior to the use of Drugsumatriptan .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the case of an adult patient with acute lymphoblastic leukemia who presented with repeated transient ischemic attacks followed by a Adverse-Effectseizure during consolidation treatment with DrugL - asparaginase .
0.9995 Adverse-Effect We report the case of an adult patient with acute lymphoblastic leukemia who presented with repeated Adverse-Effecttransient ischemic attacks followed by a seizure during consolidation treatment with DrugL - asparaginase .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectProliferation of abnormal bone marrow histiocytes , an undesired effect of Druggranulocyte macrophage - colony - stimulating factor therapy in a patient with Hurler's syndrome undergoing bone marrow transplantation.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The diagnosis was based on the rapid onset of Adverse-Effectrenal failure , presence of eosinophilia, skin rash, and characteristic renal biopsy finding, following the administration of Drugampicillin .
1.0000 Adverse-Effect The diagnosis was based on the rapid onset of renal failure, presence of eosinophilia, Adverse-Effectskin rash , and characteristic renal biopsy finding, following the administration of Drugampicillin .
1.0000 Adverse-Effect The diagnosis was based on the rapid onset of renal failure, presence of Adverse-Effecteosinophilia , skin rash, and characteristic renal biopsy finding, following the administration of Drugampicillin .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Monitoring of liver function tests should be mandatory in patients receiving high doses of Drugcyproterone acetate ; the drug should be withdrawn immediately if Adverse-Effectabnormal liver function tests are found.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The first patient developed a Adverse-Effectmonoarthritis 2 weeks after initiation of DrugIFN - beta , which persisted during the 14 months of therapy and resolved with discontinuation of the medication.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect DrugNaproxen , the most common offender, has been associated with a dimorphic clinical pattern : a PCT - like presentation and one simulating Adverse-Effecterythropoietic protoporphyria in the pediatric population.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Parenteral pyridoxine, the specific antidote for DrugINH - induced Adverse-Effectrefractory seizures , should be readily available in every emergency department in the areas similarly experiencing increasing trends of TB.
0.9997 Adverse-Effect Parenteral Drugpyridoxine , the specific antidote for INH - induced Adverse-Effectrefractory seizures , should be readily available in every emergency department in the areas similarly experiencing increasing trends of TB.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Alternating sinus rhythm and Adverse-Effectintermittent sinoatrial ( S - A ) block was observed in a 57 - year - old woman, under treatment for angina with 80 mg Drugpropranolol daily.
1.0000 Adverse-Effect Adverse-EffectAlternating sinus rhythm and intermittent sinoatrial ( S - A ) block was observed in a 57 - year - old woman, under treatment for angina with 80 mg Drugpropranolol daily.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe the development of Adverse-Effectischemic colitis in a woman who was treated with Drugtegaserod and review the relationship among ischemic colitis, tegaserod use, and irritable bowel syndrome.
1.0000 Adverse-Effect We describe the development of ischemic colitis in a woman who was treated with Drugtegaserod and review the relationship among Adverse-Effectischemic colitis , tegaserod use, and irritable bowel syndrome.
0.9999 Adverse-Effect We describe the development of ischemic colitis in a woman who was treated with tegaserod and review the relationship among ischemic colitis, Drugtegaserod use, and Adverse-Effectirritable bowel syndrome .
0.9992 Adverse-Effect We describe the development of ischemic colitis in a woman who was treated with tegaserod and review the relationship among Adverse-Effectischemic colitis , Drugtegaserod use, and irritable bowel syndrome.
0.9991 Adverse-Effect We describe the development of Adverse-Effectischemic colitis in a woman who was treated with tegaserod and review the relationship among ischemic colitis, Drugtegaserod use, and irritable bowel syndrome.
0.9987 Adverse-Effect We describe the development of ischemic colitis in a woman who was treated with Drugtegaserod and review the relationship among ischemic colitis, tegaserod use, and Adverse-Effectirritable bowel syndrome .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 7 - year - old girl developed diabetes mellitus and Adverse-Effectexocrine pancreatic insufficiency after 3. 5 years of almost continuous treatment with Drugazathioprine and / or prednisone for idiopathic auto - immune haemolytic anaemia.
1.0000 Adverse-Effect A 7 - year - old girl developed Adverse-Effectdiabetes mellitus and exocrine pancreatic insufficiency after 3. 5 years of almost continuous treatment with Drugazathioprine and / or prednisone for idiopathic auto - immune haemolytic anaemia.
1.0000 Adverse-Effect A 7 - year - old girl developed diabetes mellitus and Adverse-Effectexocrine pancreatic insufficiency after 3. 5 years of almost continuous treatment with azathioprine and / or Drugprednisone for idiopathic auto - immune haemolytic anaemia.
0.9999 Adverse-Effect A 7 - year - old girl developed Adverse-Effectdiabetes mellitus and exocrine pancreatic insufficiency after 3. 5 years of almost continuous treatment with azathioprine and / or Drugprednisone for idiopathic auto - immune haemolytic anaemia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Flare of Kaposi's sarcoma ( Adverse-EffectKS ) is well described in immunosuppressed patients treated with corticosteroids and Drugrituximab , but has not yet been reported during treatment with imatinib.
1.0000 Adverse-Effect Flare of Adverse-EffectKaposi's sarcoma ( KS ) is well described in immunosuppressed patients treated with corticosteroids and Drugrituximab , but has not yet been reported during treatment with imatinib.
Score Relation Text (Head - Tail)
0.9997 Adverse-Effect The uncomplicated long - term use of adequately - dosed DrugAZA and stable non - toxic metabolite levels could not acknowledge TPMT deficiency as a primary cause of the Adverse-Effectleukopenia .
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect Theoretical basal ganglia toxicologic mechanisms of Drugmethanol Adverse-Effectmethanol poisoning are reviewed, and the role of brain imaging studies will regard to diagnosis, prognosis and impact on management is discussed.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of biopsy - proven Adverse-Effectacute tubulointerstitial nephritis associated with a second course of Drugflurbiprofen , a nonsteroidal anti - inflammatory drug of the propionic acid class.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 17 - year - old boy with refractory psoriatic arthritis and alpha - 1 antitrypsin deficiency who developed a Adverse-Effectsyringotropic hypersensitivity reaction after 9 months of therapy with Druginfliximab and leflunomide is described.
1.0000 Adverse-Effect A 17 - year - old boy with refractory psoriatic arthritis and alpha - 1 antitrypsin deficiency who developed a Adverse-Effectsyringotropic hypersensitivity reaction after 9 months of therapy with infliximab and Drugleflunomide is described.
1.0000 Adverse-Effect A 17 - year - old boy with refractory psoriatic arthritis and alpha - 1 antitrypsin deficiency who developed a Adverse-Effectsyringotropic hypersensitivity reaction after 9 months of therapy with Druginfliximab and leflunomide is described.
0.9999 Adverse-Effect A 17 - year - old boy with refractory psoriatic arthritis and alpha - 1 antitrypsin deficiency who developed a Adverse-Effectsyringotropic hypersensitivity reaction after 9 months of therapy with infliximab and Drugleflunomide is described.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Dipyrone, also known as Drugmetamizole , is an analgesic and antipyretic drug that was banned by the United States Food and Drug Administration because of its association with Adverse-Effectagranulocytosis .
0.9999 Adverse-Effect DrugDipyrone , also known as metamizole, is an analgesic and antipyretic drug that was banned by the United States Food and Drug Administration because of its association with Adverse-Effectagranulocytosis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This is, to the best of our knowledge, the first report of a case in which Adverse-Effectagranulocytosis followed treatment with both Drugpropylthiouracil and methimazole in the same patient.
1.0000 Adverse-Effect This is, to the best of our knowledge, the first report of a case in which Adverse-Effectagranulocytosis followed treatment with both propylthiouracil and Drugmethimazole in the same patient.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Although they had only a few nodules at diagnosis, the Adverse-Effectnodules increased in number and size 3 to 4 months after the start of Drugmethotrexate therapy in both patients.
0.9997 Adverse-Effect Although they had only a few Adverse-Effectnodules at diagnosis, the nodules increased in number and size 3 to 4 months after the start of Drugmethotrexate therapy in both patients.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CASE : We present an 11 - year old male with Budd - Chiari syndrome who experienced profound Adverse-Effectworsening of chronic aphthous ulcers after immunosuppressive therapy was changed from Drugtacrolimus to sirolimus.
1.0000 Adverse-Effect CASE : We present an 11 - year old male with Budd - Chiari syndrome who experienced profound Adverse-Effectworsening of chronic aphthous ulcers after immunosuppressive therapy was changed from tacrolimus to Drugsirolimus .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Though hypotension, dry mouth, and constipation are well - documented possible adverse effects, the possibility of Drugclonidine - induced Adverse-Effectbradycardia is less well recognized and is rare.
0.9998 Adverse-Effect Though hypotension, dry mouth, and Adverse-Effectconstipation are well - documented possible adverse effects, the possibility of Drugclonidine - induced bradycardia is less well recognized and is rare.
0.9992 Adverse-Effect Though Adverse-Effecthypotension , dry mouth, and constipation are well - documented possible adverse effects, the possibility of Drugclonidine - induced bradycardia is less well recognized and is rare.
0.9992 Adverse-Effect Though hypotension, Adverse-Effectdry mouth , and constipation are well - documented possible adverse effects, the possibility of Drugclonidine - induced bradycardia is less well recognized and is rare.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CASES : " A " was an 8 - year - old boy with attention deficit and chronic tic disorder who developed Adverse-Effectobsessive - compulsive symptoms within 2 weeks of starting Drugrisperidone .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a 71 - year male with castration - resistant metastatic prostate cancer who was treated with weekly Drugdocetaxel for 12 weeks and developed significant Adverse-Effecteye irritation and dryness during treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSION : All doctors need to be aware of the need to review the indications for Druggabapentin use during periods of acute illness, especially with regard to Adverse-Effectrenal impairment .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In the presented case Drugfluvoxamine - induced Adverse-Effectakathisia in an OCD patient was partially resistant to the anticholinergic agent biperiden, and was successfully treated with the 5 - HT2A / 5 - HT2C antagonist mianserin.
Score Relation Text (Head - Tail)
0.9975 Adverse-Effect The wide use of phenytoin during the recent tuberculosis epidemic makes it imperative to suspect this drug interaction in patients exhibiting clinical features that might be related to Drugphenytoin Adverse-Effectphenytoin toxicity .
0.9891 Adverse-Effect The wide use of Drugphenytoin during the recent tuberculosis epidemic makes it imperative to suspect this drug interaction in patients exhibiting clinical features that might be related to Adverse-Effectphenytoin toxicity .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Review of the literature relating to Drugmethicillin - induced Adverse-Effectnephropathy suggests a hypersensitivity origin for this disorder, but immunologic and ultrastructural investigation to date has failed to elucidate pathogenesis.
0.9794 Adverse-Effect Review of the literature relating to Drugmethicillin - induced nephropathy suggests a Adverse-Effecthypersensitivity origin for this disorder, but immunologic and ultrastructural investigation to date has failed to elucidate pathogenesis.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect We hypothesize that Drugcaffeine Adverse-Effectcaffeine toxicity injured the muscle cells, which were fragile due to the potassium depletion induced by the coexisting hyponatremia, to result in unusually severe rhabdomyolysis.
0.9992 Adverse-Effect We hypothesize that Drugcaffeine toxicity injured the muscle cells, which were fragile due to the potassium depletion induced by the coexisting hyponatremia, to result in unusually severe Adverse-Effectrhabdomyolysis .
0.9991 Adverse-Effect We hypothesize that Drugcaffeine toxicity injured the muscle cells, which were fragile due to the potassium depletion induced by the Adverse-Effectcoexisting hyponatremia , to result in unusually severe rhabdomyolysis.
0.9990 Adverse-Effect We hypothesize that Drugcaffeine toxicity injured the muscle cells, which were fragile due to the Adverse-Effectpotassium depletion induced by the coexisting hyponatremia, to result in unusually severe rhabdomyolysis.
Adverse-Effect We hypothesize that Drugcaffeine toxicity Adverse-Effectinjured the muscle cells , which were fragile due to the potassium depletion induced by the coexisting hyponatremia, to result in unusually severe rhabdomyolysis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In conclusion, Adverse-EffectRSDS is a relevant osteoarticular complication in patients receiving either anticalcineurinic drug ( DrugCyA or tacrolimus ), even under monotherapy or with a low steroid dose.
1.0000 Adverse-Effect In conclusion, Adverse-EffectRSDS is a relevant osteoarticular complication in patients receiving either anticalcineurinic drug ( CyA or Drugtacrolimus ), even under monotherapy or with a low steroid dose.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of Adverse-Effectinterstitial pneumonitis induced by Drugbicalutamide and / or leuprorelin acetate given as therapy for prostate cancer, in which the pneumonitis was successfully managed by steroid treatment.
0.9993 Adverse-Effect We report a case of Adverse-Effectinterstitial pneumonitis induced by bicalutamide and / or Drugleuprorelin acetate given as therapy for prostate cancer, in which the pneumonitis was successfully managed by steroid treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This case report describes a patient who was previously prescribed alendronate ( Fosamax ) and presented with postoperative hypophosphatemia and Adverse-Effecthypocalcemic tetany after bowel preparation with DrugFleet Phospho - Soda .
1.0000 Adverse-Effect This case report describes a patient who was previously prescribed alendronate ( DrugFosamax ) and presented with postoperative Adverse-Effecthypophosphatemia and hypocalcemic tetany after bowel preparation with Fleet Phospho - Soda.
0.9999 Adverse-Effect This case report describes a patient who was previously prescribed alendronate ( DrugFosamax ) and presented with postoperative hypophosphatemia and Adverse-Effecthypocalcemic tetany after bowel preparation with Fleet Phospho - Soda.
0.9999 Adverse-Effect This case report describes a patient who was previously prescribed Drugalendronate ( Fosamax ) and presented with postoperative Adverse-Effecthypophosphatemia and hypocalcemic tetany after bowel preparation with Fleet Phospho - Soda.
0.9998 Adverse-Effect This case report describes a patient who was previously prescribed Drugalendronate ( Fosamax ) and presented with postoperative hypophosphatemia and Adverse-Effecthypocalcemic tetany after bowel preparation with Fleet Phospho - Soda.
0.9995 Adverse-Effect This case report describes a patient who was previously prescribed alendronate ( Fosamax ) and presented with postoperative Adverse-Effecthypophosphatemia and hypocalcemic tetany after bowel preparation with DrugFleet Phospho - Soda .
1.0000 Adverse-Effect This case report describes a patient who was previously prescribed alendronate ( DrugFosamax ) and presented with Adverse-Effectpostoperative hypophosphatemia and hypocalcemic tetany after bowel preparation with Fleet Phospho - Soda.
0.9999 Adverse-Effect This case report describes a patient who was previously prescribed Drugalendronate ( Fosamax ) and presented with Adverse-Effectpostoperative hypophosphatemia and hypocalcemic tetany after bowel preparation with Fleet Phospho - Soda.
0.9997 Adverse-Effect This case report describes a patient who was previously prescribed alendronate ( Fosamax ) and presented with Adverse-Effectpostoperative hypophosphatemia and hypocalcemic tetany after bowel preparation with DrugFleet Phospho - Soda .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Patients from endemic areas referred to transplant centers may be at high risk for Adverse-Effectdisseminated histoplasmosis when treated with long - term Drugprednisone for graft - versus - host disease.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The third patient had been suffering from serious Adverse-Effectakathisia while on Drugrisperidone , and was cured after switching to olanzapine, but thereafter the patient suffered from RLS at nighttime.
1.0000 Adverse-Effect The third patient had been suffering from serious akathisia while on risperidone, and was cured after switching to Drugolanzapine , but thereafter the patient suffered from Adverse-EffectRLS at nighttime.
0.9999 Adverse-Effect The third patient had been suffering from serious akathisia while on Drugrisperidone , and was cured after switching to olanzapine, but thereafter the patient suffered from Adverse-EffectRLS at nighttime.
0.9995 Adverse-Effect The third patient had been suffering from serious Adverse-Effectakathisia while on risperidone, and was cured after switching to Drugolanzapine , but thereafter the patient suffered from RLS at nighttime.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect RESULTS : We recently experienced a case of fatal Drugerlotinib - induced Adverse-EffectILD , diagnosed based on clinical and radiologic findings, which occurred in a patient with radiation fibrosis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In the second case, five cardiac arrests due to ventricular tachycardia and Adverse-Effectfibrillation occurred during several hours after beginning a trial of Drugbretylium maintenance therapy for complex ventricular ectopy.
0.9999 Adverse-Effect In the second case, five cardiac arrests due to Adverse-Effectventricular tachycardia and fibrillation occurred during several hours after beginning a trial of Drugbretylium maintenance therapy for complex ventricular ectopy.
0.9999 Adverse-Effect In the second case, five Adverse-Effectcardiac arrests due to ventricular tachycardia and fibrillation occurred during several hours after beginning a trial of Drugbretylium maintenance therapy for complex ventricular ectopy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect However, one patient exhibited severe hypersensitivity reactions including cardiac arrest and apnea, and another four patients developed eruptions, hypotension, and Adverse-Effecttachycardia soon after administration of DrugCBDCA .
1.0000 Adverse-Effect However, one patient exhibited severe hypersensitivity reactions including cardiac arrest and apnea, and another four patients developed eruptions, Adverse-Effecthypotension , and tachycardia soon after administration of DrugCBDCA .
1.0000 Adverse-Effect However, one patient exhibited severe hypersensitivity reactions including cardiac arrest and apnea, and another four patients developed Adverse-Effecteruptions , hypotension, and tachycardia soon after administration of DrugCBDCA .
0.9999 Adverse-Effect However, one patient exhibited severe hypersensitivity reactions including Adverse-Effectcardiac arrest and apnea, and another four patients developed eruptions, hypotension, and tachycardia soon after administration of DrugCBDCA .
0.9999 Adverse-Effect However, one patient exhibited severe hypersensitivity reactions including cardiac arrest and Adverse-Effectapnea , and another four patients developed eruptions, hypotension, and tachycardia soon after administration of DrugCBDCA .
0.9999 Adverse-Effect However, one patient exhibited Adverse-Effectsevere hypersensitivity reactions including cardiac arrest and apnea, and another four patients developed eruptions, hypotension, and tachycardia soon after administration of DrugCBDCA .
Score Relation Text (Head - Tail)
0.9883 Adverse-Effect A patient with chronic myeloid leukaemia treated with Drugbusulphan for 4 - 5 years, developed signs of busulphan toxicity and portal hypertension with ascites, oesophageal varices and Adverse-Effectjaundice .
0.9865 Adverse-Effect A patient with chronic myeloid leukaemia treated with Drugbusulphan for 4 - 5 years, developed signs of busulphan toxicity and portal hypertension with ascites, Adverse-Effectoesophageal varices and jaundice.
0.9864 Adverse-Effect A patient with chronic myeloid leukaemia treated with Drugbusulphan for 4 - 5 years, developed signs of busulphan toxicity and portal hypertension with Adverse-Effectascites , oesophageal varices and jaundice.
0.9737 Adverse-Effect A patient with chronic myeloid leukaemia treated with Drugbusulphan for 4 - 5 years, developed signs of busulphan toxicity and Adverse-Effectportal hypertension with ascites, oesophageal varices and jaundice.
0.9988 Adverse-Effect A patient with chronic myeloid leukaemia treated with Drugbusulphan for 4 - 5 years, developed signs of Adverse-Effectbusulphan toxicity and portal hypertension with ascites, oesophageal varices and jaundice.
0.9874 Adverse-Effect A patient with chronic myeloid leukaemia treated with busulphan for 4 - 5 years, developed signs of Drugbusulphan Adverse-Effectbusulphan toxicity and portal hypertension with ascites, oesophageal varices and jaundice.
0.8683 Adverse-Effect A patient with chronic myeloid leukaemia treated with busulphan for 4 - 5 years, developed signs of Drugbusulphan toxicity and portal hypertension with Adverse-Effectascites , oesophageal varices and jaundice.
0.8632 Adverse-Effect A patient with chronic myeloid leukaemia treated with busulphan for 4 - 5 years, developed signs of Drugbusulphan toxicity and portal hypertension with ascites, Adverse-Effectoesophageal varices and jaundice.
0.8610 Adverse-Effect A patient with chronic myeloid leukaemia treated with busulphan for 4 - 5 years, developed signs of Drugbusulphan toxicity and portal hypertension with ascites, oesophageal varices and Adverse-Effectjaundice .
0.7955 Adverse-Effect A patient with chronic myeloid leukaemia treated with busulphan for 4 - 5 years, developed signs of Drugbusulphan toxicity and Adverse-Effectportal hypertension with ascites, oesophageal varices and jaundice.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 65 - year - old woman, in the intensive care unit because of septic shock and acute renal failure, had a Adverse-Effectsmall - bowel obstruction due to DrugAmphojel concretions.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect To our knowledge, this is the first case report that demonstrates the occurrence of Adverse-Effectfever with low - dose Drugamifostine therapy without the manifestation of accompanying rash or hypotension.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 17 - year - old boy with acute lymphoblastic leukemia developed Adverse-Effectacute renal failure within 48 h of an intravenous high - dose Drugmethotrexate ( 5 g / m2 ) infusion.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the case of a 17 - year - old male who developed chest pain, elevated cardiac biomarkers, and Adverse-Effectacute left ventricular dysfunction following a single dose of Drugmethylphenidate .
1.0000 Adverse-Effect We report the case of a 17 - year - old male who developed chest pain, Adverse-Effectelevated cardiac biomarkers , and acute left ventricular dysfunction following a single dose of Drugmethylphenidate .
0.9999 Adverse-Effect We report the case of a 17 - year - old male who developed Adverse-Effectchest pain , elevated cardiac biomarkers, and acute left ventricular dysfunction following a single dose of Drugmethylphenidate .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A Adverse-Effectfatal pancytopenia occurred in a patient with an history of depression with hypomanic rebounds, admitted for a manic episode and treated with Druglevomepromazine , diazepam and lithium carbonate.
0.9998 Adverse-Effect A Adverse-Effectfatal pancytopenia occurred in a patient with an history of depression with hypomanic rebounds, admitted for a manic episode and treated with levomepromazine, Drugdiazepam and lithium carbonate.
0.9995 Adverse-Effect A Adverse-Effectfatal pancytopenia occurred in a patient with an history of depression with hypomanic rebounds, admitted for a manic episode and treated with levomepromazine, diazepam and Druglithium carbonate .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Although Adverse-Effecttardive dyskinesia is a known adverse reaction of sustained treatment with traditional neuroleptic agents, it was only rarely reported in association with Drugsulpiride , a selective D2 - receptor antagonist.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 58 - year - old woman developed Adverse-Effectunilateral acute angle - closure glaucoma four days after the application of a patch of transdermal Drugscopolamine delivery system ( TRANSDERM - V ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect At the end of his fifth cycle of Drugsunitinib therapy, the patient complained of the Adverse-Effectdevelopment of abnormally large mammary glands associated with pain and peri - areolar erythema.
1.0000 Adverse-Effect At the end of his fifth cycle of Drugsunitinib therapy, the patient complained of the development of abnormally large mammary glands associated with Adverse-Effectpain and peri - areolar erythema.
0.9999 Adverse-Effect At the end of his fifth cycle of Drugsunitinib therapy, the patient complained of the development of abnormally large mammary glands associated with pain and Adverse-Effectperi - areolar erythema .
1.0000 Adverse-Effect At the end of his fifth cycle of Drugsunitinib therapy, the patient complained of the development of Adverse-Effectabnormally large mammary glands associated with pain and peri - areolar erythema.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect CONCLUSIONS : This observation of " on - off " risperidone treatment suggests that Drugrisperidone may have worsened both Adverse-Effectpsychiatric and physical manifestations of the mitochondrial disorder in this adolescent.
0.9993 Adverse-Effect CONCLUSIONS : This observation of " on - off " Drugrisperidone treatment suggests that risperidone may have worsened both Adverse-Effectpsychiatric and physical manifestations of the mitochondrial disorder in this adolescent.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 50 - year - old woman with a history of migraine without aura, predominantly occurring around her menstrual periods, developed a Adverse-Effectspinal cord lesion following the use of Drugzolmitriptan .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSION : Healthcare professionals should be aware of the possible development of Adverse-Effectserotonin syndrome as a complication of initiation of Drugfentanyl and other phenylpiperidine opioids in patients treated with SSRIs.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This report describes a case of acute compromise of renal function associated with Adverse-Effecthypotension in a 7 - year - old boy treated with the ACE inhibitor Druglisinopril and the ARB losartan.
1.0000 Adverse-Effect This report describes a case of acute compromise of renal function associated with Adverse-Effecthypotension in a 7 - year - old boy treated with the ACE inhibitor lisinopril and the ARB Druglosartan .
0.9998 Adverse-Effect This report describes a case of Adverse-Effectacute compromise of renal function associated with hypotension in a 7 - year - old boy treated with the ACE inhibitor Druglisinopril and the ARB losartan.
0.9994 Adverse-Effect This report describes a case of Adverse-Effectacute compromise of renal function associated with hypotension in a 7 - year - old boy treated with the ACE inhibitor lisinopril and the ARB Druglosartan .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The first patient developed mild nitritoid symptoms and pain in a band - like distribution, corresponding to Adverse-EffectT10 - T12 dermatomes , shortly after Druggold sodium thiomalate ( GSTM ) injection.
0.9998 Adverse-Effect The first patient developed mild nitritoid symptoms and pain in a band - like distribution, corresponding to Adverse-EffectT10 - T12 dermatomes , shortly after gold sodium thiomalate ( DrugGSTM ) injection.
0.9998 Adverse-Effect The first patient developed mild nitritoid symptoms and Adverse-Effectpain in a band - like distribution, corresponding to T10 - T12 dermatomes, shortly after Druggold sodium thiomalate ( GSTM ) injection.
0.9997 Adverse-Effect The first patient developed Adverse-Effectmild nitritoid symptoms and pain in a band - like distribution, corresponding to T10 - T12 dermatomes, shortly after Druggold sodium thiomalate ( GSTM ) injection.
0.9993 Adverse-Effect The first patient developed mild nitritoid symptoms and Adverse-Effectpain in a band - like distribution, corresponding to T10 - T12 dermatomes, shortly after gold sodium thiomalate ( DrugGSTM ) injection.
0.9993 Adverse-Effect The first patient developed Adverse-Effectmild nitritoid symptoms and pain in a band - like distribution, corresponding to T10 - T12 dermatomes, shortly after gold sodium thiomalate ( DrugGSTM ) injection.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the case of an 11 - month - old female infant with a Adverse-Effectdepressed level of consciousness after ingestion of Drugibuprofen whose mental status markedly improved with administration of naloxone.
Score Relation Text (Head - Tail)
0.9969 Adverse-Effect Acute DrugINH Adverse-Effectneurotoxicity was not suspected on the first admission ; however, when readmitted 4 weeks later with another seizure, the diagnosis of acute INH neurotoxicity was made.
0.9950 Adverse-Effect Acute INH neurotoxicity was not suspected on the first admission ; however, when readmitted 4 weeks later with another seizure, the diagnosis of acute DrugINH Adverse-Effectneurotoxicity was made.
0.9828 Adverse-Effect Acute INH neurotoxicity was not suspected on the first admission ; however, when readmitted 4 weeks later with another seizure, the diagnosis of acute DrugINH Adverse-EffectINH neurotoxicity was made.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 58 - year - old man with advanced renal cell carcinoma developed grade 3 Adverse-Effectproteinuria ( 8. 5 g / 24 h ) without microscopic hematuria or renal insufficiency five days after Drugtemsirolimus infusion.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Two patients treated for chronic myeloid leukemia with high doses of DrugCCNU ( 1100 mg / m2 and 1240 mg / m2, respectively ) developed a Adverse-Effectfatal pulmonary fibrosis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the cases of two patients who developed Adverse-Effectacute hepatitis after taking Drugriluzole at the recommended dose ( 100 mg daily ) for 7 and 4 weeks, respectively.
Adverse-Effect We report the cases of two patients who developed acute Adverse-Effecthepatitis after taking Drugriluzole at the recommended dose ( 100 mg daily ) for 7 and 4 weeks, respectively.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSION : A 37 - year - old African - American man with G6PD deficiency developed hemolytic anemia, hepatitis, orthostatic hypotension, and Adverse-Effectaseptic meningitis simultaneously after using Drugtrimethoprim - sulfamethoxazole.
0.9999 Adverse-Effect CONCLUSION : A 37 - year - old African - American man with G6PD deficiency developed hemolytic anemia, hepatitis, orthostatic hypotension, and Adverse-Effectaseptic meningitis simultaneously after using trimethoprim - Drugsulfamethoxazole .
0.9999 Adverse-Effect CONCLUSION : A 37 - year - old African - American man with G6PD deficiency developed hemolytic anemia, hepatitis, Adverse-Effectorthostatic hypotension , and aseptic meningitis simultaneously after using Drugtrimethoprim - sulfamethoxazole.
0.9999 Adverse-Effect CONCLUSION : A 37 - year - old African - American man with G6PD deficiency developed Adverse-Effecthemolytic anemia , hepatitis, orthostatic hypotension, and aseptic meningitis simultaneously after using Drugtrimethoprim - sulfamethoxazole.
0.9999 Adverse-Effect CONCLUSION : A 37 - year - old African - American man with G6PD deficiency developed hemolytic anemia, Adverse-Effecthepatitis , orthostatic hypotension, and aseptic meningitis simultaneously after using Drugtrimethoprim - sulfamethoxazole.
0.9999 Adverse-Effect CONCLUSION : A 37 - year - old African - American man with G6PD deficiency developed Adverse-Effecthemolytic anemia , hepatitis, orthostatic hypotension, and aseptic meningitis simultaneously after using trimethoprim - Drugsulfamethoxazole .
0.9998 Adverse-Effect CONCLUSION : A 37 - year - old African - American man with G6PD deficiency developed hemolytic anemia, hepatitis, Adverse-Effectorthostatic hypotension , and aseptic meningitis simultaneously after using trimethoprim - Drugsulfamethoxazole .
0.9998 Adverse-Effect CONCLUSION : A 37 - year - old African - American man with G6PD deficiency developed hemolytic anemia, Adverse-Effecthepatitis , orthostatic hypotension, and aseptic meningitis simultaneously after using trimethoprim - Drugsulfamethoxazole .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectHashimoto's disease during Druginterferon - alpha therapy in a patient with pre - treatment negative anti - thyroid autoantibodies and with the specific genetic susceptibility to the thyroid disease.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect It should be emphasized that the recurrence of Adverse-Effectnephrotic syndrome was observed after the following chemotherapy, including DrugM - CSF , whereas the bone marrow still remained completely remitted.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Ceftriaxone was approved in 1997 for the treatment of otitis media despite previous studies that documented an association of Drugceftriaxone with Adverse-Effectelevated hepato - biliary enzymes and transient biliary stasis.
0.9991 Adverse-Effect Ceftriaxone was approved in 1997 for the treatment of otitis media despite previous studies that documented an association of Drugceftriaxone with elevated hepato - biliary enzymes and Adverse-Effecttransient biliary stasis .
0.9969 Adverse-Effect DrugCeftriaxone was approved in 1997 for the treatment of otitis media despite previous studies that documented an association of ceftriaxone with Adverse-Effectelevated hepato - biliary enzymes and transient biliary stasis.
0.9953 Adverse-Effect DrugCeftriaxone was approved in 1997 for the treatment of otitis media despite previous studies that documented an association of ceftriaxone with elevated hepato - biliary enzymes and Adverse-Effecttransient biliary stasis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of a women in whom a Adverse-Effectmalignant mixed mesodermal tumor was diagnosed while she was taking Drugraloxifene , which is also a selective estrogen receptor modulator.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : The risk of drug - induced Adverse-Effectrhabdomyolysis due to the potential interaction between Druglovastatin and azithromycin or clarithromycin should be considered before the concomitant use of these agents.
0.9999 Adverse-Effect CONCLUSIONS : The risk of drug - induced Adverse-Effectrhabdomyolysis due to the potential interaction between lovastatin and Drugazithromycin or clarithromycin should be considered before the concomitant use of these agents.
0.9999 Adverse-Effect CONCLUSIONS : The risk of drug - induced Adverse-Effectrhabdomyolysis due to the potential interaction between lovastatin and azithromycin or Drugclarithromycin should be considered before the concomitant use of these agents.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Four days after the initial injection of 3. 6 mg of Druggoserelin acetate , Adverse-Effectsevere dyspnea developed due to worsening pleuritis carcinomatosa, which was considered as a flare - up.
0.9994 Adverse-Effect Four days after the initial injection of 3. 6 mg of Druggoserelin acetate , severe dyspnea developed due to Adverse-Effectworsening pleuritis carcinomatosa , which was considered as a flare - up.
0.9991 Adverse-Effect Four days after the initial injection of 3. 6 mg of Druggoserelin acetate , severe dyspnea developed due to worsening pleuritis carcinomatosa, which was considered as a Adverse-Effectflare - up .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 43 - year - old woman with multiple sclerosis ( MS ) had Adverse-Effectnephrotic syndrome 21 months after starting treatment with Druginterferon ( IFN ) - beta - 1b ( subcutaneous administration ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect BACKGROUND : Interferon ( DrugIFN ) - associated Adverse-Effectretinopathy is typically characterized by retinal hemorrhages and cotton wool spots at the posterior fundus, but visual function is usually maintained.
0.9998 Adverse-Effect BACKGROUND : Interferon ( DrugIFN ) - associated retinopathy is typically characterized by Adverse-Effectretinal hemorrhages and cotton wool spots at the posterior fundus, but visual function is usually maintained.
0.9998 Adverse-Effect BACKGROUND : Interferon ( DrugIFN ) - associated retinopathy is typically characterized by retinal hemorrhages and Adverse-Effectcotton wool spots at the posterior fundus, but visual function is usually maintained.
0.9997 Adverse-Effect BACKGROUND : DrugInterferon ( IFN ) - associated Adverse-Effectretinopathy is typically characterized by retinal hemorrhages and cotton wool spots at the posterior fundus, but visual function is usually maintained.
0.9992 Adverse-Effect BACKGROUND : DrugInterferon ( IFN ) - associated retinopathy is typically characterized by Adverse-Effectretinal hemorrhages and cotton wool spots at the posterior fundus, but visual function is usually maintained.
0.9992 Adverse-Effect BACKGROUND : DrugInterferon ( IFN ) - associated retinopathy is typically characterized by retinal hemorrhages and Adverse-Effectcotton wool spots at the posterior fundus, but visual function is usually maintained.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Four months after receiving an orthotopic liver transplant, a 51 - year - old man was admitted for progressive liver failure and Adverse-Effectsevere hepatocellular necrosis thought to be due to Drugtacrolimus .
0.9999 Adverse-Effect Four months after receiving an orthotopic liver transplant, a 51 - year - old man was admitted for Adverse-Effectprogressive liver failure and severe hepatocellular necrosis thought to be due to Drugtacrolimus .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect We present a case of a 20 - year - old woman who ingested 900 mg of Drugglyburide causing refractory Adverse-Effecthypoglycemia resistant to treatment with intravenous dextrose, glucagon, and diazoxide.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 25 - year - old man with a history of mid - borderline ( BB ) Hansen's disease developing a Adverse-Effectreversal reaction after starting Drugdapsone and rifampin therapy is presented.
1.0000 Adverse-Effect A 25 - year - old man with a history of mid - borderline ( BB ) Hansen's disease developing a Adverse-Effectreversal reaction after starting dapsone and Drugrifampin therapy is presented.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect One of these was Drugclofazimine , an aniline aposafranine derivative known to produce a Adverse-Effectceroid - like pigment in the tissues of patients treated with this drug or lepromatous leprosy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect It was restarted 6 weeks later, and 10 weeks after that, the patient presented with Adverse-Effectfulminant hepatic failure , which resolved rapidly after cessation of Drugnicotinic acid therapy.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect We report a case of an infant with complex congenital heart disease who was placed on Drugcaptopril for afterload reduction following cardiac surgery and subsequently developed Adverse-Effectpulmonary infiltrates with eosinophilia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of a child with neurodevelopmental delay with chronic constipation and a history of chronic Drugmineral oil ingestion presenting as asymptomatic Adverse-Effectexogenous lipoid pneumonia ( ELP ).
0.9999 Adverse-Effect We report a case of a child with neurodevelopmental delay with chronic constipation and a history of chronic Drugmineral oil ingestion presenting as asymptomatic exogenous lipoid pneumonia ( Adverse-EffectELP ).
1.0000 Adverse-Effect We report a case of a child with neurodevelopmental delay with chronic constipation and a history of chronic Drugmineral oil ingestion presenting as Adverse-Effectasymptomatic exogenous lipoid pneumonia ( ELP ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of a previously healthy, postmenopausal woman who developed Adverse-Effectanticonvulsant hypersensitivity syndrome while taking DrugBellamine S ( belladonna alkaloids ; ergotamine ; phenobarbital ) for hot flashes.
0.9999 Adverse-Effect We report a case of a previously healthy, postmenopausal woman who developed Adverse-Effectanticonvulsant hypersensitivity syndrome while taking Bellamine S ( belladonna alkaloids ; ergotamine ; Drugphenobarbital ) for hot flashes.
0.9999 Adverse-Effect We report a case of a previously healthy, postmenopausal woman who developed Adverse-Effectanticonvulsant hypersensitivity syndrome while taking Bellamine S ( belladonna alkaloids ; Drugergotamine ; phenobarbital ) for hot flashes.
0.9999 Adverse-Effect We report a case of a previously healthy, postmenopausal woman who developed Adverse-Effectanticonvulsant hypersensitivity syndrome while taking Bellamine S ( Drugbelladonna alkaloids ; ergotamine ; phenobarbital ) for hot flashes.
1.0000 Adverse-Effect We report a case of a previously healthy, postmenopausal woman who developed anticonvulsant Adverse-Effecthypersensitivity syndrome while taking DrugBellamine S ( belladonna alkaloids ; ergotamine ; phenobarbital ) for hot flashes.
0.9998 Adverse-Effect We report a case of a previously healthy, postmenopausal woman who developed anticonvulsant Adverse-Effecthypersensitivity syndrome while taking Bellamine S ( belladonna alkaloids ; ergotamine ; Drugphenobarbital ) for hot flashes.
0.9998 Adverse-Effect We report a case of a previously healthy, postmenopausal woman who developed anticonvulsant Adverse-Effecthypersensitivity syndrome while taking Bellamine S ( belladonna alkaloids ; Drugergotamine ; phenobarbital ) for hot flashes.
0.9998 Adverse-Effect We report a case of a previously healthy, postmenopausal woman who developed anticonvulsant Adverse-Effecthypersensitivity syndrome while taking Bellamine S ( Drugbelladonna alkaloids ; ergotamine ; phenobarbital ) for hot flashes.
Score Relation Text (Head - Tail)
0.9996 Adverse-Effect Adverse-EffectPortal vein thrombosis in a patient with severe haemophilia A and F V G1691A mutation during continuous infusion of DrugF VIII after intramural jejunal bleeding - - successful thrombolysis under heparin therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Oncologists supervising future clinical trials for lung cancer should be alert to the fact that Drugsorafenib can potentially induce serious Adverse-Effectinterstitial lung disease , although this might depend on racial differences.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Escape atrial complexes, which occurred following junctional premature complexes, failed to initiate tachycardia in the control state but Adverse-Effecttachycardia was always reinitiated by an identical escape sequence after Drugprocainamide .
0.9921 Adverse-Effect Escape atrial complexes, which occurred following junctional premature complexes, failed to initiate Adverse-Effecttachycardia in the control state but tachycardia was always reinitiated by an identical escape sequence after Drugprocainamide .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Similar to reports in patients receiving gefitinib, those with pathologic findings of UIP on resected lung specimens or known pulmonary fibrosis may be at particular risk for Drugerlotinib Adverse-Effectpulmonary toxicity .
0.9997 Adverse-Effect Similar to reports in patients receiving gefitinib, those with pathologic findings of UIP on resected lung specimens or known Adverse-Effectpulmonary fibrosis may be at particular risk for Drugerlotinib pulmonary toxicity.
0.9958 Adverse-Effect Similar to reports in patients receiving Druggefitinib , those with pathologic findings of UIP on resected lung specimens or known Adverse-Effectpulmonary fibrosis may be at particular risk for erlotinib pulmonary toxicity.
0.9744 Adverse-Effect Similar to reports in patients receiving Druggefitinib , those with pathologic findings of UIP on resected lung specimens or known pulmonary fibrosis may be at particular risk for erlotinib Adverse-Effectpulmonary toxicity .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a patient who experienced chronic nausea and an episode of Adverse-Effectconfusion while treated with a small, stable dose of oral Drugmorphine in the setting of mild renal insufficiency.
1.0000 Adverse-Effect We describe a patient who experienced Adverse-Effectchronic nausea and an episode of confusion while treated with a small, stable dose of oral Drugmorphine in the setting of mild renal insufficiency.
1.0000 Adverse-Effect We describe a patient who experienced chronic Adverse-Effectnausea and an episode of confusion while treated with a small, stable dose of oral Drugmorphine in the setting of mild renal insufficiency.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 22 - year - old drug - abuser injected Drugflunitrazepam tablets dissolved in tap water into her left femoral artery and presented with clinical signs of Adverse-Effectacute ischaemia of the left leg .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report four cases of hemodynamically significant Adverse-Effectpericardial effusion in patients with refractory lymphoma who were receiving Druggemcitabine , all of whom had a history of mediastinal radiation without subcarinal blocking.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectHyperammonemia has been described as a complication of Drugvalproic acid therapy but may often be overlooked as a cause of lethargy in the postictal patient who presents to the emergency department.
0.9996 Adverse-Effect Hyperammonemia has been described as a complication of Drugvalproic acid therapy but may often be overlooked as a cause of Adverse-Effectlethargy in the postictal patient who presents to the emergency department.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 66 - year - old mand suffering from severe coronary heart disease took Drugdigoxin with suicidal intent an was treated for the ensuing Adverse-Effectcomplete atrioventricular block with digoxin - specific antibody fragments.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We described a very atypical case of a high stage, high grade Adverse-Effectendometrial cancer associated with Drugtamoxifen in a 64 - year - old woman with a past history of breast cancer.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the first case of an acute flare of Adverse-Effecteosinophilic cystitis in a 51 - year - old woman after bladder instillation with Drugdimethyl sulfoxide ( DMSO ) for presumed interstitial cystitis.
0.9999 Adverse-Effect We report the first case of an acute flare of Adverse-Effecteosinophilic cystitis in a 51 - year - old woman after bladder instillation with dimethyl sulfoxide ( DrugDMSO ) for presumed interstitial cystitis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We conclude that vincristine and Drugactinomycin D were the cause of this rare from of Adverse-Effecthepatotoxicity and that chemotherapy for the underlying malignant disease could be given safely after clinical recovery.
0.9998 Adverse-Effect We conclude that Drugvincristine and actinomycin D were the cause of this rare from of Adverse-Effecthepatotoxicity and that chemotherapy for the underlying malignant disease could be given safely after clinical recovery.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Adverse-EffectTransient anuria following administration of angiotensin I - converting enzyme inhibitor ( DrugSQ 14225 ) in a patient with renal artery stenosis of the solitary kidney successfully treated with renal autotransplantation.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Flutamide withdrawal syndrome is characterized by a Adverse-Effectdecrease in prostate - specific antigen ( PSA ) after Drugflutamide withdrawal in a subset of patients with progressing metastatic carcinoma of the prostate.
0.9995 Adverse-Effect DrugFlutamide withdrawal syndrome is characterized by a Adverse-Effectdecrease in prostate - specific antigen ( PSA ) after flutamide withdrawal in a subset of patients with progressing metastatic carcinoma of the prostate.
1.0000 Adverse-Effect DrugFlutamide Adverse-Effectwithdrawal syndrome is characterized by a decrease in prostate - specific antigen ( PSA ) after flutamide withdrawal in a subset of patients with progressing metastatic carcinoma of the prostate.
0.9999 Adverse-Effect Flutamide Adverse-Effectwithdrawal syndrome is characterized by a decrease in prostate - specific antigen ( PSA ) after Drugflutamide withdrawal in a subset of patients with progressing metastatic carcinoma of the prostate.
Adverse-Effect DrugFlutamide Adverse-EffectFlutamide withdrawal syndrome is characterized by a decrease in prostate - specific antigen ( PSA ) after flutamide withdrawal in a subset of patients with progressing metastatic carcinoma of the prostate.
Adverse-Effect Adverse-EffectFlutamide withdrawal syndrome is characterized by a decrease in prostate - specific antigen ( PSA ) after Drugflutamide withdrawal in a subset of patients with progressing metastatic carcinoma of the prostate.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect All patients had taken Drugphenytoin for variable time periods ( range 16 - 80 days ; mean : 40 ) and were on the medication when the Adverse-Effectskin lesions first appeared.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect On day 7 of Druglinezolid treatment, the patient developed Adverse-Effectsevere pruritus , macular rash, facial edema, eosinophilia, marked increase in serum creatinine level, and mild hepatitis.
1.0000 Adverse-Effect On day 7 of Druglinezolid treatment, the patient developed severe pruritus, Adverse-Effectmacular rash , facial edema, eosinophilia, marked increase in serum creatinine level, and mild hepatitis.
1.0000 Adverse-Effect On day 7 of Druglinezolid treatment, the patient developed severe pruritus, macular rash, Adverse-Effectfacial edema , eosinophilia, marked increase in serum creatinine level, and mild hepatitis.
1.0000 Adverse-Effect On day 7 of Druglinezolid treatment, the patient developed severe pruritus, macular rash, facial edema, eosinophilia, Adverse-Effectmarked increase in serum creatinine level , and mild hepatitis.
1.0000 Adverse-Effect On day 7 of Druglinezolid treatment, the patient developed severe pruritus, macular rash, facial edema, Adverse-Effecteosinophilia , marked increase in serum creatinine level, and mild hepatitis.
0.9999 Adverse-Effect On day 7 of Druglinezolid treatment, the patient developed severe pruritus, macular rash, facial edema, eosinophilia, marked increase in serum creatinine level, and Adverse-Effectmild hepatitis .
0.9999 Adverse-Effect On day 7 of Druglinezolid treatment, the patient developed severe pruritus, macular rash, facial edema, eosinophilia, marked Adverse-Effectincrease in serum creatinine level , and mild hepatitis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugGemcitabine is a known risk factor for Adverse-Effecthemolytic uremic syndrome ( HUS ), which can often have a rapidly fatal clinical course despite intervention with steroids, plasmapheresis and hemodialysis.
1.0000 Adverse-Effect DrugGemcitabine is a known risk factor for hemolytic uremic syndrome ( Adverse-EffectHUS ), which can often have a rapidly fatal clinical course despite intervention with steroids, plasmapheresis and hemodialysis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CASE : We report a case of a woman with severe Drughuman insulin - induced Adverse-Effectlipoatrophy who has been treated exclusively with recombinant DNA human insulin since the onset of IDDM.
0.9999 Adverse-Effect CASE : We report a case of a woman with severe human insulin - induced Adverse-Effectlipoatrophy who has been treated exclusively with Drugrecombinant DNA human insulin since the onset of IDDM.
0.9999 Adverse-Effect CASE : We report a case of a woman with severe human insulin - induced lipoatrophy who has been treated exclusively with Drugrecombinant DNA human insulin since the onset of Adverse-EffectIDDM .
0.9971 Adverse-Effect CASE : We report a case of a woman with severe Drughuman insulin - induced lipoatrophy who has been treated exclusively with recombinant DNA human insulin since the onset of Adverse-EffectIDDM .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the first case of Adverse-Effectpolymorphic ventricular tachycardia with normal QT interval associated with the oral use of Druglevofloxacin in the absence of other etiologies known to cause these arrhythmias.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In this case, it was suspected that a combination of cigarette smoking, pulmonary fibrosis, and low - dose Drugmethotrexate therapy might have promoted the development of Adverse-Effectlung cancer .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Based on our experience and on previously published data, serum ammonia levels appear to be indicated in all ED patients on Drugvalproic acid therapy who present with Adverse-Effectaltered mental status .
Score Relation Text (Head - Tail)
0.9992 Adverse-Effect CONCLUSIONS : Optic neuritis in combination with other Adverse-Effectneurological signs , simulating multiple sclerosis, should be included in the list of adverse effects of recombinant and natural Druginterferon alpha administration.
0.9988 Adverse-Effect CONCLUSIONS : Adverse-EffectOptic neuritis in combination with other neurological signs, simulating multiple sclerosis, should be included in the list of adverse effects of recombinant and natural Druginterferon alpha administration.
0.9996 Adverse-Effect CONCLUSIONS : Optic neuritis in combination with other neurological signs, simulating Adverse-Effectmultiple sclerosis , should be included in the list of adverse effects of recombinant and natural Druginterferon alpha administration.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In a patient suffering from rheumatoid arthritis, we report the first simultaneous occurrence of two side effects of low - dose Drugmethotrexate : an Adverse-Effectacute megaloblastic anaemia and a pneumonitis.
0.9999 Adverse-Effect In a patient suffering from rheumatoid arthritis, we report the first simultaneous occurrence of two side effects of low - dose Drugmethotrexate : an acute megaloblastic anaemia and a Adverse-Effectpneumonitis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Here we report a patient with newly diagnosed acute promyelocytic leukemia who developed acute focal myositis, synovitis, and Adverse-Effectpossible vasculitis , after receiving Drugall - trans retinoic acid therapy.
0.9998 Adverse-Effect Here we report a patient with newly diagnosed acute promyelocytic leukemia who developed acute focal myositis, Adverse-Effectsynovitis , and possible vasculitis, after receiving Drugall - trans retinoic acid therapy.
0.9996 Adverse-Effect Here we report a patient with newly diagnosed acute promyelocytic leukemia who developed Adverse-Effectacute focal myositis , synovitis, and possible vasculitis, after receiving Drugall - trans retinoic acid therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CASE REPORT : We report a case of Adverse-Effectintracerebral hemorrhage occurring in a middle - aged man who suffered from chronic sinusitis and had been ingesting Drugpseudoephedrine daily for one year.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In addition, an immediate Adverse-Effecterythematous macule was observed on the photopatch test site of Drugmequitazine directly after UV exposure which was similar to the immediate erythema noted in chlorpromazine photoallergy.
0.9962 Adverse-Effect In addition, an immediate erythematous macule was observed on the photopatch test site of Drugmequitazine directly after UV exposure which was similar to the immediate Adverse-Effecterythema noted in chlorpromazine photoallergy.
Adverse-Effect In addition, an immediate erythematous macule was observed on the photopatch test site of Drugmequitazine directly after UV exposure which was similar to the Adverse-Effectimmediate erythema noted in chlorpromazine photoallergy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We present here a female patient who developed Adverse-Effectacute bilateral parotitis within minutes of i. v. Drugenalaprilat injection and recovered within 24 hours of stopping the drug and with symptomatic treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A patient with intracranial osteosarcoma that arose 16 years after radiation therapy for hereditary retinoblastoma developed fatal cerebral edema and Adverse-Effectbrainstem herniation after she received a single dose of intravenous Drugmethotrexate .
1.0000 Adverse-Effect A patient with intracranial osteosarcoma that arose 16 years after radiation therapy for hereditary retinoblastoma developed Adverse-Effectfatal cerebral edema and brainstem herniation after she received a single dose of intravenous Drugmethotrexate .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the case of a 20 - year - old female with polyarteritis nodosa ( PAN ) who developed Adverse-Effectbilateral sensorineural hearing loss 25 minutes after receiving 30 mg of intravenous Drugketoralac .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CASE SUMMARIES : Two patients with stable hypothyroidism experienced symptoms of hypothyroidism with Adverse-Effectincreased serum thyroid - stimulating hormone ( TSH ) concentrations after switching from 1 Druglevothyroxine product to another.
1.0000 Adverse-Effect CASE SUMMARIES : Two patients with stable hypothyroidism experienced symptoms of hypothyroidism with increased serum thyroid - stimulating hormone ( Adverse-EffectTSH ) concentrations after switching from 1 Druglevothyroxine product to another.
1.0000 Adverse-Effect CASE SUMMARIES : Two patients with stable hypothyroidism experienced symptoms of Adverse-Effecthypothyroidism with increased serum thyroid - stimulating hormone ( TSH ) concentrations after switching from 1 Druglevothyroxine product to another.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A search of the United States Food and Drug Administration's Adverse Event Reporting System identified nine cases of Drugoxcarbazepine - associated Adverse-Effectangioedema in pediatric patients aged 16 years and younger.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This fourth type of cutaneous Drugminocycline Adverse-Effecthyperpigmentation may be a variant of Type I, but based on clinical, pathological and microanalytical differences, appears to be a new entity.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This report presents a case of Adverse-Effectacute lung injury developing within hours after administration of Drugmefloquine for a low - level Plasmodium falciparum malaria, which was persistent despite halofantrine therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect An evaluation of ovarian structure and function should be considered in women of reproductive age being treated with Drugvalproate for epilepsy, especially if they develop Adverse-Effectmenstrual cycle disturbances during treatment.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect We speculate that platelet activation induced by DrugpFVIII may have contributed to Adverse-Effectthrombosis and suggest that pFVIII be used with caution in elderly patients with pre - existing cardiovascular risk factors.
0.9999 Adverse-Effect We speculate that Adverse-Effectplatelet activation induced by DrugpFVIII may have contributed to thrombosis and suggest that pFVIII be used with caution in elderly patients with pre - existing cardiovascular risk factors.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We strongly suspect that this Adverse-Effectlethal anuria was mainly due to Drugifosfamide , occurring in a patient having received previous cisplatin chemotherapy and with poor kidney perfusion due to transient hypotension.
0.9995 Adverse-Effect We strongly suspect that this Adverse-Effectlethal anuria was mainly due to ifosfamide, occurring in a patient having received previous Drugcisplatin chemotherapy and with poor kidney perfusion due to transient hypotension.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A study following large patient groups on theophylline and a combination of Drugtheophylline and steroids might clarify the risk of Adverse-Effectulcer formation in patients being treated with these medications for asthma.
1.0000 Adverse-Effect A study following large patient groups on Drugtheophylline and a combination of theophylline and steroids might clarify the risk of Adverse-Effectulcer formation in patients being treated with these medications for asthma.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect CONCLUSION : The chronic use of DrugHCQ for rheumatic diseases, or as an anti - malarial drug, should be balanced against the risk of developing potentially lethal Adverse-Effectcardiac arrhythmias .
1.0000 Adverse-Effect CONCLUSION : The chronic use of DrugHCQ for rheumatic diseases, or as an anti - malarial drug, should be balanced against the risk of developing potentially Adverse-Effectlethal cardiac arrhythmias .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect When the patient was treated again with Drugfludarabine nine months later, the Adverse-EffectDAT became positive with anti - IgG and anti - C3d antiglobulins after the second course of treatment.
Adverse-Effect When the patient was treated again with Drugfludarabine nine months later, the Adverse-EffectDAT became positive with anti - IgG and anti - C3d antiglobulins after the second course of treatment.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect CASE SUMMARIES : While conducting a protocol evaluating the efficacy of intraperitoneal Drugcisplatin and hyperthermia in the treatment of recurrent ovarian cancer, 3 patients were noted to exhibit Adverse-Effectanaphylactoid reactions .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect DrugRecombinant human interferon - alpha has been used in the treatment of several cancers, but there have been several reports that it may Adverse-Effectexacerbate psoriasis or trigger off its onset .
0.9999 Adverse-Effect DrugRecombinant human interferon - alpha has been used in the treatment of several cancers, but there have been several reports that it may Adverse-Effectexacerbate psoriasis or trigger off its onset.
0.9999 Adverse-Effect Recombinant human Druginterferon - alpha has been used in the treatment of several cancers, but there have been several reports that it may Adverse-Effectexacerbate psoriasis or trigger off its onset.
0.9999 Adverse-Effect Recombinant Drughuman interferon - alpha has been used in the treatment of several cancers, but there have been several reports that it may Adverse-Effectexacerbate psoriasis or trigger off its onset.
0.9999 Adverse-Effect DrugRecombinant human interferon - alpha has been used in the treatment of several cancers, but there have been several reports that it may Adverse-Effectexacerbate psoriasis or trigger off its onset.
0.9999 Adverse-Effect DrugRecombinant human interferon - alpha has been used in the treatment of several cancers, but there have been several reports that it may Adverse-Effectexacerbate psoriasis or trigger off its onset.
0.9999 Adverse-Effect DrugRecombinant human interferon - alpha has been used in the treatment of several cancers, but there have been several reports that it may Adverse-Effectexacerbate psoriasis or trigger off its onset.
0.9999 Adverse-Effect Recombinant human Druginterferon - alpha has been used in the treatment of several cancers, but there have been several reports that it may Adverse-Effectexacerbate psoriasis or trigger off its onset .
0.9999 Adverse-Effect Recombinant human Druginterferon - alpha has been used in the treatment of several cancers, but there have been several reports that it may Adverse-Effectexacerbate psoriasis or trigger off its onset.
0.9999 Adverse-Effect Recombinant human Druginterferon - alpha has been used in the treatment of several cancers, but there have been several reports that it may Adverse-Effectexacerbate psoriasis or trigger off its onset.
0.9999 Adverse-Effect Recombinant Drughuman interferon - alpha has been used in the treatment of several cancers, but there have been several reports that it may Adverse-Effectexacerbate psoriasis or trigger off its onset .
0.9999 Adverse-Effect Recombinant human Druginterferon - alpha has been used in the treatment of several cancers, but there have been several reports that it may Adverse-Effectexacerbate psoriasis or trigger off its onset.
0.9999 Adverse-Effect Recombinant Drughuman interferon - alpha has been used in the treatment of several cancers, but there have been several reports that it may Adverse-Effectexacerbate psoriasis or trigger off its onset.
0.9999 Adverse-Effect Recombinant Drughuman interferon - alpha has been used in the treatment of several cancers, but there have been several reports that it may Adverse-Effectexacerbate psoriasis or trigger off its onset.
0.9999 Adverse-Effect Recombinant Drughuman interferon - alpha has been used in the treatment of several cancers, but there have been several reports that it may Adverse-Effectexacerbate psoriasis or trigger off its onset.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : The value of multihormonal therapy in breast carcinoma is not established, and the addition of progestogens to Drugtamoxifen may not reduce of developing Adverse-Effectendometrial lesions , including carcinoma.
0.9999 Adverse-Effect CONCLUSIONS : The value of multihormonal therapy in breast carcinoma is not established, and the addition of progestogens to Drugtamoxifen may not reduce of developing endometrial lesions, including Adverse-Effectcarcinoma .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : This case describes the clinically significant Adverse-Effectincrease of INR in an elderly patient after adding a chemotherapy regimen of Druglevamisole and 5 - FU to a previous regimen of warfarin alone.
1.0000 Adverse-Effect CONCLUSIONS : This case describes the clinically significant Adverse-Effectincrease of INR in an elderly patient after adding a chemotherapy regimen of levamisole and Drug5 - FU to a previous regimen of warfarin alone.
0.9999 Adverse-Effect CONCLUSIONS : This case describes the clinically significant Adverse-Effectincrease of INR in an elderly patient after adding a chemotherapy regimen of levamisole and 5 - FU to a previous regimen of Drugwarfarin alone.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In addition, a 31 - year - old man with obsessive - compulsive disorder developed Adverse-EffectRBD soon after starting Drugfluoxetine therapy, which persisted at PSG study 19 months after fluoxetine discontinuation.
0.9997 Adverse-Effect In addition, a 31 - year - old man with obsessive - compulsive disorder developed Adverse-EffectRBD soon after starting fluoxetine therapy, which persisted at PSG study 19 months after Drugfluoxetine discontinuation.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Most cardiac surgical patients have had previous exposure to heparin for diagnostic or therapeutic interventions and hence have an increased susceptibility to developing Drugheparin - induced Adverse-Effectthrombocytopenia ( HIT ) postoperatively.
0.9991 Adverse-Effect Most cardiac surgical patients have had previous exposure to heparin for diagnostic or therapeutic interventions and hence have an increased susceptibility to developing Drugheparin - induced thrombocytopenia ( Adverse-EffectHIT ) postoperatively.
0.9907 Adverse-Effect Most cardiac surgical patients have had previous exposure to Drugheparin for diagnostic or therapeutic interventions and hence have an increased susceptibility to developing heparin - induced Adverse-Effectthrombocytopenia ( HIT ) postoperatively.
0.9860 Adverse-Effect Most cardiac surgical patients have had previous exposure to Drugheparin for diagnostic or therapeutic interventions and hence have an increased susceptibility to developing heparin - induced thrombocytopenia ( Adverse-EffectHIT ) postoperatively.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect However, given the clinically significant result to the interaction between tolazoline and cimetidine we report, the use of cimetidine in Drugtolazoline induced Adverse-Effectupper gastrointestinal hemorrhage should deserve more attention.
0.9971 Adverse-Effect However, given the clinically significant result to the interaction between tolazoline and cimetidine we report, the use of Drugcimetidine in tolazoline induced Adverse-Effectupper gastrointestinal hemorrhage should deserve more attention.
0.9963 Adverse-Effect However, given the clinically significant result to the interaction between tolazoline and Drugcimetidine we report, the use of cimetidine in tolazoline induced Adverse-Effectupper gastrointestinal hemorrhage should deserve more attention.
0.9957 Adverse-Effect However, given the clinically significant result to the interaction between Drugtolazoline and cimetidine we report, the use of cimetidine in tolazoline induced Adverse-Effectupper gastrointestinal hemorrhage should deserve more attention.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In this case report, we present clinical and laboratory findings of a case with chronic hepatitis B that developed Adverse-Effectacute dystonia soon after the first dose of Drugpegylated interferon alpha .
0.9999 Adverse-Effect In this case report, we present clinical and laboratory findings of a case with chronic Drughepatitis B that developed Adverse-Effectacute dystonia soon after the first dose of pegylated interferon alpha.
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect The induced hyperglycaemia could not be controlled sufficiently, despite a high dose of Druginsulin ( > 110 units / day ), suggesting the existence of Adverse-Effectinsulin insensitivity and hyperinsulinaemia.
0.9997 Adverse-Effect The induced hyperglycaemia could not be controlled sufficiently, despite a high dose of Druginsulin ( > 110 units / day ), suggesting the existence of insulin insensitivity and Adverse-Effecthyperinsulinaemia .
1.0000 Adverse-Effect The induced Adverse-Effecthyperglycaemia could not be controlled sufficiently, despite a high dose of Druginsulin ( > 110 units / day ), suggesting the existence of insulin insensitivity and hyperinsulinaemia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Continuous EEG monitoring is helpful in managing Adverse-Effectseizures that occur as a complication of DrugCBZ OD, after the course of recovery or worsening, and in providing assistance with prognosis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 57 - year - old woman with right bundle branch block + LPH and ventricular premature contractions developed complete heart block ( Adverse-EffectCHB ) following administration of Drugdisopyramide phosphate ( Norpace ).
0.9999 Adverse-Effect A 57 - year - old woman with right bundle branch block + LPH and ventricular premature contractions developed complete heart block ( Adverse-EffectCHB ) following administration of disopyramide phosphate ( DrugNorpace ).
0.9999 Adverse-Effect A 57 - year - old woman with right bundle branch block + LPH and ventricular premature contractions developed Adverse-Effectcomplete heart block ( CHB ) following administration of Drugdisopyramide phosphate ( Norpace ).
0.9997 Adverse-Effect A 57 - year - old woman with right bundle branch block + LPH and ventricular premature contractions developed Adverse-Effectcomplete heart block ( CHB ) following administration of disopyramide phosphate ( DrugNorpace ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Use of the Naranjo adverse drug reaction probability scale indicated a probable relationship ( score of 5 ) between the patient's development of Adverse-Effecthepatotoxicity and the DrugTMP - SMX therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 40 - year - old man with relapsing - remitting multiple sclerosis ( MS ) developed primary central nervous system lymphoma ( Adverse-EffectPCNSL ) after having received 21 doses of Drugnatalizumab monotherapy.
1.0000 Adverse-Effect A 40 - year - old man with relapsing - remitting multiple sclerosis ( MS ) developed Adverse-Effectprimary central nervous system lymphoma ( PCNSL ) after having received 21 doses of Drugnatalizumab monotherapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugWarfarin - associated Adverse-Effectbleeding generally is considered deleterious ; however, in our patient it unmasked an early stage of colon cancer and thus may have saved the patient's life.
0.9995 Adverse-Effect DrugWarfarin - associated bleeding generally is considered Adverse-Effectdeleterious ; however, in our patient it unmasked an early stage of colon cancer and thus may have saved the patient's life.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 44 - year - old woman is described in whom amiodarone, disopyramide, and Drugquinidine , administered alone separately, induced Adverse-Effectatypical ventricular tachycardia ( AVT, torsade de pointes ).
0.9999 Adverse-Effect A 44 - year - old woman is described in whom amiodarone, Drugdisopyramide , and quinidine, administered alone separately, induced Adverse-Effectatypical ventricular tachycardia ( AVT, torsade de pointes ).
0.9999 Adverse-Effect A 44 - year - old woman is described in whom Drugamiodarone , disopyramide, and quinidine, administered alone separately, induced Adverse-Effectatypical ventricular tachycardia ( AVT, torsade de pointes ).
0.9999 Adverse-Effect A 44 - year - old woman is described in whom amiodarone, disopyramide, and Drugquinidine , administered alone separately, induced atypical ventricular tachycardia ( AVT, Adverse-Effecttorsade de pointes ).
0.9997 Adverse-Effect A 44 - year - old woman is described in whom amiodarone, disopyramide, and Drugquinidine , administered alone separately, induced atypical ventricular tachycardia ( Adverse-EffectAVT , torsade de pointes ).
0.9997 Adverse-Effect A 44 - year - old woman is described in whom amiodarone, Drugdisopyramide , and quinidine, administered alone separately, induced atypical ventricular tachycardia ( AVT, Adverse-Effecttorsade de pointes ).
0.9997 Adverse-Effect A 44 - year - old woman is described in whom Drugamiodarone , disopyramide, and quinidine, administered alone separately, induced atypical ventricular tachycardia ( AVT, Adverse-Effecttorsade de pointes ).
0.9993 Adverse-Effect A 44 - year - old woman is described in whom amiodarone, Drugdisopyramide , and quinidine, administered alone separately, induced atypical ventricular tachycardia ( Adverse-EffectAVT , torsade de pointes ).
0.9993 Adverse-Effect A 44 - year - old woman is described in whom Drugamiodarone , disopyramide, and quinidine, administered alone separately, induced atypical ventricular tachycardia ( Adverse-EffectAVT , torsade de pointes ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report four cases of Adverse-Effectsensorimotor axonal neuropathy in children aged 10 - 15 years, treated with Drugthalidomide for myxopapillary ependymoma, Crohn's disease and recurrent giant aphthous ulceration.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To report a case of Adverse-Effectserotonin syndrome associated with interaction between Drugfentanyl and citalopram, as evidenced by medication history, clinical features and reversal following discontinuation of fentanyl.
0.9998 Adverse-Effect OBJECTIVE : To report a case of Adverse-Effectserotonin syndrome associated with interaction between fentanyl and Drugcitalopram , as evidenced by medication history, clinical features and reversal following discontinuation of fentanyl.
0.9993 Adverse-Effect OBJECTIVE : To report a case of Adverse-Effectserotonin syndrome associated with interaction between fentanyl and citalopram, as evidenced by medication history, clinical features and reversal following discontinuation of Drugfentanyl .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We review the literature on previously reported cases of Adverse-Effectcutaneous necrosis after injection of standard Druginterferon alfa or pegylated interferon alfa - 2b and discuss the different pathophysiologic mechanisms that might be involved.
0.9997 Adverse-Effect We review the literature on previously reported cases of Adverse-Effectcutaneous necrosis after injection of standard interferon alfa or Drugpegylated interferon alfa - 2b and discuss the different pathophysiologic mechanisms that might be involved.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We present a pediatric patient with leukemia and a severe, DrugL - asparaginase - induced Adverse-Effectnecrotizing pancreatitis , treated successfully with percutaneous drainage used to flush the infected necrotic parts.
Score Relation Text (Head - Tail)
0.9994 Adverse-Effect The authors postulate that two types of combined lithium - neuroleptic toxicity occur : a neuroleptic malignant extrapyramidal syndrome and a Druglithium Adverse-Effectlithium toxicity that occurs in combination with phenothiazines, primarily thioridazine.
0.9991 Adverse-Effect The authors postulate that two types of combined lithium - neuroleptic toxicity occur : a Adverse-Effectneuroleptic malignant extrapyramidal syndrome and a lithium toxicity that occurs in combination with phenothiazines, primarily Drugthioridazine .
0.9952 Adverse-Effect The authors postulate that two types of combined lithium - neuroleptic toxicity occur : a neuroleptic malignant extrapyramidal syndrome and a Adverse-Effectlithium toxicity that occurs in combination with phenothiazines, primarily Drugthioridazine .
0.9940 Adverse-Effect The authors postulate that two types of combined lithium - neuroleptic toxicity occur : a Adverse-Effectneuroleptic malignant extrapyramidal syndrome and a Druglithium toxicity that occurs in combination with phenothiazines, primarily thioridazine.
0.9997 Adverse-Effect The authors postulate that two types of combined Druglithium - neuroleptic toxicity occur : a Adverse-Effectneuroleptic malignant extrapyramidal syndrome and a lithium toxicity that occurs in combination with phenothiazines, primarily thioridazine.
0.9991 Adverse-Effect The authors postulate that two types of combined lithium - neuroleptic toxicity occur : a Adverse-Effectneuroleptic malignant extrapyramidal syndrome and a lithium toxicity that occurs in combination with Drugphenothiazines , primarily thioridazine.
0.9984 Adverse-Effect The authors postulate that two types of combined lithium - neuroleptic toxicity occur : a neuroleptic malignant extrapyramidal syndrome and a Adverse-Effectlithium toxicity that occurs in combination with Drugphenothiazines , primarily thioridazine.
0.9882 Adverse-Effect The authors postulate that two types of combined Druglithium - neuroleptic toxicity occur : a neuroleptic malignant extrapyramidal syndrome and a Adverse-Effectlithium toxicity that occurs in combination with phenothiazines, primarily thioridazine.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The possibility can be raised that DrugM - CSF accelerated the underlying Adverse-Effectrenal disease in this case through enhancing macrophage accumulation into the glomerulus, leading to the development of nephrotic syndrome.
0.9989 Adverse-Effect The possibility can be raised that DrugM - CSF accelerated the underlying renal disease in this case through enhancing macrophage accumulation into the glomerulus, leading to the development of Adverse-Effectnephrotic syndrome .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect We report here on a heretofore undescribed Adverse-Effectrespiratory syncytial virus ( RSV ) infection in a patient with a long - standing history of refractory CLL that was treated with Drugfludarabine phosphate .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of hyponatremia associated with a Adverse-Effectgrand mal seizure in a 28 month - old child after intra - nasal Drugdesmopressin administration for high fluid intake with nocturnal enuresis.
1.0000 Adverse-Effect We report a case of Adverse-Effecthyponatremia associated with a grand mal seizure in a 28 month - old child after intra - nasal Drugdesmopressin administration for high fluid intake with nocturnal enuresis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report an additional case of Drugisotretinoin Adverse-Effectteratogenicity in which the patient had agenesis of the cerebellar vermis, multiple leptomeningeal neuroglial heterotopias, hydrocephalus, and abnormalities of the corticospinal tracts.
0.9999 Adverse-Effect We report an additional case of Drugisotretinoin teratogenicity in which the patient had Adverse-Effectagenesis of the cerebellar vermis , multiple leptomeningeal neuroglial heterotopias, hydrocephalus, and abnormalities of the corticospinal tracts.
0.9999 Adverse-Effect We report an additional case of Drugisotretinoin teratogenicity in which the patient had agenesis of the cerebellar vermis, multiple leptomeningeal neuroglial heterotopias, hydrocephalus, and Adverse-Effectabnormalities of the corticospinal tracts .
0.9998 Adverse-Effect We report an additional case of Drugisotretinoin teratogenicity in which the patient had agenesis of the cerebellar vermis, Adverse-Effectmultiple leptomeningeal neuroglial heterotopias , hydrocephalus, and abnormalities of the corticospinal tracts.
0.9998 Adverse-Effect We report an additional case of Drugisotretinoin teratogenicity in which the patient had agenesis of the cerebellar vermis, multiple leptomeningeal neuroglial heterotopias, Adverse-Effecthydrocephalus , and abnormalities of the corticospinal tracts.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect However, continued low - dose DrugMTX led, in spite of normal liver tests, 8 years after the last biopsy to Adverse-Effectliver failure and death in 1 of our patients.
0.9999 Adverse-Effect However, continued low - dose DrugMTX led, in spite of normal liver tests, 8 years after the last biopsy to liver failure and Adverse-Effectdeath in 1 of our patients.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 56 - year - old woman with scleroderma developed rapidly progressive glomerulonephritis with epithelial crescents associated with Adverse-Effecthemoptysis after 27 months of DrugD - penicillamine therapy and a cumulative dose of 1, 200 g.
0.9996 Adverse-Effect A 56 - year - old woman with scleroderma developed rapidly progressive glomerulonephritis with Adverse-Effectepithelial crescents associated with hemoptysis after 27 months of DrugD - penicillamine therapy and a cumulative dose of 1, 200 g.
0.9995 Adverse-Effect A 56 - year - old woman with scleroderma developed Adverse-Effectrapidly progressive glomerulonephritis with epithelial crescents associated with hemoptysis after 27 months of DrugD - penicillamine therapy and a cumulative dose of 1, 200 g.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In a phase II study of Drughycanthone in patients with breast cancer we have recently observed Adverse-Effectsevere hepatotoxicity , even at lower doses, which resulted in two drug - related deaths.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The development of systemic lupus erythematosus ( Adverse-EffectSLE ) after 38 months of therapy with Drugrecombinant human interferon gamma ( rIFN - gamma ) was observed in a patient with rheumatoid arthritis.
0.9998 Adverse-Effect The development of systemic lupus erythematosus ( Adverse-EffectSLE ) after 38 months of therapy with recombinant human interferon gamma ( DrugrIFN - gamma ) was observed in a patient with rheumatoid arthritis.
0.9997 Adverse-Effect The development of Adverse-Effectsystemic lupus erythematosus ( SLE ) after 38 months of therapy with Drugrecombinant human interferon gamma ( rIFN - gamma ) was observed in a patient with rheumatoid arthritis.
0.9985 Adverse-Effect The development of Adverse-Effectsystemic lupus erythematosus ( SLE ) after 38 months of therapy with recombinant human interferon gamma ( DrugrIFN - gamma ) was observed in a patient with rheumatoid arthritis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report 2 cases of maculopapular eruption and Adverse-Effectfever in patients infected with human immunodeficiency virus ( HIV ) on the 2nd day of first administration of Drugritonavir , a protease inhibitor.
1.0000 Adverse-Effect We report 2 cases of Adverse-Effectmaculopapular eruption and fever in patients infected with human immunodeficiency virus ( HIV ) on the 2nd day of first administration of Drugritonavir , a protease inhibitor.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Even after a strict warning, he took another quinine tablet that evening, which triggered his fifth episode of severe thrombocytopenia, and confirmed the etiology of Drugquinine - induced Adverse-Effectthrombocytopenia .
0.9762 Adverse-Effect Even after a strict warning, he took another quinine tablet that evening, which triggered his fifth episode of severe Adverse-Effectthrombocytopenia , and confirmed the etiology of Drugquinine - induced thrombocytopenia.
0.9844 Adverse-Effect Even after a strict warning, he took another quinine tablet that evening, which triggered his fifth episode of Adverse-Effectsevere thrombocytopenia , and confirmed the etiology of Drugquinine - induced thrombocytopenia.
Adverse-Effect Even after a strict warning, he took another Drugquinine tablet that evening, which triggered his fifth episode of severe Adverse-Effectthrombocytopenia , and confirmed the etiology of quinine - induced thrombocytopenia.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Six patients developed Adverse-Effectperipheral neuropathy and five patients bone marrow depression, blood transfusions were given to three patients and in all five patients bone marrow function normalized after cessation of Druglinezolid .
0.9999 Adverse-Effect Six patients developed peripheral neuropathy and five patients Adverse-Effectbone marrow depression , blood transfusions were given to three patients and in all five patients bone marrow function normalized after cessation of Druglinezolid .
Score Relation Text (Head - Tail)
0.9962 Adverse-Effect Herein is reported an unusual case of coexistent warfarin - induced skin necrosis and Drugheparin - induced Adverse-Effectthrombocytopenia following mitral valve replacement for thromboembolic phenomena associated with marantic endocarditis and bronchial adenocarcinoma.
0.9957 Adverse-Effect Herein is reported an unusual case of coexistent Drugwarfarin - induced Adverse-Effectskin necrosis and heparin - induced thrombocytopenia following mitral valve replacement for thromboembolic phenomena associated with marantic endocarditis and bronchial adenocarcinoma.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect BACKGROUND : We describe the ophthalmic features and clinical course of two cases of acute syphilitic posterior placoid chorioretinitis ( Adverse-EffectASPPC ) that developed after intravitreal Drugtriamcinolone acetonide ( IVTA ) injection.
0.9999 Adverse-Effect BACKGROUND : We describe the ophthalmic features and clinical course of two cases of acute syphilitic posterior placoid chorioretinitis ( Adverse-EffectASPPC ) that developed after intravitreal triamcinolone acetonide ( DrugIVTA ) injection.
0.9999 Adverse-Effect BACKGROUND : We describe the ophthalmic features and clinical course of two cases of Adverse-Effectacute syphilitic posterior placoid chorioretinitis ( ASPPC ) that developed after intravitreal Drugtriamcinolone acetonide ( IVTA ) injection.
0.9996 Adverse-Effect BACKGROUND : We describe the ophthalmic features and clinical course of two cases of Adverse-Effectacute syphilitic posterior placoid chorioretinitis ( ASPPC ) that developed after intravitreal triamcinolone acetonide ( DrugIVTA ) injection.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a case of intraoperative Druggelatine - induced Adverse-Effectanaphylaxis whose diagnosis was delayed as the use of gelatine during surgical procedures was omitted for two times in patient's medical records.
0.9999 Adverse-Effect We describe a case of intraoperative gelatine - induced Adverse-Effectanaphylaxis whose diagnosis was delayed as the use of Druggelatine during surgical procedures was omitted for two times in patient's medical records.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Here, we describe a case of Adverse-EffectVogt - Koyanagi - Harada disease occurring 4 months after the start of Druginterferon alpha treatment, probably induced by the immunomodulatory effects of interferon.
0.9960 Adverse-Effect Here, we describe a case of Adverse-EffectVogt - Koyanagi - Harada disease occurring 4 months after the start of interferon alpha treatment, probably induced by the immunomodulatory effects of Druginterferon .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectPheripheral edema was observed in five female patients after taking proton pump inhibitors Drugomeprazole , lansoprazole, or pantoprazole for 7 - 15 days for peptic acid diseases in recommended standard doses.
0.9999 Adverse-Effect Adverse-EffectPheripheral edema was observed in five female patients after taking proton pump inhibitors omeprazole, Druglansoprazole , or pantoprazole for 7 - 15 days for peptic acid diseases in recommended standard doses.
0.9999 Adverse-Effect Adverse-EffectPheripheral edema was observed in five female patients after taking proton pump inhibitors omeprazole, lansoprazole, or Drugpantoprazole for 7 - 15 days for peptic acid diseases in recommended standard doses.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect We describe two patients in whom painful erosions of their psoriasis developed as the presenting sign of Drugmethotrexate Adverse-Effectmethotrexate toxicity and review the literature, emphasizing the risk factors associated with this manifestation.
0.9995 Adverse-Effect We describe two patients in whom Adverse-Effectpainful erosions of their psoriasis developed as the presenting sign of Drugmethotrexate toxicity and review the literature, emphasizing the risk factors associated with this manifestation.
0.9991 Adverse-Effect We describe two patients in whom painful Adverse-Effecterosions of their psoriasis developed as the presenting sign of Drugmethotrexate toxicity and review the literature, emphasizing the risk factors associated with this manifestation.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We recommend that a TMA in association with quinine be consistently referred to as Drugquinine - associated Adverse-Effectthrombotic microangiopathy ( quinine - TMA ) to better distinguish this entity from idiopathic TTP.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 77 - year - old woman with no history of epilepsy presented a probable Adverse-Effectnonconvulsive status epilepticus while receiving continuous intravenous Drugmorphine for back pain relating to vertebral metastasis of a malignant lymphoma.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We present a case of the syndrome of inappropriate antidiuretic hormone ( Adverse-EffectSIADH ) secondary to Drugcisplatin therapy in a patient with advanced - stage large cell neuroendocrine carcinoma of the cervix.
0.9999 Adverse-Effect We present a case of the Adverse-Effectsyndrome of inappropriate antidiuretic hormone ( SIADH ) secondary to Drugcisplatin therapy in a patient with advanced - stage large cell neuroendocrine carcinoma of the cervix.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Prenatal cytomegalovirus ( CMV ) infection associated with severe Adverse-Effectbrain damage was detected in an infant whose mother had been treated with Drugprednisolone and azathioprine for systemic lupus erythematosus ( SLE ).
1.0000 Adverse-Effect Prenatal cytomegalovirus ( CMV ) infection associated with severe Adverse-Effectbrain damage was detected in an infant whose mother had been treated with prednisolone and Drugazathioprine for systemic lupus erythematosus ( SLE ).
1.0000 Adverse-Effect Adverse-EffectPrenatal cytomegalovirus ( CMV ) infection associated with severe brain damage was detected in an infant whose mother had been treated with Drugprednisolone and azathioprine for systemic lupus erythematosus ( SLE ).
0.9999 Adverse-Effect Adverse-EffectPrenatal cytomegalovirus ( CMV ) infection associated with severe brain damage was detected in an infant whose mother had been treated with prednisolone and Drugazathioprine for systemic lupus erythematosus ( SLE ).
1.0000 Adverse-Effect Prenatal cytomegalovirus ( CMV ) infection associated with Adverse-Effectsevere brain damage was detected in an infant whose mother had been treated with Drugprednisolone and azathioprine for systemic lupus erythematosus ( SLE ).
1.0000 Adverse-Effect Prenatal cytomegalovirus ( CMV ) infection associated with Adverse-Effectsevere brain damage was detected in an infant whose mother had been treated with prednisolone and Drugazathioprine for systemic lupus erythematosus ( SLE ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a patient with chronic renal failure and ischemic heart disease who developed clinically significant Adverse-Effectmethemoglobinemia after an axillary block with Drugbupivacaine and additional injection of lidocaine in the operative field.
0.9999 Adverse-Effect We report a patient with chronic renal failure and ischemic heart disease who developed clinically significant Adverse-Effectmethemoglobinemia after an axillary block with bupivacaine and additional injection of Druglidocaine in the operative field.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Review of this and previously reported cases indicates the need for early diagnosis of Drugamiodarone Adverse-Effectpneumonitis , immediate withdrawal of amiodarone, and prompt but continued steroid therapy to ensure full recovery.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Two years later, 24 hours following an increase in the dose of Drugdisopyramide from 300 to 600 mg / day, Adverse-EffectAVT with syncope occurred ; isoproterenol abolished the arrhythmia instantly.
0.9999 Adverse-Effect Two years later, 24 hours following an increase in the dose of Drugdisopyramide from 300 to 600 mg / day, AVT with Adverse-Effectsyncope occurred ; isoproterenol abolished the arrhythmia instantly.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 74 - year - old patient with idiopathic Parkinson's disease was evaluated for Adverse-Effectunintended sleep episodes that occurred after long - term treatment with 400 mg / day of DrugL - dopa .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Prior to surgery, Druglevodopa induced Adverse-Effectdyskinesia had improved ( < or = 50 % ) under treatment with amantadine ( 400 mg / day, po ) in all three patients.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report on a patient with acromegaly who developed severe drug - induced Adverse-Effecthepatitis during combined treatment with the long - acting somatostatin - analog Drugoctreotide and the GH receptor antagonist pegvisomant.
0.9999 Adverse-Effect We report on a patient with acromegaly who developed severe drug - induced Adverse-Effecthepatitis during combined treatment with the long - acting somatostatin - analog octreotide and the GH receptor antagonist Drugpegvisomant .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : DrugTopiramate may be associated with Adverse-Effectciliochoroidal effusion with forward displacement of the lens - iris diaphragm and anterior chamber shallowing, resulting in acute myopia and angle - closure glaucoma.
1.0000 Adverse-Effect CONCLUSIONS : DrugTopiramate may be associated with ciliochoroidal effusion with forward Adverse-Effectdisplacement of the lens - iris diaphragm and anterior chamber shallowing, resulting in acute myopia and angle - closure glaucoma.
0.9999 Adverse-Effect CONCLUSIONS : DrugTopiramate may be associated with ciliochoroidal effusion with forward displacement of the lens - iris diaphragm and anterior chamber shallowing, resulting in acute myopia and Adverse-Effectangle - closure glaucoma .
0.9999 Adverse-Effect CONCLUSIONS : DrugTopiramate may be associated with ciliochoroidal effusion with forward displacement of the lens - iris diaphragm and anterior chamber shallowing, resulting in Adverse-Effectacute myopia and angle - closure glaucoma.
0.9999 Adverse-Effect CONCLUSIONS : DrugTopiramate may be associated with ciliochoroidal effusion with forward displacement of the lens - iris diaphragm and Adverse-Effectanterior chamber shallowing , resulting in acute myopia and angle - closure glaucoma.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case of high - grade endometrial stromal sarcoma, confined into an Adverse-Effectintrauterine polypoid growth , in a woman with a history of breast cancer who was treated with adjuvant Drugtamoxifen .
1.0000 Adverse-Effect A case of Adverse-Effecthigh - grade endometrial stromal sarcoma , confined into an intrauterine polypoid growth, in a woman with a history of breast cancer who was treated with adjuvant Drugtamoxifen .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Because of serious side effects of an increase in the QT interval causing Adverse-Effecttorsades de pointes , Drugdofetilide must be initiated with close monitoring of the QT interval in an inpatient setting.
0.9999 Adverse-Effect Because of serious side effects of an Adverse-Effectincrease in the QT interval causing torsades de pointes, Drugdofetilide must be initiated with close monitoring of the QT interval in an inpatient setting.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The typical Drugfluoxetine - induced symptoms of Adverse-Effectrestlessness , constant pacing, purposeless movements of the feet and legs, and marked anxiety were indistinguishable from those of neuroleptic - induced akathisia.
0.9999 Adverse-Effect The typical Drugfluoxetine - induced symptoms of restlessness, constant pacing, Adverse-Effectpurposeless movements of the feet and legs , and marked anxiety were indistinguishable from those of neuroleptic - induced akathisia.
0.9999 Adverse-Effect The typical Drugfluoxetine - induced symptoms of restlessness, Adverse-Effectconstant pacing , purposeless movements of the feet and legs, and marked anxiety were indistinguishable from those of neuroleptic - induced akathisia.
0.9997 Adverse-Effect The typical Drugfluoxetine - induced symptoms of restlessness, constant pacing, purposeless movements of the feet and legs, and Adverse-Effectmarked anxiety were indistinguishable from those of neuroleptic - induced akathisia.
0.8799 Adverse-Effect The typical Drugfluoxetine - induced symptoms of restlessness, constant pacing, purposeless movements of the feet and legs, and marked anxiety were indistinguishable from those of neuroleptic - induced Adverse-Effectakathisia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To report a case of Drugphenolphthalein - induced Adverse-Effecttoxic epidermal necrolysis ( TEN ) in a patient maintained on several other medications more commonly known to be associated with TEN.
1.0000 Adverse-Effect OBJECTIVE : To report a case of Drugphenolphthalein - induced toxic epidermal necrolysis ( Adverse-EffectTEN ) in a patient maintained on several other medications more commonly known to be associated with TEN.
0.9998 Adverse-Effect OBJECTIVE : To report a case of Drugphenolphthalein - induced toxic epidermal necrolysis ( TEN ) in a patient maintained on several other medications more commonly known to be associated with Adverse-EffectTEN .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect After Druginfliximab treatment, additional sleep studies revealed an Adverse-Effectincrease in the number of apneic events and SaO2 dips suggesting that TNFalpha plays an important role in the pathophysiology of sleep apnea.
0.9999 Adverse-Effect After Druginfliximab treatment, additional sleep studies revealed an increase in the number of apneic events and Adverse-EffectSaO2 dips suggesting that TNFalpha plays an important role in the pathophysiology of sleep apnea.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : We report a patient who developed neutropenia on Drugclozapine , but behind the cell count decrease showed to be a Adverse-Effectdiurnal variation of the white blood cells ( WBC ).
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect An infant girl with choanal atresia, Adverse-Effectathelia , minor anomalies, and mild to moderate mental retardation was born to a woman treated for hyperthyroidism throughout pregnancy with Drugmethimazole and propranolol.
0.9999 Adverse-Effect An infant girl with Adverse-Effectchoanal atresia , athelia, minor anomalies, and mild to moderate mental retardation was born to a woman treated for hyperthyroidism throughout pregnancy with Drugmethimazole and propranolol.
0.9998 Adverse-Effect An infant girl with choanal atresia, Adverse-Effectathelia , minor anomalies, and mild to moderate mental retardation was born to a woman treated for hyperthyroidism throughout pregnancy with methimazole and Drugpropranolol .
0.9997 Adverse-Effect An infant girl with Adverse-Effectchoanal atresia , athelia, minor anomalies, and mild to moderate mental retardation was born to a woman treated for hyperthyroidism throughout pregnancy with methimazole and Drugpropranolol .
Adverse-Effect An infant girl with choanal atresia, athelia, minor anomalies, and mild to moderate Adverse-Effectmental retardation was born to a woman treated for hyperthyroidism throughout pregnancy with methimazole and Drugpropranolol .
Adverse-Effect An infant girl with choanal atresia, athelia, minor anomalies, and mild to moderate Adverse-Effectmental retardation was born to a woman treated for hyperthyroidism throughout pregnancy with Drugmethimazole and propranolol.
Score Relation Text (Head - Tail)
0.9995 Adverse-Effect Acute Drugnitrite Adverse-Effectnitrite toxicity results from industrial exposure, accidental ingestion ( e. g., abuse of organic nitrites as an aphrodisiac, especially in the male homosexual population ), and suicidal ingestion.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Severe rash, including the Stevens - Johnson syndrome ( Adverse-EffectSJS ), is the major toxicity of Drugnevirapine and is described in the package labeling with a prominent, boxed warning.
0.9999 Adverse-Effect Adverse-EffectSevere rash , including the Stevens - Johnson syndrome ( SJS ), is the major toxicity of Drugnevirapine and is described in the package labeling with a prominent, boxed warning.
0.9999 Adverse-Effect Severe rash, including the Adverse-EffectStevens - Johnson syndrome ( SJS ), is the major toxicity of Drugnevirapine and is described in the package labeling with a prominent, boxed warning.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Presented is a case story of a woman with classical rheumatoid arthritis, who during introduction of sulphasalazine ( DrugSASP ) therapy developed a severe and lasting Adverse-Effectpsoriasis - like skin reaction .
0.9999 Adverse-Effect Presented is a case story of a woman with classical rheumatoid arthritis, who during introduction of Drugsulphasalazine ( SASP ) therapy developed a severe and lasting Adverse-Effectpsoriasis - like skin reaction .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case is reported in which severe hypocalcemia, with a low plasma parathyroid hormone ( Adverse-EffectPTH ) concentration, resulted from the therapeutic use of Drugmagnesium sulfate for toxemia of pregnancy.
0.9999 Adverse-Effect A case is reported in which severe hypocalcemia, with a Adverse-Effectlow plasma parathyroid hormone ( PTH ) concentration, resulted from the therapeutic use of Drugmagnesium sulfate for toxemia of pregnancy.
0.9998 Adverse-Effect A case is reported in which Adverse-Effectsevere hypocalcemia , with a low plasma parathyroid hormone ( PTH ) concentration, resulted from the therapeutic use of Drugmagnesium sulfate for toxemia of pregnancy.
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect The electrocardiogram ( ECG ), which was read as normal prior to ritodrine infusion, demonstrated a Adverse-Effecttype I second - degree AV block which disappeared upon discontinuation of Drugritodrine therapy.
0.9997 Adverse-Effect The electrocardiogram ( ECG ), which was read as normal prior to Drugritodrine infusion, demonstrated a Adverse-Effecttype I second - degree AV block which disappeared upon discontinuation of ritodrine therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case is reported of an elderly woman who developed Adverse-Effectfebrile agranulocytosis several weeks after commencing Drugticlopidine but who had a favorable outcome after cessation of that drug and treatment with filgastrim.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect METHODS : Two patients with exudative age - related macular degeneration were treated sequentially with an intravitreal injection of Drugbevacizumab and developed signs of severe but Adverse-Effectpainless infectious endophthalmitis 2 days later.
1.0000 Adverse-Effect METHODS : Two patients with exudative age - related Adverse-Effectmacular degeneration were treated sequentially with an intravitreal injection of Drugbevacizumab and developed signs of severe but painless infectious endophthalmitis 2 days later.
Adverse-Effect METHODS : Two patients with exudative Adverse-Effectage - related macular degeneration were treated sequentially with an intravitreal injection of Drugbevacizumab and developed signs of severe but painless infectious endophthalmitis 2 days later.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect 3. Thus, the Adverse-Effectdecreased plasma cortisol level during Drugalprazolam treatment of panic disorder was suggested to be caused not by symptom alleviation due to alprazolam but by alprazolam administration itself.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Although the Adverse-Effectt - AML developed following oral Drugetoposide therapy, the child had previously received high - dose, multiagent chemotherapy, and rearrangement of the MLL gene was not demonstrated.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 66 - year - old Japanese woman with severe scleroderma developed anemia and Adverse-Effectthrombocytopenia due to DrugD - penicillamine ( D - Pen ) treatment, although the leukopenia was not markedly severe.
0.9996 Adverse-Effect A 66 - year - old Japanese woman with severe scleroderma developed Adverse-Effectanemia and thrombocytopenia due to DrugD - penicillamine ( D - Pen ) treatment, although the leukopenia was not markedly severe.
0.9994 Adverse-Effect A 66 - year - old Japanese woman with severe scleroderma developed anemia and Adverse-Effectthrombocytopenia due to D - penicillamine ( DrugD - Pen ) treatment, although the leukopenia was not markedly severe.
0.9988 Adverse-Effect A 66 - year - old Japanese woman with severe scleroderma developed Adverse-Effectanemia and thrombocytopenia due to D - penicillamine ( DrugD - Pen ) treatment, although the leukopenia was not markedly severe.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect While Drugdoxorubicin was administered, the patient presented Adverse-Effectthoracic pain and breathing distress due to superior vena cava perforation by the central catheter and subsequent extravasation of the drug into the mediastinum.
0.9999 Adverse-Effect While Drugdoxorubicin was administered, the patient presented thoracic pain and Adverse-Effectbreathing distress due to superior vena cava perforation by the central catheter and subsequent extravasation of the drug into the mediastinum.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 67 - year - old patient, with primary polymyositis and without previous evidence of liver disease, developed clinical and biochemical features of Adverse-Effectsevere cholestasis 3 months after initiation of Drugazathioprine therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a life threatening side effect of acute Drugepoprostenol infusion ( Adverse-Effectpulmonary edema ) in a patient with pulmonary hypertension associated with limited scleroderma and discuss its management and potential etiology.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Six patients with no previous signs or symptoms suggestive of coronary artery disease developed acute coronary ischemia / Adverse-Effectinfarction shortly after Drugcis - diamine - dichloroplatinum II ( cisplatin ) - based chemotherapy.
0.9998 Adverse-Effect Six patients with no previous signs or symptoms suggestive of coronary artery disease developed acute coronary ischemia / Adverse-Effectinfarction shortly after cis - diamine - dichloroplatinum II ( Drugcisplatin ) - based chemotherapy.
0.9997 Adverse-Effect Six patients with no previous signs or symptoms suggestive of coronary artery disease developed Adverse-Effectacute coronary ischemia / infarction shortly after Drugcis - diamine - dichloroplatinum II ( cisplatin ) - based chemotherapy.
0.9990 Adverse-Effect Six patients with no previous signs or symptoms suggestive of coronary artery disease developed Adverse-Effectacute coronary ischemia / infarction shortly after cis - diamine - dichloroplatinum II ( Drugcisplatin ) - based chemotherapy.
1.0000 Adverse-Effect Six patients with no previous signs or symptoms suggestive of coronary artery disease developed acute coronary ischemia / Adverse-Effectinfarction shortly after Drugcis - diamine - dichloroplatinum II ( cisplatin ) - based chemotherapy.
0.9997 Adverse-Effect Six patients with no previous signs or symptoms suggestive of coronary artery disease developed Adverse-Effectacute coronary ischemia / infarction shortly after Drugcis - diamine - dichloroplatinum II ( cisplatin ) - based chemotherapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In three of these patients the infection was clinically unsuspected ; in the fourth, Adverse-Effectcutaneous herpes zoster developed after administration of 300 mg of Drugcytarabine daily for the preceding five days.
Score Relation Text (Head - Tail)
0.9997 Adverse-Effect INTRODUCTION - The aim of this case report is to present a 15 - year follow - up of a patient with phenytoin ( DrugPHT ) intoxication with Adverse-Effectunilateral gingival hyperplasia ( GH ).
0.9993 Adverse-Effect INTRODUCTION - The aim of this case report is to present a 15 - year follow - up of a patient with Drugphenytoin ( PHT ) intoxication with Adverse-Effectunilateral gingival hyperplasia ( GH ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Though physicians treating large populations of patients with HIV are well aware of this complication, only one other report of Drugnevirapine - associated Adverse-EffectSJS has been documented in the dermatology literature.
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect Adverse-EffectGrade 3 hepatotoxicity ( AST and ALT > 5 to 20 upper limit normal ) or higher has been observed in as many as 1. 4 % of MS patients on DrugIFN beta .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVES : To describe the clinicopathologic features of 3 patients with CML who rapidly progressed from chronic phase to Adverse-Effectblast crisis while taking Drugimatinib and to perform a review of the literature.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect The purpose of this review is to increase awareness among physicians and other health care professionals that Adverse-EffectDIC may be a rare but potentially severe complication of Druganti - D IGIV treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Our patient was a 72 - year - old man with advanced Parkinson's disease ( PD ) who received Druglevodopa and anti - cholinergic drugs and whose head had become almost Adverse-Effectcompletely bald .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : These results suggest that Drugclozapine may cause Adverse-EffectTD ; however, the prevalence is low and the severity is relatively mild, with no or mild self - reported discomfort.
0.9999 Adverse-Effect CONCLUSIONS : These results suggest that Drugclozapine may cause TD ; however, the prevalence is low and the severity is relatively mild, with no or mild self - reported Adverse-Effectdiscomfort .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : The observation that Adverse-Effectneurotoxicity developed with a delay of 24 to 48 hours after Drugacyclovir peak serum concentrations could explain the wide range of acyclovir levels reported in similar cases.
0.9998 Adverse-Effect CONCLUSIONS : The observation that Adverse-Effectneurotoxicity developed with a delay of 24 to 48 hours after acyclovir peak serum concentrations could explain the wide range of Drugacyclovir levels reported in similar cases.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We highlight two instances of Adverse-Effectsystemic allergic reaction , and discuss the potential side effects of local Drugaprotinin injections in the orthopaedic setting as well as the evidence base for its use.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Diarrhoea, T - CD4 + lymphopenia and Adverse-Effectbilateral patchy pulmonary infiltrates developed in a male 60 yrs of age, who was treated with Drugoxaliplatinum and 5 - fluorouracil for unresectable rectum carcinoma.
1.0000 Adverse-Effect Adverse-EffectDiarrhoea , T - CD4 + lymphopenia and bilateral patchy pulmonary infiltrates developed in a male 60 yrs of age, who was treated with Drugoxaliplatinum and 5 - fluorouracil for unresectable rectum carcinoma.
0.9999 Adverse-Effect Diarrhoea, Adverse-EffectT - CD4 + lymphopenia and bilateral patchy pulmonary infiltrates developed in a male 60 yrs of age, who was treated with Drugoxaliplatinum and 5 - fluorouracil for unresectable rectum carcinoma.
0.9999 Adverse-Effect Diarrhoea, T - CD4 + lymphopenia and Adverse-Effectbilateral patchy pulmonary infiltrates developed in a male 60 yrs of age, who was treated with oxaliplatinum and Drug5 - fluorouracil for unresectable rectum carcinoma.
0.9999 Adverse-Effect Adverse-EffectDiarrhoea , T - CD4 + lymphopenia and bilateral patchy pulmonary infiltrates developed in a male 60 yrs of age, who was treated with oxaliplatinum and Drug5 - fluorouracil for unresectable rectum carcinoma.
0.9998 Adverse-Effect Diarrhoea, Adverse-EffectT - CD4 + lymphopenia and bilateral patchy pulmonary infiltrates developed in a male 60 yrs of age, who was treated with oxaliplatinum and Drug5 - fluorouracil for unresectable rectum carcinoma.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Several cases of Druglithium - induced Adverse-EffectCreutzfeldt - Jakob syndrome have been reported to date ; all of them were elderly patients and a half had " therapeutic " lithium serum levels.
0.9999 Adverse-Effect Several cases of lithium - induced Adverse-EffectCreutzfeldt - Jakob syndrome have been reported to date ; all of them were elderly patients and a half had " therapeutic " Druglithium serum levels.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of Adverse-Effectfulminant hepatic failure associated with Drugdidanosine and masquerading as a surgical abdomen and compare the clinical, biologic, histologic, and ultrastructural findings with reports described previously.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the case of a 43 - year - old man with ITP refractory to steroids and intravenous immunoglobulin who developed acute respiratory distress syndrome ( Adverse-EffectARDS ) after a single infusion of Drugrituximab .
1.0000 Adverse-Effect We report the case of a 43 - year - old man with ITP refractory to steroids and intravenous immunoglobulin who developed Adverse-Effectacute respiratory distress syndrome ( ARDS ) after a single infusion of Drugrituximab .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report an unusual case of simultaneous transitional cell carcinoma of the renal pelvis and Adverse-Effectdistal ureter without transitional cell carcinoma of the bladder occurring after chronic Drugcyclophosphamide therapy for nonHodgkin's lymphoma.
1.0000 Adverse-Effect We report an unusual case of simultaneous Adverse-Effecttransitional cell carcinoma of the renal pelvis and distal ureter without transitional cell carcinoma of the bladder occurring after chronic Drugcyclophosphamide therapy for nonHodgkin's lymphoma.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect One week after the initial - dose of Drugadalimumab ( 160 mg ), which was initiated due to an acute exacerbation of Crohn's disease, the patient developed a Adverse-Effectfulminant cardiomyopathy .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Because there were no other obvious causes of renal failure in either patient, we propose that Adverse-Effectskeletal muscle ischemia developed during Drugvasopressin infusion, followed by release of myoglobin and renal damage.
0.9975 Adverse-Effect Because there were no other obvious causes of renal failure in either patient, we propose that skeletal muscle ischemia developed during Drugvasopressin infusion, followed by release of myoglobin and Adverse-Effectrenal damage .
0.9995 Adverse-Effect Because there were no other obvious causes of Adverse-Effectrenal failure in either patient, we propose that skeletal muscle ischemia developed during Drugvasopressin infusion, followed by release of myoglobin and renal damage.
0.9804 Adverse-Effect Because there were no other obvious causes of renal failure in either patient, we propose that Adverse-Effectskeletal muscle ischemia developed during vasopressin infusion, followed by release of Drugmyoglobin and renal damage.
0.9510 Adverse-Effect Because there were no other obvious causes of Adverse-Effectrenal failure in either patient, we propose that skeletal muscle ischemia developed during vasopressin infusion, followed by release of Drugmyoglobin and renal damage.
0.6259 Adverse-Effect Because there were no other obvious causes of renal failure in either patient, we propose that skeletal muscle ischemia developed during vasopressin infusion, followed by release of Drugmyoglobin and Adverse-Effectrenal damage .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The authors describe a case of Adverse-Effectvalvular heart disease in a 48 - year - old woman receiving Drugbenfluorex ( 150 mg t. i. d. for 8 years ) and leading to surgical mitral valve replacement.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectCD20 - negative T - cell - rich B - cell lymphoma as a progression of a nodular lymphocyte - predominant Hodgkin's lymphoma treated with Drugrituximab : a molecular analysis using laser capture microdissection.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 65 - year - old man on Drugwarfarin therapy with a sudden spontaneous onset of Adverse-Effectsub - conjunctival haematoma associated with bloody tears was assessed in the clinic following a referral from an optometrist.
0.9999 Adverse-Effect A 65 - year - old man on Drugwarfarin therapy with a sudden spontaneous onset of sub - conjunctival haematoma associated with Adverse-Effectbloody tears was assessed in the clinic following a referral from an optometrist.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe the clinical response, as determined by Adverse-Effectincreases in total Hb and decreased transfusion needs, in five patients with thalassemia intermedia treated with DrugHU alone or in combination with SPB.
0.9999 Adverse-Effect We describe the clinical response, as determined by Adverse-Effectincreases in total Hb and decreased transfusion needs, in five patients with thalassemia intermedia treated with HU alone or in combination with DrugSPB .
1.0000 Adverse-Effect We describe the clinical response, as determined by increases in total Hb and Adverse-Effectdecreased transfusion needs , in five patients with thalassemia intermedia treated with DrugHU alone or in combination with SPB.
0.9998 Adverse-Effect We describe the clinical response, as determined by increases in total Hb and Adverse-Effectdecreased transfusion needs , in five patients with thalassemia intermedia treated with HU alone or in combination with DrugSPB .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a 31 - year - old women with recurrent Hodgkin's lymphoma and unrecognized HMSN - 1 who developed Adverse-Effectsevere motor neuropathy 3 weeks after the first cycle of treatment including 2 mg of Drugvincristine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This paper reports an autopsy case of a 78 - year - old male with Adverse-Effectmultiple nodules in the liver developed after long - termed administration of Drugphosphate diethylstilbestrol ( PDES ) for prostatic cancer.
0.9999 Adverse-Effect This paper reports an autopsy case of a 78 - year - old male with Adverse-Effectmultiple nodules in the liver developed after long - termed administration of phosphate diethylstilbestrol ( DrugPDES ) for prostatic cancer.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In this report we described a case of juvenile idiopathic arthritis patient who developed thymic enlargement ( true thymic hyperplasia ), mediastinal lymphadenopathy and Adverse-Effectpleurisy associated with systemic symptoms under DrugEtanercept treatment.
0.9999 Adverse-Effect In this report we described a case of juvenile idiopathic arthritis patient who developed thymic enlargement ( true thymic hyperplasia ), Adverse-Effectmediastinal lymphadenopathy and pleurisy associated with systemic symptoms under DrugEtanercept treatment.
0.9999 Adverse-Effect In this report we described a case of juvenile idiopathic arthritis patient who developed thymic enlargement ( true Adverse-Effectthymic hyperplasia ), mediastinal lymphadenopathy and pleurisy associated with systemic symptoms under DrugEtanercept treatment.
0.9999 Adverse-Effect In this report we described a case of juvenile idiopathic arthritis patient who developed Adverse-Effectthymic enlargement ( true thymic hyperplasia ), mediastinal lymphadenopathy and pleurisy associated with systemic symptoms under DrugEtanercept treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect However, the use of Druglithium should be avoided with any patient who is purging, since it may exacerbate the Adverse-Effectloss of intracellular potassium , thereby increasing the risk of cardiac toxicity.
0.9999 Adverse-Effect However, the use of Druglithium should be avoided with any patient who is purging, since it may exacerbate the loss of intracellular potassium, thereby increasing the risk of Adverse-Effectcardiac toxicity .
Score Relation Text (Head - Tail)
0.9996 Adverse-Effect CONCLUSIONS : This is the first report of a possible interaction between propafenone and Drugcitalopram , which caused propafenone adverse effects ( eg, Adverse-Effectdizziness , falls ) and mimicked coronary artery disease.
0.9994 Adverse-Effect CONCLUSIONS : This is the first report of a possible interaction between Drugpropafenone and citalopram, which caused propafenone adverse effects ( eg, Adverse-Effectdizziness , falls ) and mimicked coronary artery disease.
0.9993 Adverse-Effect CONCLUSIONS : This is the first report of a possible interaction between propafenone and Drugcitalopram , which caused propafenone adverse effects ( eg, dizziness, Adverse-Effectfalls ) and mimicked coronary artery disease.
0.9990 Adverse-Effect CONCLUSIONS : This is the first report of a possible interaction between Drugpropafenone and citalopram, which caused propafenone adverse effects ( eg, dizziness, Adverse-Effectfalls ) and mimicked coronary artery disease.
0.9989 Adverse-Effect CONCLUSIONS : This is the first report of a possible interaction between propafenone and Drugcitalopram , which caused propafenone adverse effects ( eg, dizziness, falls ) and mimicked Adverse-Effectcoronary artery disease .
0.9984 Adverse-Effect CONCLUSIONS : This is the first report of a possible interaction between Drugpropafenone and citalopram, which caused propafenone adverse effects ( eg, dizziness, falls ) and mimicked Adverse-Effectcoronary artery disease .
0.9998 Adverse-Effect CONCLUSIONS : This is the first report of a possible interaction between propafenone and citalopram, which caused Drugpropafenone adverse effects ( Adverse-Effecteg , dizziness, falls ) and mimicked coronary artery disease.
0.9997 Adverse-Effect CONCLUSIONS : This is the first report of a possible interaction between propafenone and Drugcitalopram , which caused propafenone adverse effects ( Adverse-Effecteg , dizziness, falls ) and mimicked coronary artery disease.
0.9996 Adverse-Effect CONCLUSIONS : This is the first report of a possible interaction between propafenone and citalopram, which caused Drugpropafenone adverse effects ( eg, Adverse-Effectdizziness , falls ) and mimicked coronary artery disease.
0.9995 Adverse-Effect CONCLUSIONS : This is the first report of a possible interaction between Drugpropafenone and citalopram, which caused propafenone adverse effects ( Adverse-Effecteg , dizziness, falls ) and mimicked coronary artery disease.
0.9993 Adverse-Effect CONCLUSIONS : This is the first report of a possible interaction between propafenone and citalopram, which caused Drugpropafenone adverse effects ( eg, dizziness, Adverse-Effectfalls ) and mimicked coronary artery disease.
0.9991 Adverse-Effect CONCLUSIONS : This is the first report of a possible interaction between propafenone and citalopram, which caused Drugpropafenone adverse effects ( eg, dizziness, falls ) and mimicked Adverse-Effectcoronary artery disease .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 61 - year - old man developed clinical lupus syndrome with positive antinuclear antibody, positive lupus erythematosus ( LE ) cell preparation, and Adverse-Effectdiffuse proliferative glomerulonephritis following 26 months of Drugprocainamide therapy.
1.0000 Adverse-Effect A 61 - year - old man developed Adverse-Effectclinical lupus syndrome with positive antinuclear antibody, positive lupus erythematosus ( LE ) cell preparation, and diffuse proliferative glomerulonephritis following 26 months of Drugprocainamide therapy.
1.0000 Adverse-Effect A 61 - year - old man developed clinical lupus syndrome with positive antinuclear antibody, Adverse-Effectpositive lupus erythematosus ( LE ) cell preparation, and diffuse proliferative glomerulonephritis following 26 months of Drugprocainamide therapy.
0.9999 Adverse-Effect A 61 - year - old man developed clinical lupus syndrome with Adverse-Effectpositive antinuclear antibody , positive lupus erythematosus ( LE ) cell preparation, and diffuse proliferative glomerulonephritis following 26 months of Drugprocainamide therapy.
0.9999 Adverse-Effect A 61 - year - old man developed clinical lupus syndrome with positive antinuclear antibody, positive lupus erythematosus ( Adverse-EffectLE ) cell preparation , and diffuse proliferative glomerulonephritis following 26 months of Drugprocainamide therapy.
Adverse-Effect A 61 - year - old man developed clinical lupus syndrome with positive antinuclear antibody, positive Adverse-Effectlupus erythematosus ( LE ) cell preparation, and diffuse proliferative glomerulonephritis following 26 months of Drugprocainamide therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This report describes a case of Drugflucytosine - associated Adverse-Effectulcerating enteritis in which the small bowel x - ray demonstrated severe luminal narrowing, ulceration, and marked separation of loops of bowel.
0.9999 Adverse-Effect This report describes a case of Drugflucytosine - associated ulcerating enteritis in which the small bowel x - ray demonstrated severe luminal narrowing, Adverse-Effectulceration , and marked separation of loops of bowel.
0.9999 Adverse-Effect This report describes a case of Drugflucytosine - associated ulcerating enteritis in which the small bowel x - ray demonstrated Adverse-Effectsevere luminal narrowing , ulceration, and marked separation of loops of bowel.
0.9998 Adverse-Effect This report describes a case of Drugflucytosine - associated ulcerating enteritis in which the small bowel x - ray demonstrated severe luminal narrowing, ulceration, and Adverse-Effectmarked separation of loops of bowel .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The Adverse-Effectpro - arrhythmic effects of Drugprocainamide may be explained on the basis of both its vagolytic action on the atrioventricular node as well as by prolongation of refractoriness in the accessory pathway.
0.9999 Adverse-Effect The pro - arrhythmic effects of Drugprocainamide may be explained on the basis of both its vagolytic action on the atrioventricular node as well as by Adverse-Effectprolongation of refractoriness in the accessory pathway .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect When Drugpilsicainide is prescribed in patients with coronary artery disease or renal dysfunction, close attention must be paid to avoid Adverse-Effectlife - threatening arrhythmias due to high plasma concentrations of the drug.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Sodium valproate and Drugcarbamazepine , antiepileptic drugs that are associated with a relatively low rate of adverse cutaneous reactions, should be added to the growing list of drugs that produce Adverse-Effectpsoriasiform eruptions .
0.9997 Adverse-Effect DrugSodium valproate and carbamazepine, antiepileptic drugs that are associated with a relatively low rate of adverse cutaneous reactions, should be added to the growing list of drugs that produce Adverse-Effectpsoriasiform eruptions .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectFatal pulmonary fibrosis associated with DrugBCNU : the relative role of platelet - derived growth factor - B, insulin - like growth factor I, transforming growth factor - beta1 and cyclooxygenase - 2.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the development of Adverse-Effectscrotal ulcer in a patient with acute promyleocytic leukemia ( APL ) within 10 days of treatment with DrugATRA at a dose of 40 mg orally twice daily.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a patient with pulmonary adenocarcinoma complicated by the syndrome of inappropriate secretion of antidiuretic hormone ( Adverse-EffectSIADH ) following systemic chemotherapy with Drugcisplatin ( CDDP ) and vindesine ( VDS ).
1.0000 Adverse-Effect We report a patient with pulmonary adenocarcinoma complicated by the syndrome of inappropriate secretion of antidiuretic hormone ( Adverse-EffectSIADH ) following systemic chemotherapy with cisplatin ( DrugCDDP ) and vindesine ( VDS ).
1.0000 Adverse-Effect We report a patient with pulmonary adenocarcinoma complicated by the Adverse-Effectsyndrome of inappropriate secretion of antidiuretic hormone ( SIADH ) following systemic chemotherapy with Drugcisplatin ( CDDP ) and vindesine ( VDS ).
1.0000 Adverse-Effect We report a patient with pulmonary adenocarcinoma complicated by the syndrome of inappropriate secretion of antidiuretic hormone ( Adverse-EffectSIADH ) following systemic chemotherapy with cisplatin ( CDDP ) and Drugvindesine ( VDS ).
1.0000 Adverse-Effect We report a patient with pulmonary adenocarcinoma complicated by the syndrome of inappropriate secretion of antidiuretic hormone ( Adverse-EffectSIADH ) following systemic chemotherapy with cisplatin ( CDDP ) and vindesine ( DrugVDS ).
0.9999 Adverse-Effect We report a patient with pulmonary adenocarcinoma complicated by the Adverse-Effectsyndrome of inappropriate secretion of antidiuretic hormone ( SIADH ) following systemic chemotherapy with cisplatin ( DrugCDDP ) and vindesine ( VDS ).
0.9999 Adverse-Effect We report a patient with pulmonary adenocarcinoma complicated by the Adverse-Effectsyndrome of inappropriate secretion of antidiuretic hormone ( SIADH ) following systemic chemotherapy with cisplatin ( CDDP ) and Drugvindesine ( VDS ).
0.9999 Adverse-Effect We report a patient with pulmonary adenocarcinoma complicated by the Adverse-Effectsyndrome of inappropriate secretion of antidiuretic hormone ( SIADH ) following systemic chemotherapy with cisplatin ( CDDP ) and vindesine ( DrugVDS ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 60 - year - old white man with chronic bronchitis was noted to develop acute respiratory failure and Adverse-Effectmetabolic acidosis four days after being started on Drugmethazolamide ( Neptazane ) for an ophthalmologic problem.
1.0000 Adverse-Effect A 60 - year - old white man with chronic bronchitis was noted to develop acute respiratory failure and Adverse-Effectmetabolic acidosis four days after being started on methazolamide ( DrugNeptazane ) for an ophthalmologic problem.
1.0000 Adverse-Effect A 60 - year - old white man with chronic bronchitis was noted to develop Adverse-Effectacute respiratory failure and metabolic acidosis four days after being started on Drugmethazolamide ( Neptazane ) for an ophthalmologic problem.
0.9999 Adverse-Effect A 60 - year - old white man with chronic bronchitis was noted to develop Adverse-Effectacute respiratory failure and metabolic acidosis four days after being started on methazolamide ( DrugNeptazane ) for an ophthalmologic problem.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect METHODS : A 76 - year - old woman with primary open - angle glaucoma and no history of ocular surgery developed a Adverse-Effectchoroidal detachment 12 hours after initiation of therapy with Drugdorzolamide eye drops.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This case report describes an adolescent with Adverse-Effectsevere lupus erythematosus who received Drugcyclophosphamide ( CY ) paired with taste ( cod liver oil ) and smell ( rose perfume ) as conditioned stimuli.
0.9999 Adverse-Effect This case report describes an adolescent with Adverse-Effectsevere lupus erythematosus who received cyclophosphamide ( DrugCY ) paired with taste ( cod liver oil ) and smell ( rose perfume ) as conditioned stimuli.
1.0000 Adverse-Effect This case report describes an adolescent with severe Adverse-Effectlupus erythematosus who received Drugcyclophosphamide ( CY ) paired with taste ( cod liver oil ) and smell ( rose perfume ) as conditioned stimuli.
0.9999 Adverse-Effect This case report describes an adolescent with severe Adverse-Effectlupus erythematosus who received cyclophosphamide ( DrugCY ) paired with taste ( cod liver oil ) and smell ( rose perfume ) as conditioned stimuli.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectARDS has been associated with the administration of other monoclonal antibodies, such as Druginfliximab , gemtuzumab ozogamicin, and OKT3 and is believed to be directly mediated by release of proinflammatory cytokines.
0.9999 Adverse-Effect Adverse-EffectARDS has been associated with the administration of other monoclonal antibodies, such as infliximab, Druggemtuzumab ozogamicin , and OKT3 and is believed to be directly mediated by release of proinflammatory cytokines.
0.9999 Adverse-Effect Adverse-EffectARDS has been associated with the administration of other monoclonal antibodies, such as infliximab, gemtuzumab ozogamicin, and DrugOKT3 and is believed to be directly mediated by release of proinflammatory cytokines.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Well - differentiated Adverse-Effectendometrial adenocarcinoma of the secretory type ( FIGO Grade 1 ) with minimal myometrial invasion occurred in a postmenopausal patient on Drugtamoxifen therapy 5 years after mastectomy for breast carcinoma.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case of Adverse-Effectsevere acute hepatitis caused by Drugcyproterone acetate in a 71 year old man with prostatic carcinoma is reported with a review of the literature on hepatic reactions to this drug.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the case of an 11 - year - old female treated for mediastinal T - cell lymphoma who presented Adverse-Effectrenal failure following the second cycle of high - dose Drugmethotrexate ( HDMTX ).
1.0000 Adverse-Effect We report the case of an 11 - year - old female treated for mediastinal T - cell lymphoma who presented Adverse-Effectrenal failure following the second cycle of high - dose methotrexate ( DrugHDMTX ).
Score Relation Text (Head - Tail)
0.9986 Adverse-Effect Since Drugethambutol is actively excreted via the renal system, compromise of renal function such as due to renal tuberculosis may lead to serum concentration elevations of ethambutol sufficient to produce Adverse-Effectoptic neuropathy .
0.9999 Adverse-Effect Since ethambutol is actively excreted via the renal system, compromise of renal function such as due to renal tuberculosis may lead to serum concentration elevations of Drugethambutol sufficient to produce Adverse-Effectoptic neuropathy .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Autopsy evidence of Adverse-Effectherpesvirus infection was found in visceral organs of four leukemic patients who had received large doses of Drugcytarabine ( cytosine arabinoside ; Ara - C ) shortly before their death.
0.9999 Adverse-Effect Autopsy evidence of Adverse-Effectherpesvirus infection was found in visceral organs of four leukemic patients who had received large doses of cytarabine ( Drugcytosine arabinoside ; Ara - C ) shortly before their death.
0.9999 Adverse-Effect Autopsy evidence of Adverse-Effectherpesvirus infection was found in visceral organs of four leukemic patients who had received large doses of cytarabine ( cytosine arabinoside ; DrugAra - C ) shortly before their death.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report three patients, all of whom had preexisting diabetic dyslipidemia, who showed a profound Adverse-Effectreduction in plasma HDL cholesterol and apolipoprotein AI levels soon after the initiation of Drugrosiglitazone therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report marked QT prolongation and torsades de pointes in a setting of flash pulmonary edema resulting from Adverse-Effectacute myocardial ischemia in a patient who was being treated with Drugdofetilide for atrial fibrillation.
0.9999 Adverse-Effect We report marked QT prolongation and torsades de pointes in a setting of Adverse-Effectflash pulmonary edema resulting from acute myocardial ischemia in a patient who was being treated with Drugdofetilide for atrial fibrillation.
0.9999 Adverse-Effect We report marked QT prolongation and Adverse-Effecttorsades de pointes in a setting of flash pulmonary edema resulting from acute myocardial ischemia in a patient who was being treated with Drugdofetilide for atrial fibrillation.
0.9999 Adverse-Effect We report marked Adverse-EffectQT prolongation and torsades de pointes in a setting of flash pulmonary edema resulting from acute myocardial ischemia in a patient who was being treated with Drugdofetilide for atrial fibrillation.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : Clinicians should be aware of a risk of serotonin syndrome with serious Adverse-Effectextrapyramidal reactions in patients receiving Drugsertraline or venlafaxine when metoclopramide is coadministered even in a single, conventional dose.
0.9999 Adverse-Effect CONCLUSIONS : Clinicians should be aware of a risk of serotonin syndrome with serious Adverse-Effectextrapyramidal reactions in patients receiving sertraline or Drugvenlafaxine when metoclopramide is coadministered even in a single, conventional dose.
0.9998 Adverse-Effect CONCLUSIONS : Clinicians should be aware of a risk of Adverse-Effectserotonin syndrome with serious extrapyramidal reactions in patients receiving Drugsertraline or venlafaxine when metoclopramide is coadministered even in a single, conventional dose.
0.9998 Adverse-Effect CONCLUSIONS : Clinicians should be aware of a risk of serotonin syndrome with serious Adverse-Effectextrapyramidal reactions in patients receiving sertraline or venlafaxine when Drugmetoclopramide is coadministered even in a single, conventional dose.
0.9995 Adverse-Effect CONCLUSIONS : Clinicians should be aware of a risk of Adverse-Effectserotonin syndrome with serious extrapyramidal reactions in patients receiving sertraline or Drugvenlafaxine when metoclopramide is coadministered even in a single, conventional dose.
0.9993 Adverse-Effect CONCLUSIONS : Clinicians should be aware of a risk of Adverse-Effectserotonin syndrome with serious extrapyramidal reactions in patients receiving sertraline or venlafaxine when Drugmetoclopramide is coadministered even in a single, conventional dose.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Although both patients recovered from the colitis after the administration of vancomycin, the first case demonstrated a relapse of the Adverse-Effectcolitis after receiving a subsequent course of the same chemotherapy with Drugcisplatin .
0.9993 Adverse-Effect Although both patients recovered from the colitis after the administration of Drugvancomycin , the first case demonstrated a relapse of the Adverse-Effectcolitis after receiving a subsequent course of the same chemotherapy with cisplatin.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Three nephrotic patients who had reduced renal function and active renal disease with progressive deterioration of renal function prior to the use of MP developed Adverse-Effecttransient renal failure following an DrugMP pulse therapy.
0.9999 Adverse-Effect Three nephrotic patients who had reduced renal function and active renal disease with progressive deterioration of renal function prior to the use of DrugMP developed Adverse-Effecttransient renal failure following an MP pulse therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We discuss a patient who developed Adverse-Effectsevere renal tubular dysfunction secondary to short - term therapy with DrugAmikacin , resulting in refractory hypokalemia, hypocalcemia, hypomagnesemia, metabolic alkalosis, and polyuria.
1.0000 Adverse-Effect We discuss a patient who developed severe renal tubular dysfunction secondary to short - term therapy with DrugAmikacin , resulting in Adverse-Effectrefractory hypokalemia , hypocalcemia, hypomagnesemia, metabolic alkalosis, and polyuria.
0.9999 Adverse-Effect We discuss a patient who developed severe renal tubular dysfunction secondary to short - term therapy with DrugAmikacin , resulting in refractory hypokalemia, Adverse-Effecthypocalcemia , hypomagnesemia, metabolic alkalosis, and polyuria.
0.9999 Adverse-Effect We discuss a patient who developed severe renal tubular dysfunction secondary to short - term therapy with DrugAmikacin , resulting in refractory hypokalemia, hypocalcemia, hypomagnesemia, metabolic alkalosis, and Adverse-Effectpolyuria .
0.9999 Adverse-Effect We discuss a patient who developed severe renal tubular dysfunction secondary to short - term therapy with DrugAmikacin , resulting in refractory hypokalemia, hypocalcemia, Adverse-Effecthypomagnesemia , metabolic alkalosis, and polyuria.
0.9999 Adverse-Effect We discuss a patient who developed severe renal tubular dysfunction secondary to short - term therapy with DrugAmikacin , resulting in refractory hypokalemia, hypocalcemia, hypomagnesemia, Adverse-Effectmetabolic alkalosis , and polyuria.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The most serious dental side effect of Drugbisphosphonate treatment ( particularly when it is administered intravenously ) is, paradoxically, Adverse-Effectosteonecrosis of the mandible or the maxilla represented by exposed nonhealing bone.
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect DrugThrombin is highly effective for stopping intractable arterial hemorrhage during stereotactic brain biopsy ; however, it is a vasospastic agent and may have been responsible for the Adverse-Effectcerebral infarctions in one patient.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We suggest that Adverse-Effectsarcoidosis may develop in chronic hepatitis C patients during Druginterferon alpha and / or ribavirin treatment, and diagnostic tests for this adverse effect should be performed during the follow - ups.
0.9998 Adverse-Effect We suggest that Adverse-Effectsarcoidosis may develop in chronic hepatitis C patients during interferon alpha and / or Drugribavirin treatment, and diagnostic tests for this adverse effect should be performed during the follow - ups.
Score Relation Text (Head - Tail)
0.9985 Adverse-Effect We postulate that gastritis caused by dexamethasone, Adverse-Effectmucositis caused by Drugdoxorubicin , and the unique anatomic nature of a Meckel diverticulum may have contributed to this extremely unlikely and previously unreported event.
0.9816 Adverse-Effect We postulate that Adverse-Effectgastritis caused by Drugdexamethasone , mucositis caused by doxorubicin, and the unique anatomic nature of a Meckel diverticulum may have contributed to this extremely unlikely and previously unreported event.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We present two cases of Drugnitrofurantoin - induced Adverse-Effectpulmonary toxicity in which the initial HRCT showed a widespread reticular pattern and associated distortion of the lung parenchyma, thought to represent established fibrosis.
0.9998 Adverse-Effect We present two cases of Drugnitrofurantoin - induced pulmonary toxicity in which the initial HRCT showed a widespread reticular pattern and associated Adverse-Effectdistortion of the lung parenchyma , thought to represent established fibrosis.
0.9998 Adverse-Effect We present two cases of Drugnitrofurantoin - induced pulmonary toxicity in which the initial HRCT showed a Adverse-Effectwidespread reticular pattern and associated distortion of the lung parenchyma, thought to represent established fibrosis.
0.9997 Adverse-Effect We present two cases of Drugnitrofurantoin - induced pulmonary toxicity in which the initial HRCT showed a widespread reticular pattern and associated distortion of the lung parenchyma, thought to represent established Adverse-Effectfibrosis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To describe a case of exacerbated Adverse-Effectmania potentially related to an interaction between Druglopinavir / ritonavir and valproic acid ( VPA ) and propose a mechanism of action for this interaction.
1.0000 Adverse-Effect OBJECTIVE : To describe a case of exacerbated Adverse-Effectmania potentially related to an interaction between lopinavir / Drugritonavir and valproic acid ( VPA ) and propose a mechanism of action for this interaction.
1.0000 Adverse-Effect OBJECTIVE : To describe a case of exacerbated Adverse-Effectmania potentially related to an interaction between lopinavir / ritonavir and valproic acid ( DrugVPA ) and propose a mechanism of action for this interaction.
0.9999 Adverse-Effect OBJECTIVE : To describe a case of exacerbated Adverse-Effectmania potentially related to an interaction between lopinavir / ritonavir and Drugvalproic acid ( VPA ) and propose a mechanism of action for this interaction.
Score Relation Text (Head - Tail)
0.9996 Adverse-Effect Adverse-EffectTranstubular potassium gradient ( TTKG ) also decreased and an inverse correlation was found between TTKG and doses of Drugphosphate ( r = - 0. 37 ; p < 0. 02 ; N = 38 ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The first known report of Drugquetiapine Adverse-Effectexacerbating OCS in a 43 - year - old man with obsessive - compulsive disorder ( OCD ), trichotillomania, delusional disorder and bipolar II disorder is presented.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect METHODS : A 79 - year - old woman being treated with Drugimiquimod 5 days per week for a nodular basal cell developed a Adverse-Effectverrucous plaque over the treatment area after 7 weeks of therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CASE SUMMARY : A 57 - year - old female with cardiomyopathy and " sulfa " ( trimethoprim / sulfamethoxazole ) allergy documented as pancreatitis presented with symptoms consistent with Adverse-Effectpancreatitis after use of Drugfurosemide .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We thus concluded that an excessive dose of DrugAZ had probably Adverse-Effectdestroyed the gastric mucosal barrier or thrombocytopenia due to bone marrow disorder and thus eventually led to the development of hemorrhagic gastritis.
0.9999 Adverse-Effect We thus concluded that an excessive dose of DrugAZ had probably destroyed the gastric mucosal barrier or thrombocytopenia due to bone marrow disorder and thus eventually led to the development of Adverse-Effecthemorrhagic gastritis .
0.9997 Adverse-Effect We thus concluded that an excessive dose of DrugAZ had probably destroyed the gastric mucosal barrier or Adverse-Effectthrombocytopenia due to bone marrow disorder and thus eventually led to the development of hemorrhagic gastritis.
Adverse-Effect We thus concluded that an excessive dose of DrugAZ had probably destroyed the gastric mucosal barrier or Adverse-Effectthrombocytopenia due to bone marrow disorder and thus eventually led to the development of hemorrhagic gastritis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In this article, we present the case of a vitiligo patient who was admitted to our facility with an Adverse-Effectintense burn after the topical use of Drug8 - methoxypsoralen solution as a suntanning agent.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 36 - year - old man being treated with cisplatinum, vinblastine, and Drugbleomycin for testicular carcinoma developed a dense Adverse-Effectleft homonymous hemianopsia , encephalopathy, and a partial nondominant parietal lobe syndrome.
0.9999 Adverse-Effect A 36 - year - old man being treated with cisplatinum, vinblastine, and Drugbleomycin for testicular carcinoma developed a dense left homonymous hemianopsia, Adverse-Effectencephalopathy , and a partial nondominant parietal lobe syndrome.
0.9999 Adverse-Effect A 36 - year - old man being treated with cisplatinum, vinblastine, and Drugbleomycin for testicular carcinoma developed a dense left homonymous hemianopsia, encephalopathy, and a Adverse-Effectpartial nondominant parietal lobe syndrome .
0.9999 Adverse-Effect A 36 - year - old man being treated with cisplatinum, Drugvinblastine , and bleomycin for testicular carcinoma developed a dense Adverse-Effectleft homonymous hemianopsia , encephalopathy, and a partial nondominant parietal lobe syndrome.
0.9998 Adverse-Effect A 36 - year - old man being treated with Drugcisplatinum , vinblastine, and bleomycin for testicular carcinoma developed a dense Adverse-Effectleft homonymous hemianopsia , encephalopathy, and a partial nondominant parietal lobe syndrome.
0.9998 Adverse-Effect A 36 - year - old man being treated with cisplatinum, Drugvinblastine , and bleomycin for testicular carcinoma developed a dense left homonymous hemianopsia, Adverse-Effectencephalopathy , and a partial nondominant parietal lobe syndrome.
0.9997 Adverse-Effect A 36 - year - old man being treated with Drugcisplatinum , vinblastine, and bleomycin for testicular carcinoma developed a dense left homonymous hemianopsia, Adverse-Effectencephalopathy , and a partial nondominant parietal lobe syndrome.
0.9997 Adverse-Effect A 36 - year - old man being treated with cisplatinum, Drugvinblastine , and bleomycin for testicular carcinoma developed a dense left homonymous hemianopsia, encephalopathy, and a Adverse-Effectpartial nondominant parietal lobe syndrome .
0.9996 Adverse-Effect A 36 - year - old man being treated with Drugcisplatinum , vinblastine, and bleomycin for testicular carcinoma developed a dense left homonymous hemianopsia, encephalopathy, and a Adverse-Effectpartial nondominant parietal lobe syndrome .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CASE SUMMARIES : In each case, the patients were treated over 5 years with Druglovastatin and developed Adverse-Effectrhabdomyolysis that coincided with the completion of a prescribed regimen of a newer macrolide antibiotic.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Retinal abnormalities, including retinal hemorrhage and Adverse-Effect" cotton - wool " spots , often occur within the first 8 weeks in the course of Druginterferon therapy in patients with chronic hepatitis C.
0.9999 Adverse-Effect Retinal abnormalities, including Adverse-Effectretinal hemorrhage and " cotton - wool " spots, often occur within the first 8 weeks in the course of Druginterferon therapy in patients with chronic hepatitis C.
0.9999 Adverse-Effect Adverse-EffectRetinal abnormalities , including retinal hemorrhage and " cotton - wool " spots, often occur within the first 8 weeks in the course of Druginterferon therapy in patients with chronic hepatitis C.
1.0000 Adverse-Effect Retinal abnormalities, including retinal hemorrhage and " Adverse-Effectcotton - wool " spots , often occur within the first 8 weeks in the course of Druginterferon therapy in patients with chronic hepatitis C.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect To date, only three cases of Adverse-Effectseizures associated with Drugamphotericin B have been reported in the literature, but healthcare providers should be aware of the potential for this rare adverse effect.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Zolpidem ( DrugAmbien ), a relatively new nonbenzodiazepine sedative - hypnotic, was involved in the Adverse-Effectdeath of a 39 - year - old obese male who was being treated for depression and insomnia.
1.0000 Adverse-Effect DrugZolpidem ( Ambien ), a relatively new nonbenzodiazepine sedative - hypnotic, was involved in the Adverse-Effectdeath of a 39 - year - old obese male who was being treated for depression and insomnia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 45 - year - old woman with steroid - dependent Crohn's colitis, successfully managed with maintenance infliximab infusions and Drugmethotrexate , developed a Adverse-Effectlupus - like syndrome eight months after her initial infusion.
0.9996 Adverse-Effect A 45 - year - old woman with steroid - dependent Crohn's colitis, successfully managed with maintenance Druginfliximab infusions and methotrexate, developed a Adverse-Effectlupus - like syndrome eight months after her initial infusion.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Although there have been numerous reports of effusions, none have provided complete pleural fluid analysis ; therefore, we report 2 patients with Drugdasatinib - induced Adverse-Effectpleural effusion with complete pleural fluid analysis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 53 year old Greenlandic male was admitted twice over a period of 4 years with a new complete Adverse-Effectright bundle branch block after ingestion of 10 g and 4 g of Drugcarbamazepine respectively.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 65 - year - old female patient presented with jaundice followed 2 days later by severe dyspnea and Adverse-Effecttachypnea which worsened when patient was lying flat, 1 week after the fourth dose of Drugadalimumab .
0.9999 Adverse-Effect A 65 - year - old female patient presented with Adverse-Effectjaundice followed 2 days later by severe dyspnea and tachypnea which worsened when patient was lying flat, 1 week after the fourth dose of Drugadalimumab .
0.9999 Adverse-Effect A 65 - year - old female patient presented with jaundice followed 2 days later by Adverse-Effectsevere dyspnea and tachypnea which worsened when patient was lying flat, 1 week after the fourth dose of Drugadalimumab .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CASE PRESENTATION : We report a patient with CF who developed recurrent eosinophilia and Adverse-Effectsevere persistent bronchospasm following repeated administration of preservative - free Drugtobramycin by inhalation, beginning at 16 months of age.
1.0000 Adverse-Effect CASE PRESENTATION : We report a patient with CF who developed Adverse-Effectrecurrent eosinophilia and severe persistent bronchospasm following repeated administration of preservative - free Drugtobramycin by inhalation, beginning at 16 months of age.
Score Relation Text (Head - Tail)
0.9989 Adverse-Effect Three patients with Drugniacin - induced Adverse-Effectvisual symptoms had cystoid maculopathy without leakage on fluorescein angiography, and a fourth patient with no fundus abnormality experienced cessation of visual symptoms upon discontinuation of niacin.
0.9901 Adverse-Effect Three patients with niacin - induced visual symptoms had cystoid maculopathy without leakage on fluorescein angiography, and a fourth patient with no fundus abnormality experienced cessation of Adverse-Effectvisual symptoms upon discontinuation of Drugniacin .
0.9279 Adverse-Effect Three patients with Drugniacin - induced visual symptoms had Adverse-Effectcystoid maculopathy without leakage on fluorescein angiography, and a fourth patient with no fundus abnormality experienced cessation of visual symptoms upon discontinuation of niacin.
0.9295 Adverse-Effect Three patients with niacin - induced visual symptoms had Adverse-Effectcystoid maculopathy without leakage on Drugfluorescein angiography, and a fourth patient with no fundus abnormality experienced cessation of visual symptoms upon discontinuation of niacin.
0.6200 Adverse-Effect Three patients with niacin - induced Adverse-Effectvisual symptoms had cystoid maculopathy without leakage on Drugfluorescein angiography, and a fourth patient with no fundus abnormality experienced cessation of visual symptoms upon discontinuation of niacin.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect After an extensive review of the literature, we believe that this is the first communication of the successful use of amiodarone to control hyperthyroidism in a patient with DrugPTU - induced Adverse-Effectfulminant hepatitis .
0.9065 Adverse-Effect After an extensive review of the literature, we believe that this is the first communication of the successful use of Drugamiodarone to control hyperthyroidism in a patient with PTU - induced Adverse-Effectfulminant hepatitis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The authors present a case study of a mentally healthy man who repeatedly experienced short - lived, Adverse-Effectobsessional - like suicidal ideas and images after ingestion of the anti - fungal drug Drugketoconazole .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 50 - year - old diabetic and hypertensive male patient is reported who had Drugticlopidine - induced Adverse-Effectmarrow aplasia partially responsive to colony - stimulating factors and corticosteroids, but experienced complete recovery with cyclosporine.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In this case report, we have described a patient with Crohn's disease who developed Adverse-Effectsubfulminant hepatitis B after the fourth infusion of Druginfliximab due to an unrecognized HBs - antigen carrier state.
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect Although Drugretinoic acid is well tolerated by the majority of patients with this disease, a potentially Adverse-Effectfatal complication of this kind of treatment has been reported : " the retinoic acid syndrome ".
0.9993 Adverse-Effect Although Drugretinoic acid is well tolerated by the majority of patients with this disease, a potentially fatal complication of this kind of treatment has been reported : " the Adverse-Effectretinoic acid syndrome ".
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Preliminary results suggest that the higher concentrations of Drugdextrose induce Adverse-Effectincreased histamine release from blood cells, and that this phenomenon is more marked in diabetic, and particularly diabetic - allergic, individuals.
Score Relation Text (Head - Tail)
0.9966 Adverse-Effect The literature is also reviewed for ARF associated with mannitol infusion in patients who received dialysis and those who did not receive dialysis ; and the possible mechanism ( s ) of Drugmannitol Adverse-Effectnephrotoxicity are discussed.
0.9954 Adverse-Effect The literature is also reviewed for Adverse-EffectARF associated with Drugmannitol infusion in patients who received dialysis and those who did not receive dialysis ; and the possible mechanism ( s ) of mannitol nephrotoxicity are discussed.
0.9860 Adverse-Effect The literature is also reviewed for ARF associated with mannitol infusion in patients who received dialysis and those who did not receive dialysis ; and the possible mechanism ( s ) of Drugmannitol Adverse-Effectmannitol nephrotoxicity are discussed.
Score Relation Text (Head - Tail)
0.9997 Adverse-Effect INTRODUCTION : We describe the neurointensive care ( NIC ) management of a patient with severe cerebral swelling and Adverse-Effectraised intracranial pressure ( ICP ) after severe Drugsodium valproic acid ( VPA ) intoxication.
0.9994 Adverse-Effect INTRODUCTION : We describe the neurointensive care ( NIC ) management of a patient with Adverse-Effectsevere cerebral swelling and raised intracranial pressure ( ICP ) after severe Drugsodium valproic acid ( VPA ) intoxication.
0.9984 Adverse-Effect INTRODUCTION : We describe the neurointensive care ( NIC ) management of a patient with severe cerebral swelling and Adverse-Effectraised intracranial pressure ( ICP ) after severe sodium valproic acid ( DrugVPA ) intoxication.
0.9980 Adverse-Effect INTRODUCTION : We describe the neurointensive care ( NIC ) management of a patient with Adverse-Effectsevere cerebral swelling and raised intracranial pressure ( ICP ) after severe sodium valproic acid ( DrugVPA ) intoxication.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Four years after the beginning of DrugIFN therapy, he acutely developed Adverse-Effectmoderate hyperglycemia and severe ketonuria with positive islet cell antibody, and then 28 units / day of insulin injection was started.
0.9997 Adverse-Effect Four years after the beginning of DrugIFN therapy, he acutely developed moderate hyperglycemia and Adverse-Effectsevere ketonuria with positive islet cell antibody, and then 28 units / day of insulin injection was started.
0.9998 Adverse-Effect Four years after the beginning of IFN therapy, he acutely developed moderate hyperglycemia and severe ketonuria with Adverse-Effectpositive islet cell antibody , and then 28 units / day of Druginsulin injection was started.
0.9997 Adverse-Effect Four years after the beginning of DrugIFN therapy, he acutely developed moderate hyperglycemia and severe ketonuria with Adverse-Effectpositive islet cell antibody , and then 28 units / day of insulin injection was started.
0.9990 Adverse-Effect Four years after the beginning of IFN therapy, he acutely developed moderate hyperglycemia and Adverse-Effectsevere ketonuria with positive islet cell antibody, and then 28 units / day of Druginsulin injection was started.
0.9989 Adverse-Effect Four years after the beginning of IFN therapy, he acutely developed Adverse-Effectmoderate hyperglycemia and severe ketonuria with positive islet cell antibody, and then 28 units / day of Druginsulin injection was started.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectARDS is rarely associated with Drugrituximab infusion for lympho - proliferative disorders, but it should be considered by those administering rituximab, especially when a patient develops severe pulmonary symptoms soon after infusion.
0.9995 Adverse-Effect ARDS is rarely associated with rituximab infusion for lympho - proliferative disorders, but it should be considered by those administering Drugrituximab , especially when a patient develops Adverse-Effectsevere pulmonary symptoms soon after infusion.
0.8815 Adverse-Effect Adverse-EffectARDS is rarely associated with rituximab infusion for lympho - proliferative disorders, but it should be considered by those administering Drugrituximab , especially when a patient develops severe pulmonary symptoms soon after infusion.
0.7604 Adverse-Effect ARDS is rarely associated with Drugrituximab infusion for lympho - proliferative disorders, but it should be considered by those administering rituximab, especially when a patient develops Adverse-Effectsevere pulmonary symptoms soon after infusion.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect However, a large case - control study included three cases of either Stevens - Johnson syndrome or Adverse-Effecttoxic epidermal necrolysis associated with Drugofloxacin use, but no details of the cases were given.
0.9999 Adverse-Effect However, a large case - control study included three cases of either Adverse-EffectStevens - Johnson syndrome or toxic epidermal necrolysis associated with Drugofloxacin use, but no details of the cases were given.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The reported case represents an unusual association between medication with the proton pump inhibitor Druglansoprazole and the development of Adverse-Effectcollagenous colitis suggesting the importance of evaluation of drug use in patients with microscopic colitis.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect This report details the pulmonary pathologic findings in four patients with rheumatoid arthritis, who developed new onset of Adverse-Effectpulmonary signs and symptoms with alveolar infiltrates temporally related to the institution of Drugetanercept therapy.
Adverse-Effect This report details the pulmonary pathologic findings in four patients with rheumatoid arthritis, who developed new onset of Adverse-Effectpulmonary signs and symptoms with alveolar infiltrates temporally related to the institution of Drugetanercept therapy.
Score Relation Text (Head - Tail)
0.9951 Adverse-Effect The former patient had complained once that his Adverse-Effectvisual acuity had decreased after the termination of DrugIFN therapy, and the latter patient complained twice during IFN therapy that his visual acuity had decreased.
0.9712 Adverse-Effect The former patient had complained once that his visual acuity had decreased after the termination of IFN therapy, and the latter patient complained twice during DrugIFN therapy that his Adverse-Effectvisual acuity had decreased .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CASE SUMMARY : A 39 - year - old white Jewish schizophrenic man treated with Drugolanzapine developed an Adverse-Effectelevated serum CK concentration with a peak concentration of 4000 IU / L ( normal < 230 ).
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect We are concerned that the Adverse-Effectmacular lesion was a retinal toxic effect of Druggentamicin because of the recent description of similar lesions occurring after the inadvertent intraocular injection of massive doses of this drug.
1.0000 Adverse-Effect We are concerned that the macular lesion was a Adverse-Effectretinal toxic effect of Druggentamicin because of the recent description of similar lesions occurring after the inadvertent intraocular injection of massive doses of this drug.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Seventy - four per cent of patients with epileptogenic disorders seen at the Emergency Unit at Groote Schuur Hospital were on Drugphenytoin and 11. 6 % of these had Adverse-Effectblood levels in the toxic range .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a case of Adverse-Effectpoisoning with Drug3, 4 - methylenedioxymet - amphetamine Ecstasy that presented with all the features suggestive of a fatal outcome, including a creatinine phosphokinase level markedly higher than any previously reported.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Total blindness with a transient tonic pupillary response, denervation supersensitivity, and Adverse-Effectabnormal visual - evoked potentials developed in a 54 - year - old man after the use of Drugquinine sulfate for leg cramps.
0.9997 Adverse-Effect Total blindness with a transient tonic pupillary response, Adverse-Effectdenervation supersensitivity , and abnormal visual - evoked potentials developed in a 54 - year - old man after the use of Drugquinine sulfate for leg cramps.
0.9997 Adverse-Effect Total blindness with a Adverse-Effecttransient tonic pupillary response , denervation supersensitivity, and abnormal visual - evoked potentials developed in a 54 - year - old man after the use of Drugquinine sulfate for leg cramps.
0.9994 Adverse-Effect Adverse-EffectTotal blindness with a transient tonic pupillary response, denervation supersensitivity, and abnormal visual - evoked potentials developed in a 54 - year - old man after the use of Drugquinine sulfate for leg cramps.
Adverse-Effect Adverse-EffectTotal blindness with a transient tonic pupillary response , denervation supersensitivity, and abnormal visual - evoked potentials developed in a 54 - year - old man after the use of Drugquinine sulfate for leg cramps.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the case of a patient who developed polyserositis ( pericardial effusion, pleural effusion, and Adverse-Effectpericarditis ) after being started on Drugclozapine , and whose symptoms remitted upon discontinuation of clozapine.
0.9999 Adverse-Effect We report the case of a patient who developed polyserositis ( pericardial effusion, pleural effusion, and Adverse-Effectpericarditis ) after being started on clozapine, and whose symptoms remitted upon discontinuation of Drugclozapine .
0.9998 Adverse-Effect We report the case of a patient who developed Adverse-Effectpolyserositis ( pericardial effusion, pleural effusion, and pericarditis ) after being started on Drugclozapine , and whose symptoms remitted upon discontinuation of clozapine.
0.9998 Adverse-Effect We report the case of a patient who developed polyserositis ( pericardial effusion, Adverse-Effectpleural effusion , and pericarditis ) after being started on Drugclozapine , and whose symptoms remitted upon discontinuation of clozapine.
0.9998 Adverse-Effect We report the case of a patient who developed polyserositis ( Adverse-Effectpericardial effusion , pleural effusion, and pericarditis ) after being started on Drugclozapine , and whose symptoms remitted upon discontinuation of clozapine.
0.9995 Adverse-Effect We report the case of a patient who developed Adverse-Effectpolyserositis ( pericardial effusion, pleural effusion, and pericarditis ) after being started on clozapine, and whose symptoms remitted upon discontinuation of Drugclozapine .
0.9995 Adverse-Effect We report the case of a patient who developed polyserositis ( pericardial effusion, Adverse-Effectpleural effusion , and pericarditis ) after being started on clozapine, and whose symptoms remitted upon discontinuation of Drugclozapine .
0.9994 Adverse-Effect We report the case of a patient who developed polyserositis ( Adverse-Effectpericardial effusion , pleural effusion, and pericarditis ) after being started on clozapine, and whose symptoms remitted upon discontinuation of Drugclozapine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This article reports the case of an otherwise healthy patient who experienced permanent Adverse-Effectsensorineural hearing loss after a brief course of Drugnaproxen and reviews the literature on NSAID - related permanent sensorineural hearing loss.
0.9962 Adverse-Effect This article reports the case of an otherwise healthy patient who experienced permanent sensorineural hearing loss after a brief course of Drugnaproxen and reviews the literature on NSAID - related permanent Adverse-Effectsensorineural hearing loss .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectHypo - oestrogenic and anabolic / androgenic side - effects of Drugdanazol are well known by the gynaecologist and some of them are present in > 50 % of patients being treated for endometriosis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 7 - year - old with congenital toxoplasmosis who took pyrimethamine and Drugsulfadiazine for reactivated chorioretinitis developed Adverse-Effectfever , severe cutaneous involvement, swelling, abdominal pain and transaminitis, persisting weeks after withholding medicines.
1.0000 Adverse-Effect A 7 - year - old with congenital toxoplasmosis who took pyrimethamine and Drugsulfadiazine for reactivated chorioretinitis developed fever, severe cutaneous involvement, swelling, Adverse-Effectabdominal pain and transaminitis, persisting weeks after withholding medicines.
1.0000 Adverse-Effect A 7 - year - old with congenital toxoplasmosis who took pyrimethamine and Drugsulfadiazine for reactivated chorioretinitis developed fever, severe cutaneous involvement, Adverse-Effectswelling , abdominal pain and transaminitis, persisting weeks after withholding medicines.
1.0000 Adverse-Effect A 7 - year - old with congenital toxoplasmosis who took pyrimethamine and Drugsulfadiazine for reactivated chorioretinitis developed fever, Adverse-Effectsevere cutaneous involvement , swelling, abdominal pain and transaminitis, persisting weeks after withholding medicines.
1.0000 Adverse-Effect A 7 - year - old with congenital toxoplasmosis who took pyrimethamine and Drugsulfadiazine for reactivated chorioretinitis developed fever, severe cutaneous involvement, swelling, abdominal pain and Adverse-Effecttransaminitis , persisting weeks after withholding medicines.
0.9999 Adverse-Effect A 7 - year - old with congenital toxoplasmosis who took Drugpyrimethamine and sulfadiazine for reactivated chorioretinitis developed Adverse-Effectfever , severe cutaneous involvement, swelling, abdominal pain and transaminitis, persisting weeks after withholding medicines.
0.9999 Adverse-Effect A 7 - year - old with congenital toxoplasmosis who took Drugpyrimethamine and sulfadiazine for reactivated chorioretinitis developed fever, severe cutaneous involvement, swelling, Adverse-Effectabdominal pain and transaminitis, persisting weeks after withholding medicines.
0.9999 Adverse-Effect A 7 - year - old with congenital toxoplasmosis who took Drugpyrimethamine and sulfadiazine for reactivated chorioretinitis developed fever, severe cutaneous involvement, Adverse-Effectswelling , abdominal pain and transaminitis, persisting weeks after withholding medicines.
0.9999 Adverse-Effect A 7 - year - old with congenital toxoplasmosis who took Drugpyrimethamine and sulfadiazine for reactivated chorioretinitis developed fever, Adverse-Effectsevere cutaneous involvement , swelling, abdominal pain and transaminitis, persisting weeks after withholding medicines.
0.9999 Adverse-Effect A 7 - year - old with congenital toxoplasmosis who took Drugpyrimethamine and sulfadiazine for reactivated chorioretinitis developed fever, severe cutaneous involvement, swelling, abdominal pain and Adverse-Effecttransaminitis , persisting weeks after withholding medicines.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect The case reported here is of a child given a large dose of intravenous Drugiron sucrose ( 16 mg / kg ) over 3 hours, who subsequently developed features of Adverse-Effectsystemic iron toxicity .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The first patient was a 61 - year - old man with a 30 - year history of fistulizing CD in whom Adverse-EffectB - cell non - Hodgkin's lymphoma was diagnosed 9 months after treatment with Druginfliximab .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The authors report a case of focal myocardial necrosis, presenting clinically as an Adverse-Effectacute myocardial infarction during the administration of the antineoplastic drug, Drugamsacrine , in a patient without coronary artery disease.
1.0000 Adverse-Effect The authors report a case of Adverse-Effectfocal myocardial necrosis , presenting clinically as an acute myocardial infarction during the administration of the antineoplastic drug, Drugamsacrine , in a patient without coronary artery disease.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : The authors described a case of Druginterferon - induced Adverse-Effectpsychosis as a framework to review the literature and discuss the decision to pursue antiviral treatment in psychiatrically ill patients with hepatitis C.
Score Relation Text (Head - Tail)
0.9997 Adverse-Effect Although gabapentin withdrawal has been previously reported and usually consists of anxiety, diaphoresis, and palpitations, this is the first reported patient with generalized seizures and Adverse-Effectstatus epilepticus secondary to Druggabapentin withdrawal.
0.9995 Adverse-Effect Although Druggabapentin withdrawal has been previously reported and usually consists of Adverse-Effectanxiety , diaphoresis, and palpitations, this is the first reported patient with generalized seizures and status epilepticus secondary to gabapentin withdrawal.
0.9892 Adverse-Effect Although gabapentin withdrawal has been previously reported and usually consists of anxiety, diaphoresis, and palpitations, this is the first reported patient with Adverse-Effectgeneralized seizures and status epilepticus secondary to Druggabapentin withdrawal.
0.9793 Adverse-Effect Although Druggabapentin withdrawal has been previously reported and usually consists of anxiety, Adverse-Effectdiaphoresis , and palpitations, this is the first reported patient with generalized seizures and status epilepticus secondary to gabapentin withdrawal.
0.9128 Adverse-Effect Although Druggabapentin withdrawal has been previously reported and usually consists of anxiety, diaphoresis, and Adverse-Effectpalpitations , this is the first reported patient with generalized seizures and status epilepticus secondary to gabapentin withdrawal.
0.5342 Adverse-Effect Although Druggabapentin withdrawal has been previously reported and usually consists of anxiety, diaphoresis, and palpitations, this is the first reported patient with Adverse-Effectgeneralized seizures and status epilepticus secondary to gabapentin withdrawal.
Adverse-Effect Although Druggabapentin withdrawal has been previously reported and usually consists of anxiety, diaphoresis, and palpitations, this is the first reported patient with generalized seizures and Adverse-Effectstatus epilepticus secondary to gabapentin withdrawal.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The possibility of Adverse-Effectdeep vein thrombosis caused by the compression of the veins by necrotic tumor should be considered in patients with abdominal or pelvic metastases of GIST, including patients treated with Drugimatinib .
1.0000 Adverse-Effect The possibility of deep vein thrombosis caused by the Adverse-Effectcompression of the veins by necrotic tumor should be considered in patients with abdominal or pelvic metastases of GIST, including patients treated with Drugimatinib .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Though proteinuria and Adverse-Effectnephrotic syndrome is a rare adverse effect of DrugIFN - beta - 1b therapy, physicians treating MS patients with this agent should pay careful attention to new clinical symptoms and laboratory findings.
0.9998 Adverse-Effect Though Adverse-Effectproteinuria and nephrotic syndrome is a rare adverse effect of DrugIFN - beta - 1b therapy, physicians treating MS patients with this agent should pay careful attention to new clinical symptoms and laboratory findings.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Possible mechanisms by which Drugclonidine decreases spasticity are described, probable mechanisms of induced Adverse-Effectbradycardia are reviewed, and specific treatment recommendations for the use of clonidine in spinal cord injured patients are presented.
0.9997 Adverse-Effect Possible mechanisms by which clonidine decreases spasticity are described, probable mechanisms of induced Adverse-Effectbradycardia are reviewed, and specific treatment recommendations for the use of Drugclonidine in spinal cord injured patients are presented.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect None of them had a history of cardiac disease, and with the possible exception of one case of Adverse-Effectcardiac arrest , where the patient received Drugdoxorubicin , no predisposing factors could be found.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Interestingly, the use of carboplatin ( CBDCA ) and VDS in the subsequent treatment course was well tolerated indicating that the Adverse-EffectSIADH was most likely to have been induced by administration of DrugCDDP .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A woman 38 - year - old, suffering for about ten years from multiple sclerosis and treated with repeated therapy cycles of intrathecal DrugDepo - Medrol , developed a Adverse-Effectspastic paraparesis at the lower limbs .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a patient with acute myeloblastic leukemia ( AML ) who developed Adverse-Effectnephrotic syndrome after receiving several courses of chemotherapy, including Drugmacrophage - colony - stimulating factor ( M - CSF ).
0.9999 Adverse-Effect We describe a patient with acute myeloblastic leukemia ( AML ) who developed Adverse-Effectnephrotic syndrome after receiving several courses of chemotherapy, including macrophage - colony - stimulating factor ( DrugM - CSF ).
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Only after three subsequent episodes of severe, symptomatic Adverse-Effectthrombocytopenia over the next four weeks did he say, upon repeat questioning, that he had continued to take Drugquinine for night leg cramps.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugCaptopril is an angiotensin - converting enzyme ( ACE ) inhibitor and their Adverse-Effectcutaneous side - effects are documented, but little has been published concerning the usefulness of patch test when they occur.
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect Slow acetylators, who comprise roughly 50 % of the South African population, are likely to develop clinical and biochemical features of Drugphenytoin Adverse-Effectphenytoin toxicity when this drug is given together with antituberculosis therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect During intravenous treatment with Drugterlipressin for recurrent gastrointestinal ( GI ) bleeding, a 50 - year - old male with no history of heart disease developed a newly Adverse-Effectprolonged QT interval and torsade de pointes.
1.0000 Adverse-Effect During intravenous treatment with Drugterlipressin for recurrent gastrointestinal ( GI ) bleeding, a 50 - year - old male with no history of heart disease developed a newly prolonged QT interval and Adverse-Effecttorsade de pointes .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect OBJECTIVE : To describe what is believed, as of November 4, 2003, to be the first case published in the literature of Adverse-Effectacute interstitial nephritis ( AIN ) due to Drugpantoprazole .
1.0000 Adverse-Effect OBJECTIVE : To describe what is believed, as of November 4, 2003, to be the first case published in the literature of acute interstitial nephritis ( Adverse-EffectAIN ) due to Drugpantoprazole .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 33 - year - old male presented with Adverse-Effectbrown discolouration of the fingernails following the application of Drug4 % hydroquinone in sorbolene cream and 0. 1 % tretinoin cream to the face intermittently for 9 months.
0.9980 Adverse-Effect A 33 - year - old male presented with Adverse-Effectbrown discolouration of the fingernails following the application of 4 % hydroquinone in sorbolene cream and Drug0. 1 % tretinoin cream to the face intermittently for 9 months.
Adverse-Effect A 33 - year - old male presented with Adverse-Effectbrown discolouration of the fingernails following the application of 4 % hydroquinone in sorbolene cream and Drug0. 1 % tretinoin cream to the face intermittently for 9 months.
Score Relation Text (Head - Tail)
0.9997 Adverse-Effect CONCLUSION : This report describes a case of a probable interaction between topical econazole lotion 1 % and Drugacenocoumarol that resulted in overanticoagulation and a life - threatening Adverse-Effectlaryngeal hematoma in this elderly patient.
0.9991 Adverse-Effect CONCLUSION : This report describes a case of a probable interaction between topical Drugeconazole lotion 1 % and acenocoumarol that resulted in overanticoagulation and a life - threatening Adverse-Effectlaryngeal hematoma in this elderly patient.
1.0000 Adverse-Effect CONCLUSION : This report describes a case of a probable interaction between topical econazole lotion 1 % and Drugacenocoumarol that resulted in Adverse-Effectoveranticoagulation and a life - threatening laryngeal hematoma in this elderly patient.
0.9995 Adverse-Effect CONCLUSION : This report describes a case of a probable interaction between topical Drugeconazole lotion 1 % and acenocoumarol that resulted in Adverse-Effectoveranticoagulation and a life - threatening laryngeal hematoma in this elderly patient.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CASE REPORT : We report a patient who developed a Adverse-EffectDAT - positive hemolytic episode after a red cell ( RBC ) transfusion was delivered during the infusion of her 17th cycle of Drugoxaliplatin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the case of a patient with the acquired immunodeficiency syndrome treated with Drugrifampicin who had a'normal'screening test for adrenal insufficiency, yet had clinical evidence of Adverse-Effectadrenal failure .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectParaplegia following prophylactic intrathecal Drugcytosine arabinoside ( Ara - C ) is described in a patient with acute myelogenous leukemia in remission who received doses of 100 mg / m2 / d for 5 consecutive days.
0.9999 Adverse-Effect Adverse-EffectParaplegia following prophylactic intrathecal cytosine arabinoside ( DrugAra - C ) is described in a patient with acute myelogenous leukemia in remission who received doses of 100 mg / m2 / d for 5 consecutive days.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Infants are particularly susceptible to chronic Drugnitrate - induced Adverse-Effectmethemoglobinemia because of their low stomach acid production, large numbers of nitrite - reducing bacteria, and the relatively easy oxidation of fetal hemoglobin.
0.7845 Adverse-Effect Infants are particularly susceptible to chronic nitrate - induced Adverse-Effectmethemoglobinemia because of their low stomach acid production, large numbers of Drugnitrite - reducing bacteria, and the relatively easy oxidation of fetal hemoglobin.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In this study, we report on three individual patients who received BTX - B and who subsequently developed Adverse-Effectparasympathetic dysfunction of the visual system after injections of DrugBTX - B at remote sites.
0.9999 Adverse-Effect In this study, we report on three individual patients who received DrugBTX - B and who subsequently developed Adverse-Effectparasympathetic dysfunction of the visual system after injections of BTX - B at remote sites.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Reversible Drugvalproic acid - induced Adverse-Effectdementia was documented in a 21 - year - old man with epilepsy who had a 3 - year history of insidious progressive decline in global cognitive abilities documented by serial neuropsychological studies.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report on a patient with subarachnoid haemorrhage who developed an acute life - threatening pseudo - obstruction of the colon, a variant of Adverse-Effectadynamic ileus , while being treated with intravenous Drugnimodipine .
0.9999 Adverse-Effect We report on a patient with subarachnoid haemorrhage who developed an acute life - threatening Adverse-Effectpseudo - obstruction of the colon , a variant of adynamic ileus, while being treated with intravenous Drugnimodipine .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Although high - dose Drugmethotrexate has been shown to be useful in the treatment of primary osteogenic sarcoma, the tumoricidal effects of therapy appear to have caused a Adverse-Effectfatal rise in intracranial pressure .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Five and one - half years after the diagnosis of myeloma, while in remission on Drugcyclophosphamide therapy, the patient experienced severe Adverse-Effectabdominal right lower quadrant pain due to a large cecal lymphoma.
0.9998 Adverse-Effect Five and one - half years after the diagnosis of myeloma, while in remission on Drugcyclophosphamide therapy, the patient experienced severe abdominal right lower quadrant pain due to a large Adverse-Effectcecal lymphoma .
1.0000 Adverse-Effect Five and one - half years after the diagnosis of myeloma, while in remission on Drugcyclophosphamide therapy, the patient experienced Adverse-Effectsevere abdominal right lower quadrant pain due to a large cecal lymphoma.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe the exceptional development of AML and Adverse-Effectlung cancer in a patient with previously diagnosed CLL in minimal residual disease status after Drugfludarabine treatment followed by autologous peripheral blood stem - cell transplantation.
1.0000 Adverse-Effect We describe the exceptional development of Adverse-EffectAML and lung cancer in a patient with previously diagnosed CLL in minimal residual disease status after Drugfludarabine treatment followed by autologous peripheral blood stem - cell transplantation.
Score Relation Text (Head - Tail)
0.9997 Adverse-Effect Three of these patients had Adverse-Effectconvulsions attributed to Drugimipenem / cilastatin ; 3. 6 % of the patients had seizure, or 2 % of imipenem / cilastatin administrations was followed by a seizure attack.
0.9976 Adverse-Effect Three of these patients had convulsions attributed to imipenem / cilastatin ; 3. 6 % of the patients had seizure, or 2 % of imipenem / Drugcilastatin administrations was followed by a Adverse-Effectseizure attack.
0.9782 Adverse-Effect Three of these patients had Adverse-Effectconvulsions attributed to imipenem / Drugcilastatin ; 3. 6 % of the patients had seizure, or 2 % of imipenem / cilastatin administrations was followed by a seizure attack.
0.9579 Adverse-Effect Three of these patients had convulsions attributed to imipenem / cilastatin ; 3. 6 % of the patients had seizure, or 2 % of Drugimipenem / cilastatin administrations was followed by a Adverse-Effectseizure attack.
0.5234 Adverse-Effect Three of these patients had convulsions attributed to imipenem / Drugcilastatin ; 3. 6 % of the patients had Adverse-Effectseizure , or 2 % of imipenem / cilastatin administrations was followed by a seizure attack.
0.9987 Adverse-Effect Three of these patients had convulsions attributed to imipenem / cilastatin ; 3. 6 % of the patients had seizure, or 2 % of imipenem / Drugcilastatin administrations was followed by a Adverse-Effectseizure attack .
0.9764 Adverse-Effect Three of these patients had convulsions attributed to imipenem / cilastatin ; 3. 6 % of the patients had seizure, or 2 % of Drugimipenem / cilastatin administrations was followed by a Adverse-Effectseizure attack .
Adverse-Effect Three of these patients had convulsions attributed to Drugimipenem / cilastatin ; 3. 6 % of the patients had Adverse-Effectseizure , or 2 % of imipenem / cilastatin administrations was followed by a seizure attack.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Since elevated cortisol levels in Cushing's disease poses a threat for pancreatitis, there is a possibility that patients with Cushing's disease might be more prone to Adverse-Effectacute pancreatitis following Drugpropofol administration.
0.9966 Adverse-Effect Since elevated cortisol levels in Cushing's disease poses a threat for Adverse-Effectpancreatitis , there is a possibility that patients with Cushing's disease might be more prone to acute pancreatitis following Drugpropofol administration.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of Adverse-Effecttorsade de pointes following a single oral dose of Drugamiodarone ( 1400 mg or 30 mg kg - 1 ) administered after short intravenous loading for prevention of paroxysmal atrial flutter.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Eighty - two patients with various malignancies who received imipenem / Drugcilastatin 143 times for Adverse-Effectneutropenic fever between March 1994 and October 1999 in Department of Pediatric Oncology, Gazi University, were identified.
1.0000 Adverse-Effect Eighty - two patients with various malignancies who received Drugimipenem / cilastatin 143 times for Adverse-Effectneutropenic fever between March 1994 and October 1999 in Department of Pediatric Oncology, Gazi University, were identified.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 36 - y - o patient with schizophrenia, who had consumed gradually increasing quantities of Drugoolong tea that eventually reached 15 L each day, became Adverse-Effectdelirious and was admitted to a psychiatric hospital.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In this report, two cases of ET which evolved into Adverse-EffectAL without prior exposure to radiation or alkylating agents, and which were treated with long - term Drughydroxyurea therapy, are described.
1.0000 Adverse-Effect In this report, two cases of Adverse-EffectET which evolved into AL without prior exposure to radiation or alkylating agents, and which were treated with long - term Drughydroxyurea therapy, are described.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Animals treated with DrugHAL showed a highly significant 32 % - 46 Adverse-Effect% loss of tyrosine hydroxylase ( TH ) immunoreactive neurons in the substantia nigra, and 20 % contraction of the TH stained dendritic arbour.
1.0000 Adverse-Effect Animals treated with DrugHAL showed a highly significant 32 % - 46 % Adverse-Effectloss of tyrosine hydroxylase ( TH ) immunoreactive neurons in the substantia nigra, and 20 % contraction of the TH stained dendritic arbour.
Adverse-Effect Animals treated with DrugHAL showed a highly Adverse-Effectsignificant 32 % - 46 % loss of tyrosine hydroxylase ( TH ) immunoreactive neurons in the substantia nigra, and 20 % contraction of the TH stained dendritic arbour.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The patient's clinical presentation, histologic features on liver biopsy and favorable course after stopping the drug suggest that Drugbarbiturates can be added to the list of agents which can cause Adverse-Effectsubmassive hepatic necrosis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Pneumonitis, bilateral pleural effusions, echocardiographic evidence of cardiac tamponade, and Adverse-Effectpositive autoantibodies developed in a 43 - year - old man, who was receiving long - term Drugsulfasalazine therapy for chronic ulcerative colitis.
1.0000 Adverse-Effect Pneumonitis, bilateral pleural effusions, echocardiographic evidence of Adverse-Effectcardiac tamponade , and positive autoantibodies developed in a 43 - year - old man, who was receiving long - term Drugsulfasalazine therapy for chronic ulcerative colitis.
1.0000 Adverse-Effect Adverse-EffectPneumonitis , bilateral pleural effusions, echocardiographic evidence of cardiac tamponade, and positive autoantibodies developed in a 43 - year - old man, who was receiving long - term Drugsulfasalazine therapy for chronic ulcerative colitis.
1.0000 Adverse-Effect Pneumonitis, Adverse-Effectbilateral pleural effusions , echocardiographic evidence of cardiac tamponade, and positive autoantibodies developed in a 43 - year - old man, who was receiving long - term Drugsulfasalazine therapy for chronic ulcerative colitis.
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect The present report illustrates a rare case of refractory Adverse-Effectakathisia after Druginterferon - alpha treatment and also that levodopa treatment would be theoretically and practically useful in reducing the neurotoxicity associated with interferon - alpha.
0.9988 Adverse-Effect The present report illustrates a rare case of refractory akathisia after interferon - alpha treatment and also that levodopa treatment would be theoretically and practically useful in reducing the Adverse-Effectneurotoxicity associated with Druginterferon - alpha .
0.9999 Adverse-Effect The present report illustrates a rare case of Adverse-Effectrefractory akathisia after Druginterferon - alpha treatment and also that levodopa treatment would be theoretically and practically useful in reducing the neurotoxicity associated with interferon - alpha.
0.6066 Adverse-Effect The present report illustrates a rare case of refractory akathisia after interferon - alpha treatment and also that Druglevodopa treatment would be theoretically and practically useful in reducing the Adverse-Effectneurotoxicity associated with interferon - alpha.
0.5589 Adverse-Effect The present report illustrates a rare case of Adverse-Effectrefractory akathisia after interferon - alpha treatment and also that Druglevodopa treatment would be theoretically and practically useful in reducing the neurotoxicity associated with interferon - alpha.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To report the case of a young woman with Graves'disease in whom ototoxicity developed because of propylthiouracil ( DrugPTU ) - induced Adverse-Effectantineutrophil cytoplasmic antibody ( ANCA ) - associated vasculitis .
1.0000 Adverse-Effect OBJECTIVE : To report the case of a young woman with Graves'disease in whom Adverse-Effectototoxicity developed because of Drugpropylthiouracil ( PTU ) - induced antineutrophil cytoplasmic antibody ( ANCA ) - associated vasculitis.
0.9999 Adverse-Effect OBJECTIVE : To report the case of a young woman with Graves'disease in whom ototoxicity developed because of Drugpropylthiouracil ( PTU ) - induced Adverse-Effectantineutrophil cytoplasmic antibody ( ANCA ) - associated vasculitis .
0.9990 Adverse-Effect OBJECTIVE : To report the case of a young woman with Graves'disease in whom Adverse-Effectototoxicity developed because of propylthiouracil ( DrugPTU ) - induced antineutrophil cytoplasmic antibody ( ANCA ) - associated vasculitis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the case of a 20 - year - old woman originally from Cameroon who was infected by the L. loa parasite and developed Adverse-Effectsevere hepatitis , identified 1 month after a single dose of Drugivermectin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Rapamycin / sirolimus ( SR ), trade named DrugRapammune ( Wyeth - Ayerst, Sydney, Australia ), is a potent immunosuppressive drug associated with Adverse-Effectmyelosuppression , hypertension, hyperlipidemia, and infection.
1.0000 Adverse-Effect Rapamycin / sirolimus ( SR ), trade named DrugRapammune ( Wyeth - Ayerst, Sydney, Australia ), is a potent immunosuppressive drug associated with myelosuppression, Adverse-Effecthypertension , hyperlipidemia, and infection.
0.9999 Adverse-Effect Rapamycin / sirolimus ( SR ), trade named DrugRapammune ( Wyeth - Ayerst, Sydney, Australia ), is a potent immunosuppressive drug associated with myelosuppression, hypertension, Adverse-Effecthyperlipidemia , and infection.
0.9999 Adverse-Effect DrugRapamycin / sirolimus ( SR ), trade named Rapammune ( Wyeth - Ayerst, Sydney, Australia ), is a potent immunosuppressive drug associated with Adverse-Effectmyelosuppression , hypertension, hyperlipidemia, and infection.
0.9999 Adverse-Effect DrugRapamycin / sirolimus ( SR ), trade named Rapammune ( Wyeth - Ayerst, Sydney, Australia ), is a potent immunosuppressive drug associated with myelosuppression, Adverse-Effecthypertension , hyperlipidemia, and infection.
0.9999 Adverse-Effect Rapamycin / Drugsirolimus ( SR ), trade named Rapammune ( Wyeth - Ayerst, Sydney, Australia ), is a potent immunosuppressive drug associated with Adverse-Effectmyelosuppression , hypertension, hyperlipidemia, and infection.
0.9999 Adverse-Effect DrugRapamycin / sirolimus ( SR ), trade named Rapammune ( Wyeth - Ayerst, Sydney, Australia ), is a potent immunosuppressive drug associated with myelosuppression, hypertension, Adverse-Effecthyperlipidemia , and infection.
0.9999 Adverse-Effect Rapamycin / sirolimus ( SR ), trade named DrugRapammune ( Wyeth - Ayerst, Sydney, Australia ), is a potent immunosuppressive drug associated with myelosuppression, hypertension, hyperlipidemia, and Adverse-Effectinfection .
0.9999 Adverse-Effect Rapamycin / Drugsirolimus ( SR ), trade named Rapammune ( Wyeth - Ayerst, Sydney, Australia ), is a potent immunosuppressive drug associated with myelosuppression, Adverse-Effecthypertension , hyperlipidemia, and infection.
0.9999 Adverse-Effect Rapamycin / Drugsirolimus ( SR ), trade named Rapammune ( Wyeth - Ayerst, Sydney, Australia ), is a potent immunosuppressive drug associated with myelosuppression, hypertension, Adverse-Effecthyperlipidemia , and infection.
0.9999 Adverse-Effect DrugRapamycin / sirolimus ( SR ), trade named Rapammune ( Wyeth - Ayerst, Sydney, Australia ), is a potent immunosuppressive drug associated with myelosuppression, hypertension, hyperlipidemia, and Adverse-Effectinfection .
0.9999 Adverse-Effect Rapamycin / Drugsirolimus ( SR ), trade named Rapammune ( Wyeth - Ayerst, Sydney, Australia ), is a potent immunosuppressive drug associated with myelosuppression, hypertension, hyperlipidemia, and Adverse-Effectinfection .
Adverse-Effect Rapamycin / sirolimus ( DrugSR ), trade named Rapammune ( Wyeth - Ayerst, Sydney, Australia ), is a potent immunosuppressive drug associated with Adverse-Effectmyelosuppression , hypertension, hyperlipidemia, and infection.
Adverse-Effect Rapamycin / sirolimus ( DrugSR ), trade named Rapammune ( Wyeth - Ayerst, Sydney, Australia ), is a potent immunosuppressive drug associated with myelosuppression, hypertension, Adverse-Effecthyperlipidemia , and infection.
Adverse-Effect Rapamycin / sirolimus ( DrugSR ), trade named Rapammune ( Wyeth - Ayerst, Sydney, Australia ), is a potent immunosuppressive drug associated with myelosuppression, Adverse-Effecthypertension , hyperlipidemia, and infection.
Adverse-Effect Rapamycin / sirolimus ( DrugSR ), trade named Rapammune ( Wyeth - Ayerst, Sydney, Australia ), is a potent immunosuppressive drug associated with myelosuppression, hypertension, hyperlipidemia, and Adverse-Effectinfection .
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect The main side - effects of DrugLp - TAE combined with HT were Adverse-Effectlow - grade fever , localized pain, myelo - suppression and liver dysfunction, but these were transient and eventually disappeared.
0.9997 Adverse-Effect The main side - effects of DrugLp - TAE combined with HT were low - grade fever, Adverse-Effectlocalized pain , myelo - suppression and liver dysfunction, but these were transient and eventually disappeared.
0.9993 Adverse-Effect The main side - effects of DrugLp - TAE combined with HT were low - grade fever, localized pain, Adverse-Effectmyelo - suppression and liver dysfunction, but these were transient and eventually disappeared.
0.9989 Adverse-Effect The main side - effects of DrugLp - TAE combined with HT were low - grade fever, localized pain, myelo - suppression and Adverse-Effectliver dysfunction , but these were transient and eventually disappeared.
1.0000 Adverse-Effect The main side - effects of Lp - TAE combined with DrugHT were Adverse-Effectlow - grade fever , localized pain, myelo - suppression and liver dysfunction, but these were transient and eventually disappeared.
0.9998 Adverse-Effect The main side - effects of Lp - TAE combined with DrugHT were low - grade fever, Adverse-Effectlocalized pain , myelo - suppression and liver dysfunction, but these were transient and eventually disappeared.
0.9994 Adverse-Effect The main side - effects of Lp - TAE combined with DrugHT were low - grade fever, localized pain, Adverse-Effectmyelo - suppression and liver dysfunction, but these were transient and eventually disappeared.
0.9990 Adverse-Effect The main side - effects of Lp - TAE combined with DrugHT were low - grade fever, localized pain, myelo - suppression and Adverse-Effectliver dysfunction , but these were transient and eventually disappeared.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Hyperkalaemia with Adverse-Effectrenal tubular dysfunction by oral therapy of Drugsulfamethoxazole - trimethoprim ( co - trimoxazole ) is described in 2 elderly Japanese patients with lymphoid malignancy, who developed Pneumocystis carinii pneumonia and improved.
0.9998 Adverse-Effect Adverse-EffectHyperkalaemia with renal tubular dysfunction by oral therapy of Drugsulfamethoxazole - trimethoprim ( co - trimoxazole ) is described in 2 elderly Japanese patients with lymphoid malignancy, who developed Pneumocystis carinii pneumonia and improved.
0.9996 Adverse-Effect Hyperkalaemia with Adverse-Effectrenal tubular dysfunction by oral therapy of sulfamethoxazole - trimethoprim ( Drugco - trimoxazole ) is described in 2 elderly Japanese patients with lymphoid malignancy, who developed Pneumocystis carinii pneumonia and improved.
0.9992 Adverse-Effect Adverse-EffectHyperkalaemia with renal tubular dysfunction by oral therapy of sulfamethoxazole - trimethoprim ( Drugco - trimoxazole ) is described in 2 elderly Japanese patients with lymphoid malignancy, who developed Pneumocystis carinii pneumonia and improved.
Score Relation Text (Head - Tail)
0.9634 Adverse-Effect A young diamond dealer developed visual impairment attributed to Adverse-Effectbilateral posterior subcapsular cataracts following only four courses of intermittent DrugDecadron used as part of a five - drug antiemetic regimen for cisplatin - associated nausea.
0.7002 Adverse-Effect A young diamond dealer developed Adverse-Effectvisual impairment attributed to bilateral posterior subcapsular cataracts following only four courses of intermittent DrugDecadron used as part of a five - drug antiemetic regimen for cisplatin - associated nausea.
Adverse-Effect A young diamond dealer developed visual impairment attributed to bilateral posterior subcapsular cataracts following only four courses of intermittent Decadron used as part of a five - drug antiemetic regimen for Drugcisplatin - associated Adverse-Effectnausea .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 22 - year - old black man developed fever, chills, fatigue, night sweats, tender lymphadenopathy, and a Adverse-Effectgeneralized, pruritic, macular eruption 3 weeks after starting Drugminocycline therapy for acne.
1.0000 Adverse-Effect A 22 - year - old black man developed fever, Adverse-Effectchills , fatigue, night sweats, tender lymphadenopathy, and a generalized, pruritic, macular eruption 3 weeks after starting Drugminocycline therapy for acne.
1.0000 Adverse-Effect A 22 - year - old black man developed fever, chills, Adverse-Effectfatigue , night sweats, tender lymphadenopathy, and a generalized, pruritic, macular eruption 3 weeks after starting Drugminocycline therapy for acne.
0.9999 Adverse-Effect A 22 - year - old black man developed Adverse-Effectfever , chills, fatigue, night sweats, tender lymphadenopathy, and a generalized, pruritic, macular eruption 3 weeks after starting Drugminocycline therapy for acne.
0.9999 Adverse-Effect A 22 - year - old black man developed fever, chills, fatigue, Adverse-Effectnight sweats , tender lymphadenopathy, and a generalized, pruritic, macular eruption 3 weeks after starting Drugminocycline therapy for acne.
0.9999 Adverse-Effect A 22 - year - old black man developed fever, chills, fatigue, night sweats, Adverse-Effecttender lymphadenopathy , and a generalized, pruritic, macular eruption 3 weeks after starting Drugminocycline therapy for acne.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To report a case of chronic, nonproductive Adverse-Effectcough secondary to the angiotensin - converting enzyme ( ACE ) inhibitor Drugquinapril , with complete resolution after switching to another ACE inhibitor, fosinopril.
0.9995 Adverse-Effect OBJECTIVE : To report a case of chronic, nonproductive Adverse-Effectcough secondary to the angiotensin - converting enzyme ( ACE ) inhibitor quinapril, with complete resolution after switching to another ACE inhibitor, Drugfosinopril .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We have described three patients with hepatitis C for whom IFN - alpha and Drugribavirin were prescribed and who developed two successive phases of silent Adverse-Effectthyroiditis followed by hyperthryroidism relapse due to Graves'disease.
0.9998 Adverse-Effect We have described three patients with hepatitis C for whom IFN - alpha and Drugribavirin were prescribed and who developed two successive phases of silent thyroiditis followed by Adverse-Effecthyperthryroidism relapse due to Graves'disease.
0.9995 Adverse-Effect We have described three patients with hepatitis C for whom DrugIFN - alpha and ribavirin were prescribed and who developed two successive phases of silent Adverse-Effectthyroiditis followed by hyperthryroidism relapse due to Graves'disease.
0.9984 Adverse-Effect We have described three patients with hepatitis C for whom DrugIFN - alpha and ribavirin were prescribed and who developed two successive phases of silent thyroiditis followed by Adverse-Effecthyperthryroidism relapse due to Graves'disease.
1.0000 Adverse-Effect We have described three patients with hepatitis C for whom IFN - alpha and Drugribavirin were prescribed and who developed two successive phases of Adverse-Effectsilent thyroiditis followed by hyperthryroidism relapse due to Graves'disease.
0.9997 Adverse-Effect We have described three patients with hepatitis C for whom DrugIFN - alpha and ribavirin were prescribed and who developed two successive phases of Adverse-Effectsilent thyroiditis followed by hyperthryroidism relapse due to Graves'disease.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect In patients with swallowing dysfunction and pneumonia, a history of Drugmineral oil use should be obtained and a diagnosis of Adverse-EffectELP should be considered in the differential diagnoses if mineral oil use has occurred.
0.9999 Adverse-Effect In patients with swallowing dysfunction and Adverse-Effectpneumonia , a history of Drugmineral oil use should be obtained and a diagnosis of ELP should be considered in the differential diagnoses if mineral oil use has occurred.
0.9997 Adverse-Effect In patients with swallowing dysfunction and pneumonia, a history of mineral oil use should be obtained and a diagnosis of Adverse-EffectELP should be considered in the differential diagnoses if Drugmineral oil use has occurred.
0.9990 Adverse-Effect In patients with Adverse-Effectswallowing dysfunction and pneumonia, a history of Drugmineral oil use should be obtained and a diagnosis of ELP should be considered in the differential diagnoses if mineral oil use has occurred.
0.9933 Adverse-Effect In patients with Adverse-Effectswallowing dysfunction and pneumonia, a history of mineral oil use should be obtained and a diagnosis of ELP should be considered in the differential diagnoses if Drugmineral oil use has occurred.
0.9933 Adverse-Effect In patients with swallowing dysfunction and Adverse-Effectpneumonia , a history of mineral oil use should be obtained and a diagnosis of ELP should be considered in the differential diagnoses if Drugmineral oil use has occurred.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : Life - threatening Adverse-Effectadrenal suppression , requiring hydrocortisone supplementation and intensive therapy, was observed and successfully treated in a newborn, whose mother had received high - dose Drugmethylprednisolone in late pregnancy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We believe the temporal association of the abnormal liver enzymes in this patient, in the absence of other offending agents, argues strongly in favor of Drug6 - TG as a cause of Adverse-Effectliver enzyme abnormalities .
1.0000 Adverse-Effect We believe the temporal association of the Adverse-Effectabnormal liver enzymes in this patient, in the absence of other offending agents, argues strongly in favor of Drug6 - TG as a cause of liver enzyme abnormalities.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Two patients with imminent gangrene of the extremities caused by Drugergot - induced Adverse-Effectarteriospasm underwent mechanical dilatation of the arteries when conventional measures such as anticoagulation, vasodilation, and sympathetic blockade produced no improvement.
1.0000 Adverse-Effect Two patients with imminent Adverse-Effectgangrene of the extremities caused by Drugergot - induced arteriospasm underwent mechanical dilatation of the arteries when conventional measures such as anticoagulation, vasodilation, and sympathetic blockade produced no improvement.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Patients receiving Drugamifostine who develop only Adverse-Effectfever should be evaluated for an adverse drug reaction, as well as for sepsis and fevers of neutropenia, and it may be necessary to discontinue the drug.
1.0000 Adverse-Effect Patients receiving Drugamifostine who develop only fever should be evaluated for an adverse drug reaction, as well as for Adverse-Effectsepsis and fevers of neutropenia, and it may be necessary to discontinue the drug.
0.9999 Adverse-Effect Patients receiving Drugamifostine who develop only fever should be evaluated for an adverse drug reaction, as well as for sepsis and Adverse-Effectfevers of neutropenia , and it may be necessary to discontinue the drug.
Score Relation Text (Head - Tail)
0.9937 Adverse-Effect Retrospectively, Drugbucillamine was believed to be the cause of the Adverse-Effectgiant hypertrophy because of its structural similarity to D - penicillamine, which was the subject of an abundance of reports of mammary hyperplasia.
0.9636 Adverse-Effect Retrospectively, bucillamine was believed to be the cause of the giant hypertrophy because of its structural similarity to DrugD - penicillamine , which was the subject of an abundance of reports of Adverse-Effectmammary hyperplasia .
0.9969 Adverse-Effect Retrospectively, bucillamine was believed to be the cause of the Adverse-Effectgiant hypertrophy because of its structural similarity Drugto D - penicillamine , which was the subject of an abundance of reports of mammary hyperplasia.
0.9888 Adverse-Effect Retrospectively, bucillamine was believed to be the cause of the giant hypertrophy because of its structural similarity to D - penicillamine, which was the subject of an abundance of reports of Drugmammary Adverse-Effectmammary hyperplasia .
0.9859 Adverse-Effect Retrospectively, Drugbucillamine was believed to be the cause of the Adverse-Effectgiant hypertrophy because of its structural similarity to D - penicillamine, which was the subject of an abundance of reports of mammary hyperplasia.
0.9857 Adverse-Effect Retrospectively, Drugbucillamine was believed to be the cause of the Adverse-Effectgiant hypertrophy because of its structural similarity to D - penicillamine, which was the subject of an abundance of reports of mammary hyperplasia.
0.9856 Adverse-Effect Retrospectively, Drugbucillamine was believed to be the cause of the Adverse-Effectgiant hypertrophy because of its structural similarity to D - penicillamine, which was the subject of an abundance of reports of mammary hyperplasia.
0.9855 Adverse-Effect Retrospectively, Drugbucillamine was believed to be the cause of the Adverse-Effectgiant hypertrophy because of its structural similarity to D - penicillamine, which was the subject of an abundance of reports of mammary hyperplasia.
0.9852 Adverse-Effect Retrospectively, Drugbucillamine was believed to be the cause of the Adverse-Effectgiant hypertrophy because of its structural similarity to D - penicillamine, which was the subject of an abundance of reports of mammary hyperplasia.
0.8666 Adverse-Effect Retrospectively, bucillamine was believed to be the cause of the giant hypertrophy because of its structural similarity Drugto D - penicillamine , which was the subject of an abundance of reports of Adverse-Effectmammary hyperplasia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Both patients were then treated with a carboplatin alternative to Drugcisplatin in the following courses, which resulted in neither a relapse of the Adverse-Effectcolitis nor a recurrence of the malignancies up to this time.
0.9999 Adverse-Effect Both patients were then treated with a carboplatin alternative to Drugcisplatin in the following courses, which resulted in neither a relapse of the colitis nor a recurrence of the Adverse-Effectmalignancies up to this time.
0.9999 Adverse-Effect Both patients were then treated with a Drugcarboplatin alternative to cisplatin in the following courses, which resulted in neither a relapse of the Adverse-Effectcolitis nor a recurrence of the malignancies up to this time.
0.9996 Adverse-Effect Both patients were then treated with a Drugcarboplatin alternative to cisplatin in the following courses, which resulted in neither a relapse of the colitis nor a recurrence of the Adverse-Effectmalignancies up to this time.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect PURPOSE / OBJECTIVES : To describe the pharmacogenetic syndrome of dihydropyrimidine dehydrogenase ( DPD ) deficiency, which predisposes patients with cancer to potentially Adverse-Effectlethal adverse reactions following Drug5 - fluorouracil ( 5 - FU ) - based chemotherapy.
0.9999 Adverse-Effect PURPOSE / OBJECTIVES : To describe the pharmacogenetic syndrome of dihydropyrimidine dehydrogenase ( DPD ) deficiency, which predisposes patients with cancer to potentially Adverse-Effectlethal adverse reactions following 5 - fluorouracil ( Drug5 - FU ) - based chemotherapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The aim of this report is to describe the clinical and electroencephalographic findings seen in an elderly woman without previous history of seizures who developed a Adverse-Effectnonconvulsive generalized status epilepticus following acute withdrawal of Druglorazepam .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 71 - year - old man with paroxysmal atrial fibrillation who had a previous anterior myocardial infarction exhibited Adverse-Effectgranulocytopenia 8 days following the administration of oral sustained - release Drugprocainamide ( 750 mg / day ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a continuous ambulatory peritoneal dialysis ( CAPD ) patient that developed Drugvancomycin - induced Adverse-Effectagranulocytosis during treatment for methicillin - resistant Staphylococcus aureus ( MRSA ) - associated external cuff infection and pneumonia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Although Drugisradipine has been associated with Adverse-Effecthepatocellular injury , there are no reports of fulminant liver failure with this agent, and our patient had been treated for > 2 years without signs of toxicity.
0.9998 Adverse-Effect Although Drugisradipine has been associated with hepatocellular injury, there are no reports of Adverse-Effectfulminant liver failure with this agent, and our patient had been treated for > 2 years without signs of toxicity.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a patient with CREST syndrome ( calcinosis, Raynaud's phenomenon, esophageal dysfunction, sclerodactyly, and telangiectasia ) who paradoxically experienced Adverse-Effectworsening of Raynaud's phenomenon when using Drugyohimbine for ED.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect A patient is described with the characteristic features of Drugphenytoin hypersensitivity syndrome ( PHS ) including fever, erythroderma, Adverse-Effecttibial and facial oedema , pinhead - sized facial pustules and abnormal liver function tests.
0.9999 Adverse-Effect A patient is described with the characteristic features of Drugphenytoin hypersensitivity syndrome ( PHS ) including fever, Adverse-Effecterythroderma , tibial and facial oedema, pinhead - sized facial pustules and abnormal liver function tests.
0.9999 Adverse-Effect A patient is described with the characteristic features of Drugphenytoin hypersensitivity syndrome ( PHS ) including Adverse-Effectfever , erythroderma, tibial and facial oedema, pinhead - sized facial pustules and abnormal liver function tests.
0.9998 Adverse-Effect A patient is described with the characteristic features of Drugphenytoin hypersensitivity syndrome ( PHS ) including fever, erythroderma, tibial and facial oedema, Adverse-Effectpinhead - sized facial pustules and abnormal liver function tests.
0.9998 Adverse-Effect A patient is described with the characteristic features of Drugphenytoin hypersensitivity syndrome ( PHS ) including fever, erythroderma, tibial and facial oedema, pinhead - sized facial pustules and Adverse-Effectabnormal liver function tests .
Adverse-Effect A patient is described with the characteristic features of Drugphenytoin Adverse-Effectphenytoin hypersensitivity syndrome ( PHS ) including fever, erythroderma, tibial and facial oedema, pinhead - sized facial pustules and abnormal liver function tests.
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect Although transient increases in ectopy after Drugbretylium therapy have been described, presumably due to catecholamine release, the occurrence of life - threatening Adverse-Effectventricular arrhythmia leading to cardiac arrest has not previously been emphasized.
0.9998 Adverse-Effect Although transient increases in ectopy after Drugbretylium therapy have been described, presumably due to catecholamine release, the occurrence of life - threatening ventricular arrhythmia leading to Adverse-Effectcardiac arrest has not previously been emphasized.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of Adverse-Effectpancytopenia in a 23 - year - old man with Crohn's disease who was treated with Drug5 - aminosalicylic acid ( Pentasa ; Nisshin, Tokyo, Japan ) 3. 0 g / day.
0.9999 Adverse-Effect We report a case of Adverse-Effectpancytopenia in a 23 - year - old man with Crohn's disease who was treated with 5 - aminosalicylic acid ( DrugPentasa ; Nisshin, Tokyo, Japan ) 3. 0 g / day.
0.9998 Adverse-Effect We report a case of Adverse-Effectpancytopenia in a 23 - year - old man with Crohn's disease who was treated with 5 - aminosalicylic acid ( Pentasa ; DrugNisshin , Tokyo, Japan ) 3. 0 g / day.
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect Adverse-EffectExtrapyramidal side effects induced by some selective serotonin reuptake inhibitors ( SSRIs ), i. e. Drugfluoxetine and sertraline, have been previously reported in patients with depression and obsessive - compulsive disorder ( OCD ).
0.9997 Adverse-Effect Adverse-EffectExtrapyramidal side effects induced by some selective serotonin reuptake inhibitors ( SSRIs ), i. e. fluoxetine and Drugsertraline , have been previously reported in patients with depression and obsessive - compulsive disorder ( OCD ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Because Drugetoposide - induced Adverse-Effectpulmonary toxicity is an uncommon but serious adverse event, clinicians must be vigilant about the possibility of it, so that the optimal treatment can start as soon as possible.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Five cases ( four from the literature and one new case ) are presented in which patients unsuspected of having vitamin B12 deficiency developed Adverse-Effectsubacute combined degeneration of the spinal cord following Drugnitrous oxide anesthesia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a case of a man treated with an EGFR - inhibitor ( Drugerlotinib ) for a cell lung cancer who developed Adverse-Effectskin manifestations localized in an uncommon area and with an atypical evolution.
Score Relation Text (Head - Tail)
0.9996 Adverse-Effect Physicians should be cognizant of this potential complication in patients receiving Drugthalidomide or thalidomide - like drugs who present with Adverse-Effectfever and pulmonary infiltrates and fail to improve despite treatment with broad - spectrum antibiotics.
0.9994 Adverse-Effect Physicians should be cognizant of this potential complication in patients receiving Drugthalidomide or thalidomide - like drugs who present with fever and Adverse-Effectpulmonary infiltrates and fail to improve despite treatment with broad - spectrum antibiotics.
0.9999 Adverse-Effect Physicians should be cognizant of this potential complication in patients receiving thalidomide or Drugthalidomide - like drugs who present with Adverse-Effectfever and pulmonary infiltrates and fail to improve despite treatment with broad - spectrum antibiotics.
0.9998 Adverse-Effect Physicians should be cognizant of this potential complication in patients receiving thalidomide or Drugthalidomide - like drugs who present with fever and Adverse-Effectpulmonary infiltrates and fail to improve despite treatment with broad - spectrum antibiotics.
Score Relation Text (Head - Tail)
0.9987 Adverse-Effect This article describes two cases of aplastic anemia, at least one of which was almost certainly induced by the use of methazolamide, and one case of Adverse-Effectagranulocytosis related to the use of Drugmethazolamide .
0.5641 Adverse-Effect This article describes two cases of Adverse-Effectaplastic anemia , at least one of which was almost certainly induced by the use of Drugmethazolamide , and one case of agranulocytosis related to the use of methazolamide.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Common adverse events ( frequency 10 % ) of Druglacosamide doses up to 600 mg / day include nonspecific central nervous system effects ( e. g., Adverse-Effectdizziness , ataxia, diplopia, and somnolence ).
1.0000 Adverse-Effect Common adverse events ( frequency 10 % ) of Druglacosamide doses up to 600 mg / day include nonspecific central nervous system effects ( e. g., dizziness, ataxia, Adverse-Effectdiplopia , and somnolence ).
1.0000 Adverse-Effect Common adverse events ( frequency 10 % ) of Druglacosamide doses up to 600 mg / day include nonspecific central nervous system effects ( e. g., dizziness, Adverse-Effectataxia , diplopia, and somnolence ).
1.0000 Adverse-Effect Common adverse events ( frequency 10 % ) of Druglacosamide doses up to 600 mg / day include nonspecific central nervous system effects ( e. g., dizziness, ataxia, diplopia, and Adverse-Effectsomnolence ).
1.0000 Adverse-Effect Common adverse events ( frequency 10 % ) of Druglacosamide doses up to 600 mg / day include Adverse-Effectnonspecific central nervous system effects ( e. g., dizziness, ataxia, diplopia, and somnolence ).
1.0000 Adverse-Effect Common adverse events ( frequency 10 % ) of Druglacosamide doses up to 600 mg / day include nonspecific Adverse-Effectcentral nervous system effects ( e. g., dizziness, ataxia, diplopia, and somnolence ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In this healthy population, the relative risk of developing Adverse-Effectendometrial carcinoma in the Drugtamoxifen arm was 2. 54, although when stratified by age, in women over 50, the risk grew to 4. 01.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect METHODS : We queried 35 rheumatologists at the Robert Breck Brigham Arthritis Center to determine if Adverse-Effectweight loss had occurred as an adverse event in patients treated with Drugleflunomide between November 1998 and January 2000.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A sixty - year - old woman with advanced breast cancer, previously treated with cisplatin, developed an irreversible lethal renal failure with Adverse-Effectanuria , the day after 5 g / m2 bolus Drugifosfamide .
0.9999 Adverse-Effect A sixty - year - old woman with advanced breast cancer, previously treated with cisplatin, developed an Adverse-Effectirreversible lethal renal failure with anuria, the day after 5 g / m2 bolus Drugifosfamide .
1.0000 Adverse-Effect A sixty - year - old woman with advanced breast cancer, previously treated with Drugcisplatin , developed an Adverse-Effectirreversible lethal renal failure with anuria, the day after 5 g / m2 bolus ifosfamide.
0.9998 Adverse-Effect A sixty - year - old woman with advanced breast cancer, previously treated with cisplatin, developed an irreversible Adverse-Effectlethal renal failure with anuria, the day after 5 g / m2 bolus Drugifosfamide .
0.9998 Adverse-Effect A sixty - year - old woman with advanced breast cancer, previously treated with Drugcisplatin , developed an irreversible Adverse-Effectlethal renal failure with anuria, the day after 5 g / m2 bolus ifosfamide.
0.9997 Adverse-Effect A sixty - year - old woman with advanced breast cancer, previously treated with Drugcisplatin , developed an irreversible lethal renal failure with Adverse-Effectanuria , the day after 5 g / m2 bolus ifosfamide.
Score Relation Text (Head - Tail)
0.9990 Adverse-Effect Until additional data are available, if intravenous acyclovir is administered concurrently with lithium, we recommend closely monitoring patients for signs of Druglithium Adverse-Effectlithium toxicity and measuring serum lithium levels every second or third day.
0.9946 Adverse-Effect Until additional data are available, if intravenous Drugacyclovir is administered concurrently with lithium, we recommend closely monitoring patients for signs of Adverse-Effectlithium toxicity and measuring serum lithium levels every second or third day.
0.9990 Adverse-Effect Until additional data are available, if intravenous acyclovir is administered concurrently with Druglithium , we recommend closely monitoring patients for signs of Adverse-Effectlithium toxicity and measuring serum lithium levels every second or third day.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Although they had complex medical problems, the high serum concentrations of ampicillin at the time of seizures without their recurrence after discontinuing the antibiotic suggest that the Adverse-Effectseizures were related to the Drugampicillin therapy.
0.9993 Adverse-Effect Although they had complex medical problems, the high serum concentrations of Drugampicillin at the time of seizures without their recurrence after discontinuing the antibiotic suggest that the Adverse-Effectseizures were related to the ampicillin therapy.
0.9999 Adverse-Effect Although they had complex medical problems, the high serum concentrations of Drugampicillin at the time of Adverse-Effectseizures without their recurrence after discontinuing the antibiotic suggest that the seizures were related to the ampicillin therapy.
0.9995 Adverse-Effect Although they had complex medical problems, the high serum concentrations of ampicillin at the time of Adverse-Effectseizures without their recurrence after discontinuing the antibiotic suggest that the seizures were related to the Drugampicillin therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We present a case of an elderly woman with a pre - existing history of ischaemic heart disease, who was treated with Drugvenlafaxine , and developed Adverse-Effectacute myocardial ischaemia within the first week of treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a patient with recurrent, increasingly severe episodes of PPE, ultimately complicated by a severe Adverse-Effectbullous eruption , following successive cycles of high - dose Drugcytarabine for the treatment of acute lymphoblastic leukaemia.
0.9999 Adverse-Effect We report a patient with recurrent, increasingly severe episodes of Adverse-EffectPPE , ultimately complicated by a severe bullous eruption, following successive cycles of high - dose Drugcytarabine for the treatment of acute lymphoblastic leukaemia.
1.0000 Adverse-Effect We report a patient with recurrent, increasingly severe episodes of PPE, ultimately complicated by a Adverse-Effectsevere bullous eruption , following successive cycles of high - dose Drugcytarabine for the treatment of acute lymphoblastic leukaemia.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect The evidence of high plasmatic levels of CBZ and the absence of other aetiologic factors lead the authors to conclude that the overdose of DrugCBZ could have represented the precipitating of the episode of Adverse-Effectacute pancreatitis .
0.9983 Adverse-Effect The evidence of high plasmatic levels of DrugCBZ and the absence of other aetiologic factors lead the authors to conclude that the overdose of CBZ could have represented the precipitating of the episode of Adverse-Effectacute pancreatitis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Assessment of cortisol response was by Druginsulin - induced Adverse-Effecthypoglycaemia in three cases, by short tetracosactrin test in two, and by low - dose tetracosactrin and 24 - hour urinary cortisol / creatinine ratio in one.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case of Adverse-Effectanaphylactoid reaction due solely to the use of DrugGelofusine in a patient with non - haemorrhagic hypovolaemia is presented, with a discussion on the management and the use of allergy identification jewellery.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSION : While Adverse-Effectthrombosis has been reported with DrugGnRH - a therapy in men with prostate cancer, its association with treatment in this benign case may have been a consequence of the massive tumor size.
0.9998 Adverse-Effect CONCLUSION : While thrombosis has been reported with DrugGnRH - a therapy in men with prostate cancer, its association with treatment in this benign case may have been a consequence of the Adverse-Effectmassive tumor size .
Score Relation Text (Head - Tail)
0.9990 Adverse-Effect Idiosyncratic factors involving vasopressin receptor affinity and distribution, Drugvasopressin - associated Adverse-Effectvasodilation in some vascular beds, and the effect of vasopressin on the renin - angiotensin system may further contribute to impaired tissue perfusion.
0.9842 Adverse-Effect Idiosyncratic factors involving vasopressin receptor affinity and distribution, vasopressin - associated vasodilation in some vascular beds, and the effect of Drugvasopressin on the renin - angiotensin system may further contribute to Adverse-Effectimpaired tissue perfusion .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 35 - year - old woman presented with neurotoxicity correlated to an i. v. regimen of Drug5 - fluorouracil as episodes of Adverse-Effectacute confusional state and abnormalities of symmetrically restricted diffusion in the periventricular white matter and corpus callosum.
0.9998 Adverse-Effect A 35 - year - old woman presented with Adverse-Effectneurotoxicity correlated to an i. v. regimen of Drug5 - fluorouracil as episodes of acute confusional state and abnormalities of symmetrically restricted diffusion in the periventricular white matter and corpus callosum.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Nine eyes from 6 patients, 74 years to 90 years of age, referred by ophthalmologists for repair of Adverse-Effectcicatricial entropion after at least 2 years of twice - a - day application of Drugdipivefrin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugMethotrexate - associated Adverse-Effectnephropathy is a rare complication in pediatric oncology, and a review of the literature suggests that exposure to nephrotoxic agents may be a significant but perhaps underrecognized risk factor for its development.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In this paper, we report a case of Adverse-Effectsevere hypercalcemia of immobilization in a 40 - year - old hemodialyzed woman treated by Drugcinacalcet HCl for a severe HPTH - II ( PTH > 1, 000 pg / mL ).
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect Although combinations of belladonna, ergotamine, and Drugphenobarbital have been used for medical treatment of menopausal symptoms since the 1960s, this is the first known case report of its association with Adverse-Effectanticonvulsant hypersensitivity syndrome .
0.9996 Adverse-Effect Although combinations of Drugbelladonna , ergotamine, and phenobarbital have been used for medical treatment of menopausal symptoms since the 1960s, this is the first known case report of its association with Adverse-Effectanticonvulsant hypersensitivity syndrome .
0.9996 Adverse-Effect Although combinations of belladonna, Drugergotamine , and phenobarbital have been used for medical treatment of menopausal symptoms since the 1960s, this is the first known case report of its association with Adverse-Effectanticonvulsant hypersensitivity syndrome .
1.0000 Adverse-Effect Although combinations of belladonna, ergotamine, and Drugphenobarbital have been used for medical treatment of Adverse-Effectmenopausal symptoms since the 1960s, this is the first known case report of its association with anticonvulsant hypersensitivity syndrome.
0.9999 Adverse-Effect Although combinations of belladonna, Drugergotamine , and phenobarbital have been used for medical treatment of Adverse-Effectmenopausal symptoms since the 1960s, this is the first known case report of its association with anticonvulsant hypersensitivity syndrome.
0.9999 Adverse-Effect Although combinations of Drugbelladonna , ergotamine, and phenobarbital have been used for medical treatment of Adverse-Effectmenopausal symptoms since the 1960s, this is the first known case report of its association with anticonvulsant hypersensitivity syndrome.
Score Relation Text (Head - Tail)
0.9985 Adverse-Effect OBJECTIVE : To report the occurrence of acute cytolytic hepatitis in a patient exposed to pulse itraconazole therapy for 24 weeks and provide a concise review of the literature on cases of Drugitraconazole - induced Adverse-Effecthepatitis .
0.9846 Adverse-Effect OBJECTIVE : To report the occurrence of Adverse-Effectacute cytolytic hepatitis in a patient exposed to pulse Drugitraconazole therapy for 24 weeks and provide a concise review of the literature on cases of itraconazole - induced hepatitis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect INTRODUCTION : In resource limited settings patients on antiretroviral treatment who develop Drugstavudine induced Adverse-Effecthyperlactatemia are often switched to zidovudine on the basis of published studies that demonstrate that this agent can be a safe alternative.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : Although Drugmirtazapine offers clinicians a combination of strong efficacy and good safety, we suggest bearing Adverse-EffectSS in mind when prescribing this drug, especially in frail, elderly patients with underlying chronic conditions.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The first reported case, in an adult, of Drugcholestyramine induced Adverse-Effecthyperchloremic metabolic acidosis is a 70 year old female with a two year history of primary biliary cirrhosis confirmed by histologic and immunologic criteria.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We have successfully overcome Adverse-Effectsevere neutropenia in an RA patient treated with Druggold salts, using granulocyte colony - stimulating factor ( G - CSF ), reducing the duration of neutropenia and risk of infection.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the case of a lung cancer patient with bronquiloalveolar carcinoma ( BAC ) presenting with BOOP after chemotherapy with docetaxel and Druggemcitabine producing Adverse-Effectsevere respiratory insufficiency , and simulating a progression of the tumor.
1.0000 Adverse-Effect We report the case of a lung cancer patient with bronquiloalveolar carcinoma ( BAC ) presenting with Adverse-EffectBOOP after chemotherapy with Drugdocetaxel and gemcitabine producing severe respiratory insufficiency, and simulating a progression of the tumor.
0.9999 Adverse-Effect We report the case of a lung cancer patient with bronquiloalveolar carcinoma ( BAC ) presenting with Adverse-EffectBOOP after chemotherapy with docetaxel and Druggemcitabine producing severe respiratory insufficiency, and simulating a progression of the tumor.
0.9999 Adverse-Effect We report the case of a lung cancer patient with bronquiloalveolar carcinoma ( BAC ) presenting with BOOP after chemotherapy with Drugdocetaxel and gemcitabine producing Adverse-Effectsevere respiratory insufficiency , and simulating a progression of the tumor.
0.9999 Adverse-Effect We report the case of a lung cancer patient with bronquiloalveolar carcinoma ( BAC ) presenting with BOOP after chemotherapy with docetaxel and Druggemcitabine producing severe respiratory insufficiency, and simulating a Adverse-Effectprogression of the tumor .
0.9997 Adverse-Effect We report the case of a lung cancer patient with bronquiloalveolar carcinoma ( BAC ) presenting with BOOP after chemotherapy with Drugdocetaxel and gemcitabine producing severe respiratory insufficiency, and simulating a Adverse-Effectprogression of the tumor .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This report details a case of Adverse-Effectbilateral avascular necrosis of the femoral heads in a patient receiving'standard'doses of Drugdexamethasone as part of the antiemetic regimen used in cisplatin - based combination chemotherapy.
0.9989 Adverse-Effect This report details a case of Adverse-Effectbilateral avascular necrosis of the femoral heads in a patient receiving'standard'doses of dexamethasone as part of the antiemetic regimen used in Drugcisplatin - based combination chemotherapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In the present paper the authors describe 2 female patients who developed Adverse-Effectincontinence secondary to the selective serotonin reuptake inhibitors Drugparoxetine and sertraline, as well as a third who developed this side effect on venlafaxine.
0.9999 Adverse-Effect In the present paper the authors describe 2 female patients who developed Adverse-Effectincontinence secondary to the selective serotonin reuptake inhibitors paroxetine and Drugsertraline , as well as a third who developed this side effect on venlafaxine.
0.9967 Adverse-Effect In the present paper the authors describe 2 female patients who developed Adverse-Effectincontinence secondary to the selective serotonin reuptake inhibitors paroxetine and sertraline, as well as a third who developed this side effect on Drugvenlafaxine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Exacerbation of Drug5 - FU Adverse-Effectdermatologic toxicities in patients with preexisting conditions suggests the importance of aggressive ocular prophylaxis, using frequent ocular lubrication and topical steroid preparations with concurrent medical management of pre - existing dermatologic conditions.
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect In this report, two newborns with congenital heart anomalies demonstrated the Adverse-Effectharlequin color change , one whose skin findings showed a course related to the dose of systemic Drugprostaglandin E1 , suggesting a possible association.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect One explanation for the noted Adverse-Effectincrease in the theophylline level Drugtheophylline level is that metabolism occurs mainly by cytochrome P450 ( CYP 1A2 ), an enzyme that is known to be inhibited with high concentrations of zafirlukast.
0.9995 Adverse-Effect One explanation for the noted Adverse-Effectincrease in the theophylline level is that metabolism occurs mainly by cytochrome P450 ( CYP 1A2 ), an enzyme that is known to be inhibited with high concentrations of Drugzafirlukast .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect With the use of optical coherence tomography ( OCT ), two patients with DrugIFN - associated Adverse-Effectretinopathy who had developed macular edema and reduced visual acuity during the clinical course of IFN therapy were observed.
0.9999 Adverse-Effect With the use of optical coherence tomography ( OCT ), two patients with IFN - associated retinopathy who had developed macular edema and Adverse-Effectreduced visual acuity during the clinical course of DrugIFN therapy were observed.
0.9985 Adverse-Effect With the use of optical coherence tomography ( OCT ), two patients with IFN - associated retinopathy who had developed Adverse-Effectmacular edema and reduced visual acuity during the clinical course of DrugIFN therapy were observed.
0.9980 Adverse-Effect With the use of optical coherence tomography ( OCT ), two patients with DrugIFN - associated retinopathy who had developed Adverse-Effectmacular edema and reduced visual acuity during the clinical course of IFN therapy were observed.
0.9974 Adverse-Effect With the use of optical coherence tomography ( OCT ), two patients with DrugIFN - associated retinopathy who had developed macular edema and Adverse-Effectreduced visual acuity during the clinical course of IFN therapy were observed.
0.9937 Adverse-Effect With the use of optical coherence tomography ( OCT ), two patients with IFN - associated Adverse-Effectretinopathy who had developed macular edema and reduced visual acuity during the clinical course of DrugIFN therapy were observed.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case of Adverse-Effectsideroblastic anemia is presented in a patient with a left ventricular assist device drive - line infection who was receiving Druglinezolid , an antibiotic used for serious infections with gram - positive organisms.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We introduce a case of a sixty years old woman with several previous episodes of rhinitis, conjunctivitis and Adverse-Effectperspiration immediately after the administration of salmon Drugcalcitonin with nasal spray or intramuscular administration ( Calsynar ).
1.0000 Adverse-Effect We introduce a case of a sixty years old woman with several previous episodes of rhinitis, conjunctivitis and Adverse-Effectperspiration immediately after the administration of salmon calcitonin with nasal spray or intramuscular administration ( DrugCalsynar ).
1.0000 Adverse-Effect We introduce a case of a sixty years old woman with several previous episodes of rhinitis, Adverse-Effectconjunctivitis and perspiration immediately after the administration of salmon Drugcalcitonin with nasal spray or intramuscular administration ( Calsynar ).
0.9999 Adverse-Effect We introduce a case of a sixty years old woman with several previous episodes of Adverse-Effectrhinitis , conjunctivitis and perspiration immediately after the administration of salmon Drugcalcitonin with nasal spray or intramuscular administration ( Calsynar ).
0.9999 Adverse-Effect We introduce a case of a sixty years old woman with several previous episodes of Adverse-Effectrhinitis , conjunctivitis and perspiration immediately after the administration of salmon calcitonin with nasal spray or intramuscular administration ( DrugCalsynar ).
0.9999 Adverse-Effect We introduce a case of a sixty years old woman with several previous episodes of rhinitis, Adverse-Effectconjunctivitis and perspiration immediately after the administration of salmon calcitonin with nasal spray or intramuscular administration ( DrugCalsynar ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Videopolysomnographic and pharmacokinetic studies with monitoring of plasma Druglevodopa levels demonstrated Adverse-Effectmarked motor hyperactivity during augmentation, with anarchic discharges of motor unit potentials, tonic grouped discharges and flexor spasms, associated with painful dysesthesia.
1.0000 Adverse-Effect Videopolysomnographic and pharmacokinetic studies with monitoring of plasma Druglevodopa levels demonstrated marked motor hyperactivity during augmentation, with anarchic discharges of motor unit potentials, tonic grouped discharges and flexor spasms, associated with Adverse-Effectpainful dysesthesia .
1.0000 Adverse-Effect Videopolysomnographic and pharmacokinetic studies with monitoring of plasma Druglevodopa levels demonstrated marked motor hyperactivity during augmentation, with Adverse-Effectanarchic discharges of motor unit potentials , tonic grouped discharges and flexor spasms, associated with painful dysesthesia.
0.9999 Adverse-Effect Videopolysomnographic and pharmacokinetic studies with monitoring of plasma Druglevodopa levels demonstrated marked motor hyperactivity during augmentation, with anarchic discharges of motor unit potentials, Adverse-Effecttonic grouped discharges and flexor spasms, associated with painful dysesthesia.
0.9999 Adverse-Effect Videopolysomnographic and pharmacokinetic studies with monitoring of plasma Druglevodopa levels demonstrated marked motor hyperactivity during augmentation, with anarchic discharges of motor unit potentials, tonic grouped discharges and Adverse-Effectflexor spasms , associated with painful dysesthesia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Currently the use of Drugzidovudine is one of the few specific measures available, and as a potentially Adverse-Effectteratogenic and fetotoxic agent, any decision for its use requires evaluation of the potential for fetal damage.
0.9999 Adverse-Effect Currently the use of Drugzidovudine is one of the few specific measures available, and as a potentially teratogenic and fetotoxic agent, any decision for its use requires evaluation of the potential for Adverse-Effectfetal damage .
0.9999 Adverse-Effect Currently the use of Drugzidovudine is one of the few specific measures available, and as a potentially teratogenic and Adverse-Effectfetotoxic agent, any decision for its use requires evaluation of the potential for fetal damage.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A patient is presented with typical hyperthyroidism, who developed a severe proximal muscle weakness and a Adverse-Effectraised creatine phosphokinase after treatment for hyperthyroidism with Drugpropylthiouracil ( 100 mg orally, three times a day ).
1.0000 Adverse-Effect A patient is presented with typical hyperthyroidism, who developed a Adverse-Effectsevere proximal muscle weakness and a raised creatine phosphokinase after treatment for hyperthyroidism with Drugpropylthiouracil ( 100 mg orally, three times a day ).
0.9999 Adverse-Effect A patient is presented with typical Adverse-Effecthyperthyroidism , who developed a severe proximal muscle weakness and a raised creatine phosphokinase after treatment for hyperthyroidism with Drugpropylthiouracil ( 100 mg orally, three times a day ).
Score Relation Text (Head - Tail)
0.9997 Adverse-Effect After a six - week course of low - dose Drugcyclosporine A , she developed a severe but reversible Adverse-Effectloss of glomerular filtration rate and effective renal plasma flow despite of low cyclosporine A plasma levels.
0.9997 Adverse-Effect After a six - week course of low - dose Drugcyclosporine A , she developed a severe but reversible loss of glomerular filtration rate and Adverse-Effecteffective renal plasma flow despite of low cyclosporine A plasma levels.
0.9998 Adverse-Effect After a six - week course of low - dose Drugcyclosporine A , she developed a severe but Adverse-Effectreversible loss of glomerular filtration rate and effective renal plasma flow despite of low cyclosporine A plasma levels.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We suggest that the previous classification of Drugnitrofurantoin induced Adverse-Effectlung injury into " acute " and " chronic " injury is an oversimplification in view of the wide variety of pathological entities that have subsequently emerged.
Adverse-Effect We suggest that the previous classification of Drugnitrofurantoin Adverse-Effectnitrofurantoin induced lung injury into " acute " and " chronic " injury is an oversimplification in view of the wide variety of pathological entities that have subsequently emerged.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To report the clinical course of a woman with cryptococcal meningitis and no previous cardiac disease who developed a Adverse-Effectfatal cardiac arrhythmia after an acute overdose of Drugamphotericin B and to review its toxicity.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The following is a case report analysis intended to draw attention to the need for better care coordination by describing the observed relationship of Drugolanzapine to metabolic changes manifested as Adverse-Effectuncontrolled diabetes mellitus and weight gain.
0.9998 Adverse-Effect The following is a case report analysis intended to draw attention to the need for better care coordination by describing the observed relationship of Drugolanzapine to metabolic changes manifested as uncontrolled diabetes mellitus and Adverse-Effectweight gain .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We consider asterixis to be an easily overlooked sign of Adverse-Effectneurotoxicity , which may occur even at low or moderate dosage levels, if certain drugs as Druglithium or clozapine are used in combination with CBZ.
0.9999 Adverse-Effect We consider asterixis to be an easily overlooked sign of Adverse-Effectneurotoxicity , which may occur even at low or moderate dosage levels, if certain drugs as lithium or Drugclozapine are used in combination with CBZ.
0.9999 Adverse-Effect We consider asterixis to be an easily overlooked sign of Adverse-Effectneurotoxicity , which may occur even at low or moderate dosage levels, if certain drugs as lithium or clozapine are used in combination with DrugCBZ .
0.9998 Adverse-Effect We consider Adverse-Effectasterixis to be an easily overlooked sign of neurotoxicity, which may occur even at low or moderate dosage levels, if certain drugs as Druglithium or clozapine are used in combination with CBZ.
0.9995 Adverse-Effect We consider Adverse-Effectasterixis to be an easily overlooked sign of neurotoxicity, which may occur even at low or moderate dosage levels, if certain drugs as lithium or Drugclozapine are used in combination with CBZ.
0.9995 Adverse-Effect We consider Adverse-Effectasterixis to be an easily overlooked sign of neurotoxicity, which may occur even at low or moderate dosage levels, if certain drugs as lithium or clozapine are used in combination with DrugCBZ .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect It was hypothesized that valproic acid may interfere with glucuronidation of Druglamotrigine , leading to Adverse-Effectincreased serum lamotrigine levels , or perhaps alter the drug's metabolism, resulting in accumulation of a toxic intermediate metabolite.
0.9995 Adverse-Effect It was hypothesized that Drugvalproic acid may interfere with glucuronidation of lamotrigine, leading to Adverse-Effectincreased serum lamotrigine levels , or perhaps alter the drug's metabolism, resulting in accumulation of a toxic intermediate metabolite.
0.9995 Adverse-Effect It was hypothesized that valproic acid may interfere with glucuronidation of Druglamotrigine , leading to increased serum lamotrigine levels, or perhaps alter the drug's metabolism, resulting in Adverse-Effectaccumulation of a toxic intermediate metabolite .
0.9990 Adverse-Effect It was hypothesized that Drugvalproic acid may interfere with glucuronidation of lamotrigine, leading to increased serum lamotrigine levels, or perhaps alter the drug's metabolism, resulting in Adverse-Effectaccumulation of a toxic intermediate metabolite .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect METHODS : A retrospective report of the first case of Druggemcitabine - related Adverse-EffectHUS , in a patient with metastatic pancreatic adenocarcinoma, treated with a variety of standard therapies in addition to rituximab is presented.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We present a case of Adverse-EffectHUS in an advanced ovarian cancer patient treated with Drugcarboplatin and gemcitabine, and described its favorable outcome after chemotherapy interruption and supportive care with a 1 year follow - up.
1.0000 Adverse-Effect We present a case of Adverse-EffectHUS in an advanced ovarian cancer patient treated with carboplatin and Druggemcitabine , and described its favorable outcome after chemotherapy interruption and supportive care with a 1 year follow - up.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a patient with transitional cell carcinoma of the renal pelvis who developed respiratory dysfunction and an Adverse-Effectabnormal chest x - ray with diffuse interstitial opacities while on chemotherapy with Drugpiritrexim , a methotrexate analog.
0.9999 Adverse-Effect We describe a patient with transitional cell carcinoma of the renal pelvis who developed Adverse-Effectrespiratory dysfunction and an abnormal chest x - ray with diffuse interstitial opacities while on chemotherapy with Drugpiritrexim , a methotrexate analog.
0.9999 Adverse-Effect We describe a patient with transitional cell carcinoma of the renal pelvis who developed respiratory dysfunction and an Adverse-Effectabnormal chest x - ray with diffuse interstitial opacities while on chemotherapy with piritrexim, a Drugmethotrexate analog.
0.9998 Adverse-Effect We describe a patient with transitional cell carcinoma of the renal pelvis who developed Adverse-Effectrespiratory dysfunction and an abnormal chest x - ray with diffuse interstitial opacities while on chemotherapy with piritrexim, a Drugmethotrexate analog.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : The Adverse-Effectpiloerection observed after the replacement of Drugfluvoxamine with milnacipran in this patient appears to have been due to an increase in the alpha ( 1 ) - adrenoceptor occupancy by endogenous norepinephrine induced by milnacipran.
0.9978 Adverse-Effect CONCLUSIONS : The Adverse-Effectpiloerection observed after the replacement of fluvoxamine with Drugmilnacipran in this patient appears to have been due to an increase in the alpha ( 1 ) - adrenoceptor occupancy by endogenous norepinephrine induced by milnacipran.
0.9850 Adverse-Effect CONCLUSIONS : The Adverse-Effectpiloerection observed after the replacement of fluvoxamine with milnacipran in this patient appears to have been due to an increase in the alpha ( 1 ) - adrenoceptor occupancy by endogenous Drugnorepinephrine induced by milnacipran.
0.9799 Adverse-Effect CONCLUSIONS : The Adverse-Effectpiloerection observed after the replacement of fluvoxamine with milnacipran in this patient appears to have been due to an increase in the alpha ( 1 ) - adrenoceptor occupancy by endogenous norepinephrine induced by Drugmilnacipran .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In summary, we report herein the first case of Adverse-EffectSIADH believed to be an adverse effect of Drugmizoribin , which may therefore needed to be added to the list of drugs which can induce SIADH.
1.0000 Adverse-Effect In summary, we report herein the first case of SIADH believed to be an adverse effect of Drugmizoribin , which may therefore needed to be added to the list of drugs which can induce Adverse-EffectSIADH .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect During the first days of Drugarsenic trioxide treatment a rapid Adverse-Effectdecrease in the D - dimers was seen ( normal values reached until day 7 ), together with a slight decrease in peripheral blood leukocytes.
0.9994 Adverse-Effect During the first days of Drugarsenic trioxide treatment a rapid decrease in the D - dimers was seen ( normal values reached until day 7 ), together with a Adverse-Effectslight decrease in peripheral blood leukocytes .
0.9993 Adverse-Effect During the first days of Drugarsenic trioxide treatment a rapid decrease in the D - dimers was seen ( normal values reached until day 7 ), together with a slight Adverse-Effectdecrease in peripheral blood leukocytes .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Therefore, although Druggarenoxacin reportedly causes fewer adverse reactions for Adverse-Effectcardiac rhythms than third - generation quinolone antibiotics, one must be cautious of the interference of other drugs during hypokalemia in order to prevent TdP.
0.9993 Adverse-Effect Therefore, although Druggarenoxacin reportedly causes fewer adverse reactions for cardiac rhythms than third - generation quinolone antibiotics, one must be cautious of the interference of other drugs during Adverse-Effecthypokalemia in order to prevent TdP.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Two children, 1 with idiopathic nephrotic syndrome and 1 with endo - extracapillary glomerulonephritis, presented an episode of seizures and Adverse-Effecttransient blindness at different times after i. v. pulse Drugmethylprednisolone ( IVPMP ) treatment.
1.0000 Adverse-Effect Two children, 1 with idiopathic nephrotic syndrome and 1 with endo - extracapillary glomerulonephritis, presented an episode of Adverse-Effectseizures and transient blindness at different times after i. v. pulse Drugmethylprednisolone ( IVPMP ) treatment.
1.0000 Adverse-Effect Two children, 1 with idiopathic nephrotic syndrome and 1 with endo - extracapillary glomerulonephritis, presented an episode of seizures and Adverse-Effecttransient blindness at different times after i. v. pulse methylprednisolone ( DrugIVPMP ) treatment.
0.9999 Adverse-Effect Two children, 1 with idiopathic nephrotic syndrome and 1 with endo - extracapillary glomerulonephritis, presented an episode of Adverse-Effectseizures and transient blindness at different times after i. v. pulse methylprednisolone ( DrugIVPMP ) treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A Drugdapsone Adverse-Effecthypersensitivity syndrome , consisting of fever, headache, nausea, vomiting, lymphadenopathy, hepatitis, hemolysis, leukopenia, and mononucleosis, has been described in patients treated with the drug for leprosy.
0.9999 Adverse-Effect A Drugdapsone hypersensitivity syndrome, consisting of fever, headache, nausea, Adverse-Effectvomiting , lymphadenopathy, hepatitis, hemolysis, leukopenia, and mononucleosis, has been described in patients treated with the drug for leprosy.
0.9999 Adverse-Effect A Drugdapsone hypersensitivity syndrome, consisting of fever, headache, Adverse-Effectnausea , vomiting, lymphadenopathy, hepatitis, hemolysis, leukopenia, and mononucleosis, has been described in patients treated with the drug for leprosy.
0.9999 Adverse-Effect A Drugdapsone hypersensitivity syndrome, consisting of fever, Adverse-Effectheadache , nausea, vomiting, lymphadenopathy, hepatitis, hemolysis, leukopenia, and mononucleosis, has been described in patients treated with the drug for leprosy.
0.9999 Adverse-Effect A Drugdapsone hypersensitivity syndrome, consisting of fever, headache, nausea, vomiting, lymphadenopathy, Adverse-Effecthepatitis , hemolysis, leukopenia, and mononucleosis, has been described in patients treated with the drug for leprosy.
0.9999 Adverse-Effect A Drugdapsone hypersensitivity syndrome, consisting of fever, headache, nausea, vomiting, lymphadenopathy, hepatitis, Adverse-Effecthemolysis , leukopenia, and mononucleosis, has been described in patients treated with the drug for leprosy.
0.9999 Adverse-Effect A Drugdapsone hypersensitivity syndrome, consisting of fever, headache, nausea, vomiting, lymphadenopathy, hepatitis, hemolysis, Adverse-Effectleukopenia , and mononucleosis, has been described in patients treated with the drug for leprosy.
0.9999 Adverse-Effect A Drugdapsone hypersensitivity syndrome, consisting of Adverse-Effectfever , headache, nausea, vomiting, lymphadenopathy, hepatitis, hemolysis, leukopenia, and mononucleosis, has been described in patients treated with the drug for leprosy.
0.9999 Adverse-Effect A Drugdapsone hypersensitivity syndrome, consisting of fever, headache, nausea, vomiting, Adverse-Effectlymphadenopathy , hepatitis, hemolysis, leukopenia, and mononucleosis, has been described in patients treated with the drug for leprosy.
0.9998 Adverse-Effect A Drugdapsone hypersensitivity syndrome, consisting of fever, headache, nausea, vomiting, lymphadenopathy, hepatitis, hemolysis, leukopenia, and Adverse-Effectmononucleosis , has been described in patients treated with the drug for leprosy.
Score Relation Text (Head - Tail)
0.9992 Adverse-Effect Cardiac glycosides are thought to prevent Drugdoxorubicin Adverse-Effectcardiomyopathy by competitively inhibiting doxorubicin at its receptor sites, but ouabain has a much shorter half life than doxorubicin and its metabolites and so is less effective than digoxin.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : The purpose of this study was to determine whether desensitization to NPH insulin, as well as standard Druginsulin desensitization, could control Adverse-Effectallergic symptoms in a patient allergic to both NPH and regular insulin.
0.9988 Adverse-Effect OBJECTIVE : The purpose of this study was to determine whether desensitization to DrugNPH insulin , as well as standard insulin desensitization, could control Adverse-Effectallergic symptoms in a patient allergic to both NPH and regular insulin.
1.0000 Adverse-Effect OBJECTIVE : The purpose of this study was to determine whether desensitization to NPH insulin, as well as standard insulin desensitization, could control Adverse-Effectallergic symptoms in a patient allergic to both DrugNPH and regular insulin.
0.9998 Adverse-Effect OBJECTIVE : The purpose of this study was to determine whether desensitization to NPH insulin, as well as standard insulin desensitization, could control Adverse-Effectallergic symptoms in a patient allergic to both NPH and regular Druginsulin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The authors present an elderly patient with mixed dementia who developed TD at multiple sites, ( including respiratory dyskinesia [ RD ], limb dyskinesia, and Adverse-Effectorofacial dyskinesia ) following abrupt withdrawal of Drugrisperidone therapy.
1.0000 Adverse-Effect The authors present an elderly patient with mixed dementia who developed TD at multiple sites, ( including respiratory dyskinesia [ Adverse-EffectRD ], limb dyskinesia, and orofacial dyskinesia ) following abrupt withdrawal of Drugrisperidone therapy.
1.0000 Adverse-Effect The authors present an elderly patient with mixed dementia who developed TD at multiple sites, ( including respiratory dyskinesia [ RD ], Adverse-Effectlimb dyskinesia , and orofacial dyskinesia ) following abrupt withdrawal of Drugrisperidone therapy.
1.0000 Adverse-Effect The authors present an elderly patient with mixed dementia who developed TD at multiple sites, ( including Adverse-Effectrespiratory dyskinesia [ RD ], limb dyskinesia, and orofacial dyskinesia ) following abrupt withdrawal of Drugrisperidone therapy.
1.0000 Adverse-Effect The authors present an elderly patient with mixed dementia who developed Adverse-EffectTD at multiple sites, ( including respiratory dyskinesia [ RD ], limb dyskinesia, and orofacial dyskinesia ) following abrupt withdrawal of Drugrisperidone therapy.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect We conjectured that the side effects of Druginsulin , such as Adverse-Effectanti - natriuresis and increased vascular permeability, might be pronounced in the presence of the hepatic dysfunction that accompanies insulin insensitivity, hyperinsulinaemia and hypoalbuminaemia.
0.9993 Adverse-Effect We conjectured that the side effects of Druginsulin , such as anti - natriuresis and Adverse-Effectincreased vascular permeability , might be pronounced in the presence of the hepatic dysfunction that accompanies insulin insensitivity, hyperinsulinaemia and hypoalbuminaemia.
0.9992 Adverse-Effect We conjectured that the side effects of Druginsulin , such as anti - natriuresis and increased vascular permeability, might be pronounced in the presence of the hepatic dysfunction that accompanies insulin insensitivity, Adverse-Effecthyperinsulinaemia and hypoalbuminaemia.
0.9990 Adverse-Effect We conjectured that the side effects of Druginsulin , such as anti - natriuresis and increased vascular permeability, might be pronounced in the presence of the hepatic dysfunction that accompanies insulin insensitivity, hyperinsulinaemia and Adverse-Effecthypoalbuminaemia .
0.9975 Adverse-Effect We conjectured that the side effects of Druginsulin , such as anti - natriuresis and increased vascular permeability, might be pronounced in the presence of the hepatic dysfunction that accompanies Adverse-Effectinsulin insensitivity , hyperinsulinaemia and hypoalbuminaemia.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect We present two cases in which both patients suffered with Adverse-EffectCLS , which we believe was caused following administration of Druggranulocyte colony - stimulating factor , to our knowledge not described in the intensive care patient previously.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The principle treatment for DPD - deficient patients with severe acute 5 - FU reactions is supportive care ; however, the administration of thymidine potentially may reverse severe Drug5 - FU - induced Adverse-Effectneurologic symptoms such as encephalopathy and coma.
0.9998 Adverse-Effect The principle treatment for DPD - deficient patients with severe acute 5 - FU reactions is supportive care ; however, the administration of thymidine potentially may reverse severe Drug5 - FU - induced neurologic symptoms such as Adverse-Effectencephalopathy and coma.
0.9998 Adverse-Effect The principle treatment for DPD - deficient patients with severe acute 5 - FU reactions is supportive care ; however, the administration of thymidine potentially may reverse severe Drug5 - FU - induced neurologic symptoms such as encephalopathy and Adverse-Effectcoma .
0.9996 Adverse-Effect The principle treatment for DPD - deficient patients with severe acute Drug5 - FU reactions is supportive care ; however, the administration of thymidine potentially may reverse severe 5 - FU - induced Adverse-Effectneurologic symptoms such as encephalopathy and coma.
0.9995 Adverse-Effect The principle treatment for DPD - deficient patients with severe acute Drug5 - FU reactions is supportive care ; however, the administration of thymidine potentially may reverse severe 5 - FU - induced neurologic symptoms such as encephalopathy and Adverse-Effectcoma .
0.9994 Adverse-Effect The principle treatment for DPD - deficient patients with severe acute Drug5 - FU reactions is supportive care ; however, the administration of thymidine potentially may reverse severe 5 - FU - induced neurologic symptoms such as Adverse-Effectencephalopathy and coma.
Adverse-Effect The principle treatment for DPD - deficient patients with Adverse-Effectsevere acute 5 - FU reactions Drug5 - FU reactions is supportive care ; however, the administration of thymidine potentially may reverse severe 5 - FU - induced neurologic symptoms such as encephalopathy and coma.
Adverse-Effect The principle treatment for DPD - deficient patients with Adverse-Effectsevere acute 5 - FU reactions is supportive care ; however, the administration of thymidine potentially may reverse severe Drug5 - FU - induced neurologic symptoms such as encephalopathy and coma.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect A case report is presented concerning the administration of ketanserin in the treatment of pulmonary vasoconstriction and Adverse-Effectright ventricular failure following the infusion of Drugprotamine in a patient undergoing coronary artery bypass surgery and mitral valve replacement.
0.9987 Adverse-Effect A case report is presented concerning the administration of ketanserin in the treatment of Adverse-Effectpulmonary vasoconstriction and right ventricular failure following the infusion of Drugprotamine in a patient undergoing coronary artery bypass surgery and mitral valve replacement.
0.9997 Adverse-Effect A case report is presented concerning the administration of Drugketanserin in the treatment of Adverse-Effectpulmonary vasoconstriction and right ventricular failure following the infusion of protamine in a patient undergoing coronary artery bypass surgery and mitral valve replacement.
0.9974 Adverse-Effect A case report is presented concerning the administration of Drugketanserin in the treatment of pulmonary vasoconstriction and Adverse-Effectright ventricular failure following the infusion of protamine in a patient undergoing coronary artery bypass surgery and mitral valve replacement.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This patient developed sequential symptoms including alternative hemiparesis, dysarthria and Adverse-Effectaltered consciousness 5 days after the second course of DrugHD - MTX ( 8 gm / m2 by 6 h continuous infusion ) with leucovorin rescue.
0.9999 Adverse-Effect This patient developed sequential symptoms including alternative hemiparesis, Adverse-Effectdysarthria and altered consciousness 5 days after the second course of DrugHD - MTX ( 8 gm / m2 by 6 h continuous infusion ) with leucovorin rescue.
0.9998 Adverse-Effect This patient developed sequential symptoms including alternative Adverse-Effecthemiparesis , dysarthria and altered consciousness 5 days after the second course of DrugHD - MTX ( 8 gm / m2 by 6 h continuous infusion ) with leucovorin rescue.
0.9994 Adverse-Effect This patient developed sequential symptoms including alternative hemiparesis, dysarthria and Adverse-Effectaltered consciousness 5 days after the second course of HD - MTX ( 8 gm / m2 by 6 h continuous infusion ) with Drugleucovorin rescue.
0.9989 Adverse-Effect This patient developed sequential symptoms including alternative hemiparesis, Adverse-Effectdysarthria and altered consciousness 5 days after the second course of HD - MTX ( 8 gm / m2 by 6 h continuous infusion ) with Drugleucovorin rescue.
0.9983 Adverse-Effect This patient developed sequential symptoms including alternative Adverse-Effecthemiparesis , dysarthria and altered consciousness 5 days after the second course of HD - MTX ( 8 gm / m2 by 6 h continuous infusion ) with Drugleucovorin rescue.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugFK506 , which began to be administered 12 days earlier, rose to a level of 44 ng / mL ( normal range, 10 - 20 ng / mL ) 1 day before Adverse-Effectneurologic abnormalities began.
Score Relation Text (Head - Tail)
0.6453 Adverse-Effect From 1996 to 2002 several medications were changed due to their adverse effects : Drugindinavir ( renal colic and Adverse-Effectfever ), nelfinavir ( cutaneous rash ), and efavirenz ( nausea and temporary memory loss ).
Adverse-Effect From 1996 to 2002 several medications were changed due to their adverse effects : Drugindinavir ( Adverse-Effectrenal colic and fever ), nelfinavir ( cutaneous rash ), and efavirenz ( nausea and temporary memory loss ).
Adverse-Effect From 1996 to 2002 several medications were changed due to their adverse effects : indinavir ( renal colic and fever ), Drugnelfinavir ( Adverse-Effectcutaneous rash ), and efavirenz ( nausea and temporary memory loss ).
Adverse-Effect From 1996 to 2002 several medications were changed due to their adverse effects : indinavir ( renal colic and fever ), nelfinavir ( cutaneous rash ), and Drugefavirenz ( nausea and Adverse-Effecttemporary memory loss ).
Adverse-Effect From 1996 to 2002 several medications were changed due to their adverse effects : indinavir ( renal colic and fever ), nelfinavir ( cutaneous rash ), and Drugefavirenz ( Adverse-Effectnausea and temporary memory loss ).
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect A 74 - year - old man received oral administration of Drugpilsicainide , a pure sodium channel blocker with slow recovery kinetics, to convert paroxysmal atrial fibrillation to sinus rhythm and developed Adverse-Effectloss of consciousness two days later.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Based on the Naranjo algorithm, the adverse reaction observed was probably related to the hydroxyurea treatment ( score = 6 ) ; however, the Drughydroxyurea chemotherapy could not be discontinued because of the Adverse-Effectmyeloproliferative disorder .
0.9983 Adverse-Effect Based on the Naranjo algorithm, the adverse reaction observed was probably related to the Drughydroxyurea treatment ( score = 6 ) ; however, the hydroxyurea chemotherapy could not be discontinued because of the Adverse-Effectmyeloproliferative disorder .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Adverse-EffectMinor electrocardiographical changes were noted in five out of six patients who were not receiving a cardiac glycoside and four out of six who were receiving Drugouabain , and none of the 16 who were receiving digoxin.
0.9998 Adverse-Effect Adverse-EffectMinor electrocardiographical changes were noted in five out of six patients who were not receiving a cardiac glycoside and four out of six who were receiving ouabain, and none of the 16 who were receiving Drugdigoxin .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Phenytoin was discontinued after admission ; however, Drugphenytoin 1 g i. v. was given for a tonic - clonic seizure two days after admission, after which Adverse-Effectswelling of the face and legs and pruritus developed.
0.9998 Adverse-Effect Phenytoin was discontinued after admission ; however, Drugphenytoin 1 g i. v. was given for a tonic - clonic seizure two days after admission, after which swelling of the face and legs and Adverse-Effectpruritus developed.
0.9994 Adverse-Effect DrugPhenytoin was discontinued after admission ; however, phenytoin 1 g i. v. was given for a tonic - clonic seizure two days after admission, after which Adverse-Effectswelling of the face and legs and pruritus developed.
0.9992 Adverse-Effect DrugPhenytoin was discontinued after admission ; however, phenytoin 1 g i. v. was given for a tonic - clonic seizure two days after admission, after which swelling of the face and legs and Adverse-Effectpruritus developed.
Score Relation Text (Head - Tail)
0.9990 Adverse-Effect It is concluded that ' Adverse-Effectcerebral atrophy ' on CT scans may represent an accumulative effect of DrugACTH and that ACTH should be given with the utmost discretion, and in as low a dose as possible.
0.9266 Adverse-Effect It is concluded that ' Adverse-Effectcerebral atrophy ' on CT scans may represent an accumulative effect of ACTH and that DrugACTH should be given with the utmost discretion, and in as low a dose as possible.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a case of advanced ovarian carcinoma who developed difficulty walking because of marked pain in the lower extremities and Adverse-Effectloss of proprioception 25 days after treatment with weekly Drugtaxol ( 80 mg / m ( 2 ) x3 ).
1.0000 Adverse-Effect We describe a case of advanced ovarian carcinoma who developed difficulty walking because of Adverse-Effectmarked pain in the lower extremities and loss of proprioception 25 days after treatment with weekly Drugtaxol ( 80 mg / m ( 2 ) x3 ).
0.9999 Adverse-Effect We describe a case of advanced ovarian carcinoma who developed Adverse-Effectdifficulty walking because of marked pain in the lower extremities and loss of proprioception 25 days after treatment with weekly Drugtaxol ( 80 mg / m ( 2 ) x3 ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report here a 26 - year - old female with diffuse large B - cell lymphoma who died of Adverse-Effectsevere pulmonary fibrosis 81 days after the administration of high - dose DrugBCNU ( 600 mg / m2 ).
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Symptoms and signs of Adverse-Effectaugmentation were related to low plasma Druglevodopa levels, abating 75 minutes after oral levodopa administration and reappearing after 3 hours, closely mirroring the rapid rise and fall of plasma levodopa concentration.
0.9985 Adverse-Effect Symptoms and signs of Adverse-Effectaugmentation were related to low plasma levodopa levels, abating 75 minutes after oral Druglevodopa administration and reappearing after 3 hours, closely mirroring the rapid rise and fall of plasma levodopa concentration.
0.9977 Adverse-Effect Symptoms and signs of Adverse-Effectaugmentation were related to low plasma levodopa levels, abating 75 minutes after oral levodopa administration and reappearing after 3 hours, closely mirroring the rapid rise and fall of plasma Druglevodopa concentration.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect METHODS : Double - blind, placebo - controlled titrated oral challenges with pancreatic enzymes resulted in definite Adverse-Effectvomiting within 1 to 1. 5 hours after challenges with DrugViokase and Pancrease MT 16, but not with placebo.
0.9999 Adverse-Effect METHODS : Double - blind, placebo - controlled titrated oral challenges with pancreatic enzymes resulted in definite Adverse-Effectvomiting within 1 to 1. 5 hours after challenges with Viokase and DrugPancrease MT 16 , but not with placebo.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect After ruling out a hydrotelluric source of fluorine, the patient's Adverse-Effectfluorosis was linked to chronic use of Drugniflumic acid , following the publication in 1978 of the 2 previously reported cases affected by this drug.
Score Relation Text (Head - Tail)
0.9997 Adverse-Effect PURPOSE : To investigate the concentration - side effect relationship in a patient with severe Drugacyclovir - induced Adverse-Effectneurotoxicity and to summarize the information available in the literature about central nervous system side effects due to acyclovir.
0.9967 Adverse-Effect PURPOSE : To investigate the concentration - side effect relationship in a patient with severe acyclovir - induced neurotoxicity and to summarize the information available in the literature about Adverse-Effectcentral nervous system side effects due to Drugacyclovir .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a 5 - year - old boy with CF who had a stricture of the hepatic flexure region with associated narrowing due to Adverse-Effectsubmucosal fibrosis of the transverse colon , secondary to Drughigh - lipase pancreatin therapy.
0.9996 Adverse-Effect We report a 5 - year - old boy with CF who had a stricture Adverse-Effectof the hepatic flexure region with associated narrowing due to submucosal fibrosis of the transverse colon, secondary to Drughigh - lipase pancreatin therapy.
0.9996 Adverse-Effect We report a 5 - year - old boy with CF who had a stricture of Adverse-Effectthe hepatic flexure region with associated narrowing due to submucosal fibrosis of the transverse colon, secondary to Drughigh - lipase pancreatin therapy.
0.9995 Adverse-Effect We report a 5 - year - old boy with CF who had a stricture of the Adverse-Effecthepatic flexure region with associated narrowing due to submucosal fibrosis of the transverse colon, secondary to Drughigh - lipase pancreatin therapy.
Adverse-Effect We report a 5 - year - old boy with CF who had a Adverse-Effectstricture of the hepatic flexure region with associated narrowing due to submucosal fibrosis of the transverse colon, secondary to Drughigh - lipase pancreatin therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The presented patient was treated with 200 mg DrugTCA and developed Adverse-EffectCushing's syndrome 6 weeks later ( cortisol and ACTH concentrations were below limits of detection, TCA concentrations were > 3 micrograms / l ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Such a rapid and relentless progression of Drugmethyldopa - induced Adverse-Effectliver injury is undoubtedly rare, but it may be prevented by careful supervision of patients who exhibit liver function abnormalities early in the course of therapy.
0.9986 Adverse-Effect Such a rapid and relentless progression of Drugmethyldopa - induced liver injury is undoubtedly rare, but it may be prevented by careful supervision of patients who exhibit Adverse-Effectliver function abnormalities early in the course of therapy.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect We report an HIV - infected woman who developed mild leukopenia as the first sign of a Drugnevirapine - related adverse event, which was followed by Adverse-Effectskin and hepatic toxicity associated with a more severe leukopenia.
0.9996 Adverse-Effect We report an HIV - infected woman who developed mild Adverse-Effectleukopenia as the first sign of a Drugnevirapine - related adverse event, which was followed by skin and hepatic toxicity associated with a more severe leukopenia.
0.9994 Adverse-Effect We report an HIV - infected woman who developed mild leukopenia as the first sign of a Drugnevirapine - related adverse event, which was followed by skin and hepatic toxicity associated with a more severe Adverse-Effectleukopenia .
0.9997 Adverse-Effect We report an HIV - infected woman who developed Adverse-Effectmild leukopenia as the first sign of a Drugnevirapine - related adverse event, which was followed by skin and hepatic toxicity associated with a more severe leukopenia.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect An 11 - year - old boy who was treated with a relatively high dose of methotrimeprazine meleate ( DrugLevemepromazine ) a phenothiazine antipsychotic drug, was admitted to the pediatric intensive care unit suffering from Adverse-Effectrespiratory distress syndrome .
0.9996 Adverse-Effect An 11 - year - old boy who was treated with a relatively high dose of Drugmethotrimeprazine meleate ( Levemepromazine ) a phenothiazine antipsychotic drug, was admitted to the pediatric intensive care unit suffering from Adverse-Effectrespiratory distress syndrome .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The day after clozapine was stopped, while he was still receiving Drugclomipramine 150 mg / d, he began Adverse-Effectbehaving oddly , started sweating profusely, shivering, and became tremulous, agitated, and confused.
0.9999 Adverse-Effect The day after Drugclozapine was stopped, while he was still receiving clomipramine 150 mg / d, he began Adverse-Effectbehaving oddly , started sweating profusely, shivering, and became tremulous, agitated, and confused.
0.9999 Adverse-Effect The day after clozapine was stopped, while he was still receiving Drugclomipramine 150 mg / d, he began behaving oddly, started Adverse-Effectsweating profusely , shivering, and became tremulous, agitated, and confused.
0.9999 Adverse-Effect The day after clozapine was stopped, while he was still receiving Drugclomipramine 150 mg / d, he began behaving oddly, started sweating profusely, Adverse-Effectshivering , and became tremulous, agitated, and confused.
0.9999 Adverse-Effect The day after clozapine was stopped, while he was still receiving Drugclomipramine 150 mg / d, he began behaving oddly, started sweating profusely, shivering, and became Adverse-Effecttremulous , agitated, and confused.
0.9999 Adverse-Effect The day after clozapine was stopped, while he was still receiving Drugclomipramine 150 mg / d, he began behaving oddly, started sweating profusely, shivering, and became tremulous, Adverse-Effectagitated , and confused.
0.9998 Adverse-Effect The day after clozapine was stopped, while he was still receiving Drugclomipramine 150 mg / d, he began behaving oddly, started sweating profusely, shivering, and became tremulous, agitated, and Adverse-Effectconfused .
0.9998 Adverse-Effect The day after Drugclozapine was stopped, while he was still receiving clomipramine 150 mg / d, he began behaving oddly, started sweating profusely, Adverse-Effectshivering , and became tremulous, agitated, and confused.
0.9998 Adverse-Effect The day after Drugclozapine was stopped, while he was still receiving clomipramine 150 mg / d, he began behaving oddly, started Adverse-Effectsweating profusely , shivering, and became tremulous, agitated, and confused.
0.9998 Adverse-Effect The day after Drugclozapine was stopped, while he was still receiving clomipramine 150 mg / d, he began behaving oddly, started sweating profusely, shivering, and became Adverse-Effecttremulous , agitated, and confused.
0.9997 Adverse-Effect The day after Drugclozapine was stopped, while he was still receiving clomipramine 150 mg / d, he began behaving oddly, started sweating profusely, shivering, and became tremulous, Adverse-Effectagitated , and confused.
0.9997 Adverse-Effect The day after Drugclozapine was stopped, while he was still receiving clomipramine 150 mg / d, he began behaving oddly, started sweating profusely, shivering, and became tremulous, agitated, and Adverse-Effectconfused .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect PATIENTS : Two patients, ages 40 and 51 years, undergoing treatment with Druginterferon alfa for malignant neoplasms experienced Adverse-Effectsudden bilateral, sequential visual loss with disc - related field defects and segmental optic disc edema.
0.9996 Adverse-Effect PATIENTS : Two patients, ages 40 and 51 years, undergoing treatment with Druginterferon alfa for malignant neoplasms experienced sudden bilateral, Adverse-Effectsequential visual loss with disc - related field defects and segmental optic disc edema.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We present the case of a patient who had undergone cholecystectomy previously, but in whom Drugmorphine given in the Emergency Department precipitated Adverse-Effectpain consistent with biliary colic ; the pain resolved promptly after administration of naloxone.
0.9999 Adverse-Effect We present the case of a patient who had undergone cholecystectomy previously, but in whom Drugmorphine given in the Emergency Department precipitated pain consistent with Adverse-Effectbiliary colic ; the pain resolved promptly after administration of naloxone.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a 74 - year - old man with rheumatoid arthritis ( RA ) who developed syndrome of inappropriate secretion of antidiuretic hormone ( Adverse-EffectSIADH ) 1. 5 months after commencement of Drugmizoribin prescription when his arthritis was improved.
0.9999 Adverse-Effect We describe a 74 - year - old man with rheumatoid arthritis ( RA ) who developed Adverse-Effectsyndrome of inappropriate secretion of antidiuretic hormone ( SIADH ) 1. 5 months after commencement of Drugmizoribin prescription when his arthritis was improved.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Rapamycin / Drugsirolimus - induced Adverse-Effectpneumonitis has been described previously in renal transplant recipients, and this report describes a stable heart - lung transplant recipient who developed a pulmonary infiltrate that reversed after ceasing SR therapy.
0.9996 Adverse-Effect DrugRapamycin / sirolimus - induced Adverse-Effectpneumonitis has been described previously in renal transplant recipients, and this report describes a stable heart - lung transplant recipient who developed a pulmonary infiltrate that reversed after ceasing SR therapy.
0.9193 Adverse-Effect Rapamycin / Drugsirolimus - induced pneumonitis has been described previously in renal transplant recipients, and this report describes a stable heart - lung transplant recipient who developed a Adverse-Effectpulmonary infiltrate that reversed after ceasing SR therapy.
0.9026 Adverse-Effect DrugRapamycin / sirolimus - induced pneumonitis has been described previously in renal transplant recipients, and this report describes a stable heart - lung transplant recipient who developed a Adverse-Effectpulmonary infiltrate that reversed after ceasing SR therapy.
Adverse-Effect Rapamycin / sirolimus - induced pneumonitis has been described previously in renal transplant recipients, and this report describes a stable heart - lung transplant recipient who developed a Adverse-Effectpulmonary infiltrate that reversed after ceasing DrugSR therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the case of a 14 - year - old female with acute promyelocytic leukemia who developed Adverse-Effectsymptomatic cardiomyopathy only 4 months into treatment with a combination of Drugdaunomycin and all - trans retinoic acid ( ATRA ).
0.9999 Adverse-Effect We report the case of a 14 - year - old female with acute promyelocytic leukemia who developed Adverse-Effectsymptomatic cardiomyopathy only 4 months into treatment with a combination of daunomycin and all - trans retinoic acid ( DrugATRA ).
0.9996 Adverse-Effect We report the case of a 14 - year - old female with acute promyelocytic leukemia who developed Adverse-Effectsymptomatic cardiomyopathy only 4 months into treatment with a combination of daunomycin and Drugall - trans retinoic acid ( ATRA ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The authors report a longitudinal case study of a woman with a history of bipolar affective disorder in which DrugL - dopa Adverse-Effectshortened the manic - depressive cycle length when administered in a double - blind trial.
0.9999 Adverse-Effect The authors report a longitudinal case study of a woman with a history of bipolar affective disorder in which DrugL - dopa Adverse-Effectdopa shortened the manic - depressive cycle length when administered in a double - blind trial.
0.9997 Adverse-Effect The authors report a longitudinal case study of a woman with a history of bipolar affective disorder in which DrugL - dopa Adverse-Effect- dopa shortened the manic - depressive cycle length when administered in a double - blind trial.
0.9994 Adverse-Effect The authors report a longitudinal case study of a woman with a history of bipolar affective disorder in which DrugL - dopa Adverse-EffectL - dopa shortened the manic - depressive cycle length when administered in a double - blind trial.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Purple glove syndrome, named for its distinctive purple discoloration and Adverse-Effectswelling of the hands in the distribution of a glove, is an uncommon complication of intravenous Drugphenytoin administration through small dorsal veins of the hands.
0.9999 Adverse-Effect Adverse-EffectPurple glove syndrome , named for its distinctive purple discoloration and swelling of the hands in the distribution of a glove, is an uncommon complication of intravenous Drugphenytoin administration through small dorsal veins of the hands.
0.9999 Adverse-Effect Purple glove syndrome, named for its distinctive Adverse-Effectpurple discoloration and swelling of the hands in the distribution of a glove, is an uncommon complication of intravenous Drugphenytoin administration through small dorsal veins of the hands.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In this report, we present a case of Adverse-Effecthypoglycaemic coma associated with DrugSP , an adverse reaction that is likely to be underreported and expected to occur with greater frequency as the use of SP increases.
0.9992 Adverse-Effect In this report, we present a case of Adverse-Effecthypoglycaemic coma associated with SP, an adverse reaction that is likely to be underreported and expected to occur with greater frequency as the use of DrugSP increases.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Administration of intravenous Drugnitroglycerin in a patient with idiopathic pulmonary hypertension resulted in an Adverse-Effectincrease in pulmonary artery pressure associated with a decrease in blood flow that is best explained by an increase in pulmonary vascular resistance.
1.0000 Adverse-Effect Administration of intravenous Drugnitroglycerin in a patient with idiopathic pulmonary hypertension resulted in an increase in pulmonary artery pressure associated with a Adverse-Effectdecrease in blood flow that is best explained by an increase in pulmonary vascular resistance.
1.0000 Adverse-Effect Administration of intravenous Drugnitroglycerin in a patient with idiopathic pulmonary hypertension resulted in an increase in pulmonary artery pressure associated with a decrease in blood flow that is best explained by an Adverse-Effectincrease in pulmonary vascular resistance .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect It was postulated that the Adverse-Effectallergic reaction was most likely caused by Drugcapecitabine or the intermediate metabolites based on the immediate reappearance of symptoms from the rechallenge, pharmacokinetic data, and well - tolerance of fluorouracil.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Prolonged responses were achieved with low doses of DrugHU ( 3 - 10 mg / kg / day ) and higher doses were associated with mild reversible hematologic or Adverse-Effecthepatic toxicity and no further increases in Hb.
Adverse-Effect Prolonged responses were achieved with low doses of DrugHU ( 3 - 10 mg / kg / day ) and higher doses were associated with Adverse-Effectmild reversible hematologic or hepatic toxicity and no further increases in Hb.
Score Relation Text (Head - Tail)
0.9996 Adverse-Effect This Adverse-Effectpanic anxiety was not relieved by taking etizolam and flunitrazepam again, but subsided rapidly by the re - administration of Drugmianserin 30 mg / day, and because of that the depressive symptom also disappeared.
1.0000 Adverse-Effect This Adverse-Effectpanic anxiety was not relieved by taking Drugetizolam and flunitrazepam again, but subsided rapidly by the re - administration of mianserin 30 mg / day, and because of that the depressive symptom also disappeared.
0.9998 Adverse-Effect This Adverse-Effectpanic anxiety was not relieved by taking etizolam and Drugflunitrazepam again, but subsided rapidly by the re - administration of mianserin 30 mg / day, and because of that the depressive symptom also disappeared.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Although visual hallucinations have not been reported as an adverse effect of this agent, we describe three patients who experienced complex visual hallucinations and Adverse-Effectaltered mental status after Drugzonisamide treatment was begun or its dosage increased.
0.9998 Adverse-Effect Although visual hallucinations have not been reported as an adverse effect of this agent, we describe three patients who experienced complex Adverse-Effectvisual hallucinations and altered mental status after Drugzonisamide treatment was begun or its dosage increased.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A child in whom a Drugphenobarbital Adverse-Effecthypersensitivity drug reaction developed which consisted of fever, a pruritic desquamating erythrodermic rash, alopecia, icterus, protein - losing enteropathy, myositis, and nephritis, is described.
1.0000 Adverse-Effect A child in whom a Drugphenobarbital hypersensitivity drug reaction developed which consisted of Adverse-Effectfever , a pruritic desquamating erythrodermic rash, alopecia, icterus, protein - losing enteropathy, myositis, and nephritis, is described.
0.9999 Adverse-Effect A child in whom a Drugphenobarbital hypersensitivity drug reaction developed which consisted of fever, a pruritic desquamating erythrodermic rash, Adverse-Effectalopecia , icterus, protein - losing enteropathy, myositis, and nephritis, is described.
0.9999 Adverse-Effect A child in whom a Drugphenobarbital hypersensitivity drug reaction developed which consisted of fever, a pruritic desquamating erythrodermic rash, alopecia, icterus, protein - losing enteropathy, Adverse-Effectmyositis , and nephritis, is described.
0.9999 Adverse-Effect A child in whom a Drugphenobarbital hypersensitivity drug reaction developed which consisted of fever, a pruritic desquamating erythrodermic rash, alopecia, Adverse-Effecticterus , protein - losing enteropathy, myositis, and nephritis, is described.
0.9999 Adverse-Effect A child in whom a Drugphenobarbital hypersensitivity drug reaction developed which consisted of fever, a pruritic desquamating erythrodermic rash, alopecia, icterus, protein - losing enteropathy, myositis, and Adverse-Effectnephritis , is described.
0.9999 Adverse-Effect A child in whom a Drugphenobarbital hypersensitivity drug reaction developed which consisted of fever, Adverse-Effecta pruritic desquamating erythrodermic rash , alopecia, icterus, protein - losing enteropathy, myositis, and nephritis, is described.
0.9999 Adverse-Effect A child in whom a Drugphenobarbital hypersensitivity drug reaction developed which consisted of fever, a pruritic desquamating erythrodermic rash, alopecia, icterus, Adverse-Effectprotein - losing enteropathy , myositis, and nephritis, is described.
1.0000 Adverse-Effect A child in whom a Drugphenobarbital Adverse-Effecthypersensitivity drug reaction developed which consisted of fever, a pruritic desquamating erythrodermic rash, alopecia, icterus, protein - losing enteropathy, myositis, and nephritis, is described.
1.0000 Adverse-Effect A child in whom a Drugphenobarbital Adverse-Effecthypersensitivity drug reaction developed which consisted of fever, a pruritic desquamating erythrodermic rash, alopecia, icterus, protein - losing enteropathy, myositis, and nephritis, is described.
0.9999 Adverse-Effect A child in whom a Drugphenobarbital hypersensitivity drug reaction developed which consisted of fever, a Adverse-Effectpruritic desquamating erythrodermic rash , alopecia, icterus, protein - losing enteropathy, myositis, and nephritis, is described.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We observed 5 reactions in 3 patients that appear to be related to a high dose - infusion time ratio, indicating that dose and rate of infusion may be important factors in precipitating Adverse-Effectanaphylactoid reactions with Drugcisplatin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The present observation suggests, that a batch of different testing doses, including lower testing doses may help to differentiate between an allergic type of contact dermatitis and an Adverse-Effectirritant type of reaction after treatment with Drugcalcipotriol .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DISCUSSION : Rhabdomyolysis is a clinical syndrome resulting from the destruction of skeletal muscle that may progress to renal failure Several drugs have been associated with Adverse-Effectrhabdomyolysis , including Druglovastatin , a hydroxymethylglutaryl - coenzyme A reductase inhibitor.
0.9998 Adverse-Effect DISCUSSION : Adverse-EffectRhabdomyolysis is a clinical syndrome resulting from the destruction of skeletal muscle that may progress to renal failure Several drugs have been associated with rhabdomyolysis, including Druglovastatin , a hydroxymethylglutaryl - coenzyme A reductase inhibitor.
0.9995 Adverse-Effect DISCUSSION : Rhabdomyolysis is a clinical syndrome resulting from the Adverse-Effectdestruction of skeletal muscle that may progress to renal failure Several drugs have been associated with rhabdomyolysis, including Druglovastatin , a hydroxymethylglutaryl - coenzyme A reductase inhibitor.
Score Relation Text (Head - Tail)
0.9995 Adverse-Effect After initiation of topical vitamin D3 ointment ( 20 micro g / g of Drugtacalcitol ) 10 g / day for the skin lesions, both the Adverse-Effectserum level of calcium and urinary excretion of calcium increased gradually.
0.9964 Adverse-Effect After initiation of topical Drugvitamin D3 ointment ( 20 micro g / g of tacalcitol ) 10 g / day for the skin lesions, both the Adverse-Effectserum level of calcium and urinary excretion of calcium increased gradually.
Adverse-Effect After initiation of topical Drugvitamin D3 ointment ( 20 micro g / g of tacalcitol ) 10 g / day for the skin lesions, both the Adverse-Effectserum level of calcium and urinary excretion of calcium increased gradually.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The use of methotrexate ( MTX ) has been contraindicated for treatment of severe psoriasis in HIV infection on the basis of six previously reported cases in which DrugMTX appeared to potentiate opportunistic infections and Adverse-Effectaccelerate HIV disease .
0.9998 Adverse-Effect The use of Drugmethotrexate ( MTX ) has been contraindicated for treatment of severe psoriasis in HIV infection on the basis of six previously reported cases in which MTX appeared to potentiate opportunistic infections and Adverse-Effectaccelerate HIV disease .
0.9998 Adverse-Effect The use of methotrexate ( DrugMTX ) has been contraindicated for treatment of severe psoriasis in HIV infection on the basis of six previously reported cases in which MTX appeared to potentiate opportunistic infections and Adverse-Effectaccelerate HIV disease .
1.0000 Adverse-Effect The use of methotrexate ( MTX ) has been contraindicated for treatment of severe psoriasis in HIV infection on the basis of six previously reported cases in which DrugMTX appeared to Adverse-Effectpotentiate opportunistic infections and accelerate HIV disease.
0.9998 Adverse-Effect The use of Drugmethotrexate ( MTX ) has been contraindicated for treatment of severe psoriasis in HIV infection on the basis of six previously reported cases in which MTX appeared to Adverse-Effectpotentiate opportunistic infections and accelerate HIV disease.
0.9998 Adverse-Effect The use of methotrexate ( DrugMTX ) has been contraindicated for treatment of severe psoriasis in HIV infection on the basis of six previously reported cases in which MTX appeared to Adverse-Effectpotentiate opportunistic infections and accelerate HIV disease.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect During clarithromycin coadministration, four out of the seven patients developed moderate - to - severe Adverse-Effecttoxic symptoms of Drugcarbamazepine , such as drowsiness, dizziness, and ataxia, which resolved within 5 days after clarithromycin discontinuation.
1.0000 Adverse-Effect During clarithromycin coadministration, four out of the seven patients developed moderate - to - severe toxic symptoms of carbamazepine, such as drowsiness, dizziness, and Adverse-Effectataxia , which resolved within 5 days after Drugclarithromycin discontinuation.
1.0000 Adverse-Effect During Drugclarithromycin coadministration, four out of the seven patients developed moderate - to - severe Adverse-Effecttoxic symptoms of carbamazepine, such as drowsiness, dizziness, and ataxia, which resolved within 5 days after clarithromycin discontinuation.
0.9999 Adverse-Effect During clarithromycin coadministration, four out of the seven patients developed moderate - to - severe toxic symptoms of carbamazepine, such as drowsiness, Adverse-Effectdizziness , and ataxia, which resolved within 5 days after Drugclarithromycin discontinuation.
0.9999 Adverse-Effect During clarithromycin coadministration, four out of the seven patients developed moderate - to - severe toxic symptoms of carbamazepine, such as Adverse-Effectdrowsiness , dizziness, and ataxia, which resolved within 5 days after Drugclarithromycin discontinuation.
0.9997 Adverse-Effect During Drugclarithromycin coadministration, four out of the seven patients developed moderate - to - severe toxic symptoms of carbamazepine, such as Adverse-Effectdrowsiness , dizziness, and ataxia, which resolved within 5 days after clarithromycin discontinuation.
0.9997 Adverse-Effect During Drugclarithromycin coadministration, four out of the seven patients developed moderate - to - severe toxic symptoms of carbamazepine, such as drowsiness, Adverse-Effectdizziness , and ataxia, which resolved within 5 days after clarithromycin discontinuation.
0.9997 Adverse-Effect During Drugclarithromycin coadministration, four out of the seven patients developed moderate - to - severe toxic symptoms of carbamazepine, such as drowsiness, dizziness, and Adverse-Effectataxia , which resolved within 5 days after clarithromycin discontinuation.
0.9997 Adverse-Effect During clarithromycin coadministration, four out of the seven patients developed moderate - to - severe toxic symptoms of Drugcarbamazepine , such as Adverse-Effectdrowsiness , dizziness, and ataxia, which resolved within 5 days after clarithromycin discontinuation.
0.9996 Adverse-Effect During clarithromycin coadministration, four out of the seven patients developed moderate - to - severe toxic symptoms of Drugcarbamazepine , such as drowsiness, Adverse-Effectdizziness , and ataxia, which resolved within 5 days after clarithromycin discontinuation.
0.9996 Adverse-Effect During clarithromycin coadministration, four out of the seven patients developed moderate - to - severe Adverse-Effecttoxic symptoms of carbamazepine, such as drowsiness, dizziness, and ataxia, which resolved within 5 days after Drugclarithromycin discontinuation.
0.9996 Adverse-Effect During clarithromycin coadministration, four out of the seven patients developed moderate - to - severe toxic symptoms of Drugcarbamazepine , such as drowsiness, dizziness, and Adverse-Effectataxia , which resolved within 5 days after clarithromycin discontinuation.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CASE SUMMARY : We report the case of a 31 - year - old patient hospitalized due to behavioral alterations and treated with oral Drugzuclopenthixol , an antipsychotic from the thioxanthene family, who developed an acute, Adverse-Effectpainful erection .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DIAGNOSIS : Severe Drugtemozolomide - induced Adverse-Effectimmunosuppression , exacerbated by corticosteroids, with profound T - cell lymphocytopenia and simultaneous opportunistic infections with Pneumocystis jiroveci pneumonia, brain abscess with Listeria monocytogenes, and cutaneous Kaposi's sarcoma.
0.9999 Adverse-Effect DIAGNOSIS : Severe Drugtemozolomide - induced immunosuppression, exacerbated by corticosteroids, with profound T - cell lymphocytopenia and simultaneous opportunistic infections with Pneumocystis jiroveci pneumonia, brain abscess with Listeria monocytogenes, and Adverse-Effectcutaneous Kaposi's sarcoma .
0.9999 Adverse-Effect DIAGNOSIS : Severe Drugtemozolomide - induced immunosuppression, exacerbated by corticosteroids, with profound T - cell lymphocytopenia and simultaneous opportunistic Adverse-Effectinfections with Pneumocystis jiroveci pneumonia , brain abscess with Listeria monocytogenes, and cutaneous Kaposi's sarcoma.
0.9998 Adverse-Effect DIAGNOSIS : Severe Drugtemozolomide - induced immunosuppression, exacerbated by corticosteroids, with profound T - cell lymphocytopenia and simultaneous opportunistic infections with Pneumocystis jiroveci pneumonia, Adverse-Effectbrain abscess with Listeria monocytogenes , and cutaneous Kaposi's sarcoma.
0.9997 Adverse-Effect DIAGNOSIS : Severe Drugtemozolomide - induced immunosuppression, exacerbated by corticosteroids, with profound Adverse-EffectT - cell lymphocytopenia and simultaneous opportunistic infections with Pneumocystis jiroveci pneumonia, brain abscess with Listeria monocytogenes, and cutaneous Kaposi's sarcoma.
0.9999 Adverse-Effect DIAGNOSIS : Severe Drugtemozolomide - induced immunosuppression, exacerbated by corticosteroids, with profound T - cell lymphocytopenia and Adverse-Effectsimultaneous opportunistic infections with Pneumocystis jiroveci pneumonia , brain abscess with Listeria monocytogenes, and cutaneous Kaposi's sarcoma.
0.9999 Adverse-Effect DIAGNOSIS : Severe Drugtemozolomide - induced immunosuppression, exacerbated by corticosteroids, with profound T - cell lymphocytopenia and simultaneous Adverse-Effectopportunistic infections with Pneumocystis jiroveci pneumonia , brain abscess with Listeria monocytogenes, and cutaneous Kaposi's sarcoma.
0.9998 Adverse-Effect DIAGNOSIS : Severe Drugtemozolomide - induced immunosuppression, Adverse-Effectexacerbated by corticosteroids , with profound T - cell lymphocytopenia and simultaneous opportunistic infections with Pneumocystis jiroveci pneumonia, brain abscess with Listeria monocytogenes, and cutaneous Kaposi's sarcoma.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Many clinicians appear to be concerned about the potential Adverse-Effecthepatotoxicity of the opiate antagonist Drugnaltrexone ( NTX ) and this may be one reason why it is not used more widely in treating both heroin and alcohol abusers.
1.0000 Adverse-Effect Many clinicians appear to be concerned about the potential Adverse-Effecthepatotoxicity of the opiate antagonist naltrexone ( DrugNTX ) and this may be one reason why it is not used more widely in treating both heroin and alcohol abusers.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Our review of 194 RA patients and 38 PsA patients receiving MTX has identified four RA patients and one PsA patient with DrugMTX - induced Adverse-Effectpneumonitis , giving a prevalence of 2. 1 % and 0. 03 %, respectively.
0.9759 Adverse-Effect Our review of 194 RA patients and 38 PsA patients receiving DrugMTX has identified four RA patients and one PsA patient with MTX - induced Adverse-Effectpneumonitis , giving a prevalence of 2. 1 % and 0. 03 %, respectively.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 7 - year - old boy developed a Adverse-Effectsevere unilateral grand mal seizure at the age of 5 years ( Drugphenobarbitone therapy ) ; 1. 5 years later valproate ( 2 - propylpentanoic acid, VPA ) was added to the therapy.
0.9999 Adverse-Effect A 7 - year - old boy developed a Adverse-Effectsevere unilateral grand mal seizure at the age of 5 years ( phenobarbitone therapy ) ; 1. 5 years later Drugvalproate ( 2 - propylpentanoic acid, VPA ) was added to the therapy.
0.9998 Adverse-Effect A 7 - year - old boy developed a Adverse-Effectsevere unilateral grand mal seizure at the age of 5 years ( phenobarbitone therapy ) ; 1. 5 years later valproate ( 2 - propylpentanoic acid, DrugVPA ) was added to the therapy.
0.9997 Adverse-Effect A 7 - year - old boy developed a Adverse-Effectsevere unilateral grand mal seizure at the age of 5 years ( phenobarbitone therapy ) ; 1. 5 years later valproate ( Drug2 - propylpentanoic acid , VPA ) was added to the therapy.
Score Relation Text (Head - Tail)
0.9989 Adverse-Effect The authors suggest that fluoxetine - induced akathisia may be caused by serotonergically mediated inhibition of dopaminergic neurotransmission and that the pathophysiology of Drugfluoxetine - induced Adverse-Effectakathisia and tricyclic antidepressant - induced " jitteriness " may be identical.
0.9982 Adverse-Effect The authors suggest that Drugfluoxetine - induced Adverse-Effectakathisia may be caused by serotonergically mediated inhibition of dopaminergic neurotransmission and that the pathophysiology of fluoxetine - induced akathisia and tricyclic antidepressant - induced " jitteriness " may be identical.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Given that discontinuation of nitrofurantoin and introduction of methylprednisolon therapy significantly lowered liver enzyme levels, restoring most of them to normal, we concluded that this was probably the case of Adverse-Effecttoxic liver damage caused by Drugnitrofurantoin .
0.9778 Adverse-Effect Given that discontinuation of nitrofurantoin and introduction of Drugmethylprednisolon therapy significantly lowered liver enzyme levels, restoring most of them to normal, we concluded that this was probably the case of Adverse-Effecttoxic liver damage caused by nitrofurantoin.
0.9524 Adverse-Effect Given that discontinuation of Drugnitrofurantoin and introduction of methylprednisolon therapy significantly lowered liver enzyme levels, restoring most of them to normal, we concluded that this was probably the case of Adverse-Effecttoxic liver damage caused by nitrofurantoin.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In this report we present four patients treated with a combination of different psychotropic drugs, in whom Adverse-Effectasterixis was triggered either by adding Drugcarbamazepine ( CBZ ) to a treatment regimen, or by increasing its dosage.
1.0000 Adverse-Effect In this report we present four patients treated with a combination of different psychotropic drugs, in whom Adverse-Effectasterixis was triggered either by adding carbamazepine ( DrugCBZ ) to a treatment regimen, or by increasing its dosage.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Approximately 15 min after the first administration of nebulised Drugmorphine the patient became markedly Adverse-Effectbradypneic ( respiratory rate : 4 - 5 bpm ), hypotensive ( BP 70 / 40 mmHg ), and responded only partially to command.
0.9999 Adverse-Effect Approximately 15 min after the first administration of nebulised Drugmorphine the patient became markedly bradypneic ( respiratory rate : 4 - 5 bpm ), Adverse-Effecthypotensive ( BP 70 / 40 mmHg ), and responded only partially to command.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Replicate brain magnetic resonance imaging examinations after six weeks and 11 months of Drugpenicillamine therapy documented the development of new Adverse-Effectbrain lesions during this period, while liver biopsy specimen data disclosed that excellent hepatic decoppering had occurred.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This case emphasizes the importance of the evaluation of Druglithium - associated Adverse-Effectpolyuria with a direct measurement of plasma vasopressin, interpreted with simultaneous plasma and urine osmolality to secure the correct diagnosis and ensure appropriate therapeutic management.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a 50 - year - old male patient with a 15 - year history of psoriasis including mutilating psoriatic arthritis, in whom the withdrawal of Drugcyclosporin A induced a Adverse-Effectgeneralised pustular exacerbation and a aggravation of the joint condition.
0.9996 Adverse-Effect We report a 50 - year - old male patient with a 15 - year history of psoriasis including mutilating psoriatic arthritis, in whom the withdrawal of Drugcyclosporin A induced a generalised pustular exacerbation and a Adverse-Effectaggravation of the joint condition .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect An objective causality assessment indicated a probable relationship between Adverse-Effectclotting abnormality and Drugwarfarin administration, although the degree of elevation of the INR was unusual in the light of the daily warfarin dose and duration of its exposure.
0.9401 Adverse-Effect An objective causality assessment indicated a probable relationship between Adverse-Effectclotting abnormality and warfarin administration, although the degree of elevation of the INR was unusual in the light of the daily Drugwarfarin dose and duration of its exposure.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Even though only a few cases of this adverse event have been reported in the literature, severe Drugdocetaxel - induced Adverse-Effectpulmonary toxicity needs to be considered in the differential diagnosis when such patients present with respiratory symptoms.
0.9994 Adverse-Effect Even though only a few cases of this adverse event have been reported in the literature, severe Drugdocetaxel - induced pulmonary toxicity needs to be considered in the differential diagnosis when such patients present with Adverse-Effectrespiratory symptoms .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect METHODS : A 68 - year - old man developed intense conjunctival hyperemia and cystoid macula edema after switching from latanoprost to Drugbimatoprost 9 months after cataract surgery in an eye at low - risk for this Adverse-Effectcystoid macular edema .
1.0000 Adverse-Effect METHODS : A 68 - year - old man developed intense conjunctival hyperemia and Adverse-Effectcystoid macula edema after switching from Druglatanoprost to bimatoprost 9 months after cataract surgery in an eye at low - risk for this cystoid macular edema.
0.9999 Adverse-Effect METHODS : A 68 - year - old man developed Adverse-Effectintense conjunctival hyperemia and cystoid macula edema after switching from Druglatanoprost to bimatoprost 9 months after cataract surgery in an eye at low - risk for this cystoid macular edema.
0.9999 Adverse-Effect METHODS : A 68 - year - old man developed intense conjunctival hyperemia and cystoid macula edema after switching from Druglatanoprost to bimatoprost 9 months after cataract surgery in an eye at low - risk for this Adverse-Effectcystoid macular edema .
0.9999 Adverse-Effect METHODS : A 68 - year - old man developed intense conjunctival hyperemia and Adverse-Effectcystoid macula edema after switching from latanoprost to Drugbimatoprost 9 months after cataract surgery in an eye at low - risk for this cystoid macular edema.
0.9997 Adverse-Effect METHODS : A 68 - year - old man developed Adverse-Effectintense conjunctival hyperemia and cystoid macula edema after switching from latanoprost to Drugbimatoprost 9 months after cataract surgery in an eye at low - risk for this cystoid macular edema.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CASE REPORT : A woman of 80 years, on long - term Drugwarfarin therapy presented with an Adverse-Effectacute dissecting thoracic aortic aneurysm ; on investigation the only precipitating factor found was an international normalised ratio of 4. 8.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a 57 - year - old man with acral erythrocyanosis progressing to acute digital ischemia and Adverse-Effectgangrene that developed after combined chemotherapy ( Drugbleomycin and methotrexate ) used to treat a metastatic squamous cell carcinoma of the hypopharynx.
1.0000 Adverse-Effect We describe a 57 - year - old man with acral erythrocyanosis progressing to acute digital ischemia and Adverse-Effectgangrene that developed after combined chemotherapy ( bleomycin and Drugmethotrexate ) used to treat a metastatic squamous cell carcinoma of the hypopharynx.
1.0000 Adverse-Effect We describe a 57 - year - old man with acral erythrocyanosis progressing to Adverse-Effectacute digital ischemia and gangrene that developed after combined chemotherapy ( Drugbleomycin and methotrexate ) used to treat a metastatic squamous cell carcinoma of the hypopharynx.
0.9999 Adverse-Effect We describe a 57 - year - old man with acral erythrocyanosis progressing to Adverse-Effectacute digital ischemia and gangrene that developed after combined chemotherapy ( bleomycin and Drugmethotrexate ) used to treat a metastatic squamous cell carcinoma of the hypopharynx.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect One patient required nursing home placement and a feeding gastrostomy as a result of the Adverse-Effectworsening parkinsonism during Drugrisperidone treatment, but was able to return home and have the gastrostomy removed after switching from risperidone to clozapine.
0.9993 Adverse-Effect One patient required nursing home placement and a Adverse-Effectfeeding gastrostomy as a result of the worsening parkinsonism during Drugrisperidone treatment, but was able to return home and have the gastrostomy removed after switching from risperidone to clozapine.
0.9990 Adverse-Effect One patient required nursing home placement and a feeding gastrostomy as a result of the Adverse-Effectworsening parkinsonism during risperidone treatment, but was able to return home and have the gastrostomy removed after switching from Drugrisperidone to clozapine.
0.9961 Adverse-Effect One patient required nursing home placement and a Adverse-Effectfeeding gastrostomy as a result of the worsening parkinsonism during risperidone treatment, but was able to return home and have the gastrostomy removed after switching from Drugrisperidone to clozapine.
0.9990 Adverse-Effect One patient required nursing home placement and a feeding gastrostomy as a result of the Adverse-Effectworsening parkinsonism during risperidone treatment, but was able to return home and have the gastrostomy removed after switching from risperidone to Drugclozapine .
0.9962 Adverse-Effect One patient required nursing home placement and a Adverse-Effectfeeding gastrostomy as a result of the worsening parkinsonism during risperidone treatment, but was able to return home and have the gastrostomy removed after switching from risperidone to Drugclozapine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the case of an 87 - year - old white woman with myasthenia gravis who presented with nausea, shortness of breath, azotemia, and Adverse-Effecthyperkalemia shortly after completing a course of intravenous Drugimmunoglobulin ( IVIG ).
1.0000 Adverse-Effect We report the case of an 87 - year - old white woman with myasthenia gravis who presented with nausea, shortness of breath, azotemia, and Adverse-Effecthyperkalemia shortly after completing a course of intravenous immunoglobulin ( DrugIVIG ).
1.0000 Adverse-Effect We report the case of an 87 - year - old white woman with myasthenia gravis who presented with nausea, shortness of breath, Adverse-Effectazotemia , and hyperkalemia shortly after completing a course of intravenous Drugimmunoglobulin ( IVIG ).
1.0000 Adverse-Effect We report the case of an 87 - year - old white woman with myasthenia gravis who presented with nausea, Adverse-Effectshortness of breath , azotemia, and hyperkalemia shortly after completing a course of intravenous Drugimmunoglobulin ( IVIG ).
1.0000 Adverse-Effect We report the case of an 87 - year - old white woman with myasthenia gravis who presented with Adverse-Effectnausea , shortness of breath, azotemia, and hyperkalemia shortly after completing a course of intravenous Drugimmunoglobulin ( IVIG ).
0.9999 Adverse-Effect We report the case of an 87 - year - old white woman with myasthenia gravis who presented with nausea, shortness of breath, Adverse-Effectazotemia , and hyperkalemia shortly after completing a course of intravenous immunoglobulin ( DrugIVIG ).
0.9999 Adverse-Effect We report the case of an 87 - year - old white woman with myasthenia gravis who presented with nausea, Adverse-Effectshortness of breath , azotemia, and hyperkalemia shortly after completing a course of intravenous immunoglobulin ( DrugIVIG ).
0.9999 Adverse-Effect We report the case of an 87 - year - old white woman with myasthenia gravis who presented with Adverse-Effectnausea , shortness of breath, azotemia, and hyperkalemia shortly after completing a course of intravenous immunoglobulin ( DrugIVIG ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect After therapy for diabetic coma with insulin ( containing the preservative Drugcresol ) and electrolyte solutions was started, the patient complained of Adverse-Effectincreasing myalgia , developed a high fever and respiratory and metabolic acidosis and lost consciousness.
0.9999 Adverse-Effect After therapy for diabetic coma with insulin ( containing the preservative Drugcresol ) and electrolyte solutions was started, the patient complained of increasing myalgia, developed a Adverse-Effecthigh fever and respiratory and metabolic acidosis and lost consciousness.
0.9999 Adverse-Effect After therapy for diabetic coma with insulin ( containing the preservative Drugcresol ) and electrolyte solutions was started, the patient complained of increasing myalgia, developed a high fever and Adverse-Effectrespiratory and metabolic acidosis and lost consciousness.
0.9999 Adverse-Effect After therapy for diabetic coma with Druginsulin ( containing the preservative cresol ) and electrolyte solutions was started, the patient complained of Adverse-Effectincreasing myalgia , developed a high fever and respiratory and metabolic acidosis and lost consciousness.
0.9999 Adverse-Effect After therapy for diabetic coma with insulin ( containing the preservative Drugcresol ) and electrolyte solutions was started, the patient complained of increasing myalgia, developed a high fever and respiratory and metabolic acidosis and Adverse-Effectlost consciousness .
0.9998 Adverse-Effect After therapy for diabetic coma with Druginsulin ( containing the preservative cresol ) and electrolyte solutions was started, the patient complained of increasing myalgia, developed a high fever and Adverse-Effectrespiratory and metabolic acidosis and lost consciousness.
0.9998 Adverse-Effect After therapy for diabetic coma with Druginsulin ( containing the preservative cresol ) and electrolyte solutions was started, the patient complained of increasing myalgia, developed a Adverse-Effecthigh fever and respiratory and metabolic acidosis and lost consciousness.
0.9998 Adverse-Effect After therapy for diabetic coma with Druginsulin ( containing the preservative cresol ) and electrolyte solutions was started, the patient complained of increasing myalgia, developed a high fever and respiratory and metabolic acidosis and Adverse-Effectlost consciousness .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A study of in vitro reactivity to L - T4, as assessed by peripheral blood lymphocyte transformation, was carried out in a patient with Hashimoto's disease who developed Adverse-Effectleukopenia during treatment with DrugL - T4 .
0.9992 Adverse-Effect A study of in vitro reactivity to DrugL - T4 , as assessed by peripheral blood lymphocyte transformation, was carried out in a patient with Hashimoto's disease who developed Adverse-Effectleukopenia during treatment with L - T4.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The clinical course suggests that Drugcaffeine , which is present in oolong tea, was mainly responsible for the Adverse-Effectrhabdomyolysis as well as the delirium, although severe hyponatremia has been reported to cause rhabdomyolysis on rare occasions.
0.9999 Adverse-Effect The clinical course suggests that Drugcaffeine , which is present in oolong tea, was mainly responsible for the rhabdomyolysis as well as the Adverse-Effectdelirium , although severe hyponatremia has been reported to cause rhabdomyolysis on rare occasions.
0.9997 Adverse-Effect The clinical course suggests that Drugcaffeine , which is present in oolong tea, was mainly responsible for the rhabdomyolysis as well as the delirium, although severe hyponatremia has been reported to cause Adverse-Effectrhabdomyolysis on rare occasions.
0.9995 Adverse-Effect The clinical course suggests that Drugcaffeine , which is present in oolong tea, was mainly responsible for the rhabdomyolysis as well as the delirium, although severe Adverse-Effecthyponatremia has been reported to cause rhabdomyolysis on rare occasions.
0.9997 Adverse-Effect The clinical course suggests that Drugcaffeine , which is present in oolong tea, was mainly responsible for the rhabdomyolysis as well as the delirium, although Adverse-Effectsevere hyponatremia has been reported to cause rhabdomyolysis on rare occasions.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A toxic encephalopathy characterized by depressed level of consciousness, marked irritability, and Adverse-Effectataxia developed in seven children, 5 years of age and younger, following administration of an antiemetic combination of Drugpentobarbital and pyrilamine maleate.
0.9999 Adverse-Effect A toxic encephalopathy characterized by Adverse-Effectdepressed level of consciousness , marked irritability, and ataxia developed in seven children, 5 years of age and younger, following administration of an antiemetic combination of Drugpentobarbital and pyrilamine maleate.
0.9999 Adverse-Effect A Adverse-Effecttoxic encephalopathy characterized by depressed level of consciousness, marked irritability, and ataxia developed in seven children, 5 years of age and younger, following administration of an antiemetic combination of Drugpentobarbital and pyrilamine maleate.
0.9999 Adverse-Effect A toxic encephalopathy characterized by depressed level of consciousness, marked irritability, and Adverse-Effectataxia developed in seven children, 5 years of age and younger, following administration of an antiemetic combination of pentobarbital and Drugpyrilamine maleate .
0.9999 Adverse-Effect A toxic encephalopathy characterized by depressed level of consciousness, Adverse-Effectmarked irritability , and ataxia developed in seven children, 5 years of age and younger, following administration of an antiemetic combination of Drugpentobarbital and pyrilamine maleate.
0.9994 Adverse-Effect A Adverse-Effecttoxic encephalopathy characterized by depressed level of consciousness, marked irritability, and ataxia developed in seven children, 5 years of age and younger, following administration of an antiemetic combination of pentobarbital and Drugpyrilamine maleate .
0.9994 Adverse-Effect A toxic encephalopathy characterized by Adverse-Effectdepressed level of consciousness , marked irritability, and ataxia developed in seven children, 5 years of age and younger, following administration of an antiemetic combination of pentobarbital and Drugpyrilamine maleate .
0.9993 Adverse-Effect A toxic encephalopathy characterized by depressed level of consciousness, Adverse-Effectmarked irritability , and ataxia developed in seven children, 5 years of age and younger, following administration of an antiemetic combination of pentobarbital and Drugpyrilamine maleate .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Careful follow - up of so - called " self - limited " Druginsulin Adverse-Effectedema is encouraged, and the early institution of diuretic therapy is advocated in elderly patients to prevent the development of overt cardiac failure.
0.9995 Adverse-Effect Careful follow - up of so - called " self - limited " Druginsulin Adverse-Effectinsulin edema is encouraged, and the early institution of diuretic therapy is advocated in elderly patients to prevent the development of overt cardiac failure.
0.4880 Adverse-Effect Careful follow - up of so - called " self - limited " Adverse-Effectinsulin edema Adverse-Effectedema is encouraged, and the early institution of diuretic therapy is advocated in elderly patients to prevent the development of overt cardiac failure.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We present a 46 - year - old African - American man with AIDS who was admitted on two different occasions within three weeks for signs and symptoms of Adverse-Effectmeningitis after using Drugtrimethoprim / sulfamethoxazole ( TMP / SMX ).
1.0000 Adverse-Effect We present a 46 - year - old African - American man with AIDS who was admitted on two different occasions within three weeks for signs and symptoms of Adverse-Effectmeningitis after using trimethoprim / Drugsulfamethoxazole ( TMP / SMX ).
1.0000 Adverse-Effect We present a 46 - year - old African - American man with AIDS who was admitted on two different occasions within three weeks for signs and symptoms of Adverse-Effectmeningitis after using trimethoprim / sulfamethoxazole ( TMP / DrugSMX ).
1.0000 Adverse-Effect We present a 46 - year - old African - American man with AIDS who was admitted on two different occasions within three weeks for signs and symptoms of Adverse-Effectmeningitis after using trimethoprim / sulfamethoxazole ( DrugTMP / SMX ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report ( to our knowledge, for the first time in a child ) the emergence of Adverse-Effectpsychosis in a 12 - year old white girl with an increased Drugefavirenz concentration and heterozygous gene polymorphism of the CYP2B6 - G516 T.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the first case of a human immunodeficiency virus type 1 ( HIV - 1 ) - infected individual receiving combination antiretroviral therapy, which included ritonavir, who developed Adverse-EffectCushing syndrome with profound complications after epidural Drugtriamcinolone injections.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect After seven months'continuous treatment for suspected tuberculosis with rifampicin and Drugethambutol a nine - year - old boy developed Adverse-Effectpolyarthritis , rash and hepatitis in association with anti - native DNA antibodies and positive antinuclear factor.
1.0000 Adverse-Effect After seven months'continuous treatment for suspected tuberculosis with rifampicin and Drugethambutol a nine - year - old boy developed polyarthritis, Adverse-Effectrash and hepatitis in association with anti - native DNA antibodies and positive antinuclear factor.
1.0000 Adverse-Effect After seven months'continuous treatment for suspected tuberculosis with rifampicin and Drugethambutol a nine - year - old boy developed polyarthritis, rash and Adverse-Effecthepatitis in association with anti - native DNA antibodies and positive antinuclear factor.
0.9999 Adverse-Effect After seven months'continuous treatment for suspected tuberculosis with rifampicin and Drugethambutol a nine - year - old boy developed polyarthritis, rash and hepatitis in association with Adverse-Effectanti - native DNA antibodies and positive antinuclear factor.
1.0000 Adverse-Effect After seven months'continuous treatment for suspected tuberculosis with Drugrifampicin and ethambutol a nine - year - old boy developed Adverse-Effectpolyarthritis , rash and hepatitis in association with anti - native DNA antibodies and positive antinuclear factor.
0.9999 Adverse-Effect After seven months'continuous treatment for suspected tuberculosis with rifampicin and Drugethambutol a nine - year - old boy developed polyarthritis, rash and hepatitis in association with anti - native DNA antibodies and Adverse-Effectpositive antinuclear factor .
0.9999 Adverse-Effect After seven months'continuous treatment for suspected tuberculosis with Drugrifampicin and ethambutol a nine - year - old boy developed polyarthritis, Adverse-Effectrash and hepatitis in association with anti - native DNA antibodies and positive antinuclear factor.
0.9999 Adverse-Effect After seven months'continuous treatment for suspected tuberculosis with Drugrifampicin and ethambutol a nine - year - old boy developed polyarthritis, rash and Adverse-Effecthepatitis in association with anti - native DNA antibodies and positive antinuclear factor.
0.9998 Adverse-Effect After seven months'continuous treatment for suspected tuberculosis with Drugrifampicin and ethambutol a nine - year - old boy developed polyarthritis, rash and hepatitis in association with Adverse-Effectanti - native DNA antibodies and positive antinuclear factor.
0.9998 Adverse-Effect After seven months'continuous treatment for suspected tuberculosis with Drugrifampicin and ethambutol a nine - year - old boy developed polyarthritis, rash and hepatitis in association with anti - native DNA antibodies and Adverse-Effectpositive antinuclear factor .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a 43 - year - old woman who developed sore throat, swelling of the lips and oral cavity and Adverse-Effectdysphagia , 2 weeks after the use of Drugbudesonide spray ( Budefat ) for treatment of bronchial asthma.
1.0000 Adverse-Effect We report a 43 - year - old woman who developed sore throat, swelling of the lips and oral cavity and Adverse-Effectdysphagia , 2 weeks after the use of budesonide spray ( DrugBudefat ) for treatment of bronchial asthma.
1.0000 Adverse-Effect We report a 43 - year - old woman who developed Adverse-Effectsore throat , swelling of the lips and oral cavity and dysphagia, 2 weeks after the use of Drugbudesonide spray ( Budefat ) for treatment of bronchial asthma.
1.0000 Adverse-Effect We report a 43 - year - old woman who developed sore throat, Adverse-Effectswelling of the lips and oral cavity and dysphagia, 2 weeks after the use of Drugbudesonide spray ( Budefat ) for treatment of bronchial asthma.
0.9999 Adverse-Effect We report a 43 - year - old woman who developed Adverse-Effectsore throat , swelling of the lips and oral cavity and dysphagia, 2 weeks after the use of budesonide spray ( DrugBudefat ) for treatment of bronchial asthma.
0.9998 Adverse-Effect We report a 43 - year - old woman who developed sore throat, Adverse-Effectswelling of the lips and oral cavity and dysphagia, 2 weeks after the use of budesonide spray ( DrugBudefat ) for treatment of bronchial asthma.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect However, in the mid - to - late 1980s, a series of letters to the editor and case reports announced an association between Drugtamoxifen therapy in women with breast cancer and the development of Adverse-Effectendometrial carcinoma .
Score Relation Text (Head - Tail)
0.9967 Adverse-Effect We report a cae of Adverse-Effectparanoid psychosis following use of a decongestant containing DrugPPA and summarize the case report literature of psychiatric adverse effects to PPA in which doses were known and stated to be within recommended guidelines.
0.4335 Adverse-Effect We report a cae of Adverse-Effectparanoid psychosis following use of a decongestant containing PPA and summarize the case report literature of psychiatric adverse effects to DrugPPA in which doses were known and stated to be within recommended guidelines.
Adverse-Effect We report a cae of paranoid psychosis following use of a decongestant containing PPA and summarize the case report literature of Adverse-Effectpsychiatric adverse effects to DrugPPA in which doses were known and stated to be within recommended guidelines.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To our knowledge, this is the first published case report of an adolescent girl with a mitochondrial disorder and depression who displayed both new - onset psychotic and Adverse-Effectincreased mood symptoms during treatment with Drugrisperidone .
1.0000 Adverse-Effect OBJECTIVE : To our knowledge, this is the first published case report of an adolescent girl with a mitochondrial disorder and depression who displayed both new - onset Adverse-Effectpsychotic and increased mood symptoms during treatment with Drugrisperidone .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Ten days after Drugitraconazole was started, he developed Adverse-Effectparalytic ileus , neurogenic bladder, mild left ptosis, and absence of deep reflexes, with severe paralysis of the lower extremities and mild weakness of the upper extremities.
1.0000 Adverse-Effect Ten days after Drugitraconazole was started, he developed paralytic ileus, Adverse-Effectneurogenic bladder , mild left ptosis, and absence of deep reflexes, with severe paralysis of the lower extremities and mild weakness of the upper extremities.
1.0000 Adverse-Effect Ten days after Drugitraconazole was started, he developed paralytic ileus, neurogenic bladder, Adverse-Effectmild left ptosis , and absence of deep reflexes, with severe paralysis of the lower extremities and mild weakness of the upper extremities.
1.0000 Adverse-Effect Ten days after Drugitraconazole was started, he developed paralytic ileus, neurogenic bladder, mild left ptosis, and Adverse-Effectabsence of deep reflexes , with severe paralysis of the lower extremities and mild weakness of the upper extremities.
1.0000 Adverse-Effect Ten days after Drugitraconazole was started, he developed paralytic ileus, neurogenic bladder, mild left ptosis, and absence of deep reflexes, with severe paralysis of the lower extremities and Adverse-Effectmild weakness of the upper extremities .
1.0000 Adverse-Effect Ten days after Drugitraconazole was started, he developed paralytic ileus, neurogenic bladder, mild left ptosis, and absence of deep reflexes, with Adverse-Effectsevere paralysis of the lower extremities and mild weakness of the upper extremities.
Score Relation Text (Head - Tail)
0.9997 Adverse-Effect Administration of intrathecal DrugAra - C in the same dose over longer intervals within 3 - 5 days between consecutive doses resulted in mild, transient neurological symptoms ( Adverse-Effectparesthesias ) in only one of 30 patients so treated.
1.0000 Adverse-Effect Administration of intrathecal DrugAra - C in the same dose over longer intervals within 3 - 5 days between consecutive doses resulted in Adverse-Effectmild, transient neurological symptoms ( paresthesias ) in only one of 30 patients so treated.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect PATIENT AND METHOD : A 34 - year - old woman with chronic hepatitis C, genotype 3, receiving pegylated interferon alpha - 2a and Drugribavirin for 6 months, developed Adverse-Effectprogressive malaise and anemia 6 months after the end of treatment.
0.9999 Adverse-Effect PATIENT AND METHOD : A 34 - year - old woman with chronic hepatitis C, genotype 3, receiving pegylated interferon alpha - 2a and Drugribavirin for 6 months, developed progressive malaise and Adverse-Effectanemia 6 months after the end of treatment.
0.9992 Adverse-Effect PATIENT AND METHOD : A 34 - year - old woman with chronic hepatitis C, genotype 3, receiving Drugpegylated interferon alpha - 2a and ribavirin for 6 months, developed progressive malaise and Adverse-Effectanemia 6 months after the end of treatment.
0.9992 Adverse-Effect PATIENT AND METHOD : A 34 - year - old woman with chronic hepatitis C, genotype 3, receiving Drugpegylated interferon alpha - 2a and ribavirin for 6 months, developed Adverse-Effectprogressive malaise and anemia 6 months after the end of treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CASE SUMMARY : A 46 - year - old African - American man experienced recurrent Adverse-Effectgrand mal seizures during intravenous infusion of Drugamphotericin B , then petit mal seizures as the infusion was stopped and the drug concentrations decreased with time.
1.0000 Adverse-Effect CASE SUMMARY : A 46 - year - old African - American man experienced Adverse-Effectrecurrent grand mal seizures during intravenous infusion of Drugamphotericin B , then petit mal seizures as the infusion was stopped and the drug concentrations decreased with time.
0.9836 Adverse-Effect CASE SUMMARY : A 46 - year - old African - American man experienced recurrent grand mal seizures during intravenous infusion of Drugamphotericin B , then Adverse-Effectpetit mal seizures as the infusion was stopped and the drug concentrations decreased with time.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the case of a young man, affected by rheumatoid arthritis who developed a rapid - onset short - of - breath, hemoptysis, and Adverse-Effectsevere weakness , about 2 weeks after the administration of Drugleflunomide .
1.0000 Adverse-Effect We report the case of a young man, affected by rheumatoid arthritis who developed a rapid - onset short - of - breath, Adverse-Effecthemoptysis , and severe weakness, about 2 weeks after the administration of Drugleflunomide .
1.0000 Adverse-Effect We report the case of a young man, affected by rheumatoid arthritis who developed a rapid - onset Adverse-Effectshort - of - breath , hemoptysis, and severe weakness, about 2 weeks after the administration of Drugleflunomide .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect It is thought that the clinico - pathological features and chronology of this case bore the hallmarks of the so - called " 3 - week sulphasalazine syndrome ", a rare, but often fatal, Adverse-Effectimmunoallergic reaction to Drugsulphasalazine .
0.9999 Adverse-Effect It is thought that the clinico - pathological features and chronology of this case bore the hallmarks of the so - called " 3 - week sulphasalazine syndrome ", a rare, but often Adverse-Effectfatal , immunoallergic reaction to Drugsulphasalazine .
0.9972 Adverse-Effect It is thought that the clinico - pathological features and chronology of this case bore the hallmarks of the so - called " 3 - week Drugsulphasalazine Adverse-Effectsulphasalazine syndrome ", a rare, but often fatal, immunoallergic reaction to sulphasalazine.
0.9959 Adverse-Effect It is thought that the clinico - pathological features and chronology of this case bore the hallmarks of the so - called " 3 - week Drugsulphasalazine syndrome ", a rare, but often Adverse-Effectfatal , immunoallergic reaction to sulphasalazine.
0.9917 Adverse-Effect It is thought that the clinico - pathological features and chronology of this case bore the hallmarks of the so - called " 3 - week Drugsulphasalazine syndrome ", a rare, but often fatal, Adverse-Effectimmunoallergic reaction to sulphasalazine.
0.9910 Adverse-Effect It is thought that the clinico - pathological features and chronology of this case bore the hallmarks of the so - called " 3 - week Adverse-Effectsulphasalazine syndrome ", a rare, but often fatal, immunoallergic reaction to Drugsulphasalazine .
Score Relation Text (Head - Tail)
0.9997 Adverse-Effect After several unrevealing medical work - ups, he was found to have a Adverse-Effecthigh blood lead level Druglead level ( 122 microg / dL ) ; he has a history of scraping and sanding lead paint without adequate protective measures.
0.9950 Adverse-Effect After several unrevealing medical work - ups, he was found to have a Adverse-Effecthigh blood lead level ( 122 microg / dL ) ; he has a history of scraping and sanding Druglead paint without adequate protective measures.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVES : The authors described a case of Adverse-EffectHashimoto's disease during Druginterferon - alpha ( IFN - alpha ) treatment for chronic viral C hepatitis in a patient with the specific genetic susceptibility associated with the thyroid disease.
0.9997 Adverse-Effect OBJECTIVES : The authors described a case of Adverse-EffectHashimoto's disease during interferon - alpha ( DrugIFN - alpha ) treatment for chronic viral C hepatitis in a patient with the specific genetic susceptibility associated with the thyroid disease.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A high dose of Drugcotrimoxazole induced Adverse-Effecthyperkalaemia with the elevation of serum creatinine and blood urea, and increased urinary N - acetyl glucosaminase after several days of the drug administration in these patients ; one patient became unconscious.
0.9999 Adverse-Effect A high dose of Drugcotrimoxazole induced hyperkalaemia with the elevation of serum creatinine and blood urea, and increased urinary N - acetyl glucosaminase after several days of the drug administration in these patients ; Adverse-Effectone patient became unconscious .
0.9999 Adverse-Effect A high dose of Drugcotrimoxazole induced hyperkalaemia with the Adverse-Effectelevation of serum creatinine and blood urea , and increased urinary N - acetyl glucosaminase after several days of the drug administration in these patients ; one patient became unconscious.
0.9999 Adverse-Effect A high dose of Drugcotrimoxazole induced hyperkalaemia with the elevation of serum creatinine and blood urea, and Adverse-Effectincreased urinary N - acetyl glucosaminase after several days of the drug administration in these patients ; one patient became unconscious.
0.9999 Adverse-Effect A high dose of Drugcotrimoxazole induced hyperkalaemia with the elevation of serum creatinine and blood urea, and increased urinary N - acetyl glucosaminase after several days of the drug administration in these patients ; one Adverse-Effectpatient became unconscious .
0.9999 Adverse-Effect A high dose of Drugcotrimoxazole induced hyperkalaemia with the elevation of serum creatinine and blood urea, and increased urinary N - acetyl glucosaminase after several days of the drug administration in these patients ; one patient Adverse-Effectbecame unconscious .
0.9999 Adverse-Effect A high dose of Drugcotrimoxazole induced hyperkalaemia with the elevation of serum creatinine and blood urea, and increased urinary N - acetyl glucosaminase after several days of the drug administration in these patients ; one patient became Adverse-Effectunconscious .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report on 7 patients ( 2 women, 5 men ) with chronic renal failure, who developed under a high dosage of the new diuretic Drugmuzolimine ( range 240 to 1440 mg per day ) Adverse-Effectfatal neuromyeloencephalopathy .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the first case of fulminant adult respiratory distress syndrome ( Adverse-EffectARDS ) associated with Drugpegylated interferon alpha - 2a ( pegIFNalpha - 2a ) and ribavirin use for hepatitis C, complicated by subsequent and ultimately fatal sepsis and multiorgan failure.
0.9998 Adverse-Effect We report the first case of fulminant Adverse-Effectadult respiratory distress syndrome ( ARDS ) associated with Drugpegylated interferon alpha - 2a ( pegIFNalpha - 2a ) and ribavirin use for hepatitis C, complicated by subsequent and ultimately fatal sepsis and multiorgan failure.
0.9997 Adverse-Effect We report the first case of fulminant adult respiratory distress syndrome ( Adverse-EffectARDS ) associated with pegylated interferon alpha - 2a ( pegIFNalpha - 2a ) and Drugribavirin use for hepatitis C, complicated by subsequent and ultimately fatal sepsis and multiorgan failure.
0.9995 Adverse-Effect We report the first case of fulminant Adverse-Effectadult respiratory distress syndrome ( ARDS ) associated with pegylated interferon alpha - 2a ( pegIFNalpha - 2a ) and Drugribavirin use for hepatitis C, complicated by subsequent and ultimately fatal sepsis and multiorgan failure.
0.9995 Adverse-Effect We report the first case of fulminant adult respiratory distress syndrome ( Adverse-EffectARDS ) associated with pegylated interferon alpha - 2a ( DrugpegIFNalpha - 2a ) and ribavirin use for hepatitis C, complicated by subsequent and ultimately fatal sepsis and multiorgan failure.
0.9990 Adverse-Effect We report the first case of fulminant Adverse-Effectadult respiratory distress syndrome ( ARDS ) associated with pegylated interferon alpha - 2a ( DrugpegIFNalpha - 2a ) and ribavirin use for hepatitis C, complicated by subsequent and ultimately fatal sepsis and multiorgan failure.
0.9998 Adverse-Effect We report the first case of Adverse-Effectfulminant adult respiratory distress syndrome ( ARDS ) associated with Drugpegylated interferon alpha - 2a ( pegIFNalpha - 2a ) and ribavirin use for hepatitis C, complicated by subsequent and ultimately fatal sepsis and multiorgan failure.
0.9996 Adverse-Effect We report the first case of Adverse-Effectfulminant adult respiratory distress syndrome ( ARDS ) associated with pegylated interferon alpha - 2a ( pegIFNalpha - 2a ) and Drugribavirin use for hepatitis C, complicated by subsequent and ultimately fatal sepsis and multiorgan failure.
0.9992 Adverse-Effect We report the first case of Adverse-Effectfulminant adult respiratory distress syndrome ( ARDS ) associated with pegylated interferon alpha - 2a ( DrugpegIFNalpha - 2a ) and ribavirin use for hepatitis C, complicated by subsequent and ultimately fatal sepsis and multiorgan failure.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Here we describe a patient with Crohn's disease who developed a severe infliximab infusion reaction ( IIR ), complicated 1 day later by Adverse-Effectsevere swelling of the forearm and hand ipsilateral to the site of Druginfliximab infusion.
0.9997 Adverse-Effect Here we describe a patient with Crohn's disease who developed a severe Druginfliximab infusion reaction ( Adverse-EffectIIR ), complicated 1 day later by severe swelling of the forearm and hand ipsilateral to the site of infliximab infusion.
0.9995 Adverse-Effect Here we describe a patient with Crohn's disease who developed a severe Druginfliximab infusion reaction ( IIR ), complicated 1 day later by Adverse-Effectsevere swelling of the forearm and hand ipsilateral to the site of infliximab infusion.
0.9995 Adverse-Effect Here we describe a patient with Crohn's disease who developed a severe infliximab infusion reaction ( Adverse-EffectIIR ), complicated 1 day later by severe swelling of the forearm and hand ipsilateral to the site of Druginfliximab infusion.
Adverse-Effect Here we describe a patient with Crohn's disease who developed a Adverse-Effectsevere infliximab infusion reaction Druginfliximab infusion reaction ( IIR ), complicated 1 day later by severe swelling of the forearm and hand ipsilateral to the site of infliximab infusion.
Adverse-Effect Here we describe a patient with Crohn's disease who developed a Adverse-Effectsevere infliximab infusion reaction ( IIR ), complicated 1 day later by severe swelling of the forearm and hand ipsilateral to the site of Druginfliximab infusion.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect However, there remain questions concerning whether these drugs, especially methimazole ( DrugMMI ), may be associated with Adverse-Effectaplasia cutis congenita ( ACC ) and how best to avoid impairment of fetal thyroid function during their use.
1.0000 Adverse-Effect However, there remain questions concerning whether these drugs, especially Drugmethimazole ( MMI ), may be associated with Adverse-Effectaplasia cutis congenita ( ACC ) and how best to avoid impairment of fetal thyroid function during their use.
0.9999 Adverse-Effect However, there remain questions concerning whether these drugs, especially Drugmethimazole ( MMI ), may be associated with aplasia cutis congenita ( Adverse-EffectACC ) and how best to avoid impairment of fetal thyroid function during their use.
0.9999 Adverse-Effect However, there remain questions concerning whether these drugs, especially methimazole ( DrugMMI ), may be associated with aplasia cutis congenita ( Adverse-EffectACC ) and how best to avoid impairment of fetal thyroid function during their use.
0.9997 Adverse-Effect However, there remain questions concerning whether these drugs, especially Drugmethimazole ( MMI ), may be associated with aplasia cutis congenita ( ACC ) and how best to avoid Adverse-Effectimpairment of fetal thyroid function during their use.
0.9996 Adverse-Effect However, there remain questions concerning whether these drugs, especially methimazole ( DrugMMI ), may be associated with aplasia cutis congenita ( ACC ) and how best to avoid Adverse-Effectimpairment of fetal thyroid function during their use.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Case 2, a 29 - year - old woman, developed bilateral optic neuritis combined with numbness of the lower extremities as well as Adverse-Effectbowel and bladder dysfunction after a 22 - month use of Drugrecombinant interferon alpha - 2b for chronic myelogenous leukemia.
0.9998 Adverse-Effect Case 2, a 29 - year - old woman, developed bilateral optic neuritis combined with Adverse-Effectnumbness of the lower extremities as well as bowel and bladder dysfunction after a 22 - month use of Drugrecombinant interferon alpha - 2b for chronic myelogenous leukemia.
0.9997 Adverse-Effect Case 2, a 29 - year - old woman, developed Adverse-Effectbilateral optic neuritis combined with numbness of the lower extremities as well as bowel and bladder dysfunction after a 22 - month use of Drugrecombinant interferon alpha - 2b for chronic myelogenous leukemia.
Score Relation Text (Head - Tail)
0.9996 Adverse-Effect We report a case of a patient with mild chronic renal insufficiency who had been taking simvastatin for over a year and developed Adverse-Effectacute weakness within 3 weeks after the start of treatment with Drugcolchicine for acute gouty bursitis.
0.9783 Adverse-Effect We report a case of a patient with mild chronic renal insufficiency who had been taking Drugsimvastatin for over a year and developed Adverse-Effectacute weakness within 3 weeks after the start of treatment with colchicine for acute gouty bursitis.
Adverse-Effect We report a case of a patient with Adverse-Effectmild chronic renal insufficiency who had been taking Drugsimvastatin for over a year and developed acute weakness within 3 weeks after the start of treatment with colchicine for acute gouty bursitis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of a patient with pulmonary hypertension and undifferentiated connective tissue disease who, after 2 months of treatment with Drugepoprostenol , presented with Adverse-Effectrapidly progressive erythema , scaling, nausea and vomiting, and fever.
1.0000 Adverse-Effect We report a case of a patient with pulmonary hypertension and undifferentiated connective tissue disease who, after 2 months of treatment with Drugepoprostenol , presented with rapidly progressive erythema, Adverse-Effectscaling , nausea and vomiting, and fever.
1.0000 Adverse-Effect We report a case of a patient with pulmonary hypertension and undifferentiated connective tissue disease who, after 2 months of treatment with Drugepoprostenol , presented with rapidly progressive erythema, scaling, Adverse-Effectnausea and vomiting, and fever.
1.0000 Adverse-Effect We report a case of a patient with pulmonary hypertension and undifferentiated connective tissue disease who, after 2 months of treatment with Drugepoprostenol , presented with rapidly progressive erythema, scaling, nausea and Adverse-Effectvomiting , and fever.
1.0000 Adverse-Effect We report a case of a patient with pulmonary hypertension and undifferentiated connective tissue disease who, after 2 months of treatment with Drugepoprostenol , presented with rapidly progressive erythema, scaling, nausea and vomiting, and Adverse-Effectfever .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : This case report showed that the clinical appearance of Adverse-EffectHashimoto's disease after DrugIFN - alpha therapy for chronic C hepatitis in our patient was associated with a specific genetic predisposition ( DR5 ) for this pathology.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of a patient with rheumatoid arthritis treated with low - dose Drugmethotrexate ( 15 mg / week ) who developed Adverse-Effectinfection with both M. tuberculosis and M. chelonae after the revision of a prosthetic hip.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The case histories are presented of two patients who developed lung disease associated with the use of Drugnitrofurantoin with histological features of Adverse-Effectbronchiolitis obliterans organising pneumonia ( BOOP ), a rare but recognised form of drug induced injury.
1.0000 Adverse-Effect The case histories are presented of two patients who developed Adverse-Effectlung disease associated with the use of Drugnitrofurantoin with histological features of bronchiolitis obliterans organising pneumonia ( BOOP ), a rare but recognised form of drug induced injury.
1.0000 Adverse-Effect The case histories are presented of two patients who developed lung disease associated with the use of Drugnitrofurantoin with histological features of bronchiolitis obliterans organising pneumonia ( Adverse-EffectBOOP ), a rare but recognised form of drug induced injury.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A selective association between Drugfluoxetine and extensive, prominent Adverse-Effecteye movements in nonrapid eye movement ( NREM ) sleep was detected, utilizing Fisher's exact one - tailed statistic ( p less than 0. 00001 for each comparison ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Our findings suggest that Adverse-Effecthyperkalemia can develop with the use of low - dose Drugheparin , within seven days of initiating heparin therapy, and that patients with diabetes mellitus or chronic renal insufficiency are especially predisposed to this complication.
0.9998 Adverse-Effect Our findings suggest that Adverse-Effecthyperkalemia can develop with the use of low - dose heparin, within seven days of initiating Drugheparin therapy, and that patients with diabetes mellitus or chronic renal insufficiency are especially predisposed to this complication.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe a case of disseminated muscular cysticercosis followed by myositis ( fever, diffuse myalgia, weakness of the lower limbs, and Adverse-Effectinflammatory reaction around dying cysticerci ) induced by Drugpraziquantel therapy, an event not described previously.
1.0000 Adverse-Effect We describe a case of disseminated muscular cysticercosis followed by Adverse-Effectmyositis ( fever, diffuse myalgia, weakness of the lower limbs, and inflammatory reaction around dying cysticerci ) induced by Drugpraziquantel therapy, an event not described previously.
1.0000 Adverse-Effect We describe a case of disseminated muscular cysticercosis followed by myositis ( fever, diffuse myalgia, Adverse-Effectweakness of the lower limbs , and inflammatory reaction around dying cysticerci ) induced by Drugpraziquantel therapy, an event not described previously.
0.9999 Adverse-Effect We describe a case of disseminated muscular cysticercosis followed by myositis ( Adverse-Effectfever , diffuse myalgia, weakness of the lower limbs, and inflammatory reaction around dying cysticerci ) induced by Drugpraziquantel therapy, an event not described previously.
0.9999 Adverse-Effect We describe a case of disseminated muscular cysticercosis followed by myositis ( fever, Adverse-Effectdiffuse myalgia , weakness of the lower limbs, and inflammatory reaction around dying cysticerci ) induced by Drugpraziquantel therapy, an event not described previously.
0.9999 Adverse-Effect We describe a case of Adverse-Effectdisseminated muscular cysticercosis followed by myositis ( fever, diffuse myalgia, weakness of the lower limbs, and inflammatory reaction around dying cysticerci ) induced by Drugpraziquantel therapy, an event not described previously.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 51 - yr - old nonsmoking male patient without any history of previous allergies, asthma, hay fever, or urticaria developed Adverse-Effectattacks of asthma when Drugcaptopril was added to the nadolol and dyazide treatment for his high blood pressure.
0.9997 Adverse-Effect A 51 - yr - old nonsmoking male patient without any history of previous allergies, asthma, hay fever, or urticaria developed Adverse-Effectattacks of asthma when captopril was added to the Drugnadolol and dyazide treatment for his high blood pressure.
0.9996 Adverse-Effect A 51 - yr - old nonsmoking male patient without any history of previous allergies, asthma, hay fever, or urticaria developed Adverse-Effectattacks of asthma when captopril was added to the nadolol and Drugdyazide treatment for his high blood pressure.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Despite a response of the meningeal tumor the patient developed in the third week of DrugMTX treatment a Adverse-Effectprogressive visual loss and loss of consciousness which worsened during subsequent Ara - C treatment and led to death within 3 weeks.
0.9999 Adverse-Effect Despite a response of the meningeal tumor the patient developed in the third week of MTX treatment a progressive visual loss and Adverse-Effectloss of consciousness which worsened during subsequent DrugAra - C treatment and led to death within 3 weeks.
0.9999 Adverse-Effect Despite a response of the meningeal tumor the patient developed in the third week of MTX treatment a progressive visual loss and loss of consciousness which worsened during subsequent DrugAra - C treatment and led to Adverse-Effectdeath within 3 weeks.
0.9997 Adverse-Effect Despite a response of the meningeal tumor the patient developed in the third week of MTX treatment a Adverse-Effectprogressive visual loss and loss of consciousness which worsened during subsequent DrugAra - C treatment and led to death within 3 weeks.
0.9995 Adverse-Effect Despite a response of the meningeal tumor the patient developed in the third week of DrugMTX treatment a progressive visual loss and Adverse-Effectloss of consciousness which worsened during subsequent Ara - C treatment and led to death within 3 weeks.
0.9990 Adverse-Effect Despite a response of the meningeal tumor the patient developed in the third week of DrugMTX treatment a progressive visual loss and loss of consciousness which worsened during subsequent Ara - C treatment and led to Adverse-Effectdeath within 3 weeks.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 32 - year - old man with a family history of type 2 diabetes mellitus presented with circulatory collapse and Adverse-Effectdeep coma after 9 days of treatment with Drugperospirone hydrochloride , a recently developed atypical antipsychotic agent available only in Japan.
0.9999 Adverse-Effect A 32 - year - old man with a family history of type 2 diabetes mellitus presented with Adverse-Effectcirculatory collapse and deep coma after 9 days of treatment with Drugperospirone hydrochloride , a recently developed atypical antipsychotic agent available only in Japan.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A woman with a 20 - year history of acral pustular psoriasis of Hallopeau and recurrent pustular lesions of the forearms and lower legs, developed a Adverse-EffectB - cell lymphoma of the lip following 4 1 / 2 years of treatment with Drugrazoxane .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectFatal lung fibrosis caused by Drugpaclitaxel toxicity has not been reported In this report, we describe the case of a 62 - year - old woman who received six cycles of paclitaxel and carboplatin as combination chemotherapy for advanced ovarian cancer.
0.9995 Adverse-Effect Adverse-EffectFatal lung fibrosis caused by paclitaxel toxicity has not been reported In this report, we describe the case of a 62 - year - old woman who received six cycles of Drugpaclitaxel and carboplatin as combination chemotherapy for advanced ovarian cancer.
0.9995 Adverse-Effect Adverse-EffectFatal lung fibrosis caused by paclitaxel toxicity has not been reported In this report, we describe the case of a 62 - year - old woman who received six cycles of paclitaxel and Drugcarboplatin as combination chemotherapy for advanced ovarian cancer.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Since Drugimiquimod induces Adverse-Effectlarge amounts of type I interferon production from TLR7 - expressing plasmacytoid dendritic cell precursors ( PDCs ), the natural interferon - producing cells of the peripheral blood, we asked whether PDCs are present in psoriatic skin.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect As this relapse coincided with development of a strong delayed - type Adverse-Effecthypersensitivity response to Drugtuberculin and improved after treatment with the anti - inflammatory agent oxpentifylline, it was probably caused by restoration of pathogen - specific cellular immunity.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In view of our experience in the present case, it should be stressed that close monitoring of coagulation capacity is necessary in critically ill patients in order to avoid Adverse-Effectfatal haemorrhage after initiating Drugwarfarin therapy regardless of the dosage.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect On day 4, following 3 doses of Drugdalteparin , the patient developed Adverse-Effectacute respiratory distress attributable to a massive right hemothorax confirmed by computed tomography pulmonary angiography ( CTPA ) and intercostal drainage of 1500 mL of frank blood.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report an 82 - year - old man who developed ventricular tachycardia and Torsades de Pointes ( Adverse-EffectTdP ) after oral administration of Druggarenoxacin , a novel quinolone antibiotic agent that differs from the third - generation quinolones, for pneumonia.
1.0000 Adverse-Effect We report an 82 - year - old man who developed ventricular tachycardia and Adverse-EffectTorsades de Pointes ( TdP ) after oral administration of Druggarenoxacin , a novel quinolone antibiotic agent that differs from the third - generation quinolones, for pneumonia.
0.9999 Adverse-Effect We report an 82 - year - old man who developed Adverse-Effectventricular tachycardia and Torsades de Pointes ( TdP ) after oral administration of Druggarenoxacin , a novel quinolone antibiotic agent that differs from the third - generation quinolones, for pneumonia.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect After the dose of Drugmethylprednisolone was reduced from 40 mg to 20 mg i. v. q6h and shifted to other anti - asthma treatment by procaterol metered dose inhaler via spacer, the Adverse-Effectpsychotic reaction disappeared a few hours later.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The cases are important in documenting that drug - induced dystonias do occur in patients with dementia, that Drugrisperidone appears to have contributed to Adverse-Effectdystonia among elderly patients, and that the categorization of dystonic reactions needs further clarification.
0.9965 Adverse-Effect The cases are important in documenting that drug - induced Adverse-Effectdystonias do occur in patients with dementia, that Drugrisperidone appears to have contributed to dystonia among elderly patients, and that the categorization of dystonic reactions needs further clarification.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect He was started on oral Druglansoprazole 60 mg twice daily and, on hospital day 2, his Adverse-Effectplatelet count decreased to 102 x 10 ( 3 ) / mm ( 3 ) ; on hospital day 3, the platelet count was 36 x 10 ( 3 ) / mm ( 3 ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Here we present the case of a woman who received high doses of Drugmethylprednisolone ( 1 g iv daily ) for active Graves'ophthalmopathy, and developed Adverse-Effectsevere hypertension followed by myocardial infarction on the fifth day of treatment.
0.9999 Adverse-Effect Here we present the case of a woman who received high doses of Drugmethylprednisolone ( 1 g iv daily ) for active Graves'ophthalmopathy, and developed severe hypertension followed by Adverse-Effectmyocardial infarction on the fifth day of treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report on three cases wherein treatment of Drugdexmedetomidine - induced Adverse-Effectbradycardia with i. v. glycopyrrolate ( 5. 0 microg / kg ) not only resulting in resolution of bradycardia but also resulting in an exaggerated increase of arterial blood pressure.
0.9997 Adverse-Effect We report on three cases wherein treatment of dexmedetomidine - induced bradycardia with i. v. Drugglycopyrrolate ( 5. 0 microg / kg ) not only resulting in resolution of bradycardia but also resulting in an Adverse-Effectexaggerated increase of arterial blood pressure .
0.9837 Adverse-Effect We report on three cases wherein treatment of Drugdexmedetomidine - induced bradycardia with i. v. glycopyrrolate ( 5. 0 microg / kg ) not only resulting in resolution of bradycardia but also resulting in an Adverse-Effectexaggerated increase of arterial blood pressure .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect While the introduction of carmustine wafers ( DrugGliadel wafers ) into the tumor resection cavity has been shown to be a beneficial therapy for malignant glioma, it is recognized that clinically significant Adverse-Effectcerebral edema is a potential adverse effect.
0.9996 Adverse-Effect While the introduction of Drugcarmustine wafers ( Gliadel wafers ) into the tumor resection cavity has been shown to be a beneficial therapy for malignant glioma, it is recognized that clinically significant Adverse-Effectcerebral edema is a potential adverse effect.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect CASE REPORT : We present a case of a 28 - yr - old male who developed a severe case of Adverse-Effectnephrotic syndrome while being treated for relapsing / remitting Multiple Sclerosis ( RRMS ) with weekly injections of Druginterferon beta 1a .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of ST elevation in right precordial leads compatible with Adverse-Effecttype 1 Brugada syndrome following administration of Drugpropafenone in a patient with Wolff - Parkinson - White syndrome who was receiving lithium at concentrations within therapeutic levels.
0.9996 Adverse-Effect We report a case of Adverse-EffectST elevation in right precordial leads compatible with type 1 Brugada syndrome following administration of Drugpropafenone in a patient with Wolff - Parkinson - White syndrome who was receiving lithium at concentrations within therapeutic levels.
0.9979 Adverse-Effect We report a case of ST elevation in right precordial leads compatible with Adverse-Effecttype 1 Brugada syndrome following administration of propafenone in a patient with Wolff - Parkinson - White syndrome who was receiving Druglithium at concentrations within therapeutic levels.
0.9973 Adverse-Effect We report a case of Adverse-EffectST elevation in right precordial leads compatible with type 1 Brugada syndrome following administration of propafenone in a patient with Wolff - Parkinson - White syndrome who was receiving Druglithium at concentrations within therapeutic levels.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The authors report a case of acute pancreatitis ( Adverse-EffectAP ) occurring in a patient under treatment with Drugcarbamazepine ( CBZ ) for post - traumatic petit mal epilepsy, and review the current literature of drug - induced AP.
1.0000 Adverse-Effect The authors report a case of Adverse-Effectacute pancreatitis ( AP ) occurring in a patient under treatment with Drugcarbamazepine ( CBZ ) for post - traumatic petit mal epilepsy, and review the current literature of drug - induced AP.
1.0000 Adverse-Effect The authors report a case of acute pancreatitis ( Adverse-EffectAP ) occurring in a patient under treatment with carbamazepine ( DrugCBZ ) for post - traumatic petit mal epilepsy, and review the current literature of drug - induced AP.
0.9999 Adverse-Effect The authors report a case of Adverse-Effectacute pancreatitis ( AP ) occurring in a patient under treatment with carbamazepine ( DrugCBZ ) for post - traumatic petit mal epilepsy, and review the current literature of drug - induced AP.
Adverse-Effect The authors report a case of acute Adverse-Effectpancreatitis ( AP ) occurring in a patient under treatment with Drugcarbamazepine ( CBZ ) for post - traumatic petit mal epilepsy, and review the current literature of drug - induced AP.
Adverse-Effect The authors report a case of acute Adverse-Effectpancreatitis ( AP ) occurring in a patient under treatment with carbamazepine ( DrugCBZ ) for post - traumatic petit mal epilepsy, and review the current literature of drug - induced AP.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect These cases were considered unusual in light of the short delay of their onset after initiation of immunosuppressive therapy and their fulminant course : 3 of these patients Adverse-Effectdied of PCP occurring during the first month of treatment with Drugprednisone .
1.0000 Adverse-Effect These cases were considered unusual in light of the short delay of their onset after initiation of immunosuppressive therapy and their fulminant course : 3 of these patients died of Adverse-EffectPCP occurring during the first month of treatment with Drugprednisone .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A small initial dose of prazosin ranging from 0. 5 to 1 mg has been recommended to avoid the first - dose phenomenon characterized by a sudden and Adverse-Effectsevere drop in blood pressure after the administration of the first dose of Drugprazosin .
0.9998 Adverse-Effect A small initial dose of Drugprazosin ranging from 0. 5 to 1 mg has been recommended to avoid the first - dose phenomenon characterized by a sudden and Adverse-Effectsevere drop in blood pressure after the administration of the first dose of prazosin.
1.0000 Adverse-Effect A small initial dose of prazosin ranging from 0. 5 to 1 mg has been recommended to avoid the first - dose phenomenon characterized by a sudden and severe Adverse-Effectdrop in blood pressure after the administration of the first dose of Drugprazosin .
0.9997 Adverse-Effect A small initial dose of Drugprazosin ranging from 0. 5 to 1 mg has been recommended to avoid the first - dose phenomenon characterized by a sudden and severe Adverse-Effectdrop in blood pressure after the administration of the first dose of prazosin.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect In a postural challenge test after administration of Drugisosorbide dinitrate ( 5 mg ), Adverse-Effectblood pressure decreased from 120 / 67 to 65 / 35 mmHg, followed by syncope with a sudden decrease in pulse rate from 85 to 60 beats / min.
0.9997 Adverse-Effect In a postural challenge test after administration of Drugisosorbide dinitrate ( 5 mg ), blood pressure decreased from 120 / 67 to 65 / 35 mmHg, followed by Adverse-Effectsyncope with a sudden decrease in pulse rate from 85 to 60 beats / min.
0.9996 Adverse-Effect In a postural challenge test after administration of Drugisosorbide dinitrate ( 5 mg ), blood pressure decreased from 120 / 67 to 65 / 35 mmHg, followed by syncope with a Adverse-Effectsudden decrease in pulse rate from 85 to 60 beats / min.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : This report indicates clindamycin phosphate vaginal cream as the most probable cause of CDIC due to the temporal relationship between the occurrence of Adverse-Effectdiarrhea and Drugclindamycin administration, lack of concomitant medications, and documentation of C. difficile toxin.
1.0000 Adverse-Effect CONCLUSIONS : This report indicates Drugclindamycin phosphate vaginal cream as the most probable cause of Adverse-EffectCDIC due to the temporal relationship between the occurrence of diarrhea and clindamycin administration, lack of concomitant medications, and documentation of C. difficile toxin.
0.9999 Adverse-Effect CONCLUSIONS : This report indicates clindamycin phosphate vaginal cream as the most probable cause of CDIC due to the temporal relationship between the occurrence of diarrhea and Drugclindamycin administration, lack of concomitant medications, and documentation of Adverse-EffectC. difficile toxin .
0.9998 Adverse-Effect CONCLUSIONS : This report indicates clindamycin phosphate vaginal cream as the most probable cause of Adverse-EffectCDIC due to the temporal relationship between the occurrence of diarrhea and Drugclindamycin administration, lack of concomitant medications, and documentation of C. difficile toxin.
0.9997 Adverse-Effect CONCLUSIONS : This report indicates Drugclindamycin phosphate vaginal cream as the most probable cause of CDIC due to the temporal relationship between the occurrence of Adverse-Effectdiarrhea and clindamycin administration, lack of concomitant medications, and documentation of C. difficile toxin.
0.9990 Adverse-Effect CONCLUSIONS : This report indicates Drugclindamycin phosphate vaginal cream as the most probable cause of CDIC due to the temporal relationship between the occurrence of diarrhea and clindamycin administration, lack of concomitant medications, and documentation of Adverse-EffectC. difficile toxin .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DISCUSSION : DrugAmphotericin B deoxycholate has been reported to produce significant Adverse-Effectcardiac toxicity , with ventricular arrhythmias and bradycardia reported in overdoses in children and in adults with preexisting cardiac disease, even when administered in conventional dosages and infusion rates.
0.9997 Adverse-Effect DISCUSSION : DrugAmphotericin B deoxycholate has been reported to produce significant cardiac toxicity, with ventricular arrhythmias and Adverse-Effectbradycardia reported in overdoses in children and in adults with preexisting cardiac disease, even when administered in conventional dosages and infusion rates.
0.9997 Adverse-Effect DISCUSSION : DrugAmphotericin B deoxycholate has been reported to produce significant cardiac toxicity, with Adverse-Effectventricular arrhythmias and bradycardia reported in overdoses in children and in adults with preexisting cardiac disease, even when administered in conventional dosages and infusion rates.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This report suggests that Adverse-Effectanemia can occur due to DrugMMF , in particular when it is given with prednisone, a side effect well documented in the transplantation literature when the triple combination of MMF, cyclosporine and prednisone is used.
0.9996 Adverse-Effect This report suggests that Adverse-Effectanemia can occur due to MMF, in particular when it is given with Drugprednisone , a side effect well documented in the transplantation literature when the triple combination of MMF, cyclosporine and prednisone is used.
0.9994 Adverse-Effect This report suggests that Adverse-Effectanemia can occur due to MMF, in particular when it is given with prednisone, a side effect well documented in the transplantation literature when the triple combination of MMF, Drugcyclosporine and prednisone is used.
0.9992 Adverse-Effect This report suggests that Adverse-Effectanemia can occur due to MMF, in particular when it is given with prednisone, a side effect well documented in the transplantation literature when the triple combination of DrugMMF , cyclosporine and prednisone is used.
0.9992 Adverse-Effect This report suggests that Adverse-Effectanemia can occur due to MMF, in particular when it is given with prednisone, a side effect well documented in the transplantation literature when the triple combination of MMF, cyclosporine and Drugprednisone is used.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 79 - year - old man with ischemic heart disease, chronic atrial fibrillation, chronic renal failure, hypothyroidism, and gout arthritis was hospitalized because of fatigue, myalgia, and Adverse-Effectleg weakness , shortly after starting treatment with Drugcolchicine .
1.0000 Adverse-Effect A 79 - year - old man with ischemic heart disease, chronic atrial fibrillation, chronic renal failure, hypothyroidism, and gout arthritis was hospitalized because of fatigue, Adverse-Effectmyalgia , and leg weakness, shortly after starting treatment with Drugcolchicine .
1.0000 Adverse-Effect A 79 - year - old man with ischemic heart disease, chronic atrial fibrillation, chronic renal failure, hypothyroidism, and gout arthritis was hospitalized because of Adverse-Effectfatigue , myalgia, and leg weakness, shortly after starting treatment with Drugcolchicine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect RESULTS : In a 22 - year - old Thai woman with Graves'disease, tinnitus, hearing impairment in the left ear ( with progression to the right ear ), and Adverse-Effectvertigo developed after 3 years of therapy with DrugPTU .
1.0000 Adverse-Effect RESULTS : In a 22 - year - old Thai woman with Graves'disease, Adverse-Effecttinnitus , hearing impairment in the left ear ( with progression to the right ear ), and vertigo developed after 3 years of therapy with DrugPTU .
1.0000 Adverse-Effect RESULTS : In a 22 - year - old Thai woman with Graves'disease, tinnitus, hearing impairment in the left ear ( with Adverse-Effectprogression to the right ear ), and vertigo developed after 3 years of therapy with DrugPTU .
0.9999 Adverse-Effect RESULTS : In a 22 - year - old Thai woman with Graves'disease, tinnitus, Adverse-Effecthearing impairment in the left ear ( with progression to the right ear ), and vertigo developed after 3 years of therapy with DrugPTU .
Adverse-Effect RESULTS : In a 22 - year - old Thai woman with Graves'disease, tinnitus, Adverse-Effecthearing impairment in the left ear ( with progression to the right ear ) , and vertigo developed after 3 years of therapy with DrugPTU .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This case is remarkable since 1 ) ECM developed after subcutaneous and not after intramuscular injection, 2 ) the injection was given by the patient himself, and 3 ) Drugglatiramer acetate can induce Adverse-Effectskin necrosis as a side effect.
0.9986 Adverse-Effect This case is remarkable since 1 ) Adverse-EffectECM developed after subcutaneous and not after intramuscular injection, 2 ) the injection was given by the patient himself, and 3 ) Drugglatiramer acetate can induce skin necrosis as a side effect.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Subsequent in vivo / vitro studies clearly demonstrated that the Adverse-Effectneurological effects were due to a synergistic action of Drugdesferrioxamine and prochlorperazine, probably resulting in exceptional fluxes of intra / extra cellular iron / copper disturbing noradrenergic and serotonergic systems.
0.9999 Adverse-Effect Subsequent in vivo / vitro studies clearly demonstrated that the Adverse-Effectneurological effects were due to a synergistic action of desferrioxamine and Drugprochlorperazine , probably resulting in exceptional fluxes of intra / extra cellular iron / copper disturbing noradrenergic and serotonergic systems.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe 2 patients with severe erosive rheumatoid arthritis and rheumatoid vasculitis, respectively, in whom Druginfliximab therapy was associated with Adverse-Effectperipheral neuropathy due to necrotizing vasculitis in one patient and to progression of preexisting mononeuritis multiplex in the other.
0.9999 Adverse-Effect We describe 2 patients with severe erosive rheumatoid arthritis and rheumatoid vasculitis, respectively, in whom Druginfliximab therapy was associated with peripheral neuropathy due to Adverse-Effectnecrotizing vasculitis in one patient and to progression of preexisting mononeuritis multiplex in the other.
0.9999 Adverse-Effect We describe 2 patients with severe erosive rheumatoid arthritis and rheumatoid vasculitis, respectively, in whom Druginfliximab therapy was associated with peripheral neuropathy due to necrotizing vasculitis in one patient and to Adverse-Effectprogression of preexisting mononeuritis multiplex in the other.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectMI related to the use of activated and non - activated DrugPCCs predominantly affects young patients who often have no preceding history of, or risk factors for, MI and tends to be associated with large cumulative doses of concentrate.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report on a 56 - year - old female who exhibited drug refractory paroxysmal atrial fibrillation, in which marked prolongation of the QT interval and Adverse-EffectT wave inversion on electrocardiogram was demonstrated reproducibly shortly after the administration of oral Drugpirmenol therapy.
1.0000 Adverse-Effect We report on a 56 - year - old female who exhibited drug refractory paroxysmal atrial fibrillation, in which marked Adverse-Effectprolongation of the QT interval and T wave inversion on electrocardiogram was demonstrated reproducibly shortly after the administration of oral Drugpirmenol therapy.
0.9999 Adverse-Effect We report on a 56 - year - old female who exhibited Adverse-Effectdrug refractory paroxysmal atrial fibrillation , in which marked prolongation of the QT interval and T wave inversion on electrocardiogram was demonstrated reproducibly shortly after the administration of oral Drugpirmenol therapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This case of Druglinezolid - associated Adverse-Effectacute interstitial nephritis within the context of a drug rash with eosinophilia and systemic symptoms ( DRESS ) syndrome in a patient treated with linezolid raises concerns about the presumed renal safety of this drug.
0.9997 Adverse-Effect This case of linezolid - associated acute interstitial nephritis within the context of a drug rash with eosinophilia and systemic symptoms ( Adverse-EffectDRESS ) syndrome in a patient treated with Druglinezolid raises concerns about the presumed renal safety of this drug.
0.9989 Adverse-Effect This case of linezolid - associated acute interstitial nephritis within the context of a Adverse-Effectdrug rash with eosinophilia and systemic symptoms ( DRESS ) syndrome in a patient treated with Druglinezolid raises concerns about the presumed renal safety of this drug.
0.9988 Adverse-Effect This case of Druglinezolid - associated acute interstitial nephritis within the context of a drug rash with eosinophilia and systemic symptoms ( Adverse-EffectDRESS ) syndrome in a patient treated with linezolid raises concerns about the presumed renal safety of this drug.
0.9988 Adverse-Effect This case of Druglinezolid - associated acute interstitial nephritis within the context of a Adverse-Effectdrug rash with eosinophilia and systemic symptoms ( DRESS ) syndrome in a patient treated with linezolid raises concerns about the presumed renal safety of this drug.
0.9954 Adverse-Effect This case of linezolid - associated Adverse-Effectacute interstitial nephritis within the context of a drug rash with eosinophilia and systemic symptoms ( DRESS ) syndrome in a patient treated with Druglinezolid raises concerns about the presumed renal safety of this drug.
Score Relation Text (Head - Tail)
0.9983 Adverse-Effect INTRODUCTION : Although Druggefitinib used for the treatment of non - small - cell lung cancer is a well - known cause of Adverse-Effectinterstitial lung disease ( ILD ), few case reports on erlotinib - induced ILD have been issued.
0.9949 Adverse-Effect INTRODUCTION : Although Druggefitinib used for the treatment of non - small - cell lung cancer is a well - known cause of interstitial lung disease ( Adverse-EffectILD ), few case reports on erlotinib - induced ILD have been issued.
0.9931 Adverse-Effect INTRODUCTION : Although gefitinib used for the treatment of non - small - cell lung cancer is a well - known cause of interstitial lung disease ( ILD ), few case reports on Drugerlotinib - induced Adverse-EffectILD have been issued.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect RESULTS : A 44 - year - old man taking naproxen for chronic low back pain and a 20 - year - old woman on Drugoxaprozin for rheumatoid arthritis presented with Adverse-Effecttense bullae and cutaneous fragility on the face and the back of the hands.
0.9999 Adverse-Effect RESULTS : A 44 - year - old man taking naproxen for chronic low back pain and a 20 - year - old woman on Drugoxaprozin for rheumatoid arthritis presented with tense bullae and Adverse-Effectcutaneous fragility on the face and the back of the hands.
0.9994 Adverse-Effect RESULTS : A 44 - year - old man taking Drugnaproxen for chronic low back pain and a 20 - year - old woman on oxaprozin for rheumatoid arthritis presented with Adverse-Effecttense bullae and cutaneous fragility on the face and the back of the hands.
0.9991 Adverse-Effect RESULTS : A 44 - year - old man taking Drugnaproxen for chronic low back pain and a 20 - year - old woman on oxaprozin for rheumatoid arthritis presented with tense bullae and Adverse-Effectcutaneous fragility on the face and the back of the hands.
Score Relation Text (Head - Tail)
0.9979 Adverse-Effect The patient's previous rash and the temporal relation of this event and the ingestion of phenolphthalein, as well as the similarity of this case to other reports, point to Drugphenolphthalein as the cause of Adverse-EffectTEN in this patient.
0.9892 Adverse-Effect The patient's previous Adverse-Effectrash and the temporal relation of this event and the ingestion of Drugphenolphthalein , as well as the similarity of this case to other reports, point to phenolphthalein as the cause of TEN in this patient.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The case history confirms that Druggold treatment, even in the same patient, can give rise to a wide range of Adverse-Effectskin disturbances , which in many cases do not break out until long after the drug has been withdrawn.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A patient receiving Drugvancomycin for a serious staphylococcal infection had a Adverse-Effectlupus - like syndrome characterized by a malar rash, pain and erythema of the cartilage of both ears, and tender erythematous and hemorrhagic lesions of the finger tips.
1.0000 Adverse-Effect A patient receiving Drugvancomycin for a serious staphylococcal infection had a lupus - like syndrome characterized by a Adverse-Effectmalar rash , pain and erythema of the cartilage of both ears, and tender erythematous and hemorrhagic lesions of the finger tips.
1.0000 Adverse-Effect A patient receiving Drugvancomycin for a serious staphylococcal infection had a lupus - like syndrome characterized by a malar rash, pain and Adverse-Effecterythema of the cartilage of both ears , and tender erythematous and hemorrhagic lesions of the finger tips.
0.9999 Adverse-Effect A patient receiving Drugvancomycin for a serious staphylococcal infection had a lupus - like syndrome characterized by a malar rash, pain and erythema of the cartilage of both ears, and tender erythematous and Adverse-Effecthemorrhagic lesions of the finger tips .
0.9999 Adverse-Effect A patient receiving Drugvancomycin for a serious staphylococcal infection had a lupus - like syndrome characterized by a malar rash, Adverse-Effectpain and erythema of the cartilage of both ears, and tender erythematous and hemorrhagic lesions of the finger tips.
0.9999 Adverse-Effect A patient receiving Drugvancomycin for a serious staphylococcal infection had a lupus - like syndrome characterized by a malar rash, pain and erythema of the cartilage of both ears, and Adverse-Effecttender erythematous and hemorrhagic lesions of the finger tips.
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect Because the combination of Drugbleomycin and vinca alkaloids is commonly used for the treatment of AIDS - related Kaposi's sarcoma, clinicians should be aware of the risk of provoking acral necrosis in patients who develop Adverse-EffectRaynaud's phenomenon under chemotherapy.
0.9997 Adverse-Effect Because the combination of Drugbleomycin and vinca alkaloids is commonly used for the treatment of AIDS - related Kaposi's sarcoma, clinicians should be aware of the risk of provoking Adverse-Effectacral necrosis in patients who develop Raynaud's phenomenon under chemotherapy.
0.9999 Adverse-Effect Because the combination of Drugbleomycin and vinca alkaloids is commonly used for the treatment of AIDS - related Adverse-EffectKaposi's sarcoma , clinicians should be aware of the risk of provoking acral necrosis in patients who develop Raynaud's phenomenon under chemotherapy.
Score Relation Text (Head - Tail)
Adverse-Effect Methotrexate ( DrugMTX ) is a commonly used second line agent for RA, and there have been several recent reports of Adverse-EffectEpstein - Barr virus ( EBV ) - associated polyclonal B cell lymphoproliferative disorder in MTX - treated RA patients.
Adverse-Effect Methotrexate ( MTX ) is a commonly used second line agent for RA, and there have been several recent reports of Adverse-EffectEpstein - Barr virus ( EBV ) - associated polyclonal B cell lymphoproliferative disorder in DrugMTX - treated RA patients.
Adverse-Effect DrugMethotrexate ( MTX ) is a commonly used second line agent for RA, and there have been several recent reports of Adverse-EffectEpstein - Barr virus ( EBV ) - associated polyclonal B cell lymphoproliferative disorder in MTX - treated RA patients.
Score Relation Text (Head - Tail)
0.9977 Adverse-Effect We present a case of acute Drugepinephrine toxicity resulting in acute myocardial ischemia in a young boy with combined variable immunodeficiency syndrome who developed Adverse-Effectsevere allergic reaction to intravenous immunoglobulin, and was subsequently given epinephrine by mistake intravenously rather than subcutaneously.
0.9871 Adverse-Effect We present a case of acute epinephrine toxicity resulting in acute myocardial ischemia in a young boy with combined variable immunodeficiency syndrome who developed Adverse-Effectsevere allergic reaction to intravenous immunoglobulin, and was subsequently given Drugepinephrine by mistake intravenously rather than subcutaneously.
0.9862 Adverse-Effect We present a case of acute Drugepinephrine toxicity resulting in Adverse-Effectacute myocardial ischemia in a young boy with combined variable immunodeficiency syndrome who developed severe allergic reaction to intravenous immunoglobulin, and was subsequently given epinephrine by mistake intravenously rather than subcutaneously.
0.9974 Adverse-Effect We present a case of acute Drugepinephrine Adverse-Effectepinephrine toxicity resulting in acute myocardial ischemia in a young boy with combined variable immunodeficiency syndrome who developed severe allergic reaction to intravenous immunoglobulin, and was subsequently given epinephrine by mistake intravenously rather than subcutaneously.
0.7901 Adverse-Effect We present a case of acute epinephrine toxicity resulting in Adverse-Effectacute myocardial ischemia in a young boy with combined variable immunodeficiency syndrome who developed severe allergic reaction to intravenous immunoglobulin, and was subsequently given Drugepinephrine by mistake intravenously rather than subcutaneously.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a myeloma patient who developed Adverse-Effectsevere paralytic ileus during Drugbortezomib therapy, which presented in the context of progressive constipation without other known causes and which regressed promptly with medical management after drug cessation, suggesting a direct causal relationship.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect These in vitro findings and clinical course suggest that TRAb / TBII without thyroid - stimulating activity may develop in patients with Drugamiodarone - induced Adverse-Effectdestructive thyroiditis , as reported in patients with destructive thyroiditis, such as subacute and silent thyroiditis.
0.9985 Adverse-Effect These in vitro findings and clinical course suggest that TRAb / TBII without thyroid - stimulating activity may develop in patients with Drugamiodarone - induced destructive thyroiditis, as reported in patients with Adverse-Effectdestructive thyroiditis , such as subacute and silent thyroiditis.
0.9972 Adverse-Effect These in vitro findings and clinical course suggest that TRAb / TBII without thyroid - stimulating activity may develop in patients with Drugamiodarone - induced destructive thyroiditis, as reported in patients with destructive thyroiditis, such as subacute and silent Adverse-Effectthyroiditis .
0.9981 Adverse-Effect These in vitro findings and clinical course suggest that DrugTRAb / TBII without thyroid - stimulating activity may develop in patients with amiodarone - induced Adverse-Effectdestructive thyroiditis , as reported in patients with destructive thyroiditis, such as subacute and silent thyroiditis.
0.9976 Adverse-Effect These in vitro findings and clinical course suggest that TRAb / TBII without thyroid - stimulating activity may develop in patients with Drugamiodarone - induced destructive thyroiditis, as reported in patients with destructive Adverse-Effectthyroiditis , such as subacute and silent thyroiditis.
0.9940 Adverse-Effect These in vitro findings and clinical course suggest that DrugTRAb / TBII without thyroid - stimulating activity may develop in patients with amiodarone - induced destructive thyroiditis, as reported in patients with Adverse-Effectdestructive thyroiditis , such as subacute and silent thyroiditis.
0.9902 Adverse-Effect These in vitro findings and clinical course suggest that DrugTRAb / TBII without thyroid - stimulating activity may develop in patients with amiodarone - induced destructive thyroiditis, as reported in patients with destructive Adverse-Effectthyroiditis , such as subacute and silent thyroiditis.
0.9900 Adverse-Effect These in vitro findings and clinical course suggest that DrugTRAb / TBII without thyroid - stimulating activity may develop in patients with amiodarone - induced destructive thyroiditis, as reported in patients with destructive thyroiditis, such as subacute and silent Adverse-Effectthyroiditis .
Adverse-Effect These in vitro findings and clinical course suggest that Adverse-EffectTRAb / TBII without thyroid - stimulating activity may develop in patients with Drugamiodarone - induced destructive thyroiditis, as reported in patients with destructive thyroiditis, such as subacute and silent thyroiditis.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect When SASP was changed to 5 - aminosalicylic acid ( Drug5 - ASA ), his skin eruptions were resolved, however, he developed Adverse-Effectweakness and atrophy in his right arm as well as progressive worsening of the dysesthesia in his legs and gait disturbance.
0.9998 Adverse-Effect When SASP was changed to 5 - aminosalicylic acid ( Drug5 - ASA ), his skin eruptions were resolved, however, he developed weakness and Adverse-Effectatrophy in his right arm as well as progressive worsening of the dysesthesia in his legs and gait disturbance.
0.9995 Adverse-Effect When SASP was changed to 5 - aminosalicylic acid ( Drug5 - ASA ), his skin eruptions were resolved, however, he developed weakness and atrophy in his right arm as well as progressive Adverse-Effectworsening of the dysesthesia in his legs and gait disturbance.
0.9995 Adverse-Effect When SASP was changed to 5 - aminosalicylic acid ( Drug5 - ASA ), his skin eruptions were resolved, however, he developed weakness and atrophy in his right arm as well as progressive worsening of the dysesthesia in his legs and Adverse-Effectgait disturbance .
0.9995 Adverse-Effect When SASP was changed to Drug5 - aminosalicylic acid ( 5 - ASA ), his skin eruptions were resolved, however, he developed Adverse-Effectweakness and atrophy in his right arm as well as progressive worsening of the dysesthesia in his legs and gait disturbance.
0.9994 Adverse-Effect When SASP was changed to Drug5 - aminosalicylic acid ( 5 - ASA ), his skin eruptions were resolved, however, he developed weakness and Adverse-Effectatrophy in his right arm as well as progressive worsening of the dysesthesia in his legs and gait disturbance.
0.9987 Adverse-Effect When SASP was changed to Drug5 - aminosalicylic acid ( 5 - ASA ), his skin eruptions were resolved, however, he developed weakness and atrophy in his right arm as well as progressive Adverse-Effectworsening of the dysesthesia in his legs and gait disturbance.
0.9987 Adverse-Effect When SASP was changed to Drug5 - aminosalicylic acid ( 5 - ASA ), his skin eruptions were resolved, however, he developed weakness and atrophy in his right arm as well as progressive worsening of the dysesthesia in his legs and Adverse-Effectgait disturbance .
0.9999 Adverse-Effect When SASP was changed to 5 - aminosalicylic acid ( Drug5 - ASA ), his Adverse-Effectskin eruptions were resolved, however, he developed weakness and atrophy in his right arm as well as progressive worsening of the dysesthesia in his legs and gait disturbance.
0.9995 Adverse-Effect When DrugSASP was changed to 5 - aminosalicylic acid ( 5 - ASA ), his skin eruptions were resolved, however, he developed Adverse-Effectweakness and atrophy in his right arm as well as progressive worsening of the dysesthesia in his legs and gait disturbance.
0.9994 Adverse-Effect When DrugSASP was changed to 5 - aminosalicylic acid ( 5 - ASA ), his Adverse-Effectskin eruptions were resolved, however, he developed weakness and atrophy in his right arm as well as progressive worsening of the dysesthesia in his legs and gait disturbance.
0.9994 Adverse-Effect When DrugSASP was changed to 5 - aminosalicylic acid ( 5 - ASA ), his skin eruptions were resolved, however, he developed weakness and Adverse-Effectatrophy in his right arm as well as progressive worsening of the dysesthesia in his legs and gait disturbance.
0.9993 Adverse-Effect When SASP was changed to Drug5 - aminosalicylic acid ( 5 - ASA ), his Adverse-Effectskin eruptions were resolved, however, he developed weakness and atrophy in his right arm as well as progressive worsening of the dysesthesia in his legs and gait disturbance.
0.9987 Adverse-Effect When DrugSASP was changed to 5 - aminosalicylic acid ( 5 - ASA ), his skin eruptions were resolved, however, he developed weakness and atrophy in his right arm as well as progressive Adverse-Effectworsening of the dysesthesia in his legs and gait disturbance.
0.9987 Adverse-Effect When DrugSASP was changed to 5 - aminosalicylic acid ( 5 - ASA ), his skin eruptions were resolved, however, he developed weakness and atrophy in his right arm as well as progressive worsening of the dysesthesia in his legs and Adverse-Effectgait disturbance .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CASE REPORT : Soon after initiation of Drugamiodarone HCl ( 200 mg / day ), a 76 - year - old man came to us with symptoms of Adverse-Effectvisual " shining , " glare, color vision anomalies, and gradually decreased vision.
0.9998 Adverse-Effect CASE REPORT : Soon after initiation of Drugamiodarone HCl ( 200 mg / day ), a 76 - year - old man came to us with symptoms of visual " shining, " Adverse-Effectglare , color vision anomalies, and gradually decreased vision.
0.9997 Adverse-Effect CASE REPORT : Soon after initiation of Drugamiodarone HCl ( 200 mg / day ), a 76 - year - old man came to us with symptoms of visual " shining, " glare, Adverse-Effectcolor vision anomalies , and gradually decreased vision.
0.9996 Adverse-Effect CASE REPORT : Soon after initiation of Drugamiodarone HCl ( 200 mg / day ), a 76 - year - old man came to us with symptoms of visual " shining, " glare, color vision anomalies, and gradually Adverse-Effectdecreased vision .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The mechanism of the Adverse-Effectdecrease in plasma potassium induced by Drugphosphate treatment was investigated in a 24 - year - old hypertensive patient with hypophosphatemic osteomalacia, who was the youngest of four patients, belonging to a 23 number kindred of five generations.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 16 - year - old white male with acute biphenotypic leukemia developed evidence of the Adverse-Effecteosinophilia myalgia syndrome associated with total parenteral nutritional support with solutions containing Drugtryptophan , which were given during his initial induction chemotherapy and also after autologous marrow transplantation.
Score Relation Text (Head - Tail)
0.9997 Adverse-Effect Subsequently, he developed Adverse-Effecthyperglycemia ( fasting blood glucose 138 mg / dL ) that resolved when Drugolanzapine was stopped and recurred ( fasting blood glucose 150 mg / dL ) after 2 days of rechallenge with olanzapine 2. 5 mg twice daily.
0.9994 Adverse-Effect Subsequently, he developed Adverse-Effecthyperglycemia ( fasting blood glucose 138 mg / dL ) that resolved when olanzapine was stopped and recurred ( fasting blood glucose 150 mg / dL ) after 2 days of rechallenge with Drugolanzapine 2. 5 mg twice daily.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect The potential development of SJS / Adverse-EffectTEN , a severe life - threatening illness, emphasizes the need for judicious use of DrugTMP - Sx and close monitoring and follow - up for patients who were given TMP - Sx for SSTIs.
0.9999 Adverse-Effect The potential development of Adverse-EffectSJS / TEN, a severe life - threatening illness, emphasizes the need for judicious use of DrugTMP - Sx and close monitoring and follow - up for patients who were given TMP - Sx for SSTIs.
0.9997 Adverse-Effect The potential development of SJS / Adverse-EffectTEN , a severe life - threatening illness, emphasizes the need for judicious use of TMP - Sx and close monitoring and follow - up for patients who were given DrugTMP - Sx for SSTIs.
0.9996 Adverse-Effect The potential development of Adverse-EffectSJS / TEN, a severe life - threatening illness, emphasizes the need for judicious use of TMP - Sx and close monitoring and follow - up for patients who were given DrugTMP - Sx for SSTIs.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a patient with type 2 diabetes mellitus who, while treated with the antitumor necrosis factor - alpha blocking agent Drugetanercept for severe plaque psoriasis, experienced Adverse-Effectpersistent hypoglycemia requiring the lowering and eventual elimination of his previous insulin regimen.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Case 1, a 62 - year - old woman, developed bilateral optic neuritis with decreased sensation of vibration and Adverse-Effectincreased deep tendon reflex in the lower extremities after a seven - month use of Drugrecombinant interferon alpha - 2a for chronic active hepatitis C.
0.9998 Adverse-Effect Case 1, a 62 - year - old woman, developed Adverse-Effectbilateral optic neuritis with decreased sensation of vibration and increased deep tendon reflex in the lower extremities after a seven - month use of Drugrecombinant interferon alpha - 2a for chronic active hepatitis C.
0.9997 Adverse-Effect Case 1, a 62 - year - old woman, developed bilateral optic neuritis with Adverse-Effectdecreased sensation of vibration and increased deep tendon reflex in the lower extremities after a seven - month use of Drugrecombinant interferon alpha - 2a for chronic active hepatitis C.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In all cases, drugs in addition to quetiapine were detected, but in cases # 1 and # 2, the cause of Adverse-Effectdeath was considered to be a Drugquetiapine overdose and the other drugs were not considered to be contributory.
0.9997 Adverse-Effect In all cases, drugs in addition to Drugquetiapine were detected, but in cases # 1 and # 2, the cause of Adverse-Effectdeath was considered to be a quetiapine overdose and the other drugs were not considered to be contributory.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Of particular interest in this patient is the Adverse-Effectfluctuation of the QT interval at a stable dose of Drugmethadone , suggesting that a single normal electrocardiogram ( ECG ) does not guarantee that the patient is not at risk of ventricular arrhythmias.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugEthambutol is frequently used in the treatment of tuberculosis, and, although Adverse-Effectoptic neuropathies have been reported with the use of ethambutol, this adverse side effect has been considered to be rare and generally reversible with discontinuation of the medication.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect The authors suggest that in the absence of any proven benefit of itraconazole prophylaxis, and given the interaction of this drug with Drugvincristine leading to severe and even potentially Adverse-Effectfatal toxicities , the combination use of these drugs should be avoided.
0.9996 Adverse-Effect The authors suggest that in the absence of any proven benefit of Drugitraconazole prophylaxis, and given the interaction of this drug with vincristine leading to severe and even potentially Adverse-Effectfatal toxicities , the combination use of these drugs should be avoided.
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect Two 65 - year - old white men with coronary heart disease, given Drugniacin therapy for dyslipidemia for 5 months, developed Adverse-Effectintense dental and gingival pain that was associated with increases in dose and that was relieved with discontinuance of niacin treatment.
0.9998 Adverse-Effect Two 65 - year - old white men with coronary heart disease, given niacin therapy for dyslipidemia for 5 months, developed Adverse-Effectintense dental and gingival pain that was associated with increases in dose and that was relieved with discontinuance of Drugniacin treatment.
0.9997 Adverse-Effect Two 65 - year - old white men with coronary heart disease, given niacin therapy for dyslipidemia for 5 months, developed intense Adverse-Effectdental and gingival pain that was associated with increases in dose and that was relieved with discontinuance of Drugniacin treatment.
0.9995 Adverse-Effect Two 65 - year - old white men with coronary heart disease, given Drugniacin therapy for dyslipidemia for 5 months, developed intense Adverse-Effectdental and gingival pain that was associated with increases in dose and that was relieved with discontinuance of niacin treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 62 - year - old woman who was being treated for squamous cell carcinoma of the head and neck developed a chemotherapy - related Adverse-Effecthemolytic - uremic syndrome during the second cycle of neoadjuvant chemotherapy consisting of Drugcisplatin , bleomycin, and methotrexate.
1.0000 Adverse-Effect A 62 - year - old woman who was being treated for squamous cell carcinoma of the head and neck developed a chemotherapy - related Adverse-Effecthemolytic - uremic syndrome during the second cycle of neoadjuvant chemotherapy consisting of cisplatin, Drugbleomycin , and methotrexate.
0.9999 Adverse-Effect A 62 - year - old woman who was being treated for squamous cell carcinoma of the head and neck developed a chemotherapy - related Adverse-Effecthemolytic - uremic syndrome during the second cycle of neoadjuvant chemotherapy consisting of cisplatin, bleomycin, and Drugmethotrexate .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A case of Adverse-Effectskeletal fluorosis induced by prolonged treatment with Drugniflumic acid , a fast - acting non - steroid antiinflammatory agent, is reported in a 35 - year - old woman suffering from rheumatoid arthritis and treated, in addition, with corticosteroids.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The reported cases of in utero exposure to Drugcyclosposphamide shared the following manifestations with our patient : growth deficiency, Adverse-Effectdevelopmental delay , craniosynostosis, blepharophimosis, flat nasal bridge, abnormal ears, and distal limb defects including hypoplastic thumbs and oligodactyly.
1.0000 Adverse-Effect The reported cases of in utero exposure to Drugcyclosposphamide shared the following manifestations with our patient : growth deficiency, developmental delay, Adverse-Effectcraniosynostosis , blepharophimosis, flat nasal bridge, abnormal ears, and distal limb defects including hypoplastic thumbs and oligodactyly.
1.0000 Adverse-Effect The reported cases of in utero exposure to Drugcyclosposphamide shared the following manifestations with our patient : growth deficiency, developmental delay, craniosynostosis, blepharophimosis, Adverse-Effectflat nasal bridge , abnormal ears, and distal limb defects including hypoplastic thumbs and oligodactyly.
1.0000 Adverse-Effect The reported cases of in utero exposure to Drugcyclosposphamide shared the following manifestations with our patient : growth deficiency, developmental delay, craniosynostosis, Adverse-Effectblepharophimosis , flat nasal bridge, abnormal ears, and distal limb defects including hypoplastic thumbs and oligodactyly.
0.9999 Adverse-Effect The reported cases of in utero exposure to Drugcyclosposphamide shared the following manifestations with our patient : growth deficiency, developmental delay, craniosynostosis, blepharophimosis, flat nasal bridge, abnormal ears, and distal limb defects including Adverse-Effecthypoplastic thumbs and oligodactyly.
0.9999 Adverse-Effect The reported cases of in utero exposure to Drugcyclosposphamide shared the following manifestations with our patient : growth deficiency, developmental delay, craniosynostosis, blepharophimosis, flat nasal bridge, abnormal ears, and Adverse-Effectdistal limb defects including hypoplastic thumbs and oligodactyly.
0.9999 Adverse-Effect The reported cases of in utero exposure to Drugcyclosposphamide shared the following manifestations with our patient : growth deficiency, developmental delay, craniosynostosis, blepharophimosis, flat nasal bridge, abnormal ears, and distal limb defects including hypoplastic thumbs and Adverse-Effectoligodactyly .
1.0000 Adverse-Effect The reported cases of in utero exposure to Drugcyclosposphamide shared the following manifestations with our patient : Adverse-Effectgrowth deficiency , developmental delay, craniosynostosis, blepharophimosis, flat nasal bridge, abnormal ears, and distal limb defects including hypoplastic thumbs and oligodactyly.
1.0000 Adverse-Effect The reported cases of in utero exposure to Drugcyclosposphamide shared the following manifestations with our patient : growth deficiency, developmental delay, craniosynostosis, blepharophimosis, flat nasal bridge, Adverse-Effectabnormal ears , and distal limb defects including hypoplastic thumbs and oligodactyly.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Seven of the eight cases of Adverse-Effectacute leukemia occurred in a series of 553 patients treated with DrugTreosulfan for ovarian cancer in the period from 1970 to 1977 and followed closely for a total of 1159 patient - years up to February 1978.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In addition, while cases of loop diuretic - induced Adverse-Effectpancreatitis , including Drugfurosemide , have been published, the allergic manifestations with both sulfonamide antibiotics and non - antibiotics in our patient suggest possible cross - reactivity between these 2 drug classes.
1.0000 Adverse-Effect In addition, while cases of loop diuretic - induced pancreatitis, including furosemide, have been published, the Adverse-Effectallergic manifestations with both Drugsulfonamide antibiotics and non - antibiotics in our patient suggest possible cross - reactivity between these 2 drug classes.
0.9958 Adverse-Effect In addition, while cases of loop diuretic - induced pancreatitis, including Drugfurosemide , have been published, the Adverse-Effectallergic manifestations with both sulfonamide antibiotics and non - antibiotics in our patient suggest possible cross - reactivity between these 2 drug classes.
0.9643 Adverse-Effect In addition, while cases of loop diuretic - induced Adverse-Effectpancreatitis , including furosemide, have been published, the allergic manifestations with both Drugsulfonamide antibiotics and non - antibiotics in our patient suggest possible cross - reactivity between these 2 drug classes.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The cause of these previously unreported side effects of Drugniacin therapy is uncertain but may be related to Adverse-Effectprostaglandin - mediated vasodilatation , hyperalgesia of sensory nerve receptors, and potentiation of inflammation in the gingiva with referral of pain to the teeth.
1.0000 Adverse-Effect The cause of these previously unreported side effects of Drugniacin therapy is uncertain but may be related to prostaglandin - mediated vasodilatation, hyperalgesia of sensory nerve receptors, and potentiation of inflammation in the gingiva with referral of Adverse-Effectpain to the teeth .
0.9999 Adverse-Effect The cause of these previously unreported side effects of Drugniacin therapy is uncertain but may be related to prostaglandin - mediated vasodilatation, Adverse-Effecthyperalgesia of sensory nerve receptors , and potentiation of inflammation in the gingiva with referral of pain to the teeth.
0.9999 Adverse-Effect The cause of these previously unreported side effects of Drugniacin therapy is uncertain but may be related to prostaglandin - mediated vasodilatation, hyperalgesia of sensory nerve receptors, and Adverse-Effectpotentiation of inflammation in the gingiva with referral of pain to the teeth.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect OBJECTIVE : To document a case of serotonin syndrome ( Adverse-EffectSS ) associated with Drugmirtazapine monotherapy, review the previously reported cases of SS associated with this tetracyclic antidepressant, and discuss the possible pathogenic mechanisms leading to this serious adverse drug reaction.
1.0000 Adverse-Effect OBJECTIVE : To document a case of Adverse-Effectserotonin syndrome ( SS ) associated with Drugmirtazapine monotherapy, review the previously reported cases of SS associated with this tetracyclic antidepressant, and discuss the possible pathogenic mechanisms leading to this serious adverse drug reaction.
0.9981 Adverse-Effect OBJECTIVE : To document a case of serotonin syndrome ( SS ) associated with Drugmirtazapine monotherapy, review the previously reported cases of Adverse-EffectSS associated with this tetracyclic antidepressant, and discuss the possible pathogenic mechanisms leading to this serious adverse drug reaction.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A variety of Adverse-Effectmovement disorders are known to occur in association with Drugcarbamazepine ( CBZ ) therapy in adults and children, but development of tics has been described infrequently and only in patients with underlying Tourette's syndrome or other movement disorders.
1.0000 Adverse-Effect A variety of movement disorders are known to occur in association with carbamazepine ( DrugCBZ ) therapy in adults and children, but development of Adverse-Effecttics has been described infrequently and only in patients with underlying Tourette's syndrome or other movement disorders.
0.9999 Adverse-Effect A variety of movement disorders are known to occur in association with Drugcarbamazepine ( CBZ ) therapy in adults and children, but development of Adverse-Effecttics has been described infrequently and only in patients with underlying Tourette's syndrome or other movement disorders.
0.9999 Adverse-Effect A variety of Adverse-Effectmovement disorders are known to occur in association with carbamazepine ( DrugCBZ ) therapy in adults and children, but development of tics has been described infrequently and only in patients with underlying Tourette's syndrome or other movement disorders.
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect Although the two local anesthetics usually do not cause methemoglobinemia, we suspect that the displacement of Druglidocaine from protein binding by bupivacaine, in combination with metabolic acidosis and treatment with other oxidants, was the reason for the development of Adverse-Effectmethemoglobinemia .
0.9986 Adverse-Effect Although the two local anesthetics usually do not cause Adverse-Effectmethemoglobinemia , we suspect that the displacement of Druglidocaine from protein binding by bupivacaine, in combination with metabolic acidosis and treatment with other oxidants, was the reason for the development of methemoglobinemia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Herein, we describe a patient with AIDS who presented to medical attention with Adverse-Effectpancytopenia 48 months postchemotherapy with Drugetoposide , prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab ( R - EPOCH ) for diffuse large B - cell lymphoma.
1.0000 Adverse-Effect Herein, we describe a patient with AIDS who presented to medical attention with Adverse-Effectpancytopenia 48 months postchemotherapy with etoposide, Drugprednisone , vincristine, cyclophosphamide, doxorubicin, and rituximab ( R - EPOCH ) for diffuse large B - cell lymphoma.
1.0000 Adverse-Effect Herein, we describe a patient with AIDS who presented to medical attention with Adverse-Effectpancytopenia 48 months postchemotherapy with etoposide, prednisone, Drugvincristine , cyclophosphamide, doxorubicin, and rituximab ( R - EPOCH ) for diffuse large B - cell lymphoma.
1.0000 Adverse-Effect Herein, we describe a patient with AIDS who presented to medical attention with Adverse-Effectpancytopenia 48 months postchemotherapy with etoposide, prednisone, vincristine, Drugcyclophosphamide , doxorubicin, and rituximab ( R - EPOCH ) for diffuse large B - cell lymphoma.
1.0000 Adverse-Effect Herein, we describe a patient with AIDS who presented to medical attention with Adverse-Effectpancytopenia 48 months postchemotherapy with etoposide, prednisone, vincristine, cyclophosphamide, Drugdoxorubicin , and rituximab ( R - EPOCH ) for diffuse large B - cell lymphoma.
1.0000 Adverse-Effect Herein, we describe a patient with AIDS who presented to medical attention with Adverse-Effectpancytopenia 48 months postchemotherapy with etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and Drugrituximab ( R - EPOCH ) for diffuse large B - cell lymphoma.
0.9990 Adverse-Effect Herein, we describe a patient with AIDS who presented to medical attention with Adverse-Effectpancytopenia 48 months postchemotherapy with etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab ( DrugR - EPOCH ) for diffuse large B - cell lymphoma.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report five cases of carboplatin ( CBDCA ) Adverse-Effecthypersensitivity after weekly low - dose Drugpaclitaxel ( 60 mg / m2 ) / CBDCA ( area under the concentration curve = 2 ) therapy in patients with recurrent ovarian cancer receiving multiple platinum - based chemotherapy.
1.0000 Adverse-Effect We report five cases of carboplatin ( DrugCBDCA ) Adverse-Effecthypersensitivity after weekly low - dose paclitaxel ( 60 mg / m2 ) / CBDCA ( area under the concentration curve = 2 ) therapy in patients with recurrent ovarian cancer receiving multiple platinum - based chemotherapy.
0.9984 Adverse-Effect We report five cases of Drugcarboplatin ( CBDCA ) Adverse-Effecthypersensitivity after weekly low - dose paclitaxel ( 60 mg / m2 ) / CBDCA ( area under the concentration curve = 2 ) therapy in patients with recurrent ovarian cancer receiving multiple platinum - based chemotherapy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect However, we recently saw two patients with renal tuberculosis treated with Drugethambutol in whom Adverse-Effectvisual loss from toxic optic neuropathies was severe and irreversible despite careful ophthalmological monitoring and prompt discontinuation of the agent at the first sign of impaired visual function.
0.9999 Adverse-Effect However, we recently saw two patients with renal tuberculosis treated with Drugethambutol in whom visual loss from Adverse-Effecttoxic optic neuropathies was severe and irreversible despite careful ophthalmological monitoring and prompt discontinuation of the agent at the first sign of impaired visual function.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The aim of this paper is to report the case of Adverse-Effectrosaceiform eruption induced by Drugerlotinib in an 81 - year - old - man and to discuss the pathogenetic role of Demodex folliculorum mites, found in the present patient, using skin scraping.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Recently, her serum Drugtheophylline Adverse-Effecttheophylline levels had increased to the toxic range ( 133. 2 micromol / L [ 24 microg / mL ] ) shortly after the addition of zafirlukast ( Accolate, Zeneca Pharmaceuticals, Wilmington, Del ) to her regimen.
0.9996 Adverse-Effect Recently, her serum Adverse-Effecttheophylline levels had increased to the toxic range ( 133. 2 micromol / L [ 24 microg / mL ] ) shortly after the addition of Drugzafirlukast ( Accolate, Zeneca Pharmaceuticals, Wilmington, Del ) to her regimen.
0.9987 Adverse-Effect Recently, her serum Adverse-Effecttheophylline levels had increased to the toxic range ( 133. 2 micromol / L [ 24 microg / mL ] ) shortly after the addition of zafirlukast ( DrugAccolate , Zeneca Pharmaceuticals, Wilmington, Del ) to her regimen.
1.0000 Adverse-Effect Recently, her serum Drugtheophylline Adverse-Effectlevels had increased to the toxic range ( 133. 2 micromol / L [ 24 microg / mL ] ) shortly after the addition of zafirlukast ( Accolate, Zeneca Pharmaceuticals, Wilmington, Del ) to her regimen.
1.0000 Adverse-Effect Recently, her serum Drugtheophylline levels Adverse-Effecthad increased to the toxic range ( 133. 2 micromol / L [ 24 microg / mL ] ) shortly after the addition of zafirlukast ( Accolate, Zeneca Pharmaceuticals, Wilmington, Del ) to her regimen.
1.0000 Adverse-Effect Recently, her serum theophylline Adverse-Effectlevels had increased to the toxic range ( 133. 2 micromol / L [ 24 microg / mL ] ) shortly after the addition of Drugzafirlukast ( Accolate, Zeneca Pharmaceuticals, Wilmington, Del ) to her regimen.
1.0000 Adverse-Effect Recently, her serum theophylline levels Adverse-Effecthad increased to the toxic range ( 133. 2 micromol / L [ 24 microg / mL ] ) shortly after the addition of Drugzafirlukast ( Accolate, Zeneca Pharmaceuticals, Wilmington, Del ) to her regimen.
1.0000 Adverse-Effect Recently, her serum theophylline levels had Adverse-Effectincreased to the toxic range ( 133. 2 micromol / L [ 24 microg / mL ] ) shortly after the addition of Drugzafirlukast ( Accolate, Zeneca Pharmaceuticals, Wilmington, Del ) to her regimen.
0.9999 Adverse-Effect Recently, her serum Drugtheophylline levels had Adverse-Effectincreased to the toxic range ( 133. 2 micromol / L [ 24 microg / mL ] ) shortly after the addition of zafirlukast ( Accolate, Zeneca Pharmaceuticals, Wilmington, Del ) to her regimen.
0.9999 Adverse-Effect Recently, her serum theophylline Adverse-Effectlevels had increased to the toxic range ( 133. 2 micromol / L [ 24 microg / mL ] ) shortly after the addition of zafirlukast ( DrugAccolate , Zeneca Pharmaceuticals, Wilmington, Del ) to her regimen.
0.9999 Adverse-Effect Recently, her serum theophylline levels Adverse-Effecthad increased to the toxic range ( 133. 2 micromol / L [ 24 microg / mL ] ) shortly after the addition of zafirlukast ( DrugAccolate , Zeneca Pharmaceuticals, Wilmington, Del ) to her regimen.
0.9999 Adverse-Effect Recently, her serum theophylline levels had Adverse-Effectincreased to the toxic range ( 133. 2 micromol / L [ 24 microg / mL ] ) shortly after the addition of zafirlukast ( DrugAccolate , Zeneca Pharmaceuticals, Wilmington, Del ) to her regimen.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The current report describes a man who was prescribed Drugzonisamide for epilepsy and subsequently developed widespread Adverse-Effectskin rash , acute kidney injury, high - grade fever, eosinophilia, liver dysfunction, lymphadenopathy and an increase in antihuman herpesvirus - 6 immunoglobulin G titer.
1.0000 Adverse-Effect The current report describes a man who was prescribed Drugzonisamide for epilepsy and subsequently developed widespread skin rash, Adverse-Effectacute kidney injury , high - grade fever, eosinophilia, liver dysfunction, lymphadenopathy and an increase in antihuman herpesvirus - 6 immunoglobulin G titer.
1.0000 Adverse-Effect The current report describes a man who was prescribed Drugzonisamide for epilepsy and subsequently developed widespread skin rash, acute kidney injury, Adverse-Effecthigh - grade fever , eosinophilia, liver dysfunction, lymphadenopathy and an increase in antihuman herpesvirus - 6 immunoglobulin G titer.
1.0000 Adverse-Effect The current report describes a man who was prescribed Drugzonisamide for epilepsy and subsequently developed widespread skin rash, acute kidney injury, high - grade fever, Adverse-Effecteosinophilia , liver dysfunction, lymphadenopathy and an increase in antihuman herpesvirus - 6 immunoglobulin G titer.
1.0000 Adverse-Effect The current report describes a man who was prescribed Drugzonisamide for epilepsy and subsequently developed widespread skin rash, acute kidney injury, high - grade fever, eosinophilia, liver dysfunction, Adverse-Effectlymphadenopathy and an increase in antihuman herpesvirus - 6 immunoglobulin G titer.
1.0000 Adverse-Effect The current report describes a man who was prescribed Drugzonisamide for epilepsy and subsequently developed widespread skin rash, acute kidney injury, high - grade fever, eosinophilia, Adverse-Effectliver dysfunction , lymphadenopathy and an increase in antihuman herpesvirus - 6 immunoglobulin G titer.
0.9999 Adverse-Effect The current report describes a man who was prescribed Drugzonisamide for epilepsy and subsequently developed widespread skin rash, acute kidney injury, high - grade fever, eosinophilia, liver dysfunction, lymphadenopathy and an increase in antihuman herpesvirus - 6 Adverse-Effectimmunoglobulin G titer .
Adverse-Effect The current report describes a man who was prescribed Drugzonisamide for epilepsy and subsequently developed widespread skin rash, acute kidney injury, high - grade fever, eosinophilia, liver dysfunction, lymphadenopathy and Adverse-Effectan increase in antihuman herpesvirus - 6 immunoglobulin G titer .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugOxcarbazepine - associated Adverse-Effectangioedema manifested by swelling of the face, eyes, lips, or tongue or difficulty swallowing or breathing ( or both ) is a rare but potentially life - threatening reaction for which early recognition and management are vital.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CASE REPORT : We describe here a case of a 60 year old female that experienced a relapse of Adverse-Effectsymptomatic hyperlactatemia after being switched from Drugstavudine to zidovudine and how the case was managed at the Infectious Diseases Institute, Kampala, Uganda.
0.9999 Adverse-Effect CASE REPORT : We describe here a case of a 60 year old female that experienced a relapse of Adverse-Effectsymptomatic hyperlactatemia after being switched from stavudine to Drugzidovudine and how the case was managed at the Infectious Diseases Institute, Kampala, Uganda.
Score Relation Text (Head - Tail)
0.9997 Adverse-Effect CONCLUSIONS : SD - OCT and AO detected abnormalities that correlate topographically with visual field loss from Drughydroxychloroquine toxicity as demonstrated by HVF 10 - 2 and may be useful in the detection of subclinical abnormalities that precede symptoms or Adverse-Effectobjective visual field loss .
0.9992 Adverse-Effect CONCLUSIONS : SD - OCT and AO detected abnormalities that correlate topographically with Adverse-Effectvisual field loss from Drughydroxychloroquine toxicity as demonstrated by HVF 10 - 2 and may be useful in the detection of subclinical abnormalities that precede symptoms or objective visual field loss.
0.9987 Adverse-Effect CONCLUSIONS : SD - OCT and AO detected Adverse-Effectabnormalities that correlate topographically with visual field loss from Drughydroxychloroquine toxicity as demonstrated by HVF 10 - 2 and may be useful in the detection of subclinical abnormalities that precede symptoms or objective visual field loss.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 64 year old man with recurrent metastatic squamous cell carcinoma of the head and neck developed severe skin rash and Adverse-Effectbone marrow aplasia 4 and 7 days, respectively, following a single dose of 40 mg / m2 Drugmethotrexate ( MTX ).
1.0000 Adverse-Effect A 64 year old man with recurrent metastatic squamous cell carcinoma of the head and neck developed Adverse-Effectsevere skin rash and bone marrow aplasia 4 and 7 days, respectively, following a single dose of 40 mg / m2 Drugmethotrexate ( MTX ).
1.0000 Adverse-Effect A 64 year old man with recurrent metastatic squamous cell carcinoma of the head and neck developed severe skin rash and Adverse-Effectbone marrow aplasia 4 and 7 days, respectively, following a single dose of 40 mg / m2 methotrexate ( DrugMTX ).
0.9999 Adverse-Effect A 64 year old man with recurrent metastatic squamous cell carcinoma of the head and neck developed Adverse-Effectsevere skin rash and bone marrow aplasia 4 and 7 days, respectively, following a single dose of 40 mg / m2 methotrexate ( DrugMTX ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The clinical course suggested that recombinant alpha - 2b peginterferon plus Drugribavirin provoked Adverse-Effecttype 1 diabetes mellitus , therefore, in patients who are candidates for interferon therapy the presence of pancreatic autoantibodies and the fasting plasma glucose level should be investigated before and during treatment.
0.9997 Adverse-Effect The clinical course suggested that Drugrecombinant alpha - 2b peginterferon plus ribavirin provoked Adverse-Effecttype 1 diabetes mellitus , therefore, in patients who are candidates for interferon therapy the presence of pancreatic autoantibodies and the fasting plasma glucose level should be investigated before and during treatment.
0.9997 Adverse-Effect The clinical course suggested that recombinant Drugalpha - 2b peginterferon plus ribavirin provoked Adverse-Effecttype 1 diabetes mellitus , therefore, in patients who are candidates for interferon therapy the presence of pancreatic autoantibodies and the fasting plasma glucose level should be investigated before and during treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect An episode of Adverse-Effectleukoencephalopathy is reported in a 13 - year - old girl who, after standard radiotherapy for a posterior fossa medulloblastoma, received 8 treatments with a protocol containing a 4 - hour infusion of 500 mg / m2 Drugmethotrexate and 12 mg intrathecal methotrexate.
0.9999 Adverse-Effect An episode of Adverse-Effectleukoencephalopathy is reported in a 13 - year - old girl who, after standard radiotherapy for a posterior fossa medulloblastoma, received 8 treatments with a protocol containing a 4 - hour infusion of 500 mg / m2 methotrexate and 12 mg intrathecal Drugmethotrexate .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In this report, one patient who developed Adverse-Effectgangrene after Drugbleomycin and vincristine / vinblastine chemotherapy for AIDS - related Kaposi's sarcoma and another HIV - infected patient who exhibited symptoms of severe Raynaud's phenomenon related to the same regimen are presented.
0.9999 Adverse-Effect In this report, one patient who developed Adverse-Effectgangrene after bleomycin and Drugvincristine / vinblastine chemotherapy for AIDS - related Kaposi's sarcoma and another HIV - infected patient who exhibited symptoms of severe Raynaud's phenomenon related to the same regimen are presented.
0.9999 Adverse-Effect In this report, one patient who developed Adverse-Effectgangrene after bleomycin and vincristine / Drugvinblastine chemotherapy for AIDS - related Kaposi's sarcoma and another HIV - infected patient who exhibited symptoms of severe Raynaud's phenomenon related to the same regimen are presented.
0.9997 Adverse-Effect In this report, one patient who developed gangrene after bleomycin and vincristine / Drugvinblastine chemotherapy for AIDS - related Kaposi's sarcoma and another HIV - infected patient who exhibited symptoms of Adverse-Effectsevere Raynaud's phenomenon related to the same regimen are presented.
0.9994 Adverse-Effect In this report, one patient who developed gangrene after bleomycin and Drugvincristine / vinblastine chemotherapy for AIDS - related Kaposi's sarcoma and another HIV - infected patient who exhibited symptoms of Adverse-Effectsevere Raynaud's phenomenon related to the same regimen are presented.
0.9993 Adverse-Effect In this report, one patient who developed gangrene after Drugbleomycin and vincristine / vinblastine chemotherapy for AIDS - related Kaposi's sarcoma and another HIV - infected patient who exhibited symptoms of Adverse-Effectsevere Raynaud's phenomenon related to the same regimen are presented.
Score Relation Text (Head - Tail)
0.9990 Adverse-Effect The polycystic changes disappeared from the ovaries in 2 of the women after valproate therapy was discontinued, and the 2 women who had gained weight and developed Adverse-Effectamenorrhea while being treated with Drugvalproate lost weight and resumed menstruating after the change in medication.
0.9909 Adverse-Effect The Adverse-Effectpolycystic changes disappeared from the ovaries in 2 of the women after Drugvalproate therapy was discontinued, and the 2 women who had gained weight and developed amenorrhea while being treated with valproate lost weight and resumed menstruating after the change in medication.
Adverse-Effect The polycystic changes disappeared from the ovaries in 2 of the women after valproate therapy was discontinued, and the 2 women who had Adverse-Effectgained weight and developed amenorrhea while being treated with Drugvalproate lost weight and resumed menstruating after the change in medication.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Six of 13 outpatients with schizophrenia who participated in a ten - week open trial of Drugrisperidone had an initial good response to the medication followed by development of Adverse-Effectintolerable affect , including feelings of agitation and depression and periods of crying and insomnia.
1.0000 Adverse-Effect Six of 13 outpatients with schizophrenia who participated in a ten - week open trial of Drugrisperidone had an initial good response to the medication followed by development of intolerable affect, including feelings of agitation and depression and periods of crying and Adverse-Effectinsomnia .
1.0000 Adverse-Effect Six of 13 outpatients with schizophrenia who participated in a ten - week open trial of Drugrisperidone had an initial good response to the medication followed by development of intolerable affect, including Adverse-Effectfeelings of agitation and depression and periods of crying and insomnia.
1.0000 Adverse-Effect Six of 13 outpatients with schizophrenia who participated in a ten - week open trial of Drugrisperidone had an initial good response to the medication followed by development of intolerable affect, including feelings of agitation and Adverse-Effectdepression and periods of crying and insomnia.
1.0000 Adverse-Effect Six of 13 outpatients with schizophrenia who participated in a ten - week open trial of Drugrisperidone had an initial good response to the medication followed by development of intolerable affect, including feelings of agitation and depression and Adverse-Effectperiods of crying and insomnia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of drug - induced Adverse-EffectKaposi's sarcoma ( KS ) on the sole of the right foot in a 71 - year - old man, treated for 6 months with corticosteroid therapy ( Drugprednisolone 25 mg / day ) for pericardial effusion.
1.0000 Adverse-Effect We report a case of drug - induced Kaposi's sarcoma ( Adverse-EffectKS ) on the sole of the right foot in a 71 - year - old man, treated for 6 months with corticosteroid therapy ( Drugprednisolone 25 mg / day ) for pericardial effusion.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In this report, a patient who had undergone a renal transplantation as a result of malignant hypertension, and who was on immunosuppressive therapy consisting of cyclosporin, prednisone and Drugazathioprine , developed Adverse-Effectthrombosis of the central retinal vein 5 years following the transplantation.
0.9999 Adverse-Effect In this report, a patient who had undergone a renal transplantation as a result of malignant hypertension, and who was on immunosuppressive therapy consisting of cyclosporin, Drugprednisone and azathioprine, developed Adverse-Effectthrombosis of the central retinal vein 5 years following the transplantation.
0.9999 Adverse-Effect In this report, a patient who had undergone a renal transplantation as a result of malignant hypertension, and who was on immunosuppressive therapy consisting of Drugcyclosporin , prednisone and azathioprine, developed Adverse-Effectthrombosis of the central retinal vein 5 years following the transplantation.
1.0000 Adverse-Effect In this report, a patient who had undergone a renal transplantation as a result of malignant hypertension, and who was on immunosuppressive therapy consisting of cyclosporin, prednisone and Drugazathioprine , developed Adverse-Effectthrombosis of the central retinal vein 5 years following the transplantation.
0.9999 Adverse-Effect In this report, a patient who had undergone a renal transplantation as a result of malignant hypertension, and who was on immunosuppressive therapy consisting of cyclosporin, Drugprednisone and azathioprine, developed Adverse-Effectthrombosis of the central retinal vein 5 years following the transplantation.
0.9999 Adverse-Effect In this report, a patient who had undergone a renal transplantation as a result of malignant hypertension, and who was on immunosuppressive therapy consisting of Drugcyclosporin , prednisone and azathioprine, developed Adverse-Effectthrombosis of the central retinal vein 5 years following the transplantation.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Based upon the observed fall of the filtration fraction, the rise in the relative clearance of 99Tc - dimercaptosuccinic acid and the increase in proteinuria, we suggest that in this case the tubules and / or interstitium are the main targets for Drugcyclosporine A Adverse-Effectnephrotoxicity .
0.9997 Adverse-Effect Based upon the observed fall of the filtration fraction, the rise in the relative clearance of 99Tc - dimercaptosuccinic acid and the Adverse-Effectincrease in proteinuria , we suggest that in this case the tubules and / or interstitium are the main targets for Drugcyclosporine A nephrotoxicity.
0.9986 Adverse-Effect Based upon the observed Adverse-Effectfall of the filtration fraction , the rise in the relative clearance of 99Tc - dimercaptosuccinic acid and the increase in proteinuria, we suggest that in this case the tubules and / or interstitium are the main targets for Drugcyclosporine A nephrotoxicity.
0.9795 Adverse-Effect Based upon the observed fall of the filtration fraction, the Adverse-Effectrise in the relative clearance of 99Tc - dimercaptosuccinic acid and the increase in proteinuria, we suggest that in this case the tubules and / or interstitium are the main targets for Drugcyclosporine A nephrotoxicity.
1.0000 Adverse-Effect Based upon the observed fall of the filtration fraction, the Adverse-Effectrise in the relative clearance of Drug99Tc - dimercaptosuccinic acid and the increase in proteinuria, we suggest that in this case the tubules and / or interstitium are the main targets for cyclosporine A nephrotoxicity.
1.0000 Adverse-Effect Based upon the observed fall of the filtration fraction, the Adverse-Effectrise in the relative clearance of Drug99Tc - dimercaptosuccinic acid and the increase in proteinuria, we suggest that in this case the tubules and / or interstitium are the main targets for cyclosporine A nephrotoxicity.
0.9988 Adverse-Effect Based upon the observed fall of the filtration fraction, the Adverse-Effectrise in the relative clearance of 99Tc - dimercaptosuccinic acid and the increase in proteinuria, we suggest that in this case the tubules and / or interstitium are the main targets for Drugcyclosporine A nephrotoxicity.
0.9988 Adverse-Effect Based upon the observed fall of the filtration fraction, the Adverse-Effectrise in the relative clearance of 99Tc - dimercaptosuccinic acid and the increase in proteinuria, we suggest that in this case the tubules and / or interstitium are the main targets for Drugcyclosporine A nephrotoxicity.
0.9983 Adverse-Effect Based upon the observed Adverse-Effectfall of the filtration fraction , the rise in the relative clearance of Drug99Tc - dimercaptosuccinic acid and the increase in proteinuria, we suggest that in this case the tubules and / or interstitium are the main targets for cyclosporine A nephrotoxicity.
0.9975 Adverse-Effect Based upon the observed fall of the filtration fraction, the Adverse-Effectrise in the relative clearance of 99Tc - dimercaptosuccinic acid Drug99Tc - dimercaptosuccinic acid and the increase in proteinuria, we suggest that in this case the tubules and / or interstitium are the main targets for cyclosporine A nephrotoxicity.
0.9952 Adverse-Effect Based upon the observed fall of the filtration fraction, the rise in the relative clearance of Drug99Tc - dimercaptosuccinic acid and the increase in proteinuria, we suggest that in this case the tubules and / or interstitium are the main targets for cyclosporine A Adverse-Effectnephrotoxicity .
0.9820 Adverse-Effect Based upon the observed fall of the filtration fraction, the rise in the relative clearance of Drug99Tc - dimercaptosuccinic acid and the Adverse-Effectincrease in proteinuria , we suggest that in this case the tubules and / or interstitium are the main targets for cyclosporine A nephrotoxicity.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Although there is one case report of Adverse-Effectcholesterol crystal embolization following Drugt - PA therapy with only extrarenal manifestations ( N Engl J Med 321 : 1270, 1989 ), this is the first reported case of atheroembolic acute renal failure following t - PA therapy.
0.9999 Adverse-Effect Although there is one case report of cholesterol crystal embolization following t - PA therapy with only extrarenal manifestations ( N Engl J Med 321 : 1270, 1989 ), this is the first reported case of Adverse-Effectatheroembolic acute renal failure following Drugt - PA therapy.
0.9878 Adverse-Effect Although there is one case report of cholesterol crystal embolization following Drugt - PA therapy with only Adverse-Effectextrarenal manifestations ( N Engl J Med 321 : 1270, 1989 ), this is the first reported case of atheroembolic acute renal failure following t - PA therapy.
0.9964 Adverse-Effect Although there is one case report of Adverse-Effectcholesterol crystal embolization following t Drug- PA therapy with only extrarenal manifestations ( N Engl J Med 321 : 1270, 1989 ), this is the first reported case of atheroembolic acute renal failure following t - PA therapy.
0.9882 Adverse-Effect Although there is one case report of cholesterol crystal embolization following t Drug- PA therapy with only Adverse-Effectextrarenal manifestations ( N Engl J Med 321 : 1270, 1989 ), this is the first reported case of atheroembolic acute renal failure following t - PA therapy.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Rebound Adverse-Effecthyperglycemia was observed with both intermediate ( Drugneutral protamine hagedorn ) and long - acting ( protamine zinc iletin ) insulins, and the range of insulin doses at which the disorder developed overlapped previously determined therapeutic doses for these insulins in the cat.
0.9998 Adverse-Effect Rebound Adverse-Effecthyperglycemia was observed with both intermediate ( neutral Drugprotamine hagedorn ) and long - acting ( protamine zinc iletin ) insulins, and the range of insulin doses at which the disorder developed overlapped previously determined therapeutic doses for these insulins in the cat.
0.9997 Adverse-Effect Rebound Adverse-Effecthyperglycemia was observed with both intermediate ( neutral protamine hagedorn ) and long - acting ( Drugprotamine zinc iletin ) insulins, and the range of insulin doses at which the disorder developed overlapped previously determined therapeutic doses for these insulins in the cat.
Adverse-Effect Adverse-EffectRebound hyperglycemia was observed with both intermediate ( neutral Drugprotamine hagedorn ) and long - acting ( protamine zinc iletin ) insulins, and the range of insulin doses at which the disorder developed overlapped previously determined therapeutic doses for these insulins in the cat.
Adverse-Effect Adverse-EffectRebound hyperglycemia was observed with both intermediate ( neutral protamine hagedorn ) and long - acting ( Drugprotamine zinc iletin ) insulins, and the range of insulin doses at which the disorder developed overlapped previously determined therapeutic doses for these insulins in the cat.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The goal of this study is to describe three patients diagnosed with migraine and epilepsy ( both under control ) who evolved into Adverse-Effectstatus migrainosus after the introduction of Drugoxcarbazepine ( OXC ), as part of a switch off from carbamazepine ( CBZ ).
1.0000 Adverse-Effect The goal of this study is to describe three patients diagnosed with migraine and epilepsy ( both under control ) who evolved into Adverse-Effectstatus migrainosus after the introduction of oxcarbazepine ( DrugOXC ), as part of a switch off from carbamazepine ( CBZ ).
0.9999 Adverse-Effect The goal of this study is to describe three patients diagnosed with migraine and epilepsy ( both under control ) who evolved into Adverse-Effectstatus migrainosus after the introduction of oxcarbazepine ( OXC ), as part of a switch off from carbamazepine ( DrugCBZ ).
0.9999 Adverse-Effect The goal of this study is to describe three patients diagnosed with migraine and epilepsy ( both under control ) who evolved into Adverse-Effectstatus migrainosus after the introduction of oxcarbazepine ( OXC ), as part of a switch off from Drugcarbamazepine ( CBZ ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Physicians should be aware of the risk of severe AIHA in CLL patients with a history of AIHA or Adverse-Effectpositivation of the DAT during previous Drugfludarabine administration, or in case of secondary fixation of complement to the red cell membrane occurring during fludarabine treatment.
0.9999 Adverse-Effect Physicians should be aware of the risk of severe AIHA in CLL patients with a history of Adverse-EffectAIHA or positivation of the DAT during previous Drugfludarabine administration, or in case of secondary fixation of complement to the red cell membrane occurring during fludarabine treatment.
0.9999 Adverse-Effect Physicians should be aware of the risk of severe Adverse-EffectAIHA in CLL patients with a history of AIHA or positivation of the DAT during previous Drugfludarabine administration, or in case of secondary fixation of complement to the red cell membrane occurring during fludarabine treatment.
0.9997 Adverse-Effect Physicians should be aware of the risk of severe AIHA in CLL patients with a history of AIHA or Adverse-Effectpositivation of the DAT during previous fludarabine administration, or in case of secondary fixation of complement to the red cell membrane occurring during Drugfludarabine treatment.
0.9996 Adverse-Effect Physicians should be aware of the risk of severe AIHA in CLL patients with a history of Adverse-EffectAIHA or positivation of the DAT during previous fludarabine administration, or in case of secondary fixation of complement to the red cell membrane occurring during Drugfludarabine treatment.
0.9996 Adverse-Effect Physicians should be aware of the risk of severe Adverse-EffectAIHA in CLL patients with a history of AIHA or positivation of the DAT during previous fludarabine administration, or in case of secondary fixation of complement to the red cell membrane occurring during Drugfludarabine treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report a case of Stevens - Johnson syndrome / toxic epidermal necrolysis ( SJS / Adverse-EffectTEN ) secondary to Drugtrimethoprim - sulfamethoxazole ( TMP - Sx ) therapy for presumed community - associated methicillin - resistant Staphylococcus aureus ( CA - MRSA ) infection.
0.9997 Adverse-Effect We report a case of Stevens - Johnson syndrome / toxic epidermal necrolysis ( Adverse-EffectSJS / TEN ) secondary to Drugtrimethoprim - sulfamethoxazole ( TMP - Sx ) therapy for presumed community - associated methicillin - resistant Staphylococcus aureus ( CA - MRSA ) infection.
0.9997 Adverse-Effect We report a case of Stevens - Johnson syndrome / toxic epidermal necrolysis ( SJS / Adverse-EffectTEN ) secondary to trimethoprim - sulfamethoxazole ( DrugTMP - Sx ) therapy for presumed community - associated methicillin - resistant Staphylococcus aureus ( CA - MRSA ) infection.
0.9996 Adverse-Effect We report a case of Adverse-EffectStevens - Johnson syndrome / toxic epidermal necrolysis ( SJS / TEN ) secondary to Drugtrimethoprim - sulfamethoxazole ( TMP - Sx ) therapy for presumed community - associated methicillin - resistant Staphylococcus aureus ( CA - MRSA ) infection.
0.9996 Adverse-Effect We report a case of Stevens - Johnson syndrome / Adverse-Effecttoxic epidermal necrolysis ( SJS / TEN ) secondary to Drugtrimethoprim - sulfamethoxazole ( TMP - Sx ) therapy for presumed community - associated methicillin - resistant Staphylococcus aureus ( CA - MRSA ) infection.
0.9991 Adverse-Effect We report a case of Stevens - Johnson syndrome / toxic epidermal necrolysis ( Adverse-EffectSJS / TEN ) secondary to trimethoprim - sulfamethoxazole ( DrugTMP - Sx ) therapy for presumed community - associated methicillin - resistant Staphylococcus aureus ( CA - MRSA ) infection.
0.9989 Adverse-Effect We report a case of Adverse-EffectStevens - Johnson syndrome / toxic epidermal necrolysis ( SJS / TEN ) secondary to trimethoprim - sulfamethoxazole ( DrugTMP - Sx ) therapy for presumed community - associated methicillin - resistant Staphylococcus aureus ( CA - MRSA ) infection.
0.9986 Adverse-Effect We report a case of Stevens - Johnson syndrome / Adverse-Effecttoxic epidermal necrolysis ( SJS / TEN ) secondary to trimethoprim - sulfamethoxazole ( DrugTMP - Sx ) therapy for presumed community - associated methicillin - resistant Staphylococcus aureus ( CA - MRSA ) infection.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSIONS : Sustained - release Drugverapamil is thought to be the cause of the Adverse-Effectasthma attack in this patient because she was not taking any other preparations ; the symptoms started with the administration of sustained - release verapamil and were relieved after its discontinuation.
0.9999 Adverse-Effect CONCLUSIONS : Sustained - release verapamil is thought to be the cause of the Adverse-Effectasthma attack in this patient because she was not taking any other preparations ; the symptoms started with the administration of sustained - release Drugverapamil and were relieved after its discontinuation.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Further studies are necessary to evaluate whether the study of HLA antigens may be a very useful tool to detect the patients with a predisposition to develop autoimmune thyroiditis, in order to make a early diagnosis of Adverse-Effectthyroid disorders during the DrugIFN - alpha treatment.
0.9980 Adverse-Effect Further studies are necessary to evaluate whether the study of HLA antigens may be a very useful tool to detect the patients with a predisposition to develop Adverse-Effectautoimmune thyroiditis , in order to make a early diagnosis of thyroid disorders during the DrugIFN - alpha treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A patient with psoriasis is described who had an abnormal response to the glucose tolerance test without other evidence of diabetes and then developed postprandial hyperglycemia and Adverse-Effectglycosuria during a period of topical administration of a corticosteroid cream, Drughalcinonide cream 0. 1 %, under occlusion.
1.0000 Adverse-Effect A patient with psoriasis is described who had an abnormal response to the glucose tolerance test without other evidence of diabetes and then developed Adverse-Effectpostprandial hyperglycemia and glycosuria during a period of topical administration of a corticosteroid cream, Drughalcinonide cream 0. 1 %, under occlusion.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 14 - year - old female developed systemic lupus erythematosus ( SLE ) - like symptoms, rash, fever, leukopenia and Adverse-Effectpositive anti - nuclear antibody ( ANA ) two weeks after administration of Drugcarbamazepine ( CBZ ; Tegretol ) used against benign Rolandic epilepsy.
1.0000 Adverse-Effect A 14 - year - old female developed systemic lupus erythematosus ( SLE ) - like symptoms, rash, fever, Adverse-Effectleukopenia and positive anti - nuclear antibody ( ANA ) two weeks after administration of Drugcarbamazepine ( CBZ ; Tegretol ) used against benign Rolandic epilepsy.
1.0000 Adverse-Effect A 14 - year - old female developed systemic lupus erythematosus ( SLE ) - like symptoms, Adverse-Effectrash , fever, leukopenia and positive anti - nuclear antibody ( ANA ) two weeks after administration of Drugcarbamazepine ( CBZ ; Tegretol ) used against benign Rolandic epilepsy.
1.0000 Adverse-Effect A 14 - year - old female developed systemic lupus erythematosus ( SLE ) - like symptoms, rash, Adverse-Effectfever , leukopenia and positive anti - nuclear antibody ( ANA ) two weeks after administration of Drugcarbamazepine ( CBZ ; Tegretol ) used against benign Rolandic epilepsy.
0.9999 Adverse-Effect A 14 - year - old female developed systemic lupus erythematosus ( SLE ) - like symptoms, Adverse-Effectrash , fever, leukopenia and positive anti - nuclear antibody ( ANA ) two weeks after administration of carbamazepine ( DrugCBZ ; Tegretol ) used against benign Rolandic epilepsy.
0.9999 Adverse-Effect A 14 - year - old female developed systemic lupus erythematosus ( SLE ) - like symptoms, rash, fever, Adverse-Effectleukopenia and positive anti - nuclear antibody ( ANA ) two weeks after administration of carbamazepine ( DrugCBZ ; Tegretol ) used against benign Rolandic epilepsy.
0.9999 Adverse-Effect A 14 - year - old female developed systemic lupus erythematosus ( SLE ) - like symptoms, Adverse-Effectrash , fever, leukopenia and positive anti - nuclear antibody ( ANA ) two weeks after administration of carbamazepine ( CBZ ; DrugTegretol ) used against benign Rolandic epilepsy.
0.9999 Adverse-Effect A 14 - year - old female developed Adverse-Effectsystemic lupus erythematosus ( SLE ) - like symptoms , rash, fever, leukopenia and positive anti - nuclear antibody ( ANA ) two weeks after administration of Drugcarbamazepine ( CBZ ; Tegretol ) used against benign Rolandic epilepsy.
0.9999 Adverse-Effect A 14 - year - old female developed systemic lupus erythematosus ( SLE ) - like symptoms, rash, fever, Adverse-Effectleukopenia and positive anti - nuclear antibody ( ANA ) two weeks after administration of carbamazepine ( CBZ ; DrugTegretol ) used against benign Rolandic epilepsy.
0.9999 Adverse-Effect A 14 - year - old female developed systemic lupus erythematosus ( SLE ) - like symptoms, rash, fever, leukopenia and Adverse-Effectpositive anti - nuclear antibody ( ANA ) two weeks after administration of carbamazepine ( DrugCBZ ; Tegretol ) used against benign Rolandic epilepsy.
0.9999 Adverse-Effect A 14 - year - old female developed systemic lupus erythematosus ( SLE ) - like symptoms, rash, fever, leukopenia and Adverse-Effectpositive anti - nuclear antibody ( ANA ) two weeks after administration of carbamazepine ( CBZ ; DrugTegretol ) used against benign Rolandic epilepsy.
0.9999 Adverse-Effect A 14 - year - old female developed systemic lupus erythematosus ( SLE ) - like symptoms, rash, Adverse-Effectfever , leukopenia and positive anti - nuclear antibody ( ANA ) two weeks after administration of carbamazepine ( DrugCBZ ; Tegretol ) used against benign Rolandic epilepsy.
0.9999 Adverse-Effect A 14 - year - old female developed systemic lupus erythematosus ( SLE ) - like symptoms, rash, Adverse-Effectfever , leukopenia and positive anti - nuclear antibody ( ANA ) two weeks after administration of carbamazepine ( CBZ ; DrugTegretol ) used against benign Rolandic epilepsy.
0.9998 Adverse-Effect A 14 - year - old female developed Adverse-Effectsystemic lupus erythematosus ( SLE ) - like symptoms , rash, fever, leukopenia and positive anti - nuclear antibody ( ANA ) two weeks after administration of carbamazepine ( DrugCBZ ; Tegretol ) used against benign Rolandic epilepsy.
0.9998 Adverse-Effect A 14 - year - old female developed Adverse-Effectsystemic lupus erythematosus ( SLE ) - like symptoms , rash, fever, leukopenia and positive anti - nuclear antibody ( ANA ) two weeks after administration of carbamazepine ( CBZ ; DrugTegretol ) used against benign Rolandic epilepsy.
1.0000 Adverse-Effect A 14 - year - old female developed systemic lupus erythematosus ( SLE ) - like symptoms, rash, fever, leukopenia and positive anti - nuclear antibody ( Adverse-EffectANA ) two weeks after administration of Drugcarbamazepine ( CBZ ; Tegretol ) used against benign Rolandic epilepsy.
1.0000 Adverse-Effect A 14 - year - old female developed systemic lupus erythematosus ( SLE ) - like symptoms, rash, fever, leukopenia and positive anti - nuclear antibody ( Adverse-EffectANA ) two weeks after administration of carbamazepine ( DrugCBZ ; Tegretol ) used against benign Rolandic epilepsy.
1.0000 Adverse-Effect A 14 - year - old female developed systemic lupus erythematosus ( SLE ) - like symptoms, rash, fever, leukopenia and positive anti - nuclear antibody ( Adverse-EffectANA ) two weeks after administration of carbamazepine ( CBZ ; DrugTegretol ) used against benign Rolandic epilepsy.
0.9999 Adverse-Effect A 14 - year - old female developed systemic lupus erythematosus ( Adverse-EffectSLE ) - like symptoms , rash, fever, leukopenia and positive anti - nuclear antibody ( ANA ) two weeks after administration of Drugcarbamazepine ( CBZ ; Tegretol ) used against benign Rolandic epilepsy.
0.9998 Adverse-Effect A 14 - year - old female developed systemic lupus erythematosus ( Adverse-EffectSLE ) - like symptoms , rash, fever, leukopenia and positive anti - nuclear antibody ( ANA ) two weeks after administration of carbamazepine ( DrugCBZ ; Tegretol ) used against benign Rolandic epilepsy.
0.9998 Adverse-Effect A 14 - year - old female developed systemic lupus erythematosus ( Adverse-EffectSLE ) - like symptoms , rash, fever, leukopenia and positive anti - nuclear antibody ( ANA ) two weeks after administration of carbamazepine ( CBZ ; DrugTegretol ) used against benign Rolandic epilepsy.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Since the Adverse-Effectthrombocyte count started to increase immediately after initiation and dropped immediately after discontinuation of Drugciprofloxacin and tazobactam / piperacillin and all other drugs were discontinued already before or were started after the nadir of the thrombocyte count, these two antibiotics were regarded causative.
0.9998 Adverse-Effect Since the Adverse-Effectthrombocyte count started to increase immediately after initiation and dropped immediately after discontinuation of ciprofloxacin and tazobactam / Drugpiperacillin and all other drugs were discontinued already before or were started after the nadir of the thrombocyte count, these two antibiotics were regarded causative.
0.9998 Adverse-Effect Since the Adverse-Effectthrombocyte count started to increase immediately after initiation and dropped immediately after discontinuation of ciprofloxacin and Drugtazobactam / piperacillin and all other drugs were discontinued already before or were started after the nadir of the thrombocyte count, these two antibiotics were regarded causative.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Our findings suggest that significant Adverse-Effectprogression of marrow reticulin fibrosis during Drugimatinib therapy can be an indicator for a return or progression of CML and, in some patients with CML, imatinib may promote cytogenetic clonal evolution, resulting in a poor response to treatment.
0.4811 Adverse-Effect Our findings suggest that significant Adverse-Effectprogression of marrow reticulin fibrosis during imatinib therapy can be an indicator for a return or progression of CML and, in some patients with CML, Drugimatinib may promote cytogenetic clonal evolution, resulting in a poor response to treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Ciprofloxacin is among the standard treatments for infected ischemic ulcers ; in the rare case of Drugciprofloxacin - induced Adverse-Effecthemorrhagic vasculitis , it might be interpreted as progression of infection, instead of a complication of the treatment, thus leading to faulty diagnosis and treatment.
0.9991 Adverse-Effect Ciprofloxacin is among the standard treatments for infected ischemic ulcers ; in the rare case of Drugciprofloxacin - induced hemorrhagic vasculitis, it might be interpreted as Adverse-Effectprogression of infection , instead of a complication of the treatment, thus leading to faulty diagnosis and treatment.
0.9805 Adverse-Effect DrugCiprofloxacin is among the standard treatments for infected ischemic ulcers ; in the rare case of ciprofloxacin - induced Adverse-Effecthemorrhagic vasculitis , it might be interpreted as progression of infection, instead of a complication of the treatment, thus leading to faulty diagnosis and treatment.
0.9709 Adverse-Effect DrugCiprofloxacin is among the standard treatments for infected ischemic ulcers ; in the rare case of ciprofloxacin - induced hemorrhagic vasculitis, it might be interpreted as Adverse-Effectprogression of infection , instead of a complication of the treatment, thus leading to faulty diagnosis and treatment.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSION : The new quinolone derivatives ( levofloxacin, sparfloxacin, grepafloxacin, trovafloxacin, gatifloxacin and Drugmoxifloxacin ), also called gyrase inhibitors, are known for their potential to cause central nervous system - related adverse effects, including Adverse-Effectheadache , dizziness and insomnia.
1.0000 Adverse-Effect CONCLUSION : The new quinolone derivatives ( levofloxacin, sparfloxacin, grepafloxacin, trovafloxacin, gatifloxacin and Drugmoxifloxacin ), also called gyrase inhibitors, are known for their potential to cause central nervous system - related adverse effects, including headache, Adverse-Effectdizziness and insomnia.
1.0000 Adverse-Effect CONCLUSION : The new quinolone derivatives ( levofloxacin, sparfloxacin, grepafloxacin, trovafloxacin, gatifloxacin and Drugmoxifloxacin ), also called gyrase inhibitors, are known for their potential to cause central nervous system - related adverse effects, including headache, dizziness and Adverse-Effectinsomnia .
1.0000 Adverse-Effect CONCLUSION : The new quinolone derivatives ( Druglevofloxacin , sparfloxacin, grepafloxacin, trovafloxacin, gatifloxacin and moxifloxacin ), also called gyrase inhibitors, are known for their potential to cause central nervous system - related adverse effects, including Adverse-Effectheadache , dizziness and insomnia.
1.0000 Adverse-Effect CONCLUSION : The new quinolone derivatives ( levofloxacin, sparfloxacin, grepafloxacin, trovafloxacin, Druggatifloxacin and moxifloxacin ), also called gyrase inhibitors, are known for their potential to cause central nervous system - related adverse effects, including Adverse-Effectheadache , dizziness and insomnia.
1.0000 Adverse-Effect CONCLUSION : The new quinolone derivatives ( levofloxacin, sparfloxacin, grepafloxacin, Drugtrovafloxacin , gatifloxacin and moxifloxacin ), also called gyrase inhibitors, are known for their potential to cause central nervous system - related adverse effects, including Adverse-Effectheadache , dizziness and insomnia.
0.9999 Adverse-Effect CONCLUSION : The new quinolone derivatives ( levofloxacin, Drugsparfloxacin , grepafloxacin, trovafloxacin, gatifloxacin and moxifloxacin ), also called gyrase inhibitors, are known for their potential to cause central nervous system - related adverse effects, including Adverse-Effectheadache , dizziness and insomnia.
0.9999 Adverse-Effect CONCLUSION : The new quinolone derivatives ( Druglevofloxacin , sparfloxacin, grepafloxacin, trovafloxacin, gatifloxacin and moxifloxacin ), also called gyrase inhibitors, are known for their potential to cause central nervous system - related adverse effects, including headache, dizziness and Adverse-Effectinsomnia .
0.9999 Adverse-Effect CONCLUSION : The new quinolone derivatives ( levofloxacin, sparfloxacin, grepafloxacin, Drugtrovafloxacin , gatifloxacin and moxifloxacin ), also called gyrase inhibitors, are known for their potential to cause central nervous system - related adverse effects, including headache, dizziness and Adverse-Effectinsomnia .
0.9999 Adverse-Effect CONCLUSION : The new quinolone derivatives ( levofloxacin, sparfloxacin, grepafloxacin, trovafloxacin, Druggatifloxacin and moxifloxacin ), also called gyrase inhibitors, are known for their potential to cause central nervous system - related adverse effects, including headache, dizziness and Adverse-Effectinsomnia .
0.9999 Adverse-Effect CONCLUSION : The new quinolone derivatives ( Druglevofloxacin , sparfloxacin, grepafloxacin, trovafloxacin, gatifloxacin and moxifloxacin ), also called gyrase inhibitors, are known for their potential to cause central nervous system - related adverse effects, including headache, Adverse-Effectdizziness and insomnia.
0.9999 Adverse-Effect CONCLUSION : The new quinolone derivatives ( levofloxacin, sparfloxacin, grepafloxacin, Drugtrovafloxacin , gatifloxacin and moxifloxacin ), also called gyrase inhibitors, are known for their potential to cause central nervous system - related adverse effects, including headache, Adverse-Effectdizziness and insomnia.
0.9999 Adverse-Effect CONCLUSION : The new quinolone derivatives ( levofloxacin, sparfloxacin, grepafloxacin, trovafloxacin, Druggatifloxacin and moxifloxacin ), also called gyrase inhibitors, are known for their potential to cause central nervous system - related adverse effects, including headache, Adverse-Effectdizziness and insomnia.
0.9999 Adverse-Effect CONCLUSION : The new quinolone derivatives ( levofloxacin, sparfloxacin, Druggrepafloxacin , trovafloxacin, gatifloxacin and moxifloxacin ), also called gyrase inhibitors, are known for their potential to cause central nervous system - related adverse effects, including Adverse-Effectheadache , dizziness and insomnia.
0.9999 Adverse-Effect CONCLUSION : The new quinolone derivatives ( levofloxacin, Drugsparfloxacin , grepafloxacin, trovafloxacin, gatifloxacin and moxifloxacin ), also called gyrase inhibitors, are known for their potential to cause central nervous system - related adverse effects, including headache, dizziness and Adverse-Effectinsomnia .
0.9999 Adverse-Effect CONCLUSION : The new quinolone derivatives ( levofloxacin, Drugsparfloxacin , grepafloxacin, trovafloxacin, gatifloxacin and moxifloxacin ), also called gyrase inhibitors, are known for their potential to cause central nervous system - related adverse effects, including headache, Adverse-Effectdizziness and insomnia.
0.9999 Adverse-Effect CONCLUSION : The new quinolone derivatives ( levofloxacin, sparfloxacin, Druggrepafloxacin , trovafloxacin, gatifloxacin and moxifloxacin ), also called gyrase inhibitors, are known for their potential to cause central nervous system - related adverse effects, including headache, dizziness and Adverse-Effectinsomnia .
0.9999 Adverse-Effect CONCLUSION : The new quinolone derivatives ( levofloxacin, sparfloxacin, Druggrepafloxacin , trovafloxacin, gatifloxacin and moxifloxacin ), also called gyrase inhibitors, are known for their potential to cause central nervous system - related adverse effects, including headache, Adverse-Effectdizziness and insomnia.
1.0000 Adverse-Effect CONCLUSION : The new quinolone derivatives ( levofloxacin, sparfloxacin, grepafloxacin, trovafloxacin, gatifloxacin and Drugmoxifloxacin ), also called gyrase inhibitors, are known for their potential to cause Adverse-Effectcentral nervous system - related adverse effects , including headache, dizziness and insomnia.
0.9999 Adverse-Effect CONCLUSION : The new quinolone derivatives ( Druglevofloxacin , sparfloxacin, grepafloxacin, trovafloxacin, gatifloxacin and moxifloxacin ), also called gyrase inhibitors, are known for their potential to cause Adverse-Effectcentral nervous system - related adverse effects , including headache, dizziness and insomnia.
0.9999 Adverse-Effect CONCLUSION : The new quinolone derivatives ( levofloxacin, sparfloxacin, grepafloxacin, trovafloxacin, Druggatifloxacin and moxifloxacin ), also called gyrase inhibitors, are known for their potential to cause Adverse-Effectcentral nervous system - related adverse effects , including headache, dizziness and insomnia.
0.9999 Adverse-Effect CONCLUSION : The new quinolone derivatives ( levofloxacin, sparfloxacin, grepafloxacin, Drugtrovafloxacin , gatifloxacin and moxifloxacin ), also called gyrase inhibitors, are known for their potential to cause Adverse-Effectcentral nervous system - related adverse effects , including headache, dizziness and insomnia.
0.9998 Adverse-Effect CONCLUSION : The new quinolone derivatives ( levofloxacin, Drugsparfloxacin , grepafloxacin, trovafloxacin, gatifloxacin and moxifloxacin ), also called gyrase inhibitors, are known for their potential to cause Adverse-Effectcentral nervous system - related adverse effects , including headache, dizziness and insomnia.
0.9998 Adverse-Effect CONCLUSION : The new quinolone derivatives ( levofloxacin, sparfloxacin, Druggrepafloxacin , trovafloxacin, gatifloxacin and moxifloxacin ), also called gyrase inhibitors, are known for their potential to cause Adverse-Effectcentral nervous system - related adverse effects , including headache, dizziness and insomnia.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect CONCLUSIONS : In our reported case, a local hyperproduction of TNF - alpha from macrophages that was induced by the injected Druginsulin could explain the Adverse-Effectdedifferentiation of the adipocytes of the subcutaneous tissue and the reversion that was induced by the local injection of dexamethasone.
1.0000 Adverse-Effect CONCLUSIONS : In our reported case, a local hyperproduction of TNF - alpha from macrophages that was induced by the injected insulin could explain the dedifferentiation of the adipocytes of the subcutaneous tissue and the Adverse-Effectreversion that was induced by the local injection of Drugdexamethasone .
0.9999 Adverse-Effect CONCLUSIONS : In our reported case, a local hyperproduction of TNF - alpha from macrophages that was induced by the injected Druginsulin could explain the Adverse-Effectdedifferentiation of the adipocytes of the subcutaneous tissue and the reversion that was induced by the local injection of dexamethasone.
0.9999 Adverse-Effect CONCLUSIONS : In our reported case, a local hyperproduction of TNF - alpha from macrophages that was induced by the injected insulin could explain the Adverse-Effectdedifferentiation of the adipocytes of the subcutaneous tissue and the reversion that was induced by the local injection of Drugdexamethasone .
0.9998 Adverse-Effect CONCLUSIONS : In our reported case, a local hyperproduction of TNF - alpha from macrophages that was induced by the injected insulin could explain the Adverse-Effectdedifferentiation of the adipocytes of the subcutaneous tissue and the reversion that was induced by the local injection of Drugdexamethasone .
0.9990 Adverse-Effect CONCLUSIONS : In our reported case, a local hyperproduction of TNF - alpha from macrophages that was induced by the injected Druginsulin could explain the dedifferentiation of the adipocytes of the subcutaneous tissue and the Adverse-Effectreversion that was induced by the local injection of dexamethasone.
Adverse-Effect CONCLUSIONS : In our reported case, a local Adverse-Effecthyperproduction of TNF - alpha from macrophages that was induced by the injected Druginsulin could explain the dedifferentiation of the adipocytes of the subcutaneous tissue and the reversion that was induced by the local injection of dexamethasone.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Factors that suggested an association between the Adverse-Effectsevere angioedematous reaction and DrugBP topical application include the strong reaction to BP in the patch - test, the temporal relationship, the complete resolution of symptoms after the drug was withdrawn and the absence of other identified explanations.
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect To develop information on the relative rarity or frequency of Adverse-Effectneurologic worsening with the initiation of Drugpenicillamine therapy, we conducted a retrospective survey of 25 additional patients with Wilson's disease who met the criteria of presenting with neurologic disease and having been treated with penicillamine.
0.9872 Adverse-Effect To develop information on the Adverse-Effectrelative rarity or frequency of neurologic worsening with the initiation of Drugpenicillamine therapy, we conducted a retrospective survey of 25 additional patients with Wilson's disease who met the criteria of presenting with neurologic disease and having been treated with penicillamine.
Adverse-Effect To develop information on the relative rarity or frequency of neurologic worsening with the initiation of penicillamine therapy, we conducted a retrospective survey of 25 additional patients with Wilson's disease who met the criteria of presenting with Adverse-Effectneurologic disease and having been treated with Drugpenicillamine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The risk of developing Adverse-EffectsAML is estimated to be between 1 % and 5 %, 2 - 20 years after exposure to Drugetoposide but may also be related to cumulative drug doses, treatment schedules, host factors and co - administration of other antineoplastic agents.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The presence of a lymphocyte alveolitis with a predominance of CD4 + T cells in 3 RA patients and CD8 + T cells with a concomitant increase in neutrophils in another case suggests that immunologically mediated reactions may be one damage mechanism in DrugMTX - induced Adverse-Effectpneumonitis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Adverse-EffectRenal failure appeared 8 to 17 days after beginning Druggentamicin therapy and was characterized by creatinine clearances 4 to 10 ml / min, urine to plasma creatinine ratios less than 20, urinary sodium concentrations 16 to 60 mEq / liter, proteinuria, and cylindruria.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect He had been taking trimethoprim - Drugsulfamethoxazole for approximately eight days when he revisited his family physician, complaining of Adverse-Effectheadaches , dizziness, difficulty with speech, weakness, and itching on the trunk of his body and legs, where a maculopapular rash was noted.
0.9999 Adverse-Effect He had been taking trimethoprim - Drugsulfamethoxazole for approximately eight days when he revisited his family physician, complaining of headaches, dizziness, Adverse-Effectdifficulty with speech , weakness, and itching on the trunk of his body and legs, where a maculopapular rash was noted.
0.9999 Adverse-Effect He had been taking trimethoprim - Drugsulfamethoxazole for approximately eight days when he revisited his family physician, complaining of headaches, dizziness, difficulty with speech, Adverse-Effectweakness , and itching on the trunk of his body and legs, where a maculopapular rash was noted.
0.9999 Adverse-Effect He had been taking trimethoprim - Drugsulfamethoxazole for approximately eight days when he revisited his family physician, complaining of headaches, Adverse-Effectdizziness , difficulty with speech, weakness, and itching on the trunk of his body and legs, where a maculopapular rash was noted.
0.9999 Adverse-Effect He had been taking Drugtrimethoprim - sulfamethoxazole for approximately eight days when he revisited his family physician, complaining of Adverse-Effectheadaches , dizziness, difficulty with speech, weakness, and itching on the trunk of his body and legs, where a maculopapular rash was noted.
0.9998 Adverse-Effect He had been taking trimethoprim - Drugsulfamethoxazole for approximately eight days when he revisited his family physician, complaining of headaches, dizziness, difficulty with speech, weakness, and itching on the trunk of his body and legs, where a Adverse-Effectmaculopapular rash was noted.
0.9997 Adverse-Effect He had been taking Drugtrimethoprim - sulfamethoxazole for approximately eight days when he revisited his family physician, complaining of headaches, dizziness, Adverse-Effectdifficulty with speech , weakness, and itching on the trunk of his body and legs, where a maculopapular rash was noted.
0.9996 Adverse-Effect He had been taking Drugtrimethoprim - sulfamethoxazole for approximately eight days when he revisited his family physician, complaining of headaches, dizziness, difficulty with speech, Adverse-Effectweakness , and itching on the trunk of his body and legs, where a maculopapular rash was noted.
0.9996 Adverse-Effect He had been taking Drugtrimethoprim - sulfamethoxazole for approximately eight days when he revisited his family physician, complaining of headaches, Adverse-Effectdizziness , difficulty with speech, weakness, and itching on the trunk of his body and legs, where a maculopapular rash was noted.
0.9995 Adverse-Effect He had been taking trimethoprim - Drugsulfamethoxazole for approximately eight days when he revisited his family physician, complaining of headaches, dizziness, difficulty with speech, weakness, and Adverse-Effectitching on the trunk of his body and legs, where a maculopapular rash was noted.
0.9995 Adverse-Effect He had been taking Drugtrimethoprim - sulfamethoxazole for approximately eight days when he revisited his family physician, complaining of headaches, dizziness, difficulty with speech, weakness, and itching on the trunk of his body and legs, where a Adverse-Effectmaculopapular rash was noted.
0.9985 Adverse-Effect He had been taking Drugtrimethoprim - sulfamethoxazole for approximately eight days when he revisited his family physician, complaining of headaches, dizziness, difficulty with speech, weakness, and Adverse-Effectitching on the trunk of his body and legs, where a maculopapular rash was noted.
0.9999 Adverse-Effect He had been taking trimethoprim - Drugsulfamethoxazole for approximately eight days when he revisited his family physician, complaining of headaches, dizziness, difficulty with speech, weakness, and Adverse-Effectitching on the trunk of his body and legs , where a maculopapular rash was noted.
0.9996 Adverse-Effect He had been taking Drugtrimethoprim - sulfamethoxazole for approximately eight days when he revisited his family physician, complaining of headaches, dizziness, difficulty with speech, weakness, and Adverse-Effectitching on the trunk of his body and legs , where a maculopapular rash was noted.
0.9996 Adverse-Effect He had been taking trimethoprim - Drugsulfamethoxazole for approximately eight days when he revisited his family physician, complaining of headaches, dizziness, difficulty with speech, weakness, and Adverse-Effectitching on the trunk of his body and legs, where a maculopapular rash was noted.
0.9996 Adverse-Effect He had been taking trimethoprim - Drugsulfamethoxazole for approximately eight days when he revisited his family physician, complaining of headaches, dizziness, difficulty with speech, weakness, and Adverse-Effectitching on the trunk of his body and legs, where a maculopapular rash was noted.
0.9995 Adverse-Effect He had been taking trimethoprim - Drugsulfamethoxazole for approximately eight days when he revisited his family physician, complaining of headaches, dizziness, difficulty with speech, weakness, and Adverse-Effectitching on the trunk of his body and legs, where a maculopapular rash was noted.
0.9995 Adverse-Effect He had been taking trimethoprim - Drugsulfamethoxazole for approximately eight days when he revisited his family physician, complaining of headaches, dizziness, difficulty with speech, weakness, and Adverse-Effectitching on the trunk of his body and legs, where a maculopapular rash was noted.
0.9986 Adverse-Effect He had been taking Drugtrimethoprim - sulfamethoxazole for approximately eight days when he revisited his family physician, complaining of headaches, dizziness, difficulty with speech, weakness, and Adverse-Effectitching on the trunk of his body and legs, where a maculopapular rash was noted.
0.9985 Adverse-Effect He had been taking Drugtrimethoprim - sulfamethoxazole for approximately eight days when he revisited his family physician, complaining of headaches, dizziness, difficulty with speech, weakness, and Adverse-Effectitching on the trunk of his body and legs, where a maculopapular rash was noted.
0.9985 Adverse-Effect He had been taking Drugtrimethoprim - sulfamethoxazole for approximately eight days when he revisited his family physician, complaining of headaches, dizziness, difficulty with speech, weakness, and Adverse-Effectitching on the trunk of his body and legs, where a maculopapular rash was noted.
0.9985 Adverse-Effect He had been taking Drugtrimethoprim - sulfamethoxazole for approximately eight days when he revisited his family physician, complaining of headaches, dizziness, difficulty with speech, weakness, and Adverse-Effectitching on the trunk of his body and legs, where a maculopapular rash was noted.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect A clinically atypical, neuropathologically verified case of Adverse-EffectCreutzfeldt - Jakob disease is described in a 32 - year - old New Zealand woman with idiopathic hypopituitarism who had been treated in late adolescence ( 1970 to 1973 ) with Drughuman growth hormone processed from pooled cadaveric pituitary glands.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In a series of 104 cases of intentional or inadvertent use of Drugzidovudine at differing gestations in pregnancy, there were eight spontaneous Adverse-Effectfirst trimester abortions , eight therapeutic terminations, and eight cases of fetal abnormality occurring among a total of 88 cases where the pregnancy progressed.
0.9999 Adverse-Effect In a series of 104 cases of intentional or inadvertent use of Drugzidovudine at differing gestations in pregnancy, there were eight spontaneous first trimester abortions, eight therapeutic terminations, and eight cases of Adverse-Effectfetal abnormality occurring among a total of 88 cases where the pregnancy progressed.
1.0000 Adverse-Effect In a series of 104 cases of intentional or inadvertent use of Drugzidovudine at differing gestations in pregnancy, there were eight Adverse-Effectspontaneous first trimester abortions , eight therapeutic terminations, and eight cases of fetal abnormality occurring among a total of 88 cases where the pregnancy progressed.
Score Relation Text (Head - Tail)
0.9975 Adverse-Effect This is the first reported case of Adverse-EffectBOOP associated with single - agent Drugrituximab , and along with two other patients we describe, as well as two prior reports of BOOP in NHL patients receiving rituximab - based combinations, strengthens the possibility of a causal relationship.
0.9940 Adverse-Effect This is the first reported case of BOOP associated with single - agent rituximab, and along with two other patients we describe, as well as two prior reports of Adverse-EffectBOOP in NHL patients receiving Drugrituximab - based combinations, strengthens the possibility of a causal relationship.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The patient completed a 10 - month follow - up, maintaining a complete resolution of the treated skin lesions ; however, the development of a Adverse-Effectpainful hand ulcer , possibly associated with the Drughydroxyurea , and new skin cancers were observed at the last follow - up visit.
0.9987 Adverse-Effect The patient completed a 10 - month follow - up, maintaining a complete resolution of the treated skin lesions ; however, the development of a painful hand ulcer, possibly associated with the Drughydroxyurea , and new Adverse-Effectskin cancers were observed at the last follow - up visit.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The case is presented of a 72 - year - old man with hormone - refractory prostate cancer and weekly administration of 30 mg / m2 Drugdocetaxel who developed Adverse-Effectsubacute interstitial pneumonitis - related pulmonary fibrosis after seven doses and died despite mechanical ventilation and high - dose corticosteroid treatment.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Therefore, it is reasonable to conclude that : 1 ) 2 - CdA can induce durable complete remission in MCD patients but unfortunately it can not cure the disease ; 2 ) the possibility that Drug2 - CdA may accelerate the Adverse-Effecttransformation of MCD to NHL can not be ruled out.
0.9745 Adverse-Effect Therefore, it is reasonable to conclude that : 1 ) Drug2 - CdA can induce durable complete remission in MCD patients but unfortunately it can not cure the disease ; 2 ) the possibility that 2 - CdA may accelerate the Adverse-Effecttransformation of MCD to NHL can not be ruled out.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 26 - year - old Japanese man, who had been receiving medical attention for ulcerative colitis for one year, presented with diffuse erythema and pustules on his face and trunk, malaise, and Adverse-Effectfever up to 39 degrees C one day after the administration of Drugsalazosulfapyridine .
1.0000 Adverse-Effect A 26 - year - old Japanese man, who had been receiving medical attention for ulcerative colitis for one year, presented with diffuse erythema and pustules on his face and trunk, Adverse-Effectmalaise , and fever up to 39 degrees C one day after the administration of Drugsalazosulfapyridine .
0.9999 Adverse-Effect A 26 - year - old Japanese man, who had been receiving medical attention for ulcerative colitis for one year, presented with diffuse erythema and Adverse-Effectpustules on his face and trunk, malaise, and fever up to 39 degrees C one day after the administration of Drugsalazosulfapyridine .
0.9999 Adverse-Effect A 26 - year - old Japanese man, who had been receiving medical attention for ulcerative colitis for one year, presented with Adverse-Effectdiffuse erythema and pustules on his face and trunk, malaise, and fever up to 39 degrees C one day after the administration of Drugsalazosulfapyridine .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We present a case report of a patient with alveolar hydatid disease, whose treatment with Drugmebendazole was brief due to side effects of Adverse-Effectalopecia and granulocytopenia ; and review the features of this disease which, with increasing international migration, may be encountered more frequently in Australia.
1.0000 Adverse-Effect We present a case report of a patient with alveolar hydatid disease, whose treatment with Drugmebendazole was brief due to side effects of alopecia and Adverse-Effectgranulocytopenia ; and review the features of this disease which, with increasing international migration, may be encountered more frequently in Australia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe 2 male patients, a 49 - year - old with psoriatic arthritis and impaired renal function and a 43 - year - old renal transplant recipient, who both sustained a marked Adverse-Effectdecline in glomerular filtration rate in conjunction with a selective inhibitor of cyclooxygenase - 2 ( COX - 2 ), Drugrofecoxib .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The main clinical features of this 58 - year - old female patient were laboratory evidence of leucopenia and cholestasis, and biopsy features of fatty liver parenchyma degeneration with granulocytic portal infiltration and Adverse-Effectbile stasis , demonstrated 20 days after the initiation of antithyroid therapy with 20 mg Drugmethimazole daily.
1.0000 Adverse-Effect The main clinical features of this 58 - year - old female patient were laboratory evidence of leucopenia and cholestasis, and biopsy features of fatty liver parenchyma degeneration with Adverse-Effectgranulocytic portal infiltration and bile stasis, demonstrated 20 days after the initiation of antithyroid therapy with 20 mg Drugmethimazole daily.
1.0000 Adverse-Effect The main clinical features of this 58 - year - old female patient were laboratory evidence of leucopenia and cholestasis, and biopsy features of Adverse-Effectfatty liver parenchyma degeneration with granulocytic portal infiltration and bile stasis, demonstrated 20 days after the initiation of antithyroid therapy with 20 mg Drugmethimazole daily.
0.9998 Adverse-Effect The main clinical features of this 58 - year - old female patient were laboratory evidence of leucopenia and Adverse-Effectcholestasis , and biopsy features of fatty liver parenchyma degeneration with granulocytic portal infiltration and bile stasis, demonstrated 20 days after the initiation of antithyroid therapy with 20 mg Drugmethimazole daily.
0.9998 Adverse-Effect The main clinical features of this 58 - year - old female patient were laboratory evidence of Adverse-Effectleucopenia and cholestasis, and biopsy features of fatty liver parenchyma degeneration with granulocytic portal infiltration and bile stasis, demonstrated 20 days after the initiation of antithyroid therapy with 20 mg Drugmethimazole daily.
Score Relation Text (Head - Tail)
0.9997 Adverse-Effect On the fifth day after administration of a high dose of DrugARA - C ( 2 g / m2 intravenously every 12 hours ), she developed bullous lesions on the hands and soles that disseminated, evolving to necrosis, Adverse-Effectsepsis , and death on the 22nd day.
0.9996 Adverse-Effect On the fifth day after administration of a high dose of DrugARA - C ( 2 g / m2 intravenously every 12 hours ), she developed bullous lesions on the hands and soles that disseminated, evolving to necrosis, sepsis, and Adverse-Effectdeath on the 22nd day.
0.9999 Adverse-Effect On the fifth day after administration of a high dose of DrugARA - C ( 2 g / m2 intravenously every 12 hours ), she developed Adverse-Effectbullous lesions on the hands and soles that disseminated, evolving to necrosis, sepsis, and death on the 22nd day.
0.9995 Adverse-Effect On the fifth day after administration of a high dose of DrugARA - C ( 2 g / m2 intravenously every 12 hours ), she developed bullous lesions on the hands and soles that disseminated, evolving to Adverse-Effectnecrosis , sepsis, and death on the 22nd day.
Adverse-Effect On the fifth day after administration of a high dose of DrugARA - C ( 2 g / m2 intravenously every 12 hours ), she developed Adverse-Effectbullous lesions on the hands and soles that disseminated, evolving to necrosis , sepsis, and death on the 22nd day.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect It is presumed that her Adverse-Effecthyperchloremic metabolic acidosis was secondary to Drugcholestyramine because of the similarity to pediatric reports ; the rapid and lasting response to intravenous sodium bicarbonate ; the absence of another etiology ; normal serum potassium, chloride and bicarbonate despite continued spironolactone therapy after recovery.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Previous studies have demonstrated the interaction of DrugMTX and a variety of non - steroidal, anti - inflammatory drugs ( NSAIDs ) with various clinical manifestations including Adverse-Effectacute renal failure , pancytopenia, vomiting, diarrhea, elevated liver transaminases, jaundice, mucosal ulcerations, and pyrexia.
1.0000 Adverse-Effect Previous studies have demonstrated the interaction of DrugMTX and a variety of non - steroidal, anti - inflammatory drugs ( NSAIDs ) with various clinical manifestations including acute renal failure, Adverse-Effectpancytopenia , vomiting, diarrhea, elevated liver transaminases, jaundice, mucosal ulcerations, and pyrexia.
1.0000 Adverse-Effect Previous studies have demonstrated the interaction of DrugMTX and a variety of non - steroidal, anti - inflammatory drugs ( NSAIDs ) with various clinical manifestations including acute renal failure, pancytopenia, vomiting, Adverse-Effectdiarrhea , elevated liver transaminases, jaundice, mucosal ulcerations, and pyrexia.
1.0000 Adverse-Effect Previous studies have demonstrated the interaction of DrugMTX and a variety of non - steroidal, anti - inflammatory drugs ( NSAIDs ) with various clinical manifestations including acute renal failure, pancytopenia, vomiting, diarrhea, elevated liver transaminases, Adverse-Effectjaundice , mucosal ulcerations, and pyrexia.
1.0000 Adverse-Effect Previous studies have demonstrated the interaction of DrugMTX and a variety of non - steroidal, anti - inflammatory drugs ( NSAIDs ) with various clinical manifestations including acute renal failure, pancytopenia, Adverse-Effectvomiting , diarrhea, elevated liver transaminases, jaundice, mucosal ulcerations, and pyrexia.
1.0000 Adverse-Effect Previous studies have demonstrated the interaction of DrugMTX and a variety of non - steroidal, anti - inflammatory drugs ( NSAIDs ) with various clinical manifestations including acute renal failure, pancytopenia, vomiting, diarrhea, elevated liver transaminases, jaundice, mucosal ulcerations, and Adverse-Effectpyrexia .
0.9999 Adverse-Effect Previous studies have demonstrated the interaction of DrugMTX and a variety of non - steroidal, anti - inflammatory drugs ( NSAIDs ) with various clinical manifestations including acute renal failure, pancytopenia, vomiting, diarrhea, elevated liver transaminases, jaundice, Adverse-Effectmucosal ulcerations , and pyrexia.
0.9999 Adverse-Effect Previous studies have demonstrated the interaction of DrugMTX and a variety of non - steroidal, anti - inflammatory drugs ( NSAIDs ) with various clinical manifestations including acute renal failure, pancytopenia, vomiting, diarrhea, Adverse-Effectelevated liver transaminases , jaundice, mucosal ulcerations, and pyrexia.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect METHOD : Case analysis of a poly - drug overdose ( venlafaxine, topiramate, divalproex sodium, risperidone, and Drugcarbamazepine ) presenting with mixed Adverse-EffectSS / NMS features and whose clinical management suggests a practical algorithm for treatment of undifferentiated SS / NMS in critical care settings.
1.0000 Adverse-Effect METHOD : Case analysis of a poly - drug overdose ( venlafaxine, topiramate, divalproex sodium, risperidone, and Drugcarbamazepine ) presenting with mixed SS / Adverse-EffectNMS features and whose clinical management suggests a practical algorithm for treatment of undifferentiated SS / NMS in critical care settings.
0.9999 Adverse-Effect METHOD : Case analysis of a poly - drug overdose ( Drugvenlafaxine , topiramate, divalproex sodium, risperidone, and carbamazepine ) presenting with mixed SS / Adverse-EffectNMS features and whose clinical management suggests a practical algorithm for treatment of undifferentiated SS / NMS in critical care settings.
0.9999 Adverse-Effect METHOD : Case analysis of a poly - drug overdose ( venlafaxine, topiramate, divalproex sodium, Drugrisperidone , and carbamazepine ) presenting with mixed SS / Adverse-EffectNMS features and whose clinical management suggests a practical algorithm for treatment of undifferentiated SS / NMS in critical care settings.
0.9998 Adverse-Effect METHOD : Case analysis of a poly - drug overdose ( venlafaxine, Drugtopiramate , divalproex sodium, risperidone, and carbamazepine ) presenting with mixed SS / Adverse-EffectNMS features and whose clinical management suggests a practical algorithm for treatment of undifferentiated SS / NMS in critical care settings.
0.9998 Adverse-Effect METHOD : Case analysis of a poly - drug overdose ( Drugvenlafaxine , topiramate, divalproex sodium, risperidone, and carbamazepine ) presenting with mixed Adverse-EffectSS / NMS features and whose clinical management suggests a practical algorithm for treatment of undifferentiated SS / NMS in critical care settings.
0.9998 Adverse-Effect METHOD : Case analysis of a poly - drug overdose ( venlafaxine, topiramate, divalproex sodium, Drugrisperidone , and carbamazepine ) presenting with mixed Adverse-EffectSS / NMS features and whose clinical management suggests a practical algorithm for treatment of undifferentiated SS / NMS in critical care settings.
0.9998 Adverse-Effect METHOD : Case analysis of a poly - drug overdose ( venlafaxine, Drugtopiramate , divalproex sodium, risperidone, and carbamazepine ) presenting with mixed Adverse-EffectSS / NMS features and whose clinical management suggests a practical algorithm for treatment of undifferentiated SS / NMS in critical care settings.
0.9997 Adverse-Effect METHOD : Case analysis of a poly - drug overdose ( venlafaxine, topiramate, Drugdivalproex sodium , risperidone, and carbamazepine ) presenting with mixed SS / Adverse-EffectNMS features and whose clinical management suggests a practical algorithm for treatment of undifferentiated SS / NMS in critical care settings.
0.9997 Adverse-Effect METHOD : Case analysis of a poly - drug overdose ( venlafaxine, topiramate, Drugdivalproex sodium , risperidone, and carbamazepine ) presenting with mixed Adverse-EffectSS / NMS features and whose clinical management suggests a practical algorithm for treatment of undifferentiated SS / NMS in critical care settings.
Score Relation Text (Head - Tail)
0.9989 Adverse-Effect After rechallenge with monotherapy pegvisomant, however, the hepatic enzyme disturbances reappeared within a few weeks, indicating that most likely Drugpegvisomant alone and not the long - acting somatostatin analog or the combination of these two drugs was responsible for this case of drug - induced Adverse-Effecthepatitis .
0.9956 Adverse-Effect After rechallenge with monotherapy pegvisomant, however, the Adverse-Effecthepatic enzyme disturbances reappeared within a few weeks, indicating that most likely Drugpegvisomant alone and not the long - acting somatostatin analog or the combination of these two drugs was responsible for this case of drug - induced hepatitis.
0.9999 Adverse-Effect After rechallenge with monotherapy pegvisomant, however, the hepatic enzyme disturbances reappeared within a few weeks, indicating that most likely pegvisomant alone and not the long - acting Drugsomatostatin analog or the combination of these two drugs was responsible for this case of drug - induced Adverse-Effecthepatitis .
0.9902 Adverse-Effect After rechallenge with monotherapy pegvisomant, however, the Adverse-Effecthepatic enzyme disturbances reappeared within a few weeks, indicating that most likely pegvisomant alone and not the long - acting Drugsomatostatin analog or the combination of these two drugs was responsible for this case of drug - induced hepatitis.
Adverse-Effect After rechallenge with monotherapy Drugpegvisomant , however, the Adverse-Effecthepatic enzyme disturbances reappeared within a few weeks, indicating that most likely pegvisomant alone and not the long - acting somatostatin analog or the combination of these two drugs was responsible for this case of drug - induced hepatitis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Possible pathophysiological mechanisms which may have been operative in this case include : a direct central nervous system ( CNS ) toxic effect of valproic acid ; a paradoxical epileptogenic effect secondary to the drug ; and an indirect CNS toxic effect mediated through Drugvalproic acid - induced Adverse-Effecthyperammonemia .
0.8683 Adverse-Effect Possible pathophysiological mechanisms which may have been operative in this case include : a direct central nervous system ( CNS ) toxic effect of Drugvalproic acid ; a paradoxical epileptogenic effect secondary to the drug ; and an indirect CNS toxic effect mediated through valproic acid - induced Adverse-Effecthyperammonemia .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The authors also determined that their case of myositis developing in the rectus abdominus muscle of a patient with pancreatic adenocarcinoma was the manifestation of radiation recall, thereby bringing the number of patients who developed Adverse-Effectradiation recall to Druggemcitabine and were discussed in the current study to 13.
0.9999 Adverse-Effect The authors also determined that their case of Adverse-Effectmyositis developing in the rectus abdominus muscle of a patient with pancreatic adenocarcinoma was the manifestation of radiation recall, thereby bringing the number of patients who developed radiation recall to Druggemcitabine and were discussed in the current study to 13.
0.9998 Adverse-Effect The authors also determined that their case of myositis developing in the rectus abdominus muscle of a patient with pancreatic adenocarcinoma was the manifestation of Adverse-Effectradiation recall , thereby bringing the number of patients who developed radiation recall to Druggemcitabine and were discussed in the current study to 13.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect These findings suggest that Drugclozapine - induced Adverse-Effectseizures can be successfully treated, that gradual dose titration can reduce the likelihood of further episodes of seizures and that concomitant use of a suitable mood stabilizer / anti - epileptic medication can improve the outcome of treatment - resistant schizophrenia.
0.9964 Adverse-Effect These findings suggest that Drugclozapine - induced seizures can be successfully treated, that gradual dose titration can reduce the likelihood of further episodes of Adverse-Effectseizures and that concomitant use of a suitable mood stabilizer / anti - epileptic medication can improve the outcome of treatment - resistant schizophrenia.
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect We report the case histories of two patients with histologically confirmed adenocarcinoma of the prostate, both of whom had been treated with steroidal anti - androgen therapy in the form of Drugcyproterone acetate prior to radical or palliative pelvic irradiation, and who subsequently developed Adverse-Effectfemoral head avascular necrosis .
0.9993 Adverse-Effect We report the case histories of two patients with histologically confirmed Adverse-Effectadenocarcinoma of the prostate , both of whom had been treated with steroidal anti - androgen therapy in the form of Drugcyproterone acetate prior to radical or palliative pelvic irradiation, and who subsequently developed femoral head avascular necrosis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Postoperatively, the first two patients treated with 1 to 2 cc of Drugthrombin were Adverse-Effectslow to awaken ; one had evidence of vasospasm by transcranial Doppler ultrasound studies and multiple infarcts on cranial computerized tomography, while the other had a moderate - sized frontal hematoma with intracranial hypertension.
0.9999 Adverse-Effect Postoperatively, the first two patients treated with 1 to 2 cc of Drugthrombin were slow to awaken ; one had evidence of Adverse-Effectvasospasm by transcranial Doppler ultrasound studies and multiple infarcts on cranial computerized tomography, while the other had a moderate - sized frontal hematoma with intracranial hypertension.
0.9998 Adverse-Effect Postoperatively, the first two patients treated with 1 to 2 cc of Drugthrombin were slow to awaken ; one had evidence of vasospasm by transcranial Doppler ultrasound studies and Adverse-Effectmultiple infarcts on cranial computerized tomography, while the other had a moderate - sized frontal hematoma with intracranial hypertension.
0.9996 Adverse-Effect Postoperatively, the first two patients treated with 1 to 2 cc of Drugthrombin were slow to awaken ; one had evidence of vasospasm by transcranial Doppler ultrasound studies and multiple infarcts on cranial computerized tomography, while the other had a moderate - sized frontal hematoma with Adverse-Effectintracranial hypertension .
0.9994 Adverse-Effect Postoperatively, the first two patients treated with 1 to 2 cc of Drugthrombin were slow to awaken ; one had evidence of vasospasm by transcranial Doppler ultrasound studies and multiple infarcts on cranial computerized tomography, while the other had a moderate - sized Adverse-Effectfrontal hematoma with intracranial hypertension.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect RESULTS : The estimated number of DrugAccutane prescriptions for reproductive - aged women has more than doubled in the past 10 years ; it is the most widely used Adverse-Effectteratogenic drug in the United States, with approximately 2. 5 per 1, 000 reproductive - aged women exposed to Accutane in 1999.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect A 27 - year - old man who had a history of bronchial asthma, eosinophilic enteritis, and eosinophilic pneumonia presented with fever, skin eruptions, cervical lymphadenopathy, hepatosplenomegaly, atypical lymphocytosis, and Adverse-Effecteosinophilia two weeks after receiving Drugtrimethoprim ( TMP ) - sulfamethoxazole ( SMX ) treatment.
1.0000 Adverse-Effect A 27 - year - old man who had a history of bronchial asthma, eosinophilic enteritis, and eosinophilic pneumonia presented with fever, skin eruptions, cervical lymphadenopathy, hepatosplenomegaly, atypical lymphocytosis, and Adverse-Effecteosinophilia two weeks after receiving trimethoprim ( TMP ) - sulfamethoxazole ( DrugSMX ) treatment.
0.9999 Adverse-Effect A 27 - year - old man who had a history of bronchial asthma, eosinophilic enteritis, and eosinophilic pneumonia presented with fever, skin eruptions, cervical lymphadenopathy, hepatosplenomegaly, atypical lymphocytosis, and Adverse-Effecteosinophilia two weeks after receiving trimethoprim ( TMP ) - Drugsulfamethoxazole ( SMX ) treatment.
0.9999 Adverse-Effect A 27 - year - old man who had a history of bronchial asthma, eosinophilic enteritis, and eosinophilic pneumonia presented with fever, skin eruptions, cervical lymphadenopathy, hepatosplenomegaly, atypical lymphocytosis, and Adverse-Effecteosinophilia two weeks after receiving trimethoprim ( DrugTMP ) - sulfamethoxazole ( SMX ) treatment.
0.9999 Adverse-Effect A 27 - year - old man who had a history of bronchial asthma, eosinophilic enteritis, and eosinophilic pneumonia presented with fever, skin eruptions, cervical lymphadenopathy, hepatosplenomegaly, Adverse-Effectatypical lymphocytosis , and eosinophilia two weeks after receiving Drugtrimethoprim ( TMP ) - sulfamethoxazole ( SMX ) treatment.
0.9999 Adverse-Effect A 27 - year - old man who had a history of bronchial asthma, eosinophilic enteritis, and eosinophilic pneumonia presented with fever, skin eruptions, Adverse-Effectcervical lymphadenopathy , hepatosplenomegaly, atypical lymphocytosis, and eosinophilia two weeks after receiving Drugtrimethoprim ( TMP ) - sulfamethoxazole ( SMX ) treatment.
0.9998 Adverse-Effect A 27 - year - old man who had a history of bronchial asthma, eosinophilic enteritis, and eosinophilic pneumonia presented with Adverse-Effectfever , skin eruptions, cervical lymphadenopathy, hepatosplenomegaly, atypical lymphocytosis, and eosinophilia two weeks after receiving Drugtrimethoprim ( TMP ) - sulfamethoxazole ( SMX ) treatment.
0.9998 Adverse-Effect A 27 - year - old man who had a history of bronchial asthma, eosinophilic enteritis, and eosinophilic pneumonia presented with fever, skin eruptions, cervical lymphadenopathy, Adverse-Effecthepatosplenomegaly , atypical lymphocytosis, and eosinophilia two weeks after receiving Drugtrimethoprim ( TMP ) - sulfamethoxazole ( SMX ) treatment.
0.9998 Adverse-Effect A 27 - year - old man who had a history of bronchial asthma, eosinophilic enteritis, and eosinophilic pneumonia presented with fever, Adverse-Effectskin eruptions , cervical lymphadenopathy, hepatosplenomegaly, atypical lymphocytosis, and eosinophilia two weeks after receiving Drugtrimethoprim ( TMP ) - sulfamethoxazole ( SMX ) treatment.
0.9997 Adverse-Effect A 27 - year - old man who had a history of bronchial asthma, eosinophilic enteritis, and eosinophilic pneumonia presented with fever, skin eruptions, cervical lymphadenopathy, hepatosplenomegaly, Adverse-Effectatypical lymphocytosis , and eosinophilia two weeks after receiving trimethoprim ( TMP ) - sulfamethoxazole ( DrugSMX ) treatment.
0.9997 Adverse-Effect A 27 - year - old man who had a history of bronchial asthma, eosinophilic enteritis, and eosinophilic pneumonia presented with fever, skin eruptions, Adverse-Effectcervical lymphadenopathy , hepatosplenomegaly, atypical lymphocytosis, and eosinophilia two weeks after receiving trimethoprim ( TMP ) - sulfamethoxazole ( DrugSMX ) treatment.
0.9997 Adverse-Effect A 27 - year - old man who had a history of bronchial asthma, eosinophilic enteritis, and eosinophilic pneumonia presented with Adverse-Effectfever , skin eruptions, cervical lymphadenopathy, hepatosplenomegaly, atypical lymphocytosis, and eosinophilia two weeks after receiving trimethoprim ( TMP ) - sulfamethoxazole ( DrugSMX ) treatment.
0.9996 Adverse-Effect A 27 - year - old man who had a history of bronchial asthma, eosinophilic enteritis, and eosinophilic pneumonia presented with fever, skin eruptions, cervical lymphadenopathy, Adverse-Effecthepatosplenomegaly , atypical lymphocytosis, and eosinophilia two weeks after receiving trimethoprim ( TMP ) - sulfamethoxazole ( DrugSMX ) treatment.
0.9996 Adverse-Effect A 27 - year - old man who had a history of bronchial asthma, eosinophilic enteritis, and eosinophilic pneumonia presented with fever, skin eruptions, Adverse-Effectcervical lymphadenopathy , hepatosplenomegaly, atypical lymphocytosis, and eosinophilia two weeks after receiving trimethoprim ( TMP ) - Drugsulfamethoxazole ( SMX ) treatment.
0.9996 Adverse-Effect A 27 - year - old man who had a history of bronchial asthma, eosinophilic enteritis, and eosinophilic pneumonia presented with Adverse-Effectfever , skin eruptions, cervical lymphadenopathy, hepatosplenomegaly, atypical lymphocytosis, and eosinophilia two weeks after receiving trimethoprim ( TMP ) - Drugsulfamethoxazole ( SMX ) treatment.
0.9996 Adverse-Effect A 27 - year - old man who had a history of bronchial asthma, eosinophilic enteritis, and eosinophilic pneumonia presented with fever, Adverse-Effectskin eruptions , cervical lymphadenopathy, hepatosplenomegaly, atypical lymphocytosis, and eosinophilia two weeks after receiving trimethoprim ( TMP ) - sulfamethoxazole ( DrugSMX ) treatment.
0.9996 Adverse-Effect A 27 - year - old man who had a history of bronchial asthma, eosinophilic enteritis, and eosinophilic pneumonia presented with fever, skin eruptions, cervical lymphadenopathy, hepatosplenomegaly, Adverse-Effectatypical lymphocytosis , and eosinophilia two weeks after receiving trimethoprim ( TMP ) - Drugsulfamethoxazole ( SMX ) treatment.
0.9996 Adverse-Effect A 27 - year - old man who had a history of bronchial asthma, eosinophilic enteritis, and eosinophilic pneumonia presented with fever, skin eruptions, cervical lymphadenopathy, Adverse-Effecthepatosplenomegaly , atypical lymphocytosis, and eosinophilia two weeks after receiving trimethoprim ( TMP ) - Drugsulfamethoxazole ( SMX ) treatment.
0.9995 Adverse-Effect A 27 - year - old man who had a history of bronchial asthma, eosinophilic enteritis, and eosinophilic pneumonia presented with fever, Adverse-Effectskin eruptions , cervical lymphadenopathy, hepatosplenomegaly, atypical lymphocytosis, and eosinophilia two weeks after receiving trimethoprim ( TMP ) - Drugsulfamethoxazole ( SMX ) treatment.
0.9995 Adverse-Effect A 27 - year - old man who had a history of bronchial asthma, eosinophilic enteritis, and eosinophilic pneumonia presented with fever, skin eruptions, Adverse-Effectcervical lymphadenopathy , hepatosplenomegaly, atypical lymphocytosis, and eosinophilia two weeks after receiving trimethoprim ( DrugTMP ) - sulfamethoxazole ( SMX ) treatment.
0.9995 Adverse-Effect A 27 - year - old man who had a history of bronchial asthma, eosinophilic enteritis, and eosinophilic pneumonia presented with Adverse-Effectfever , skin eruptions, cervical lymphadenopathy, hepatosplenomegaly, atypical lymphocytosis, and eosinophilia two weeks after receiving trimethoprim ( DrugTMP ) - sulfamethoxazole ( SMX ) treatment.
0.9995 Adverse-Effect A 27 - year - old man who had a history of bronchial asthma, eosinophilic enteritis, and eosinophilic pneumonia presented with fever, skin eruptions, cervical lymphadenopathy, hepatosplenomegaly, Adverse-Effectatypical lymphocytosis , and eosinophilia two weeks after receiving trimethoprim ( DrugTMP ) - sulfamethoxazole ( SMX ) treatment.
0.9994 Adverse-Effect A 27 - year - old man who had a history of bronchial asthma, eosinophilic enteritis, and eosinophilic pneumonia presented with fever, skin eruptions, cervical lymphadenopathy, Adverse-Effecthepatosplenomegaly , atypical lymphocytosis, and eosinophilia two weeks after receiving trimethoprim ( DrugTMP ) - sulfamethoxazole ( SMX ) treatment.
0.9994 Adverse-Effect A 27 - year - old man who had a history of bronchial asthma, eosinophilic enteritis, and eosinophilic pneumonia presented with fever, Adverse-Effectskin eruptions , cervical lymphadenopathy, hepatosplenomegaly, atypical lymphocytosis, and eosinophilia two weeks after receiving trimethoprim ( DrugTMP ) - sulfamethoxazole ( SMX ) treatment.
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect Although it is difficult to be certain of the direct link of amiodarone on the basis of a single case, it is reasonable to presume that this histopathology is associated with Drugamiodarone - induced Adverse-Effecthypothyroidism and that involution changes represent the hypofunctional status of this drug - induced disorder.
Score Relation Text (Head - Tail)
0.9994 Adverse-Effect It also highlights a current major etiologic question, that is, whether and to what degree Druglead exposure contributes to the development of Adverse-Effecthypertension , and raises the issue of whether lead - induced hypertension constitutes a subset of hypertension that is especially amenable to therapy with dietary calcium.
0.9993 Adverse-Effect It also highlights a current major etiologic question, that is, whether and to what degree lead exposure contributes to the development of hypertension, and raises the issue of whether Druglead - induced Adverse-Effecthypertension constitutes a subset of hypertension that is especially amenable to therapy with dietary calcium.
0.9481 Adverse-Effect It also highlights a current major etiologic question, that is, whether and to what degree lead exposure contributes to the development of hypertension, and raises the issue of whether Druglead - induced hypertension constitutes a subset of Adverse-Effecthypertension that is especially amenable to therapy with dietary calcium.
Adverse-Effect It also highlights a current major etiologic question, that is, whether and to what degree lead exposure contributes to the development of hypertension, and raises the issue of whether Druglead Adverse-Effectlead - induced hypertension constitutes a subset of hypertension that is especially amenable to therapy with dietary calcium.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect DrugRisperidone is a frequently used member of a new class of atypical antipsychotics - the serotonin - dopamine antagonists ( SDAs ) - due to its comparatively high efficacy and low D2 / 5HT2 binding ratio, which results in a low incidence of extrapyramidal side effects including tardive dyskinesia ( Adverse-EffectTD ).
0.9999 Adverse-Effect DrugRisperidone is a frequently used member of a new class of atypical antipsychotics - the serotonin - dopamine antagonists ( SDAs ) - due to its comparatively high efficacy and low D2 / 5HT2 binding ratio, which results in a low incidence of extrapyramidal side effects including Adverse-Effecttardive dyskinesia ( TD ).
0.9999 Adverse-Effect DrugRisperidone is a frequently used member of a new class of atypical antipsychotics - the serotonin - dopamine antagonists ( SDAs ) - due to its comparatively high efficacy and low D2 / 5HT2 binding ratio, which results in a low incidence of Adverse-Effectextrapyramidal side effects including tardive dyskinesia ( TD ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect DrugVancomycin is widely used against methicillin - resistant Staphylococcus aureus infections, but it is associated with many adverse effects such as Adverse-Effectnephrotoxicity , ototoxicity, gastrointestinal disturbances, blood disorders, and two types of hypersensitivity reactions - an anaphylactoid reaction known as " red man syndrome " and anaphylaxis.
1.0000 Adverse-Effect DrugVancomycin is widely used against methicillin - resistant Staphylococcus aureus infections, but it is associated with many adverse effects such as nephrotoxicity, ototoxicity, Adverse-Effectgastrointestinal disturbances , blood disorders, and two types of hypersensitivity reactions - an anaphylactoid reaction known as " red man syndrome " and anaphylaxis.
1.0000 Adverse-Effect DrugVancomycin is widely used against methicillin - resistant Staphylococcus aureus infections, but it is associated with many adverse effects such as nephrotoxicity, Adverse-Effectototoxicity , gastrointestinal disturbances, blood disorders, and two types of hypersensitivity reactions - an anaphylactoid reaction known as " red man syndrome " and anaphylaxis.
1.0000 Adverse-Effect DrugVancomycin is widely used against methicillin - resistant Staphylococcus aureus infections, but it is associated with many adverse effects such as nephrotoxicity, ototoxicity, gastrointestinal disturbances, blood disorders, and two types of hypersensitivity reactions - an anaphylactoid reaction known as " Adverse-Effectred man syndrome " and anaphylaxis.
1.0000 Adverse-Effect DrugVancomycin is widely used against methicillin - resistant Staphylococcus aureus infections, but it is associated with many adverse effects such as nephrotoxicity, ototoxicity, gastrointestinal disturbances, Adverse-Effectblood disorders , and two types of hypersensitivity reactions - an anaphylactoid reaction known as " red man syndrome " and anaphylaxis.
0.9999 Adverse-Effect DrugVancomycin is widely used against methicillin - resistant Staphylococcus aureus infections, but it is associated with many adverse effects such as nephrotoxicity, ototoxicity, gastrointestinal disturbances, blood disorders, and two types of hypersensitivity reactions - an anaphylactoid reaction known as " red man syndrome " and Adverse-Effectanaphylaxis .
0.9999 Adverse-Effect DrugVancomycin is widely used against methicillin - resistant Staphylococcus aureus infections, but it is associated with many adverse effects such as nephrotoxicity, ototoxicity, gastrointestinal disturbances, blood disorders, and two types of Adverse-Effecthypersensitivity reactions - an anaphylactoid reaction known as " red man syndrome " and anaphylaxis.
0.9998 Adverse-Effect DrugVancomycin is widely used against methicillin - resistant Staphylococcus aureus infections, but it is associated with many adverse effects such as nephrotoxicity, ototoxicity, gastrointestinal disturbances, blood disorders, and two types of hypersensitivity reactions - an Adverse-Effectanaphylactoid reaction known as " red man syndrome " and anaphylaxis.
1.0000 Adverse-Effect DrugVancomycin is widely used against methicillin - resistant Staphylococcus aureus infections, but it is associated with many adverse effects such as nephrotoxicity, ototoxicity, gastrointestinal disturbances, blood disorders, and two types of hypersensitivity reactions - an Adverse-Effectanaphylactoid reaction known as " red man syndrome " and anaphylaxis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Among 12 thyrotoxic patients, a patient with arrhythmogenic right ventricular dysplasia, who had been taking Drugamiodarone for 4 years, developed Adverse-Effectthyrotoxicosis with subacute onset, accompanied by transiently positive thyrotropin ( TSH ) receptor antibody ( TRAb ), or thyrotropin - binding inhibiting immunoglobulin ( TBII ).
0.9999 Adverse-Effect Among 12 thyrotoxic patients, a patient with arrhythmogenic right ventricular dysplasia, who had been taking Drugamiodarone for 4 years, developed thyrotoxicosis with subacute onset, accompanied by Adverse-Effecttransiently positive thyrotropin ( TSH ) receptor antibody ( TRAb ), or thyrotropin - binding inhibiting immunoglobulin ( TBII ).
0.9995 Adverse-Effect Among 12 thyrotoxic patients, a patient with arrhythmogenic right ventricular dysplasia, who had been taking Drugamiodarone for 4 years, developed thyrotoxicosis with subacute onset, accompanied by transiently positive thyrotropin ( TSH ) receptor antibody ( TRAb ), or Adverse-Effectthyrotropin - binding inhibiting immunoglobulin ( TBII ).
0.9999 Adverse-Effect Among 12 thyrotoxic patients, a patient with arrhythmogenic right ventricular dysplasia, who had been taking Drugamiodarone for 4 years, developed thyrotoxicosis with Adverse-Effectsubacute onset , accompanied by transiently positive thyrotropin ( TSH ) receptor antibody ( TRAb ), or thyrotropin - binding inhibiting immunoglobulin ( TBII ).
0.9997 Adverse-Effect Among 12 thyrotoxic patients, a patient with arrhythmogenic right ventricular dysplasia, who had been taking Drugamiodarone for 4 years, developed thyrotoxicosis with subacute onset, accompanied by transiently positive thyrotropin ( TSH ) receptor antibody ( TRAb ), or Adverse-Effectthyrotropin - binding inhibiting immunoglobulin ( TBII ).
0.9995 Adverse-Effect Among 12 thyrotoxic patients, a patient with arrhythmogenic right ventricular dysplasia, who had been taking Drugamiodarone for 4 years, developed thyrotoxicosis with subacute onset, accompanied by transiently positive thyrotropin ( TSH ) receptor antibody ( TRAb ), or Adverse-Effectthyrotropin - binding inhibiting immunoglobulin ( TBII ).
0.9994 Adverse-Effect Among 12 thyrotoxic patients, a patient with arrhythmogenic right ventricular dysplasia, who had been taking Drugamiodarone for 4 years, developed thyrotoxicosis with subacute onset, accompanied by transiently positive thyrotropin ( TSH ) receptor antibody ( TRAb ), or Adverse-Effectthyrotropin - binding inhibiting immunoglobulin ( TBII ).
0.9991 Adverse-Effect Among 12 thyrotoxic patients, a patient with arrhythmogenic right ventricular dysplasia, who had been taking Drugamiodarone for 4 years, developed thyrotoxicosis with subacute onset, accompanied by transiently positive thyrotropin ( TSH ) receptor antibody ( Adverse-EffectTRAb ), or thyrotropin - binding inhibiting immunoglobulin ( TBII ).
Score Relation Text (Head - Tail)
0.9414 Adverse-Effect Adverse-EffectThrombocytopenia with or without microangiopathy following Drugquinine is often referred to as quinine " hypersensitivity. " When schistocytes are present it is frequently termed " quinine - associated TTP / HUS. " A severe deficiency of the vWF - cleaving protease, ADAMTS13, is associated with idiopathic TTP.
0.6825 Adverse-Effect Thrombocytopenia with or without microangiopathy following quinine is often referred to as Drugquinine " Adverse-Effecthypersensitivity . " When schistocytes are present it is frequently termed " quinine - associated TTP / HUS. " A severe deficiency of the vWF - cleaving protease, ADAMTS13, is associated with idiopathic TTP.
0.6060 Adverse-Effect Thrombocytopenia with or without microangiopathy following quinine is often referred to as quinine " hypersensitivity. " When schistocytes are present it is frequently termed " Drugquinine - associated TTP / Adverse-EffectHUS . " A severe deficiency of the vWF - cleaving protease, ADAMTS13, is associated with idiopathic TTP.
Adverse-Effect Thrombocytopenia with or without microangiopathy following quinine is often referred to as quinine " hypersensitivity. " When schistocytes are present it is frequently termed " Drugquinine - associated Adverse-EffectTTP / HUS . " A severe deficiency of the vWF - cleaving protease, ADAMTS13, is associated with idiopathic TTP.
Score Relation Text (Head - Tail)
0.9995 Adverse-Effect Intravenous Drugverapamil therapy in babies may cause Adverse-Effectapnea , hypotension, and bradycardia ; continued episodes of atrial flutter in a child may cause sudden death ; quinidine may be related to the death ; children with " familial seizure disorders " may in fact have the long QT interval syndrome.
0.9924 Adverse-Effect Intravenous Drugverapamil therapy in babies may cause apnea, Adverse-Effecthypotension , and bradycardia ; continued episodes of atrial flutter in a child may cause sudden death ; quinidine may be related to the death ; children with " familial seizure disorders " may in fact have the long QT interval syndrome.
0.9874 Adverse-Effect Intravenous Drugverapamil therapy in babies may cause apnea, hypotension, and Adverse-Effectbradycardia ; continued episodes of atrial flutter in a child may cause sudden death ; quinidine may be related to the death ; children with " familial seizure disorders " may in fact have the long QT interval syndrome.
0.9707 Adverse-Effect Intravenous Drugverapamil therapy in babies may cause apnea, hypotension, and bradycardia ; continued episodes of atrial flutter in a child may cause Adverse-Effectsudden death ; quinidine may be related to the death ; children with " familial seizure disorders " may in fact have the long QT interval syndrome.
0.9533 Adverse-Effect Intravenous verapamil therapy in babies may cause apnea, hypotension, and bradycardia ; continued episodes of atrial flutter in a child may cause sudden death ; Drugquinidine may be related to the death ; children with " familial seizure disorders " may in fact have the Adverse-Effectlong QT interval syndrome .
0.8352 Adverse-Effect Intravenous Drugverapamil therapy in babies may cause apnea, hypotension, and bradycardia ; continued episodes of Adverse-Effectatrial flutter in a child may cause sudden death ; quinidine may be related to the death ; children with " familial seizure disorders " may in fact have the long QT interval syndrome.
0.5138 Adverse-Effect Intravenous verapamil therapy in babies may cause Adverse-Effectapnea , hypotension, and bradycardia ; continued episodes of atrial flutter in a child may cause sudden death ; Drugquinidine may be related to the death ; children with " familial seizure disorders " may in fact have the long QT interval syndrome.
0.7548 Adverse-Effect Intravenous Drugverapamil therapy in babies may cause apnea, hypotension, and bradycardia ; continued episodes of atrial flutter in a child may cause sudden death ; quinidine may be related to the death ; children with " familial seizure disorders " may in fact have the Adverse-Effectlong QT interval syndrome .
0.6422 Adverse-Effect Intravenous verapamil therapy in babies may cause apnea, hypotension, and bradycardia ; continued episodes of atrial flutter in a child may cause Adverse-Effectsudden death ; Drugquinidine may be related to the death ; children with " familial seizure disorders " may in fact have the long QT interval syndrome.
Adverse-Effect Intravenous verapamil therapy in babies may cause apnea, hypotension, and bradycardia ; continued episodes of atrial flutter in a child may cause sudden death ; Drugquinidine may be related to the Adverse-Effectdeath ; children with " familial seizure disorders " may in fact have the long QT interval syndrome.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The pharmaceutical company producing DrugHalfan has reported 8 Adverse-Effectcardiac arrests , leading to 6 deaths, when a higher dose than recommended was used, there was recent or concomitant treatment with mefloquine, there was pre - existing prolongation of the QT interval or the patient had a thiamine deficiency.
0.9999 Adverse-Effect The pharmaceutical company producing Halfan has reported 8 cardiac arrests, leading to 6 Adverse-Effectdeaths , when a higher dose than recommended was used, there was recent or concomitant treatment with Drugmefloquine , there was pre - existing prolongation of the QT interval or the patient had a thiamine deficiency.
0.9997 Adverse-Effect The pharmaceutical company producing DrugHalfan has reported 8 cardiac arrests, leading to 6 Adverse-Effectdeaths , when a higher dose than recommended was used, there was recent or concomitant treatment with mefloquine, there was pre - existing prolongation of the QT interval or the patient had a thiamine deficiency.
0.9997 Adverse-Effect The pharmaceutical company producing Halfan has reported 8 Adverse-Effectcardiac arrests , leading to 6 deaths, when a higher dose than recommended was used, there was recent or concomitant treatment with Drugmefloquine , there was pre - existing prolongation of the QT interval or the patient had a thiamine deficiency.
0.9998 Adverse-Effect The pharmaceutical company producing Halfan has reported 8 cardiac arrests, leading to 6 deaths, when a higher dose than recommended was used, there was recent or concomitant treatment with Drugmefloquine , there was pre - existing Adverse-Effectprolongation of the QT interval or the patient had a thiamine deficiency.
0.9983 Adverse-Effect The pharmaceutical company producing DrugHalfan has reported 8 cardiac arrests, leading to 6 deaths, when a higher dose than recommended was used, there was recent or concomitant treatment with mefloquine, there was pre - existing Adverse-Effectprolongation of the QT interval or the patient had a thiamine deficiency.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The administration of " sweet spirits of nitre " ( Drug4 % ethyl nitrite CH3CH2ONO in 70 % ethyl alcohol ) was followed by Adverse-Effectacute methemoglobinemia and severe anoxic metabolic acidosis in infant twins, Methylene blue administration reversed methemoglobinemia in both, but one twin died from the consequences of hypoxemia.
0.9997 Adverse-Effect The administration of " sweet spirits of nitre " ( Drug4 % ethyl nitrite CH3CH2ONO in 70 % ethyl alcohol ) was followed by acute methemoglobinemia and Adverse-Effectsevere anoxic metabolic acidosis in infant twins, Methylene blue administration reversed methemoglobinemia in both, but one twin died from the consequences of hypoxemia.
0.9995 Adverse-Effect The administration of " Drugsweet spirits of nitre " ( 4 % ethyl nitrite CH3CH2ONO in 70 % ethyl alcohol ) was followed by Adverse-Effectacute methemoglobinemia and severe anoxic metabolic acidosis in infant twins, Methylene blue administration reversed methemoglobinemia in both, but one twin died from the consequences of hypoxemia.
0.9987 Adverse-Effect The administration of " Drugsweet spirits of nitre " ( 4 % ethyl nitrite CH3CH2ONO in 70 % ethyl alcohol ) was followed by acute methemoglobinemia and Adverse-Effectsevere anoxic metabolic acidosis in infant twins, Methylene blue administration reversed methemoglobinemia in both, but one twin died from the consequences of hypoxemia.
0.9980 Adverse-Effect The administration of " sweet spirits of nitre " ( Drug4 % ethyl nitrite CH3CH2ONO in 70 % ethyl alcohol ) was followed by acute methemoglobinemia and severe anoxic metabolic acidosis in infant twins, Methylene blue administration reversed methemoglobinemia in both, but one twin Adverse-Effectdied from the consequences of hypoxemia.
0.9980 Adverse-Effect The administration of " Drugsweet spirits of nitre " ( 4 % ethyl nitrite CH3CH2ONO in 70 % ethyl alcohol ) was followed by acute methemoglobinemia and severe anoxic metabolic acidosis in infant twins, Methylene blue administration reversed methemoglobinemia in both, but one twin Adverse-Effectdied from the consequences of hypoxemia.
0.9946 Adverse-Effect The administration of " sweet spirits of nitre " ( Drug4 % ethyl nitrite CH3CH2ONO in 70 % ethyl alcohol ) was followed by acute methemoglobinemia and severe anoxic metabolic acidosis in infant twins, Methylene blue administration reversed methemoglobinemia in both, but one twin died from the consequences of Adverse-Effecthypoxemia .
0.9944 Adverse-Effect The administration of " Drugsweet spirits of nitre " ( 4 % ethyl nitrite CH3CH2ONO in 70 % ethyl alcohol ) was followed by acute methemoglobinemia and severe anoxic metabolic acidosis in infant twins, Methylene blue administration reversed methemoglobinemia in both, but one twin died from the consequences of Adverse-Effecthypoxemia .
0.9996 Adverse-Effect The administration of " sweet Drugspirits of nitre " ( 4 % ethyl nitrite CH3CH2ONO in 70 % ethyl alcohol ) was followed by Adverse-Effectacute methemoglobinemia and severe anoxic metabolic acidosis in infant twins, Methylene blue administration reversed methemoglobinemia in both, but one twin died from the consequences of hypoxemia.
0.9988 Adverse-Effect The administration of " sweet Drugspirits of nitre " ( 4 % ethyl nitrite CH3CH2ONO in 70 % ethyl alcohol ) was followed by acute methemoglobinemia and Adverse-Effectsevere anoxic metabolic acidosis in infant twins, Methylene blue administration reversed methemoglobinemia in both, but one twin died from the consequences of hypoxemia.
0.9982 Adverse-Effect The administration of " sweet Drugspirits of nitre " ( 4 % ethyl nitrite CH3CH2ONO in 70 % ethyl alcohol ) was followed by acute methemoglobinemia and severe anoxic metabolic acidosis in infant twins, Methylene blue administration reversed methemoglobinemia in both, but one twin Adverse-Effectdied from the consequences of hypoxemia.
0.9949 Adverse-Effect The administration of " sweet Drugspirits of nitre " ( 4 % ethyl nitrite CH3CH2ONO in 70 % ethyl alcohol ) was followed by acute methemoglobinemia and severe anoxic metabolic acidosis in infant twins, Methylene blue administration reversed methemoglobinemia in both, but one twin died from the consequences of Adverse-Effecthypoxemia .
Score Relation Text (Head - Tail)
0.9997 Adverse-Effect Although the literature on the use of Drugrisperidone in elderly patients with dementia consists largely of uncontrolled trials, case reports, and chart reviews, it appears that this agent is effective for managing agitation in this population and does so with a low frequency of Adverse-Effectextrapyramidal symptoms ( EPS ).
0.9995 Adverse-Effect Although the literature on the use of Drugrisperidone in elderly patients with dementia consists largely of uncontrolled trials, case reports, and chart reviews, it appears that this agent is effective for managing agitation in this population and does so with a low frequency of extrapyramidal symptoms ( Adverse-EffectEPS ).
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect Two patients with ovarian cancer who had received multiple courses of Drugcisplatin without complications experienced Adverse-Effecthypersensitivity reactions to cisplatin : one, involving intrahepatic artery infusion, manifested general erythema, dyspnea, and hypotension ; the other, involving intravenous infusion, manifested abdominal pain, general erythema, and fever.
0.9998 Adverse-Effect Two patients with ovarian cancer who had received multiple courses of cisplatin without complications experienced Adverse-Effecthypersensitivity reactions to Drugcisplatin : one, involving intrahepatic artery infusion, manifested general erythema, dyspnea, and hypotension ; the other, involving intravenous infusion, manifested abdominal pain, general erythema, and fever.
0.9984 Adverse-Effect Two patients with ovarian cancer who had received multiple courses of cisplatin without complications experienced hypersensitivity reactions to Drugcisplatin : one, involving intrahepatic artery infusion, manifested Adverse-Effectgeneral erythema , dyspnea, and hypotension ; the other, involving intravenous infusion, manifested abdominal pain, general erythema, and fever.
0.9964 Adverse-Effect Two patients with ovarian cancer who had received multiple courses of cisplatin without complications experienced hypersensitivity reactions to Drugcisplatin : one, involving intrahepatic artery infusion, manifested general erythema, Adverse-Effectdyspnea , and hypotension ; the other, involving intravenous infusion, manifested abdominal pain, general erythema, and fever.
0.9951 Adverse-Effect Two patients with ovarian cancer who had received multiple courses of cisplatin without complications experienced hypersensitivity reactions to Drugcisplatin : one, involving intrahepatic artery infusion, manifested general erythema, dyspnea, and Adverse-Effecthypotension ; the other, involving intravenous infusion, manifested abdominal pain, general erythema, and fever.
0.9916 Adverse-Effect Two patients with ovarian cancer who had received multiple courses of Drugcisplatin without complications experienced hypersensitivity reactions to cisplatin : one, involving intrahepatic artery infusion, manifested general erythema, Adverse-Effectdyspnea , and hypotension ; the other, involving intravenous infusion, manifested abdominal pain, general erythema, and fever.
0.9916 Adverse-Effect Two patients with ovarian cancer who had received multiple courses of cisplatin without complications experienced hypersensitivity reactions to Drugcisplatin : one, involving intrahepatic artery infusion, manifested general erythema, dyspnea, and hypotension ; the other, involving intravenous infusion, manifested Adverse-Effectabdominal pain , general erythema, and fever.
0.9907 Adverse-Effect Two patients with ovarian cancer who had received multiple courses of cisplatin without complications experienced hypersensitivity reactions to Drugcisplatin : one, involving intrahepatic artery infusion, manifested general erythema, dyspnea, and hypotension ; the other, involving intravenous infusion, manifested abdominal pain, general erythema, and Adverse-Effectfever .
0.9894 Adverse-Effect Two patients with ovarian cancer who had received multiple courses of Drugcisplatin without complications experienced hypersensitivity reactions to cisplatin : one, involving intrahepatic artery infusion, manifested general erythema, dyspnea, and Adverse-Effecthypotension ; the other, involving intravenous infusion, manifested abdominal pain, general erythema, and fever.
0.9857 Adverse-Effect Two patients with ovarian cancer who had received multiple courses of Drugcisplatin without complications experienced hypersensitivity reactions to cisplatin : one, involving intrahepatic artery infusion, manifested Adverse-Effectgeneral erythema , dyspnea, and hypotension ; the other, involving intravenous infusion, manifested abdominal pain, general erythema, and fever.
0.9852 Adverse-Effect Two patients with ovarian cancer who had received multiple courses of cisplatin without complications experienced hypersensitivity reactions to Drugcisplatin : one, involving intrahepatic artery infusion, manifested general erythema, dyspnea, and hypotension ; the other, involving intravenous infusion, manifested abdominal pain, Adverse-Effectgeneral erythema , and fever.
0.9839 Adverse-Effect Two patients with ovarian cancer who had received multiple courses of Drugcisplatin without complications experienced hypersensitivity reactions to cisplatin : one, involving intrahepatic artery infusion, manifested general erythema, dyspnea, and hypotension ; the other, involving intravenous infusion, manifested Adverse-Effectabdominal pain , general erythema, and fever.
0.9835 Adverse-Effect Two patients with ovarian cancer who had received multiple courses of Drugcisplatin without complications experienced hypersensitivity reactions to cisplatin : one, involving intrahepatic artery infusion, manifested general erythema, dyspnea, and hypotension ; the other, involving intravenous infusion, manifested abdominal pain, general erythema, and Adverse-Effectfever .
0.9733 Adverse-Effect Two patients with ovarian cancer who had received multiple courses of Drugcisplatin without complications experienced hypersensitivity reactions to cisplatin : one, involving intrahepatic artery infusion, manifested general erythema, dyspnea, and hypotension ; the other, involving intravenous infusion, manifested abdominal pain, Adverse-Effectgeneral erythema , and fever.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect We report 5 patients ( 3 patients with chronic hepatitis C treated with pegylated interferon alfa - 2b in association with oral ribavirin and two patients with chronic myelocytic leukemia ) who developed Adverse-Effectlocal cutaneous reactions at sites of injection after the administration of weekly subcutaneous injections of Drugpegylated interferon alfa - 2b at different doses.
0.9990 Adverse-Effect We report 5 patients ( 3 patients with chronic hepatitis C treated with pegylated interferon alfa - 2b in association with oral Drugribavirin and two patients with chronic myelocytic leukemia ) who developed Adverse-Effectlocal cutaneous reactions at sites of injection after the administration of weekly subcutaneous injections of pegylated interferon alfa - 2b at different doses.
0.9968 Adverse-Effect We report 5 patients ( 3 patients with chronic hepatitis C treated with Drugpegylated interferon alfa - 2b in association with oral ribavirin and two patients with chronic myelocytic leukemia ) who developed Adverse-Effectlocal cutaneous reactions at sites of injection after the administration of weekly subcutaneous injections of pegylated interferon alfa - 2b at different doses.
Score Relation Text (Head - Tail)
0.9995 Adverse-Effect Although this type of hyperpigmentation has been previously seen in patients with cancer who are receiving bleomycin, this is, to our knowledge, the first reported case of Drugbleomycin - induced Adverse-Effecthyperpigmentation in an AIDS patient and should be added to the growing list of cutaneous eruptions seen in these patients.
0.9953 Adverse-Effect Although this type of Adverse-Effecthyperpigmentation has been previously seen in patients with cancer who are receiving Drugbleomycin , this is, to our knowledge, the first reported case of bleomycin - induced hyperpigmentation in an AIDS patient and should be added to the growing list of cutaneous eruptions seen in these patients.
0.8172 Adverse-Effect Although this type of hyperpigmentation has been previously seen in patients with cancer who are receiving bleomycin, this is, to our knowledge, the first reported case of Drugbleomycin - induced hyperpigmentation in an AIDS patient and should be added to the growing list of Adverse-Effectcutaneous eruptions seen in these patients.
Score Relation Text (Head - Tail)
0.9997 Adverse-Effect Our report suggested that DrugCBDCA Adverse-Effecthypersensitivity was correlated with the total dose of previously administered platinum agents and that CBDCA should be excluded in patients who have received multiple platinum - based chemotherapy, even in platinum - sensitive cases, because CBDCA hypersensitivity can occur even with low - dose CBDCA administration.
0.9996 Adverse-Effect Our report suggested that CBDCA hypersensitivity was correlated with the total dose of previously administered platinum agents and that CBDCA should be excluded in patients who have received multiple platinum - based chemotherapy, even in platinum - sensitive cases, because DrugCBDCA Adverse-Effecthypersensitivity can occur even with low - dose CBDCA administration.
0.9995 Adverse-Effect Our report suggested that CBDCA hypersensitivity was correlated with the total dose of previously administered platinum agents and that CBDCA should be excluded in patients who have received multiple platinum - based chemotherapy, even in platinum - sensitive cases, because CBDCA Adverse-Effecthypersensitivity can occur even with low - dose DrugCBDCA administration.
0.5250 Adverse-Effect Our report suggested that CBDCA Adverse-Effecthypersensitivity was correlated with the total dose of previously administered platinum agents and that CBDCA should be excluded in patients who have received multiple platinum - based chemotherapy, even in platinum - sensitive cases, because DrugCBDCA hypersensitivity can occur even with low - dose CBDCA administration.
0.8084 Adverse-Effect Our report suggested that CBDCA hypersensitivity was correlated with the total dose of previously administered platinum agents and that DrugCBDCA should be excluded in patients who have received multiple platinum - based chemotherapy, even in platinum - sensitive cases, because CBDCA Adverse-Effecthypersensitivity can occur even with low - dose CBDCA administration.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This paper reports on a 6. 9 - year - old autistic male who developed repeated episodes of Adverse-Effectacute dystonic reactions associated with Drugpimozide administration at the doses of 0. 096 mg / kg / day and 0. 032 mg / kg / day and 32 hours following pimozide withdrawal, as well as during subsequent thioridazine administration.
0.9994 Adverse-Effect This paper reports on a 6. 9 - year - old autistic male who developed repeated episodes of Adverse-Effectacute dystonic reactions associated with pimozide administration at the doses of 0. 096 mg / kg / day and 0. 032 mg / kg / day and 32 hours following pimozide withdrawal, as well as during subsequent Drugthioridazine administration.
0.9992 Adverse-Effect This paper reports on a 6. 9 - year - old autistic male who developed repeated episodes of Adverse-Effectacute dystonic reactions associated with pimozide administration at the doses of 0. 096 mg / kg / day and 0. 032 mg / kg / day and 32 hours following Drugpimozide withdrawal, as well as during subsequent thioridazine administration.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect We have seen a case of terminal malignant melanoma in which clinical manifestations, indicative of Adverse-Effectanterior spinal artery syndrome , developed following the injection of 0. 3 ml of 10 % Drugphenol - glycerine into the cervical subarachnoid space at the C4 - - C5 level for the control of severe right arm pain.
0.9994 Adverse-Effect We have seen a case of Adverse-Effectterminal malignant melanoma in which clinical manifestations, indicative of anterior spinal artery syndrome, developed following the injection of 0. 3 ml of 10 % Drugphenol - glycerine into the cervical subarachnoid space at the C4 - - C5 level for the control of severe right arm pain.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Contrary to previous recommendations, our experience cautions against the further use of high - dose Drugcytarabine in patients who develop Adverse-EffectPPE , and is a timely reminder of the potential toxicity of this agent, which is now increasingly being used as first - line treatment in the management of haematologic malignancies.
Score Relation Text (Head - Tail)
Adverse-Effect Attempts were made to stop and then restart the Drugtheophylline therapy at progressively lower doses ; however, with each attempt, the patient's Adverse-Effectreaction to the drug became more toxic , with serum theophylline levels ranging between 99. 9 and 149. 9 micromol / L ( 18 and 27 microg / mL ).
Adverse-Effect Attempts were made to stop and then restart the theophylline therapy at progressively lower doses ; however, with each attempt, the patient's Adverse-Effectreaction to the drug became more toxic , with serum Drugtheophylline levels ranging between 99. 9 and 149. 9 micromol / L ( 18 and 27 microg / mL ).
Score Relation Text (Head - Tail)
0.9991 Adverse-Effect Since recent studies have reported no negative interactions with concurrent use, we here report three cases ( one case of a prolonged seizure, a serotonin syndrome and a Adverse-Effectfocal seizure ) of severe Druglithium - induced side effects while patients underwent ECT without complications and lithium serum levels were still subtherapeutic.
0.9990 Adverse-Effect Since recent studies have reported no negative interactions with concurrent use, we here report three cases ( one case of a Adverse-Effectprolonged seizure , a serotonin syndrome and a focal seizure ) of severe Druglithium - induced side effects while patients underwent ECT without complications and lithium serum levels were still subtherapeutic.
0.9990 Adverse-Effect Since recent studies have reported no negative interactions with concurrent use, we here report three cases ( one case of a prolonged seizure, a Adverse-Effectserotonin syndrome and a focal seizure ) of severe Druglithium - induced side effects while patients underwent ECT without complications and lithium serum levels were still subtherapeutic.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Eleven patients developed Adverse-Effectinfection requiring hospitalization while taking Drugleflunomide including : lower respiratory tract infections ( 3 ), cellulitis ( 2 ), disseminated herpes zoster ( 2 ), probable TB liver ( 1 ), abdominal sepsis ( 1 ), mycotic aneurysm ( 1 ) and gastroenteritis ( 1 ).
1.0000 Adverse-Effect Eleven patients developed infection requiring hospitalization while taking Drugleflunomide including : Adverse-Effectlower respiratory tract infections ( 3 ), cellulitis ( 2 ), disseminated herpes zoster ( 2 ), probable TB liver ( 1 ), abdominal sepsis ( 1 ), mycotic aneurysm ( 1 ) and gastroenteritis ( 1 ).
0.9999 Adverse-Effect Eleven patients developed infection requiring hospitalization while taking Drugleflunomide including : lower respiratory tract infections ( 3 ), cellulitis ( 2 ), Adverse-Effectdisseminated herpes zoster ( 2 ), probable TB liver ( 1 ), abdominal sepsis ( 1 ), mycotic aneurysm ( 1 ) and gastroenteritis ( 1 ).
0.9999 Adverse-Effect Eleven patients developed infection requiring hospitalization while taking Drugleflunomide including : lower respiratory tract infections ( 3 ), Adverse-Effectcellulitis ( 2 ), disseminated herpes zoster ( 2 ), probable TB liver ( 1 ), abdominal sepsis ( 1 ), mycotic aneurysm ( 1 ) and gastroenteritis ( 1 ).
0.9999 Adverse-Effect Eleven patients developed infection requiring hospitalization while taking Drugleflunomide including : lower respiratory tract infections ( 3 ), cellulitis ( 2 ), disseminated herpes zoster ( 2 ), probable TB liver ( 1 ), Adverse-Effectabdominal sepsis ( 1 ), mycotic aneurysm ( 1 ) and gastroenteritis ( 1 ).
0.9998 Adverse-Effect Eleven patients developed infection requiring hospitalization while taking Drugleflunomide including : lower respiratory tract infections ( 3 ), cellulitis ( 2 ), disseminated herpes zoster ( 2 ), probable TB liver ( 1 ), abdominal sepsis ( 1 ), Adverse-Effectmycotic aneurysm ( 1 ) and gastroenteritis ( 1 ).
0.9998 Adverse-Effect Eleven patients developed infection requiring hospitalization while taking Drugleflunomide including : lower respiratory tract infections ( 3 ), cellulitis ( 2 ), disseminated herpes zoster ( 2 ), probable Adverse-EffectTB liver ( 1 ), abdominal sepsis ( 1 ), mycotic aneurysm ( 1 ) and gastroenteritis ( 1 ).
0.9998 Adverse-Effect Eleven patients developed infection requiring hospitalization while taking Drugleflunomide including : lower respiratory tract infections ( 3 ), cellulitis ( 2 ), disseminated herpes zoster ( 2 ), probable TB liver ( 1 ), abdominal sepsis ( 1 ), mycotic aneurysm ( 1 ) and Adverse-Effectgastroenteritis ( 1 ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect During dose - finding studies for intravenous proton pump inhibitors omeprazole and pantoprazole, three of six young female volunteers receiving omeprazole and two young female volunteers receiving Drugpantoprazole developed Adverse-Effectperipheral edema within 8 hr when high doses of the proton pump inhibitors were applied by continuous infusion together with large volumes of fluid.
0.9981 Adverse-Effect During dose - finding studies for intravenous proton pump inhibitors omeprazole and pantoprazole, three of six young female volunteers receiving Drugomeprazole and two young female volunteers receiving pantoprazole developed Adverse-Effectperipheral edema within 8 hr when high doses of the proton pump inhibitors were applied by continuous infusion together with large volumes of fluid.
0.9971 Adverse-Effect During dose - finding studies for intravenous proton pump inhibitors omeprazole and Drugpantoprazole , three of six young female volunteers receiving omeprazole and two young female volunteers receiving pantoprazole developed Adverse-Effectperipheral edema within 8 hr when high doses of the proton pump inhibitors were applied by continuous infusion together with large volumes of fluid.
0.9967 Adverse-Effect During dose - finding studies for intravenous proton pump inhibitors Drugomeprazole and pantoprazole, three of six young female volunteers receiving omeprazole and two young female volunteers receiving pantoprazole developed Adverse-Effectperipheral edema within 8 hr when high doses of the proton pump inhibitors were applied by continuous infusion together with large volumes of fluid.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Only two case reports of adults with allergic contact dermatitis to this chemical exist in the literature, and we describe three more cases of children with recalcitrant atopic dermatitis found to have potential Adverse-Effectallergic contact dermatitis to Drugbisabolol - a component of the Aquaphor emollient they were using to treat their atopic dermatitis.
Score Relation Text (Head - Tail)
0.9987 Adverse-Effect We describe the infectious toxicities experienced by the first two patients in our institution treated with dexamethasone ( 10 mg / m ( 2 ) / day for 4 weeks with gradual tapering ) during induction according to the dexamethasone arm of BFM 2000 and review the relevant literature that suggests an increased risk of Adverse-Effectinfectious complications with Drugdexamethasone .
0.9954 Adverse-Effect We describe the Adverse-Effectinfectious toxicities experienced by the first two patients in our institution treated with Drugdexamethasone ( 10 mg / m ( 2 ) / day for 4 weeks with gradual tapering ) during induction according to the dexamethasone arm of BFM 2000 and review the relevant literature that suggests an increased risk of infectious complications with dexamethasone.
0.7104 Adverse-Effect We describe the Adverse-Effectinfectious toxicities experienced by the first two patients in our institution treated with dexamethasone ( 10 mg / m ( 2 ) / day for 4 weeks with gradual tapering ) during induction according to the Drugdexamethasone arm of BFM 2000 and review the relevant literature that suggests an increased risk of infectious complications with dexamethasone.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We report the case histories of identical twin brothers who developed concordant acute lymphoblastic leukemia at the age of 4 years and who later developed leukoencephalopathy and Adverse-Effecthydrocephalus related to central nervous system prophylaxis by, in the first case intrathecally administered Drugmethotrexate and, in the second by intrathecally administered methotrexate and cranial irradiation.
0.9999 Adverse-Effect We report the case histories of identical twin brothers who developed concordant acute lymphoblastic leukemia at the age of 4 years and who later developed Adverse-Effectleukoencephalopathy and hydrocephalus related to central nervous system prophylaxis by, in the first case intrathecally administered Drugmethotrexate and, in the second by intrathecally administered methotrexate and cranial irradiation.
0.9998 Adverse-Effect We report the case histories of identical twin brothers who developed concordant acute lymphoblastic leukemia at the age of 4 years and who later developed leukoencephalopathy and Adverse-Effecthydrocephalus related to central nervous system prophylaxis by, in the first case intrathecally administered methotrexate and, in the second by intrathecally administered Drugmethotrexate and cranial irradiation.
0.9997 Adverse-Effect We report the case histories of identical twin brothers who developed concordant acute lymphoblastic leukemia at the age of 4 years and who later developed Adverse-Effectleukoencephalopathy and hydrocephalus related to central nervous system prophylaxis by, in the first case intrathecally administered methotrexate and, in the second by intrathecally administered Drugmethotrexate and cranial irradiation.
1.0000 Adverse-Effect We report the case histories of identical twin brothers who developed concordant acute lymphoblastic leukemia at the age of 4 years and who later developed leukoencephalopathy and hydrocephalus related to Adverse-Effectcentral nervous system prophylaxis by, in the first case intrathecally administered Drugmethotrexate and, in the second by intrathecally administered methotrexate and cranial irradiation.
0.9999 Adverse-Effect We report the case histories of identical twin brothers who developed Adverse-Effectconcordant acute lymphoblastic leukemia at the age of 4 years and who later developed leukoencephalopathy and hydrocephalus related to central nervous system prophylaxis by, in the first case intrathecally administered Drugmethotrexate and, in the second by intrathecally administered methotrexate and cranial irradiation.
0.9998 Adverse-Effect We report the case histories of identical twin brothers who developed concordant acute lymphoblastic leukemia at the age of 4 years and who later developed leukoencephalopathy and hydrocephalus related to Adverse-Effectcentral nervous system prophylaxis by, in the first case intrathecally administered methotrexate and, in the second by intrathecally administered Drugmethotrexate and cranial irradiation.
0.9996 Adverse-Effect We report the case histories of identical twin brothers who developed Adverse-Effectconcordant acute lymphoblastic leukemia at the age of 4 years and who later developed leukoencephalopathy and hydrocephalus related to central nervous system prophylaxis by, in the first case intrathecally administered methotrexate and, in the second by intrathecally administered Drugmethotrexate and cranial irradiation.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CASE SUMMARY : A 65 - year - old patient chronically treated with the selective serotonin reuptake inhibitor ( SSRI ) Drugcitalopram developed Adverse-Effectconfusion , agitation, tachycardia, tremors, myoclonic jerks and unsteady gait, consistent with serotonin syndrome, following initiation of fentanyl, and all symptoms and signs resolved following discontinuation of fentanyl.
1.0000 Adverse-Effect CASE SUMMARY : A 65 - year - old patient chronically treated with the selective serotonin reuptake inhibitor ( SSRI ) citalopram developed confusion, agitation, tachycardia, tremors, myoclonic jerks and unsteady gait, consistent with Adverse-Effectserotonin syndrome , following initiation of Drugfentanyl , and all symptoms and signs resolved following discontinuation of fentanyl.
0.9999 Adverse-Effect CASE SUMMARY : A 65 - year - old patient chronically treated with the selective serotonin reuptake inhibitor ( SSRI ) Drugcitalopram developed confusion, Adverse-Effectagitation , tachycardia, tremors, myoclonic jerks and unsteady gait, consistent with serotonin syndrome, following initiation of fentanyl, and all symptoms and signs resolved following discontinuation of fentanyl.
0.9999 Adverse-Effect CASE SUMMARY : A 65 - year - old patient chronically treated with the selective serotonin reuptake inhibitor ( SSRI ) Drugcitalopram developed confusion, agitation, Adverse-Effecttachycardia , tremors, myoclonic jerks and unsteady gait, consistent with serotonin syndrome, following initiation of fentanyl, and all symptoms and signs resolved following discontinuation of fentanyl.
0.9998 Adverse-Effect CASE SUMMARY : A 65 - year - old patient chronically treated with the selective serotonin reuptake inhibitor ( SSRI ) Drugcitalopram developed confusion, agitation, tachycardia, tremors, Adverse-Effectmyoclonic jerks and unsteady gait, consistent with serotonin syndrome, following initiation of fentanyl, and all symptoms and signs resolved following discontinuation of fentanyl.
0.9998 Adverse-Effect CASE SUMMARY : A 65 - year - old patient chronically treated with the selective serotonin reuptake inhibitor ( SSRI ) Drugcitalopram developed confusion, agitation, tachycardia, Adverse-Effecttremors , myoclonic jerks and unsteady gait, consistent with serotonin syndrome, following initiation of fentanyl, and all symptoms and signs resolved following discontinuation of fentanyl.
0.9998 Adverse-Effect CASE SUMMARY : A 65 - year - old patient chronically treated with the selective serotonin reuptake inhibitor ( SSRI ) citalopram developed confusion, agitation, tachycardia, tremors, myoclonic jerks and Adverse-Effectunsteady gait , consistent with serotonin syndrome, following initiation of Drugfentanyl , and all symptoms and signs resolved following discontinuation of fentanyl.
0.9998 Adverse-Effect CASE SUMMARY : A 65 - year - old patient chronically treated with the selective serotonin reuptake inhibitor ( SSRI ) Drugcitalopram developed confusion, agitation, tachycardia, tremors, myoclonic jerks and Adverse-Effectunsteady gait , consistent with serotonin syndrome, following initiation of fentanyl, and all symptoms and signs resolved following discontinuation of fentanyl.
0.9997 Adverse-Effect CASE SUMMARY : A 65 - year - old patient chronically treated with the selective serotonin reuptake inhibitor ( SSRI ) citalopram developed confusion, agitation, tachycardia, tremors, Adverse-Effectmyoclonic jerks and unsteady gait, consistent with serotonin syndrome, following initiation of Drugfentanyl , and all symptoms and signs resolved following discontinuation of fentanyl.
0.9997 Adverse-Effect CASE SUMMARY : A 65 - year - old patient chronically treated with the selective serotonin reuptake inhibitor ( SSRI ) citalopram developed confusion, agitation, tachycardia, tremors, myoclonic jerks and unsteady gait, consistent with Adverse-Effectserotonin syndrome , following initiation of fentanyl, and all symptoms and signs resolved following discontinuation of Drugfentanyl .
0.9997 Adverse-Effect CASE SUMMARY : A 65 - year - old patient chronically treated with the selective serotonin reuptake inhibitor ( SSRI ) Drugcitalopram developed confusion, agitation, tachycardia, tremors, myoclonic jerks and unsteady gait, consistent with Adverse-Effectserotonin syndrome , following initiation of fentanyl, and all symptoms and signs resolved following discontinuation of fentanyl.
0.9997 Adverse-Effect CASE SUMMARY : A 65 - year - old patient chronically treated with the selective serotonin reuptake inhibitor ( SSRI ) citalopram developed confusion, agitation, tachycardia, Adverse-Effecttremors , myoclonic jerks and unsteady gait, consistent with serotonin syndrome, following initiation of Drugfentanyl , and all symptoms and signs resolved following discontinuation of fentanyl.
0.9997 Adverse-Effect CASE SUMMARY : A 65 - year - old patient chronically treated with the selective serotonin reuptake inhibitor ( SSRI ) citalopram developed confusion, Adverse-Effectagitation , tachycardia, tremors, myoclonic jerks and unsteady gait, consistent with serotonin syndrome, following initiation of Drugfentanyl , and all symptoms and signs resolved following discontinuation of fentanyl.
0.9997 Adverse-Effect CASE SUMMARY : A 65 - year - old patient chronically treated with the selective serotonin reuptake inhibitor ( SSRI ) citalopram developed confusion, agitation, Adverse-Effecttachycardia , tremors, myoclonic jerks and unsteady gait, consistent with serotonin syndrome, following initiation of Drugfentanyl , and all symptoms and signs resolved following discontinuation of fentanyl.
0.9995 Adverse-Effect CASE SUMMARY : A 65 - year - old patient chronically treated with the selective serotonin reuptake inhibitor ( SSRI ) citalopram developed Adverse-Effectconfusion , agitation, tachycardia, tremors, myoclonic jerks and unsteady gait, consistent with serotonin syndrome, following initiation of Drugfentanyl , and all symptoms and signs resolved following discontinuation of fentanyl.
0.9993 Adverse-Effect CASE SUMMARY : A 65 - year - old patient chronically treated with the selective serotonin reuptake inhibitor ( SSRI ) citalopram developed confusion, agitation, tachycardia, tremors, Adverse-Effectmyoclonic jerks and unsteady gait, consistent with serotonin syndrome, following initiation of fentanyl, and all symptoms and signs resolved following discontinuation of Drugfentanyl .
0.9992 Adverse-Effect CASE SUMMARY : A 65 - year - old patient chronically treated with the selective serotonin reuptake inhibitor ( SSRI ) citalopram developed confusion, agitation, tachycardia, tremors, myoclonic jerks and Adverse-Effectunsteady gait , consistent with serotonin syndrome, following initiation of fentanyl, and all symptoms and signs resolved following discontinuation of Drugfentanyl .
0.9991 Adverse-Effect CASE SUMMARY : A 65 - year - old patient chronically treated with the selective serotonin reuptake inhibitor ( SSRI ) citalopram developed confusion, Adverse-Effectagitation , tachycardia, tremors, myoclonic jerks and unsteady gait, consistent with serotonin syndrome, following initiation of fentanyl, and all symptoms and signs resolved following discontinuation of Drugfentanyl .
0.9991 Adverse-Effect CASE SUMMARY : A 65 - year - old patient chronically treated with the selective serotonin reuptake inhibitor ( SSRI ) citalopram developed confusion, agitation, tachycardia, Adverse-Effecttremors , myoclonic jerks and unsteady gait, consistent with serotonin syndrome, following initiation of fentanyl, and all symptoms and signs resolved following discontinuation of Drugfentanyl .
0.9991 Adverse-Effect CASE SUMMARY : A 65 - year - old patient chronically treated with the selective serotonin reuptake inhibitor ( SSRI ) citalopram developed confusion, agitation, Adverse-Effecttachycardia , tremors, myoclonic jerks and unsteady gait, consistent with serotonin syndrome, following initiation of fentanyl, and all symptoms and signs resolved following discontinuation of Drugfentanyl .
0.9987 Adverse-Effect CASE SUMMARY : A 65 - year - old patient chronically treated with the selective serotonin reuptake inhibitor ( SSRI ) citalopram developed Adverse-Effectconfusion , agitation, tachycardia, tremors, myoclonic jerks and unsteady gait, consistent with serotonin syndrome, following initiation of fentanyl, and all symptoms and signs resolved following discontinuation of Drugfentanyl .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We describe longitudinal diffusion - weighted MRI findings of Adverse-Effectsub - acute leukoencephalopathy following Drugmethotrexate therapy in a 24 - year - old man diagnosed with pre - B - cell acute lymphoblastic leukemia ( ALL ), presenting with right - sided paralysis and aphasia after second consolidation with intrathecal triple - drug therapy given intrathecally.
0.9998 Adverse-Effect We describe longitudinal diffusion - weighted MRI findings of sub - acute leukoencephalopathy following Drugmethotrexate therapy in a 24 - year - old man diagnosed with pre - B - cell acute lymphoblastic leukemia ( ALL ), presenting with right - sided paralysis and Adverse-Effectaphasia after second consolidation with intrathecal triple - drug therapy given intrathecally.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect This report describes an individual with mental retardation who experienced Adverse-Effectbehavioral exacerbation associated with Drugclonazepam prescribed at 2 mg / day ( 0. 02 mg / kg / day ) to treat aggression, self - injurious behavior, property destruction, and screaming, which was measured with a 15 - minute partial interval recording measurement method.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect In this article lithium is not discussed, although there are a number of concerns about Druglithium ' s potential Adverse-Effectteratogenicity , and it has been implicated in Epstein's anomaly, a congenital heart defect among infants born to women taking lithium ; as with other medications, however, the data have specific limitations.
0.9994 Adverse-Effect In this article lithium is not discussed, although there are a number of concerns about Druglithium ' s potential teratogenicity, and it has been implicated in Adverse-EffectEpstein's anomaly , a congenital heart defect among infants born to women taking lithium ; as with other medications, however, the data have specific limitations.
0.9992 Adverse-Effect In this article lithium is not discussed, although there are a number of concerns about lithium's potential teratogenicity, and it has been implicated in Adverse-EffectEpstein's anomaly , a congenital heart defect among infants born to women taking Druglithium ; as with other medications, however, the data have specific limitations.
0.9985 Adverse-Effect In this article lithium is not discussed, although there are a number of concerns about lithium's potential Adverse-Effectteratogenicity , and it has been implicated in Epstein's anomaly, a congenital heart defect among infants born to women taking Druglithium ; as with other medications, however, the data have specific limitations.
1.0000 Adverse-Effect In this article lithium is not discussed, although there are a number of concerns about lithium's potential teratogenicity, and it has been implicated in Epstein's anomaly, a Adverse-Effectcongenital heart defect among infants born to women taking Druglithium ; as with other medications, however, the data have specific limitations.
0.9992 Adverse-Effect In this article lithium is not discussed, although there are a number of concerns about Druglithium ' s potential teratogenicity, and it has been implicated in Epstein's anomaly, a Adverse-Effectcongenital heart defect among infants born to women taking lithium ; as with other medications, however, the data have specific limitations.
0.9990 Adverse-Effect In this article Druglithium is not discussed, although there are a number of concerns about lithium's potential Adverse-Effectteratogenicity , and it has been implicated in Epstein's anomaly, a congenital heart defect among infants born to women taking lithium ; as with other medications, however, the data have specific limitations.
0.9975 Adverse-Effect In this article Druglithium is not discussed, although there are a number of concerns about lithium's potential teratogenicity, and it has been implicated in Adverse-EffectEpstein's anomaly , a congenital heart defect among infants born to women taking lithium ; as with other medications, however, the data have specific limitations.
0.9971 Adverse-Effect In this article Druglithium is not discussed, although there are a number of concerns about lithium's potential teratogenicity, and it has been implicated in Epstein's anomaly, a Adverse-Effectcongenital heart defect among infants born to women taking lithium ; as with other medications, however, the data have specific limitations.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CASE SUMMARY : A 61 - year - old woman with no apparent risk factors for liver injury developed Adverse-Effectacute hepatitis one week after the final dose of a long - term course of pulse Drugitraconazole therapy ( 200 mg orally twice daily, 1 wk on, 3 wk off, for 24 wk ) for onychomycosis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Thirty - six patients with AL received, in a three - month period, 51 cycles of combined chemotherapy which included, in all of them, cytosine arabinoside ( DrugARA - C ) ; among them, along with myelosuppression, five experienced Adverse-Effectfever , infectious complications, gastrointestinal tract symptoms and severe myalgias.
0.9999 Adverse-Effect Thirty - six patients with AL received, in a three - month period, 51 cycles of combined chemotherapy which included, in all of them, cytosine arabinoside ( DrugARA - C ) ; among them, along with myelosuppression, five experienced fever, Adverse-Effectinfectious complications , gastrointestinal tract symptoms and severe myalgias.
0.9998 Adverse-Effect Thirty - six patients with AL received, in a three - month period, 51 cycles of combined chemotherapy which included, in all of them, Drugcytosine arabinoside ( ARA - C ) ; among them, along with myelosuppression, five experienced Adverse-Effectfever , infectious complications, gastrointestinal tract symptoms and severe myalgias.
0.9998 Adverse-Effect Thirty - six patients with AL received, in a three - month period, 51 cycles of combined chemotherapy which included, in all of them, cytosine arabinoside ( DrugARA - C ) ; among them, along with myelosuppression, five experienced fever, infectious complications, Adverse-Effectgastrointestinal tract symptoms and severe myalgias.
0.9997 Adverse-Effect Thirty - six patients with AL received, in a three - month period, 51 cycles of combined chemotherapy which included, in all of them, cytosine arabinoside ( DrugARA - C ) ; among them, along with myelosuppression, five experienced fever, infectious complications, gastrointestinal tract symptoms and Adverse-Effectsevere myalgias .
0.9995 Adverse-Effect Thirty - six patients with AL received, in a three - month period, 51 cycles of combined chemotherapy which included, in all of them, Drugcytosine arabinoside ( ARA - C ) ; among them, along with myelosuppression, five experienced fever, Adverse-Effectinfectious complications , gastrointestinal tract symptoms and severe myalgias.
0.9991 Adverse-Effect Thirty - six patients with AL received, in a three - month period, 51 cycles of combined chemotherapy which included, in all of them, Drugcytosine arabinoside ( ARA - C ) ; among them, along with myelosuppression, five experienced fever, infectious complications, Adverse-Effectgastrointestinal tract symptoms and severe myalgias.
0.9991 Adverse-Effect Thirty - six patients with AL received, in a three - month period, 51 cycles of combined chemotherapy which included, in all of them, Drugcytosine arabinoside ( ARA - C ) ; among them, along with myelosuppression, five experienced fever, infectious complications, gastrointestinal tract symptoms and Adverse-Effectsevere myalgias .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect 1. Adverse-EffectChanges in the plasma cortisol level were reported in a male patient with panic disorder during the period of low - dose Drugalprazolam treatment ( mean 0. 62 + / - 0. 15 mg / day ) compared with during the period of high - dose period ( mean 1. 08 + / - 0. 28 mg / day ).
Score Relation Text (Head - Tail)
0.9979 Adverse-Effect DISCUSSION : After exclusion of other causes, the onset of Adverse-Effectthrombocytopenia after administration of Druglansoprazole , the resolution of the adverse reaction after discontinuation of the drug, and the fact that no other medicines were introduced during this time frame lead us to believe that this was most likely an idiosyncratic thrombocytopenic response to lansoprazole.
0.9996 Adverse-Effect DISCUSSION : After exclusion of other causes, the onset of thrombocytopenia after administration of lansoprazole, the resolution of the adverse reaction after discontinuation of the drug, and the fact that no other medicines were introduced during this time frame lead us to believe that this was most likely an Adverse-Effectidiosyncratic thrombocytopenic response to Druglansoprazole .
Adverse-Effect DISCUSSION : After exclusion of other causes, the onset of thrombocytopenia after administration of lansoprazole, the resolution of the adverse reaction after discontinuation of the drug, and the fact that no other medicines were introduced during this time frame lead us to believe that this was most likely an idiosyncratic Adverse-Effectthrombocytopenic response to Druglansoprazole .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect In a single practice during the 21 years 1971 - 1991, the incidence of Adverse-Effectgestational diabetes in pregnancies in which Drugnorethisterone was prescribed was 32. 4 % ( 22 of 69 ) in comparison with 7. 1 % in pregnancies in which the women did not take norethisterone ( 137 of 1, 684 ) ( p < 0. 001 ).
0.9987 Adverse-Effect In a single practice during the 21 years 1971 - 1991, the incidence of Adverse-Effectgestational diabetes in pregnancies in which norethisterone was prescribed was 32. 4 % ( 22 of 69 ) in comparison with 7. 1 % in pregnancies in which the women did not take Drugnorethisterone ( 137 of 1, 684 ) ( p < 0. 001 ).
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect These findings are consistent with an immune - complex form of glomerulopathy in which gold is neither the antigen nor a hapten in the glomerular deposits, and they suggest the hypothesis that antibodies to tubular epithelial antigens induced by gold therapy may be a causative factor in the Adverse-Effectrenal disease associated with Druggold therapy in rheumatoid arthritis.
0.9999 Adverse-Effect These findings are consistent with an immune - complex form of glomerulopathy in which gold is neither the antigen nor a hapten in the glomerular deposits, and they suggest the hypothesis that antibodies to tubular epithelial antigens induced by Druggold therapy may be a causative factor in the Adverse-Effectrenal disease associated with gold therapy in rheumatoid arthritis.
0.8323 Adverse-Effect These findings are consistent with an immune - complex form of glomerulopathy in which Druggold is neither the antigen nor a hapten in the glomerular deposits, and they suggest the hypothesis that antibodies to tubular epithelial antigens induced by gold therapy may be a causative factor in the Adverse-Effectrenal disease associated with gold therapy in rheumatoid arthritis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect The latter form ( DrugMacrodantin ) is reported to engender less gastrointestinal intolerance but it can produce the same adverse effects as the conventional form - - liver damage, Adverse-Effectacute and chronic pulmonary reactions , peripheral neuropathy, blood dyscrasias and allergic reactions - - and does so just as rapidly and floridly ; one such case is reported here.
1.0000 Adverse-Effect The latter form ( DrugMacrodantin ) is reported to engender less gastrointestinal intolerance but it can produce the same adverse effects as the conventional form - - liver damage, acute and chronic pulmonary reactions, peripheral neuropathy, blood dyscrasias and Adverse-Effectallergic reactions - - and does so just as rapidly and floridly ; one such case is reported here.
1.0000 Adverse-Effect The latter form ( DrugMacrodantin ) is reported to engender less gastrointestinal intolerance but it can produce the same adverse effects as the conventional form - - liver damage, acute and chronic pulmonary reactions, Adverse-Effectperipheral neuropathy , blood dyscrasias and allergic reactions - - and does so just as rapidly and floridly ; one such case is reported here.
0.9999 Adverse-Effect The latter form ( DrugMacrodantin ) is reported to engender less gastrointestinal intolerance but it can produce the same adverse effects as the conventional form - - Adverse-Effectliver damage , acute and chronic pulmonary reactions, peripheral neuropathy, blood dyscrasias and allergic reactions - - and does so just as rapidly and floridly ; one such case is reported here.
0.9999 Adverse-Effect The latter form ( DrugMacrodantin ) is reported to engender less gastrointestinal intolerance but it can produce the same adverse effects as the conventional form - - liver damage, acute and chronic pulmonary reactions, peripheral neuropathy, Adverse-Effectblood dyscrasias and allergic reactions - - and does so just as rapidly and floridly ; one such case is reported here.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect RESULTS : After 4 - to 14 - month period of therapy with the combination of indapamide ( 2. 5 mg / day ) and fosinopril ( 10 mg / day ) in three patients and 6 - month period of monotherapy with Drugindapamide ( 2. 5 mg / day ) in one patient, glucose levels of all patients increased and achieve criteria of Adverse-Effectdiabetes diagnoses.
0.9997 Adverse-Effect RESULTS : After 4 - to 14 - month period of therapy with the combination of indapamide ( 2. 5 mg / day ) and Drugfosinopril ( 10 mg / day ) in three patients and 6 - month period of monotherapy with indapamide ( 2. 5 mg / day ) in one patient, glucose levels of all patients increased and achieve criteria of Adverse-Effectdiabetes diagnoses.
0.9997 Adverse-Effect RESULTS : After 4 - to 14 - month period of therapy with the combination of Drugindapamide ( 2. 5 mg / day ) and fosinopril ( 10 mg / day ) in three patients and 6 - month period of monotherapy with indapamide ( 2. 5 mg / day ) in one patient, glucose levels of all patients increased and achieve criteria of Adverse-Effectdiabetes diagnoses.
Score Relation Text (Head - Tail)
0.9994 Adverse-Effect This case demonstrates an occupational activity ( construction ) that has now become the dominant source of lead exposure for U. S. adults, the importance of a good occupational history to suspecting and making a diagnosis, the possible outcomes of chronic Druglead Adverse-Effectlead toxicity , and the importance of preventing further exposure and using proper methods to treat acute toxicity.
0.9942 Adverse-Effect This case demonstrates an occupational activity ( construction ) that has now become the dominant source of lead exposure for U. S. adults, the importance of a good occupational history to suspecting and making a diagnosis, the possible outcomes of chronic Druglead toxicity, and the importance of preventing further exposure and using proper methods to treat Adverse-Effectacute toxicity .
0.9823 Adverse-Effect This case demonstrates an occupational activity ( construction ) that has now become the dominant source of Druglead exposure for U. S. adults, the importance of a good occupational history to suspecting and making a diagnosis, the possible outcomes of chronic Adverse-Effectlead toxicity , and the importance of preventing further exposure and using proper methods to treat acute toxicity.
0.9681 Adverse-Effect This case demonstrates an occupational activity ( construction ) that has now become the dominant source of Druglead exposure for U. S. adults, the importance of a good occupational history to suspecting and making a diagnosis, the possible outcomes of chronic lead toxicity, and the importance of preventing further exposure and using proper methods to treat Adverse-Effectacute toxicity .
Score Relation Text (Head - Tail)
0.9997 Adverse-Effect By means of the in vitro heparin - induced platelet activation ( HIPA ) assay it was shown that standard heparin and the LMW heparins Fragmin and DrugFraxiparin ( Sanofi Labaz, Munich, FRG ), as well as the enoxaparine Clexane ( Nattermann, Cologne, FRG ), all induced Adverse-Effectplatelet activation with the patient's serum.
0.9997 Adverse-Effect By means of the in vitro heparin - induced platelet activation ( HIPA ) assay it was shown that standard heparin and the LMW heparins DrugFragmin and Fraxiparin ( Sanofi Labaz, Munich, FRG ), as well as the enoxaparine Clexane ( Nattermann, Cologne, FRG ), all induced Adverse-Effectplatelet activation with the patient's serum.
0.9992 Adverse-Effect By means of the in vitro heparin - induced platelet activation ( HIPA ) assay it was shown that standard Drugheparin and the LMW heparins Fragmin and Fraxiparin ( Sanofi Labaz, Munich, FRG ), as well as the enoxaparine Clexane ( Nattermann, Cologne, FRG ), all induced Adverse-Effectplatelet activation with the patient's serum.
1.0000 Adverse-Effect By means of the in vitro Drugheparin - induced Adverse-Effectplatelet activation ( HIPA ) assay it was shown that standard heparin and the LMW heparins Fragmin and Fraxiparin ( Sanofi Labaz, Munich, FRG ), as well as the enoxaparine Clexane ( Nattermann, Cologne, FRG ), all induced platelet activation with the patient's serum.
0.9997 Adverse-Effect By means of the in vitro heparin - induced platelet activation ( HIPA ) assay it was shown that standard heparin and the LMW heparins Fragmin and Fraxiparin ( Sanofi Labaz, Munich, FRG ), as well as the Drugenoxaparine Clexane ( Nattermann, Cologne, FRG ), all induced Adverse-Effectplatelet activation with the patient's serum.
0.9993 Adverse-Effect By means of the in vitro heparin - induced platelet activation ( HIPA ) assay it was shown that standard heparin and the LMW heparins Fragmin and Fraxiparin ( DrugSanofi Labaz , Munich, FRG ), as well as the enoxaparine Clexane ( Nattermann, Cologne, FRG ), all induced Adverse-Effectplatelet activation with the patient's serum.
0.9863 Adverse-Effect By means of the in vitro heparin - induced Adverse-Effectplatelet activation ( HIPA ) assay it was shown that standard Drugheparin and the LMW heparins Fragmin and Fraxiparin ( Sanofi Labaz, Munich, FRG ), as well as the enoxaparine Clexane ( Nattermann, Cologne, FRG ), all induced platelet activation with the patient's serum.
0.9862 Adverse-Effect By means of the in vitro Drugheparin - induced platelet activation ( HIPA ) assay it was shown that standard heparin and the LMW heparins Fragmin and Fraxiparin ( Sanofi Labaz, Munich, FRG ), as well as the enoxaparine Clexane ( Nattermann, Cologne, FRG ), all induced Adverse-Effectplatelet activation with the patient's serum.
0.9856 Adverse-Effect By means of the in vitro heparin - induced Adverse-Effectplatelet activation ( HIPA ) assay it was shown that standard heparin and the LMW heparins Fragmin and DrugFraxiparin ( Sanofi Labaz, Munich, FRG ), as well as the enoxaparine Clexane ( Nattermann, Cologne, FRG ), all induced platelet activation with the patient's serum.
0.9828 Adverse-Effect By means of the in vitro heparin - induced Adverse-Effectplatelet activation ( HIPA ) assay it was shown that standard heparin and the LMW heparins DrugFragmin and Fraxiparin ( Sanofi Labaz, Munich, FRG ), as well as the enoxaparine Clexane ( Nattermann, Cologne, FRG ), all induced platelet activation with the patient's serum.
0.9641 Adverse-Effect By means of the in vitro heparin - induced Adverse-Effectplatelet activation ( HIPA ) assay it was shown that standard heparin and the LMW heparins Fragmin and Fraxiparin ( Sanofi Labaz, Munich, FRG ), as well as the Drugenoxaparine Clexane ( Nattermann, Cologne, FRG ), all induced platelet activation with the patient's serum.
0.9625 Adverse-Effect By means of the in vitro heparin - induced Adverse-Effectplatelet activation ( HIPA ) assay it was shown that standard heparin and the LMW heparins Fragmin and Fraxiparin ( DrugSanofi Labaz , Munich, FRG ), as well as the enoxaparine Clexane ( Nattermann, Cologne, FRG ), all induced platelet activation with the patient's serum.
Adverse-Effect By means of the in vitro heparin - induced platelet activation ( HIPA ) assay it was shown that standard heparin and the LMW heparins Fragmin and Fraxiparin ( Sanofi Labaz, Munich, FRG ), as well as the enoxaparine DrugClexane ( Nattermann, Cologne, FRG ), all induced Adverse-Effectplatelet activation with the patient's serum.
Score Relation Text (Head - Tail)
0.9993 Adverse-Effect CASE PRESENTATION : Three cases of Leishmania infantum leishmaniasis in corticosteroid ( CS ) - treated patients are reported : an isolated lingual leishmaniasis in a farmer treated with CS for asthma, a severe visceral Drugleishmaniasis associated with Adverse-Effectcutaneous lesions in a woman with myasthenia gravis, and a visceral involvement after cutaneous leishmaniasis in a man receiving CS.
0.9858 Adverse-Effect CASE PRESENTATION : Three cases of Leishmania infantum leishmaniasis in corticosteroid ( DrugCS ) - treated patients are reported : an isolated lingual leishmaniasis in a farmer treated with CS for asthma, a severe visceral leishmaniasis associated with Adverse-Effectcutaneous lesions in a woman with myasthenia gravis, and a visceral involvement after cutaneous leishmaniasis in a man receiving CS.
0.9784 Adverse-Effect CASE PRESENTATION : Three cases of Leishmania infantum leishmaniasis in corticosteroid ( CS ) - treated patients are reported : an isolated lingual leishmaniasis in a farmer treated with DrugCS for asthma, a severe visceral leishmaniasis associated with Adverse-Effectcutaneous lesions in a woman with myasthenia gravis, and a visceral involvement after cutaneous leishmaniasis in a man receiving CS.
0.9762 Adverse-Effect CASE PRESENTATION : Three cases of Leishmania infantum leishmaniasis in corticosteroid ( CS ) - treated patients are reported : an isolated lingual leishmaniasis in a farmer treated with CS for asthma, a severe visceral leishmaniasis associated with cutaneous lesions in a woman with myasthenia gravis, and a Adverse-Effectvisceral involvement after cutaneous leishmaniasis in a man receiving DrugCS .
0.9724 Adverse-Effect CASE PRESENTATION : Three cases of Leishmania infantum leishmaniasis in Drugcorticosteroid ( CS ) - treated patients are reported : an isolated lingual leishmaniasis in a farmer treated with CS for asthma, a severe visceral leishmaniasis associated with Adverse-Effectcutaneous lesions in a woman with myasthenia gravis, and a visceral involvement after cutaneous leishmaniasis in a man receiving CS.
0.9530 Adverse-Effect CASE PRESENTATION : Three cases of Leishmania infantum leishmaniasis in corticosteroid ( CS ) - treated patients are reported : an isolated lingual leishmaniasis in a farmer treated with CS for asthma, a severe visceral leishmaniasis associated with cutaneous lesions in a woman with myasthenia gravis, and a Adverse-Effectvisceral involvement after cutaneous Drugleishmaniasis in a man receiving CS.
0.9413 Adverse-Effect CASE PRESENTATION : Three cases of Leishmania infantum leishmaniasis in corticosteroid ( CS ) - treated patients are reported : an isolated lingual Drugleishmaniasis in a farmer treated with CS for asthma, a severe visceral leishmaniasis associated with Adverse-Effectcutaneous lesions in a woman with myasthenia gravis, and a visceral involvement after cutaneous leishmaniasis in a man receiving CS.
0.9276 Adverse-Effect CASE PRESENTATION : Three cases of Leishmania infantum leishmaniasis in corticosteroid ( DrugCS ) - treated patients are reported : an isolated lingual leishmaniasis in a farmer treated with CS for asthma, a severe visceral leishmaniasis associated with cutaneous lesions in a woman with myasthenia gravis, and a Adverse-Effectvisceral involvement after cutaneous leishmaniasis in a man receiving CS.
0.8765 Adverse-Effect CASE PRESENTATION : Three cases of Leishmania infantum leishmaniasis in Drugcorticosteroid ( CS ) - treated patients are reported : an isolated lingual leishmaniasis in a farmer treated with CS for asthma, a severe visceral leishmaniasis associated with cutaneous lesions in a woman with myasthenia gravis, and a Adverse-Effectvisceral involvement after cutaneous leishmaniasis in a man receiving CS.
0.8750 Adverse-Effect CASE PRESENTATION : Three cases of Leishmania infantum leishmaniasis in corticosteroid ( CS ) - treated patients are reported : an isolated lingual leishmaniasis in a farmer treated with DrugCS for asthma, a severe visceral leishmaniasis associated with cutaneous lesions in a woman with myasthenia gravis, and a Adverse-Effectvisceral involvement after cutaneous leishmaniasis in a man receiving CS.
0.8479 Adverse-Effect CASE PRESENTATION : Three cases of Leishmania infantum leishmaniasis in corticosteroid ( CS ) - treated patients are reported : an isolated lingual leishmaniasis in a farmer treated with CS for asthma, a severe visceral leishmaniasis associated with Adverse-Effectcutaneous lesions in a woman with myasthenia gravis, and a visceral involvement after cutaneous leishmaniasis in a man receiving DrugCS .
0.7184 Adverse-Effect CASE PRESENTATION : Three cases of Leishmania infantum leishmaniasis in corticosteroid ( CS ) - treated patients are reported : an isolated lingual Drugleishmaniasis in a farmer treated with CS for asthma, a severe visceral leishmaniasis associated with cutaneous lesions in a woman with myasthenia gravis, and a Adverse-Effectvisceral involvement after cutaneous leishmaniasis in a man receiving CS.
0.7129 Adverse-Effect CASE PRESENTATION : Three cases of Leishmania infantum leishmaniasis in corticosteroid ( CS ) - treated patients are reported : an isolated lingual leishmaniasis in a farmer treated with CS for asthma, a severe visceral Drugleishmaniasis associated with cutaneous lesions in a woman with myasthenia gravis, and a Adverse-Effectvisceral involvement after cutaneous leishmaniasis in a man receiving CS.
0.6962 Adverse-Effect CASE PRESENTATION : Three cases of Leishmania infantum leishmaniasis in corticosteroid ( CS ) - treated patients are reported : an isolated lingual leishmaniasis in a farmer treated with CS for asthma, a severe visceral leishmaniasis associated with Adverse-Effectcutaneous lesions in a woman with myasthenia gravis, and a visceral involvement after cutaneous Drugleishmaniasis in a man receiving CS.
Adverse-Effect CASE PRESENTATION : Three cases of Leishmania infantum leishmaniasis in corticosteroid ( CS ) - treated patients are reported : an isolated lingual leishmaniasis in a farmer treated with CS for asthma, a severe visceral leishmaniasis associated with cutaneous lesions in a woman with myasthenia gravis, and a visceral involvement after Adverse-Effectcutaneous leishmaniasis in a man receiving DrugCS .
Adverse-Effect CASE PRESENTATION : Three cases of Leishmania infantum leishmaniasis in Drugcorticosteroid ( CS ) - treated patients are reported : an isolated Adverse-Effectlingual leishmaniasis in a farmer treated with CS for asthma, a severe visceral leishmaniasis associated with cutaneous lesions in a woman with myasthenia gravis, and a visceral involvement after cutaneous leishmaniasis in a man receiving CS.
Adverse-Effect CASE PRESENTATION : Three cases of Adverse-EffectLeishmania infantum leishmaniasis in corticosteroid ( CS ) - treated patients are reported : an isolated lingual leishmaniasis in a farmer treated with DrugCS for asthma, a severe visceral leishmaniasis associated with cutaneous lesions in a woman with myasthenia gravis, and a visceral involvement after cutaneous leishmaniasis in a man receiving CS.
Adverse-Effect CASE PRESENTATION : Three cases of Leishmania infantum leishmaniasis in corticosteroid ( CS ) - treated patients are reported : an isolated Adverse-Effectlingual leishmaniasis in a farmer treated with DrugCS for asthma, a severe visceral leishmaniasis associated with cutaneous lesions in a woman with myasthenia gravis, and a visceral involvement after cutaneous leishmaniasis in a man receiving CS.
Adverse-Effect CASE PRESENTATION : Three cases of Adverse-EffectLeishmania infantum leishmaniasis in Drugcorticosteroid ( CS ) - treated patients are reported : an isolated lingual leishmaniasis in a farmer treated with CS for asthma, a severe visceral leishmaniasis associated with cutaneous lesions in a woman with myasthenia gravis, and a visceral involvement after cutaneous leishmaniasis in a man receiving CS.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Although the existence of an acute pericarditis or an acute myocarditis as possible causes of the ST elevation can not be fully ruled out, the sudden onset, prominent magnitude, and brief duration of the ST elevation are perhaps more indicative of an acute ischemic event, possibly related to a Adverse-Effecttransient coronary vasoconstriction induced by the Drugdopamine infusion.
0.9998 Adverse-Effect Although the existence of an acute pericarditis or an acute myocarditis as possible causes of the ST elevation can not be fully ruled out, the sudden onset, prominent magnitude, and brief duration of the ST elevation are perhaps more indicative of an Adverse-Effectacute ischemic event , possibly related to a transient coronary vasoconstriction induced by the Drugdopamine infusion.
Adverse-Effect Although the existence of an acute pericarditis or an acute myocarditis as possible causes of the ST elevation can not be fully ruled out, the sudden onset, prominent magnitude, and brief duration of the ST elevation are perhaps more indicative of an acute ischemic event, possibly related to a transient Adverse-Effectcoronary vasoconstriction induced by the Drugdopamine infusion.
Score Relation Text (Head - Tail)
0.9861 Adverse-Effect Its overall Adverse-Effecttoxicity is considerably less compared to standard induction chemotherapy ; however, it is associated with a high incidence of a potentially fatal symptom complex referred to as " Drugretinoic acid syndrome. " This report describes a patient with APL who developed the syndrome a few weeks after initiating induction therapy with ATRA despite being treated for hyperleukocytosis.
0.9840 Adverse-Effect Its overall toxicity is considerably less compared to standard induction chemotherapy ; however, it is associated with a high incidence of a potentially fatal symptom complex referred to as " Drugretinoic acid Adverse-Effectretinoic acid syndrome . " This report describes a patient with APL who developed the syndrome a few weeks after initiating induction therapy with ATRA despite being treated for hyperleukocytosis.
0.9809 Adverse-Effect Its overall toxicity is considerably less compared to standard induction chemotherapy ; however, it is associated with a high incidence of a Adverse-Effectpotentially fatal symptom complex referred to as " Drugretinoic acid syndrome. " This report describes a patient with APL who developed the syndrome a few weeks after initiating induction therapy with ATRA despite being treated for hyperleukocytosis.
0.9776 Adverse-Effect Its overall toxicity is considerably less compared to standard induction chemotherapy ; however, it is associated with a high incidence of a potentially Adverse-Effectfatal symptom complex referred to as " Drugretinoic acid syndrome. " This report describes a patient with APL who developed the syndrome a few weeks after initiating induction therapy with ATRA despite being treated for hyperleukocytosis.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect We further used immunohistochemistry ( IHC ) to examine the relative role of platelet - derived growth factor - B ( PDGF - B ), insulin - like growth factor I ( IGF - I ), transforming growth factor - beta1 ( TGF - beta1 ) and cyclooxygenase - 2 ( COX - 2 ) in the pathogenesis of DrugBCNU - related Adverse-Effectpulmonary fibrosis .
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect CONCLUSION : The present findings suggest that : ( i ) amantadine probably exerts its anti - dyskinetic effect by acting on the " indirect " pathway ; ( ii ) the pathophysiological mechanisms of subthalamotomy induced dyskinesias may differ from those involved in DrugL - dopa induced Adverse-Effectdyskinesias ; ( iii ) dyskinesias induced by STN surgery resolve spontaneously as compensatory mechanisms develop.
0.9310 Adverse-Effect CONCLUSION : The present findings suggest that : ( i ) amantadine probably exerts its anti - dyskinetic effect by acting on the " indirect " pathway ; ( ii ) the pathophysiological mechanisms of subthalamotomy induced Adverse-Effectdyskinesias may differ from those involved in DrugL - dopa induced dyskinesias ; ( iii ) dyskinesias induced by STN surgery resolve spontaneously as compensatory mechanisms develop.
0.6383 Adverse-Effect CONCLUSION : The present findings suggest that : ( i ) Drugamantadine probably exerts its anti - dyskinetic effect by acting on the " indirect " pathway ; ( ii ) the pathophysiological mechanisms of subthalamotomy induced Adverse-Effectdyskinesias may differ from those involved in L - dopa induced dyskinesias ; ( iii ) dyskinesias induced by STN surgery resolve spontaneously as compensatory mechanisms develop.
0.6129 Adverse-Effect CONCLUSION : The present findings suggest that : ( i ) Drugamantadine probably exerts its anti - dyskinetic effect by acting on the " indirect " pathway ; ( ii ) the pathophysiological mechanisms of subthalamotomy induced dyskinesias may differ from those involved in L - dopa induced Adverse-Effectdyskinesias ; ( iii ) dyskinesias induced by STN surgery resolve spontaneously as compensatory mechanisms develop.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect A 10 - year - old boy with osteosarcoma and normal renal function manifested laboratory evidence of impending renal toxicity and extreme elevation of aspartate aminotrasferase and alanine aminotransferase within 2 hours after the completion of a 4 - hour infusion of high - dose methotrexate ( DrugMTX ) ( 12 g / m2 ), and went on to develop Adverse-Effectacute renal failure with life - threatening hyperkalemia 29 hours later.
0.9999 Adverse-Effect A 10 - year - old boy with osteosarcoma and normal renal function manifested laboratory evidence of impending renal toxicity and extreme Adverse-Effectelevation of aspartate aminotrasferase and alanine aminotransferase within 2 hours after the completion of a 4 - hour infusion of high - dose Drugmethotrexate ( MTX ) ( 12 g / m2 ), and went on to develop acute renal failure with life - threatening hyperkalemia 29 hours later.
0.9998 Adverse-Effect A 10 - year - old boy with osteosarcoma and normal renal function manifested laboratory evidence of impending Adverse-Effectrenal toxicity and extreme elevation of aspartate aminotrasferase and alanine aminotransferase within 2 hours after the completion of a 4 - hour infusion of high - dose Drugmethotrexate ( MTX ) ( 12 g / m2 ), and went on to develop acute renal failure with life - threatening hyperkalemia 29 hours later.
0.9998 Adverse-Effect A 10 - year - old boy with osteosarcoma and normal renal function manifested laboratory evidence of impending renal toxicity and extreme elevation of aspartate aminotrasferase and alanine aminotransferase within 2 hours after the completion of a 4 - hour infusion of high - dose Drugmethotrexate ( MTX ) ( 12 g / m2 ), and went on to develop Adverse-Effectacute renal failure with life - threatening hyperkalemia 29 hours later.
0.9997 Adverse-Effect A 10 - year - old boy with osteosarcoma and normal renal function manifested laboratory evidence of impending renal toxicity and extreme Adverse-Effectelevation of aspartate aminotrasferase and alanine aminotransferase within 2 hours after the completion of a 4 - hour infusion of high - dose methotrexate ( DrugMTX ) ( 12 g / m2 ), and went on to develop acute renal failure with life - threatening hyperkalemia 29 hours later.
0.9995 Adverse-Effect A 10 - year - old boy with osteosarcoma and normal renal function manifested laboratory evidence of impending Adverse-Effectrenal toxicity and extreme elevation of aspartate aminotrasferase and alanine aminotransferase within 2 hours after the completion of a 4 - hour infusion of high - dose methotrexate ( DrugMTX ) ( 12 g / m2 ), and went on to develop acute renal failure with life - threatening hyperkalemia 29 hours later.
0.9999 Adverse-Effect A 10 - year - old boy with osteosarcoma and normal renal function manifested laboratory evidence of Adverse-Effectimpending renal toxicity and extreme elevation of aspartate aminotrasferase and alanine aminotransferase within 2 hours after the completion of a 4 - hour infusion of high - dose Drugmethotrexate ( MTX ) ( 12 g / m2 ), and went on to develop acute renal failure with life - threatening hyperkalemia 29 hours later.
0.9998 Adverse-Effect A 10 - year - old boy with osteosarcoma and normal renal function manifested laboratory evidence of Adverse-Effectimpending renal toxicity and extreme elevation of aspartate aminotrasferase and alanine aminotransferase within 2 hours after the completion of a 4 - hour infusion of high - dose methotrexate ( DrugMTX ) ( 12 g / m2 ), and went on to develop acute renal failure with life - threatening hyperkalemia 29 hours later.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Although risk factors for DrugMTX - induced Adverse-Effectpulmonary toxicity are poorly understood, the presence in 3 out of 5 of our patients of pre - existing lung disease, represented by diffuse interstitial changes on chest X - ray, and mild bronchial asthma in two RA patients and by pulmonary silicosis in the patient with PsA may account for a predisposition to the development of MTX pneumonitis.
0.7323 Adverse-Effect Although risk factors for DrugMTX - induced pulmonary toxicity are poorly understood, the presence in 3 out of 5 of our patients of pre - existing lung disease, represented by diffuse interstitial changes on chest X - ray, and Adverse-Effectmild bronchial asthma in two RA patients and by pulmonary silicosis in the patient with PsA may account for a predisposition to the development of MTX pneumonitis.
0.5160 Adverse-Effect Although risk factors for DrugMTX - induced pulmonary toxicity are poorly understood, the presence in 3 out of 5 of our patients of pre - existing lung disease, represented by diffuse interstitial changes on chest X - ray, and mild bronchial asthma in two RA patients and by Adverse-Effectpulmonary silicosis in the patient with PsA may account for a predisposition to the development of MTX pneumonitis.
0.4001 Adverse-Effect Although risk factors for DrugMTX - induced pulmonary toxicity are poorly understood, the presence in 3 out of 5 of our patients of pre - existing lung disease, represented by diffuse interstitial changes on chest X - ray, and mild bronchial asthma in two RA patients and by pulmonary silicosis in the patient with PsA may account for a predisposition to the development of MTX Adverse-Effectpneumonitis .
Adverse-Effect Although risk factors for MTX - induced pulmonary toxicity are poorly understood, the presence in 3 out of 5 of our patients of pre - existing lung disease, represented by diffuse interstitial changes on chest X - ray, and mild bronchial asthma in two RA patients and by pulmonary silicosis in the patient with PsA may account for a predisposition to the development of DrugMTX Adverse-Effectpneumonitis .
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect A retrospective epidemiological study of deaths from Adverse-Effecthepatic angiosarcoma ( HAS ) in the U. S. showed that during 1964 - - 74 there were 168 such cases, of which 37 ( 22 % ) were associated with previously known causes ( Drugvinyl chloride ,'Thorotrast ', and inorganic arsenic ) and 4 ( 3. 1 % ) of the remaining 131 cases with the use of androgenic - anabolic steroids.
0.9998 Adverse-Effect A retrospective epidemiological study of deaths from Adverse-Effecthepatic angiosarcoma ( HAS ) in the U. S. showed that during 1964 - - 74 there were 168 such cases, of which 37 ( 22 % ) were associated with previously known causes ( vinyl chloride, ' DrugThorotrast ', and inorganic arsenic ) and 4 ( 3. 1 % ) of the remaining 131 cases with the use of androgenic - anabolic steroids.
0.9997 Adverse-Effect A retrospective epidemiological study of deaths from Adverse-Effecthepatic angiosarcoma ( HAS ) in the U. S. showed that during 1964 - - 74 there were 168 such cases, of which 37 ( 22 % ) were associated with previously known causes ( vinyl chloride,'Thorotrast ', and Druginorganic arsenic ) and 4 ( 3. 1 % ) of the remaining 131 cases with the use of androgenic - anabolic steroids.
0.9999 Adverse-Effect A retrospective epidemiological study of Adverse-Effectdeaths from hepatic angiosarcoma ( HAS ) in the U. S. showed that during 1964 - - 74 there were 168 such cases, of which 37 ( 22 % ) were associated with previously known causes ( Drugvinyl chloride ,'Thorotrast ', and inorganic arsenic ) and 4 ( 3. 1 % ) of the remaining 131 cases with the use of androgenic - anabolic steroids.
0.9999 Adverse-Effect A retrospective epidemiological study of Adverse-Effectdeaths from hepatic angiosarcoma ( HAS ) in the U. S. showed that during 1964 - - 74 there were 168 such cases, of which 37 ( 22 % ) were associated with previously known causes ( vinyl chloride, ' DrugThorotrast ', and inorganic arsenic ) and 4 ( 3. 1 % ) of the remaining 131 cases with the use of androgenic - anabolic steroids.
0.9998 Adverse-Effect A retrospective epidemiological study of Adverse-Effectdeaths from hepatic angiosarcoma ( HAS ) in the U. S. showed that during 1964 - - 74 there were 168 such cases, of which 37 ( 22 % ) were associated with previously known causes ( vinyl chloride,'Thorotrast ', and Druginorganic arsenic ) and 4 ( 3. 1 % ) of the remaining 131 cases with the use of androgenic - anabolic steroids.
0.9993 Adverse-Effect A retrospective epidemiological study of Adverse-Effectdeaths from hepatic angiosarcoma ( HAS ) in the U. S. showed that during 1964 - - 74 there were 168 such cases, of which 37 ( 22 % ) were associated with previously known causes ( vinyl chloride,'Thorotrast ', and inorganic arsenic ) and 4 ( 3. 1 % ) of the remaining 131 cases with the use of Drugandrogenic - anabolic steroids .
0.9988 Adverse-Effect A retrospective epidemiological study of deaths from Adverse-Effecthepatic angiosarcoma ( HAS ) in the U. S. showed that during 1964 - - 74 there were 168 such cases, of which 37 ( 22 % ) were associated with previously known causes ( vinyl chloride,'Thorotrast ', and inorganic arsenic ) and 4 ( 3. 1 % ) of the remaining 131 cases with the use of Drugandrogenic - anabolic steroids .
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect Although his renal function recovered completely with high - dose leucovorin, hemodialysis, charcoal hemoperfusion, and carboxypeptidase G2, we present this case to emphasize that signs of Adverse-Effectrenal toxicity may be present as early as 2 hours after the completion of a 4 - hour DrugMTX infusion, and to suggest that monitoring for MTX toxicity should perhaps begin within a few hours after the completion of 4 - hour MTX infusion.
0.9954 Adverse-Effect Although his renal function recovered completely with high - dose leucovorin, hemodialysis, charcoal hemoperfusion, and carboxypeptidase G2, we present this case to emphasize that signs of Adverse-Effectrenal toxicity may be present as early as 2 hours after the completion of a 4 - hour MTX infusion, and to suggest that monitoring for DrugMTX toxicity should perhaps begin within a few hours after the completion of 4 - hour MTX infusion.
0.9935 Adverse-Effect Although his renal function recovered completely with high - dose leucovorin, hemodialysis, charcoal hemoperfusion, and carboxypeptidase G2, we present this case to emphasize that signs of Adverse-Effectrenal toxicity may be present as early as 2 hours after the completion of a 4 - hour MTX infusion, and to suggest that monitoring for MTX toxicity should perhaps begin within a few hours after the completion of 4 - hour DrugMTX infusion.
0.9376 Adverse-Effect Although his renal function recovered completely with high - dose leucovorin, hemodialysis, charcoal hemoperfusion, and Drugcarboxypeptidase G2 , we present this case to emphasize that signs of Adverse-Effectrenal toxicity may be present as early as 2 hours after the completion of a 4 - hour MTX infusion, and to suggest that monitoring for MTX toxicity should perhaps begin within a few hours after the completion of 4 - hour MTX infusion.
Score Relation Text (Head - Tail)
0.9999 Adverse-Effect We suggest that Drugnicotinic acid was the cause of his Adverse-Effectliver disease , that this case is of particular note because of the rather short period of therapy before the onset of liver injury and the severity of the hepatic failure, and that the probable increased use of nicotinic acid for serum cholesterol control makes it especially important for physicians and their patients to be alert to the signs of hepatotoxicity.
0.9946 Adverse-Effect We suggest that nicotinic acid was the cause of his liver disease, that this case is of particular note because of the rather short period of therapy before the onset of liver injury and the severity of the hepatic failure, and that the probable increased use of Drugnicotinic acid for serum cholesterol control makes it especially important for physicians and their patients to be alert to the signs of Adverse-Effecthepatotoxicity .
0.9397 Adverse-Effect We suggest that nicotinic acid was the cause of his Adverse-Effectliver disease , that this case is of particular note because of the rather short period of therapy before the onset of liver injury and the severity of the hepatic failure, and that the probable increased use of Drugnicotinic acid for serum cholesterol control makes it especially important for physicians and their patients to be alert to the signs of hepatotoxicity.
0.9879 Adverse-Effect We suggest that Drugnicotinic acid was the cause of his liver disease, that this case is of particular note because of the rather short period of therapy before the onset of Adverse-Effectliver injury and the severity of the hepatic failure, and that the probable increased use of nicotinic acid for serum cholesterol control makes it especially important for physicians and their patients to be alert to the signs of hepatotoxicity.
0.9872 Adverse-Effect We suggest that Drugnicotinic acid was the cause of his liver disease, that this case is of particular note because of the rather short period of therapy before the onset of liver injury and the severity of the Adverse-Effecthepatic failure , and that the probable increased use of nicotinic acid for serum cholesterol control makes it especially important for physicians and their patients to be alert to the signs of hepatotoxicity.
0.9720 Adverse-Effect We suggest that nicotinic acid was the cause of his liver disease, that this case is of particular note because of the rather short period of therapy before the onset of liver injury and the severity of the Adverse-Effecthepatic failure , and that the probable increased use of Drugnicotinic acid for serum cholesterol control makes it especially important for physicians and their patients to be alert to the signs of hepatotoxicity.
0.8768 Adverse-Effect We suggest that nicotinic acid was the cause of his liver disease, that this case is of particular note because of the rather short period of therapy before the onset of Adverse-Effectliver injury and the severity of the hepatic failure, and that the probable increased use of Drugnicotinic acid for serum cholesterol control makes it especially important for physicians and their patients to be alert to the signs of hepatotoxicity.
0.4252 Adverse-Effect We suggest that Drugnicotinic acid was the cause of his liver disease, that this case is of particular note because of the rather short period of therapy before the onset of liver injury and the severity of the hepatic failure, and that the probable increased use of nicotinic acid for serum cholesterol control makes it especially important for physicians and their patients to be alert to the signs of Adverse-Effecthepatotoxicity .
Score Relation Text (Head - Tail)
0.9998 Adverse-Effect In case no. 2, the pathogenic mechanism seemed to be persistent light reaction preceded by systemic photoallergy, as he had taken mequitazine for 6 months, and there were strong positive photopatch test results with immediate erythema reaction, cross - reaction to promethazine, decreased MED to both UVA and UVB, and Adverse-Effectpersistence of the photosensitivity over a 3 - year follow - up period after discontinuation of the Drugmequitazine .
0.9994 Adverse-Effect In case no. 2, the pathogenic mechanism seemed to be persistent light reaction preceded by systemic photoallergy, as he had taken Drugmequitazine for 6 months, and there were strong positive photopatch test results with immediate Adverse-Effecterythema reaction, cross - reaction to promethazine, decreased MED to both UVA and UVB, and persistence of the photosensitivity over a 3 - year follow - up period after discontinuation of the mequitazine.
0.9989 Adverse-Effect In case no. 2, the pathogenic mechanism seemed to be persistent light reaction preceded by systemic photoallergy, as he had taken mequitazine for 6 months, and there were strong positive photopatch test results with immediate Adverse-Effecterythema reaction, cross - reaction to Drugpromethazine , decreased MED to both UVA and UVB, and persistence of the photosensitivity over a 3 - year follow - up period after discontinuation of the mequitazine.
0.9985 Adverse-Effect In case no. 2, the pathogenic mechanism seemed to be persistent light reaction preceded by systemic photoallergy, as he had taken mequitazine for 6 months, and there were strong positive photopatch test results with immediate erythema reaction, cross - reaction to promethazine, Adverse-Effectdecreased MED to both UVA and UVB , and persistence of the photosensitivity over a 3 - year follow - up period after discontinuation of the Drugmequitazine .
0.9985 Adverse-Effect In case no. 2, the pathogenic mechanism seemed to be persistent light reaction preceded by systemic photoallergy, as he had taken mequitazine for 6 months, and there were strong positive photopatch test results with immediate erythema reaction, cross - reaction to Drugpromethazine , decreased MED to both UVA and UVB, and Adverse-Effectpersistence of the photosensitivity over a 3 - year follow - up period after discontinuation of the mequitazine.
0.9972 Adverse-Effect In case no. 2, the pathogenic mechanism seemed to be persistent light reaction preceded by systemic photoallergy, as he had taken Drugmequitazine for 6 months, and there were strong positive photopatch test results with immediate erythema reaction, cross - reaction to promethazine, decreased MED to both UVA and UVB, and Adverse-Effectpersistence of the photosensitivity over a 3 - year follow - up period after discontinuation of the mequitazine.
0.9970 Adverse-Effect In case no. 2, the pathogenic mechanism seemed to be persistent light reaction preceded by systemic photoallergy, as he had taken Drugmequitazine for 6 months, and there were strong positive photopatch test results with immediate erythema reaction, cross - reaction to promethazine, Adverse-Effectdecreased MED to both UVA and UVB , and persistence of the photosensitivity over a 3 - year follow - up period after discontinuation of the mequitazine.
0.9969 Adverse-Effect In case no. 2, the pathogenic mechanism seemed to be persistent light reaction preceded by systemic photoallergy, as he had taken mequitazine for 6 months, and there were strong positive photopatch test results with immediate Adverse-Effecterythema reaction, cross - reaction to promethazine, decreased MED to both UVA and UVB, and persistence of the photosensitivity over a 3 - year follow - up period after discontinuation of the Drugmequitazine .
0.9962 Adverse-Effect In case no. 2, the pathogenic mechanism seemed to be persistent light reaction preceded by systemic photoallergy, as he had taken mequitazine for 6 months, and there were strong positive photopatch test results with immediate erythema reaction, cross - reaction to Drugpromethazine , Adverse-Effectdecreased MED to both UVA and UVB , and persistence of the photosensitivity over a 3 - year follow - up period after discontinuation of the mequitazine.
0.9998 Adverse-Effect In case no. 2, the pathogenic mechanism seemed to be persistent light reaction preceded by systemic photoallergy, as he had taken mequitazine for 6 months, and there were strong positive photopatch test results with immediate erythema reaction, Adverse-Effectcross - reaction to Drugpromethazine , decreased MED to both UVA and UVB, and persistence of the photosensitivity over a 3 - year follow - up period after discontinuation of the mequitazine.
0.9997 Adverse-Effect In case no. 2, the pathogenic mechanism seemed to be persistent light reaction preceded by systemic photoallergy, as he had taken Drugmequitazine for 6 months, and there were strong positive photopatch test results with immediate Adverse-Effecterythema reaction , cross - reaction to promethazine, decreased MED to both UVA and UVB, and persistence of the photosensitivity over a 3 - year follow - up period after discontinuation of the mequitazine.
0.9995 Adverse-Effect In case no. 2, the pathogenic mechanism seemed to be persistent light reaction preceded by systemic photoallergy, as he had taken mequitazine for 6 months, and there were strong positive photopatch test results with immediate Adverse-Effecterythema reaction , cross - reaction to Drugpromethazine , decreased MED to both UVA and UVB, and persistence of the photosensitivity over a 3 - year follow - up period after discontinuation of the mequitazine.
0.9986 Adverse-Effect In case no. 2, the pathogenic mechanism seemed to be persistent light reaction preceded by systemic photoallergy, as he had taken Drugmequitazine for 6 months, and there were strong positive photopatch test results with immediate erythema reaction, Adverse-Effectcross - reaction to promethazine, decreased MED to both UVA and UVB, and persistence of the photosensitivity over a 3 - year follow - up period after discontinuation of the mequitazine.
0.9986 Adverse-Effect In case no. 2, the pathogenic mechanism seemed to be persistent light reaction preceded by systemic photoallergy, as he had taken mequitazine for 6 months, and there were strong positive photopatch test results with immediate Adverse-Effecterythema reaction , cross - reaction to promethazine, decreased MED to both UVA and UVB, and persistence of the photosensitivity over a 3 - year follow - up period after discontinuation of the Drugmequitazine .
0.9965 Adverse-Effect In case no. 2, the pathogenic mechanism seemed to be persistent light reaction preceded by systemic photoallergy, as he had taken mequitazine for 6 months, and there were strong positive photopatch test results with immediate erythema reaction, Adverse-Effectcross - reaction to promethazine, decreased MED to both UVA and UVB, and persistence of the photosensitivity over a 3 - year follow - up period after discontinuation of the Drugmequitazine .
0.9963 Adverse-Effect In case no. 2, the pathogenic mechanism seemed to be persistent light reaction preceded by systemic photoallergy, as he had taken mequitazine for 6 months, and there were strong positive photopatch test results with immediate erythema reaction, cross - reaction to promethazine, Adverse-Effectdecreased MED to both UVA and UVB, and persistence of the photosensitivity over a 3 - year follow - up period after discontinuation of the Drugmequitazine .
0.9957 Adverse-Effect In case no. 2, the pathogenic mechanism seemed to be persistent light reaction preceded by systemic photoallergy, as he had taken mequitazine for 6 months, and there were strong positive photopatch test results with immediate erythema reaction, cross - reaction to promethazine, Adverse-Effectdecreased MED to both UVA and UVB, and persistence of the photosensitivity over a 3 - year follow - up period after discontinuation of the Drugmequitazine .
0.9930 Adverse-Effect In case no. 2, the pathogenic mechanism seemed to be persistent light reaction preceded by systemic photoallergy, as he had taken Drugmequitazine for 6 months, and there were strong positive photopatch test results with immediate erythema reaction, cross - reaction to promethazine, Adverse-Effectdecreased MED to both UVA and UVB, and persistence of the photosensitivity over a 3 - year follow - up period after discontinuation of the mequitazine.
0.9923 Adverse-Effect In case no. 2, the pathogenic mechanism seemed to be persistent light reaction preceded by systemic photoallergy, as he had taken Drugmequitazine for 6 months, and there were strong positive photopatch test results with immediate erythema reaction, cross - reaction to promethazine, Adverse-Effectdecreased MED to both UVA and UVB, and persistence of the photosensitivity over a 3 - year follow - up period after discontinuation of the mequitazine.
0.9911 Adverse-Effect In case no. 2, the pathogenic mechanism seemed to be persistent light reaction preceded by systemic photoallergy, as he had taken mequitazine for 6 months, and there were strong positive photopatch test results with immediate erythema reaction, cross - reaction to Drugpromethazine , Adverse-Effectdecreased MED to both UVA and UVB, and persistence of the photosensitivity over a 3 - year follow - up period after discontinuation of the mequitazine.
0.9902 Adverse-Effect In case no. 2, the pathogenic mechanism seemed to be persistent light reaction preceded by systemic photoallergy, as he had taken mequitazine for 6 months, and there were strong positive photopatch test results with immediate erythema reaction, cross - reaction to Drugpromethazine , Adverse-Effectdecreased MED to both UVA and UVB, and persistence of the photosensitivity over a 3 - year follow - up period after discontinuation of the mequitazine.
Adverse-Effect In case no. 2, the pathogenic mechanism seemed to be persistent light reaction preceded by systemic photoallergy, as he had taken Drugmequitazine for 6 months, and there were strong positive photopatch test results with immediate erythema reaction, Adverse-Effectcross - reaction to promethazine , decreased MED to both UVA and UVB, and persistence of the photosensitivity over a 3 - year follow - up period after discontinuation of the mequitazine.
Adverse-Effect In case no. 2, the pathogenic mechanism seemed to be persistent light reaction preceded by systemic photoallergy, as he had taken mequitazine for 6 months, and there were strong positive photopatch test results with immediate erythema reaction, Adverse-Effectcross - reaction to promethazine , decreased MED to both UVA and UVB, and persistence of the photosensitivity over a 3 - year follow - up period after discontinuation of the Drugmequitazine .
Adverse-Effect In case no. 2, the pathogenic mechanism seemed to be persistent light reaction preceded by systemic photoallergy, as he had taken mequitazine for 6 months, and there were strong positive photopatch test results with immediate erythema reaction, Adverse-Effectcross - reaction to promethazine Drugpromethazine , decreased MED to both UVA and UVB, and persistence of the photosensitivity over a 3 - year follow - up period after discontinuation of the mequitazine.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect Major points illustrated are, ( 1 ) occurrence of Adverse-EffectHIT with any dose or form of Drugheparin ; ( 2 ) misperceptions on the diagnostic criteria ; ( 3 ) correct ( thrombin inhibitors ) and incorrect ( platelet transfusions and warfarin ) management ; ( 4 ) influence of management strategy on clinical outcomes ; ( 5 ) severity of the syndrome ; and ( 6 ) potential for both anamnestic response to heparin and disappearance of HIT antibodies over time.
0.9655 Adverse-Effect Major points illustrated are, ( 1 ) occurrence of Adverse-EffectHIT with any dose or form of heparin ; ( 2 ) misperceptions on the diagnostic criteria ; ( 3 ) correct ( thrombin inhibitors ) and incorrect ( platelet transfusions and warfarin ) management ; ( 4 ) influence of management strategy on clinical outcomes ; ( 5 ) severity of the syndrome ; and ( 6 ) potential for both anamnestic response to Drugheparin and disappearance of HIT antibodies over time.
0.9587 Adverse-Effect Major points illustrated are, ( 1 ) occurrence of Adverse-EffectHIT with any dose or form of heparin ; ( 2 ) misperceptions on the diagnostic criteria ; ( 3 ) correct ( thrombin inhibitors ) and incorrect ( platelet transfusions and Drugwarfarin ) management ; ( 4 ) influence of management strategy on clinical outcomes ; ( 5 ) severity of the syndrome ; and ( 6 ) potential for both anamnestic response to heparin and disappearance of HIT antibodies over time.
Score Relation Text (Head - Tail)
1.0000 Adverse-Effect These findings mean that the effect of the MP pulse therapy on renal function depends on the clinical state of the patient and that renal deterioration after the pulse therapy may be more marked in patients who are more nephrotic and more impaired in renal function and suggest that increasing sodium and water retention during an MP therapy and the associated renal interstitial edema, proposed as one of the mechanisms of acute renal failure occurring in patients with minimal - change nephrotic syndrome, may be responsible for the DrugMP - induced Adverse-Effecttransient renal failure .
0.9934 Adverse-Effect These findings mean that the effect of the MP pulse therapy on renal function depends on the clinical state of the patient and that renal deterioration after the pulse therapy may be more marked in patients who are more nephrotic and more impaired in renal function and suggest that increasing sodium and water retention during an DrugMP therapy and the associated Adverse-Effectrenal interstitial edema , proposed as one of the mechanisms of acute renal failure occurring in patients with minimal - change nephrotic syndrome, may be responsible for the MP - induced transient renal failure.
0.9868 Adverse-Effect These findings mean that the effect of the MP pulse therapy on renal function depends on the clinical state of the patient and that renal deterioration after the pulse therapy may be more marked in patients who are more nephrotic and more impaired in renal function and suggest that increasing sodium and water retention during an MP therapy and the associated Adverse-Effectrenal interstitial edema , proposed as one of the mechanisms of acute renal failure occurring in patients with minimal - change nephrotic syndrome, may be responsible for the DrugMP - induced transient renal failure.
0.9720 Adverse-Effect These findings mean that the effect of the DrugMP pulse therapy on renal function depends on the clinical state of the patient and that renal deterioration after the pulse therapy may be more marked in patients who are more nephrotic and more impaired in renal function and suggest that increasing sodium and water retention during an MP therapy and the associated renal interstitial edema, proposed as one of the mechanisms of acute renal failure occurring in patients with minimal - change nephrotic syndrome, may be responsible for the MP - induced Adverse-Effecttransient renal failure .
0.9662 Adverse-Effect These findings mean that the effect of the DrugMP pulse therapy on renal function depends on the clinical state of the patient and that renal deterioration after the pulse therapy may be more marked in patients who are more nephrotic and more impaired in renal function and suggest that increasing sodium and water retention during an MP therapy and the associated Adverse-Effectrenal interstitial edema , proposed as one of the mechanisms of acute renal failure occurring in patients with minimal - change nephrotic syndrome, may be responsible for the MP - induced transient renal failure.
0.9527 Adverse-Effect These findings mean that the effect of the MP pulse therapy on renal function depends on the clinical state of the patient and that renal deterioration after the pulse therapy may be more marked in patients who are more nephrotic and more impaired in renal function and suggest that increasing sodium and water retention during an DrugMP therapy and the associated renal interstitial edema, proposed as one of the mechanisms of acute renal failure occurring in patients with minimal - change nephrotic syndrome, may be responsible for the MP - induced Adverse-Effecttransient renal failure .